FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Bresciani, FR
   Santi, L
   Beys-da-Silva, WO
   Berger, M
   Barcellos, VD
   Schripsema, J
   von Poser, GL
   Guimaraes, JA
   Vainstein, MH
AF Bresciani, Fernanda R.
   Santi, Lucelia
   Beys-da-Silva, Walter O.
   Berger, Markus
   Barcellos, Vanessa de A.
   Schripsema, Jan
   von Poser, Gilsane L.
   Guimaraes, Jorge A.
   Vainstein, Marilene H.
TI Antifungal activity ofAllamanda polyanthaseed extract and its iridoids
   promote morphological alterations inCryptococcusspp.
SO ARCHIV DER PHARMAZIE
LA English
DT Article
DE Allamanda polyantha; antifungal activity; Cryptococcusspp; plumieride;
   plumieridine
ID CRYPTOCOCCUS-NEOFORMANS; ALLAMANDA-CATHARTICA; NATURAL-PRODUCTS;
   POLYSACCHARIDE CAPSULE; CHEMICAL-SHIFTS; AMPHOTERICIN-B; CELL-DEATH;
   PLUMIERIDE; APOPTOSIS; GATTII
AB Cryptococcosis, caused byCryptococcusspp., is an invasive fungal infection of the central nervous system, associated with high mortality, affecting mainly immunocompromised patients. Due to the development of resistance to the current therapy, there is an urgent need for less toxic and more effective antifungal agents. In this study, we describe the antifungal activity againstCryptococcusspp. of an aqueous seed extract fromAllamanda polyantha(ASEAP) and two iridoids, plumieride and plumieridine, isolated from this extract with an antifungal activity. The capsule formation and the morphological alterations were evaluated using fluorescent microscopy. The cytotoxic activity was also investigated. The minimal inhibitory concentration (MIC) values of ASEAP forCryptococcus gattiiwere 70 and 36 mu g/ml (for the R265 and R272 strains, respectively) and 563 mu g/ml forCryptococcus neoformansH99. ASEAP inhibitedC. neoformansH99 capsule formation, an important virulence factor, and decreased the cell body size for both theC. gattiistrains. H99 cells also presented morphological alterations, with defects in bud detachment and nuclear fragmentation. Plumieride and plumieridine presented higher MIC values than ASEAP, indicating that other compounds might contribute to antifungal activity and/or that combination of the compounds results in a higher antifungal activity.
C1 [Bresciani, Fernanda R.; Santi, Lucelia; Beys-da-Silva, Walter O.; Barcellos, Vanessa de A.; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Postgrad Program Cellular & Mol Biol, Porto Alegre, RS, Brazil.
   [Santi, Lucelia; Beys-da-Silva, Walter O.; von Poser, Gilsane L.] Univ Fed Rio Grande do Sul, Fac Pharm, Ave Ipiranga 2752,Suit 508, Porto Alegre, RS, Brazil.
   [Santi, Lucelia; Beys-da-Silva, Walter O.; Berger, Markus; Guimaraes, Jorge A.] Clin Hosp Porto Alegre, Expt Res Ctr, Porto Alegre, RS, Brazil.
   [Schripsema, Jan] State Univ North Fluminense Darcy Ribeiro, Metabol Grp, Rio De Janeiro, Brazil.
RP Santi, L (corresponding author), Univ Fed Rio Grande do Sul, Fac Pharm, Ave Ipiranga 2752,Suit 508, Porto Alegre, RS, Brazil.
EM lucelia.santi@ufrgs.br
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES
FX Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq);
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
CR Abdel-Kader MS, 1997, J NAT PROD, V60, P1294, DOI 10.1021/np970253e
   ABE F, 1984, CHEM PHARM BULL, V32, P2947
   ADAM G, 1979, PHYTOCHEMISTRY, V18, P1399, DOI 10.1016/0031-9422(79)83035-6
   Almeida B, 2008, BBA-MOL CELL RES, V1783, P1436, DOI 10.1016/j.bbamcr.2008.01.005
   Amin S, 2004, MICROBIOL-SGM, V150, P1937, DOI 10.1099/mic.0.26830-0
   Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06
   Baker LG, 2009, EUKARYOT CELL, V8, P1692, DOI 10.1128/EC.00227-09
   Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005
   Bonomini TJ, 2017, REGUL TOXICOL PHARM, V91, P9, DOI 10.1016/j.yrtph.2017.10.005
   Casadevall A, 2019, VIRULENCE, V10, P822, DOI 10.1080/21505594.2018.1431087
   CHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912
   Clinical and Laboratory Standards Institute (CLSI), 2002, M27A2 CLSI
   COPPEN JJW, 1983, PHYTOCHEMISTRY, V22, P125, DOI 10.1016/S0031-9422(00)80071-0
   Dannaoui E, 2006, ANTIMICROB AGENTS CH, V50, P2464, DOI 10.1128/AAC.01520-05
   Di Santo R, 2010, NAT PROD REP, V27, P1084, DOI 10.1039/b914961a
   Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753
   Gomez-Lopez A, 2008, CLIN MICROBIOL INFEC, V14, P727, DOI 10.1111/j.1469-0691.2008.02021.x
   Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v
   Hao BH, 2013, ANTIMICROB AGENTS CH, V57, P326, DOI 10.1128/AAC.01366-12
   Hwang B, 2011, BIOCHEM BIOPH RES CO, V408, P89, DOI 10.1016/j.bbrc.2011.03.125
   Idnurm A, 2005, NAT REV MICROBIOL, V3, P753, DOI 10.1038/nrmicro1245
   Khan ZU, 2009, INT J ANTIMICROB AG, V33, P559, DOI 10.1016/j.ijantimicag.2008.11.007
   Kmetzsch L, 2011, MOL MICROBIOL, V81, P206, DOI 10.1111/j.1365-2958.2011.07686.x
   Koch I, 2015, LISTA ESPECIES FLORA
   Kontoyiannis DP, 2002, LANCET, V359, P1135, DOI 10.1016/S0140-6736(02)08162-X
   Krishnarao TV, 1997, ANTIMICROB AGENTS CH, V41, P1957, DOI 10.1128/AAC.41.9.1957
   Kwon-Chung KJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00357-16
   Kwon-Chung KJ, 2015, J FUNGI, V1, P154, DOI 10.3390/jof1020154
   Malheiros A, 1997, QUIM NOVA, V20, P457, DOI 10.1590/S0100-40421997000500002
   Mone M., 2014, Archives of Phytopathology and Plant Protection, V47, P1311, DOI 10.1080/03235408.2013.840103
   Mpoza E, 2018, MED MYCOL CASE REP, V19, P30, DOI 10.1016/j.mmcr.2017.11.004
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Newman DJ, 2000, NAT PROD REP, V17, P215, DOI 10.1039/a902202c
   O'Meara TR, 2012, CLIN MICROBIOL REV, V25, P387, DOI 10.1128/CMR.00001-12
   Petricevich VL, 2019, MOLECULES, V24, DOI 10.3390/molecules24071238
   Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444
   Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100
   Ramsdale M, 2008, BBA-MOL CELL RES, V1783, P1369, DOI 10.1016/j.bbamcr.2008.01.021
   Rodero L, 2003, ANTIMICROB AGENTS CH, V47, P3653, DOI 10.1128/AAC.47.11.3653-3656.2003
   Rodrigues ML, 2008, EUKARYOT CELL, V7, P602, DOI 10.1128/EC.00307-07
   Roe CC, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00499-17, 10.1128/msphere.00499-17]
   Saleem M, 2011, J ASIAN NAT PROD RES, V13, P1122, DOI 10.1080/10286020.2011.618452
   SCHLIEMANN W, 1982, PHYTOCHEMISTRY, V21, P1438, DOI 10.1016/0031-9422(82)80160-X
   Shourian M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00066
   Singh J, 2017, INT IMMUNOPHARMACOL, V48, P203, DOI 10.1016/j.intimp.2017.05.009
   Tiwari TN, 2002, PHYTOTHER RES, V16, P393, DOI 10.1002/ptr.967
   Tsirilakis K, 2012, MYCOPATHOLOGIA, V173, P83, DOI 10.1007/s11046-011-9483-x
   Vu K, 2018, MED MYCOL, V56, P857, DOI 10.1093/mmy/myx135
   Williamson PR, 2017, LANCET INFECT DIS, V17, P790, DOI 10.1016/S1473-3099(17)30245-1
   YAMAUCHI T, 1981, CHEM PHARM BULL, V29, P3051
   Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003
   Zaragoza O, 2006, MOL MICROBIOL, V59, P67, DOI 10.1111/j.1365-2958.2005.04928.x
   Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68
   Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0
NR 54
TC 1
Z9 1
U1 2
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0365-6233
EI 1521-4184
J9 ARCH PHARM
JI Arch. Pharm.
PD OCT
PY 2020
VL 353
IS 10
AR e2000133
DI 10.1002/ardp.202000133
EA JUL 2020
PG 9
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA NZ4XB
UT WOS:000546038000001
PM 32638423
DA 2020-11-24
ER

PT J
AU Ayres, LS
   Berger, M
   Durli, ICLD
   Kuhl, CP
   Terraciano, PB
   Garcez, TNA
   dos Santos, BG
   Guimaraes, JA
   Passos, EP
   Cirne-Lima, EO
AF Ayres, Laura Silveira
   Berger, Markus
   Lima de Oliveira Durli, Isabel Cirne
   Kuhl, Cristiana Palma
   Terraciano, Paula Barros
   Alves Garcez, Tuane Nerissa
   dos Santos, Bruna Gomes
   Guimaraes, Jorge Almeida
   Passos, Eduardo Pandolfi
   Cirne-Lima, Elizabeth Obino
TI Kallikrein-kinin system and oxidative stress in cisplatin-induced
   ovarian toxicity
SO REPRODUCTIVE TOXICOLOGY
LA English
DT Article
DE Cisplatin; Chemotherapy; Inflammatory cytokines; Ovarian toxicity;
   Bradykinin
ID B-2 RECEPTOR; NITRIC-OXIDE; EXPRESSION; BRADYKININ; CANCER;
   CHEMOTHERAPY; FERTILITY; OVULATION; INJURY; CELLS
AB Kallikrein-kinin system (KKS) is involved in vascular reactivity and inflammatory response to cytotoxic drugs. Since cisplatin is a widely used chemotherapy and its cytotoxic mechanism can trigger inflammation and oxidative damage, in this work we evaluated the role of KKS in an animal model of cisplatin-induced ovarian toxicity. Biomarkers of ovarian stem cells, activity of KKS, inflammation and oxidative damage were measured in ovarian tissue of C57BL/6 female mice treated with vehicle or cisplatin (2.5 mg/kg). Cisplatin group presented greater number of atretic follicles, and lower numbers of antral and total viable follicles. Ki67, DDX4 and OCT-4 markers were similar between groups. Cisplatin triggered plasma and ovarian tissue kallikrein generation; and increased expression of bradykinin receptors B1 and B2. Neutrophil and macrophage infiltration markers increased. Superoxide anion generation also increased, while reduced glutathione levels decreased. These results suggest that KKS is activated and contributes to ovarian injury during cisplatin treatment.
C1 [Ayres, Laura Silveira; Lima de Oliveira Durli, Isabel Cirne; Kuhl, Cristiana Palma; Terraciano, Paula Barros; dos Santos, Bruna Gomes; Passos, Eduardo Pandolfi; Cirne-Lima, Elizabeth Obino] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Lab Embriol & Diferenciacao Celular, Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
   [Berger, Markus; Guimaraes, Jorge Almeida] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Lab Bioquim Farmacol, Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
   [Alves Garcez, Tuane Nerissa] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Unidade Expt Anim, Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
   [Ayres, Laura Silveira; Berger, Markus; Lima de Oliveira Durli, Isabel Cirne; Kuhl, Cristiana Palma; Terraciano, Paula Barros; Passos, Eduardo Pandolfi; Cirne-Lima, Elizabeth Obino] Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Ciencias Saude Ginecol & Obstet, Ramiro Barcelos 2400, BR-90035003 Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Av Bento Goncalves 9500,Campus Vale Bldg 43421, BR-91501970 Porto Alegre, RS, Brazil.
RP Ayres, LS (corresponding author), Hosp Clin Porto Alegre, Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
EM laura.ayres@gmail.com; markusoliveira@hcpa.edu.br;
   belcirnelima@hotmail.com; crisakuhl@gmail.com;
   paulaterraciano@gmail.com; tgarcez@hcpa.ufrgs.br; bgsantos@hcpa.edu.br;
   jguimaraes14@gmail.com; epassos@hcpa.ufrgs.br; cirnelima@hcpa.edu.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministerio
   da Educacao, Brazil (CAPES-MEC) Projetos Conjuntos de Pesquisa em Drug
   Discovery [41/2014]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Ministerio da Ciencia e Tecnologia, Brazil (Chamada
   Universal MCTI/CNPq) [01/2016, 309371/2011-2, 28/2018, 422347/2018-3];
   Fundo de Incentivo a Pesquisa e Eventos (FIPE-HCPA) at Hospital de
   Clinicas de Porto Alegre [19-0001, 17-0420]
FX This work was supported by funding and fellowships from the following
   Brazilian Agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, Ministerio da Educacao, Brazil (CAPES-MEC) Projetos Conjuntos
   de Pesquisa em Drug Discovery, Edital No 41/2014); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Ministerio da Ciencia e
   Tecnologia, Brazil (Chamada Universal MCTI/CNPq No 01/2016, Grant
   309371/2011-2 and MCTI/CNPq No 28/2018, Grant 422347/2018-3), Fundo de
   Incentivo a Pesquisa e Eventos (FIPE-HCPA, GPPG Grant no 19-0001 and
   17-0420) at Hospital de Clinicas de Porto Alegre. The sponsors were not
   involved in study design; in the collection, analysis and interpretation
   of data; in the writing of the report; and in the decision to submit the
   article for publication.
CR ALEXANDER MH, 1988, J NUTR, V118, P883
   ALMULLA A, 2018, OPEN J OBSTET GYNECO, V8, P85
   Anderson RA, 2015, LANCET DIABETES ENDO, V3, P556, DOI 10.1016/S2213-8587(15)00039-X
   Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x
   Basini G, 2015, REPRODUCTION, V150, pR1, DOI 10.1530/REP-14-0524
   Brann D.W., 2002, BMC PHYSL, V2, P1, DOI [10.1186/1472-6793-2-1, DOI 10.1186/1472-6793-2-1]
   Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012
   Ceschin Álvaro Pigatto, 2004, Acta Cir. Bras., V19, P27, DOI 10.1590/S0102-86502004000100004
   Chow EJ, 2016, LANCET ONCOL, V17, P567, DOI 10.1016/S1470-2045(16)00086-3
   Diedrich K, 2011, REPROD BIOMED ONLINE, V22, P232, DOI 10.1016/j.rbmo.2010.11.001
   Estrela GR, 2014, INT IMMUNOPHARMACOL, V22, P115, DOI 10.1016/j.intimp.2014.06.025
   Estrela GR, 2014, J MOL MED, V92, P399, DOI 10.1007/s00109-013-1116-z
   Faure C, 2014, ANTIOXID REDOX SIGN, V21, P565, DOI 10.1089/ars.2014.5831
   Goldman JM, 2007, BIRTH DEFECTS RES B, V80, P84, DOI 10.1002/bdrb.20106
   Holland AM, 2001, J ENDOCRINOL, V170, P243, DOI 10.1677/joe.0.1700243
   Ilha GF, 2011, PEPTIDES, V32, P2122, DOI 10.1016/j.peptides.2011.08.028
   Jensen AK, 2017, J ASSIST REPROD GEN, V34, P324, DOI 10.1007/s10815-016-0843-9
   Kayashima Y, 2012, CURR OPIN NEPHROL HY, V21, P92, DOI 10.1097/MNH.0b013e32834d54b1
   Khedr NF, 2015, EXP BIOL MED, V240, P1682, DOI 10.1177/1535370215576304
   Kihara T, 2000, BIOL REPROD, V62, P1160, DOI 10.1095/biolreprod62.5.1160
   Luyckx V, 2014, FERTIL STERIL, V101, P1149, DOI 10.1016/j.fertnstert.2013.12.025
   Mahajan Nalini, 2015, J Hum Reprod Sci, V8, P3, DOI 10.4103/0974-1208.153119
   McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200
   Ohkura R, 2003, ZOOL SCI, V20, P847, DOI 10.2108/zsj.20.847
   Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826
   Plendl J, 2002, BIOL CHEM, V383, P1917, DOI 10.1515/BC.2002.215
   Ramesh G, 2002, J CLIN INVEST, V110, P835, DOI 10.1172/JCI200215606
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   Renne T, 2012, SEMIN IMMUNOPATHOL, V34, P31, DOI 10.1007/s00281-011-0288-2
   Sawhney P, 2005, J ANDROL, V26, P136
   Sriraman K, 2015, REPROD SCI, V22, P884, DOI 10.1177/1933719115576727
   Szturz P, 2017, ONCOLOGIST, V22, P1056, DOI 10.1634/theoncologist.2017-0015
   Talbot S, 2011, PEPTIDES, V32, P1447, DOI 10.1016/j.peptides.2011.05.005
   Tilly JL, 2009, BIOL REPROD, V80, P2, DOI 10.1095/biolreprod.108.069088
   YOSHIMURA Y, 1988, ENDOCRINOLOGY, V122, P2540, DOI 10.1210/endo-122-6-2540
NR 35
TC 0
Z9 0
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0890-6238
J9 REPROD TOXICOL
JI Reprod. Toxicol.
PD APR
PY 2020
VL 93
BP 1
EP 9
DI 10.1016/j.reprotox.2019.12.002
PG 9
WC Reproductive Biology; Toxicology
SC Reproductive Biology; Toxicology
GA LG1PC
UT WOS:000527880700001
PM 31874189
DA 2020-11-24
ER

PT J
AU Beys-da-Silva, WO
   Quincozes-Santos, A
   Tureta, EF
   Rosa, RL
   Berger, M
   Bobermin, LD
   Souza, DO
   Guimaraes, JA
   Santi, L
AF Beys-da-Silva, Walter O.
   Quincozes-Santos, Andre
   Tureta, Emanuela F.
   Rosa, Rafael L.
   Berger, Markus
   Bobermin, Larissa D.
   Souza, Diogo O.
   Guimaraes, Jorge A.
   Santi, Lucelia
TI Association between Zika virus and future neurological diseases
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Zika virus; Brain diseases; Infection; Outbreak; Brazil
ID RESPONSES
C1 [Beys-da-Silva, Walter O.; Tureta, Emanuela F.; Rosa, Rafael L.; Santi, Lucelia] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.
   [Beys-da-Silva, Walter O.; Rosa, Rafael L.; Berger, Markus; Guimaraes, Jorge A.; Santi, Lucelia] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
   [Quincozes-Santos, Andre; Bobermin, Larissa D.; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br
RI Quincozes-Santos, Andre/AAO-2714-2020; Beys-da-Silva, Walter
   O/M-3760-2018; Santi, Lucelia/AAB-8349-2020; Berger, Markus/U-7682-2019;
   Santi, Lucelia/AAK-9527-2020; Souza, Diogo/J-8894-2014
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Santi,
   Lucelia/0000-0002-5698-7006; Berger, Markus/0000-0001-7670-2584; Souza,
   Diogo/0000-0002-4322-0404; Quincozes-Santos, Andre/0000-0001-8611-4890
FU Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)CAPES;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440763/2016-9]
FX The authors would like to thank the Brazilian funding agencies
   Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   and the funding provided by the Edital
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/, project #440763/2016-9 for
   supporting the ZIKA Taskforce.
CR Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x
   Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118
   Davis AC, 2016, HANDBOOK ON PERSONALIZED LEARNING FOR STATES, DISTRICTS, AND SCHOOLS, P37
   Dehhaghi M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00466
   Delpech JC, 2019, TRENDS NEUROSCI, V42, P361, DOI 10.1016/j.tins.2019.02.007
   Farah R, 2018, BIOMED J, V41, P63, DOI 10.1016/j.bj.2018.03.004
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Peltier DC, 2013, J VIROL, V87, P1821, DOI 10.1128/JVI.02858-12
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Rappaport Noa, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0124s47
   Rosa RL, 2020, J NEUROVIROL, V26, P77, DOI 10.1007/s13365-019-00799-y
   Schipper HM, 2019, PROG NEUROBIOL, V172, P40, DOI 10.1016/j.pneurobio.2018.06.008
   Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wang MD, 2017, NEUROTOXICOLOGY, V61, P101, DOI 10.1016/j.neuro.2016.06.015
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2020
VL 409
AR 116617
DI 10.1016/j.jns.2019.116617
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KO3DU
UT WOS:000515428900037
PM 31835212
DA 2020-11-24
ER

PT J
AU Rosa, RL
   Santi, L
   Berger, M
   Tureta, EF
   Quincozes-Santos, A
   Souza, DO
   Guimaraes, JA
   Beys-da-Silva, WO
AF Rosa, Rafael L.
   Santi, Lucelia
   Berger, Markus
   Tureta, Emanuela F.
   Quincozes-Santos, Andre
   Souza, Diogo O.
   Guimaraes, Jorge A.
   Beys-da-Silva, Walter O.
TI ZIKAVID-Zika virus infection database: a new platform to analyze the
   molecular impact of Zika virus infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Database; Host; Strains
ID RESOURCE; CELLS
AB The recent outbreak of Zika virus (ZIKV) in Brazil and other countries globally demonstrated the relevance of ZIKV studies. During and after this outbreak, there was an intense increase in scientific production on ZIKV infections, especially toward alterations promoted by the infection and related to clinical outcomes. Considering this massive amount of new data, mainly thousands of genes and proteins whose expression is impacted by ZIKV infection, the ZIKA Virus Infection Database (ZIKAVID) was created. ZIKAVID is an online database that comprises all genes or proteins, and associated information, for which expression was experimentally measured and found to be altered after ZIKV infection. The database, available at , contains 16,984 entries of gene expression measurements from a total of 7348 genes. It allows users to easily perform searches for different experimental hosts (cell lines, tissues, and animal models), ZIKV strains (African, Asian, and Brazilian), and target molecules (messenger RNA [mRNA] and protein), among others, used in differential expression studies regarding ZIKV infection. In this way, the ZIKAVID will serve as an additional and important resource to improve the characterization of the molecular impact and pathogenesis associated with ZIKV infection.
C1 [Rosa, Rafael L.; Santi, Lucelia; Tureta, Emanuela F.; Beys-da-Silva, Walter O.] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.
   [Rosa, Rafael L.; Santi, Lucelia; Berger, Markus; Guimaraes, Jorge A.; Beys-da-Silva, Walter O.] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
   [Quincozes-Santos, Andre; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.; Beys-da-Silva, WO (corresponding author), Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Santi, Lucelia/AAB-8349-2020;
   Santi, Lucelia/AAK-9527-2020; Quincozes-Santos, Andre/AAO-2714-2020;
   Berger, Markus/U-7682-2019; Souza, Diogo/J-8894-2014
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Santi,
   Lucelia/0000-0002-5698-7006; Berger, Markus/0000-0001-7670-2584;
   Quincozes-Santos, Andre/0000-0001-8611-4890; Souza,
   Diogo/0000-0002-4322-0404
CR Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guirimand T, 2015, NUCLEIC ACIDS RES, V43, pD583, DOI 10.1093/nar/gku1121
   Gurumayum S, 2018, VIROLOGY, V514, P203, DOI 10.1016/j.virol.2017.11.007
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Hu T, 2019, VIROL SIN, V34, P1, DOI 10.1007/s12250-018-0078-2
   Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901
   Jiang X, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01067
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mishra A, 2017, INT REV IMMUNOL, V36, P89, DOI 10.1080/08830185.2017.1291640
   Mitchell RD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102104
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Papanikolaou NL, 2015, METHODS, V74, P47, DOI 10.1016/j.ymeth.2014.10.026
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Przybyla P, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw145
   Pylro VS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004817
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
NR 38
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD FEB
PY 2020
VL 26
IS 1
BP 77
EP 83
DI 10.1007/s13365-019-00799-y
PG 7
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KU0BZ
UT WOS:000519378600010
PM 31512145
DA 2020-11-24
ER

PT J
AU Paranhos-Neto, FP
   Neto, LV
   Madeira, M
   Moraes, AB
   Mendonca, LMC
   Lima, ICB
   Chagas, CLR
   Lira, DA
   Spitz, JF
   Guimaraes, JAM
   Duarte, MEL
   Farias, MLF
AF Paranhos-Neto, F. P.
   Vieira Neto, L.
   Madeira, M.
   Moraes, A. B.
   Mendonca, L. M. C.
   Lima, I. C. B.
   Chagas, C. L. R.
   Lira, D. A.
   Spitz, J. F.
   Guimaraes, J. A. M.
   Duarte, M. E. L.
   Farias, M. L. F.
TI Vitamin D deficiency is associated with cortical bone loss and fractures
   in the elderly
SO EUROPEAN JOURNAL OF ENDOCRINOLOGY
LA English
DT Article
ID 25-HYDROXYVITAMIN D LEVELS; POSTMENOPAUSAL WOMEN; PRIMARY
   HYPERPARATHYROIDISM; MINERAL DENSITY; HR-PQCT; MICROARCHITECTURE;
   POROSITY; TURNOVER; ARCHITECTURE; POPULATION
AB Introduction: The role of vitamin D on bone microarchitecture and fragility is not clear.
   Objective: To investigate whether vitamin D deficiency (25(OH)D <20 ng/mL) increases cortical bone loss and the severity of fractures.
   Design: Cross-sectional study of 287 elderly women with at least one prevalent low-impact fracture.
   Methods: Biochemistry, X-rays to identify vertebral fractures (VFs) and to confirm non-vertebral fractures (NonVFs), and high-resolution peripheral quantitative computed tomography (HR-pQCT) to evaluate bone microstructure.
   Results: Serum 25(OH)D levels were associated with body mass index (BMI: r= -0.161, P = 0.006), PTH (r= -0.165; P= 0.005), CTX (r= -0.119; P= 0.043) and vBMD at cortical bone (Dcomp: r= 0.132; P= 0.033) and entire bone (D100: r= 0.162 P= 0.009) at the distal radius, but not at the tibia. Age and PTH levels were potential confounding variables, but in the multiple linear regressions only BMI (95% CI: 0.11-4.16; P <0.01), 25(OH)D (95% CI: -0.007 to 1.70; P= 0.05) and CTX (95% CI: -149.04 to 21.80; P < 0.01) predicted Dcomp, while BMI (95% CI: 1.13-4.18; P < 0.01) and 25(OH)D (95% CI: 0.24-1.52; P < 0.01) predicted D100. NonVFs predominated in patients with 25(OH)D <20 ng/mL (P = 0.013). Logistic regression analysis showed a decrease in the likelihood of presenting grade 2-3 VFs/NonVFs for every increase in 25(OH)D (OR = 0.962, 95% CI: 0.940-0.984; P = 0.001), BMI (OR = 0.932, 95% CI: 0.885-0.981; P= 0.007) and D100 at radius (OR = 0.994, 95% CI: 0.990-0.998; P = 0.005).
   Conclusion: In elderly patients with prevalent fractures, vitamin D deficiency was associated with cortical bone loss and severity of fractures.
C1 [Paranhos-Neto, F. P.; Vieira Neto, L.; Madeira, M.; Moraes, A. B.; Farias, M. L. F.] Univ Fed Rio de Janeiro, Div Endocrinol, Clementino Fraga Filho Univ Hosp, Rio de Janeiro, RJ, Brazil.
   [Mendonca, L. M. C.] Univ Fed Rio de Janeiro, Div Reumathol, Clementino Fraga Filho Univ Hosp, Rio de Janeiro, RJ, Brazil.
   [Lima, I. C. B.] Univ Fed Rio de Janeiro, Program Nucl Engn, COPPE, Rio de Janeiro, RJ, Brazil.
   [Chagas, C. L. R.; Lira, D. A.; Spitz, J. F.; Guimaraes, J. A. M.; Duarte, M. E. L.] Natl Inst Orthoped & Traumatol, Res Div, Rio De Janeiro, RJ, Brazil.
RP Paranhos-Neto, FP (corresponding author), Univ Fed Rio de Janeiro, Div Endocrinol, Clementino Fraga Filho Univ Hosp, Rio de Janeiro, RJ, Brazil.
EM francisco.paranhos@hotmail.com
FU Funding Authority for Studies and Projects (FINEP), Ministry of Science
   and Technology of Brazil [01.08.0647-00]; Brazilian National Council for
   Scientific and Technological Development (CNPq), Ministry of Science and
   Technology of BrazilNational Council for Scientific and Technological
   Development (CNPq) [141704/2014-4]
FX This work was supported by Funding Authority for Studies and Projects
   (FINEP), Ministry of Science and Technology of Brazil (grant number
   01.08.0647-00, 2012); and Brazilian National Council for Scientific and
   Technological Development (CNPq), Ministry of Science and Technology of
   Brazil (grant number 141704/2014-4).
CR Ahmed LA, 2015, OSTEOPOROSIS INT, V26, P2137, DOI 10.1007/s00198-015-3118-x
   Alvarenga JC, 2017, OSTEOPOROSIS INT, V28, P1335, DOI 10.1007/s00198-016-3876-0
   Araujo MC, 2014, PUBLIC HEALTH NUTR, V17, P2740, DOI 10.1017/S1368980013003005
   Bandeira F, 2010, ARQ BRAS ENDOCRINOL, V54, P227, DOI 10.1590/S0004-27302010000200020
   Bislev LS, 2019, CALCIFIED TISSUE INT, V104, P160, DOI [10.1007/s00223-018-0481-6, 10.1007/s00223-018-]
   Bjornerem A, 2018, J BONE MINER RES, V33, P598, DOI 10.1002/jbmr.3333
   Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258
   Boutroy S, 2016, J BONE MINER RES, V31, P1158, DOI 10.1002/jbmr.2796
   Boyd SK, 2015, OSTEOPOROSIS INT, V26, P2375, DOI 10.1007/s00198-015-3110-5
   Burghardt AJ, 2010, J CLIN ENDOCR METAB, V95, P5045, DOI 10.1210/jc.2010-0226
   Charopoulos I, 2006, J CLIN ENDOCR METAB, V91, P1748, DOI 10.1210/jc.2005-2102
   Cohen A, 2010, OSTEOPOROSIS INT, V21, P263, DOI 10.1007/s00198-009-0945-7
   Ensrud KE, 2009, J CLIN ENDOCR METAB, V94, P2773, DOI 10.1210/jc.2008-2786
   Garnero P, 1996, J BONE MINER RES, V11, P337, DOI 10.1002/jbmr.5650110307
   GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477
   LIPS P, 2019, EUROPEAN J ENDOCRINO, V180, P23, DOI DOI 10.1530/EJE-18-0736
   Lv QB, 2017, ONCOTARGET, V8, P39849, DOI 10.18632/oncotarget.16337
   Madeira E, 2014, BONE, V59, P89, DOI 10.1016/j.bone.2013.11.004
   Moreira ML, 2018, J CLIN DENSITOM, V21, P91, DOI 10.1016/j.jocd.2017.01.008
   Murad MH, 2011, J CLIN ENDOCR METAB, V96, P2997, DOI 10.1210/jc.2011-1193
   PARISIEN M, 1990, J CLIN ENDOCR METAB, V70, P930, DOI 10.1210/jcem-70-4-930
   Passeri G, 2003, J CLIN ENDOCR METAB, V88, P5109, DOI 10.1210/jc.2003-030515
   Pinheiro MM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-6
   Rejnmark L, 2011, CALCIFIED TISSUE INT, V88, P238, DOI 10.1007/s00223-010-9454-0
   Ritzel H, 1997, J BONE MINER RES, V12, P89, DOI 10.1359/jbmr.1997.12.1.89
   Rodbro LL, 2018, OSTEOPOROSIS INT, V29, P2211, DOI 10.1007/s00198-018-4602-x
   Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704
   Sahota O, 2004, BONE, V35, P312, DOI 10.1016/j.bone.2004.02.003
   Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886
   Sakuma M, 2006, OSTEOPOROSIS INT, V17, P1608, DOI 10.1007/s00198-006-0167-1
   Sakuma M, 2011, J ORTHOP SCI, V16, P418, DOI 10.1007/s00776-011-0089-4
   Schneider DL, 2006, CURR OPIN ENDOCRINOL, V13, P483, DOI [10.1097/MED.0b013e328010ab20, DOI 10.1097/MED.0B013E328010AB20]
   Shanbhogue VV, 2016, EUR J ENDOCRINOL, V174, P115, DOI 10.1530/EJE-15-0860
   Sornay-Rendu E, 2009, OSTEOPOROSIS INT, V20, P1291, DOI 10.1007/s00198-009-1008-9
   Sornay-Rendu E, 2017, J BONE MINER RES, V32, P1243, DOI 10.1002/jbmr.3105
   Sornay-Rendu E, 2009, J BONE MINER RES, V24, P737, DOI [10.1359/JBMR.081223, 10.1359/jbmr.081223]
   Stein EM, 2013, J BONE MINER RES, V28, P1029, DOI 10.1002/jbmr.1841
   Sundh D, 2016, J INTERN MED, V280, P496, DOI 10.1111/joim.12514
   Vestergaard P, 2009, CALCIFIED TISSUE INT, V84, P103, DOI 10.1007/s00223-008-9198-2
   Vilayphiou N, 2016, BONE, V83, P233, DOI 10.1016/j.bone.2015.10.012
   Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690
   Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0
NR 46
TC 0
Z9 0
U1 0
U2 1
PU BIOSCIENTIFICA LTD
PI BRISTOL
PA STARLING HOUSE, 1600 BRISTOL PARKWAY N, BRISTOL, ENGLAND
SN 0804-4643
EI 1479-683X
J9 EUR J ENDOCRINOL
JI Eur. J. Endocrinol.
PD NOV
PY 2019
VL 181
IS 5
BP 509
EP 517
DI 10.1530/EJE-19-0197
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA JS4CK
UT WOS:000500254600016
PM 31484162
OA Bronze
DA 2020-11-24
ER

PT J
AU Rosa, RL
   Berger, M
   Santi, L
   Driemeier, D
   Terraciano, PB
   Campos, AR
   Guimaraes, JA
   Vainstein, MH
   Yates, II
   Beys-da-Silva, WO
AF Rosa, Rafael L.
   Berger, Markus
   Santi, Lucelia
   Driemeier, David
   Terraciano, Paula Barros
   Campos, Alexandre R.
   Guimaraes, Jorge A.
   Vainstein, Marilene H.
   Yates, John R., II
   Beys-da-Silva, Walter O.
TI Proteomics of Rat Lungs Infected by Cryptococcus gattii Reveals a
   Potential Warburg-like Effect
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Cryptococcus gattii; MudPIT; lung infection; host; Warburg effect
ID DENDRITIC CELLS; MACROPHAGES; GLYCOLYSIS; METABOLISM; SURVIVAL; BIOLOGY;
   CANCER
AB Cryptococcus gattii is the causative agent of cryptococcosis infection that can lead to pneumonia and meningitis in immunocompetent individuals. The molecular basis of the pathogenic process and impact on the host biochemistry are poorly understood and remain largely unknown. In this context, a comparative proteomic analysis was performed to investigate the response of the host during an infection caused by C. gattii. Lungs of experimentally infected rats were analyzed by shotgun proteomics to identify differentially expressed proteins induced by C. gattii clinical strain. The proteomic results were characterized using bioinformatic tools, and subsequently, the molecular findings were validated in cell culture and lungs of infected animals. A dramatic change was observed in protein expression triggered by C. gattii infection, especially related to energy metabolism. The main pathways affected include aerobic glycolysis cycle, TCA cycle, and pyrimidine and purine metabolism. Analyses in human lung fibroblast cells confirmed the altered metabolic status found in infected lungs. Thus, it is clear that C. gattii infection triggers important changes in energy metabolism leading to the activation of glycolysis and lactate accumulation in lung cells, culminating in a cancerlike metabolic status known as the Warburg effect. The results presented here provide important insights to better understand C. gattii molecular pathogenesis.
C1 [Rosa, Rafael L.; Santi, Lucelia; Guimaraes, Jorge A.; Vainstein, Marilene H.; Beys-da-Silva, Walter O.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, BR-90040060 Porto Alegre, RS, Brazil.
   [Rosa, Rafael L.; Berger, Markus; Santi, Lucelia; Terraciano, Paula Barros; Guimaraes, Jorge A.; Beys-da-Silva, Walter O.] Univ Fed Rio Grande do Sul, Ctr Pesquisa Expt, Lab Bioquim Farmacol, Hosp Clin Porto Alegre, BR-90035007 Porto Alegre, RS, Brazil.
   [Rosa, Rafael L.; Santi, Lucelia; Beys-da-Silva, Walter O.] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   [Driemeier, David] Univ Fed Rio Grande do Sul, Fac Med Vet, Dept Patol Clin Vet, BR-91540000 Porto Alegre, RS, Brazil.
   [Campos, Alexandre R.] Sanford Burnham Prebys Med Discovery Inst, Prote Core, La Jolla, CA 92037 USA.
   [Yates, John R., II] Scripps Res Inst, Dept Chem Physiol & Mol & Cellular Neurosci, La Jolla, CA 92037 USA.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, BR-90040060 Porto Alegre, RS, Brazil.; Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Ctr Pesquisa Expt, Lab Bioquim Farmacol, Hosp Clin Porto Alegre, BR-90035007 Porto Alegre, RS, Brazil.; Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Santi, Lucelia/AAB-8349-2020;
   Berger, Markus/U-7682-2019; Santi, Lucelia/AAK-9527-2020
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Santi,
   Lucelia/0000-0002-5698-7006; Berger, Markus/0000-0001-7670-2584; Yates,
   John/0000-0001-5267-1672
FU Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)CAPES;
   Fundacio de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NIH/NIHGM P41 GM103533-22, NIH/NIMH 5
   R01 MH067880-14]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH067880, R01MH067880] Funding Source: NIH RePORTER
FX This work was supported by the Brazilian funding agencies Coordenacao de
   Aperfeicoamento Pessoal de Nivel Superior (CAPES), Fundacio de Amparo a
   Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq). The study was also
   supported by NIH grants NIH/NIHGM P41 GM103533-22 and NIH/NIMH 5 R01
   MH067880-14 (to J.RY.).
CR Allen TC, 1992, LAB METHODS HISTOTEC, P53
   Appelberg R, 2015, IMMUNOLOGY, V145, P498, DOI 10.1111/imm.12464
   Bar-Or D, 2018, J CRIT CARE, V43, P197, DOI 10.1016/j.jcrc.2017.09.012
   Beys-da-Silva WO, 2014, J PROTEOME RES, V13, P2282, DOI 10.1021/pr401204y
   Carvalho Paulo C, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1319s40
   Cheng SC, 2016, NAT IMMUNOL, V17, P406, DOI 10.1038/ni.3398
   Czyi D. M., 2017, J BACTERIOL, V199
   De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   Dominguez-Andres J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006632
   Escoll P, 2018, FEBS J, V285, P2146, DOI 10.1111/febs.14446
   Fischer K, 2007, BLOOD, V109, P3812, DOI 10.1182/blood-2006-07-035972
   Gleeson LE, 2016, J IMMUNOL, V196, P2444, DOI 10.4049/jimmunol.1501612
   He XM, 2012, AM J PATHOL, V181, P1356, DOI 10.1016/j.ajpath.2012.06.012
   Huston SM, 2016, J IMMUNOL, V196, P1259, DOI 10.4049/jimmunol.1501089
   Jeoung Nam Ho, 2010, Korean Diabetes J, V34, P274, DOI 10.4093/kdj.2010.34.5.274
   Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691
   Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68
   Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101
   Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038
   Li QB, 2011, J PROTEOME RES, V10, P2425, DOI 10.1021/pr101245u
   Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001
   Luca M. D., 2014, COMMUN INTEGR BIOL, V7
   McArdle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002502
   Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613
   O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70
   Poff A, 2019, SEMIN CANCER BIOL, V56, P135, DOI 10.1016/j.semcancer.2017.12.011
   Potter M, 2016, BIOCHEM SOC T, V44, P1499, DOI 10.1042/BST20160094
   Rajasingham R., 2019, LANCET INFECT DIS, V8, P873
   REISS E, 1986, MYCOPATHOLOGIA, V93, P45, DOI 10.1007/BF00437014
   Shi LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18176
   Shourian M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00066
   Surmann K, 2016, DATA BRIEF, V7, P1031, DOI 10.1016/j.dib.2016.03.027
   Tucey TM, 2018, CELL METAB, V27, P988, DOI 10.1016/j.cmet.2018.03.019
   VANSCHAFTINGEN E, 1982, EUR J BIOCHEM, V129, P191
   White DL, 2008, AM J EPIDEMIOL, V167, P377, DOI 10.1093/aje/kwm315
   Wong J, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00025
   Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Zheng J, 2012, ONCOL LETT, V4, P1151, DOI 10.3892/ol.2012.928
NR 40
TC 3
Z9 3
U1 1
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD NOV
PY 2019
VL 18
IS 11
BP 3885
EP 3895
DI 10.1021/acs.jproteome.9b00326
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA JK0SD
UT WOS:000494558900008
PM 31502459
DA 2020-11-24
ER

PT J
AU Guimaraes, JA
   Goncalves, FM
   Borges, S
   Monteiro, JJ
   Mateus, PS
   Trigo, J
   Moreira, JI
AF Alves Guimaraes, J.
   Goncalves, F. M.
   Borges, S.
   Monteiro, J. J.
   Mateus, P. S.
   Trigo, J.
   Moreira, J. I.
TI New onset atrial fibrillation in acute coronary syndrome: early vs late
   onset
SO EUROPEAN HEART JOURNAL
LA English
DT Meeting Abstract
CT Congress of the European-Society-of-Cardiology (ESC) / World Congress of
   Cardiology
CY AUG 31-SEP 04, 2019
CL Paris, FRANCE
SP European Soc Cardiol
C1 [Alves Guimaraes, J.; Goncalves, F. M.; Borges, S.; Monteiro, J. J.; Mateus, P. S.; Trigo, J.; Moreira, J. I.] Hosp Ctr Tras Os Montes & Alto Douro, Vila Real, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD OCT
PY 2019
VL 40
SU 1
MA 4183
BP 2531
EP 2531
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KC6VN
UT WOS:000507313000441
DA 2020-11-24
ER

PT J
AU Guimaraes, JA
   Goncalves, FM
   Borges, S
   Monteiro, JJ
   Mateus, PS
   Trigo, J
   Moreira, JI
AF Alves Guimaraes, J.
   Goncalves, F. M.
   Borges, S.
   Monteiro, J. J.
   Mateus, P. S.
   Trigo, J.
   Moreira, J. I.
TI The acute on chronic glycaemic ratio: a simple tool to stratify risk in
   acute coronary syndrome patients
SO EUROPEAN HEART JOURNAL
LA English
DT Meeting Abstract
CT Congress of the European-Society-of-Cardiology (ESC) / World Congress of
   Cardiology
CY AUG 31-SEP 04, 2019
CL Paris, FRANCE
SP European Soc Cardiol
C1 [Alves Guimaraes, J.; Goncalves, F. M.; Borges, S.; Monteiro, J. J.; Mateus, P. S.; Trigo, J.; Moreira, J. I.] Hosp Ctr Tras Os Montes & Alto Douro, Vila Real, Portugal.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0195-668X
EI 1522-9645
J9 EUR HEART J
JI Eur. Heart J.
PD OCT
PY 2019
VL 40
SU 1
MA P6442
BP 4042
EP 4042
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA KC6VN
UT WOS:000507313003703
DA 2020-11-24
ER

PT J
AU Beys-da-Silva, WO
   Rosa, RL
   Santi, L
   Berger, M
   Park, SK
   Campos, AR
   Terraciano, P
   Varela, APM
   Teixeira, TF
   Roehe, PM
   Quincozes-Santos, A
   Yates, JR
   Souza, DO
   Cirne-Lima, EO
   Guimaraes, JA
AF Beys-da-Silva, Walter O.
   Rosa, Rafael L.
   Santi, Lucelia
   Berger, Markus
   Park, Sung Kyu
   Campos, Alexandre R.
   Terraciano, Paula
   Varela, Ana Paula M.
   Teixeira, Thais F.
   Roehe, Paulo M.
   Quincozes-Santos, Andre
   Yates, John R., III
   Souza, Diogo O.
   Cirne-Lima, Elizabeth O.
   Guimaraes, Jorge A.
TI Zika Virus Infection of Human Mesenchymal Stem Cells Promotes
   Differential Expression of Proteins Linked to Several Neurological
   Diseases
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Zika virus; Brain diseases; Human mesenchymal stem cells; Proteome;
   Microcephaly
ID NF-KAPPA-B; TANDEM MASS-SPECTRA; ASSOCIATION; ENVIRONMENT; ANNOTATION;
   ACTIVATION; INSIGHTS; REVEALS; GROWTH; BRAZIL
AB The recent microcephaly outbreak in Brazil has been associated with Zika virus (ZIKV) infection. The current understanding of damage caused by ZIKV infection is still unclear, since it has been implicated in other neurodegenerative and developmental complications. Here, the differential proteome analysis of human mesenchymal stem cells (hMSC) infected with a Brazilian strain of ZIKV was identified by shotgun proteomics (MudPIT). Our results indicate that ZIKV induces a potential reprogramming of the metabolic machinery in nucleotide metabolism, changes in the energy production via glycolysis and other metabolic pathways, and potentially inhibits autophagy, neurogenesis, and immune response by downregulation of signaling pathways. In addition, proteins previously described in several brain pathologies, such as Alzheimer's disease, autism spectrum disorder, amyotrophic lateral sclerosis, and Parkinson's disease, were found with altered expression due to ZIKV infection in hMSC. This potential link between ZIKV and several neuropathologies beyond microcephaly is being described here for the first time and can be used to guide specific follow-up studies concerning these specific diseases and ZIKV infection.
C1 [Beys-da-Silva, Walter O.; Santi, Lucelia] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.
   [Beys-da-Silva, Walter O.; Rosa, Rafael L.; Santi, Lucelia; Berger, Markus; Terraciano, Paula; Cirne-Lima, Elizabeth O.; Guimaraes, Jorge A.] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
   [Rosa, Rafael L.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.
   [Park, Sung Kyu; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol, La Jolla, CA 92037 USA.
   [Campos, Alexandre R.] Sanford Burnham Prebys Med Discovery Inst, Prote Core, La Jolla, CA USA.
   [Varela, Ana Paula M.; Teixeira, Thais F.] Fundacao Univ Cardiol, Inst Cardiol, Ctr Cardiol Expt, Porto Alegre, RS, Brazil.
   [Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Dept Microbiol, Porto Alegre, RS, Brazil.
   [Quincozes-Santos, Andre; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.
   [Cirne-Lima, Elizabeth O.] Univ Fed Rio Grande do Sul, Programa Posgrad Ginecol & Obstet, Porto Alegre, RS, Brazil.
   [Cirne-Lima, Elizabeth O.] Univ Fed Rio Grande do Sul, Fac Vet, Dept Patol Clin Vet, Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.; Beys-da-Silva, WO; Guimaraes, JA (corresponding author), Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.; Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br; guimar@cbiot.ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Berger, Markus/U-7682-2019; Santi,
   Lucelia/AAB-8349-2020; Guimaraes, Jorge Almeida/V-2196-2019; Terraciano,
   Paula B/H-1653-2015; Quincozes-Santos, Andre/AAO-2714-2020; Santi,
   Lucelia/AAK-9527-2020; Cirne-Lima, Elizabeth Obino/N-9796-2018; Souza,
   Diogo/J-8894-2014
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Berger,
   Markus/0000-0001-7670-2584; Santi, Lucelia/0000-0002-5698-7006;
   Quincozes-Santos, Andre/0000-0001-8611-4890; Campos,
   Alexandre/0000-0003-3988-7764; Souza, Diogo/0000-0002-4322-0404
FU Brazilian funding agency Coordenacao de Aperfeicoamento Pessoal de Nivel
   Superior (CAPES)CAPES; Brazilian funding agency FAPERGSFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Brazilian funding
   agency Edital MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit [14/2016,
   440763/2016-9]; NIH grantsUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH/NIHGM P41
   GM103533-22, NIH/NIMH 5 R01 MH067880-14]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01MH067880, R01MH067880] Funding Source: NIH RePORTER
FX This work was supported by the Brazilian funding agencies Coordenacao de
   Aperfeicoamento Pessoal de Nivel Superior (CAPES), FAPERGS, Edital
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/No 14/2016, project 440763/2016-9.
   The study was also supported by NIH grants NIH/NIHGM P41 GM103533-22 and
   NIH/NIMH 5 R01 MH067880-14 (to JRY).
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Berger M, 2015, ARCH TOXICOL, V89, P459, DOI 10.1007/s00204-014-1264-0
   Beys-da-Silva WO, 2014, J PROTEOME RES, V13, P2282, DOI 10.1021/pr401204y
   Brahma R, 2018, VIRAL IMMUNOL, V31, P321, DOI 10.1089/vim.2017.0116
   D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Enav H, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-9
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042
   Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   He L, 2015, ANAL CHEM, V87, P11361, DOI 10.1021/acs.analchem.5b02721
   Janssens Sylvie, 2018, mSystems, V3, DOI [10.1128/msystems.00219-17, 10.1128/mSystems.00219-17]
   Kaur U, 2015, CURR TOP MED CHEM, V15, P446, DOI 10.2174/1568026615666150114160543
   Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5
   Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036
   McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397
   McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/FMC.11.12, 10.4155/fmc.11.12]
   Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]
   Qimron U, 2010, MICROBE, V5, P117
   Rappaport N, 2017, NUCLEIC ACIDS RES, V45, pD877, DOI 10.1093/nar/gkw1012
   Rappaport N, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat018
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Sadleir KR, 2012, J BIOL CHEM, V287, P7224, DOI 10.1074/jbc.M111.333914
   Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038
   Santi L, 2014, J PROTEOME RES, V13, P1545, DOI 10.1021/pr401075f
   Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]
   Scardoni Giovanni, 2014, F1000Res, V3, P139, DOI 10.12688/f1000research.4477.1
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sontag JM, 2012, J BIOL CHEM, V287, P14984, DOI 10.1074/jbc.M111.338681
   Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937
   Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q
   Terraciano P, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/720753
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Wang LZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01357-4
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Zelenaia O, 2000, MOL PHARMACOL, V57, P667
   Zomer HD, 2015, STEM CELLS CLONING, V8, P125, DOI 10.2147/SCCAA.S88036
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 50
TC 8
Z9 8
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUL
PY 2019
VL 56
IS 7
BP 4708
EP 4717
DI 10.1007/s12035-018-1417-x
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA IT8VJ
UT WOS:000483159700007
PM 30377986
OA Green Accepted
DA 2020-11-24
ER

PT J
AU Brondani, LA
   Crispim, D
   Pisco, J
   Guimaraes, JA
   Berger, M
AF Brondani, Leticia A.
   Crispim, Daisy
   Pisco, Julia
   Guimaraes, Jorge A.
   Berger, Markus
TI The G Allele of the rs12050217 Polymorphism in the BDKRB1 Gene Is
   Associated with Protection for Diabetic Retinopathy
SO CURRENT EYE RESEARCH
LA English
DT Article
DE Diabetic retinopathy; B1 receptor; BDKRB1; type 2 diabetes mellitus; DNA
   polymorphism
ID KALLIKREIN-KININ SYSTEM; B-1 RECEPTOR ANTAGONIST; BRADYKININ B-1;
   NITRIC-OXIDE; PLASMA EXTRAVASATION; RESPONSES; MICROALBUMINURIA;
   HERITABILITY; ACTIVATION; EXPRESSION
AB Purpose: The plasma kallikrein-kinin system is activated during vascular injury caused by diabetic retinopathy (DR), being involved in hyperpermeability and inflammation. Bradykinin B1 receptor (B1R) is expressed in human retina, and its levels are increased in murine models of diabetes. Experimental studies reveal that B1R antagonists ameliorate retinal injury caused by diabetes in rodents. Thus, the aim of this study was to investigate the association between the rs12050217A/G polymorphism in the BDKRB1 gene, the gene that codifies B1R, and DR in type 2 diabetes mellitus (T2DM) patients. Methods: We analyzed 636 T2DM patients and 443 non-diabetic subjects. T2DM patients were categorized by the presence of non-proliferative DR (NPDR, n = 267), proliferative DR (PDR, n = 197), and absence of DR (n = 172). The BDKRB1 rs12050217A/G polymorphism was genotyped by real-time PCR using TaqMan MGB probes. Results: The genotype frequencies of the BDKRB1 rs12050217A/G polymorphism are in Hardy-Weinberg equilibrium and did not differ between T2DM patients and non-diabetic subjects (P > 0.05). The presence of the genotypes containing the rs12050217 G allele was less frequent in patients with PDR when compared to patients with NPDR and without DR (32.0%, 41.9%, and 43.0%, P = 0.045, respectively). Interestingly, the presence of G allele was associated with similar to 40% protection for PDR, which was confirmed after correction for the presence of hypertension, ethnicity, age, HDL, and gender (odds ratio = 0.616, 95% confidence interval 0.385-0.986, P = 0.043). Conclusion: For the first time, we showed that BDKRB1 rs12050217 G allele is associated with protection for the advanced stage of DR in T2DM patients; however, further studies are needed to confirm this finding.
C1 [Brondani, Leticia A.; Crispim, Daisy; Pisco, Julia] Hosp Clin Porto Alegre, Endocrine Div, Ramiro Barcelos St 2350,Bldg 12,4 Floor, BR-90035003 Porto Alegre, RS, Brazil.
   [Brondani, Leticia A.; Crispim, Daisy] Univ Fed Rio Grande do Sul, Fac Med, Postgrad Program Med Sci Endocrinol, Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.; Berger, Markus] Hosp Clin Porto Alegre, Ctr Expt Res, Biochem Pharmacol Lab, Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Inst Biociencias, Ctr Biotechnol, Postgrad Program Cell & Mol Biol, Porto Alegre, RS, Brazil.
   [Berger, Markus] Univ Fed Rio Grande do Sul, Fac Med, Postgrad Program Hlth Sci Gynecol & Obstet, Porto Alegre, RS, Brazil.
RP Brondani, LA (corresponding author), Hosp Clin Porto Alegre, Endocrine Div, Ramiro Barcelos St 2350,Bldg 12,4 Floor, BR-90035003 Porto Alegre, RS, Brazil.
EM lbrondani@hcpa.edu.br
RI Crispim, Daisy/R-5170-2019; Berger, Markus/U-7682-2019
OI Crispim, Daisy/0000-0001-5095-9269; Berger, Markus/0000-0001-7670-2584
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq
   -Chamada Universal MCTI/CNPq)National Council for Scientific and
   Technological Development (CNPq) [01/2016]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Capes - Projetos Conjuntos
   de Pesquisa em Drug Discovery) [41/2014]; Fundo de Incentivo a Pesquisa
   e Eventos (FIPE-HCPA, GPPG) at Hospital de Clinicas de Porto Alegre
   [16-0053]; CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX The authors are grateful to Claudia de Aguiar Pisco for customizing the
   figure. This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq -Chamada Universal
   MCTI/CNPq N degrees 01/2016), Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (Capes - Projetos Conjuntos de Pesquisa em Drug
   Discovery, Edital N degrees 41/2014), and Fundo de Incentivo a Pesquisa
   e Eventos (FIPE-HCPA, GPPG N degrees 16-0053) at Hospital de Clinicas de
   Porto Alegre. D.C. is a recipient from a scholarship from CNPq. The
   authors declare that they have no conflicts of interest with the
   contents of this article.
CR Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48
   Abdouh M, 2003, BRIT J PHARMACOL, V140, P33, DOI 10.1038/sj.bjp.0705210
   Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059
   Ahlqvist E, 2015, NAT REV NEPHROL, V11, P277, DOI 10.1038/nrneph.2015.37
   [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005
   Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073
   Arar NH, 2008, INVEST OPHTH VIS SCI, V49, P3839, DOI 10.1167/iovs.07-1633
   Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673
   Boelter MC, 2006, BRAZ J MED BIOL RES, V39, P1033, DOI 10.1590/S0100-879X2006000800006
   Brondani LA, 2014, METAB SYNDR RELAT D, V12, P16, DOI 10.1089/met.2013.0077
   Brondani LA, 2012, INVEST OPHTH VIS SCI, V53, P7449, DOI 10.1167/iovs.12-10660
   Brovkovych V, 2011, J CELL MOL MED, V15, P258, DOI 10.1111/j.1582-4934.2009.00992.x
   Busse R, 1996, DIABETES, V45, pS8, DOI 10.2337/diab.45.1.S8
   Calixto J B, 2001, Curr Opin Anaesthesiol, V14, P519, DOI 10.1097/00001503-200110000-00010
   Campos MM, 2001, EUR J PHARMACOL, V416, P169, DOI 10.1016/S0014-2999(01)00883-4
   Catanzaro O, 2012, PEPTIDES, V34, P349, DOI 10.1016/j.peptides.2012.02.008
   Cho H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0515-z
   Duchene J, 2007, J IMMUNOL, V179, P4849, DOI 10.4049/jimmunol.179.7.4849
   Erdogan C, 2003, OPHTHALMIC RES, V35, P251, DOI 10.1159/000072145
   Eshaq Randa S, 2017, Pathophysiology, V24, P229, DOI 10.1016/j.pathophys.2017.07.001
   Figueroa CD, 2015, INNATE IMMUN-LONDON, V21, P289, DOI 10.1177/1753425914529169
   Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9
   Hietala K, 2008, DIABETES, V57, P2176, DOI 10.2337/db07-1495
   Incerti J, 2005, NEPHROL DIAL TRANSPL, V20, P2402, DOI 10.1093/ndt/gfi074
   Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564
   Joussen AM, 2002, FASEB J, V16, P76, DOI 10.1096/fj.02-0157fje
   Kase S, 2009, INVEST OPHTH VIS SCI, V50, P5909, DOI 10.1167/iovs.09-3767
   Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004
   Kwak SH, 2015, ENDOCRINOL METAB, V30, P147, DOI 10.3803/EnM.2015.30.2.147
   Lawson SR, 2005, EUR J PHARMACOL, V514, P69, DOI 10.1016/j.ejphar.2005.03.023
   Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2
   Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2
   Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7
   Liu J, 2013, BIOL CHEM, V394, P319, DOI 10.1515/hsz-2012-0316
   Lutty GA, 1997, AM J PATHOL, V151, P707
   Ma JX, 1996, EXP EYE RES, V63, P19, DOI 10.1006/exer.1996.0087
   Mejia AJ, 2015, ARCH DERMATOL RES, V307, P803, DOI 10.1007/s00403-015-1595-6
   Mesquita TRR, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00228
   Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836
   Murakami T, 2015, DIABETES, V64, P3350, DOI 10.2337/db15-0746
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Noda K, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/279037
   Pesquero JB, 2006, BIOL CHEM, V387, P119, DOI 10.1515/BC.2006.017
   Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997
   Pouliot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033864
   Pruneau D, 2010, CURR OPIN INVEST DR, V11, P507
   TANG SB, 1995, GRAEF ARCH CLIN EXP, V233, P21, DOI 10.1007/BF00177781
   Toda N, 2007, PROG RETIN EYE RES, V26, P205, DOI 10.1016/j.preteyeres.2007.01.004
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
   Warpeha KM, 2003, EYE, V17, P305, DOI 10.1038/sj.eye.6700348
   Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5
   Wu HY, 2014, CLIN SCI, V126, P441, DOI 10.1042/CS20130204
   Yang XH, 1996, BIOCHEM BIOPH RES CO, V222, P718, DOI 10.1006/bbrc.1996.0810
   Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909
   Zelmanovitz T, 1997, DIABETES CARE, V20, P516, DOI 10.2337/diacare.20.4.516
NR 55
TC 0
Z9 1
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0271-3683
EI 1460-2202
J9 CURR EYE RES
JI Curr. Eye Res.
PD SEP 2
PY 2019
VL 44
IS 9
BP 994
EP 999
DI 10.1080/02713683.2019.1610178
EA MAY 2019
PG 6
WC Ophthalmology
SC Ophthalmology
GA IU5EG
UT WOS:000470598800001
PM 31017477
DA 2020-11-24
ER

PT J
AU Santi, L
   Coutinho-Rodrigues, CJB
   Berger, M
   Klein, LAS
   De Souza, EM
   Rosa, RL
   Guimaraes, JA
   Yates, JR
   Perinotto, WMS
   Bittencourt, VREP
   Beys-da-Silva, WO
AF Santi, Lucelia
   Coutinho-Rodrigues, Caio J. B.
   Berger, Markus
   Klein, Lisete A. S.
   De Souza, Eduardo M.
   Rosa, Rafael L.
   Guimaraes, Jorge A.
   Yates, John R.
   Perinotto, Wendell M. S.
   Bittencourt, Vania R. E. P.
   Beys-da-Silva, Walter O.
TI Secretomic analysis of Beauveria bassiana related to cattle tick,
   Rhipicephalus microplus, infection
SO FOLIA MICROBIOLOGICA
LA English
DT Article
ID METARHIZIUM-ANISOPLIAE; ENTOMOPATHOGENIC FUNGI; HYPOCREALES
   CLAVICIPITACEAE; BIOLOGICAL-CONTROL; VIRULENCE; PROTEINS; CUTICLE;
   ACARI; GENE; IDENTIFICATION
AB Beauveria bassiana is widely studied as an alternative to chemical acaricides in controlling the cattle tick Rhipicephalus microplus. Although its biocontrol efficiency has been proved in laboratory and field scales, there is a need to a better understanding of host interaction process at molecular level related to biocontrol activity. In this work, applying a proteomic technique multidimensional protein identification technology (MudPIT), the differential secretome of B. bassiana induced by the host R. microplus cuticle was evaluated. The use of the host cuticle in a culture medium, mimicking an infection condition, is an established experimental model that triggers the secretion of inducible enzymes. From a total of 236 proteins, 50 proteins were identified exclusively in infection condition, assigned to different aspects of infection like host adhesion, cuticle penetration and fungal defense, and stress. Other 32 proteins were considered up- or down-regulated. In order to get a meaningful global view of the secretome, several bioinformatic analyses were performed. Regarding molecular function classification, the highest number of proteins in the differential secretome was assigned in to hydrolase activity, enzyme class of all cuticle-degrading enzymes like lipases and proteases. These activities were also further validated through enzymatic assays. The results presented here reveal dozens of specific proteins and different processes potentially implicated in cattle tick infection improving the understanding of molecular basis of biocontrol of B. bassiana against R. microplus.
C1 [Santi, Lucelia; Beys-da-Silva, Walter O.] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.
   [Santi, Lucelia; Berger, Markus; Guimaraes, Jorge A.; Beys-da-Silva, Walter O.] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, R Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
   [Coutinho-Rodrigues, Caio J. B.; Bittencourt, Vania R. E. P.] Univ Fed Rural Rio de Janeiro, Dept Parasitol Anim, Rod BR 465,Km 7, BR-23890000 Seropedica, RJ, Brazil.
   [Klein, Lisete A. S.; De Souza, Eduardo M.] Univates, Av Avelino Tahiti 171, BR-95914014 Lajeado, RS, Brazil.
   [Rosa, Rafael L.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
   [Yates, John R.] Scripps Res Inst, Dept Chem Physiol & Mol & Cellular Neurosci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Perinotto, Wendell M. S.] Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Tv Primeira Brejinhos 540-736, BR-44380000 Cruz Das Almas, BA, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.; Beys-da-Silva, WO (corresponding author), Hosp Clin Porto Alegre, Ctr Pesquisa Expt, R Ramiro Barcelos 2350, BR-90035903 Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Berger, Markus/U-7682-2019;
   Guimaraes, Jorge Almeida/V-2196-2019; Santi, Lucelia/AAB-8349-2020;
   Coutinho-Rodrigues, Caio J B/AAH-6732-2020; Santi, Lucelia/AAK-9527-2020
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Berger,
   Markus/0000-0001-7670-2584; Santi, Lucelia/0000-0002-5698-7006;
   Coutinho-Rodrigues, Caio J B/0000-0003-0393-3458; Perinotto,
   Wendell/0000-0002-8712-7850
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Office to Improve University Research (CAPES)CAPES; Rio de
   Janeiro State Research Foundation (FAPERJ)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [NIH/NIHGM P41 GM103533-22]
FX This research was supported by grants from the National Council for
   Scientific and Technological Development (CNPq), the Office to Improve
   University Research (CAPES), and the Rio de Janeiro State Research
   Foundation (FAPERJ). The study was also supported by NIH grant NIH/NIHGM
   P41 GM103533-22 (to JRY).
CR Anderson JP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10405-y
   Angelo IC, 2015, PARASITOL RES, V114, P219, DOI 10.1007/s00436-014-4181-5
   Bell-Sakyi L, 2018, TICKS TICK-BORNE DIS, V9, P1364, DOI 10.1016/j.ttbdis.2018.05.015
   Beys-da-Silva WO, 2014, J PROTEOME RES, V13, P2282, DOI 10.1021/pr401204y
   Bhadauria V, 2010, EUR J PLANT PATHOL, V126, P81, DOI 10.1007/s10658-009-9521-4
   Bittencourt V. R. E. P., 1996, Revista Brasileira de Parasitologia Veterinaria, V5, P81
   Bye NJ, 2008, ARCH MICROBIOL, V189, P81, DOI 10.1007/s00203-007-0296-8
   Carvalho Paulo C, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1319s40
   Chantasingh D, 2013, BIOL CONTROL, V67, P85, DOI 10.1016/j.biocontrol.2013.08.004
   Rodrigues CJBC, 2016, BIOCONTROL SCI TECHN, V26, P239, DOI 10.1080/09583157.2015.1091876
   Da Silva WOB, 2010, FUNGAL BIOL-UK, V114, P10, DOI 10.1016/j.mycres.2009.08.003
   de Bekker C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070609
   De Meneghi D, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00239
   Dionisio G, 2016, INSECTS, V7, DOI 10.3390/insects7040054
   Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003
   Eley KL, 2007, CHEMBIOCHEM, V8, P289, DOI 10.1002/cbic.200600398
   Felix C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01096
   Feng J, 2011, PLANT PATHOL, V60, P698, DOI 10.1111/j.1365-3059.2011.02434.x
   Fernandes EKK, 2011, VET PARASITOL, V182, P307, DOI 10.1016/j.vetpar.2011.05.046
   Freimoser FM, 2005, MICROBIOL-SGM, V151, P361, DOI 10.1099/mic.0.27560-0
   Girard V, 2013, PROTEOMICS, V13, P597, DOI 10.1002/pmic.201200282
   Grell MN, 2011, FUNGAL GENET BIOL, V48, P343, DOI 10.1016/j.fgb.2010.12.003
   Grisi L, 2014, REV BRAS PARASITOL V, V23, P150, DOI 10.1590/S1984-29612014042
   Heinig RL, 2015, J APPL ECOL, V52, P1558, DOI 10.1111/1365-2664.12522
   HUNT LM, 1986, ANN TROP MED PARASIT, V80, P245, DOI 10.1080/00034983.1986.11812008
   Lino ZRJ, 2014, BRAZ J MICROBIOL, V45, P551, DOI 10.1590/S1517-83822014000200025
   Kim HK, 1999, BIOTECHNOL LETT, V21, P777, DOI 10.1023/A:1005583324654
   Kim J, 2018, FOLIA MICROBIOL, V63, P13, DOI 10.1007/s12223-017-0529-4
   Kim SG, 2013, J PROTEOMICS, V78, P58, DOI 10.1016/j.jprot.2012.10.029
   Kirkland BH, 2005, J MED ENTOMOL, V42, P346, DOI 10.1603/0022-2585(2005)042[0346:OAAAFA]2.0.CO;2
   Kordi MK, 2015, J CROP PROT, V4, P675
   Kulkarni RD, 2003, TRENDS BIOCHEM SCI, V28, P118, DOI 10.1016/S0968-0004(03)00025-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leggett M, 2011, CAN J PLANT PATHOL, V33, P101, DOI 10.1080/07060661.2011.563050
   Li J, 2010, APPL MICROBIOL BIOT, V85, P975, DOI 10.1007/s00253-009-2083-8
   Liang LM, 2013, APPL MICROBIOL BIOT, V97, P8683, DOI 10.1007/s00253-013-5178-1
   Liu TB, 2009, J ZHEJIANG UNIV-SC B, V10, P434, DOI 10.1631/jzus.B0920017
   Manalil NS, 2010, FUNGAL BIOL-UK, V114, P637, DOI 10.1016/j.funbio.2010.05.005
   Mascarin GM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2131-3
   Mascarin GM, 2018, J INVERTEBR PATHOL, P30365
   McCotter SW, 2016, CURR GENET, V62, P533, DOI 10.1007/s00294-016-0578-2
   Meijer HJG, 2014, MOL CELL PROTEOMICS, V13, P2101, DOI 10.1074/mcp.M113.035873
   Ment D, 2010, J INVERTEBR PATHOL, V103, P132, DOI 10.1016/j.jip.2009.12.010
   Moon E, 2015, J PROTEOMICS, V117, P70, DOI 10.1016/j.jprot.2014.12.016
   Perinotto WMS, 2014, VET PARASITOL, V203, P189, DOI 10.1016/j.vetpar.2014.02.011
   Rampitsch C, 2013, PROTEOMICS, V13, P1913, DOI 10.1002/pmic.201200446
   Samish M, 2004, PARASITOLOGY, V129, pS389, DOI 10.1017/S0031182004005219
   Santi L, 2012, TICKS DIS MANAGEMENT, P217
   Santi L, 2010, TOXICON, V55, P874, DOI 10.1016/j.toxicon.2009.12.012
   Santi L, 2009, RES MICROBIOL, V160, P824, DOI 10.1016/j.resmic.2009.09.012
   Shah P, 2009, J PROTEOME RES, V8, P1123, DOI 10.1021/pr8003002
   Silva WOB, 2005, PROCESS BIOCHEM, V40, P321, DOI [10.1016/j.procbio.2003.11.053, 10.1016/j.procbio.2004.01.005]
   Staats CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-822
   Stafford KC, 2010, J MED ENTOMOL, V47, P1107, DOI 10.1603/ME10019
   Tong SM, 2016, ENV MICROBIOL REP, V8, P295, DOI 10.1111/1758-2229.12380
   Tong SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20566
   Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002
   Vaknin Y, 2014, FUNGAL GENET BIOL, V63, P55, DOI 10.1016/j.fgb.2013.12.005
   Valero-Jimenez CA, 2017, EVOL APPL, V10, P433, DOI 10.1111/eva.12451
   Valero-Jimenez CA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-479
   Wang JJ, 2017, J INVERTEBR PATHOL, V145, P45, DOI 10.1016/j.jip.2017.03.010
   Wang ZK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153007
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008
   Webster A, 2015, VET PARASITOL, V207, P302, DOI 10.1016/j.vetpar.2014.11.021
   Weeks ENI, 2017, MED VET ENTOMOL, V31, P15, DOI 10.1111/mve.12201
   Xia CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02394
   Xiao GH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00483
   Xu YQ, 2009, FUNGAL GENET BIOL, V46, P353, DOI 10.1016/j.fgb.2009.03.001
   Zhu WJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01807
NR 70
TC 1
Z9 1
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0015-5632
EI 1874-9356
J9 FOLIA MICROBIOL
JI Folia Microbiol.
PD MAY
PY 2019
VL 64
IS 3
BP 361
EP 372
DI 10.1007/s12223-018-0659-3
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA HZ4UT
UT WOS:000468847600008
PM 30361880
DA 2020-11-24
ER

PT J
AU Berger, M
   de Moraes, JA
   Beys-da-Silva, WO
   Santi, L
   Terraciano, PB
   Driemeier, D
   Cirne-Lima, EO
   Passos, EP
   Vieira, MAR
   Barja-Fidalgo, TC
   Guimaraes, JA
AF Berger, Markus
   de Moraes, Joao Alfredo
   Beys-da-Silva, Walter Orlando
   Santi, Lucelia
   Terraciano, Paula Barros
   Driemeier, David
   Cirne-Lima, Elizabeth Obino
   Passos, Eduardo Pandolfi
   Ribeiro Vieira, Maria Aparecida
   Barja-Fidalgo, Thereza Christina
   Guimaraes, Jorge Almeida
TI Renal and vascular effects of kallikrein inhibition in a model of
   Lonomia obliqua venom-induced acute kidney injury
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID PLASMA KALLIKREIN; KININ B-1; BLOOD INCOAGULABILITY; NADPH OXIDASE;
   CATERPILLAR; ACTIVATION; BRADYKININ; RECEPTORS; HEME; B1
AB Background Lonomia obliqua venom is nephrotoxic and acute kidney injury (AKI) is the main cause of death among envenomed victims. Mechanism underlying L. obliqua-induced AKI involves renal hypoperfusion, inflammation, tubular necrosis and loss of glomerular filtration and tubular reabsorption capacities. In the present study, we aimed to investigate the contribution of kallikrein to the hemodynamic instability, inflammation and consequent renal and vascular impairment
   Methodology/Principal findings Addition of L. obliqua venom to purified prekallikrein and human plasma in vitro or to vascular smooth muscle cells (VSMC) in culture, was able to generate kallikrein in a dose-dependent manner. Injected in rats, the venom induced AKI and increased kallikrein levels in plasma and kidney. Kallikrein inhibition by aprotinin prevented glomerular injury and the decrease in glomerular filtration rate, restoring fluid and electrolyte homeostasis. The mechanism underlying these effects was associated to lowering renal inflammation, with decrease in pro-inflammatory cytokines and matrix metalloproteinase expression, reduced tubular degeneration, and protection against oxidative stress. Supporting the key role of kallikrein, we demonstrated that aprotinin inhibited effects directly associated with vascular injury, such as the generation of intracellular reactive oxygen species (ROS) and migration of VSMC induced by L. obliqua venom or by diluted plasma obtained from envenomed rats. In addition, kallikrein inhibition also ameliorated venom-induced blood incoagulability and decreased kidney tissue factor expression
   Conclusions/Significance These data indicated that kallikrein and consequently kinin release have a key role in kidney injury and vascular remodeling. Thus, blocking kallikrein may be a therapeutic alternative to control the progression of venom-induced AKI and vascular disturbances.
   Author summary The envenomation by venomous animals is considered a common and serious occupational disease, especially in rural areas of tropical developing countries. Its public health relevance has been largely ignored by medical authorities worldwide. Specifically in regions of southern and southeast Brazil, accidents with the venomous caterpillar Lonomia obliqua have been an emergent problem, not only for their high incidence rates, but also by the severity of the clinical consequences observed in envenomation cases. Frequently, envenomed victims present a severe hemorrhagic syndrome that can progress to acute kidney injury (AKI) and death. L. obliqua venom is highly nephrotoxic, AKI is the main cause of death between patients and its mechanisms are poorly understood. Even after the introduction of antivenom therapy in 1995, there was no reduction in the incidence of AKI. In this work we investigated the contribution of kallikrein to the hemodynamic instability, inflammation and consequent renal and vascular impairment during envenomation. A multidisciplinary approach was employed including methods of renal physiology/biochemistry, morphological and cell culture analysis. We believe the data presented here give new insights to the actual knowledge presenting kallikrein and the kinin system as key points to control the progression of renal disease, which may be explored as an approach complementary to serotherapy.
C1 [Berger, Markus; Beys-da-Silva, Walter Orlando; Santi, Lucelia; Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, HCPA, CPE, Lab Bioquim Farmacol, Porto Alegre, RS, Brazil.
   [Berger, Markus; Terraciano, Paula Barros; Cirne-Lima, Elizabeth Obino; Passos, Eduardo Pandolfi] Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Ciencias Saude Ginecol & Obstet, Porto Alegre, RS, Brazil.
   [de Moraes, Joao Alfredo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Biol REDOX, Rio de Janeiro, RJ, Brazil.
   [de Moraes, Joao Alfredo; Barja-Fidalgo, Thereza Christina] Univ Estado Rio De Janeiro, Lab Cellular & Mol Pharmacol, IBRAG, Rio De Janeiro, RJ, Brazil.
   [Beys-da-Silva, Walter Orlando; Santi, Lucelia] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil.
   [Terraciano, Paula Barros; Cirne-Lima, Elizabeth Obino; Passos, Eduardo Pandolfi] Univ Fed Rio Grande do Sul, HCPA, CPE, Lab Embriol & Diferenciacao Celular, Porto Alegre, RS, Brazil.
   [Driemeier, David] Univ Fed Rio Grande do Sul, Fac Med Vet, Dept Patol Clin Vet, Porto Alegre, RS, Brazil.
   [Ribeiro Vieira, Maria Aparecida] Univ Fed Minas Gerais, ICB, Dept Fisiol & Biofis, Lab Fisiol Renal, Belo Horizonte, MG, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotecnol Cbiot, PPGBCM, Porto Alegre, RS, Brazil.
RP Berger, M (corresponding author), Univ Fed Rio Grande do Sul, HCPA, CPE, Lab Bioquim Farmacol, Porto Alegre, RS, Brazil.; Berger, M (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Ciencias Saude Ginecol & Obstet, Porto Alegre, RS, Brazil.
EM markusoliveira@hcpa.edu.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Driemeier, David/H-3461-2012;
   Terraciano, Paula B/H-1653-2015; Beys-da-Silva, Walter O/M-3760-2018;
   Berger, Markus/U-7682-2019; Santi, Lucelia/AAK-9527-2020; Santi,
   Lucelia/AAB-8349-2020; Passos, Eduardo P/A-2842-2012; Cirne-Lima,
   Elizabeth Obino/N-9796-2018; Moraes, Joao Alfredo A/E-3557-2017
OI Driemeier, David/0000-0003-3766-0654; Beys-da-Silva, Walter
   O/0000-0001-8329-7839; Berger, Markus/0000-0001-7670-2584; Santi,
   Lucelia/0000-0002-5698-7006; Moraes, Joao Alfredo A/0000-0002-8563-6432
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministerio
   da Educacao, Brazil (CAPES-MEC) - Projetos Conjuntos de Pesquisa em Drug
   Discovery [41/2014, 007/2014]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Ministerio da Ciencia e Tecnologia, Brazil
   (Chamada Universal MCTIC/CNPq) [01/2016, 407041/2016-8]; Fundacao de
   Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Foundation for
   Research Support of the State of Rio Grande do Sul (FAPERGS)
   [2252-2551/14-0, PqG 02/14]; Fundo de Incentivo a Pesquisa e Eventos
   (FIPE-HCPA, GPPG) at Hospital de Clinicas de Porto Alegre [16-0054]
FX This work was supported by funding and fellowships from the following
   Brazilian Agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior, Ministerio da Educacao, Brazil (CAPES-MEC) - Projetos
   Conjuntos de Pesquisa em Drug Discovery, Edital No 41/2014, Grant no
   007/2014); Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Ministerio da Ciencia e Tecnologia, Brazil (Chamada
   Universal MCTIC/CNPq No 01/2016, Grant no 407041/2016-8), Fundacao de
   Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS, Grant no
   2252-2551/14-0, Edital PqG 02/14) and Fundo de Incentivo a Pesquisa e
   Eventos (FIPE-HCPA, GPPG Grant no 16-0054) at Hospital de Clinicas de
   Porto Alegre. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673
   Barcellos-de-Souza P, 2013, AM J PHYSIOL-CELL PH, V304, pC170, DOI 10.1152/ajpcell.00078.2012
   Berger M., 2012, RENAL FAILURE FACTS, P157
   Berger M, 2015, ARCH TOXICOL, V89, P459, DOI 10.1007/s00204-014-1264-0
   Berger M, 2013, TOXICON, V74, P179, DOI 10.1016/j.toxicon.2013.08.061
   Berger M, 2010, TOXICON, V55, P33, DOI 10.1016/j.toxicon.2009.06.033
   Bjorkqvist J, 2013, THROMB HAEMOSTASIS, V110, P399, DOI 10.1160/TH13-03-0258
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   BON C, 1996, ENVENOMINGS THEIR TR, P3
   Calixto JB, 2004, BRIT J PHARMACOL, V143, P803, DOI 10.1038/sj.bjp.0706012
   Campos MM, 2006, TRENDS PHARMACOL SCI, V27, P646, DOI 10.1016/j.tips.2006.10.007
   Cassini-Vieira P, 2015, BIO-PROTOCOL, V5, pe1662
   Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   Day JRS, 2006, ANN THORAC SURG, V81, P619, DOI 10.1016/j.athoracsur.2005.07.056
   Duchene J, 2009, CURR OPIN PHARMACOL, V9, P125, DOI 10.1016/j.coph.2008.11.011
   Fan HW, 1999, BRIT MED J, V318, P1451, DOI 10.1136/bmj.318.7196.1451
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Gob E, 2015, ANN NEUROL, V77, P784, DOI 10.1002/ana.24380
   Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160
   GUDER WG, 1984, KIDNEY INT, V26, P101, DOI 10.1038/ki.1984.143
   GUIMARAES JA, 1986, EUR J PHARMACOL, V130, P177, DOI 10.1016/0014-2999(86)90266-9
   GUTIERREZ JM, 2009, ANIMAL TOXINS STATE, P393
   Hara DB, 2008, BRIT J PHARMACOL, V154, P1276, DOI 10.1038/bjp.2008.212
   Hohmann MSN, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/627046
   Kakoki M, 2010, P NATL ACAD SCI USA, V107, P10190, DOI 10.1073/pnas.1005144107
   Kayashima Y, 2012, CURR OPIN NEPHROL HY, V21, P92, DOI 10.1097/MNH.0b013e32834d54b1
   Klein J, 2009, FASEB J, V23, P134, DOI 10.1096/fj.08-115600
   Klein J, 2010, J AM SOC NEPHROL, V21, P1157, DOI 10.1681/ASN.2009090887
   Lalloo DG, 2003, J TOXICOL-CLIN TOXIC, V41, P277, DOI 10.1081/CLT-120021113
   Malaque CMS, 2006, AM J TROP MED HYG, V74, P807, DOI 10.4269/ajtmh.2006.74.807
   MANDLE R, 1977, J BIOL CHEM, V252, P6097
   Gutierrez JM, 2010, TOXICON, V56, P1223, DOI 10.1016/j.toxicon.2009.11.020
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   Moraes JA, 2012, ATHEROSCLEROSIS, V224, P394, DOI 10.1016/j.atherosclerosis.2012.07.043
   Moraes JA, 2017, TOXINS, V9, DOI 10.3390/toxins9110360
   Nascimento-Silva V, 2012, TOXICON, V60, P50, DOI 10.1016/j.toxicon.2012.03.016
   Okamoto H, 1998, BBA-MOL CELL RES, V1404, P329, DOI 10.1016/S0167-4889(98)00074-3
   Pinho-Ribeiro FA, 2015, CHEM-BIOL INTERACT, V228, P88, DOI 10.1016/j.cbi.2015.01.011
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Pinto AFM, 2010, TOXICON, V56, P1103, DOI 10.1016/j.toxicon.2010.01.013
   Quintao NLM, 2008, J NEUROSCI, V28, P2856, DOI 10.1523/JNEUROSCI.4389-07.2008
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   Reis CV, 2001, THROMB RES, V102, P437, DOI 10.1016/S0049-3848(01)00268-7
   Renne T, 2012, SEMIN IMMUNOPATHOL, V34, P31, DOI 10.1007/s00281-011-0288-2
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   RODGERS GM, 1983, BLOOD, V61, P1155
   Sano-Martins IS, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759024, 10.1590/s1678-9946201759024]
   Schmitberger PA, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-14
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059
   Shariat-Madar Z, 2002, INT IMMUNOPHARMACOL, V2, P1841, DOI 10.1016/S1567-5769(02)00178-9
   Smith A, 2015, FRONT PHYSIOL, V30, P1
   Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542
   Sparkenbaugh EM, 2015, HAEMATOLOGICA, V100, P308, DOI 10.3324/haematol.2014.114728
   Talbot S, 2011, PEPTIDES, V32, P1447, DOI 10.1016/j.peptides.2011.05.005
   Theakston R. D. G., 2003, Toxicon, V41, P541, DOI 10.1016/S0041-0101(02)00393-8
   Veiga A. B. G., 2009, ANIMAL TOXINS STATE, P371
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   VIEIRA MAR, 1994, BIOCHEM PHARMACOL, V47, P1693, DOI 10.1016/0006-2952(94)90549-5
   Wang PHM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003050
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 64
TC 2
Z9 2
U1 1
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD FEB
PY 2019
VL 13
IS 2
AR e0007197
DI 10.1371/journal.pntd.0007197
PG 28
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA HN1TU
UT WOS:000459970700065
PM 30763408
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Schuler-Faccini, L
   Roehe, P
   Zimmer, ER
   Quincozes-Santos, A
   de Assis, AM
   Lima, EOC
   Guimares, JA
   Victora, C
   Neto, VM
   Souza, DO
AF Schuler-Faccini, Lavinia
   Roehe, Paulo
   Zimmer, Eduardo R.
   Quincozes-Santos, Andre
   de Assis, Adriano M.
   Cirne Lima, Elizabeth Obino
   Guimares, Jorge Almeida
   Victora, Cesar
   Neto, Vivaldo Moura
   Souza, Diogo O.
TI ZIKA Virus and Neuroscience: the Need for a Translational Collaboration
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE ZIKV; Microcephaly; Translational research; Brazil
ID DENGUE VIRUS; INFECTION; BRAZIL; AMERICA; POTENT
AB Zika virus (ZIKV) has become a major challenge for scientists and health agencies. ZIKV's involvement with human fetal microcephaly and Guillain-Barr, syndrome and its transmission through Aedes africanus and Aedes aegypti mosquitos highlighted the epidemiological and neurological risks associated to ZIKV infection. In 2013, ZIKV arrives in Brazil but the first outbreak in the country was reported in 2015. Here, we used the Web of Science as a search tool for comparing the evolution of world and Brazilian scientific research on dengue virus (DENV)-also present in mosquito-, ZIKV and microcephaly. The association between ZIKV and microcephaly was only evidenced in 2015. Interestingly, Brazil and the USA are the responsible for most of these reports. Furthermore, the level of double-counted articles indicates a high degree of international collaborative effort in studying ZIKV and microcephaly. The ZIKV research clearly requires multidisciplinary expertise including epidemiologic, clinical, virological, and neurochemical backgrounds. This letter intends to emphasize the need of multidisciplinary studies and put forward some as yet unanswered questions in attempting to contribute to the understanding of this multifaceted health problem. In line with this, we recently constituted a collaborative and multidisciplinary taskforce encompassing eight Brazilian scientific institutions of excellence, The ZIKV translational research taskforce. This taskforce comprises a vast international network of collaborators and welcomes additional collaborators. We intend to advance fast in terms of mechanisms, which can potentially contribute to treat or halt ZIKV spreading around the world.
C1 [Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil.
   [Roehe, Paulo] Univ Fed Rio Grande do Sul, Lab Virol, Microbiol Immunobiol & Parasitol, Porto Alegre, RS, Brazil.
   [Zimmer, Eduardo R.; Quincozes-Santos, Andre; de Assis, Adriano M.; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Dept Biochem, ICBS, 2600 Ramiro Barcelos St, BR-90035003 Porto Alegre, RS, Brazil.
   [Zimmer, Eduardo R.] Pontif Catholic Univ Rio Grande do Sul PUCRS, Brain Inst BraIns Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Cirne Lima, Elizabeth Obino] Hosp Clin Porto Alegre, Embryol & Cell Differentiat Lab, Porto Alegre, RS, Brazil.
   [Guimares, Jorge Almeida] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil.
   [Guimares, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Lab Biochem Pharmacol, Porto Alegre, RS, Brazil.
   [Victora, Cesar] Univ Fed Pelotas, Postgrad Program Epidemiol, Int Ctr Equ Hlth, Rua Marechal Deodoro, Pelotas, Brazil.
   [Neto, Vivaldo Moura] Secretaria Estadual Saude Rio de Janeiro, Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, Brazil.
RP Souza, DO (corresponding author), Univ Fed Rio Grande do Sul, Dept Biochem, ICBS, 2600 Ramiro Barcelos St, BR-90035003 Porto Alegre, RS, Brazil.
EM diogo@ufrgs.br
RI Cirne-Lima, Elizabeth Obino/N-9796-2018; Quincozes-Santos,
   Andre/AAO-2714-2020; Zimmer, Eduardo R Rigon/I-2932-2015;
   SCHULER-FACCINI, LAVINIA/C-8309-2013; de Assis, Adriano/H-2606-2013;
   Victora, Cesar Gomes/Y-2455-2019; Guimaraes, Jorge Almeida/V-2196-2019;
   Souza, Diogo/J-8894-2014
OI Zimmer, Eduardo R Rigon/0000-0002-5349-0053; SCHULER-FACCINI,
   LAVINIA/0000-0002-2428-0460; de Assis, Adriano/0000-0002-1953-7831;
   Victora, Cesar Gomes/0000-0002-2465-2180; Souza,
   Diogo/0000-0002-4322-0404; Quincozes-Santos, Andre/0000-0001-8611-4890
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR)
   [440763/2016-9] Funding Source: Medline
CR Aguiar DP, 2014, DEVELOPMENT, V141, P2494, DOI 10.1242/dev.101790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frost JL, 2016, TRENDS CELL BIOL, V26, P587, DOI 10.1016/j.tcb.2016.02.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Le Douarin N, 1999, DEV CELL BIOL SERIES, V36
   Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 22
TC 5
Z9 5
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD FEB
PY 2018
VL 55
IS 2
BP 1551
EP 1555
DI 10.1007/s12035-017-0429-2
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA FW8YX
UT WOS:000425624000053
PM 28185126
DA 2020-11-24
ER

PT J
AU Moraes, JA
   Rodrigues, G
   Nascimento-Silva, V
   Renovato-Martins, M
   Berger, M
   Guimaraes, JA
   Barja-Fidalgo, C
AF Moraes, Joao Alfredo
   Rodrigues, Genilson
   Nascimento-Silva, Vany
   Renovato-Martins, Mariana
   Berger, Markus
   Guimaraes, Jorge Almeida
   Barja-Fidalgo, Christina
TI Effects of Lonomia obliqua Venom on Vascular Smooth Muscle Cells:
   Contribution of NADPH Oxidase-Derived Reactive Oxygen Species
SO TOXINS
LA English
DT Article
DE Lonomia obliqua venom; vascular smooth muscle cells; reactive oxygen
   species
ID CATERPILLAR ENVENOMATION; HEMORRHAGIC SYNDROME; MIGRATION; CONTACT;
   RATS; ATHEROSCLEROSIS; PROLIFERATION; INFLAMMATION; SATURNIIDAE;
   RESPONSES
AB Envenomation caused by human contact with the caterpillar Lonomia is characterized by deleterious effects on coagulation and patency of blood vessels. The cellular effects induced by Lonomia obliqua venom highlights its capacity to activate endothelial cells, leading to a proinflammatory phenotype. Having more knowledge about the mechanisms involved in envenomation may contribute to better treatment. We aimed to evaluate the effects of Lonomia obliqua caterpillar bristle extract (LOCBE) on vascular smooth muscle cells (VSMC). We observed that LOCBE induced VSMC migration, which was preceded by alterations in actin cytoskeleton dynamics and Focal Adhesion Kinase activation. LOCBE also induced Extracellular Signal-Regulated Kinase (ERK) phosphorylation in VSMC, and the inhibition of this pathway impaired cell proliferation. Stimulation of VSMC with LOCBE triggered reactive oxygen species (ROS) production through the activation of NADPH oxidase. The rapid increase in these ROS further induced mitochondrial ROS production, however only NADPH oxidase-derived ROS were involved in ERK activation in VSMC. We that demonstrated the chemotactic and proliferative effects of LOCBE on VSMC were dependent on ROS production, mainly through NADPH oxidase. Together, the data show that Lonomia obliqua venom can interact with and activate VSMC. These effects rely on ROS production, suggesting new potential targets for treatment against vascular damage during envenomation.
C1 [Moraes, Joao Alfredo] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Biol RedOx, BR-21941902 Rio De Janeiro, Brazil.
   [Moraes, Joao Alfredo; Rodrigues, Genilson; Nascimento-Silva, Vany; Renovato-Martins, Mariana; Barja-Fidalgo, Christina] Univ Estado Rio de Janeiro, Dept Biol Celular, Lab Farmacol Celular & Mol, BR-20550030 Rio De Janeiro, Brazil.
   [Berger, Markus; Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, HCPA, CPE, Lab Bioquim Farmacol, BR-90035903 Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-95150197 Porto Alegre, RS, Brazil.
RP Barja-Fidalgo, C (corresponding author), Univ Estado Rio de Janeiro, Dept Biol Celular, Lab Farmacol Celular & Mol, BR-20550030 Rio De Janeiro, Brazil.
EM jmoraesbr@yahoo.com; biogenilson@yahoo.com.br; vanysilva@hotmail.com;
   m_renovatomartins@yahoo.com.br; mbergeroliveira@gmail.com;
   jguimaraes14@gmail.com; barja-fidalgo@uerj.br
RI Moraes, Joao Alfredo A/E-3557-2017; Renovato-Martins,
   Mariana/V-1661-2019; Berger, Markus/U-7682-2019; Guimaraes, Jorge
   Almeida/V-2196-2019
OI Moraes, Joao Alfredo A/0000-0002-8563-6432; Renovato-Martins,
   Mariana/0000-0002-9860-5272; Berger, Markus/0000-0001-7670-2584; 
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX This work was supported by grants from: Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq). We thank Gabriele Muniz
   for technical assistance.
CR Arocha-Pinango CL, 2001, HAEMOSTASIS, V31, P288
   AROCHAPINANGO CL, 1969, LANCET, V1, P810
   Berger M, 2015, ARCH TOXICOL, V89, P459, DOI 10.1007/s00204-014-1264-0
   Berger M, 2013, TOXICON, V74, P179, DOI 10.1016/j.toxicon.2013.08.061
   Berger M, 2010, J THROMB THROMBOLYS, V30, P300, DOI 10.1007/s11239-010-0449-5
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   Burridge K, 2017, FEBS J, V284, P3355, DOI 10.1111/febs.14195
   Carrijo-Carvalho LC, 2007, TOXICON, V49, P741, DOI 10.1016/j.toxicon.2006.11.033
   Da Silva GH, 2004, MICROSC RES TECHNIQ, V65, P276, DOI 10.1002/jemt.20114
   da Silva GH, 2004, TOXICON, V44, P625, DOI 10.1016/j.toxicon.2004.07.016
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Guerrero B, 2003, REV INVEST CLIN, V44, P155
   Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, P283, DOI 10.3109/15569549509019465
   Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313
   Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705
   Moraes JA, 2012, ATHEROSCLEROSIS, V224, P394, DOI 10.1016/j.atherosclerosis.2012.07.043
   Moraes J, 2010, ATHEROSCLEROSIS, V212, P406, DOI 10.1016/j.atherosclerosis.2010.06.009
   Moraes JA, 2016, DATA BRIEF, V6, P330, DOI 10.1016/j.dib.2015.11.053
   Moraes JA, 2015, ATHEROSCLEROSIS, V243, P477, DOI 10.1016/j.atherosclerosis.2015.09.026
   Nascimento-Silva V, 2012, TOXICON, V60, P50, DOI 10.1016/j.toxicon.2012.03.016
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325
   Ricci-Silva ME, 2008, TOXICON, V51, P1017, DOI 10.1016/j.toxicon.2008.01.013
   Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412
   Tang DD, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0544-7
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
NR 30
TC 8
Z9 8
U1 0
U2 3
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6651
J9 TOXINS
JI Toxins
PD NOV
PY 2017
VL 9
IS 11
AR 360
DI 10.3390/toxins9110360
PG 14
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA FO2FI
UT WOS:000416589800025
PM 29112156
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Zanotto, SR
   Haeffner, C
   Guimaraes, JA
AF Zanotto, Sonia R.
   Haeffner, Cristina
   Guimaraes, Jorge A.
TI Unbalanced international collaboration affects adversely the usefulness
   of countries' scientific output as well as their technological and
   social impact
SO SCIENTOMETRICS
LA English
DT Article
DE Scientific production; Impact; International collaboration;
   Double-counting of articles; Bibliometric analysis
ID PUBLICATION; SCIENCE; PRODUCTIVITY; JOURNALS
AB The unbalanced international scientific collaboration as cause of misleading information on the country's contribution to the scientific world output was analyzed. ESI Data Base (Thomson Reuters' InCites), covering the scientific production of 217 active countries in the period 2010-2014 was used. International collaboration implicates in a high percentage (33.1 %) of double-counted world articles, thus impacting qualitative data as citations, impact and impact relative to word. The countries were divided into three groups, according to their individual contribution to the world publications: Group I (24 countries, at least 1 %) representing 83.9 % of the total double-counted world articles. Group II (40 countries, 0.1-0.99 % each). Group III, 153 countries (70.5 %) with < 0.1 % and altogether 1.9 % of the world. Qualitative characteristics of each group were also analyzed: percentage of the country's GNP applied in R&D, proportion of Scientists and Engineers per million inhabitants and Human Development Index. Average international collaboration were: Group I, 43.0 %; Group II, 55.8 % and Group III, 85.2 %. We concluded that very high and unbalanced international collaboration, as presented by many countries, misrepresent the importance of their scientific production, technological and social outputs. Furthermore, it jeopardizes qualitative outputs of the countries themselves, artificially increasing their scientific impact, affecting all fields and therefore, the whole world. The data confirm that when dealing with the qualitative contribution of countries, it is necessary to take in consideration the level of international cooperation because, as seen here, it can and in fact it does create false impression of the real contribution of countries.
C1 [Zanotto, Sonia R.] Univ Fed Rio Grande do Sul, Programa Posgrad Educ Ciencias Quim Vida & Saude, Porto Alegre, RS, Brazil.
   [Zanotto, Sonia R.] Inst Brasileiro Geog & Estat IBGE RS, Porto Alegre, RS, Brazil.
   [Haeffner, Cristina] Hosp Moinhos Vento, Biblioteca Inst Educ & Pesquisa IEP, Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Ave Bento Goncalves 9500,CP 15005, BR-91501970 Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Ave Bento Goncalves 9500,CP 15005, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Ave Bento Goncalves 9500,CP 15005, BR-91501970 Porto Alegre, RS, Brazil.; Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Ave Bento Goncalves 9500,CP 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM jguimaraes14@gmail.com
RI Haeffner, Cristina/AAV-8010-2020; Guimaraes, Jorge Almeida/V-2196-2019;
   Haeffner, Cristina C.H./K-8310-2014
OI Haeffner, Cristina/0000-0003-3275-6665; Haeffner, Cristina
   C.H./0000-0003-3275-6665
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [309371/2011-2]; Fundacao de Amparo a Pesquisa do Estado do Rio
   Grande do Sul (FAPERGS)Foundation for Research Support of the State of
   Rio Grande do Sul (FAPERGS) [2252-2551/14-0]
FX The authors acknowledge Dr. Celia R. Carlini for critically reading this
   manuscript. This work received financial support from the Brazilian
   agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq, Grant 309371/2011-2) and Fundacao de Amparo a Pesquisa do Estado
   do Rio Grande do Sul (FAPERGS, Grant 2252-2551/14-0).
CR Abramo G, 2009, HIGH EDUC, V57, P155, DOI 10.1007/s10734-008-9139-z
   Akre O, 2011, J EPIDEMIOL COMMUN H, V65, P119, DOI 10.1136/jech.2009.088690
   Australian Academy of Science, 2010, INT AUSTR SCI
   Barjak F., 2007, SOCIAL GEOGRAPHY DIS, V3, P121, DOI DOI 10.5194/SGD-3-121-2007
   Beys-da-Silva W. O., 2014, Journal of Sustainable Development, V7, P40
   Bornmann L, 2012, J INFORMETR, V6, P11, DOI 10.1016/j.joi.2011.08.004
   Bozeman B, 2004, RES POLICY, V33, P599, DOI 10.1016/j.respol.2004.01.008
   de Almeida ECE, 2013, SCIENTOMETRICS, V97, P287, DOI 10.1007/s11192-013-0967-y
   Finardi U, 2015, SCIENTOMETRICS, V102, P1139, DOI 10.1007/s11192-014-1490-5
   FRAME JD, 1979, SOC STUD SCI, V9, P481
   Gauffriau M, 2005, SCIENTOMETRICS, V64, P85, DOI 10.1007/s11192-005-0239-6
   Gauffriau M, 2007, SCIENTOMETRICS, V73, P175, DOI 10.1007/s11192-007-1800-2
   Gevers M., 2014, BIBLIOMETRICS USE AB, V37
   Glanzel W., 2001, SCIENTOMETRICS, V50, P185
   Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1
   King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a
   Larsen PO, 2010, SCIENTOMETRICS, V84, P575, DOI 10.1007/s11192-010-0202-z
   Leite P, 2011, SCIENTOMETRICS, V88, P311, DOI 10.1007/s11192-011-0379-9
   LUUKKONEN T, 1992, SCI TECHNOL HUM VAL, V17, P101, DOI 10.1177/016224399201700106
   Martin-Sempere MJ, 2002, SCIENTOMETRICS, V55, P377, DOI 10.1023/A:1020462712923
   May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793
   Meneghini R, 2010, BRAZ J MED BIOL RES, V43, P812, DOI 10.1590/S0100-879X2010000900001
   Meneghini R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003804
   NARIN F, 1991, SCIENTOMETRICS, V21, P313, DOI 10.1007/BF02093973
   Persson O, 2004, SCIENTOMETRICS, V60, P421, DOI 10.1023/B:SCIE.0000034384.35498.7d
   Press WH, 2013, SCIENCE, V342, P817, DOI 10.1126/science.342.6160.817
   Richmond G, 2016, SCIENCE, V351, P427, DOI 10.1126/science.aaf2869
   Smith MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109195
   SUBRAMANYAM K, 1983, J INFORM SCI, V6, P33, DOI 10.1177/016555158300600105
   Tahamtan I, 2016, SCIENTOMETRICS, V107, P1195, DOI 10.1007/s11192-016-1889-2
   UNESCO Science Report, 2010, UNESCO SCI REP
   Van Raan A, 1997, SCI PUBL POLICY, V24, P290, DOI DOI 10.1093/SPP/24.5.290
   Van Raan AFJ, 1998, SCIENTOMETRICS, V42, P423, DOI 10.1007/BF02458380
   Wadworth J., 2014, R D MAGAZINE
   Wagner CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131816
   World Bank, 2015, WORLD DEV IND
NR 36
TC 17
Z9 17
U1 0
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0138-9130
EI 1588-2861
J9 SCIENTOMETRICS
JI Scientometrics
PD DEC
PY 2016
VL 109
IS 3
BP 1789
EP 1814
DI 10.1007/s11192-016-2126-8
PG 26
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA EE1JA
UT WOS:000389336100019
PM 27942081
OA Green Published, Other Gold
DA 2020-11-24
ER

PT J
AU Gomes, WJ
   Leal, JC
   Braile, DM
   Guimaraes, JA
   Lopes, RD
   Lima, MA
   Nader, HB
AF Gomes, Walter J.
   Leal, Joao Carlos
   Braile, Domingo M.
   Guimaraes, Jorge A.
   Lopes, Renato D.
   Lima, Marcelo A.
   Nader, Helena B.
TI A Brazilian perspective for the use of bovine heparin in open heart
   surgery
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Letter
C1 [Gomes, Walter J.; Leal, Joao Carlos; Braile, Domingo M.] Brazilian Soc Cardiovasc Surg, Sao Paulo, SP, Brazil.
   [Gomes, Walter J.; Lopes, Renato D.; Lima, Marcelo A.; Nader, Helena B.] Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Sao Paulo, Brazil.
   [Leal, Joao Carlos; Braile, Domingo M.] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
   [Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
   [Lopes, Renato D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA.
RP Nader, HB (corresponding author), Univ Fed Sao Paulo UNIFESP, Escola Paulista Med, Sao Paulo, Brazil.
EM hbnader.bioq@epm.br
RI Guimaraes, Jorge Almeida/V-2196-2019; BRAILE, DOMINGO/B-8228-2008
OI BRAILE, DOMINGO/0000-0001-7704-2258; NADER, HELENA/0000-0002-7569-2166;
   Gomes, Walter Jose/0000-0003-3385-0215
CR Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200
   Pan J, 2010, J BIOL CHEM, V285, P22964, DOI 10.1074/jbc.M109.063735
NR 2
TC 3
Z9 5
U1 0
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD NOV 15
PY 2016
VL 223
BP 611
EP 612
DI 10.1016/j.ijcard.2016.08.033
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB0LV
UT WOS:000387036200167
PM 27561168
DA 2020-11-24
ER

PT J
AU Marks, FS
   Almeida, LL
   Driemeier, D
   Canal, C
   Barcellos, DESN
   Guimaraes, JA
   Reck, J
AF Marks, Fernanda S.
   Almeida, Laura L.
   Driemeier, David
   Canal, Claudio
   Barcellos, David E. S. N.
   Guimaraes, Jorge A.
   Reck, Jose
TI Porcine circovirus 2 (PCV2) increases the expression of endothelial
   adhesion/junction molecules
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Swine; Infectious diseases; Pathogenesis; Viral infection; Cell adhesion
ID MULTISYSTEMIC WASTING SYNDROME; TIGHT JUNCTION PROTEINS;
   BLOOD-BRAIN-BARRIER; ADHESION MOLECULES; TRANSENDOTHELIAL MIGRATION;
   VASCULAR-LESIONS; TYPE-2; INFECTION; VIRUS; PIGS
AB Porcine circovirus type 2 (PCV2) is the primary causative agent of porcine circovirus disease, a complex multisystem syndrome in domestic pigs. Despite the significant economic losses caused by porcine circovirus disease, the mechanisms of pathogenesis underlying the clinical findings remain largely unclear. As various reports have highlighted the potential key role of vascular lesions in the pathogenesis of porcine circovirus disease, the aim of this work was to investigate effects of PCV2 infection on vascular endothelial cells, focusing on cell viability and expression of adhesion/junction molecules. PCV2 infection reduced endothelial cell viability, while viral infection did not affected the viability of several other classical cell lines. Also, PCV2 infection in endothelial cells displayed a dual/biphasic effect: initially, infection increased ICAM-1 expression, which can favor leukocyte recruitment and emigration to tissues and possibly inducing characteristic porcine circovirus disease inflammatory lesions; then, secondarily, infection caused an increase in zonula occludens 1 tight junction protein (ZO-1) expression, which in turn can result in difficulties for cell traffic across the endothelium and a potential impairment the immune response in peripheral tissues. These virus-induced endothelial changes could directly impact the inflammatory process of porcine circovirus disease and associated vascular/immune system disturbances. Data suggest that, among the wide range of effects induced by PCV2 on the host, endothelial modulation can be a pivotal process which can help to explain PCV2 pathogenesis in some porcine circovirus disease presentations. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.
C1 [Marks, Fernanda S.] Ctr Univ UniRitter, Porto Alegre, RS, Brazil.
   [Almeida, Laura L.; Reck, Jose] Fundacao Estadual Pesquisa Agr FEPAGRO, IPVDF, Estr Conde 6000, BR-92990000 Eldorado Do Sul, RS, Brazil.
   [Driemeier, David; Canal, Claudio; Barcellos, David E. S. N.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP Reck, J (corresponding author), Fundacao Estadual Pesquisa Agr FEPAGRO, IPVDF, Estr Conde 6000, BR-92990000 Eldorado Do Sul, RS, Brazil.
EM jose-reck@fepagro.rs.gov.br
RI de L Almeida, Laura Lopes/D-5654-2013; Canal, Claudio W./J-7253-2012;
   Reck, Jose/AAH-3373-2020; Guimaraes, Jorge Almeida/V-2196-2019;
   Driemeier, David/H-3461-2012
OI de L Almeida, Laura Lopes/0000-0002-6131-9221; Canal, Claudio
   W./0000-0002-0621-243X; Reck, Jose/0000-0002-0969-792X; Driemeier,
   David/0000-0003-3766-0654; Emilio Santos Neves de Barcellos,
   David/0000-0002-4963-435X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Estadual de Amparo a Pesquisa do Rio Grande do
   Sul (FAPERGS); Financiadora de Estudos e Projetos (FINEP)Ciencia
   Tecnologia e Inovacao (FINEP); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX We thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES), Fundacao Estadual de Amparo a Pesquisa do Rio Grande do Sul
   (FAPERGS), Financiadora de Estudos e Projetos (FINEP) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for
   financial support of this work. Special thanks to I. Vaz (UFRGS) for
   help in flow cytometry analysis and to Simbios Biotecnologia (Canoas,
   RS) for the use of real-time PCR facility.
CR Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Chang HW, 2005, VET MICROBIOL, V108, P167, DOI 10.1016/j.vetmic.2005.03.010
   Cino-Ozuna AG, 2011, J CLIN MICROBIOL, V49, P2012, DOI 10.1128/JCM.02543-10
   Dittmar S, 2008, J VIROL, V82, P11273, DOI 10.1128/JVI.00775-08
   Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170
   Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   FRESHNEY R.I., 2000, CULTURE ANIMAL CELLS
   Galindo-Cardiel I, 2011, J COMP PATHOL, V144, P63, DOI 10.1016/j.jcpa.2010.06.003
   Gibbons GH, 1998, THROMBOSIS HEMORRHAG, P307
   GONZALEZ X, 1999, REV CUBANA HEMATOL I, V15, P21
   Hajjar DP, 1997, ANN NY ACAD SCI, V15, P155
   Lai CY, 2012, J NEUROCHEM, V123, P250, DOI 10.1111/j.1471-4159.2012.07889.x
   Li S, 2010, BBA-PROTEINS PROTEOM, V1804, P1882, DOI 10.1016/j.bbapap.2010.05.011
   Luscinskas FW, 2002, SEMIN IMMUNOL, V14, P105, DOI 10.1006/smim.2001.0347
   Marks FS, 2010, VET MICROBIOL, V141, P22, DOI 10.1016/j.vetmic.2009.08.004
   McEver RP, 1998, THROMBOSIS HEMORRHAG, P371
   Olvera A, 2004, J VIROL METHODS, V117, P75, DOI 10.1016/j.jviromet.2003.12.007
   Opriessnig T, 2013, VET PATHOL, V50, P23, DOI 10.1177/0300985812450726
   Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601
   Quezada M., 2004, Agro-Ciencia, V20, P119
   Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4
   Correa AMR, 2007, J VET DIAGN INVEST, V19, P109, DOI 10.1177/104063870701900120
   Seeliger FA, 2007, VET PATHOL, V44, P621, DOI 10.1354/vp.44-5-621
   Segales J, 2004, VET MICROBIOL, V98, P137, DOI 10.1016/j.vetmic.2003.10.006
   Segales J, 2012, VIRUS RES, V164, P10, DOI 10.1016/j.virusres.2011.10.007
   Smith DJ, 2001, EQUINE VET J, V33, P138, DOI 10.1111/j.2042-3306.2001.tb00591.x
   Sorden SD, 2000, SWINE HEALTH PROD, V8, P133
   Szeredi L, 2012, VET PATHOL, V49, P264, DOI 10.1177/0300985811406888
   Szeredi L, 2008, ACTA VET HUNG, V56, P101, DOI 10.1556/AVet.56.2008.1.10
   TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0
   Tomas A, 2010, VET RES, V41, DOI 10.1051/vetres/2009060
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Vincent IE, 2003, J VIROL, V77, P13288, DOI 10.1128/JVI.77.24.13288-13300.2003
   Xu ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037886
   Yeh TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055018
NR 37
TC 3
Z9 3
U1 0
U2 6
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD OCT-DEC
PY 2016
VL 47
IS 4
BP 870
EP 875
DI 10.1016/j.bjm.2016.07.001
PG 6
WC Microbiology
SC Microbiology
GA ED1QI
UT WOS:000388619600013
PM 27522934
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Berger, M
   Santi, L
   Beys-da-Silva, WO
   Oliveira, FMS
   Caliari, MV
   Yates, JR
   Vieira, MAR
   Guimares, JA
AF Berger, Markus
   Santi, Lucelia
   Beys-da-Silva, Walter O.
   Silva Oliveira, Fabricio Marcus
   Caliari, Marcelo Vidigal
   Yates, John R., III
   Ribeiro Vieira, Maria Aparecida
   Guimares, Jorge Almeida
TI Mechanisms of acute kidney injury induced by experimental Lonomia
   obliqua envenomation
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE Venom; Lonomia; Renal; Acute kidney injury; Nephrotoxicity; Acute
   tubular necrosis
ID ACUTE-RENAL-FAILURE; CATERPILLAR BRISTLE EXTRACT; HEMORRHAGIC SYNDROME;
   BLOOD INCOAGULABILITY; SHOTGUN PROTEOMICS; ACCIDENTAL CONTACT;
   EPITHELIAL-CELLS; YEAST PROTEOME; SNAKE-VENOM; RATS
AB Lonomia obliqua caterpillar envenomation causes acute kidney injury (AKI), which can be responsible for its deadly actions. This study evaluates the possible mechanisms involved in the pathogenesis of renal dysfunction. To characterize L. obliqua venom effects, we subcutaneously injected rats and examined renal functional, morphological and biochemical parameters at several time points. We also performed discovery-based proteomic analysis to measure protein expression to identify molecular pathways of renal disease. L. obliqua envenomation causes acute tubular necrosis, which is associated with renal inflammation; formation of hematic casts, resulting from intravascular hemolysis; increase in vascular permeability and fibrosis. The dilation of Bowman's space and glomerular tuft is related to fluid leakage and intra-glomerular fibrin deposition, respectively, since tissue factor procoagulant activity increases in the kidney. Systemic hypotension also contributes to these alterations and to the sudden loss of basic renal functions, including filtration and excretion capacities, urinary concentration and maintenance of fluid homeostasis. In addition, envenomed kidneys increase the expression of proteins involved in cell stress, inflammation, tissue injury, heme-induced oxidative stress, coagulation and complement system activation. Finally, the localization of the venom in renal tissue agrees with morphological and functional alterations, suggesting also a direct nephrotoxic activity. In conclusion, the mechanisms of L. obliqua-induced AKI are complex involving mainly glomerular and tubular functional impairment and vascular alterations. These results are important to understand the mechanisms of renal injury and may suggest more efficient ways to prevent or attenuate the pathology of Lonomia's envenomation.
C1 [Berger, Markus; Guimares, Jorge Almeida] Univ Fed Rio Grande do Sul, Lab Bioquim Farmacol, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Santi, Lucelia; Beys-da-Silva, Walter O.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.
   [Silva Oliveira, Fabricio Marcus; Caliari, Marcelo Vidigal] Univ Fed Minas Gerais, Lab Protozooses, Dept Patol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
   [Ribeiro Vieira, Maria Aparecida] Univ Fed Minas Gerais, Lab Fisiol Renal, Dept Fisiol & Biofis, Inst Ciencias Biol, Belo Horizonte, MG, Brazil.
RP Guimares, JA (corresponding author), Univ Fed Rio Grande do Sul, Lab Bioquim Farmacol, Ctr Biotecnol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Berger, Markus/U-7682-2019; Caliari, Marcelo V/N-1171-2016; Santi,
   Lucelia/AAK-9527-2020; Guimaraes, Jorge Almeida/V-2196-2019; Santi,
   Lucelia/K-4856-2015; Santi, Lucelia/AAB-8349-2020; Beys-da-Silva, Walter
   O/M-3760-2018
OI Berger, Markus/0000-0001-7670-2584; Caliari, Marcelo
   V/0000-0001-8354-8407; Santi, Lucelia/0000-0002-5698-7006;
   Beys-da-Silva, Walter O/0000-0001-8329-7839; Guimaraes, Jorge
   A./0000-0001-6354-6789; Oliveira, Fabricio Marcus/0000-0001-9963-1758
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministerio
   da Educacao, Brazil (CAPES-MEC)-Edital Toxinologia [Processo:
   23038.006277/2011-85]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Ministerio da Ciencia e Tecnologia, Brazil
   (CNPq-MCT)National Council for Scientific and Technological Development
   (CNPq); NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P41 GM103533]; NATIONAL CENTER FOR
   RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533] Funding Source: NIH RePORTER
FX This work was supported by funding and fellowships from the Brazilian
   Agencies: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior,
   Ministerio da Educacao, Brazil (CAPES-MEC)-Edital Toxinologia (Processo:
   23038.006277/2011-85) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Ministerio da Ciencia e Tecnologia, Brazil
   (CNPq-MCT). This work was also supported by NIH Grant P41 GM103533 (to
   J.R.Y.). We thank Dr. Jeffrey N. Savas for his advice on the mass
   spectrometric analysis and for a critical reading of the manuscript.
CR Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377
   Ambatipudi KS, 2009, J PROTEOME RES, V8, P5093, DOI 10.1021/pr900478h
   Basnakian AG, 2002, ANTIOXID REDOX SIGN, V4, P915, DOI 10.1089/152308602762197452
   Berger M., 2012, RENAL FAILURE FACTS, P157
   Berger M, 2013, TOXICON, V74, P179, DOI 10.1016/j.toxicon.2013.08.061
   Berger M, 2010, TOXICON, V55, P33, DOI 10.1016/j.toxicon.2009.06.033
   Boer-Lima PA, 1999, AM J TROP MED HYG, V61, P698, DOI 10.4269/ajtmh.1999.61.698
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   Bowler RP, 2004, AM J PHYSIOL-LUNG C, V286, pL1095, DOI 10.1152/ajplung.00304.2003
   Brocker C, 2010, J BIOL CHEM, V285, P18452, DOI 10.1074/jbc.M109.077925
   Burdmann EA, 1996, CLIN NEPHROL, V46, P337
   Caliari MV, 1997, PRINCIPIOS MORFOMETR
   Camara NOS, 2005, FREE RADICAL BIO MED, V38, P426, DOI 10.1016/j.freeradbiomed.2004.11.019
   Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P2892, DOI 10.1161/ATVBAHA.112.254078
   Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316
   Carvalho PC, 2012, CURR PROTOC BIOINFOR, P19
   Chandler RJ, 2009, FASEB J, V23, P1252, DOI 10.1096/fj.08-121848
   Chang SH, 2000, AM J PATHOL, V156, P637, DOI 10.1016/S0002-9440(10)64768-2
   Chen GP, 2001, J BIOL CHEM, V276, P49142, DOI 10.1074/jbc.M104879200
   Chinnaiyan AM, 2001, AM J PATHOL, V159, P1199, DOI 10.1016/S0002-9440(10)62505-9
   Da Silva GH, 2004, MICROSC RES TECHNIQ, V65, P276, DOI 10.1002/jemt.20114
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   Devarajan P, 2010, AM J KIDNEY DIS, V56, P632, DOI 10.1053/j.ajkd.2010.04.014
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   DUARTE A, 1994, NEPHROL LATINOAMERIC, V1, P38
   DUARTE AC, 1997, THESIS U FEDERAL RIO
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533
   Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Fan Hui Wen, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P119
   Feng MG, 2010, AM J PHYSIOL-RENAL, V299, pF310, DOI 10.1152/ajprenal.00149.2010
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Godoy JR, 2011, FREE RADICAL BIO MED, V51, P552, DOI 10.1016/j.freeradbiomed.2011.04.036
   GUDER WG, 1984, KIDNEY INT, V26, P101, DOI 10.1038/ki.1984.143
   Khan FY, 2009, NETH J MED, V67, P272
   Klein MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045795
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118
   Linardi A, 2011, BBA-GEN SUBJECTS, V1810, P895, DOI 10.1016/j.bbagen.2011.06.006
   McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603
   Mimura I, 2010, AM J PHYSIOL-RENAL, V299, pF1120, DOI 10.1152/ajprenal.00145.2010
   MORRISSEY JH, 1995, THROMB HAEMOSTASIS, V74, P185
   Nascimento-Silva V, 2012, TOXICON, V60, P50, DOI 10.1016/j.toxicon.2012.03.016
   Nishi H, 2011, AM J PATHOL, V178, P128, DOI 10.1016/j.ajpath.2010.11.011
   Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   Pawluczyk IZA, 1998, KIDNEY INT, V54, P62, DOI 10.1046/j.1523-1755.1998.00965.x
   Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v
   Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Pinto AFM, 2010, TOXICON, V56, P1103, DOI 10.1016/j.toxicon.2010.01.013
   Pompermayer K, 2005, KIDNEY INT, V67, P1785, DOI 10.1111/j.1523-1755.2005.00276.x
   Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696
   Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325
   Revelo MP, 2005, NEPHROL DIAL TRANSPL, V20, P2812, DOI 10.1093/ndt/gfi172
   Ricci-Silva ME, 2008, TOXICON, V51, P1017, DOI 10.1016/j.toxicon.2008.01.013
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041
   Safadi FF, 1999, J CLIN INVEST, V103, P239, DOI 10.1172/JCI5244
   Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   Shashidharamurthy R, 2010, EXP TOXICOL PATHOL, V62, P587, DOI 10.1016/j.etp.2009.08.002
   Sitprija V, 2006, NEPHROLOGY, V11, P442, DOI 10.1111/j.1440-1797.2006.00599.x
   Son D, 2008, AM J PHYSIOL-RENAL, V294, pF62, DOI 10.1152/ajprenal.00113.2007
   Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823
   Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q
   Takatsuka H, 2006, HEMATOLOGY, V11, P101, DOI 10.1080/10245330600574219
   Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207
   Thukral SK, 2005, TOXICOL PATHOL, V33, P343, DOI 10.1080/01926230590927230
   Tofovic SP, 1998, CLIN EXP HYPERTENS, V20, P329, DOI 10.3109/10641969809052125
   Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921
   Trof RJ, 2006, SHOCK, V26, P245, DOI 10.1097/01.shk.0000225415.5969694.ce
   Turnberg D, 2006, J IMMUNOL, V177, P4094, DOI 10.4049/jimmunol.177.6.4094
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Zager RA, 1996, KIDNEY INT, V49, P314, DOI 10.1038/ki.1996.48
   Zager RA, 2012, AM J PHYSIOL-RENAL, V303, pF1460, DOI 10.1152/ajprenal.00426.2012
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 85
TC 12
Z9 14
U1 1
U2 17
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD MAR
PY 2015
VL 89
IS 3
BP 459
EP 483
DI 10.1007/s00204-014-1264-0
PG 25
WC Toxicology
SC Toxicology
GA CC0MP
UT WOS:000350030200014
PM 24798088
OA Green Accepted
DA 2020-11-24
ER

PT J
AU Guimaraes, JA
   de Almeida, ECE
AF Guimaraes, Jorge Almeida
   Edler de Almeida, Elenara Chaves
TI Response to the comments on the article: Brazil's growing production of
   scientific articles-how are we doing with review articles and other
   qualitative indicators?
SO SCIENTOMETRICS
LA English
DT Letter
C1 [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge Almeida] CAPES, Brazilian Fed Agcy Support & Evaluat Grad Educ, Brasilia, DF, Brazil.
   [Edler de Almeida, Elenara Chaves] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Edler de Almeida, Elenara Chaves] CAPES Portal Periodicos, Brasilia, DF, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil.
EM jorge.guimaraes@capes.gov.br; elenara.almeida@capes.gov.br
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
NR 0
TC 0
Z9 0
U1 0
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0138-9130
EI 1588-2861
J9 SCIENTOMETRICS
JI Scientometrics
PD DEC
PY 2014
VL 101
IS 3
BP 2079
EP 2080
DI 10.1007/s11192-014-1413-5
PG 2
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA AT7RW
UT WOS:000345136000028
DA 2020-11-24
ER

PT J
AU Reck, J
   Bandarra, P
   Pavarini, S
   Termignoni, C
   Driemeier, D
   Martins, JR
   Guimaraes, JA
AF Reck, Jose
   Bandarra, Paulo
   Pavarini, Saulo
   Termignoni, Carlos
   Driemeier, David
   Martins, Joao Ricardo
   Guimaraes, Jorge A.
TI Experimentally induced tick toxicosis in rats bitten by Ornithodoros
   brasiliensis (Chelicerata: Argasidae): A clinico-pathological
   characterization
SO TOXICON
LA English
DT Article
DE Argasidae; Venomous arthropod; Skin lesion; Hemorrhage
ID CREATINE-PHOSPHOKINASE; MOURO TICK; PARALYSIS; DISEASE; ACARI
AB Ornithodoros brasiliensis, also known as the mouro tick, is an argasid tick only found in the highlands of Southern Brazil. O. brasiliensis parasitism is associated with severe reactions in its hosts ranging from local pruritus and pain to systemic disturbances. Recently, the reemergence of O. brasiliensis parasitism in humans and dogs drew attention to the clinical findings induced by its bite, which are poorly understood and described. Moreover, rare experimental data about tick bite effects under controlled conditions were available. Thus, this study aimed to describe clinical and pathological findings induced by O. brasiliensis bites in experimentally parasitized rats. Ticks feed for similar to 40 min in rats, and their weight increased by approximately four times after the blood meal. Rats bitten by five adult ticks showed hyperemia of the oral/ocular mucosa, piloerection, tachypnea, claudication, ocular and nasal discharge, pruritus, and swollen and erythemic lesions. A large hemorrhagic lesion was observed on rat skin in tick attachment sites, reaching similar to 17 mm in diameter 12 h after a bite. Bitten rats also presented an increased bleeding tendency (similar to 50%) 6 h after a tick bite, evaluated by the tail-cut rat model of bleeding. Blood samples of bitten rats were taken, and clinical pathology analysis showed significant alterations in the eosinophil and basophil counts, in creatine phosphokinase (CPK) and CPK MB fraction, and lactate dehydrogenase (LDH) activity, and fibrinogen level. Histopathological analysis revealed marked subcutaneous hemorrhage, edema and slight muscle degeneration at the bite site. Also, muscle degeneration and necrosis were observed in the myocardium of bitten rats 72 h after bites by histopathology and immunohistochemistry against troponin C. This work showed the ability of O. brasiliensis to cause severe disturbances in experimentally parasitized rats, compatible with a tick toxicosis syndrome. This observation associated with the re-emergence of O. brasiliensis parasitism makes this parasite as a public health hazard in southern Brazil. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Reck, Jose; Martins, Joao Ricardo] FEPAGRO, IPVDF, Eldorado Do Sul, RS, Brazil.
   [Bandarra, Paulo] Univ Fed Pelotas UFPel, Fac Vet, Pelotas, RS, Brazil.
   [Pavarini, Saulo; Driemeier, David] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil.
   [Termignoni, Carlos; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
   [Termignoni, Carlos] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Reck, J (corresponding author), IPVDF, Parasitol Lab, Estrada Conde,6000, BR-92990000 Eldorado Do Sul, RS, Brazil.
EM jose.reck@gmail.com
RI Guimaraes, Jorge Almeida/V-2196-2019; Driemeier, David/H-3461-2012;
   Termignoni, Carlos/AAB-8943-2020; Reck, Jose/AAH-3373-2020
OI Driemeier, David/0000-0003-3766-0654; Termignoni,
   Carlos/0000-0002-2789-2518; Reck, Jose/0000-0002-0969-792X; Guimaraes,
   Jorge A./0000-0001-6354-6789
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Estadual de Pesquisa Agropecuaria (FEPAGRO);
   Fundacao Estadual de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX We thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES), Fundacao Estadual de Pesquisa Agropecuaria (FEPAGRO), Fundacao
   Estadual de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for
   financial support to this work. Special thanks to Inspetoria Veterinaria
   (IVZ) from Sao Francisco de Paula, namely to Mr. Angelo Valim, for the
   valuable technical support; to Dr. Renata Terra (UFRGS) for critical
   review of this manuscript; to Dr. Fernanda Marks and Dr. Markus Berger
   (UFRGS) for their valuable suggestions; and to Zelma Regina de Almeida
   for help in animal handling.
CR Aragao H. B., 1931, MEM I O CRUZ, V25, P227
   Aragao H. B., 1923, BRAS MED, V37, P20
   Aragao H.de B., 1936, Memorias do Instituto Oswaldo Cruz, V31, P759
   BOFFEY GC, 1973, CAN MED ASSOC J, V108, P866
   Bratton RL, 2005, AM FAM PHYSICIAN, V71, P2323
   Carstens E, 2000, ILAR J, V41, P62
   Costa JJ, 1997, JAMA-J AM MED ASSOC, V278, P1815, DOI 10.1001/jama.278.22.1815
   di Primio R, 1937, ARQ RIOGRAND MED, V306, P406
   DOLAN TT, 1980, TROP ANIM HEALTH PRO, V12, P119, DOI 10.1007/BF02242621
   Francischetti IMB, 2003, BIOCHEM BIOPH RES CO, V305, P869, DOI 10.1016/S0006-291X(03)00857-X
   Gautam Parshotam Lal, 2004, Rev. Bras. Anestesiol., V54, P491, DOI 10.1590/S0034-70942004000400005
   GEIGER T, 1988, EUR J IMMUNOL, V18, P717, DOI 10.1002/eji.1830180510
   GUTIERREZ JM, 1985, TOXICON, V23, P887, DOI 10.1016/0041-0101(85)90380-0
   Hoogstraal H., 1982, LANCET, V320, P288
   Mans BJ, 2008, TICKS: BIOLOGY, DISEASE AND CONTROL, P108, DOI 10.1017/CBO9780511551802.006
   Mans BJ, 2002, TOXICON, V40, P1007, DOI 10.1016/S0041-0101(02)00098-3
   Martins JR, 2011, NEOTROP ENTOMOL, V40, P143, DOI 10.1590/S1519-566X2011000100022
   Nazareth RA, 2006, THROMB HAEMOSTASIS, V96, P7, DOI 10.1160/TH06-02-0105
   Ortmann C, 2000, INT J LEGAL MED, V113, P215, DOI 10.1007/s004149900094
   PARRY BW, 1989, VET CLIN N AM-SMALL, V19, P729, DOI 10.1016/S0195-5616(89)50081-0
   Pinto C., 1931, REV MED CIR BRAS, V34, P5
   Quinton J.F., 2003, NOUVEAUX ANIMAUX COM, P208
   Reck J, 2009, RES VET SCI, V86, P56, DOI 10.1016/j.rvsc.2008.05.007
   Reck J, 2013, PARASITOL RES, V112, P1749, DOI 10.1007/s00436-013-3333-3
   Reck J, 2013, TICKS TICK-BORNE DIS, V4, P101, DOI 10.1016/j.ttbdis.2012.09.004
   Reck J, 2011, VET CLIN PATH, V40, P356, DOI 10.1111/j.1939-165X.2011.00338.x
   Sharifi K, 2003, VET REC, V153, P631, DOI 10.1136/vr.153.20.631
   SOBEL BE, 1972, CIRCULATION, V45, P471, DOI 10.1161/01.CIR.45.2.471
   VANDERVEEN KJ, 1966, CLIN CHIM ACTA, V13, P312, DOI 10.1016/0009-8981(66)90209-9
   Venzal JM, 2007, EXP APPL ACAROL, V42, P217, DOI 10.1007/s10493-007-9089-7
   Walker DH, 1998, ANNU REV PUBL HEALTH, V19, P237, DOI 10.1146/annurev.publhealth.19.1.237
NR 31
TC 4
Z9 4
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD SEP 15
PY 2014
VL 88
BP 99
EP 106
DI 10.1016/j.toxicon.2014.06.017
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA AN6GA
UT WOS:000340691800012
PM 24973739
DA 2020-11-24
ER

PT J
AU Veiga, ABG
   Ribeiro, JMC
   Francischetti, IMB
   Xu, XQ
   Guimaraes, JA
   Andersen, JF
AF Veiga, Ana B. G.
   Ribeiro, Jose M. C.
   Francischetti, Ivo M. B.
   Xu, Xueqing
   Guimaraes, Jorge A.
   Andersen, John F.
TI Examination of the Ligand-Binding and Enzymatic Properties of a
   Bilin-Binding Protein from the Poisonous Caterpillar Lonomia obliqua
SO PLOS ONE
LA English
DT Article
ID OXYGENASE HMU O; MANDUCA-SEXTA L; CORYNEBACTERIUM-DIPHTHERIAE;
   PSEUDOMONAS-AERUGINOSA; HEMORRHAGIC SYNDROME; MOLECULAR-STRUCTURE;
   OXIDATIVE CLEAVAGE; COUPLED OXIDATION; CRYSTAL-STRUCTURE; TOBACCO
   HORNWORM
AB The bilin-binding proteins (BBP) from lepidopteran insects are members of the lipocalin family of proteins and play a special role in pigmentation through the binding of biliverdin IX gamma. Lopap, a BBP-like protein from the venom of the toxic caterpillar Lonomia obliqua has been reported to act as a serine protease that activates the coagulation proenzyme prothrombin. Here we show that BBPLo, a variant of lopap from the same organism binds biliverdin IX gamma, forming a complex that is spectrally identical with previously described BBP proteins. Although BBPLo is nearly identical in sequence to lopap, no prothrombinase activity was detected in our recombinant preparations using reconstituted systems containing coagulation factors Xa and Va, as well as anionic phospholipids. In addition to biliverdin, BBPLo was found to form a 1:1 complex with heme prompting us to examine whether the unusual biliverdin IX gamma ligand of BBPs forms as a result of oxidation of bound heme in situ rather than by a conventional heme oxygenase. Using ascorbate or a NADPH+-ferredoxin reductase-ferredoxin system as a source of reducing equivalents, spectral changes are seen that suggest an initial reduction of heme to the Fe(II) state and formation of an oxyferrous complex. The complex then disappears and a product identified as a 5-coordinate carbonyl complex of verdoheme, an intermediate in the biosynthesis of biliverdin, is formed. However, further reaction to form biliverdin was not observed, making it unlikely that biliverdin IX gamma is formed by this pathway.
C1 [Veiga, Ana B. G.; Ribeiro, Jose M. C.; Francischetti, Ivo M. B.; Xu, Xueqing; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
   [Veiga, Ana B. G.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil.
RP Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.
EM jandersen@niaid.nih.gov
RI Veiga, Ana B. G./N-8581-2013; Guimaraes, Jorge Almeida/V-2196-2019;
   Ribeiro, Jose/J-7011-2015
OI Veiga, Ana B. G./0000-0003-1462-5506; Ribeiro, Jose/0000-0002-9107-0818;
   Guimaraes, Jorge A./0000-0001-6354-6789
FU intramural research program of the NIAID, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [ZIAAI000810, ZIAAI000810,
   ZIAAI001012, ZIAAI001012, ZIAAI001012, ZIAAI000810, ZIAAI000810,
   ZIAAI001012, ZIAAI001012, ZIAAI000810, ZIAAI001012, ZIAAI000810,
   ZIAAI000810, ZIAAI001012, ZIAAI000810, ZIAAI001012, ZIAAI001012,
   ZIAAI001012, ZIAAI000810, ZIAAI000810] Funding Source: NIH RePORTER
FX This work was supported by the intramural research program of the NIAID,
   National Institutes of Health. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Andersen JF, 1998, STRUCTURE, V6, P1315, DOI 10.1016/S0969-2126(98)00131-2
   Andersen JF, 2000, J BIOL CHEM, V275, P30496, DOI 10.1074/jbc.M002857200
   Andersen JF, 2003, J BIOL CHEM, V278, P4611, DOI 10.1074/jbc.M211438200
   Avila L, 2003, J AM CHEM SOC, V125, P4103, DOI 10.1021/ja029311v
   BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9
   Caignan GA, 2002, J AM CHEM SOC, V124, P14879, DOI 10.1021/ja0274960
   de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221
   Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p
   GOODMAN WG, 1985, BIOCHEMISTRY-US, V24, P1168, DOI 10.1021/bi00326a017
   Gudderra NP, 2005, J BIOL CHEM, V280, P25022, DOI 10.1074/jbc.M504386200
   HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x
   HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8
   Monteiro RQ, 2005, BIOCHEM J, V387, P871, DOI 10.1042/BJ20041738
   Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325
   RILEY CT, 1984, J BIOL CHEM, V259, P3159
   Roberts SA, 2001, BIOCHEMISTRY-US, V40, P11327, DOI 10.1021/bi0109257
   Robinson CR, 1997, BIOCHEMISTRY-US, V36, P16141, DOI 10.1021/bi971470h
   Sigman JA, 2001, J AM CHEM SOC, V123, P6945, DOI 10.1021/ja015776u
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Wegele R, 2004, J BIOL CHEM, V279, P45791, DOI 10.1074/jbc.M408303200
   Wilks A, 2000, J BIOL CHEM, V275, P11686, DOI 10.1074/jbc.275.16.11686
   Wilks A, 1996, BIOCHEMISTRY-US, V35, P930, DOI 10.1021/bi952405f
   Wilks A, 1998, J BIOL CHEM, V273, P837, DOI 10.1074/jbc.273.2.837
NR 25
TC 0
Z9 1
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 27
PY 2014
VL 9
IS 6
AR e95424
DI 10.1371/journal.pone.0095424
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AK6BK
UT WOS:000338512200003
PM 24972000
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Meireles, JR
   Guimaraes, JA
   Rosas, MJ
   Vaz, R
AF Meireles, J. R.
   Guimaraes, J. A.
   Rosas, M. J.
   Vaz, R.
TI Nutritional profile of dystonic patients submitted to functional surgery
SO MOVEMENT DISORDERS
LA English
DT Meeting Abstract
CT 18th International Congress of Parkinson's Disease and Movement
   Disorders
CY JUN 08-12, 2014
CL Stockholm, SWEDEN
SP Int Parkinson & Movement Disorder Soc
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-3185
EI 1531-8257
J9 MOVEMENT DISORD
JI Mov. Disord.
PD MAY
PY 2014
VL 29
SU 1
MA 1257
BP S462
EP S462
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA AJ5AT
UT WOS:000337693403144
DA 2020-11-24
ER

PT J
AU Beys-da-Silva, WO
   Santi, L
   Berger, M
   Calzolari, D
   Passos, DO
   Guimaraes, JA
   Moresco, JJ
   Yates, JR
AF Beys-da-Silva, Walter O.
   Santi, Lucelia
   Berger, Markus
   Calzolari, Diego
   Passos, Dario O.
   Guimaraes, Jorge A.
   Moresco, James J.
   Yates, John R.
TI Secretome of the Biocontrol Agent Metarhizium anisopliae Induced by the
   Cuticle of the Cotton Pest Dysdercus peruvianus Reveals New Insights
   into Infection
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Metarhizium anisopliae; shotgun proteomics; biocontrol; host infection;
   Dysdercus peruvianus
ID DIFFERENTIAL SHOTGUN PROTEOMICS; PROTEIN-TYROSINE-PHOSPHATASE;
   BOTRYTIS-CINEREA SECRETOME; FUSARIUM-GRAMINEARUM; VAR.-ACRIDUM; CELL
   WALL; IN-VITRO; HOST; EXPRESSION; GENE
AB Metarhizium anisopliae is an entomopathogenic fungus that has evolved specialized strategies to infect insect hosts. Here we analyzed secreted proteins related to Dysdercus peruvianus infection. Using shotgun proteomics, abundance changes in 71 proteins were identified after exposure to host cuticle. Among these proteins were classical fungal effectors secreted by pathogens to degrade physical barriers and alter host physiology. These include lipolytic enzymes, Pr1A, B, C, I, and J proteases, ROS-related proteins, oxidorreductases, and signaling proteins. Protein interaction networks were generated postulating interesting candidates for further studies, including Pr1C, based on possible functional interactions. On the basis of these results, we propose that M. anisopliae is degrading host components and actively secreting proteins to manage the physiology of the host. Interestingly, the secretion of these factors occurs in the absence of a host response. The findings presented here are an important step in understanding the host pathogen interaction and developing more efficient biocontrol of D. peruvianus by M. anisopliae.
C1 [Beys-da-Silva, Walter O.; Santi, Lucelia; Calzolari, Diego; Moresco, James J.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.
   [Passos, Dario O.] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA.
   [Berger, Markus; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Scripps Res Inst, Dept Physiol Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.
EM wbeys@scripps.edu
RI Santi, Lucelia/AAK-9527-2020; Santi, Lucelia/AAB-8349-2020;
   Beys-da-Silva, Walter O/M-3760-2018; Guimaraes, Jorge
   Almeida/V-2196-2019; Berger, Markus/U-7682-2019; Santi,
   Lucelia/K-4856-2015
OI Santi, Lucelia/0000-0002-5698-7006; Beys-da-Silva, Walter
   O/0000-0001-8329-7839; Berger, Markus/0000-0001-7670-2584; Moresco,
   James/0000-0003-1178-1642; Guimaraes, Jorge A./0000-0001-6354-6789
FU National Center for Research ResourcesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [5P41RR011823-17]; National
   Institute of General Medical SciencesUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [8 P41 GM103533-17];
   National Heart, Lung, and Blood InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [HHSN268201000035C];
   National Institute on AgingUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Aging (NIA) [R01AG027463-04]; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [R01AG027463, R01AG027463,
   R01AG027463, R01AG027463, R01AG027463, R01AG027463] Funding Source: NIH
   RePORTER
FX We thank Dr. Augusto Schrank who kindly provided the M. anisopliae
   strain, Dr. Celia Carlini who kindly provided the insects used in this
   work, and Dr. Jeffrey Savas for technical advice. J.J.M. and J.R.Y. were
   supported by the National Center for Research Resources
   (5P41RR011823-17), National Institute of General Medical Sciences (8 P41
   GM103533-17), National Heart, Lung, and Blood Institute
   (HHSN268201000035C), and National Institute on Aging (R01AG027463-04).
   This work was also supported by grants from the following Brazilian
   agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES). W.O.B.-d.-S. and L.S. are fellows from Brazilian program
   Ciencia Sem Fronteiras, CAPES.
CR Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031
   Baltoumas FA, 2013, J STRUCT BIOL, V182, P209, DOI 10.1016/j.jsb.2013.03.004
   Barros BHR, 2010, FUNGAL BIOL-UK, V114, P572, DOI 10.1016/j.funbio.2010.04.007
   Da Silva WOB, 2010, FUNGAL BIOL-UK, V114, P911, DOI 10.1016/j.funbio.2010.08.007
   Beys-da-Silva WO, 2013, T ROY SOC TROP MED H, V107, P59, DOI 10.1093/trstmh/trs006
   Broetto L, 2010, FEMS MICROBIOL LETT, V312, P101, DOI 10.1111/j.1574-6968.2010.02103.x
   Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731
   Bye NJ, 2008, ARCH MICROBIOL, V189, P81, DOI 10.1007/s00203-007-0296-8
   Carneiro-Leao MP, 2011, GENET MOL RES, V10, P769, DOI 10.4238/vol10-2gmr1094
   Carvalho Paulo C, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1319s40
   Carvalho PC, 2012, BIOINFORMATICS, V28, P1652, DOI 10.1093/bioinformatics/bts247
   Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Cortazar AR, 2014, AMINO ACIDS, V46, P471, DOI 10.1007/s00726-013-1649-z
   Cosentino-Gomes D, 2013, CURR MICROBIOL, V66, P467, DOI 10.1007/s00284-012-0296-z
   Da Silva WOB, 2010, FUNGAL BIOL-UK, V114, P10, DOI 10.1016/j.mycres.2009.08.003
   Deon M, 2012, PLANT SCI, V185, P227, DOI 10.1016/j.plantsci.2011.10.017
   do Amaral AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049904
   Donofrio NM, 2012, CURR OPIN MICROBIOL, V15, P692, DOI 10.1016/j.mib.2012.10.004
   Dou DL, 2012, CELL HOST MICROBE, V12, P484, DOI 10.1016/j.chom.2012.09.003
   Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Espino JJ, 2010, PROTEOMICS, V10, P3020, DOI 10.1002/pmic.201000037
   Fischer S, 2011, CURR PROTOC BIOINFOR, V35
   Freimoser FM, 2005, MICROBIOL-SGM, V151, P361, DOI 10.1099/mic.0.27560-0
   Girard V, 2013, PROTEOMICS, V13, P597, DOI 10.1002/pmic.201200282
   Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365
   He YT, 2013, J MED CHEM, V56, P832, DOI 10.1021/jm301781p
   Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355
   Heyno E, 2013, PHYSIOL PLANTARUM, V149, P340, DOI 10.1111/ppl.12042
   Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696
   Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259
   Fernandez-Acero FJ, 2010, PROTEOMICS, V10, P2270, DOI 10.1002/pmic.200900408
   Li Z, 2008, J INVERTEBR PATHOL, V99, P151, DOI 10.1016/j.jip.2008.07.002
   Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563
   Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036
   Manalil NS, 2010, FUNGAL BIOL-UK, V114, P637, DOI 10.1016/j.funbio.2010.05.005
   Manalil NS, 2009, CURR GENET, V55, P571, DOI 10.1007/s00294-009-0270-x
   McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603
   Midega CAO, 2012, CROP PROT, V42, P193, DOI 10.1016/j.cropro.2012.07.010
   Hernandez CEM, 2010, APPL MICROBIOL BIOT, V87, P1033, DOI 10.1007/s00253-010-2517-3
   Murad AM, 2008, MICROBIOL-SGM, V154, P3766, DOI 10.1099/mic.0.2008/022913-0
   Okino N, 2007, J BIOL CHEM, V282, P6021, DOI 10.1074/jbc.M603088200
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Phalip V, 2005, CURR GENET, V48, P366, DOI 10.1007/s00294-005-0040-3
   Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392
   Rampitsch C, 2013, PROTEOMICS, V13, P1913, DOI 10.1002/pmic.201200446
   Santi L, 2012, TICKS DIS MANAGEMENT, P217
   Santi L, 2011, WORLD J MICROB BIOT, V27, P2297, DOI 10.1007/s11274-011-0695-5
   Santi L, 2010, FUNGAL BIOL-UK, V114, P312, DOI 10.1016/j.funbio.2010.01.006
   Santi L, 2010, TOXICON, V55, P874, DOI 10.1016/j.toxicon.2009.12.012
   Santi L, 2009, RES MICROBIOL, V160, P824, DOI 10.1016/j.resmic.2009.09.012
   Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048
   Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098
   Shah P, 2012, J PROTEOME RES, V11, P2178, DOI 10.1021/pr200965c
   Shah P, 2009, J PROTEOME RES, V8, P1123, DOI 10.1021/pr8003002
   Shang YF, 2012, J INVERTEBR PATHOL, V109, P105, DOI 10.1016/j.jip.2011.10.004
   Silva WOB, 2009, PROCESS BIOCHEM, V44, P829, DOI 10.1016/j.procbio.2009.03.019
   Silva WOB, 2005, PROCESS BIOCHEM, V40, P321, DOI [10.1016/j.procbio.2003.11.053, 10.1016/j.procbio.2004.01.005]
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   St Leger RJ, 2010, APPL MICROBIOL BIOT, V85, P901, DOI 10.1007/s00253-009-2306-z
   Su YB, 2013, CAN J MICROBIOL, V59, P443, DOI 10.1139/cjm-2013-0096
   Suarez MB, 2005, FUNGAL GENET BIOL, V42, P924, DOI 10.1016/j.fgb.2005.08.002
   Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q
   Tudzynski P, 2012, CURR OPIN MICROBIOL, V15, P653, DOI 10.1016/j.mib.2012.10.002
   Wang CS, 2005, EUKARYOT CELL, V4, P937, DOI 10.1128/EC.4.5.937-947.2005
   Wang ZL, 2013, ENVIRON MICROBIOL, V15, P409, DOI 10.1111/j.1462-2920.2012.02848.x
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Wawra S, 2012, CURR OPIN MICROBIOL, V15, P685, DOI 10.1016/j.mib.2012.10.008
   Xie XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030298
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Yang F, 2012, MOL PLANT PATHOL, V13, P445, DOI 10.1111/j.1364-3703.2011.00759.x
NR 74
TC 23
Z9 22
U1 0
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD MAY
PY 2014
VL 13
IS 5
BP 2282
EP 2296
DI 10.1021/pr401204y
PG 15
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA AG5WY
UT WOS:000335490600006
PM 24702058
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU Santi, L
   Beys-Da-Silva, WO
   Berger, M
   Calzolari, D
   Guimaraes, JA
   Moresco, JJ
   Yates, JR
AF Santi, Lucelia
   Beys-da-Silva, Walter O.
   Berger, Markus
   Calzolari, Diego
   Guimaraes, Jorge A.
   Moresco, James J.
   Yates, John R., III
TI Proteomic Profile of Cryptococcus neoformans Biofilm Reveals Changes in
   Metabolic Processes
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Cryptococcus neoformans; biofilm; shotgun proteomics; metabolic changes;
   resistance
ID CANDIDA-ALBICANS; PLASMINOGEN-BINDING; GENE ONTOLOGY; PROTEIN; TOOL;
   IDENTIFICATION; RESISTANCE; INFECTION; DISCOVERY; SURFACE
AB Cryptococcus neoformans, a pathogenic yeast, causes meningoencephalitis, especially in immunocompromised patients, leading in some cases to death. Microbes in biofilms can cause persistent infections, which are harder to treat. Cryptococcal biofilms are becoming common due to the growing use of brain valves and other medical devices. Using shotgun proteomics we determine the differences in protein abundance between biofilm and planktonic cells. Applying bioinformatic tools, we also evaluated the metabolic pathways involved in biofilm maintenance and protein interactions. Our proteomic data suggest general changes in metabolism, protein turnover, and global stress responses. Biofilm cells show an increase in proteins related to oxidation reduction, proteolysis, and response to stress and a reduction in proteins related to metabolic process, transport, and translation. An increase in pyruvate-utilizing enzymes was detected, suggesting a shift from the TCA cycle to fermentation-derived energy acquisition. Additionally, we assign putative roles to 33 proteins previously categorized as hypothetical. Many changes in metabolic enzymes were identified in studies of bacterial biofilm, potentially revealing a conserved strategy in biofilm lifestyle.
C1 [Santi, Lucelia; Beys-da-Silva, Walter O.; Calzolari, Diego; Moresco, James J.; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.
   [Berger, Markus; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, BR-91501970 Porto Alegre, RS, Brazil.
RP Santi, L (corresponding author), Scripps Res Inst, Dept Physiol Chem, North Torrey Pines Rd,Suite 11, La Jolla, CA 92037 USA.
EM lsanti@scripps.edu; jyates@scripps.edu
RI Santi, Lucelia/AAB-8349-2020; Santi, Lucelia/AAK-9527-2020;
   Beys-da-Silva, Walter O/M-3760-2018; Berger, Markus/U-7682-2019; Santi,
   Lucelia/K-4856-2015; Guimaraes, Jorge Almeida/V-2196-2019
OI Santi, Lucelia/0000-0002-5698-7006; Beys-da-Silva, Walter
   O/0000-0001-8329-7839; Berger, Markus/0000-0001-7670-2584; Moresco,
   James/0000-0003-1178-1642; Guimaraes, Jorge A./0000-0001-6354-6789
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; National Center for Research ResourcesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR)
   [SP41RR011823-17]; National Institute of General Medical SciencesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [8 P41 GM103533-17]; National Institute on AgingUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [R01AG027463-04]; National
   Heart, Lung, and Blood InstituteUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [5R01 HL019442]; NATIONAL CENTER
   FOR RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823, P41RR011823,
   P41RR011823, P41RR011823, P41RR011823, P41RR011823] Funding Source: NIH
   RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL079442,
   R01HL079442, R01HL079442, R01HL079442, R01HL079442, R01HL079442,
   R01HL079442, R01HL079442, R01HL079442, R01HL079442] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533, P41GM103533, P41GM103533, P41GM103533, P41GM103533,
   P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON
   AGINGUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [R01AG027463, R01AG027463, R01AG027463, R01AG027463, R01AG027463,
   R01AG027463] Funding Source: NIH RePORTER
FX We thank Dr. Marlene H. Vainstein for providing the C. neoformans H99
   strain and Dr. Dario Passos for technical support. This work was
   supported by grants from the following Brazilian agencies: Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).
   W.O.B.S. and L.S. are fellows from Brazilian program Ciencia Sem
   Fronteiras, CAPES. J.J.M. and J.R.Y. were supported by the National
   Center for Research Resources (SP41RR011823-17), National Institute of
   General Medical Sciences (8 P41 GM103533-17), National Institute on
   Aging (R01AG027463-04), and National Heart, Lung, and Blood Institute
   (5R01 HL019442).
CR Allison KR, 2011, CURR OPIN MICROBIOL, V14, P593, DOI 10.1016/j.mib.2011.09.002
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Banerjee U, 1997, J MED VET MYCOL, V35, P139
   Berger M, 2008, TOXICON, V51, P488, DOI [10.1016/j.toxicon.2007-09.005, 10.1016/j.toxicon.2007.09.005]
   BRAUN DK, 1994, AM J KIDNEY DIS, V24, P864, DOI 10.1016/S0272-6386(12)80683-4
   Brown SM, 2007, CURR OPIN MICROBIOL, V10, P320, DOI 10.1016/j.mib.2007.05.014
   Gomez NC, 2013, INT J FOOD MICROBIOL, V167, P202, DOI 10.1016/j.ijfoodmicro.2013.08.019
   Carvalho Paulo C, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1319s40
   Carvalho PC, 2012, BIOINFORMATICS, V28, P1652, DOI 10.1093/bioinformatics/bts247
   Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316
   Charlier C, 2009, INFECT IMMUN, V77, P120, DOI 10.1128/IAI.01065-08
   Chew J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-189
   Chong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042835
   Clark ME, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-138
   Collopy I, 2006, FEMS YEAST RES, V6, P1010, DOI 10.1111/j.1567-1364.2006.00105.x
   Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610
   Cosentino-Gomes D, 2013, CURR MICROBIOL, V66, P467, DOI 10.1007/s00284-012-0296-z
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crestani J, 2012, J PROTEOME RES, V11, P189, DOI 10.1021/pr2005296
   Crowe JD, 2003, MOL MICROBIOL, V47, P1637, DOI 10.1046/j.1365-2958.2003.03390.x
   Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037
   Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903
   ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2
   Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004
   Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06
   Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367
   Fox D, 2001, MED MYCOL, V39, P495
   Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176
   He YT, 2013, J MED CHEM, V56, P832, DOI 10.1021/jm301781p
   Hooper SD, 2005, BIOINFORMATICS, V21, P4432, DOI 10.1093/bioinformatics/bti696
   il Yoo J, 2004, J CLIN MICROBIOL, V42, P722, DOI 10.1128/JCM.42.2.722-726.2004
   Jain S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-562
   Jensen LJ, 2003, BIOINFORMATICS, V19, P635, DOI 10.1093/bioinformatics/btg036
   Johannsson B, 2009, DIAGN MICR INFEC DIS, V64, P76, DOI 10.1016/j.diagmicrobio.2009.01.005
   Kakeya H, 1999, CLIN EXP IMMUNOL, V115, P485
   Kakeya H, 1997, INFECT IMMUN, V65, P1653, DOI 10.1128/IAI.65.5.1653-1658.1997
   Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320
   Klein MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045795
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522
   Kwan BW, 2013, ANTIMICROB AGENTS CH, V57, P1468, DOI 10.1128/AAC.02135-12
   Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045
   Leung CY, 2012, J HOSP INFECT, V81, P79, DOI 10.1016/j.jhin.2011.09.014
   Li JS, 2013, PROTEOMICS, V13, P3470, DOI 10.1002/pmic.201300077
   Ma HS, 2009, ADV APPL MICROBIOL, V67, P131, DOI 10.1016/S0065-2164(08)01005-8
   Ma YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047255
   Martinez LR, 2006, ANTIMICROB AGENTS CH, V50, P1021, DOI 10.1128/AAC.50.3.1021-1033.2006
   Martinez LR, 2007, APPL ENVIRON MICROB, V73, P4592, DOI 10.1128/AEM.02506-06
   Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913
   McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603
   MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515
   Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06
   Paddick JS, 2006, APPL ENVIRON MICROB, V72, P3774, DOI 10.1128/AEM.72.5.3774-3779.2006
   Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Petrova OE, 2012, MOL MICROBIOL, V86, P819, DOI 10.1111/mmi.12018
   Phillips NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038303
   Ramage G, 2013, ADV APPL MICROBIOL, V84, P27, DOI 10.1016/B978-0-12-407673-0.00002-3
   Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436
   Rathsam C, 2005, MICROBIOL-SGM, V151, P1823, DOI 10.1099/mic.0.27830-0
   Rodrigues ML, 2003, MICROB PATHOGENESIS, V34, P65, DOI 10.1016/S0882-4010(02)00195-X
   Saar-Dover R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002891
   Santi L, 2010, TOXICON, V55, P874, DOI 10.1016/j.toxicon.2009.12.012
   Seneviratne CJ, 2012, PROTEOMICS, V12, P651, DOI 10.1002/pmic.201100356
   Seneviratne CJ, 2010, PROTEOMICS, V10, P1444, DOI 10.1002/pmic.200900611
   Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53
   Shi MQ, 2012, CELL MICROBIOL, V14, P1819, DOI 10.1111/cmi.12027
   Silveira CP, 2013, FUNGAL GENET BIOL, V60, P53, DOI 10.1016/j.fgb.2013.08.005
   Stie J, 2012, MICROBIOL-SGM, V158, P240, DOI 10.1099/mic.0.051524-0
   Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q
   Thomas DP, 2006, PROTEOMICS, V6, P5795, DOI 10.1002/pmic.200600332
   Tournu H, 2005, CURR DRUG TARGETS, V6, P909, DOI 10.2174/138945005774912690
   Vaejo MC, 2012, J PROTEOME RES, V11, P1676, DOI 10.1021/pr200872s
   Van Acker H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058943
   Vu K, 2013, INFECT IMMUN, V81, P3139, DOI 10.1128/IAI.00554-13
   WALSH TJ, 1986, NEUROSURGERY, V18, P373, DOI 10.1097/00006123-198603000-00025
   Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033371
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174
   Yeom J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057730
NR 82
TC 32
Z9 33
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD MAR
PY 2014
VL 13
IS 3
BP 1545
EP 1559
DI 10.1021/pr401075f
PG 15
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA AC8AV
UT WOS:000332756300034
PM 24467693
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU de Paula, FT
   Frauches, PQ
   Pedebos, C
   Berger, M
   Gnoatto, SCB
   Gossmann, G
   Verli, H
   Guimaraes, JA
   Graebin, CS
AF de Paula, Fernando T.
   Frauches, Petrina Q.
   Pedebos, Conrado
   Berger, Markus
   Gnoatto, Simone C. B.
   Gossmann, Grace
   Verli, Hugo
   Guimaraes, Jorge A.
   Graebin, Cedric S.
TI Improving the Thrombin Inhibitory Activity of Glycyrrhizin, a
   Triterpenic Saponin, Through a Molecular Simplification of the
   Carbohydrate Moiety
SO CHEMICAL BIOLOGY & DRUG DESIGN
LA English
DT Article
DE glucuronic acid; glycyrrhetinic acid; glycyrrhizin; saponin; thrombin
ID GLYCYRRHETINIC ACID-DERIVATIVES; ANTICOAGULANTS; CELLS
AB Glycyrrhizin, a saponin, and its aglycone glycyrrhetinic acid are natural products found in the Liquorice (Glycyrrhiza glabra L.) root extract. This saponin is known for its in vitro and in vivo thrombin inhibitory activity. The design and synthesis of five glycyrrhizin derivatives were carried out to improve the natural product activity. Compound 3b, a phthalic ester derivative of glycyrrhizin, presented a more pronounced thrombin inhibition (IC50=114.4 +/- 1.3m) than the saponin (IC50=235.7 +/- 1.4m). Molecular docking simulations performed to investigate the molecular interaction between compound 3b and the enzyme indicate that this product is, as previously determined for glycyrrhizin, an allosteric thrombin inhibitor.
C1 [de Paula, Fernando T.; Frauches, Petrina Q.; Graebin, Cedric S.] Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Lab Diversidade Mol & Quim Med LaDMol QM, Dept Quim, BR-23897000 Seropedica, RJ, Brazil.
   [Pedebos, Conrado; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Grp Bioinformat Estrutural, BR-91501970 Porto Alegre, RS, Brazil.
   [Berger, Markus; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, BR-91501970 Porto Alegre, RS, Brazil.
   [Gnoatto, Simone C. B.; Gossmann, Grace] Univ Fed Rio Grande do Sul, Fac Farm, Lab Fitoquim, BR-90610000 Porto Alegre, RS, Brazil.
RP Graebin, CS (corresponding author), Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Lab Diversidade Mol & Quim Med LaDMol QM, Dept Quim, Rodovia BR-465,Km 7, BR-23897000 Seropedica, RJ, Brazil.
EM cedric@ufrrj.br
RI Gnoatto, Simone/K-6877-2012; Gosmann, Grace/G-3331-2012; Gosmann,
   Grace/AAJ-9760-2020; Guimaraes, Jorge Almeida/V-2196-2019; Verli,
   Hugo/G-8703-2012; Berger, Markus/U-7682-2019; Graebin, Cedric
   S/F-2009-2010
OI Gosmann, Grace/0000-0001-6823-8312; Gosmann, Grace/0000-0001-6823-8312;
   Verli, Hugo/0000-0002-4796-8620; Berger, Markus/0000-0001-7670-2584;
   Graebin, Cedric S/0000-0003-1410-1227; Gnoatto,
   Simone/0000-0002-8806-3182; Pedebos, Conrado/0000-0003-0378-4851;
   Guimaraes, Jorge A./0000-0001-6354-6789
FU Universidade Federal Rural do Rio de Janeiro; FAPERJ (Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ); CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq); CAPES
   (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)CAPES;
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do
   Sul)Foundation for Research Support of the State of Rio Grande do Sul
   (FAPERGS)
FX F. T. de Paula acknowledges funding from the Universidade Federal Rural
   do Rio de Janeiro. Petrina Q. Frauches and C. S. Graebin acknowledge
   funding from FAPERJ (Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro). H. Verli, C. Pedebos and M. Berger acknowledge funding from
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico),
   CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and
   FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul).
CR Al-Horani RA, 2011, J MED CHEM, V54, P6125, DOI 10.1021/jm2008387
   Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538
   Chintharlapalli S, 2007, MOL CANCER THER, V6, P1588, DOI 10.1158/1535-7163.MCT-07-0022
   Dahmer T, 2012, J MED FOOD, V15, P1073, DOI 10.1089/jmf.2011.0320
   Fernandez PV, 2013, J BIOL CHEM, V288, P223, DOI 10.1074/jbc.M112.386441
   Graebin CS, 2010, J BRAZIL CHEM SOC, V21, P1595, DOI 10.1590/S0103-50532010000900002
   Huang L, 2008, BIOORGAN MED CHEM, V16, P6696, DOI 10.1016/j.bmc.2008.05.078
   Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0
   Liu D, 2007, BIOORGAN MED CHEM, V15, P5432, DOI 10.1016/j.bmc.2007.05.057
   Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735
   Melnikova I, 2009, NAT REV DRUG DISCOV, V8, P353, DOI 10.1038/nrd2851
   Mendes-Silva W, 2003, THROMB RES, V112, P93, DOI 10.1016/j.thromres.2003.10.014
   Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705
   Strobeck JE, 2012, CARDIOVASC DRUG THER, V26, P331, DOI 10.1007/s10557-012-6396-y
   Tsiridis E, 2011, CURR VASC PHARMACOL, V9, P42, DOI 10.2174/157016111793744670
   Yu DL, 2006, J MED CHEM, V49, P5462, DOI 10.1021/jm0601912
NR 16
TC 6
Z9 6
U1 0
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1747-0277
EI 1747-0285
J9 CHEM BIOL DRUG DES
JI Chem. Biol. Drug Des.
PD DEC
PY 2013
VL 82
IS 6
BP 756
EP 760
DI 10.1111/cbdd.12204
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 255RH
UT WOS:000327257000010
PM 23964664
DA 2020-11-24
ER

PT J
AU de Almeida, ECE
   Guimaraes, JA
AF Edler de Almeida, Elenara Chaves
   Guimaraes, Jorge Almeida
TI Brazil's growing production of scientific articles-how are we doing with
   review articles and other qualitative indicators?
SO SCIENTOMETRICS
LA English
DT Review
DE Brazilian science; Brazilian review articles; Scientific production; S&T
   qualitative data; Brazilian postgraduate programs; Growth of scientific
   production
ID SCIENCE; IMPACT
AB This article identifies scientific fields in Brazil that have been generating new knowledge, their evolution, tendencies and the relationship between scientific production and the National Postgraduate Program (Programa Nacional de Ps-Gradua double dagger o-PNPG). It works with review articles and assesses: (a) articles published as reviews by international databases; (b) the growth of Brazilian participation in that context; (c) institutional participation; (d) the predominant fields of knowledge; (e) the most productive authors, and (f) periodicals that published the greatest number of review articles by Brazilian authors. The 5,348 review articles published between 2000 and 2009 were made available in 1,309 scientific publications, and the fields that published the most reviews were Pharmacology, Chemistry, Neurosciences, Biochemistry and Molecular Biology, Psychiatry, Neurology, Endocrinology and Internal Medicine. The reviews were produced by 27,096 authors under the auspices of 20 institutions which, together, answer for 95 % of the Brazilian production, and are public, excepting for the Pontificia Universidade Catlica do Rio Grande do Sul (PUC-RS). In the international scenario, we find that 31 countries are responsible for 90.11 % of the total scientific production and 94.08 % of the review articles. To establish a comparison between Brazil and its closest competitors, these countries can be classified arbitrarily in three groups: (1) countries with a large number of review articles (> 3100), an average number of citations above 18, and an h-index greater than 95; (2) countries with a significant production of articles (between 2,000 and 3,000), average number of citations between 12 and 17, and an h-index below 95. Brazil is in the third group, (3) formed by countries with a lower level of production and the two qualitative indicators at opposite poles: the average of citations on a par with the first group (> 18) and h-indexes like those of the second group (< 95).
C1 [Edler de Almeida, Elenara Chaves] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Edler de Almeida, Elenara Chaves] CAPES Portal Period, Brasilia, DF, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil.
EM elenara.almeida@capes.gov.br; jorge.guimaraes@capes.gov.br
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR Almeida E. C. E, 2010, REV BRAS POS GRADUAC, V7, P218
   Batovski B. D, 2008, ASSUMPTION U J TECHN, V11, P199
   Coutinho RX, 2012, SCIENTOMETRICS, V92, P697, DOI 10.1007/s11192-012-0645-5
   de Meis L, 2007, IUBMB LIFE, V59, P227, DOI 10.1080/15216540701258140
   Filgueiras C. A. L, 1990, QUIM NOVA, V13, P222
   Guimaraes J. A, 2007, PARCERIAS ESTRATEGIC
   GUIMARAES JA, 1995, SCIENTOMETRICS, V34, P101, DOI 10.1007/BF02019176
   Guimarães Jorge A., 2004, Ciênc. saúde coletiva, V9, P303, DOI 10.1590/S1413-81232004000200009
   King D, 2004, NATURE, V432, P8, DOI 10.1038/432008b
   King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a
   LUCK JM, 1981, ANNU REV BIOCHEM, V50, P1, DOI 10.1146/annurev.bi.50.070181.000245
   Rapple C, 2011, ANN REV WHITE PAPERS
   Taylor D, 2008, WRITING HLTH SCI COM, V1
NR 13
TC 25
Z9 31
U1 0
U2 38
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0138-9130
EI 1588-2861
J9 SCIENTOMETRICS
JI Scientometrics
PD NOV
PY 2013
VL 97
IS 2
BP 287
EP 315
DI 10.1007/s11192-013-0967-y
PG 29
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA 232EW
UT WOS:000325475300009
DA 2020-11-24
ER

PT J
AU Berger, M
   Beys-da-Silva, WO
   Santi, L
   de Oliveira, IM
   Jorge, PM
   Henriques, JAP
   Driemeier, D
   Vieira, MAR
   Guimaraes, JA
AF Berger, Markus
   Beys-da-Silva, Walter Orlando
   Santi, Lucelia
   de Oliveira, Iuri Marques
   Jorge, Patricia Mendes
   Pegas Henriques, Joao Antonio
   Driemeier, David
   Ribeiro Vieira, Maria Aparecida
   Guimaraes, Jorge Almeida
TI Acute Lonomia obliqua caterpillar envenomation-induced
   physiopathological alterations in rats: Evidence of new toxic venom
   activities and the efficacy of serum therapy to counteract systemic
   tissue damage
SO TOXICON
LA English
DT Article
DE Lonomia; Caterpillar; Venom; Hemorrhagic syndrome; Genotoxicity;
   Nephrotoxicity
ID ACUTE-RENAL-FAILURE; TERRIFICUS SNAKE-VENOM; HEMORRHAGIC SYNDROME;
   BRISTLE EXTRACT; PROTHROMBIN ACTIVATOR; BLOOD INCOAGULABILITY;
   ACCIDENTAL CONTACT; PHOSPHOLIPASE A(2); CREATINE-KINASE; SOUTHERN BRAZIL
AB The clinical manifestations of Lonomia obliqua caterpillar envenomation are systemic hemorrhage and acute kidney injury. In an effort to better understand the physiopathological mechanisms of envenomation, a rat model was established to study systemic tissue damage during L. oblique envenomation. An array of acute venom effects was characterized, including biochemical, hematological, histopathological, myotoxic and genotoxic alterations. Rapid increases in serum alanine and aspartate transaminases, gamma-glutamyl transferase, lactate dehydrogenase, hemoglobin, bilirubin, creatinine, urea and uric acid were observed, indicating that intravascular hemolysis and liver and kidney damage had occurred. Treatment with a specific antivenom (antilonomic serum) for up to 2 h post-venom injection neutralized the biochemical alterations. However, treatment after 6 h post-venom injection failed to normalize all biochemical parameters, despite its efficacy in reversing coagulation dysfunction. The hematological findings were consistent with hemolytic anemia and neutrophilic leukocytosis. The histopathological alterations were mainly related to hemorrhage and inflammation in the subcutaneous tissue, lung, heart and kidneys. Signs of congestion and hemosiderosis were evident in the spleen, and hemoglobin and/or myoglobin casts were also detected in the renal tubules. Increased levels of creatine kinase and creatine kinase-MB were correlated with the myocardial necrosis observed in vivo and confirmed the myotoxicity detected in vitro in isolated extensor digitorum longus muscles. Significant DNA damage was observed in the kidneys, heart, lung, liver and lymphocytes. The majority of the DNA lesions in the kidney were due to oxidative damage. The results presented here will aid in understanding the pathology underlying Lonomia's envenomation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Berger, Markus; Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, BR-91501970 Porto Alegre, RS, Brazil.
   [Beys-da-Silva, Walter Orlando; Santi, Lucelia] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.
   [de Oliveira, Iuri Marques; Jorge, Patricia Mendes; Pegas Henriques, Joao Antonio] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biofis, BR-91501970 Porto Alegre, RS, Brazil.
   [Driemeier, David] Univ Fed Rio Grande do Sul, Fac Med Vet, Dept Patol Clin Vet, BR-91501970 Porto Alegre, RS, Brazil.
   [Ribeiro Vieira, Maria Aparecida] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Lab Fisiol Renal, Belo Horizonte, MG, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Guimaraes, Jorge
   Almeida/V-2196-2019; marques de oliveira, Iuri/L-7585-2015; Driemeier,
   David/H-3461-2012; Santi, Lucelia/K-4856-2015; Santi,
   Lucelia/AAK-9527-2020; Berger, Markus/U-7682-2019; Santi,
   Lucelia/AAB-8349-2020; de Olveira, Iuri/AAV-2953-2020
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Driemeier,
   David/0000-0003-3766-0654; Berger, Markus/0000-0001-7670-2584; Santi,
   Lucelia/0000-0002-5698-7006; Guimaraes, Jorge A./0000-0001-6354-6789
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Ministerio
   da Educacao, Brazil (CAPES-MEC) - Edital Toxinologia
   [23038.006277/2011-85]; Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico, Ministerio da Ciencia e Tecnologia, Brazil
   (CNPq-MCT)National Council for Scientific and Technological Development
   (CNPq)
FX We would like to thank Dr. Carlos Termignoni (Departamento de Bioquimica
   e Centro de Biotecnologia - Universidade Federal do Rio Grande do Sul)
   for his critical review of the manuscript. We are also indebted to Mrs.
   Zelma Regina de Almeida for her animal handling. This work was supported
   by funding and fellowships from the Brazilian Agencies: Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior, Ministerio da Educacao,
   Brazil (CAPES-MEC) - Edital Toxinologia (Processo: 23038.006277/2011-85)
   and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Ministerio da Ciencia e Tecnologia, Brazil (CNPq-MCT).
CR Abdulkader RCRM, 2008, SEMIN NEPHROL, V28, P373, DOI 10.1016/j.semnephrol.2008.04.006
   Alegre VD, 2010, TOXICON, V56, P402, DOI 10.1016/j.toxicon.2010.04.003
   APPLE FS, 1994, J CLIN IMMUNOASSAY, V17, P24
   Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   Azqueta A, 2009, MUTAT RES-GEN TOX EN, V674, P101, DOI 10.1016/j.mrgentox.2008.10.013
   Berger M., 2012, RENAL FAILURE FACTS, P157
   Berger M, 2010, J THROMB THROMBOLYS, V30, P300, DOI 10.1007/s11239-010-0449-5
   Berger M, 2010, TOXICON, V55, P33, DOI 10.1016/j.toxicon.2009.06.033
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   Burdmann EA, 1996, CLIN NEPHROL, V46, P337
   Burlinson B, 2007, MUTAT RES-GEN TOX EN, V627, P31, DOI 10.1016/j.mrgentox.2006.08.011
   Caovilla JJ, 2004, TOXICON, V43, P811, DOI 10.1016/j.toxicon.2004.03.014
   Da Silva GH, 2004, MICROSC RES TECHNIQ, V65, P276, DOI 10.1002/jemt.20114
   da Silva GH, 2004, TOXICON, V44, P625, DOI 10.1016/j.toxicon.2004.07.016
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Ejaz AA, 2007, CLIN J AM SOC NEPHRO, V2, P16, DOI 10.2215/CJN.00350106
   Frezzatti R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001312
   Fuly AL, 2003, INT J BIOCHEM CELL B, V35, P1470, DOI 10.1016/S1357-2725(03)00129-8
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Garcia CM, 2007, REV SOC BRAS MED TRO, V40, P242, DOI 10.1590/S0037-86822007000200021
   Goncalves LRC, 2007, TOXICON, V50, P349, DOI 10.1016/j.toxicon.2007.04.004
   Greggio S, 2009, NEUROBIOL DIS, V36, P435, DOI 10.1016/j.nbd.2009.08.008
   Guimaraes J.A., 2011, DOENCAS NEGLIGENCIAD, P34
   Hossler EW, 2010, J AM ACAD DERMATOL, V62, P13, DOI 10.1016/j.jaad.2009.08.061
   Kowacs PA, 2006, ARQ NEURO-PSIQUIAT, V64, P1030, DOI 10.1590/S0004-282X2006000600029
   Malaque CMS, 2006, AM J TROP MED HYG, V74, P807, DOI 10.4269/ajtmh.2006.74.807
   Marcussi S, 2013, TOXICON, V65, P9, DOI 10.1016/j.toxicon.2012.12.020
   Marcussi S, 2011, MUTAT RES-GEN TOX EN, V724, P59, DOI 10.1016/j.mrgentox.2011.06.004
   MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545
   Nadin SB, 2001, J HISTOCHEM CYTOCHEM, V49, P1183, DOI 10.1177/002215540104900912
   Nascimento-Silva V, 2012, TOXICON, V60, P50, DOI 10.1016/j.toxicon.2012.03.016
   Otero R, 2002, TOXICON, V40, P1107, DOI 10.1016/S0041-0101(02)00104-6
   Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   Pinho FMO, 2005, KIDNEY INT, V67, P659, DOI 10.1111/j.1523-1755.2005.67122.x
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Pinto AFM, 2010, TOXICON, V56, P1103, DOI 10.1016/j.toxicon.2010.01.013
   Prado M, 2010, TOXICON, V56, P1007, DOI 10.1016/j.toxicon.2010.07.005
   Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325
   Reis CV, 2001, THROMB RES, V102, P437, DOI 10.1016/S0049-3848(01)00268-7
   Ricci-Silva ME, 2008, TOXICON, V51, P1017, DOI 10.1016/j.toxicon.2008.01.013
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   Seibert CS, 2010, TOXICON, V55, P1323, DOI 10.1016/j.toxicon.2010.02.003
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   Shashidharamurthy R, 2010, EXP TOXICOL PATHOL, V62, P587, DOI 10.1016/j.etp.2009.08.002
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Sitprija V, 2006, NEPHROLOGY, V11, P442, DOI 10.1111/j.1440-1797.2006.00599.x
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Veiga A. B. G., 2009, ANIMAL TOXINS STATE, P371
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Yamasaki SC, 2008, TOXICON, V52, P445, DOI 10.1016/j.toxicon.2008.06.015
   Zager RA, 1996, KIDNEY INT, V49, P314, DOI 10.1038/ki.1996.48
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
   Zelanis A, 2011, PROTEOMICS, V11, P4218, DOI 10.1002/pmic.201100287
NR 58
TC 8
Z9 8
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD NOV
PY 2013
VL 74
BP 179
EP 192
DI 10.1016/j.toxicon.2013.08.061
PG 14
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 239EM
UT WOS:000326005400021
PM 23994591
DA 2020-11-24
ER

PT J
AU Reck, J
   Marks, FS
   Termignoni, C
   Guimaraes, JA
   Martins, JR
AF Reck, Jose
   Marks, Fernanda S.
   Termignoni, Carlos
   Guimaraes, Jorge A.
   Martins, Joao Ricardo
TI Ornithodoros brasiliensis (mouro tick) salivary gland homogenates
   inhibit in vivo wound healing and in vitro endothelial cell
   proliferation
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID ANGIOGENESIS; EXTRACTS; DISEASES
AB Ornithodoros brasiliensis is a nidicolous tick only found in the southern Brazilian highlands region. O. brasiliensis parasitism is frequently associated with toxicosis syndrome, which can lead to severe reactions, ranging from local pruritus and pain to systemic disturbances both in humans and dogs. One of the most frequent findings associated with an O. brasiliensis bite is a slow healing lesion at the site of tick attachment, which can take several weeks to heal. This work tested the hypothesis that an O. brasiliensis salivary gland homogenate is able to modulate the skin wound-healing process in vivo, using a model of excisional skin lesion in rats, which are divided into two groups: (1) control group and (2) treated group, which topically received salivary gland homogenate equivalent to the protein amount of one whole salivary gland (a parts per thousand 5 mu g protein). The hypothesis that O. brasiliensis salivary gland homogenates interfere with endothelial cell proliferation, a key role phenomenon in wound healing, was also tested. O. brasiliensis salivary gland homogenates significantly delay skin wound healing. The time to full healing of skin lesions in control rats was 15 days, contrasting with 24 days in rats topically treated with O. brasiliensis salivary gland homogenates. The calculated HT50 (healing time to recover 50 % of the wound area) for control groups was 3.6 days (95 % CI, 3.2-3.9) and for salivary gland treated rats was 7.7 days (95 % CI, 7.0-8.4). Salivary gland homogenates have a strong cytotoxic activity on cultured endothelial cells (LC50, 13.6 mg/ml). Also, at sublethal concentrations (a parts per thousand currency sign3 mg/ml), salivary gland homogenates have a remarkable anti-proliferative activity (IC50 0.7 mg/ml) on endothelial cells, equivalent to a parts per thousand 0.03 salivary gland pairs, an activity which seems to be much greater than reported for any other tick species. This is the first report about the biological activities of O. brasiliensis salivary compounds and provides the first in vivo evidence to support the concept of wound-healing modulation by tick salivary secretions. Results shown here contribute to an understanding of O. brasiliensis tick toxicosis syndrome, and also increase our knowledge of tick salivary bioactive compounds.
C1 [Reck, Jose; Martins, Joao Ricardo] Fundacao Estadual Pesquisa Agr FEPAGRO, IPVDF, Eldorado Do Sul, RS, Brazil.
   [Marks, Fernanda S.; Termignoni, Carlos; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Reck, Jose] IPVDF, BR-92990000 Eldorado Do Sul, RS, Brazil.
RP Reck, J (corresponding author), IPVDF, Estr Conde 6000, BR-92990000 Eldorado Do Sul, RS, Brazil.
EM jose.reck@gmail.com
RI Reck, Jose/AAH-3373-2020; Termignoni, Carlos/AAB-8943-2020; Guimaraes,
   Jorge Almeida/V-2196-2019; Reck, Jose/M-4805-2013
OI Reck, Jose/0000-0002-0969-792X; Termignoni, Carlos/0000-0002-2789-2518;
   Guimaraes, Jorge A./0000-0001-6354-6789
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Estadual de Pesquisa Agropecuaria (FEPAGRO);
   Fundacao Estadual de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Colegio Brasileiro de Parasitologia Veterinaria (CBPV)
FX We thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES), Fundacao Estadual de Pesquisa Agropecuaria (FEPAGRO), Fundacao
   Estadual de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS), and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for
   financial support of this work. Special thanks to Dr. Renata Terra
   (UFRGS) for critical review of this manuscript and to Colegio Brasileiro
   de Parasitologia Veterinaria (CBPV) for the 2012 Uriel Franco Rocha
   Award granted to this work.
CR Ahmed J, 2002, PARASITOL RES, V88, pS51, DOI 10.1007/s00436-001-0574-3
   Aragao H. B., 1923, BRAS MED, V37, P20
   Aragao H.de B., 1936, Memorias do Instituto Oswaldo Cruz, V31, P759
   Cancado PHD, 2008, PARASITOL RES, V103, P371, DOI 10.1007/s00436-008-0982-8
   DAVIS GE, 1952, J PARASITOL, V38, P473, DOI 10.2307/3273927
   di Primio R, 1937, ARQ RIOGRAND MED, V306, P406
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   FAUTZ R, 1991, MUTAT RES, V253, P173, DOI 10.1016/0165-1161(91)90130-Z
   Francischetti IMB, 2005, THROMB HAEMOSTASIS, V94, P167, DOI 10.1160/TH04-09-0566
   Hebling LMGF, 2013, PARASITOL RES, V112, P577, DOI 10.1007/s00436-012-3169-2
   Heggers J P, 1996, J Altern Complement Med, V2, P271, DOI 10.1089/acm.1996.2.271
   Herms W. B., 1916, Journal of Parasitology Urbana, V2, DOI 10.2307/3271197
   HOOGSTRAAL H, 1982, LANCET, V2, P288
   Hubalek Z, 2012, PARASITOL RES, V111, P9, DOI 10.1007/s00436-012-2910-1
   Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002
   Mans J, 2004, PARASITOLOGY, V129, pS95, DOI 10.1017/S0031182003004670
   Martins Nelson Lúcio Parada, 2006, Acta Cir. Bras., V21, P66, DOI 10.1590/S0102-86502006000900010
   Mejri N, 2002, PARASITOL RES, V88, P192, DOI 10.1007/s00436-001-0515-1
   Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148
   Pinto C., 1931, REV MED CIR BRAS, V34, P5
   Reck J, 2009, PARASITOLOGY, V136, P1339, DOI 10.1017/S0031182009990618
   Reck J, 2013, TICKS TICK-BORNE DIS, V4, P101, DOI 10.1016/j.ttbdis.2012.09.004
   Walker DH, 1998, ANNU REV PUBL HEALTH, V19, P237, DOI 10.1146/annurev.publhealth.19.1.237
   Yamaji K, 2009, PARASITOL RES, V106, P61, DOI 10.1007/s00436-009-1626-3
   Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com
NR 25
TC 6
Z9 6
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD APR
PY 2013
VL 112
IS 4
BP 1749
EP 1753
DI 10.1007/s00436-013-3333-3
PG 5
WC Parasitology
SC Parasitology
GA 109JL
UT WOS:000316363100044
PM 23397378
DA 2020-11-24
ER

PT J
AU Reck, J
   Marks, FS
   Guimaraes, JA
   Termignoni, C
   Martins, JR
AF Reck, Jose
   Marks, Fernanda S.
   Guimaraes, Jorge A.
   Termignoni, Carlos
   Martins, Joao Ricardo
TI Epidemiology of Ornithodoros brasiliensis (mouro tick) in the southern
   Brazilian highlands and the description of human and animal
   retrospective cases of tick parasitism
SO TICKS AND TICK-BORNE DISEASES
LA English
DT Article
DE Argasidae; Epidemiology; Risk factor; Human parasitism; Toxicosis
ID ARGASIDAE; DISEASE; ACARI; TRANSMISSION; INFECTIONS; IXODOIDEA; IXODIDA;
   FEVER; HOSTS
AB Ornithodoros brasiliensis, also known as the "mouro" tick, is an argasid tick found exclusively in the southern Brazilian highlands. O. brasiliensis parasitism is frequently associated with severe symptoms directly induced by the tick bite, a condition compatible with the definition of tick toxicosis. The objectives of this work include (i) the determination of the distribution of O. brasiliensis in farms located in the tickendemic region, (ii) the description of the characteristics of O. brasiliensis habitats, (iii) the analysis of risk factors associated with O. brasiliensis, and (iv) the retrospective description of cases of human and animal parasitism by O. brasiliensis. Of the 30 farms included in this study, O. brasiliensis was identified on 5 farms (frequency 16.7%), in which several ticks found in high density buried in soil were collected. Information regarding the tick habitats and the local population was recorded. The data indicated that O. brasiliensis feeds on humans, dogs, armadillos (Dasypus hybridus), and possibly skunks (Conepatus chinga). The analysis of risk factors indicated that the presence of house basements with an unpaved (natural soil) floor on farms and insufficient sanitary conditions significantly enhanced the probability of identifying O. brasiliensis. Additionally, we describe retrospectively cases of tick parasitism in 28 humans and 11 dogs including the most common symptoms associated with tick toxicosis. This is the first study concerning O. brasiliensis epidemiology, distribution, and habitat, and the report represents the most comprehensive characterization of Ornithodoros bite-associated toxicosis syndrome. (C) 2012 Elsevier GmbH. All rights reserved.
C1 [Reck, Jose; Martins, Joao Ricardo] IPVDF, Fundacao Estadual Pesquisa Agr FEPAGRO, BR-92990000 Eldorado Do Sul, RS, Brazil.
   [Marks, Fernanda S.] Univ Fed Rio Grande do Sul, Fac Vet, Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.; Termignoni, Carlos] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil.
   [Termignoni, Carlos] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Reck, J (corresponding author), IPVDF, Estr Conde 6000, BR-92990000 Eldorado Do Sul, RS, Brazil.
EM jose.reck@gmail.com
RI Termignoni, Carlos/AAB-8943-2020; Reck, Jose/AAH-3373-2020; Guimaraes,
   Jorge Almeida/V-2196-2019; Reck, Jose/M-4805-2013
OI Termignoni, Carlos/0000-0002-2789-2518; Reck, Jose/0000-0002-0969-792X;
   Guimaraes, Jorge A./0000-0001-6354-6789
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao Estadual de Pesquisa AgropecuAria (FEPAGRO);
   Fundacao Estadual de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX We thank Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES) for PhD fellowship to J.R. and Fundacao Estadual de Pesquisa
   Agropecuaria (FEPAGRO), Fundacao Estadual de Amparo a Pesquisa do Rio
   Grande do Sul (FAPERGS) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for financial support to this work.
   Special thanks to Inspetoria Veterinaria de Sao Francisco de Paula,
   namely to Mr. Angelo Valim for the valuable technical support and to Dr.
   Renata Terra (UFRGS) and to Mrs. Rosana Fabrin for critical review of
   this manuscript.
CR Aragao H. B., 1923, BRAS MED, V37, P20
   Aragao H.de B., 1936, Memorias do Instituto Oswaldo Cruz, V31, P759
   Arnez M, 2009, EXPERT REV ANTI-INFE, V7, P1251, DOI [10.1586/eri.09.99, 10.1586/ERI.09.99]
   Arteche C.C.P., 1979, Boletim do Instituto de Pesquisas Veterinarias 'Desiderio Finamor', V6, P29
   Bratton RL, 2005, AM FAM PHYSICIAN, V71, P2323
   CLIFFORD CM, 1980, J PARASITOL, V66, P312, DOI 10.2307/3280825
   DAVIS GE, 1952, J PARASITOL, V38, P473, DOI 10.2307/3273927
   de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200
   di Primio R, 1937, ARQ RIOGRAND MED, V306, P406
   Diaz JH, 2010, J MED TOXICOL, V6, P15, DOI 10.1007/s13181-010-0028-3
   Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739
   Evans DE, 2000, MEM I OSWALDO CRUZ, V95, P453, DOI 10.1590/S0074-02762000000400003
   FAILING RM, 1972, CALIF MED, V116, P16
   Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363
   Hall-Mendelin S, 2011, ANN TROP MED PARASIT, V105, P95, DOI 10.1179/136485911X12899838413628
   HOOGSTRAAL H, 1982, LANCET, V2, P288
   Horak IG, 2002, EXP APPL ACAROL, V28, P27, DOI 10.1023/A:1025381712339
   Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967
   Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761
   Mans J, 2004, PARASITOLOGY, V129, pS95, DOI 10.1017/S0031182003004670
   Martins JR, 2011, NEOTROP ENTOMOL, V40, P143, DOI 10.1590/S1519-566X2011000100022
   OLEAGAPEREZ A, 1990, VET REC, V126, P32
   Pinto C., 1931, REV MED CIR BRAS, V34, P5
   Reck J, 2011, VET CLIN PATH, V40, P356, DOI 10.1111/j.1939-165X.2011.00338.x
   Ribeiro V. L. S., 1997, Ciencia Rural, V27, P285, DOI 10.1590/S0103-84781997000200019
   Salinas LJ, 2010, AM J MED SCI, V340, P194, DOI 10.1097/MAJ.0b013e3181e93817
   Sonenshine D. E., 1991, BIOL TICKS, V2, P66
NR 27
TC 15
Z9 15
U1 1
U2 10
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1877-959X
EI 1877-9603
J9 TICKS TICK-BORNE DIS
JI Ticks Tick-Borne Dis.
PY 2013
VL 4
IS 1-2
BP 101
EP 109
DI 10.1016/j.ttbdis.2012.09.004
PG 9
WC Infectious Diseases; Microbiology; Parasitology
SC Infectious Diseases; Microbiology; Parasitology
GA 111KA
UT WOS:000316519000015
PM 23238249
DA 2020-11-24
ER

PT J
AU Beys-da-Silva, WO
   Santi, L
   Berger, M
   Guimaraes, JA
   Schrank, A
   Vainstein, MH
AF Beys-da-Silva, Walter O.
   Santi, Lucelia
   Berger, Markus
   Guimaraes, Jorge A.
   Schrank, Augusto
   Vainstein, Marilene H.
TI Susceptibility of Loxosceles sp to the arthropod pathogenic fungus
   Metarhizium anisopliae: potential biocontrol of the brown spider
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Loxosceles sp.; Loxoscelism; Biological control; Metarhizium anisopliae
AB Background: Loxosceles genus (brown spider) is an important pest with great impact on public health. Thus, more effective strategies for spider control are necessary.
   Methods: Three isolates of Metarhizium anisopliae fungus were tested for the control of Loxosceles sp.
   Results: Metarhizium anisopliae isolate E6 was highly virulent to the Loxosceles sp. spider, causing 100% mortality at 10(9) conidia/ml after 12 days and 9 days for juvenile and adult spiders, respectively.
   Conclusions: This is the first report of the pathogenicity of M. anisopliae against a venomous arthropod. This fungus could offer an interesting alternative to reduce toxoscetism in future biocontrol strategies.
C1 [Beys-da-Silva, Walter O.; Santi, Lucelia; Berger, Markus; Guimaraes, Jorge A.; Schrank, Augusto; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM walterbeys@yahoo.com.br
RI Vainstein, Marilene H/J-5452-2014; Santi, Lucelia/AAB-8349-2020;
   Schrank, Augusto/G-4688-2012; Guimaraes, Jorge Almeida/V-2196-2019;
   Santi, Lucelia/K-4856-2015; Santi, Lucelia/AAK-9527-2020; Beys-da-Silva,
   Walter O/M-3760-2018; Berger, Markus/U-7682-2019
OI Vainstein, Marilene H/0000-0002-3914-2300; Santi,
   Lucelia/0000-0002-5698-7006; Schrank, Augusto/0000-0002-5248-4620;
   Beys-da-Silva, Walter O/0000-0001-8329-7839; Berger,
   Markus/0000-0001-7670-2584; Guimaraes, Jorge A./0000-0001-6354-6789
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [23038006269/2011-39]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [481162/2010-0]
FX This work was supported by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) [grant no. 23038006269/2011-39] and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [grant no.
   481162/2010-0].
CR da Silva PH, 2004, TOXICON, V44, P693, DOI 10.1016/j.toxicon.2004.07.012
   Da Silva WOB, 2010, FUNGAL BIOL-UK, V114, P10, DOI 10.1016/j.mycres.2009.08.003
   Rocha LFN, 2011, T ROY SOC TROP MED H, V105, P417, DOI 10.1016/j.trstmh.2011.04.012
   Santi L, 2012, TICKS DIS MANAGEMENT, P217
   Santi L, 2011, WORLD J MICROB BIOT, V27, P2297, DOI 10.1007/s11274-011-0695-5
NR 5
TC 3
Z9 3
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD JAN
PY 2013
VL 107
IS 1
BP 59
EP 61
DI 10.1093/trstmh/trs006
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 079TI
UT WOS:000314194700009
PM 23296698
DA 2020-11-24
ER

PT J
AU Thompson, CE
   Beys-da-Silva, WO
   Santi, L
   Berger, M
   Vainstein, MH
   Raes, JAG
   Vasconcelos, ATR
AF Thompson, Claudia Elizabeth
   Beys-da-Silva, Walter Orlando
   Santi, Lucelia
   Berger, Markus
   Vainstein, Marilene Henning
   Guima Raes, Jorge Almeida
   Ribeiro Vasconcelos, Ana Tereza
TI A potential source for cellulolytic enzyme discovery and environmental
   aspects revealed through metagenomics of Brazilian mangroves
SO AMB EXPRESS
LA English
DT Article
DE Brazilian mangrove; Cellulase; Metagenomics; Biomass decomposition;
   Bacterial diversity
ID CULTURABLE BACTERIA; FUNCTIONAL-ANALYSIS; DIVERSITY; SEDIMENTS;
   IDENTIFICATION; BIODIVERSITY; CELLULOSOMES; ANNOTATION; CELLULASE;
   SEQUENCES
AB The mangroves are among the most productive and biologically important environments. The possible presence of cellulolytic enzymes and microorganisms useful for biomass degradation as well as taxonomic and functional aspects of two Brazilian mangroves were evaluated using cultivation and metagenomic approaches. From a total of 296 microorganisms with visual differences in colony morphology and growth (including bacteria, yeast and filamentous fungus), 179 (60.5%) and 117 (39.5%) were isolated from the Rio de Janeiro (RJ) and Bahia (BA) samples, respectively. RJ metagenome showed the higher number of microbial isolates, which is consistent with its most conserved state and higher diversity. The metagenomic sequencing data showed similar predominant bacterial phyla in the BA and RJ mangroves with an abundance of Proteobacteria (57.8% and 44.6%), Firmicutes (11% and 12.3%) and Actinobacteria (8.4% and 7.5%). A higher number of enzymes involved in the degradation of polycyclic aromatic compounds were found in the BA mangrove. Specific sequences involved in the cellulolytic degradation, belonging to cellulases, hemicellulases, carbohydrate binding domains, dockerins and cohesins were identified, and it was possible to isolate cultivable fungi and bacteria related to biomass decomposition and with potential applications for the production of biofuels. These results showed that the mangroves possess all fundamental molecular tools required for building the cellulosome, which is required for the efficient degradation of cellulose material and sugar release.
C1 [Thompson, Claudia Elizabeth; Ribeiro Vasconcelos, Ana Tereza] Lab Nacl Comp Cient, BR-25651070 Rio De Janeiro, Brazil.
   [Thompson, Claudia Elizabeth; Beys-da-Silva, Walter Orlando; Santi, Lucelia; Berger, Markus; Vainstein, Marilene Henning; Guima Raes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501070 Porto Alegre, RS, Brazil.
RP Thompson, CE (corresponding author), Lab Nacl Comp Cient, BR-25651070 Rio De Janeiro, Brazil.
EM thompson@lncc.br; guimar@cbiot.ufrgs.br; atrv@lncc.br
RI Santi, Lucelia/K-4856-2015; Santi, Lucelia/AAK-9527-2020; Santi,
   Lucelia/AAB-8349-2020; Vasconcelos, Ana Tereza R/I-1011-2012; Berger,
   Markus/U-7682-2019; Thompson, Claudia/C-3203-2014; Vainstein, Marilene
   H/J-5452-2014; Guimaraes, Jorge Almeida/V-2196-2019; Beys-da-Silva,
   Walter O/M-3760-2018
OI Santi, Lucelia/0000-0002-5698-7006; Vasconcelos, Ana Tereza
   R/0000-0002-4632-2086; Berger, Markus/0000-0001-7670-2584; Thompson,
   Claudia/0000-0003-3639-1851; Vainstein, Marilene H/0000-0002-3914-2300;
   Beys-da-Silva, Walter O/0000-0001-8329-7839; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX We would like to thank the staff of LNCC, Eloi Garcia (Fiocruz/INMETRO),
   and Wanderley de Souza (UFRJ/INMETRO) for insightful discussions, to
   Janaina Cavalcanti (INMETRO) for the DNA preparation, and the editors
   from American Journal Experts (AJE) for professional language editing
   services. This work was supported by Fundacao Carlos Chagas Filho de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Almeida LGP, 2004, BIOINFORMATICS, V20, P2832, DOI 10.1093/bioinformatics/bth273
   Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andreote FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038600
   Angelov A, 2011, APPL ENVIRON MICROB, V77, P5483, DOI 10.1128/AEM.00523-11
   Arias AH, 2010, ENVIRON MONIT ASSESS, V160, P301, DOI 10.1007/s10661-008-0696-5
   Bensmihen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026114
   Bernard D, 1996, MAR POLLUT BULL, V32, P734, DOI 10.1016/0025-326X(96)00034-3
   Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105
   Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Cha J, 2007, J MICROBIOL BIOTECHN, V17, P1782
   Challacombe JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024882
   Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250
   Dias ACF, 2010, ANTON LEEUW INT J G, V98, P541, DOI 10.1007/s10482-010-9471-z
   Dias ACF, 2009, WORLD J MICROB BIOT, V25, P1305, DOI 10.1007/s11274-009-0013-7
   Dittmar T, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002570
   Doi RH, 2004, NAT REV MICROBIOL, V2, P541, DOI 10.1038/nrmicro925
   dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943
   Dourado MN, 2012, BIOTECHNOL RES INT, V2012, P1, DOI DOI 10.1155/2012/759865
   Duan CJ, 2010, BIOTECHNOL LETT, V32, P1765, DOI 10.1007/s10529-010-0356-z
   Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b
   EONG OJ, 1993, CHEMOSPHERE, V27, P1097, DOI 10.1016/0045-6535(93)90070-L
   Faure D, 2011, APPL ENVIRON MICROB, V67, P2380
   Feller IC, 2010, ANNU REV MAR SCI, V2, P395, DOI 10.1146/annurev.marine.010908.163809
   Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367
   Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603
   Gao ZM, 2010, APPL MICROBIOL BIOT, V87, P1373, DOI 10.1007/s00253-010-2554-y
   Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x
   Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x
   Gonzalez-Acosta B, 2006, FEMS MICROBIOL ECOL, V55, P311, DOI 10.1111/j.1574-6941.2005.00019.x
   Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387
   Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319
   Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922
   Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161
   Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111
   IARC, 2002, IARC MON EV CARC RIS, V82
   Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988
   Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126
   Kumar R, 2008, J IND MICROBIOL BIOT, V35, P377, DOI 10.1007/s10295-008-0327-8
   Medie FM, 2012, NAT REV MICROBIOL, V10, P227, DOI 10.1038/nrmicro2729
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkt263]
   Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041
   Pason P, 2006, J MICROBIOL BIOTECHN, V16, P1269
   Peixoto R, 2011, ANTON LEEUW INT J G, V99, P341, DOI 10.1007/s10482-010-9499-0
   Pointing SB, 1999, MYCOL RES, V103, P696, DOI 10.1017/S0953756298007655
   Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107
   RAGHUKUMAR S, 1995, AQUAT MICROB ECOL, V9, P117, DOI 10.3354/ame009117
   Rho M, 2010, NUCLEIC ACIDS RES, V38, pe121
   Sahoo K, 2009, INDIAN J MAR SCI, V38, P249
   Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0
   Slutzki M, 2012, METHOD ENZYMOL, V510, P453, DOI 10.1016/B978-0-12-415931-0.00024-0
   Spalding M., 1997, WORLD MANGROVE ATLAS
   Spiers AG, 1999, 144 SUP SCI, P63
   Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129
   Sun FL, 2012, ECOTOXICOLOGY, V21, P1651, DOI 10.1007/s10646-012-0946-8
   TAKAGI M, 1993, J BACTERIOL, V175, P7119, DOI 10.1128/jb.175.21.7119-7122.1993
   Taketani RG, 2010, ANTON LEEUW INT J G, V97, P401, DOI 10.1007/s10482-010-9422-8
   Taketani RG, 2010, J MICROBIOL, V48, P7, DOI 10.1007/s12275-009-0147-1
   TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982
   Tian Y, 2008, MAR POLLUT BULL, V56, P1184, DOI 10.1016/j.marpolbul.2008.02.014
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269
   Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x
   Xu J, 2011, CURR MED CHEM, V18, P5224, DOI 10.2174/092986711798184307
   Yang Z, 2001, Wei Sheng Wu Xue Bao, V41, P76
   Zhou HW, 2009, MICROB ECOL, V58, P153, DOI 10.1007/s00248-008-9456-x
   Zhu LF, 2011, P NATL ACAD SCI USA, V108, P17714, DOI 10.1073/pnas.1017956108
   Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275
NR 76
TC 24
Z9 25
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2191-0855
J9 AMB EXPRESS
JI AMB Express
PY 2013
VL 3
AR 65
DI 10.1186/2191-0855-3-65
PG 18
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA V39XG
UT WOS:000209443100065
PM 24160319
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Dahmer, T
   Berger, M
   Barlette, AG
   Reck, J
   Segalin, J
   Verza, S
   Ortega, GG
   Gnoatto, SCB
   Guimaraes, JA
   Verli, H
   Gosmann, G
AF Dahmer, Tabitha
   Berger, Markus
   Barlette, Adriana Gregory
   Reck, Jose, Jr.
   Segalin, Jeferson
   Verza, Simone
   Ortega, George Gonzalez
   Baggio Gnoatto, Simone Cristina
   Guimaraes, Jorge Almeida
   Verli, Hugo
   Gosmann, Grace
TI Antithrombotic Effect of Chikusetsusaponin IVa Isolated from Ilex
   paraguariensis (Mate)
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE chikusetsusaponin; hemostasis; Ilex paraguariensis; platelet
   aggregation; thrombosis; thrombin
ID THROMBIN INHIBITOR; ALPHA-THROMBIN; SAPONINS; DRUGS; ACID;
   ANTICOAGULANT; GLYCYRRHIZIN; PURIFICATION; AGGREGATION; DERIVATIVES
AB The triterpene chikusetsusaponin IVa was isolated from the fruit of Ilex paraguariensis. Using biochemical and pharmacological methods, we demonstrated that chikusetsusaponin IVa (1) prolongs the recalcification time, prothrombin time, activated partial thromboplastin time, and thrombin time of normal human plasma in a dose-dependent manner, (2) inhibits the amidolytic activity of thrombin and factor Xa upon synthetic substrates S2238 and S2222, (3) inhibits thrombin-induced fibrinogen clotting (50% inhibition concentration, 199.4 +/- 9.1 mu M), and (4) inhibits thrombin- and collagen-induced platelet aggregation. The results also indicate that chikusetsusaponin IVa preferentially inhibits thrombin in a competitive manner (K-i = 219.6 mu M). Furthermore, when administered intravenously to rats, chikusetsusaponin IVa inhibited thrombus formation in a stasis model of venous thrombosis, although it did not induce a significant bleeding effect. Chikusetsusaponin IVa also prolonged the ex vivo activated partial thromboplastin time. Altogether, these data suggest that chikusetsusaponin IVa exerts antithrombotic effects, including minor hemorrhagic events. This appears to be important for the development of new therapeutic agents.
C1 [Dahmer, Tabitha; Barlette, Adriana Gregory; Verza, Simone; Ortega, George Gonzalez; Baggio Gnoatto, Simone Cristina; Verli, Hugo; Gosmann, Grace] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   [Berger, Markus; Reck, Jose, Jr.; Segalin, Jeferson; Guimaraes, Jorge Almeida; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-90610000 Porto Alegre, RS, Brazil.
RP Gosmann, G (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Ipiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.
EM hverli@cbiot.ufrgs.br; grace.gosmann@ufrgs.br
RI Gnoatto, Simone/K-6877-2012; Berger, Markus/U-7682-2019; Verza,
   Simone/AAX-1640-2020; Guimaraes, Jorge Almeida/V-2196-2019; Verli,
   Hugo/G-8703-2012; Reck, Jose/M-4805-2013; Reck, Jose/AAH-3373-2020;
   Gosmann, Grace/G-3331-2012; Gosmann, Grace/AAJ-9760-2020
OI Berger, Markus/0000-0001-7670-2584; Verza, Simone/0000-0001-9581-7272;
   Verli, Hugo/0000-0002-4796-8620; Reck, Jose/0000-0002-0969-792X;
   Gosmann, Grace/0000-0001-6823-8312; Gosmann, Grace/0000-0001-6823-8312;
   Guimaraes, Jorge A./0000-0001-6354-6789; Gnoatto,
   Simone/0000-0002-8806-3182
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   Ministerio de Ciencia e Tecnologia; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior, Ministerio da Educacao, Brasilia, DF, Brazil
FX We are grateful to the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, Ministerio de Ciencia e Tecnologia and to the Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior, Ministerio da Educacao,
   Brasilia, DF, Brazil, for their financial support and fellowships.
CR AMIMOTO K, 1992, CHEM PHARM BULL, V40, P3138, DOI 10.1248/cpb.40.3138
   Berger M, 2010, TOXICON, V55, P33, DOI 10.1016/j.toxicon.2009.06.033
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   BOUTON MC, 1995, BIOCHEM J, V305, P635, DOI 10.1042/bj3050635
   DEMARCO L, 1994, J BIOL CHEM, V269, P6478
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   Gnoatto SCB, 2008, BIOORGAN MED CHEM, V16, P771, DOI 10.1016/j.bmc.2007.10.031
   Heck CI, 2007, J FOOD SCI, V72, pR138, DOI 10.1111/j.1750-3841.2007.00535.x
   Hosono-Nishiyama K, 2006, PLANTA MED, V72, P193, DOI 10.1055/s-2005-916176
   Iwatsuki Y, 2011, EUR J PHARMACOL, V673, P49, DOI 10.1016/j.ejphar.2011.10.009
   Laux V, 2009, THROMB HAEMOSTASIS, V102, P892, DOI 10.1160/TH09-02-0134
   Liang C, 2010, BIOORG MED CHEM LETT, V20, P7110, DOI 10.1016/j.bmcl.2010.09.074
   Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2
   MATSUDA H, 1989, PLANTA MED, P18, DOI 10.1055/s-2006-961767
   Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735
   Mendes-Silva W, 2003, THROMB RES, V112, P93, DOI 10.1016/j.thromres.2003.10.014
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   Pires VS, 1997, J AGR FOOD CHEM, V45, P1027, DOI 10.1021/jf960637v
   Radnaabazar C, 2011, J MED FOOD, V14, P625, DOI 10.1089/jmf.2010.1233
   Rattanathongkom A, 2009, PLANTA MED, V75, P829, DOI 10.1055/s-0029-1185436
   Reck J, 2009, PARASITOLOGY, V136, P1339, DOI 10.1017/S0031182009990618
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   Schulman S, 2010, J THROMB HAEMOST, V8, P641, DOI 10.1111/j.1538-7836.2010.03737.x
   Taketa ATC, 2004, J BRAZIL CHEM SOC, V15, P205, DOI 10.1590/S0103-50532004000200008
   Toschi V, 2011, BRIT J CLIN PHARMACO, V72, P563, DOI 10.1111/j.1365-2125.2011.04001.x
   VOGEL GMT, 1989, THROMB RES, V54, P399, DOI 10.1016/0049-3848(89)90210-7
   Wang JR, 2008, CHEM BIODIVERS, V5, P1369, DOI 10.1002/cbdv.200890125
   Weitz JI, 2008, CHEST, V134, P473
   Weitz JI, 2008, CHEST, V133, p234S, DOI 10.1378/chest.08-0673
   Yogeeswari P, 2005, CURR MED CHEM, V12, P657, DOI 10.2174/0929867053202214
   Yoo HH, 2006, BIOL PHARM BULL, V29, P1053, DOI 10.1248/bpb.29.1053
NR 32
TC 16
Z9 17
U1 0
U2 11
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD DEC
PY 2012
VL 15
IS 12
BP 1073
EP 1080
DI 10.1089/jmf.2011.0320
PG 8
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition &
   Dietetics
GA 055VV
UT WOS:000312446800006
PM 23134458
DA 2020-11-24
ER

PT J
AU Nascimento-Silva, V
   da Silva, GR
   Moraes, JA
   Cyrino, FZ
   Seabra, SH
   Bouskela, E
   Guimaraes, JA
   Barja-Fidalgo, C
AF Nascimento-Silva, Vany
   da Silva, Genilson Rodrigues
   Moraes, Joao Alfredo
   Cyrino, Fatima Z.
   Seabra, Sergio H.
   Bouskela, Eliete
   Guimaraes, Jorge Almeida
   Barja-Fidalgo, Christina
TI A pro-inflammatory profile of endothelial cell in Lonomia obliqua
   envenomation
SO TOXICON
LA English
DT Article
DE Lonomia obliqua venom; Endothelial cell; Vascular response; Inflammatory
   mediators
ID FOCAL ADHESION KINASE; HAMSTER-CHEEK POUCH; MATRIX METALLOPROTEINASES;
   PROTHROMBIN ACTIVATOR; GENE-EXPRESSION; CATERPILLAR; SATURNIIDAE; LOPAP;
   VENOM; LEPIDOPTERA
AB Lonomia obliqua envenomation is characterized by intense local inflammatory reaction, which, dependent on the severity of the case, is followed by severe clinical manifestations related to hemorrhagic disorders that can lead to fatal outcome. These effects were imputed to several toxins present in L obliqua venom, which are responsible for procoagulant, anticoagulant as well as antithrombotic activities, being also able to interfere with vascular cells functions. In this work, the intravital microscopy analysis show that after administration of low doses of L. obliqua venom (1-3 mu g/ml) on hamster cheek pouch, there was no alterations neither on arterioles or venules caliber nor in the vascular permeability up to 30 min. However, after 10 min in contact with venom occurred a clear activation in the vascular bed, characterized by an increase in leukocyte rolling and adhesion on endothelium of hamster cheek pouch venules. A confocal analysis of vascular beds, confirmed these results showing an increase in endothelial E-selectin and VCAM-1 expression. The effects of L. obliqua venom on human endothelial cell (EC) in vitro were also investigated. The treatment of EC with venom (1-3 mu g/ml) did not affect cell viability. However, at concentrations as low as 3 mu g/ml of L. obliqua venom modifies actin cytoskeleton dynamics, and increases focal adhesion contacts, inducing stress fiber formation, focal adhesion kinase (FAK) phosphorylation and its subsequent association to actin. These effects are followed by the activation of NF-kappa B pathway, a critical signaling in several events associated to vascular inflammation. Accordingly, L. obliqua venom leads to a significant increase in COX-2, NOS-2, HO-1, MMP-2 and MMP-9 expression. Taken together the data show that, even at low concentrations, L. obliqua venom can activate endothelial cells, which assume a pro-inflammatory profile, contributing for local effects and probably also for systemic disturbances due to its ability to modulate the properties of the vascular system. (c) 2012 Elsevier Ltd. All rights reserved.
C1 [Nascimento-Silva, Vany; da Silva, Genilson Rodrigues; Moraes, Joao Alfredo; Barja-Fidalgo, Christina] Univ Estado Rio de Janeiro, IBRAG, Lab Biochem & Cellular Pharmacol, BR-20550011 Rio De Janeiro, Brazil.
   [Cyrino, Fatima Z.; Bouskela, Eliete] Univ Estado Rio de Janeiro, IBRAG, Lab Clin & Expt Res Vasc Biol BioVasc, BR-20550011 Rio De Janeiro, Brazil.
   [Seabra, Sergio H.] Ctr Univ Estadual Zona Oeste UEZO, LTBM, Rio De Janeiro, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, Porto Alegre, RS, Brazil.
RP Barja-Fidalgo, C (corresponding author), Lab Farmacol Bioquim & Celular, Av 28 Setembro 87 Fundos,5 Andar, BR-20551030 Rio De Janeiro, Brazil.
EM barja-fidalgo@uerj.br
RI Moraes, Joao Alfredo A/E-3557-2017; Guimaraes, Jorge Almeida/V-2196-2019
OI Moraes, Joao Alfredo A/0000-0002-8563-6432; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES)CAPES
FX Financial Support: Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de
   Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES).
CR Abella H.B., 2006, TOXICOVIGILANCIA TOX, P29
   Flores MPA, 2009, PATHOPHYSIOL HAEMO T, V37, P1, DOI 10.1159/000320067
   Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   Behrendt D, 2002, AM J CARDIOL, V90, p40L, DOI 10.1016/S0002-9149(02)02963-6
   Berger M, 2010, J THROMB THROMBOLYS, V30, P300, DOI 10.1007/s11239-010-0449-5
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   BOUSKELA E, 1992, AM J PHYSIOL, V262, pH478
   Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184
   Burdmann EA, 1996, CLIN NEPHROL, V46, P337
   Carrijo-Carvalho LC, 2007, TOXICON, V49, P741, DOI 10.1016/j.toxicon.2006.11.033
   Chen FE, 1998, NATURE, V391, P410
   Chudzinski-Tavassi AM, 2006, PATHOPHYSIOL HAEMO T, V35, P410
   Chudzinski-Tavassi AM, 2001, HAEMOSTASIS, V31, P257
   Coelho ALJ, 2004, EXP CELL RES, V292, P371, DOI 10.1016/j.yexcr.2003.09.013
   Corrêa Maria Sueli, 2004, Rev. Soc. Bras. Med. Trop., V37, P418, DOI 10.1590/S0037-86822004000500011
   Cyrino FZGA, 2004, CLIN EXP PHARMACOL P, V31, P159, DOI 10.1111/j.1440-1681.2004.03974.x
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Fan Hui Wen, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P119
   Fritzen M, 2005, BIOCHEM BIOPH RES CO, V333, P517, DOI 10.1016/j.bbrc.2005.05.140
   Garcia CM, 2007, REV SOC BRAS MED TRO, V40, P242, DOI 10.1590/S0037-86822007000200021
   GRANGER DN, 1994, J LEUKOCYTE BIOL, V55, P662
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, P283, DOI 10.3109/15569549509019465
   Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053
   Kowacs PA, 2006, ARQ NEURO-PSIQUIAT, V64, P1030, DOI 10.1590/S0004-282X2006000600029
   Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003
   McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238
   Nascimento-Silva V, 2007, THROMB HAEMOSTASIS, V97, P88, DOI 10.1160/TH06-06-0315
   Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Pinto AFM, 2010, TOXICON, V56, P1103, DOI 10.1016/j.toxicon.2010.01.013
   Prasain N, 2009, MICROVASC RES, V77, P53, DOI 10.1016/j.mvr.2008.09.012
   Ramos AT, 2004, TOXICON, V43, P761, DOI 10.1016/j.toxicon.2004.03.010
   Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Sampaio ALF, 2010, J LEUKOCYTE BIOL, V87, P877, DOI 10.1189/jlb.1009670
   Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112
   Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008
   Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029
   TAKAHASI K, 1992, IN VITRO CELL DEV-AN, V28A, P380
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137
NR 43
TC 9
Z9 9
U1 0
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JUL
PY 2012
VL 60
IS 1
BP 50
EP 60
DI 10.1016/j.toxicon.2012.03.016
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 955WU
UT WOS:000305052400008
PM 22779081
DA 2020-11-24
ER

PT J
AU Pol-Fachin, L
   Becker, CF
   Guimaraes, JA
   Verli, H
AF Pol-Fachin, Laercio
   Becker, Camila Franco
   Guimaraes, Jorge Almeida
   Verli, Hugo
TI Effects of glycosylation on heparin binding and antithrombin activation
   by heparin
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE glycan; glycosaminoglycan; intermediate; serpin; transmission pathway
ID MOLECULAR-DYNAMICS SIMULATIONS; PLASMA-DERIVED ANTITHROMBIN;
   HIGH-AFFINITY; ALLOSTERIC ACTIVATION; CONFORMATIONAL-CHANGE;
   BETA-ANTITHROMBIN; PENTASACCHARIDE SEQUENCE; RECOMBINANT ANTITHROMBIN;
   CRYSTAL-STRUCTURE; AQUEOUS-SOLUTION
AB Antithrombin (AT), a serine protease inhibitor, circulates in blood in two major isoforms, alpha and beta, which differ in their amount of glycosylation and affinity for heparin. After binding to this glycosaminoglycan, the native AT conformation, relatively inactive as a protease inhibitor, is converted to an activated form. In this process, beta-AT presents the higher affinity for heparin, being suggested as the major AT glycoform inhibitor in vivo. However, either the molecular basis demonstrating the differences in heparin binding to both AT isoforms or the mechanism of its conformational activation are not fully understood. Thus, the present work evaluated the effects of glycosylation and heparin binding on AT structure, function, and dynamics. Based on the obtained data, besides the native and activated forms of AT, an intermediate state, previously proposed to exist between such conformations, was also spontaneously observed in solution. Additionally, Asn135-linked oligosaccharide caused a bending in AT-bounded heparin, moving such polysaccharide away from helix D, which supports its reduced affinity for alpha-AT. The obtained data supported the proposal of an atomic-level, solvent and amino acid residues accounting, putative model for the transmission of the conformational signal from heparin binding exosite to beta-sheet A and the reactive center loop, also supporting the identification of differences in such transmission between the serpin glycoforms involving helix D, where the Asn135-linked oligosaccharide stands. Such intramolecular rearrangements, together with heparin dynamics over AT surface, may support an atomic-level explanation for the Asn135-linked glycan influence over heparin binding and AT activation.
C1 [Pol-Fachin, Laercio; Becker, Camila Franco; Guimaraes, Jorge Almeida; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
   [Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
RP Verli, H (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,CP 15005, BR-91500970 Porto Alegre, RS, Brazil.
EM hverli@cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico,
   MCTNational Council for Scientific and Technological Development (CNPq)
   [472174/2007-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), MEC, Brasilia, DF, BrazilCAPES
FX Grant sponsor: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico, MCT; Grant number: CNPq#472174/2007-0; Grant sponsor:
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   MEC, Brasilia, DF, Brazil
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200
   Arocas V, 2000, BIOCHEMISTRY-US, V39, P8512, DOI 10.1021/bi9928243
   Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018
   Belzar KJ, 2002, J BIOL CHEM, V277, P8551, DOI 10.1074/jbc.M110807200
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   BJORK I, 1992, BIOCHEM J, V286, P793
   Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385
   BRENNAN SO, 1987, FEBS LETT, V219, P431, DOI 10.1016/0014-5793(87)80266-1
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   dela Cruz RGC, 2006, J BIOL CHEM, V281, P31668, DOI 10.1074/jbc.M604826200
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Demelbauer UM, 2005, J CHROMATOGR A, V1080, P15, DOI 10.1016/j.chroma.2005.01.057
   Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200
   ErsdalBadju E, 1997, J BIOL CHEM, V272, P19393, DOI 10.1074/jbc.272.31.19393
   Fernandes CL, 2010, CARBOHYD RES, V345, P663, DOI 10.1016/j.carres.2009.12.018
   FRANZEN LE, 1980, J BIOL CHEM, V255, P5090
   Frebelius S, 1996, ARTERIOSCL THROM VAS, V16, P1292, DOI 10.1161/01.ATV.16.10.1292
   Garone L, 1996, BIOCHEMISTRY-US, V35, P8881, DOI 10.1021/bi960542m
   Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+
   Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Huntington JA, 2000, J BIOL CHEM, V275, P15377, DOI 10.1074/jbc.275.20.15377
   Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119
   Jairajpuri MA, 2003, J BIOL CHEM, V278, P15941, DOI 10.1074/jbc.M212319200
   Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683
   Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200
   Johnson DJD, 2003, BIOCHEMISTRY-US, V42, P8712, DOI 10.1021/bi034524y
   Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646
   Khan S, 2010, J MOL BIOL, V395, P504, DOI 10.1016/j.jmb.2009.10.064
   KUSCHE M, 1990, J BIOL CHEM, V265, P7292
   Langdown J, 2004, J BIOL CHEM, V279, P47288, DOI 10.1074/jbc.M408961200
   Langdown J, 2009, J MOL BIOL, V386, P1278, DOI 10.1016/j.jmb.2009.01.028
   Mandal TK, 2001, BIOPOLYMERS, V59, P11, DOI 10.1002/1097-0282(200107)59:1<11::AID-BIP1001>3.0.CO;2-W
   McCoy AJ, 2003, J MOL BIOL, V326, P823, DOI 10.1016/S0022-2836(02)01382-7
   McNaught AD, 1996, PURE APPL CHEM, V68, P1919, DOI 10.1351/pac199668101919
   Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   OLSON ST, 1992, J BIOL CHEM, V267, P12528
   Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384
   OLSON ST, 1981, J BIOL CHEM, V256, P1073
   Olson ST, 1997, ARCH BIOCHEM BIOPHYS, V341, P212, DOI 10.1006/abbi.1997.9973
   Olson ST, 2010, BIOCHIMIE, V92, P1587, DOI 10.1016/j.biochi.2010.05.011
   PETERSON CB, 1985, J BIOL CHEM, V260, P610
   PICARD V, 1995, BIOCHEMISTRY-US, V34, P8433, DOI 10.1021/bi00026a026
   Plematl A, 2005, PROTEOMICS, V5, P4025, DOI 10.1002/pmic.200401238
   Pol-Fachin L, 2008, CARBOHYD RES, V343, P1435, DOI 10.1016/j.carres.2008.04.016
   Pol-Fachin L, 2009, CARBOHYD RES, V344, P491, DOI 10.1016/j.carres.2008.12.025
   POLFACHIN L, 2010, STRATEGIES DETERMINA, P103
   Rau JC, 2007, J THROMB HAEMOST, V5, P102, DOI 10.1111/j.1538-7836.2007.02516.x
   Richard B, 2009, J BIOL CHEM, V284, P27054, DOI 10.1074/jbc.M109.029892
   Schaftenaar G, 2000, J COMPUT AID MOL DES, V14, P123, DOI 10.1023/A:1008193805436
   Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l
   Schedin-Weiss S, 2010, ARCH BIOCHEM BIOPHYS, V504, P169, DOI 10.1016/j.abb.2010.08.021
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f
   Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798
   Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492
   TURKO IV, 1993, FEBS LETT, V335, P9, DOI 10.1016/0014-5793(93)80429-X
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423
   Verli H, 2005, J MOL GRAPH MODEL, V24, P203, DOI 10.1016/j.jmgm.2005.07.002
   Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026
   Whisstock JC, 2000, J MOL BIOL, V301, P1287, DOI 10.1006/jmbi.2000.3982
   WITMER MR, 1991, ARTERIOSCLER THROMB, V11, P530, DOI 10.1161/01.ATV.11.3.530
   Woods RJ, 1998, GLYCOCONJUGATE J, V15, P209, DOI 10.1023/A:1006984709892
   Zuegg J, 2000, GLYCOBIOLOGY, V10, P959, DOI 10.1093/glycob/10.10.959
NR 70
TC 17
Z9 18
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD SEP
PY 2011
VL 79
IS 9
BP 2735
EP 2745
DI 10.1002/prot.23102
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 816OE
UT WOS:000294611100012
PM 21769943
DA 2020-11-24
ER

PT B
AU Dantas, AC
   Guimaraes, JA
   Camara, ACL
   Afonso, JAB
   Mendonca, CL
AF Dantas, A. C.
   Guimaraes, J. A.
   Camara, A. C. L.
   Afonso, J. A. B.
   Mendonca, C. L.
BE RietCorrea, F
   Pfister, J
   Schild, AL
   Wierenga, T
TI Toxicity of Dieffenbachia spp. with a Focus on Livestock Poisoning
SO POISONING BY PLANTS, MYCOTOXINS, AND RELATED TOXINS
LA English
DT Proceedings Paper
CT 8th International Symposium on Poisonous Plants (ISOPP)
CY MAY 04-08, 2009
CL Joao Pessoa, BRAZIL
ID CONTACT-DERMATITIS; PLANT; INJURY
C1 [Dantas, A. C.; Guimaraes, J. A.; Afonso, J. A. B.; Mendonca, C. L.] Univ Fed Rural Pernambuco, Clin Bovinos, Campus Garanhuns,POB 152, BR-55292901 Garanhuns, PE, Brazil.
   [Camara, A. C. L.] Univ Brasilia, Hosp Escola Grandes Anim, BR-70636200 Brasilia, DF, Brazil.
RP Dantas, AC (corresponding author), Univ Fed Rural Pernambuco, Clin Bovinos, Campus Garanhuns,POB 152, BR-55292901 Garanhuns, PE, Brazil.
RI Guimaraes, Jorge Almeida/V-2196-2019; Afonso, Jose Augusto
   Bastos/J-2337-2016
OI Afonso, Jose Augusto Bastos/0000-0003-4874-2356
CR ARDITTI J, 1982, J ETHNOPHARMACOL, V5, P293, DOI 10.1016/0378-8741(82)90015-0
   Burrows GE, 2001, TOXIC PLANTS N AM, P105
   Chiou AGY, 1997, BRIT J OPHTHALMOL, V81, P168
   Corazza M, 1998, J EUR ACAD DERMATOL, V10, P87, DOI 10.1111/j.1468-3083.1998.tb00937.x
   Cumpston KL, 2003, J EMERG MED, V25, P391, DOI 10.1016/j.jemermed.2003.02.005
   Dantas A. C., 2007, Ciencia Veterinaria nos Tropicos, V10, P119
   Dip EC, 2004, TOXICON, V43, P729, DOI 10.1016/j.toxicon.2004.03.005
   Froberg B, 2007, EMERG MED CLIN N AM, V25, P375, DOI 10.1016/j.emc.2007.02.013
   GARDNER DG, 1994, ORAL SURG ORAL MED O, V78, P631, DOI 10.1016/0030-4220(94)90177-5
   Hsueh Kuo-Fang, 2004, J Chin Med Assoc, V67, P93
   Kissman KG, 1961, EC BOTANIC, V38, P119
   KUBALLA B, 1981, TOXICOL APPL PHARM, V58, P444, DOI 10.1016/0041-008X(81)90097-1
   Lightfoot Teresa L., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P229, DOI 10.1016/j.cvex.2008.01.006
   Osweiler GD, 1998, TOXICOLOGIA VET, P386
   Pedaci L, 1999, VET HUM TOXICOL, V41, P335
   Plumlee KH, 2002, VET CLIN N AM-SMALL, V32, P383, DOI 10.1016/S0195-5616(01)00006-7
   Radostits OM, 2002, CLIN VET TRATADO DOE, P1432
   RAUBER A, 1985, J TOXICOL-CLIN TOXIC, V23, P79, DOI 10.3109/15563658508990619
   Sanchez-Morillas L, 2005, CONTACT DERMATITIS, V53, P172, DOI 10.1111/j.0105-1873.2005.0407e.x
   Snajdauf J, 2005, J PEDIATR SURG, V40, DOI 10.1016/j.jpedsurg.2005.03.036
   Tokarnia C.H, 2000, PLANTAS TOXICAS BRAS
NR 21
TC 0
Z9 0
U1 0
U2 1
PU CABI PUBLISHING-C A B INT
PI WALLINGFORD
PA CABI PUBLISHING, WALLINGFORD 0X10 8DE, OXON, ENGLAND
BN 978-1-84593-833-8
PY 2011
BP 437
EP 440
PG 4
WC Plant Sciences
SC Plant Sciences
GA BG9BK
UT WOS:000392976400073
DA 2020-11-24
ER

PT J
AU de Lima, ME
   Fortes-Dias, CL
   Carlini, CR
   Guimaraes, JA
AF de Lima, Maria Elena
   Fortes-Dias, Consuelo Latorre
   Carlini, Celia R.
   Guimaraes, Jorge A.
TI Toxinology in Brazil: A big challenge for a rich biodiversity
SO TOXICON
LA English
DT Article; Proceedings Paper
CT 16th World Congress of the International-Society-on-Toxinology/10th
   Congress of the Brazilian-Society-Toxicology
CY MAR, 2009
CL BRAZIL
SP Int Soc Toxinol, Brazilian Soc Toxicol
DE Vital Brazil; Carlos Diniz; Mauricio Rocha e Silva; Butantan;
   antivenoms; Citations
ID BRADYKININ-POTENTIATING FACTOR; SNAKE-VENOM; TOXICON
AB Toxinology in Brazil developed specially during the 19th and 20th centuries. A very brief description of the main contributions made by pioneer toxinologists is presented here in an attempt to give an idea of the evolution of toxinology in our country, from its first steps until the XVI World Congress of the International Society on Toxinology, held in Recife, Brazil in March of 2009. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Carlini, Celia R.] Univ Fed Rio Grande do Sul, Dept Biophys, BR-91501970 Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
   [de Lima, Maria Elena] Univ Fed Minas Gerais, Inst Biol Sci, Dept Biochem & Immunol, Lab Venoms & Anim Toxins, Belo Horizonte, MG, Brazil.
   [Fortes-Dias, Consuelo Latorre] Fundacao Ezequiel Dias, Ctr Res & Dev Carlos Ribeiro Diniz, Lab Mol Biol & Bioinformat, Belo Horizonte, MG, Brazil.
RP Carlini, CR (corresponding author), Univ Fed Rio Grande do Sul, Dept Biophys, BR-91501970 Porto Alegre, RS, Brazil.
EM ccarlini@ufrgs.br
RI Fortes-Dias, Consuelo L/I-4896-2012; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011; Lima, Maria E/P-1707-2017; Fortes-Dias, Consuelo
   Latorre/U-9962-2019; Guimaraes, Jorge Almeida/V-2196-2019
OI Fortes-Dias, Consuelo L/0000-0002-4494-5108; da Silva Carlini, Celia
   Regina Ribeiro/0000-0002-7027-2445; Lima, Maria E/0000-0001-6185-4032;
   Fortes-Dias, Consuelo Latorre/0000-0002-4494-5108; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BERALDO WT, 1981, CIENCIA CULTURA, V33, P448
   BOUQUET P, 1983, SNAKE VENOMS
   BRAZIL OV, 1987, MEM I BUTANTAN, V49, P7
   BUSS P, 2001, OSWALDO CRUZ FDN 100, V65, P8
   CHAVES BS, 2007, FUNDACAO EZEQUIEL DI, P175
   DINIZ CR, 1978, HDB EXPT PHARMACOLOG, V48, P379
   FERREIRA SH, 1970, NATURE, V225, P379, DOI 10.1038/225379a0
   FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005
   FERREIRA SH, 1965, BRIT J PHARM CHEMOTH, V24, P163, DOI 10.1111/j.1476-5381.1965.tb02091.x
   Guimaraes JA, 2004, TOXICON, V44, P345, DOI 10.1016/j.toxicon.2004.05.002
   HAWGOOD BJ, 1992, TOXICON, V30, P573, DOI 10.1016/0041-0101(92)90851-U
   Hawgood BJ, 1997, TOXICON, V35, P1569, DOI 10.1016/S0041-0101(97)00008-1
   Hawgood BJ, 2001, TOXICON, V39, P1277, DOI 10.1016/S0041-0101(00)00264-6
   HOUSSAY BA, 1966, MEM I BUTANTAN SIMP, V33, pR13
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   LACERDA JBD, 1884, HDB EXPT PHARM, V42, P1130
   Prado MAM, 2000, TOXICON, V38, P603
   ROCHA E, 1949, CIENCIA CULTURA, V1, P32
   ROCHA E, 1974, EDITORA HUCITEC LTDA, P335
   Rocha E.S.M., 1949, AM J PHYSIOL, V156, P261
   RUSSELL FE, 1987, TOXICON, V25, P3, DOI 10.1016/0041-0101(87)90148-6
   Slotta KH, 1938, BER DTSCH CHEM GES, V71, P1076, DOI 10.1002/cber.19380710527
   TAYLOR P, 1996, PHARMACOL BASIS THER, P1905
   VERGARA MR, 2005, CADERNOS SAUDE COLET, V2, P511
NR 25
TC 4
Z9 4
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 15
PY 2010
VL 56
IS 7
SI SI
BP 1084
EP 1091
DI 10.1016/j.toxicon.2010.05.005
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 710XM
UT WOS:000286550300002
PM 20685368
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Berger, M
   Reck, J
   Terra, RMS
   Guimaraes, JA
AF Pinto, Antonio F. M.
   Berger, Markus
   Reck, Jose, Jr.
   Terra, Renata M. S.
   Guimaraes, Jorge A.
TI Lonomia obliqua venom: In vivo effects and molecular aspects associated
   with the hemorrhagic syndrome
SO TOXICON
LA English
DT Article; Proceedings Paper
CT 16th World Congress of the International-Society-on-Toxinology/10th
   Congress of the Brazilian-Society-Toxicology
CY MAR, 2009
CL BRAZIL
SP Int Soc Toxinol (IST), Brazilian Soc Toxicol
DE Lonomia oblique; Caterpillar; Envenomation; Venom; Experimental model;
   Hemorrhagic syndrome
ID CATERPILLAR BRISTLE EXTRACT; PHOSPHOLIPASE A(2); BLOOD INCOAGULABILITY;
   ACCIDENTAL CONTACT; SOUTHERN BRAZIL; ENVENOMATION; RATS; COAGULATION;
   TOXINS; PROCOAGULANT
AB Caterpillar envenomation has been an emergent health issue. Lonomia obliqua is a medically important animal that causes a hemorrhagic syndrome that can progress to acute renal failure, intracranial hemorrhage and death. In the past few years the molecular characterization of L obliqua venom in addition to experimental models has provided fundamental information to the understanding of the envenomation syndrome. Herein studies from several authors which characterized the complex toxic-pharmacological actions of whole venom are reviewed. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Pinto, Antonio F. M.; Berger, Markus; Reck, Jose, Jr.; Terra, Renata M. S.; Guimaraes, Jorge A.] Ctr Biotecnol UFRGS, Lab Bioquim Farmacol, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Ctr Biotecnol UFRGS, Lab Bioquim Farmacol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Reck, Jose/AAH-3373-2020; Reck, Jose/M-4805-2013; Berger,
   Markus/U-7682-2019; Guimaraes, Jorge Almeida/V-2196-2019
OI Reck, Jose/0000-0002-0969-792X; Berger, Markus/0000-0001-7670-2584;
   Pinto, Antonio/0000-0002-1573-8011; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR Abella H.B., 2006, TOXICOVIGILANCIA TOX, P29
   Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   AROCHAPINANGO CL, 1969, LANCET, V1, P810
   AROCHAPINANGO CL, 1992, THROMB HAEMOSTASIS, V67, P402
   Berger M, 2010, TOXICON, V55, P33, DOI 10.1016/j.toxicon.2009.06.033
   Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   Burdmann EA, 1996, CLIN NEPHROL, V46, P337
   Caovilla JJ, 2004, TOXICON, V43, P811, DOI 10.1016/j.toxicon.2004.03.014
   Corrêa Maria Sueli, 2004, Rev. Soc. Bras. Med. Trop., V37, P418, DOI 10.1590/S0037-86822004000500011
   Da Silva GH, 2004, MICROSC RES TECHNIQ, V65, P276, DOI 10.1002/jemt.20114
   da Silva GH, 2004, TOXICON, V44, P625, DOI 10.1016/j.toxicon.2004.07.016
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Diaz JH, 2005, AM J TROP MED HYG, V72, P347, DOI 10.4269/ajtmh.2005.72.347
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Fan Hui Wen, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P119
   *FUNASA, 2001, AC LEP MAN DIAGN TRA, P67
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Garcia CM, 2007, REV SOC BRAS MED TRO, V40, P242, DOI 10.1590/S0037-86822007000200021
   Goncalves LRC, 2007, TOXICON, V50, P349, DOI 10.1016/j.toxicon.2007.04.004
   Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, pR7, DOI 10.3109/15569549509019464
   Kerns RT, 1999, ARCH BIOCHEM BIOPHYS, V369, P107, DOI 10.1006/abbi.1999.1345
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Kowacs PA, 2006, ARQ NEURO-PSIQUIAT, V64, P1030, DOI 10.1590/S0004-282X2006000600029
   Maiorano VA, 2005, J ETHNOPHARMACOL, V102, P364, DOI 10.1016/j.jep.2005.06.039
   Malaque CMS, 2006, AM J TROP MED HYG, V74, P807, DOI 10.4269/ajtmh.2006.74.807
   Gutierrez JM, 2007, CURR PHARM DESIGN, V13, P2935, DOI 10.2174/138161207782023784
   Monroe DM, 2006, ARTERIOSCL THROM VAS, V26, P41, DOI 10.1161/01.ATV.0000193624.28251.83
   Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Prezoto BC, 2002, BRAZ J MED BIOL RES, V35, P703, DOI 10.1590/S0100-879X2002000600011
   Ramos AT, 2004, TOXICON, V43, P761, DOI 10.1016/j.toxicon.2004.03.010
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   Ricci-Silva ME, 2008, TOXICON, V51, P1017, DOI 10.1016/j.toxicon.2008.01.013
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   SanoMartins IS, 1997, THROMB RES, V87, P183, DOI 10.1016/S0049-3848(97)00118-7
   *SECR VIG SAUD MIN, 2009, B ELECT EPIDEMIOLOGI, V9, P17
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   Domingos TFS, 2009, NAT PROD COMMUN, V4, P1075
   THORSEN LI, 1986, THROMB RES, V44, P611, DOI 10.1016/0049-3848(86)90163-5
   Tsai HM, 2006, KIDNEY INT, V70, P16, DOI 10.1038/sj.ki.5001535
   VAUGHAN DE, 1998, THROMBOSIS HEMORRHAG, P155
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Wang HB, 2006, BIOL CHEM, V387, P11, DOI 10.1515/BC.2006.003
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 53
TC 14
Z9 18
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD DEC 15
PY 2010
VL 56
IS 7
SI SI
BP 1103
EP 1112
DI 10.1016/j.toxicon.2010.01.013
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 710XM
UT WOS:000286550300004
PM 20114060
DA 2020-11-24
ER

PT J
AU Berger, M
   Reck, J
   Terra, RMS
   da Silva, WOB
   Santi, L
   Pinto, AFM
   Vainstein, MH
   Termignoni, C
   Guimaraes, JA
AF Berger, Markus
   Reck, Jose, Jr.
   Terra, Renata M. S.
   Beys da Silva, Walter O.
   Santi, Lucelia
   Pinto, Antonio F. M.
   Vainstein, Marilene H.
   Termignoni, Carlos
   Guimaraes, Jorge A.
TI Lonomia obliqua venomous secretion induces human platelet adhesion and
   aggregation
SO JOURNAL OF THROMBOSIS AND THROMBOLYSIS
LA English
DT Article
DE Lonomia; Platelets; Hemorrhagic syndrome; Coagulation; Phospholipase A2
ID CATERPILLAR BRISTLE EXTRACT; PHOSPHOLIPASE A(2); SNAKE-VENOM;
   HEMORRHAGIC SYNDROME; BOTHROPS-JARARACA; COLLAGEN ACTIVATION; SOUTHERN
   BRAZIL; THROMBIN; THROMBOCYTOPENIA; ENVENOMATION
AB The caterpillar Lonomia obliqua is a venomous animal that causes numerous accidents, especially in southern Brazil, where it is considered a public health problem. The clinical manifestations include several haemostatic disturbances that lead to a hemorrhagic syndrome. Considering that platelets play a central role in hemostasis, in this work we investigate the effects of L. obliqua venomous secretion upon blood platelets responses in vitro. Results obtained shows that L. obliqua venom directly induces aggregation and ATP secretion in human washed platelets in a dose-dependent manner. Electron microscopy studies clearly showed that the venomous bristle extract was also able to produce direct platelets shape change and adhesion as well as activation and formation of platelet aggregates. Differently from other enzyme inhibitors, the venom-induced platelet aggregation was significatively inhibited by p-bromophenacyl bromide, a specific inhibitor of phospholipases A2. Additional experiments with different pharmacological antagonists indicate that the aggregation response triggered by the venom active components occurs through a calcium-dependent mechanism involving arachidonic acid metabolite(s) of the cyclooxygenase pathway and activation of phosphodiesterase 3A, an enzyme that leads to the consumption of intracellular cAMP content. It was additionally found that L. obliqua-induced platelet aggregation was independent of ADP release. Altogether, these findings are in line with the need for a better understanding of the complex hemorrhagic syndrome resulting from the envenomation caused by L. obliqua caterpillars, and can also give new insights into the management of its clinical profile.
C1 [Berger, Markus; Reck, Jose, Jr.; Terra, Renata M. S.; Beys da Silva, Walter O.; Pinto, Antonio F. M.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Lab Bioquim Farmacol, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Santi, Lucelia; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Lab Biol Mol Fungos Importancia Med, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Termignoni, Carlos] Univ Fed Rio Grande do Sul, Lab Peptideos & Enzimas Proteolit, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Termignoni, Carlos] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Lab Bioquim Farmacol, Ctr Biotecnol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Termignoni, Carlos/AAB-8943-2020; Guimaraes, Jorge Almeida/V-2196-2019;
   Berger, Markus/U-7682-2019; Santi, Lucelia/AAK-9527-2020; Reck,
   Jose/AAH-3373-2020; Beys-da-Silva, Walter O/M-3760-2018; Santi,
   Lucelia/K-4856-2015; Vainstein, Marilene H/J-5452-2014; Santi,
   Lucelia/AAB-8349-2020; Reck, Jose/M-4805-2013
OI Termignoni, Carlos/0000-0002-2789-2518; Berger,
   Markus/0000-0001-7670-2584; Reck, Jose/0000-0002-0969-792X;
   Beys-da-Silva, Walter O/0000-0001-8329-7839; Vainstein, Marilene
   H/0000-0002-3914-2300; Santi, Lucelia/0000-0002-5698-7006; Pinto,
   Antonio/0000-0002-1573-8011; Guimaraes, Jorge A./0000-0001-6354-6789
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq-MCT), BrazilNational Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES-MEC), BrazilCAPES
FX This work was supported by fellowship grants from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq-MCT), Brazil, and also
   from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES-MEC), Brazil.
CR BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y
   BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066
   Berger M, 2010, TOXICON, V55, P33, DOI 10.1016/j.toxicon.2009.06.033
   BLOCKMANS D, 1995, BLOOD REV, V9, P143, DOI 10.1016/0268-960X(95)90020-9
   Clutton P, 2001, PHARMACOL RES, V44, P255, DOI 10.1006/phrs.2001.0861
   Corrêa Maria Sueli, 2004, Rev. Soc. Bras. Med. Trop., V37, P418, DOI 10.1590/S0037-86822004000500011
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   FITZGERALD GA, 1991, AM J CARDIOL, V68, pB11, DOI 10.1016/0002-9149(91)90379-Y
   Fuly AL, 2004, BIOCHIMIE, V86, P731, DOI 10.1016/j.biochi.2004.07.001
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Garcia CM, 2007, REV SOC BRAS MED TRO, V40, P242, DOI 10.1590/S0037-86822007000200021
   GEAR ARL, 1984, BRIT J HAEMATOL, V56, P387, DOI 10.1111/j.1365-2141.1984.tb03969.x
   Harrison P, 2005, BLOOD REV, V19, P111, DOI 10.1016/j.blre.2004.05.002
   Jackson SP, 2003, NAT REV DRUG DISCOV, V2, P775, DOI 10.1038/nrd1198
   Jennings B, 2005, TOXICON, V46, P687, DOI 10.1016/j.toxicon.2005.07.011
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Kini RM, 1995, TOXICON, V33, P1585, DOI 10.1016/0041-0101(95)00103-4
   Kowacs PA, 2006, ARQ NEURO-PSIQUIAT, V64, P1030, DOI 10.1590/S0004-282X2006000600029
   Malaque CMS, 2006, AM J TROP MED HYG, V74, P807, DOI 10.4269/ajtmh.2006.74.807
   Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   Oenick MDB, 2004, BIOPHYS CHEM, V112, P187, DOI 10.1016/j.bpc.2004.07.018
   Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Reck J, 2009, PARASITOLOGY, V136, P1339, DOI 10.1017/S0031182009990618
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   Roberts DE, 2004, J BIOL CHEM, V279, P19421, DOI 10.1074/jbc.M308864200
   Roberts DE, 2002, ANN NY ACAD SCI, V976, P345
   Rosado JA, 2001, J BIOL CHEM, V276, P15666, DOI 10.1074/jbc.M009217200
   Rucavado A, 2005, THROMB HAEMOSTASIS, V94, P123
   Rucavado A, 2001, THROMB HAEMOSTASIS, V85, P710
   SANDERS WE, 1988, LAB INVEST, V59, P443
   SanoMartins IS, 1997, THROMB RES, V87, P183, DOI 10.1016/S0049-3848(97)00118-7
   Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   TANI T, 1992, ADV SEC MESS PHOSPH, V25, P215
   Veiga A. B. G., 2009, ANIMAL TOXINS STATE, P371
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Vieira DF, 2004, ACTA BIOCH BIOPH SIN, V36, P798, DOI 10.1093/abbs/36.12.798
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
   Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522
   Zychar BC, 2010, TOXICON, V55, P227, DOI 10.1016/j.toxicon.2009.07.025
NR 46
TC 12
Z9 13
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0929-5305
EI 1573-742X
J9 J THROMB THROMBOLYS
JI J. Thromb. Thrombolysis
PD OCT
PY 2010
VL 30
IS 3
BP 300
EP 310
DI 10.1007/s11239-010-0449-5
PG 11
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Hematology
GA 655BD
UT WOS:000282215300007
PM 20157842
DA 2020-11-24
ER

PT J
AU de Amorim, HLN
   Netz, PA
   Guimaraes, JA
AF Neubauer de Amorim, Hermes Luis
   Netz, Paulo Augusto
   Guimaraes, Jorge Almeida
TI Thrombin allosteric modulation revisited: a molecular dynamics study
SO JOURNAL OF MOLECULAR MODELING
LA English
DT Article
DE Thrombin; Allosterism; Specificity; Molecular dynamics
ID HUMAN ALPHA-THROMBIN; PRO-ARG CHLOROMETHYLKETONE; CRYSTAL-STRUCTURE; NA+
   BINDING; ACTIVE-SITE; PROTEIN-C; THROMBOMODULIN COMPLEX; STRUCTURAL
   BASIS; SLOW FORM; SIMULATIONS
AB The regulatory properties of thrombin are derived predominantly from its capacity to produce different functional conformations. Functional studies have revealed that two antagonistic thrombin conformations exist in equilibrium: the fast (procoagulant) and slow (anticoagulant) forms. The mechanisms whereby thrombin activity is regulated by the binding of different effectors remain among the most enigmatic and controversial subjects in the field of protein function. In order to obtain more detailed information on the dynamic events originating from the interaction with the Na+ effector and ligand binding at the active site and anion binding exosite 1 (ABE1), we carried out molecular dynamics simulations of thrombin in different bound states. The results indicated that Na+ release results in a more closed conformation of thrombin, which can be compared to the slow form. The conformational changes induced by displacement of the sodium ion from the Na-binding site include: (1) distortion of the 220- and 186-loops that constitute the Na-binding site; (2) folding back of the Trp148 loop towards the body of the protein, (3) a 180 rotation of the Asp189 side-chain, and (4) projection of the Trp60D loop toward the solvent accompanied by the rearrangement of the Trp215 side chain toward the 95-100 loop. Our findings correlate well with the known structural and recognition properties of the slow and fast forms of thrombin, and are in accordance with the hypothesis that there is communication between the diverse functional domains of thrombin. The theoretical models generated from our MD simulations complement and advance the structural information currently available, leading to a more detailed understanding of thrombin structure and function.
C1 [Neubauer de Amorim, Hermes Luis] Univ Luterana Brasil ULBRA, Lab Bioinformat Estrutural LaBiE, BR-92450900 Canoas, RS, Brazil.
   [Netz, Paulo Augusto] Univ Fed Rio Grande do Sul, Dept Quim Fis, Inst Quim, BR-91501970 Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande Sul UFRGS, Lab Bioquim Farmacol, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP de Amorim, HLN (corresponding author), Univ Luterana Brasil ULBRA, Lab Bioinformat Estrutural LaBiE, Sala 122,Predio 01,Av Farroupilha 1001, BR-92450900 Canoas, RS, Brazil.
EM hamorim@cbiot.ufrgs.br
RI Netz, Paulo/B-1921-2010; Netz, Paulo/N-1205-2019; Amorim,
   Hermes/E-4072-2013; Guimaraes, Jorge Almeida/V-2196-2019
OI Netz, Paulo/0000-0003-4242-0591; Guimaraes, Jorge
   A./0000-0001-6354-6789; de Amorim, Hermes/0000-0001-8362-078X
CR AYALA YM, 1995, J MOL BIOL, V253, P787, DOI 10.1006/jmbi.1995.0591
   Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   BERENDSEN HJC, 1997, J PHYS CHEM-US, V24, P6269
   BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x
   BODE W, 1992, PROTEIN SCI, V1, P426
   Bode W, 2006, SEMIN THROMB HEMOST, V32, P16, DOI 10.1055/s-2006-939551
   CAVES LSD, 1990, MOL DYNAMICS OVERVIE, P27
   Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x
   DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Day R, 2003, ADV PROTEIN CHEM, V66, P373
   De Cristofaro R, 1999, EUR J BIOCHEM, V260, P97, DOI 10.1046/j.1432-1327.1999.00118.x
   De Filippis V, 2005, BIOCHEM J, V390, P485, DOI 10.1042/BJ20050252
   De Filippis V, 2002, BIOCHEMISTRY-US, V41, P13556, DOI 10.1021/bi0203482
   De Mori GMS, 2005, MINI-REV MED CHEM, V5, P353, DOI 10.2174/1389557053544038
   Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001
   Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a
   DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091
   DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089
   Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160
   Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Guinto ER, 1997, BIOPHYS CHEM, V64, P103, DOI 10.1016/S0301-4622(96)02211-9
   Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2
   Huntington JA, 2008, BIOL CHEM, V389, P1025, DOI 10.1515/BC.2008.113
   Huntington James A, 2005, Biochem J, V390, pe1
   Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102
   Lu GM, 2005, J BIOL CHEM, V280, P15471, DOI 10.1074/jbc.M500881200
   Mann KG, 2003, ARTERIOSCL THROM VAS, V23, P17, DOI 10.1161/01.ATV.0000046238.23903.FC
   Marque PE, 2000, J BIOL CHEM, V275, P809, DOI 10.1074/jbc.275.2.809
   Mengwasser KE, 2005, J BIOL CHEM, V280, P26997, DOI 10.1074/jbc.M502678200
   Monteiro RQ, 1999, BIOCHEM BIOPH RES CO, V262, P819, DOI 10.1006/bbrc.1999.1297
   Morra G, 2008, CURR PROTEIN PEPT SC, V9, P181, DOI 10.2174/138920308783955234
   Myles T, 2001, BIOCHEMISTRY-US, V40, P4972, DOI 10.1021/bi0023549
   Nienaber VL, 1996, BIOCHEMISTRY-US, V35, P9690, DOI 10.1021/bi952164b
   NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   PARRY MAA, 1993, BIOCHEM J, V290, P665, DOI 10.1042/bj2900665
   Pineda AO, 2002, J BIOL CHEM, V277, P40177, DOI 10.1074/jbc.C200465200
   Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200
   Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200
   PRIESTLE JP, 1993, PROTEIN SCI, V2, P1630, DOI 10.1002/pro.5560021009
   Rezaie AR, 1996, EUR J BIOCHEM, V242, P477, DOI 10.1111/j.1432-1033.1996.477rr.x
   REZAIE AR, 1993, J BIOL CHEM, V268, P19943
   STUBBS MT, 1992, EUR J BIOCHEM, V206, P187, DOI 10.1111/j.1432-1033.1992.tb16916.x
   STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6
   STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8
   van der Spoel D., 2005, GROMACS USER MANUAL
   vandeLocht A, 1997, EMBO J, V16, P2977, DOI 10.1093/emboj/16.11.2977
   Wang SX, 2001, BIOCHEMISTRY-US, V40, P10038, DOI 10.1021/bi010712h
NR 57
TC 14
Z9 14
U1 1
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1610-2940
EI 0948-5023
J9 J MOL MODEL
JI J. Mol. Model.
PD APR
PY 2010
VL 16
IS 4
BP 725
EP 735
DI 10.1007/s00894-009-0590-2
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Chemistry,
   Multidisciplinary; Computer Science, Interdisciplinary Applications
SC Biochemistry & Molecular Biology; Biophysics; Chemistry; Computer
   Science
GA 563IM
UT WOS:000275122000010
PM 19816721
DA 2020-11-24
ER

PT J
AU Santi, L
   da Silva, WOB
   Berger, M
   Guimaraes, JA
   Schrank, A
   Vainstein, MH
AF Santi, Lucelia
   Beys da Silva, Walter O.
   Berger, Markus
   Guimaraes, Jorge A.
   Schrank, Augusto
   Vainstein, Marilene H.
TI Conidial surface proteins of Metarhizium anisopliae: Source of
   activities related with toxic effects, host penetration and pathogenesis
SO TOXICON
LA English
DT Article
DE Chitinase; Conidia; Host-infection; Lipase; Metarhizium anisopliae;
   Protease; Spore surface protein
ID CUTICLE-DEGRADING PROTEASES; BEAUVERIA-BASSIANA;
   ULTRASTRUCTURAL-LOCALIZATION; ENTOMOPATHOGENIC FUNGUS;
   SUPEROXIDE-DISMUTASE; CANDIDA-ALBICANS; IN-VITRO; SUBSTRATE-SPECIFICITY;
   GERMINATION SPEED; VIRULENCE FACTOR
AB Conidial contact with an arthropod surface is the first step of the fungal penetration and infection process. However, conidia of Metarhizium anisopline have associated components, like enzymes that could be involved in triggering the penetration process and toxic effects that have not yet been well characterized. Fungi produce many enzymes that also are toxic components found in bacteria and animal venoms and thus may be considered as potential virulence factors. In this work, we report several enzymatic activities from spore surface protein extracts. The major proteolytic activities observed in spore surface proteins (SSP) were Pr1 and Pr2 activities, in that order. According to the zymograms obtained, SSP contain different proteases. SSP contain trehalase, exo- and endo-chitinase activities, and seven different chitinase bands which have been observed in zymograms. Activities involved in protection against reactive oxygen species (ROS) were also detected. Two lipolytic enzymes were also detected in lipase zymograms. Phospholipase C activity, closely related to microbial pathogenesis, was detected for the first time in M. anisopliae conidia. These activities described could be an initial step towards understanding the mechanisms involved in the first stage of M. anisopliae infection process and its toxic effects against arthropod hosts. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Santi, Lucelia; Beys da Silva, Walter O.; Berger, Markus; Guimaraes, Jorge A.; Schrank, Augusto; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Guimaraes, Jorge A.; Schrank, Augusto] Univ Fed Rio Grande do Sul, Dept Biol Mol & Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Vainstein, MH (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM mhv@cbiot.ufrgs.br
RI Vainstein, Marilene H/J-5452-2014; Santi, Lucelia/AAB-8349-2020; Santi,
   Lucelia/AAK-9527-2020; Beys-da-Silva, Walter O/M-3760-2018; Berger,
   Markus/U-7682-2019; Schrank, Augusto/G-4688-2012; Guimaraes, Jorge
   Almeida/V-2196-2019; Santi, Lucelia/K-4856-2015
OI Vainstein, Marilene H/0000-0002-3914-2300; Santi,
   Lucelia/0000-0002-5698-7006; Beys-da-Silva, Walter
   O/0000-0001-8329-7839; Berger, Markus/0000-0001-7670-2584; Schrank,
   Augusto/0000-0002-5248-4620; Guimaraes, Jorge A./0000-0001-6354-6789
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Programa de Aperfeicoamento Pessoal de Nivel Superior
   (CAPES)CAPES
FX This work was supported by grants and fellowships from: Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa
   de Aperfeicoamento Pessoal de Nivel Superior (CAPES).
CR Bagga S, 2004, GENE, V324, P159, DOI 10.1016/j.gene.2003.09.031
   Berger M, 2008, TOXICON, V51, P488, DOI [10.1016/j.toxicon.2007-09.005, 10.1016/j.toxicon.2007.09.005]
   Berto P, 1999, FEMS MICROBIOL LETT, V180, P183, DOI 10.1111/j.1574-6968.1999.tb08794.x
   BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1
   Bittencourt SET, 2004, RES MICROBIOL, V155, P681, DOI 10.1016/j.resmic.2004.04.012
   Bogo MR, 1998, CURR MICROBIOL, V37, P221, DOI 10.1007/s002849900368
   CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222
   Charnley AK, 2003, ADV BOT RES, V40, P241, DOI 10.1016/S0065-2296(05)40006-3
   Dani MP, 2005, COMP BIOCHEM PHYS B, V141, P373, DOI 10.1016/j.cbpc.2005.04.010
   Davies KA, 2000, PHYSIOL MOL PLANT P, V57, P63, DOI 10.1006/pmpp.2000.0282
   de Moraes CK, 2003, CURR MICROBIOL, V46, P205, DOI 10.1007/s00284-002-3863-x
   Diaz P, 1999, BIOTECHNIQUES, V27, P696, DOI 10.2144/99274bm14
   Donatti AC, 2008, CURR MICROBIOL, V56, P256, DOI 10.1007/s00284-007-9071-y
   Fan YH, 2007, APPL ENVIRON MICROB, V73, P295, DOI 10.1128/AEM.01974-06
   Frazzon APG, 2000, VET PARASITOL, V94, P117, DOI 10.1016/S0304-4017(00)00368-X
   Freimoser FM, 2005, MICROBIOL-SGM, V151, P361, DOI 10.1099/mic.0.27560-0
   Garre V, 1998, PHYTOPATHOLOGY, V88, P744, DOI 10.1094/PHYTO.1998.88.8.744
   Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000
   Gillespie JP, 1998, J INVERTEBR PATHOL, V71, P128, DOI 10.1006/jipa.1997.4733
   Gottlich E, 1995, MYCOSES, V38, P489, DOI 10.1111/j.1439-0507.1995.tb00026.x
   IBRAHIM AS, 1995, INFECT IMMUN, V63, P1993, DOI 10.1128/IAI.63.5.1993-1998.1995
   Joshi L, 1999, J BIOL CHEM, V274, P9803, DOI 10.1074/jbc.274.14.9803
   KURIOKA S, 1976, ANAL BIOCHEM, V75, P281, DOI 10.1016/0003-2697(76)90078-6
   LIU Y, 2004, PROTEIN EXPRES PURIF, V54, P66
   Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Qazi SS, 2007, J INVERTEBR PATHOL, V95, P48, DOI 10.1016/j.jip.2006.12.002
   Quesada-Moraga E, 2004, J INVERTEBR PATHOL, V87, P51, DOI 10.1016/j.jip.2004.07.002
   Rangel DEN, 2004, J INVERTEBR PATHOL, V87, P77, DOI 10.1016/j.jip.2004.06.007
   Rangel DEN, 2008, MYCOL RES, V112, P1355, DOI 10.1016/j.mycres.2008.04.011
   Roberts DW, 2004, ADV APPL MICROBIOL, V54, P1, DOI 10.1016/S0065-2164(04)54001-7
   Salyers A, 1994, BACTERIAL PATHOGENES, P30
   Schofield DA, 2005, FEMS MICROBIOL LETT, V244, P359, DOI 10.1016/j.femsle.2005.02.015
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Schrank Augusto, 1993, Ciencia e Cultura (Sao Paulo), V45, P200
   Screen SE, 2000, J BIOL CHEM, V275, P6689, DOI 10.1074/jbc.275.9.6689
   Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0
   Shah FA, 2007, FEMS MICROBIOL LETT, V276, P60, DOI 10.1111/j.1574-6968.2007.00927.x
   Shah PA, 2003, APPL MICROBIOL BIOT, V61, P413, DOI 10.1007/s00253-003-1240-8
   SILVA MV, 2005, RES MICROBIOL, V156, P382
   Silva WOB, 2005, PROCESS BIOCHEM, V40, P321, DOI [10.1016/j.procbio.2003.11.053, 10.1016/j.procbio.2004.01.005]
   Small CL, 2005, MYCOL RES, V109, P307, DOI 10.1017/S0953756204001856
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   St Leger RJ, 1998, APPL ENVIRON MICROB, V64, P709
   Stehr F, 2003, J MOL CATAL B-ENZYM, V22, P347, DOI 10.1016/S1381-1177(03)00049-3
   StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P1257, DOI 10.1128/AEM.62.4.1257-1264.1996
   STLEGER RJ, 1993, J INVERTEBR PATHOL, V61, P81, DOI 10.1006/jipa.1993.1014
   StLeger RJ, 1996, APPL ENVIRON MICROB, V62, P907, DOI 10.1128/AEM.62.3.907-912.1996
   Vieira IC, 2003, QUIM NOVA, V26, P39, DOI 10.1590/S0100-40422003000100009
   Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x
   Xia Y, 2002, J INVERTEBR PATHOL, V80, P139, DOI 10.1016/S0022-2011(02)00105-2
   Zhang YJ, 2008, RES MICROBIOL, V159, P462, DOI 10.1016/j.resmic.2008.04.004
   Zimmermann P, 2006, PLANT CELL ENVIRON, V29, P1049, DOI 10.1111/j.1365-3040.2005.01459.x
NR 53
TC 40
Z9 43
U1 0
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD APR 1
PY 2010
VL 55
IS 4
BP 874
EP 880
DI 10.1016/j.toxicon.2009.12.012
PG 7
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 570VB
UT WOS:000275705300023
PM 20034509
DA 2020-11-24
ER

PT J
AU Marks, FS
   Reck, J
   Almeida, LL
   Berger, M
   Correa, AMR
   Driemeier, D
   Barcellos, DESN
   Guimaraes, JA
   Termignoni, C
   Canal, CW
AF Marks, Fernanda S.
   Reck, Jose, Jr.
   Almeida, Laura L.
   Berger, Markus
   Correa, Andre M. R.
   Driemeier, David
   Barcellos, David E. S. N.
   Guimaraes, Jorge A.
   Termignoni, Carlos
   Canal, Claudio W.
TI Porcine circovirus 2 (PCV2) induces a procoagulant state in naturally
   infected swine and in cultured endothelial cells
SO VETERINARY MICROBIOLOGY
LA English
DT Article
DE Porcine circovirus type 2; Swine virus; Coagulation; Hemostasis;
   Endothelium; Viral pathogenesis
ID MULTISYSTEMIC WASTING SYNDROME; POLYMERASE-CHAIN-REACTION;
   VIRUS-INFECTION; AFFECTED PIGS; THROMBIN; ACTIVATION; TYPE-2; PCR;
   PORCINE-CIRCOVIRUS-2; PURIFICATION
AB Porcine circovirus 2 (PCV2) is the primary causative agent of porcine circovirus disease (PCVD). PCVD is an emerging disease that has been reported worldwide, associated with wasting, lymphoid depletion, enteritis, pneumonia, vasculitis, ischemic lesions, and necrotizing dermatitis. Although PCVD causes considerable economic losses, the pathogenesis of PCV2 has not been fully understood. The aim of the present work was to study the participation of hemostatic system and of vascular endothelium in PCV2 infection, as well as their possible role in PCVD pathogenesis. Our results showed that naturally PCV2-infected swine displayed a prothrombotic state in vivo, since a diminished coagulation time (recalcification time, activated partial thromboplastin time and prothrombin time), a higher platelet aggregation ability (despite a diminished platelet blood count), and an increased thrombin plasma activity (associated with a reduced fibrinogen level) were observed. The PCV2-infected animals showed vasculitis and positive staining for PCV2 antigen in capillary vessels. Furthermore, PCV2-infected endothelial cells displayed an activated phenotype, characterized by an increase in cell surface procoagulant activity. Moreover, the PCV2-infected endothelial cells pre-treated with exogenous thrombin displayed an increased viral load. This work reports, for the first time, the role of the hemostatic system and of endothelium in the pathogenesis and infectivity of PCV2. The study reinforces the importance of the phenomena which occur during PCV2 infection, and affords a better knowledge of the mechanisms behind the pathophysiology of PCVD. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Marks, Fernanda S.; Almeida, Laura L.; Canal, Claudio W.] Univ Fed Rio Grande do Sul, Virol Lab, Fac Vet, BR-91540000 Porto Alegre, RS, Brazil.
   [Reck, Jose, Jr.; Berger, Markus; Guimaraes, Jorge A.; Termignoni, Carlos] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91540000 Porto Alegre, RS, Brazil.
   [Correa, Andre M. R.; Driemeier, David] Univ Fed Rio Grande do Sul, Setor Patol Vet, Fac Vet, BR-91540000 Porto Alegre, RS, Brazil.
   [Barcellos, David E. S. N.] Univ Fed Rio Grande do Sul, Setor Suinos, Fac Vet, BR-91540000 Porto Alegre, RS, Brazil.
   [Termignoni, Carlos] Univ Fed Rio Grande do Sul, Dept Bioquim, BR-91540000 Porto Alegre, RS, Brazil.
RP Canal, CW (corresponding author), Univ Fed Rio Grande do Sul, Virol Lab, Fac Vet, Av Bento Goncalves 9090, BR-91540000 Porto Alegre, RS, Brazil.
EM claudio.canal@ufrgs.br
RI Termignoni, Carlos/AAB-8943-2020; Berger, Markus/U-7682-2019; Canal,
   Claudio W./J-7253-2012; de L Almeida, Laura Lopes/D-5654-2013; Reck,
   Jose/AAH-3373-2020; Reck, Jose/M-4805-2013; Driemeier,
   David/H-3461-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Termignoni, Carlos/0000-0002-2789-2518; Berger,
   Markus/0000-0001-7670-2584; Canal, Claudio W./0000-0002-0621-243X; de L
   Almeida, Laura Lopes/0000-0002-6131-9221; Reck,
   Jose/0000-0002-0969-792X; Driemeier, David/0000-0003-3766-0654; Emilio
   Santos Neves de Barcellos, David/0000-0002-4963-435X; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior(CAPES)CAPES
FX The authors thank Conselho Nacional de Pesquisa (CNPq), and the
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(CAPES) for
   the financial support. Special thanks to Tatiane Watanabe (Faculdade de
   Veterinaria, UFRGS) for her assistance in the execution of this work.
   The authors are also indebted to Dr. Fabiana Horn (Departamento de
   Biofisica, UFRGS) for kindly providing EAhy926 cells, and to Simbios
   Biotecnologia for the use of real-time PCR facility.
CR Behling-Kelly E., 2007, Animal Health Research Reviews, V8, P47, DOI 10.1017/S1466252307001296
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Chae C, 2004, VET J, V168, P41, DOI 10.1016/j.tvjl.2003.09.018
   Correa AMR, 2006, PESQUI VET BRASIL, V26, P9, DOI 10.1590/S0100-736X2006000100003
   Darwich L, 2004, ARCH VIROL, V149, P857, DOI 10.1007/s00705-003-0280-9
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   Franca TD, 2005, PESQUI VET BRASIL, V25, P39, DOI 10.1590/S0100-736X2005000100009
   FRESHNEY R.I., 2000, CULTURE ANIMAL CELLS
   Gibbons GH, 1998, THROMBOSIS HEMORRHAG, P307
   GONZALEZ X, 1999, REV CUBANA HEMATOL I, V15, P21
   GUIMARAES J A, 1981, Ciencia e Cultura (Sao Paulo), V33, P1456
   Hajjar DP, 1997, ANN NY ACAD SCI, V15, P155
   Imai DM, 2006, J VET DIAGN INVEST, V18, P496, DOI 10.1177/104063870601800516
   KROLL MH, 1998, THROMBOSIS HEMORRHAG, P261
   LANGE JV, 1985, AM J TROP MED HYG, V34, P999, DOI 10.4269/ajtmh.1985.34.999
   Larochelle R, 1999, J VIROL METHODS, V80, P69, DOI 10.1016/S0166-0934(99)00032-4
   Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D
   Misinzo G, 2006, J VIROL, V80, P3487, DOI 10.1128/JVI.80.7.3487-3494.2006
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   Olvera A, 2004, J VIROL METHODS, V117, P75, DOI 10.1016/j.jviromet.2003.12.007
   Opriessnig T, 2007, J VET DIAGN INVEST, V19, P591, DOI 10.1177/104063870701900601
   Phaneuf LR, 2007, J AM ASSOC LAB ANIM, V46, P68
   Poddar SK, 2002, J VIROL METHODS, V99, P63, DOI 10.1016/S0166-0934(01)00380-9
   Quezada M., 2004, Agro-Ciencia, V20, P119
   RECK J, PARASITOLOG IN PRESS
   Reck J, 2009, RES VET SCI, V86, P56, DOI 10.1016/j.rvsc.2008.05.007
   Correa AMR, 2007, J VET DIAGN INVEST, V19, P109, DOI 10.1177/104063870701900120
   Seeliger FA, 2007, VET PATHOL, V44, P621, DOI 10.1354/vp.44-5-621
   Segales J, 2004, VET MICROBIOL, V98, P151, DOI 10.1016/j.vetmic.2003.10.007
   Segales J, 2004, VET MICROBIOL, V98, P137, DOI 10.1016/j.vetmic.2003.10.006
   Segales Joaquim, 2005, Animal Health Research Reviews, V6, P119, DOI 10.1079/AHR2005106
   Soares RM, 1999, J VIROL METHODS, V78, P191, DOI 10.1016/S0166-0934(98)00177-3
   Sorden SD, 2000, SWINE HEALTH PROD, V8, P133
   Sutherland MR, 2007, J THROMB HAEMOST, V5, P1055, DOI 10.1111/j.1538-7836.2007.02441.x
   Szeredi L, 2008, ACTA VET HUNG, V56, P101, DOI 10.1556/AVet.56.2008.1.10
   TISCHER I, 1982, NATURE, V295, P64, DOI 10.1038/295064a0
   Vallee I, 2001, J VIROL, V75, P10372, DOI 10.1128/JVI.75.21.10372-10382.2001
   van Gorp ECM, 2001, BRIT J HAEMATOL, V113, P94, DOI 10.1046/j.1365-2141.2001.02710.x
   VANKUPPEVELD FJM, 1992, APPL ENVIRON MICROB, V58, P2606, DOI 10.1128/AEM.58.8.2606-2615.1992
   VILCEK S, 1994, ARCH VIROL, V136, P309, DOI 10.1007/BF01321060
   VISSER MR, 1988, P NATL ACAD SCI USA, V85, P8227, DOI 10.1073/pnas.85.21.8227
   Visseren FLJ, 2000, THROMB HAEMOSTASIS, V84, P319
NR 42
TC 13
Z9 16
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1135
EI 1873-2542
J9 VET MICROBIOL
JI Vet. Microbiol.
PD FEB 24
PY 2010
VL 141
IS 1-2
BP 22
EP 30
DI 10.1016/j.vetmic.2009.08.004
PG 9
WC Microbiology; Veterinary Sciences
SC Microbiology; Veterinary Sciences
GA 569PO
UT WOS:000275610200004
PM 19733020
DA 2020-11-24
ER

PT J
AU Graebin, CS
   Verli, H
   Guimaraes, JA
AF Graebin, Cedric S.
   Verli, Hugo
   Guimaraes, Jorge A.
TI Glycyrrhizin and Glycyrrhetic Acid: Scaffolds to Promising New
   Pharmacologically Active Compounds
SO JOURNAL OF THE BRAZILIAN CHEMICAL SOCIETY
LA English
DT Review
DE glycyrrhizin; glycyrrhetic acid; glycyrrhetinic acid; licquorice;
   organic synthesis; pharmacological activity
ID 18-BETA-GLYCYRRHETINIC ACID; IMMUNOMODULATING ACTIVITY; TRITERPENE
   DERIVATIVES; ANTIVIRAL ACTIVITY; D-GLUCOSAMINE; INHIBITION; LICORICE;
   INTERFERON; OLEANANE; LEUKEMIA
AB Glycyrrhizinic acid (GL), also known as glycyrrhizin, is a triterpene saponin, a natural product found on the root of Glycyrrhyza glabra L. ("licquorice"), used worldwide as sweetener and in the traditional eastern medicines. This review is focused on a series of new derivatives synthesized using GL and its aglycon, glycyrrhetinic acid (GLA), as starting materials, the pharmacological activities described for those compounds, as well as new activities reported for GL and GLA themselves.
C1 [Graebin, Cedric S.; Verli, Hugo; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
   [Graebin, Cedric S.] Univ Fed Rural Rio de Janeiro, Inst Ciencias Exatas, Dept Quim, BR-23890000 Seropedica, RJ, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Ave Bento Goncalves 9500, BR-91500970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Verli, Hugo/G-8703-2012; Graebin,
   Cedric S/F-2009-2010
OI Verli, Hugo/0000-0002-4796-8620; Graebin, Cedric S/0000-0003-1410-1227;
   Guimaraes, Jorge A./0000-0001-6354-6789
CR Ablise M, 2004, CHEM PHARM BULL, V52, P1436, DOI 10.1248/cpb.52.1436
   Baltina LA, 2006, CHEM NAT COMPD+, V42, P543, DOI 10.1007/s10600-006-0210-7
   Baltina LA, 2003, CURR MED CHEM, V10, P155, DOI 10.2174/0929867033368538
   Baltina LA, 1996, BIOORG KHIM+, V22, P926
   Bang EK, 2009, TETRAHEDRON LETT, V50, P2545, DOI 10.1016/j.tetlet.2009.03.049
   Cavalli A, 2009, J MED CHEM, V52, P7339, DOI 10.1021/jm9004835
   Chadalapaka G, 2008, BIOORG MED CHEM LETT, V18, P2633, DOI 10.1016/j.bmcl.2008.03.031
   Chintharlapalli S, 2007, MOL CANCER THER, V6, P1588, DOI 10.1158/1535-7163.MCT-07-0022
   Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Duarte CD, 2007, MINI-REV MED CHEM, V7, P1108, DOI 10.2174/138955707782331722
   Ech-Chahad A, 2005, TETRAHEDRON LETT, V46, P5113, DOI 10.1016/j.tetlet.2005.05.131
   Fiore C, 2005, J ETHNOPHARMACOL, V99, P317, DOI 10.1016/j.jep.2005.04.015
   Harada S, 2005, BIOCHEM J, V392, P191, DOI 10.1042/BJ20051069
   Hibasami H, 2006, INT J MOL MED, V17, P215
   Hoever G, 2005, J MED CHEM, V48, P1256, DOI 10.1021/jm0493008
   Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230
   Huang L, 2008, BIOORGAN MED CHEM, V16, P6696, DOI 10.1016/j.bmc.2008.05.078
   Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0
   Ikeda T, 2005, BIOL PHARM BULL, V28, P1779, DOI 10.1248/bpb.28.1779
   Kalaiarasi P, 2009, EUR J PHARMACOL, V606, P269, DOI 10.1016/j.ejphar.2008.12.057
   Kitagawa I, 2002, PURE APPL CHEM, V74, P1189, DOI 10.1351/pac200274071189
   Kondratenko RM, 2006, RUSS J BIOORG CHEM+, V32, P595, DOI 10.1134/S1068162006060136
   Kondratenko RM, 2005, CHEM NAT COMPD+, V41, P7, DOI 10.1007/s10600-005-0061-7
   Kondratenko RM, 2004, RUSS J BIOORG CHEM+, V30, P275, DOI 10.1023/B:RUBI.0000030135.97089.37
   Kondratenko RM, 2004, RUSS J BIOORG CHEM+, V30, P148, DOI 10.1023/B:RUBI.0000023100.52170.6b
   Kondratenko RM, 2004, RUSS J BIOORG CHEM+, V30, P53, DOI 10.1023/B:RUBI.0000015774.09619.80
   Kondratenko RM, 2003, RUSS J BIOORG CHEM+, V29, P601, DOI 10.1023/B:RUBI.0000008903.65076.93
   Krausse R, 2004, J ANTIMICROB CHEMOTH, V54, P243, DOI 10.1093/jac/dkh287
   Liu D, 2007, BIOORGAN MED CHEM, V15, P5432, DOI 10.1016/j.bmc.2007.05.057
   Liu LJ, 2006, CHEM J CHINESE U, V27, P1669
   Maitraie D, 2009, BIOORGAN MED CHEM, V17, P2785, DOI 10.1016/j.bmc.2009.02.025
   Mendes-Silva W, 2003, THROMB RES, V112, P93, DOI 10.1016/j.thromres.2003.10.014
   Mikhailova LR, 2007, CHEM NAT COMPD+, V43, P571, DOI 10.1007/s10600-007-0195-x
   Mikhailova LR, 2006, CHEM NAT COMPD+, V42, P553, DOI 10.1007/s10600-006-0212-5
   Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007
   Mustafina SR, 2006, CHEM NAT COMPD+, V42, P67, DOI 10.1007/s10600-006-0037-2
   Nakagawa-Goto K, 2007, BIOORG MED CHEM LETT, V17, P2894, DOI 10.1016/j.bmcl.2007.02.051
   Nakata N, 2008, J ORTHOP SCI, V13, P456, DOI 10.1007/s00776-008-1259-x
   Oh HM, 2009, EXP BIOL MED, V234, P263, DOI 10.3181/0805-RM-178
   Park HY, 2004, ARCH PHARM RES, V27, P57, DOI 10.1007/BF02980047
   Ram A, 2006, INT IMMUNOPHARMACOL, V6, P1468, DOI 10.1016/j.intimp.2006.04.020
   Shi JH, 2006, CHEM NAT COMPD+, V42, P325, DOI 10.1007/s10600-006-0111-9
   Su XD, 2007, J STEROID BIOCHEM, V104, P312, DOI 10.1016/j.jsbmb.2007.03.019
   Tatsuzaki J, 2007, BIOORGAN MED CHEM, V15, P6193, DOI 10.1016/j.bmc.2007.06.027
   Vicker N, 2004, BIOORG MED CHEM LETT, V14, P3263, DOI 10.1016/j.bmcl.2004.03.107
   Williams G. M., 2006, WHO FOOD ADDITIVES S, V54
   Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012
   Yong JP, 2008, CHEM NAT COMPD+, V44, P194, DOI 10.1007/s10600-008-9012-4
   Yu DL, 2006, J MED CHEM, V49, P5462, DOI 10.1021/jm0601912
   Zhai DS, 2007, PLANTA MED, V73, P128, DOI 10.1055/s-2006-957067
NR 51
TC 32
Z9 33
U1 0
U2 39
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0103-5053
EI 1678-4790
J9 J BRAZIL CHEM SOC
JI J. Braz. Chem. Soc.
PY 2010
VL 21
IS 9
BP 1595
EP 1615
DI 10.1590/S0103-50532010000900002
PG 21
WC Chemistry, Multidisciplinary
SC Chemistry
GA 637IR
UT WOS:000280811300002
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Berger, M
   Reck, J
   Terra, RMS
   Pinto, AFM
   Termignoni, C
   Guimaraes, JA
AF Berger, Markus
   Reck, Jose, Jr.
   Terra, Renata M. S.
   Pinto, Antonio F. M.
   Termignoni, Carlos
   Guimaraes, Jorge A.
TI Lonomia obliqua caterpillar envenomation causes platelet hypoaggregation
   and blood incoagulability in rats
SO TOXICON
LA English
DT Article
DE Lonomia; Caterpillar; Envenomation; Platelet function; Hemorrhagic
   syndrome
ID JARARACA SNAKE-VENOM; NITRIC-OXIDE; HEMORRHAGIC SYNDROME; BRISTLE
   EXTRACT; BOTHROPS-JARARACA; INTRACEREBRAL HEMORRHAGE; PHOSPHOLIPASE
   A(2); SOUTHERN BRAZIL; COAGULATION; THROMBIN
AB Envenomation caused by Lonomia obliqua is a public health hazard in Southern Brazil. Envenomed victims present severe hemorrhagic syndrome that can progress to intracranial hemorrhage and death. To understand the mechanisms that lead to hemorrhage, we investigated the platelet dysfunction and blood coagulation disturbances following experimental envenomation in rats. L obliqua bristle extract was injected (s.c.) and blood collected at different times post-venom administration for determination of platelet response and analysis of blood coagulation. Rats presented hypofibrinogenemia and platelet hypoaggregation in platelet rich plasma (PRP). After addition of exogenous fibrinogen to PRP, platelet hypoaggregation was not corrected. Interestingly, normoaggregation was observed when platelets were separated from plasma. In addition, incubation of plasma from envenomed rats inhibits aggregation response of normal washed platelets. These results indicate that an aggregation inhibitor is generated in plasma during envenomation. Moreover, rats presented an increase in nitric oxide plasmatic levels which coincided with maximum inhibition in platelet aggregation. Animals also showed blood incoagulability and a significant increase in thrombin, plasmin and urokinase plasmatic activities. Despite this intravascular thrombin generation, only a slight decrease in platelet numbers was detected. Certainly, the platelet hypoaggregation and blood incoagulability described herein contribute to systemic bleeding observed in patients. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Berger, Markus; Reck, Jose, Jr.; Terra, Renata M. S.; Pinto, Antonio F. M.; Termignoni, Carlos; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, BR-91501970 Porto Alegre, RS, Brazil.
   [Termignoni, Carlos] Univ Fed Rio Grande do Sul, Dept Bioquim, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, Av Bento Goncalves,9500 Cx Postal 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Reck, Jose/AAH-3373-2020; Reck, Jose/M-4805-2013; Guimaraes, Jorge
   Almeida/V-2196-2019; Berger, Markus/U-7682-2019; Termignoni,
   Carlos/AAB-8943-2020
OI Reck, Jose/0000-0002-0969-792X; Berger, Markus/0000-0001-7670-2584;
   Termignoni, Carlos/0000-0002-2789-2518; Guimaraes, Jorge
   A./0000-0001-6354-6789; Pinto, Antonio/0000-0002-1573-8011
FU Conselho Nacional de Desenvolvimento, Cientifico e Tecnologico
   (CNPq-MCT), BrazilNational Council for Scientific and Technological
   Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES-MEC), BrazilCAPES
FX We thank Dr. Robson Queiroz Monteiro, (Institute of Medical Biochemistry
   - Federal University of Rio de Janeiro, Brazil) for suggestions and for
   kindly providing GPRP and Dra. Celia R. Carlini (Department of
   Biophysics - Federal University of Rio Grande do Sul, Brazil) for
   careful revision of the manuscript. We are also indebted to Zelma Regina
   de Almeida for animal handling. This work was supported by fellowship
   grants from Conselho Nacional de Desenvolvimento, Cientifico e
   Tecnologico (CNPq-MCT), Brazil, and also by Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES-MEC), Brazil.
CR Abella H.B., 2006, TOXICOVIGILANCIA TOX, P29
   Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   Barros SF, 1998, MEDIAT INFLAMM, V7, P339, DOI 10.1080/09629359890866
   BERGENTZ SE, 1972, SURGERY, V71, P190
   Berger M, 2008, TOXICON, V51, P488, DOI [10.1016/j.toxicon.2007-09.005, 10.1016/j.toxicon.2007.09.005]
   BLOCKMANS D, 1995, BLOOD REV, V9, P143, DOI 10.1016/0268-960X(95)90020-9
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   Burdmann EA, 1996, CLIN NEPHROL, V46, P337
   BUSSE R, 1990, FEBS LETT, V275, P87, DOI 10.1016/0014-5793(90)81445-T
   Caovilla JJ, 2004, TOXICON, V43, P811, DOI 10.1016/j.toxicon.2004.03.014
   Chaim OM, 2006, TOXICOL APPL PHARM, V211, P64, DOI 10.1016/j.taap.2005.05.015
   Chaves F, 2006, INFLAMM RES, V55, P245, DOI 10.1007/s00011-006-0078-9
   CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   Duarte AC, 1996, LANCET, V348, P1033, DOI 10.1016/S0140-6736(05)64961-6
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Ekmekci H, 2006, THROMB RES, V117, P249, DOI 10.1016/j.thromres.2005.03.006
   Escalante T, 2003, TOXICOL APPL PHARM, V193, P17, DOI 10.1016/S0041-008X(03)00337-5
   Fritzen M, 2005, BIOCHEM BIOPH RES CO, V333, P517, DOI 10.1016/j.bbrc.2005.05.140
   Fuly AL, 2004, BIOCHIMIE, V86, P731, DOI 10.1016/j.biochi.2004.07.001
   Gamborgi GP, 2006, TOXICON, V47, P68, DOI 10.1016/j.toxicon.2005.09.012
   Garcia CM, 2007, REV SOC BRAS MED TRO, V40, P242, DOI 10.1590/S0037-86822007000200021
   GILES AR, 1990, THROMB HAEMOSTASIS, V63, P476
   Goncalves LRC, 2007, TOXICON, V50, P349, DOI 10.1016/j.toxicon.2007.04.004
   Gouveia AID, 2005, TOXICON, V45, P403, DOI 10.1016/j.toxicon.2004.11.008
   Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958
   HOGG N, 1992, BIOCHEM J, V281, P419, DOI 10.1042/bj2810419
   Joseph Roy, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P437, DOI 10.2174/1568006043335808
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, P283, DOI 10.3109/15569549509019465
   Kleinbongard P, 2007, THROMB HAEMOSTASIS, V98, P970, DOI 10.1160/TH07-04-0305
   Kowacs PA, 2006, ARQ NEURO-PSIQUIAT, V64, P1030, DOI 10.1590/S0004-282X2006000600029
   LIBBY P, 1991, LAB INVEST, V64, P5
   Malaque CMS, 2006, AM J TROP MED HYG, V74, P807, DOI 10.4269/ajtmh.2006.74.807
   Michelson AD, 1996, AM J PHYSIOL-HEART C, V270, pH1640
   Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319
   NAHAS L, 1975, TOXICON, V13, P457, DOI 10.1016/0041-0101(75)90175-0
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   Oenick MDB, 2004, BIOPHYS CHEM, V112, P187, DOI 10.1016/j.bpc.2004.07.018
   OLSEN F, 1972, ACTA PATH MICRO IM A, VA 80, P253
   Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   PETRICEVICH VL, 2000, TOXICON, V92, P369
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Pinto AFM, 2008, TOXICON, V51, P1119, DOI 10.1016/j.toxicon.2008.01.010
   Prezoto BC, 2002, BRAZ J MED BIOL RES, V35, P703, DOI 10.1590/S0100-879X2002000600011
   RADI R, 1991, J BIOL CHEM, V266, P4244
   Reck J, 2009, RES VET SCI, V86, P56, DOI 10.1016/j.rvsc.2008.05.007
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   Rucavado A, 2005, THROMB HAEMOSTASIS, V94, P123
   SanoMartins IS, 1997, THROMB RES, V87, P183, DOI 10.1016/S0049-3848(97)00118-7
   Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   SHIMAMURA K, 1983, ARCH PATHOL LAB MED, V107, P543
   THORSEN LI, 1986, THROMB RES, V44, P611, DOI 10.1016/0049-3848(86)90163-5
   TIMMONS S, 1989, METHOD ENZYMOL, V169, P11
   TOH CH, 1993, BRIT J HAEMATOL, V85, P751, DOI 10.1111/j.1365-2141.1993.tb03219.x
   UMANS JG, 1995, ANNU REV PHYSIOL, V57, P771, DOI 10.1146/annurev.ph.57.030195.004011
   VANOOST B, 1983, BLOOD, V62, P433
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 66
TC 15
Z9 16
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JAN
PY 2010
VL 55
IS 1
BP 33
EP 44
DI 10.1016/j.toxicon.2009.06.033
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 547WX
UT WOS:000273921500005
PM 19577588
DA 2020-11-24
ER

PT J
AU Terra, RMS
   Pinto, AFM
   Guimaraes, JA
   Fox, JW
AF Terra, Renata M. S.
   Pinto, Antonio F. M.
   Guimaraes, Jorge A.
   Fox, Jay W.
TI Proteomic profiling of snake venom metalloproteinases (SVMPs): Insights
   into venom induced pathology
SO TOXICON
LA English
DT Article
DE Bothrops jararaca; Bothrops lanceolatus; Snake venom; SVMP;
   Metalloproteases; Proteome
ID BOTHROPS-JARARACA VENOM; HEMORRHAGIC METALLOPROTEINASES;
   FUNCTIONAL-CHARACTERIZATION; PROTHROMBIN ACTIVATOR; LANCEOLATUS;
   ENVENOMATION; MARTINIQUE; ANTIVENOM; PURIFICATION; VIPERA
AB Bothrops sp. snakebites account for the majority of envenomations in South and Central America. Bothrops jararaca accidents are characterized by edema, hemorrhage and necrosis, mainly attributed to the action of hemorrhagic snake venom metalloproteinases (SVMPs). Interestingly, accidents involving Bothrops lanceolatus (Fer-de-Lance) have a prothrombotic profile with necrosis and hemorrhage rarely reported. Here we describe biochemical and proteomic approaches to compare the venom composition of these snakes, focusing on the presence and activity of SVMPs. The total relative amount of SVMPs was found to be approximately the same in the venom of both species, the difference being in the distribution of SVMPs subgroups. Fer-de-Lance venom has relatively more PI SVMPs peptides identified (23-16%) while Jararaca venom has a higher amount of PIII SVMPs (54-43%). Gelatinolytic activity in the PIII mass range is also higher in Jararaca venom. Interestingly, the homologous band region in the Fer-de-Lance zymogram was only very weakly gelatinolytic. According to these findings it is feasible that the different distribution of SVMPs subgroups and their particular biochemical and pharmacological characteristics are two of the main factors contributing to these two radically different venom induced pathologies. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Terra, Renata M. S.; Pinto, Antonio F. M.; Fox, Jay W.] Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA.
   [Terra, Renata M. S.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Lab Bioquim Farmacol, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP Fox, JW (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Microbiol, Charlottesville, VA 22908 USA.
EM jwf8x@virginia.edu
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Pinto, Antonio/0000-0002-1573-8011; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), Brasilia, BrazilCAPES; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)National Council
   for Scientific and Technological Development (CNPq); University of
   Virginia Office of Research Core Administration
FX The authors thank the Brazilian agency Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), Brasilia, Brazil, for the PDEE
   fellowship to R.M.S. Terra. This work was supported by Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil) (J.A.G.),
   CAPES (R.M.S.T.) and the University of Virginia Office of Research Core
   Administration (J.W.F.).
CR Angulo Y, 2008, J PROTEOME RES, V7, P708, DOI 10.1021/pr700610z
   BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0
   Bazaa A, 2005, PROTEOMICS, V5, P4223, DOI 10.1002/pmic.200402024
   Berger M, 2008, TOXICON, V51, P488, DOI [10.1016/j.toxicon.2007-09.005, 10.1016/j.toxicon.2007.09.005]
   BJARNASON JB, 1995, METHOD ENZYMOL, V248, P345
   BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   Calvete JJ, 2007, J PROTEOME RES, V6, P2732, DOI 10.1021/pr0701714
   Cidade DAP, 2006, TOXICON, V48, P437, DOI 10.1016/j.toxicon.2006.07.008
   Costa EP, 2002, INFLAMMATION, V26, P13, DOI 10.1023/A:1014465611487
   de Roodt AR, 2003, TOXICON, V41, P949, DOI 10.1016/S0041-0101(02)00392-6
   Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018
   Fernandez P, 2008, TOXICON, V52, P530, DOI 10.1016/j.toxicon.2008.06.018
   Fox JW, 2008, FEBS J, V275, P3016, DOI 10.1111/j.1742-4658.2008.06466.x
   Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777
   Fox JW, 2006, TOXICON, V47, P700, DOI 10.1016/j.toxicon.2006.01.022
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   Georgieva D, 2008, J PROTEOME RES, V7, P866, DOI 10.1021/pr070376c
   GOVERSRIEMSLAG JWP, 1987, BIOCHIM BIOPHYS ACTA, V916, P388, DOI 10.1016/0167-4838(87)90185-3
   Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Laing GD, 2005, TOXICON, V45, P987, DOI 10.1016/j.toxicon.2005.02.013
   Malbranque S, 2008, AM J TROP MED HYG, V78, P856, DOI 10.4269/ajtmh.2008.78.856
   Gutierrez JM, 2008, J PROTEOME RES, V7, P4396, DOI 10.1021/pr8003826
   Pinho Fábia Maria Oliveira, 2004, Rev. Assoc. Med. Bras., V50, P93, DOI 10.1590/S0104-42302004000100043
   Rafael A, 2008, TOXICON, V51, P479, DOI 10.1016/j.toxicon.2007.08.014
   SANOMARTINS IS, 1995, BRAZ J MED BIOL RES, V28, P303
   Santoro ML, 2008, TOXICON, V51, P1440, DOI 10.1016/j.toxicon.2008.03.018
   Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120
   Serrano SMT, 2005, PROTEOMICS, V5, P501, DOI 10.1002/pmic.200400931
   Serrano SMT, 2007, FEBS J, V274, P3611, DOI 10.1111/j.1742-4658.2007.05895.x
   Silva MB, 2003, BIOCHEM J, V369, P129, DOI 10.1042/BJ20020449
   Stroka A, 2005, TOXICON, V45, P411, DOI 10.1016/j.toxicon.2004.11.010
   THOMAS L, 1995, AM J TROP MED HYG, V52, P419, DOI 10.4269/ajtmh.1995.52.419
   Thomas L, 2006, TOXICON, V48, P23, DOI 10.1016/j.toxicon.2006.04.007
   Wang WJ, 2004, BIOCHEM BIOPH RES CO, V324, P224, DOI 10.1016/j.bbrc.2004.09.031
NR 35
TC 23
Z9 23
U1 2
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD NOV
PY 2009
VL 54
IS 6
BP 836
EP 844
DI 10.1016/j.toxicon.2009.06.010
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 504OQ
UT WOS:000270626900015
PM 19539639
DA 2020-11-24
ER

PT J
AU Reck, J
   Berger, M
   Marks, FS
   Zingali, RB
   Canal, CW
   Ferreira, CAS
   Guimaraes, JA
   Termignoni, C
AF Reck, J., Jr.
   Berger, M.
   Marks, F. S.
   Zingali, R. B.
   Canal, C. W.
   Ferreira, C. A. S.
   Guimaraes, J. A.
   Termignoni, C.
TI Pharmacological action of tick saliva upon haemostasis and the
   neutralization ability of sera from repeatedly infested hosts
SO PARASITOLOGY
LA English
DT Article
DE Rhipicephalus (Boophilus) microplus; tick; haematophagous; haemostasis;
   coagulation; platelet; endothelium; thrombosis; bovine resistance
ID PATHWAY INHIBITOR TFPI; BOOPHILUS-MICROPLUS; IXODES-SCAPULARIS;
   ORNITHODOROS-SAVIGNYI; CELL-PROLIFERATION; THROMBIN INHIBITOR;
   ENDOTHELIAL-CELLS; POTENT INHIBITOR; CATTLE; PURIFICATION
AB Ticks are blood-feeding arthropods widely distributed in the world and vectors of several diseases. As haematophagy demands evasion strategies and repeatedly infested hosts develop protective immune responses, we investigated the mechanisms of the Rhipicephalus (Boophilus) microplus saliva anti-haemostatic activity and the possible relationship between the acquired natural anti-tick host resistance and anti-haemostatic action. For this purpose, We Studied the effects of R. microplus saliva on different pathways of haemostasis and tested whether repeated infested bovine sera (RIBS) are able to abolish salivary anti-haemostatic activities. R. microplus saliva (i) displays inhibitory activity upon collagen-induced platelet aggregation; (ii) inhibits the induction of endothelial pro-coagulant state; and (iii) reduces thrombogenesis in vivo. RIBS were shown to be able to partially block the delay of coagulation and the anti-thrombotic effect of saliva, and to totally abolish the modulation of endothelium activation. Conversely, RIBS has no effect on the inhibition of platelet aggregation. These results show, for the first time, the neutralization ability of sera from acquired resistance hosts against tick anti-haemostatics. Moreover, this is the first report of a haematophagous parasite able to modulate endothelial cell procoagulant state, and addresses the presence of anti-platelet and anti-thrombotic activity in R. microplus saliva.
C1 [Reck, J., Jr.; Berger, M.; Guimaraes, J. A.; Termignoni, C.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Marks, F. S.; Canal, C. W.] Univ Fed Rio Grande do Sul, Dept Patol Clin Vet, Fac Vet, BR-91501970 Porto Alegre, RS, Brazil.
   [Zingali, R. B.] Univ Fed Rio de Janeiro UFRJ, Inst Bioquim Med, Rio De Janeiro, Brazil.
   [Ferreira, C. A. S.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Fac Biociencias, Dept Biol Celular & Mol, Porto Alegre, RS, Brazil.
   [Termignoni, C.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Dept Bioquim, ICBS, Porto Alegre, RS, Brazil.
RP Termignoni, C (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM ctermignoni@cbiot.ufrgs.br
RI Ferreira, Carlos A S/J-3672-2015; Termignoni, Carlos/AAB-8943-2020;
   Reck, Jose/M-4805-2013; Canal, Claudio W./J-7253-2012; Berger,
   Markus/U-7682-2019; Guimaraes, Jorge Almeida/V-2196-2019; Reck,
   Jose/AAH-3373-2020; Zingali, Russolina/G-4862-2012
OI Ferreira, Carlos A S/0000-0002-3727-5097; Termignoni,
   Carlos/0000-0002-2789-2518; Canal, Claudio W./0000-0002-0621-243X;
   Berger, Markus/0000-0001-7670-2584; Reck, Jose/0000-0002-0969-792X;
   Guimaraes, Jorge A./0000-0001-6354-6789
FU Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio Grande do Sul (FAPERGS)Foundation for Research Support of
   the State of Rio Grande do Sul (FAPERGS); Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES
FX We are indebted to the Conselho Nacional de Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for
   financial support. Special thanks to Dr Lucelia Santi, Dr Renata Terra
   and Dr Antonio Pinto (Centro de Biotecnologia, UFRGS) for their
   assistance in the execution of this work, to Ana Cruz (PUCRS) and
   Professor Sergio Silva (Faculdade de Veterinaria, UFPel) for kindly
   providing of cattle serum samples, to Professor Fabiana Horn
   (Departamento de Biofisica, UFRGS) for critical review of this
   manuscript and for kindly providing endothelial cells, and to Dr
   Cora-Jean Edgell (Department of Pathology, University of North Carolina)
   for the permission to use EAhy926 cells.
CR ALLEN JR, 1994, REV SCI TECH OIE, V13, P1287, DOI 10.20506/rst.13.4.824
   Berger M, 2008, TOXICON, V51, P488, DOI [10.1016/j.toxicon.2007-09.005, 10.1016/j.toxicon.2007.09.005]
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   Brossard M, 2004, PARASITOLOGY, V129, pS161, DOI 10.1017/S0031182004004834
   BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2
   Champagne Donald E., 1996, P85
   Ciprandi A, 2006, EXP PARASITOL, V114, P40, DOI 10.1016/j.exppara.2006.02.010
   Cruz APR, 2008, VET PARASITOL, V158, P152, DOI 10.1016/j.vetpar.2008.08.016
   Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689
   DICKINSON RG, 1976, AUST J EXP BIOL MED, V54, P475, DOI 10.1038/icb.1976.48
   EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734
   FASS, 1999, GUID CAR US AGR AN A
   Ferreira CAS, 2002, EXP PARASITOL, V101, P25, DOI 10.1016/S0014-4894(02)00032-2
   FIORAVANTI C, 1993, THROMB RES, V71, P317, DOI 10.1016/0049-3848(93)90200-8
   Francischetti IMB, 2005, THROMB HAEMOSTASIS, V94, P167, DOI 10.1160/TH04-09-0566
   Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237
   Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363
   Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715
   Gibbons GH, 1998, THROMBOSIS HEMORRHAG, P307
   Guimaraes J.H., 2001, ECTOPARASITOS IMPORT
   Horn F, 2000, ARCH BIOCHEM BIOPHYS, V384, P68, DOI 10.1006/abbi.2000.2076
   JACKSON LA, 1995, VET PARASITOL, V58, P129, DOI 10.1016/0304-4017(94)00703-F
   JOHNSON S, 1995, INFECT IMMUN, V63, P3166, DOI 10.1128/IAI.63.8.3166-3173.1995
   JOHNSTON LAY, 1986, INT J PARASITOL, V16, P27, DOI 10.1016/0020-7519(86)90061-5
   Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967
   Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x
   KEMP DH, 1983, EXPERIENTIA, V39, P725, DOI 10.1007/BF01990293
   KIMARO EE, 1994, VET PARASITOL, V52, P61, DOI 10.1016/0304-4017(94)90036-1
   Konnai S, 2009, IMMUNOLOGY, V126, P209, DOI 10.1111/j.1365-2567.2008.02890.x
   Kotsyfakis M, 2008, J IMMUNOL, V181, P5209, DOI 10.4049/jimmunol.181.8.5209
   Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200
   Makrides SC, 1998, THROMBOSIS HEMORRHAG, P295
   Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007
   Mans BJ, 1998, COMP BIOCHEM PHYS B, V120, P617, DOI 10.1016/S0305-0491(98)10061-5
   Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200
   Maritz-Olivier C, 2007, TRENDS PARASITOL, V23, P397, DOI 10.1016/j.pt.2007.07.005
   Maxwell SS, 2005, ANN TROP MED PARASIT, V99, P661, DOI 10.1179/136485905X51490
   Murrell A, 2003, SYST PARASITOL, V56, P169, DOI 10.1023/B:SYPA.0000003802.36517.a0
   Nazareth RA, 2006, THROMB HAEMOSTASIS, V96, P7, DOI 10.1160/TH06-02-0105
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   Prevot PP, 2007, VACCINE, V25, P3284, DOI 10.1016/j.vaccine.2007.01.008
   Reck J, 2009, RES VET SCI, V86, P56, DOI 10.1016/j.rvsc.2008.05.007
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   RIBEIRO JMC, 1989, EXP APPL ACAROL, V7, P15, DOI 10.1007/BF01200449
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   Ricci CG, 2007, EXP APPL ACAROL, V42, P291, DOI 10.1007/s10493-007-9097-7
   RUTTER JM, 1976, INFECT IMMUN, V13, P667, DOI 10.1128/IAI.13.3.667-676.1976
   Simmonds RE, 1998, THROMBOSIS HEMORRHAG, P45
   STEEVES EBT, 1991, INT J PARASITOL, V21, P265, DOI 10.1016/0020-7519(91)90020-8
   TIMMONS S, 1989, METHOD ENZYMOL, V169, P11
   Visseren FLJ, 2000, THROMB HAEMOSTASIS, V84, P319
   VOGEL GMT, 1989, THROMB RES, V54, P399, DOI 10.1016/0049-3848(89)90210-7
   Walker DH, 1998, ANNU REV PUBL HEALTH, V19, P237, DOI 10.1146/annurev.publhealth.19.1.237
   Wikel S. K., 1996, The immunology of host-ectoparasitic arthropod relationships., P204
   WIKEL SK, 1986, VET PARASITOL, V20, P149, DOI 10.1016/0304-4017(86)90098-1
   WIKEL SK, 1982, ANNU REV ENTOMOL, V27, P21, DOI 10.1146/annurev.en.27.010182.000321
   Wikel SK, 1996, ANNU REV ENTOMOL, V41, P1, DOI 10.1146/annurev.en.41.010196.000245
   WILLADSEN P, 1987, INT J PARASITOL, V17, P671, DOI 10.1016/0020-7519(87)90145-7
   WILLADSEN P, 1995, PARASITOLOGY, V110, pS43, DOI 10.1017/S0031182000001487
NR 61
TC 12
Z9 12
U1 0
U2 8
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0031-1820
EI 1469-8161
J9 PARASITOLOGY
JI Parasitology
PD SEP
PY 2009
VL 136
IS 11
BP 1339
EP 1349
DI 10.1017/S0031182009990618
PG 11
WC Parasitology
SC Parasitology
GA 500VN
UT WOS:000270333800011
PM 19627637
OA Green Published
DA 2020-11-24
ER

PT J
AU Andrades, ME
   Lorenzi, R
   Berger, M
   Guimaraes, JA
   Moreira, JCF
   Dal-Pizzol, F
AF Andrades, M. E.
   Lorenzi, R.
   Berger, M.
   Guimaraes, J. A.
   Moreira, J. C. F.
   Dal-Pizzol, F.
TI Glycolaldehyde induces fibrinogen post-translational modification, delay
   in clotting and resistance to enzymatic digestion
SO CHEMICO-BIOLOGICAL INTERACTIONS
LA English
DT Article
DE Glycolaldehyde; Carbonyl; Fibrinogen; Fibrinolysis; Coagulation
ID DISSEMINATED INTRAVASCULAR COAGULATION; GLYCATION END-PRODUCTS; MAILLARD
   REACTION; PLASMINOGEN-ACTIVATOR; MODIFIED PROTEINS; PLASMA-PROTEINS;
   INFLAMMATION; MECHANISM; INACTIVATION; ULTRASTRUCTURE
AB Glycolaldehyde (GA) is a highly reactive aldehyde that can be generated during inflammation and hyperglycemia. It can react with arginine and lysine residues impairing protein function. As inflammation and diabetes present haemostatic dysfunction, we hypothesized that GA could participate in this process. The aim of this study was to investigate if plasma incubated in the presence of GA presents alteration in the coagulation process. We also aimed to evaluate the role of fibrinogen in GA-induced haemostatic dysfunction. For this purpose, plasma and fibrinogen were each incubated separately, either in the presence or absence of 1 mM GA for 8 and 4 h, respectively. After that, plasma coagulation and fibrin polymerization kinetics were recorded, as well as the kinetic of plasma clot digestion and fibrinolysis protein carbonylation was quantified. An SDS-PAGE was run to check the presence of cross-linking between fibrinogen chains. GA induced a delay in plasma coagulation and in fibrin polymerization. Maximum absorbance decreased after GA treatment, indicating the generation of thinner fibers. Fibrin generated after complete coagulation showed resistance to enzymatic digestion, which could be related to the generation of thinner fibers. Protein carbonylation also increased after GA treatment. All parameters could be reversed with AMG (a carbonyl trap) co-treatment. The data presented herein indicate that GA causes post-translational modification of lysine and arginine residues, which are central to many events involving fibrinogen to fibrin conversion, as well as to fibrinolysis. These modifications lead to the generation of persistent clots and may contribute to mortality seen in pathologies such diabetes and sepsis. (C) 2009 Published by Elsevier Ireland Ltd.
C1 [Andrades, M. E.; Lorenzi, R.; Moreira, J. C. F.; Dal-Pizzol, F.] Univ Fed Rio Grande do Sul, Dpto Bioquim, Ctr Estudos Estresse Oxidat, Porto Alegre, RS, Brazil.
   [Berger, M.; Guimaraes, J. A.] Univ Fed Rio Grande do Sul, Ctr Biotechnol, Lab Bioquim Farmacol, Porto Alegre, RS, Brazil.
   [Dal-Pizzol, F.] Univ Extremo Sul Catarinense, Lab Fiosiopatol Expt, Criciuma, SC, Brazil.
RP Andrades, ME (corresponding author), ANEXO, Lab 32, Rua Ramiro Barcelos 2600, BR-90035003 Porto Alegre, RS, Brazil.
EM andrades_m@yahoo.com.br
RI Andrades, Michael/S-5394-2019; Berger, Markus/U-7682-2019; Dal-Pizzol,
   Felipe/F-2756-2015; Guimaraes, Jorge Almeida/V-2196-2019
OI Andrades, Michael/0000-0003-0337-9661; Berger,
   Markus/0000-0001-7670-2584; Dal-Pizzol, Felipe/0000-0003-3003-8977;
   Lorenzi, Rodrigo/0000-0001-7676-7636; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU CNPqNational Council for Scientific and Technological Development (CNPq)
FX We are grateful to CNPq for their financial support.
CR ACHARYA AS, 1983, P NATL ACAD SCI-BIOL, V80, P3590, DOI 10.1073/pnas.80.12.3590
   Anderson MM, 2003, DIABETES, V52, P2137, DOI 10.2337/diabetes.52.8.2137
   Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176
   BLOMBACK B, 1994, THROMB RES, V75, P521, DOI 10.1016/0049-3848(94)90227-5
   Brown BE, 2005, DIABETOLOGIA, V48, P361, DOI 10.1007/s00125-004-1648-4
   Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X
   Choi NS, 2005, J BIOCHEM MOL BIOL, V38, P177
   Dempfle CE, 2004, THROMB HAEMOSTASIS, V91, P213, DOI 10.1160/TH03-03-0182
   DING ZK, 1995, PREP BIOCHEM, V25, P21, DOI 10.1080/10826069508010105
   Flood VH, 2007, BRIT J HAEMATOL, V138, P117, DOI 10.1111/j.1365-2141.2007.06630.x
   Flood VH, 2006, BRIT J HAEMATOL, V134, P220, DOI 10.1111/j.1365-2141.2006.06129.x
   Gale Christopher P, 2004, Diab Vasc Dis Res, V1, P34, DOI 10.3132/dvdr.2004.004
   Gando S, 2007, INFLAMMATION, V30, P118, DOI 10.1007/s10753-007-9027-1
   GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017
   HADDELAND U, 1995, THROMB RES, V77, P329, DOI 10.1016/0049-3848(95)93836-O
   Jaleel A, 2005, DIABETES CARE, V28, P645, DOI 10.2337/diacare.28.3.645
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lerant I, 2000, BBA-PROTEIN STRUCT M, V1480, P311, DOI 10.1016/S0167-4838(00)00083-2
   Levi M, 2005, TRENDS CARDIOVAS MED, V15, P254, DOI 10.1016/j.tcm.2005.07.004
   LEVINE RL, 1994, METHOD ENZYMOL, V233, P346
   Mondoro TH, 1996, BLOOD, V88, P3824, DOI 10.1182/blood.V88.10.3824.bloodjournal88103824
   Morgan PE, 2002, ARCH BIOCHEM BIOPHYS, V403, P259, DOI 10.1016/S0003-9861(02)00222-9
   MOSESSON MW, 1987, BLOOD, V69, P1073
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   MURAKAMI T, 1990, THROMB RES, V58, P23, DOI 10.1016/0049-3848(90)90240-D
   Nagai R, 2002, J BIOL CHEM, V277, P48905, DOI 10.1074/jbc.M205688200
   Nielsen VG, 2004, ANESTH ANALG, V98, P1312, DOI 10.1213/01.ANE.0000111105.38836.F6
   Pieters M, 2008, THROMB HAEMOSTASIS, V99, P691, DOI 10.1160/TH07-11-0699
   Salvemini D, 2002, FREE RADICAL BIO MED, V33, P1173, DOI 10.1016/S0891-5849(02)00961-9
   Sauls DL, 2003, J THROMB HAEMOST, V1, P300, DOI 10.1046/j.1538-7836.2003.00053.x
   Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489
   SHACTER E, 1994, FREE RADICAL BIO MED, V17, P429, DOI 10.1016/0891-5849(94)90169-4
   Stegenga ME, 2006, DIABETES, V55, P1807, DOI 10.2337/db05-1543
   Taguchi T, 1998, BIOCHEM PHARMACOL, V55, P1667, DOI 10.1016/S0006-2952(98)00010-0
   Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013
   Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9
   Ukeda H, 1997, BIOSCI BIOTECH BIOCH, V61, P2039, DOI 10.1271/bbb.61.2039
   Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Zeng JM, 2006, BIOCHEM J, V398, P197, DOI 10.1042/BJ20060019
NR 40
TC 15
Z9 15
U1 1
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-2797
EI 1872-7786
J9 CHEM-BIOL INTERACT
JI Chem.-Biol. Interact.
PD AUG 14
PY 2009
VL 180
IS 3
BP 478
EP 484
DI 10.1016/j.cbi.2009.04.005
PG 7
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 471SA
UT WOS:000268077400021
PM 19397901
DA 2020-11-24
ER

PT J
AU Domingos, TFS
   Carvalho, C
   Moura, LD
   Teixeira, VL
   Pereira, RC
   Bianco, EM
   Ferreira, WJ
   Ramos, CJB
   de Miranda, ALP
   Melo, PA
   Guimaraes, JA
   Fuly, AL
AF Souza Domingos, Thaisa Francielle
   Carvalho, Carla
   Moura, Laura de Andrade
   Teixeira, Valeria Laneuville
   Pereira, Renato Crespo
   Bianco, Everson Miguel
   Ferreira, Wilton Jose
   Brito Ramos, Carlos Jose
   Palhares de Miranda, Ana Luiza
   Melo, Paulo Assis
   Guimaraes, Jorge Almeida
   Fuly, Andre Lopes
TI Antilonomic Effects of Brazilian Brown Seaweed Extracts
SO NATURAL PRODUCT COMMUNICATIONS
LA English
DT Article
DE Canistrocarpus cervicornis; Dictyota pfaffi; Stypopodium zonale; Lonomia
   obliqua venom; antilonomic effect
ID LONOMIA-OBLIQUA CATERPILLARS; ACTIVATOR SERINE-PROTEASE; HEMORRHAGIC
   SYNDROME; PHOSPHOLIPASE A(2); BRISTLE EXTRACT; VENOM; COAGULATION;
   LOPAP; CONTACT; TOXINS
AB The aim of this work was to investigate the hemolysis and blood clotting activity of Lomonia obliqua venom and the ability of some Brazilian marine algal extracts (Canistrocarpus cervicornis, Stypopodium zonale and Dictyota pfaffi) to antagonize such biological activities. L. obliqua caterpillars are dangerous to human beings and envenomation symptoms are characterized by hemorrhagic, hemolytic and blood clotting disorders, and acute renal failure, which sometimes lead to the death of the victims. Through in vitro experiments we have shown that L. obliqua venom is able to clot human plasma and hemolize human erythrocytes and that the coagulation activity of the venom is inhibited by the extracts of C. cervicornis, S. zonale and D. pfaffi In contrast, C cervicornis and S. zonale extracts did not inhibit the hemolytic activity of L. oblqua, as did the extract of D. pfaffi. These finding indicate that marine algae may be used as antivenoms or may contribute to the development of compounds with antilonomic effects.
C1 [Souza Domingos, Thaisa Francielle; Carvalho, Carla; Moura, Laura de Andrade; Fuly, Andre Lopes] Univ Fed Fluminense, Inst Biol, Dept Biol Mol & Celular, BR-24001970 Niteroi, RJ, Brazil.
   [Teixeira, Valeria Laneuville; Pereira, Renato Crespo; Brito Ramos, Carlos Jose] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, BR-24001970 Niteroi, RJ, Brazil.
   [Bianco, Everson Miguel; Ferreira, Wilton Jose] Univ Fed Fluminense, Inst Quim, Programa Posgrad Quim Organ, BR-24020901 Niteroi, RJ, Brazil.
   [Palhares de Miranda, Ana Luiza] Univ Fed Rio de Janeiro, Fac Farm, BR-21944970 Rio De Janeiro, RJ, Brazil.
   [Melo, Paulo Assis] Univ Fed Rio de Janeiro, Dept Farmacol Basica & Clin, BR-21941590 Rio De Janeiro, RJ, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Domingos, TFS (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Biol Mol & Celular, BR-24001970 Niteroi, RJ, Brazil.
EM valerialaneuville@gmail.com; andfuly@vm.uff.br
RI Pereira, Renato Crespo/AAA-7832-2020; Guimaraes, Jorge
   Almeida/V-2196-2019; Domingos, Thaisa/T-6403-2019; Teixeira, Valeria
   L/E-8241-2018; Fuly, Andre/U-1538-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Teixeira, Valeria
   Laneuville/0000-0003-4962-6912
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundcao de Amparo A Pesquisa do Estado do Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); UFF/PROPP; International Foundation for
   ScienceInternational Foundation for Science [F/4571-1]
FX The authors thank Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), Fundcao de Amparo A Pesquisa do Estado do Rio de
   Janeiro (FAPERJ), UFF/PROPP and International Foundation for Science
   (IFS, Grant F/4571-1) for financial support.
CR Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   Arocha-Pinango CL, 2001, HAEMOSTASIS, V31, P288
   BIANCO EM, 2008, NATURAL PRODUCT COMM, V4, P1
   Carrijo-Carvalho LC, 2007, TOXICON, V49, P741, DOI 10.1016/j.toxicon.2006.11.033
   Chudzinski-Tavassi AM, 2005, PATHOPHYSIOL HAEMO T, V34, P228, DOI 10.1159/000092429
   Cirne-Santos CC, 2008, ANTIVIR RES, V77, P64, DOI 10.1016/j.antiviral.2007.08.006
   Corrêa Maria Sueli, 2004, Rev. Soc. Bras. Med. Trop., V37, P418, DOI 10.1590/S0037-86822004000500011
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   del Val Antonio Gonzalez, 2001, International Microbiology, V4, P35
   Duarte AC, 1996, LANCET, V348, P1033, DOI 10.1016/S0140-6736(05)64961-6
   Flores M. P. A., 2006, Biochemical and Biophysical Research Communications, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   Fuly AL, 2000, TOXICON, V38, P961, DOI 10.1016/S0041-0101(99)00208-1
   Goncalves LRC, 2007, TOXICON, V50, P349, DOI 10.1016/j.toxicon.2007.04.004
   Jongaramruong J, 2007, J ASIAN NAT PROD RES, V9, P743, DOI 10.1080/10286020701189203
   LEMAIRE C, 1972, ANN SOC ENTOMOL FR, V8, P767
   Melo FR, 2008, THROMB HAEMOSTASIS, V99, P531, DOI 10.1160/TH07-10-0649
   Pereira R. C., 2003, Braz. J. Biol., V63, P665, DOI 10.1590/S1519-69842003000400013
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Reis CV, 2001, THROMB RES, V102, P427, DOI 10.1016/S0049-3848(01)00265-1
   Reis CV, 2001, THROMB RES, V102, P437, DOI 10.1016/S0049-3848(01)00268-7
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   Rocha FD, 2007, PHYTOTHER RES, V21, P170, DOI 10.1002/ptr.2038
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 27
TC 8
Z9 8
U1 0
U2 8
PU NATURAL PRODUCTS INC
PI WESTERVILLE
PA 7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA
SN 1934-578X
EI 1555-9475
J9 NAT PROD COMMUN
JI Nat. Prod. Commun.
PD AUG
PY 2009
VL 4
IS 8
BP 1075
EP 1078
PG 4
WC Chemistry, Medicinal; Food Science & Technology
SC Pharmacology & Pharmacy; Food Science & Technology
GA 489PQ
UT WOS:000269433300011
PM 19768986
DA 2020-11-24
ER

PT J
AU Silva, WOB
   Santi, L
   Berger, M
   Pinto, AFM
   Guimaraes, JA
   Schrank, A
   Vainstein, MH
AF Silva, Walter O. B.
   Santi, Lucelia
   Berger, Markus
   Pinto, Antonio F. M.
   Guimaraes, Jorge A.
   Schrank, Augusto
   Vainstein, Marilene H.
TI Characterization of a spore surface lipase from the biocontrol agent
   Metarhizium anisopliae
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Metarhizium anisopliae; Insect fungus; Spore surface lipase; Substrate
   specificity; Enzyme characteristics
ID EXTRACELLULAR LIPASE; ENTOMOPATHOGENIC FUNGUS; THERMOSTABLE LIPASE;
   MICROBIAL LIPASES; PURIFICATION; VIRULENCE; EXPRESSION; PROTEINS; STRAIN
AB A Metarhizium anisopliae spore surface lipase (MASSL) strongly bound to the fungal spore surface has been purified by ion exchange chromatography on DEAE sepharose followed by ultrafiltration and hydrophobic interaction chromatography on phenyl sepharose. Electrophoretic analyses showed that the molecular weight of this lipase is similar to 66 kDa and pI is 5.6. Protein sequencing revealed that identified peptides in MASSL shared identity with several lipases or lipase-related sequences. The enzyme was able to hydrolyze triolein, the animal lipid cholesteryl stearate and all pNP ester substrates tested with some preference for esters with a short acyl chain. The values of K-m and V-max for the substrates pNP palmitate and pNP laurate were respectively 0.474 mM and 1.093 mMol min(-1) mg(-1) and 0.712 mM and 5.696 mMol min(-1) mg-1. The optimum temperature of the purified lipase was 30 degrees C and the enzyme was most stable within the most acid pH range (pH 3-6). Triton X-100 increased and SDS reduced enzyme lipolytic activity. MASSL activity was stimulated by Ca2+, Mg2+ and Co2+ and inhibited by Mn2+. The inhibitory effect on activity exerted by EDTA and ECTA was limited, while the lipase inhibitor Ebelactone B completely inhibited MASSL activity as well as PMSF. Methanol 0.5% apparently did not affect MASSL activity while beta-mercaptoethanol activated the enzyme. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Silva, Walter O. B.; Santi, Lucelia; Berger, Markus; Pinto, Antonio F. M.; Guimaraes, Jorge A.; Schrank, Augusto; Vainstein, Marilene H.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Schrank, Augusto] Univ Fed Rio Grande do Sul, Dept Biol Mol & Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Pinto, Antonio F. M.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.
RP Vainstein, MH (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM mhv@cbiot.ufrgs.br
RI Beys-da-Silva, Walter O/M-3760-2018; Vainstein, Marilene H/J-5452-2014;
   Santi, Lucelia/AAK-9527-2020; Schrank, Augusto/G-4688-2012; Santi,
   Lucelia/K-4856-2015; Santi, Lucelia/AAB-8349-2020; Berger,
   Markus/U-7682-2019; Guimaraes, Jorge Almeida/V-2196-2019
OI Beys-da-Silva, Walter O/0000-0001-8329-7839; Vainstein, Marilene
   H/0000-0002-3914-2300; Schrank, Augusto/0000-0002-5248-4620; Santi,
   Lucelia/0000-0002-5698-7006; Berger, Markus/0000-0001-7670-2584;
   Guimaraes, Jorge A./0000-0001-6354-6789; Pinto,
   Antonio/0000-0002-1573-8011
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); CAPESCAPES
FX We thank Dr. Jay W. Fox and Dr. Nicholas E. Sherman from Microbiology
   Department, University of Virginia for their assistance with the mass
   spectrometric analyses. This work was supported by grants and
   fellowships from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) and CAPES.
CR Abramic M, 1999, ENZYME MICROB TECH, V25, P522, DOI 10.1016/S0141-0229(99)00077-0
   Aryee ANA, 2007, ENZYME MICROB TECH, V40, P394, DOI 10.1016/j.enzmictec.2006.07.009
   Askary H, 1999, J INVERTEBR PATHOL, V74, P1, DOI 10.1006/jipa.1999.4857
   Berto P, 1999, FEMS MICROBIOL LETT, V180, P183, DOI 10.1111/j.1574-6968.1999.tb08794.x
   Chattopadhyay M, 1999, FOLIA MICROBIOL, V44, P37, DOI 10.1007/BF02816218
   Choo DW, 1998, APPL ENVIRON MICROB, V64, P486
   COMMENIL P, 1995, LIPIDS, V30, P356
   de Melo DR, 2008, ANN NY ACAD SCI, V1149, P388, DOI 10.1196/annals.1428.009
   Gacser A, 2007, FUNGAL GENET BIOL, V44, P1336, DOI 10.1016/j.fgb.2007.02.002
   HACKMAN RH, 1982, PHYSL TICKS CURRENT, V1, P35
   Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315
   Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5
   Jarrold SL, 2007, MYCOL RES, V111, P240, DOI 10.1016/j.mycres.2006.10.007
   Kambourova M, 2003, J MOL CATAL B-ENZYM, V22, P307, DOI 10.1016/S1381-1177(03)00045-6
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Moraes APR, 2008, ANN NY ACAD SCI, V1149, P384, DOI 10.1196/annals.1428.008
   Nawani N, 1998, BIOTECHNOL LETT, V20, P997, DOI 10.1023/A:1005430215849
   Nini L, 2001, BBA-MOL CELL BIOL L, V1534, P34, DOI 10.1016/S1388-1981(01)00172-X
   Nthangeni MB, 2001, ENZYME MICROB TECH, V28, P705, DOI 10.1016/S0141-0229(01)00316-7
   Pinto ADS, 1997, CAN J MICROBIOL, V43, P322, DOI 10.1139/m97-045
   ROSATO YB, 1981, J INVERTEBR PATHOL, V38, P1, DOI 10.1016/0022-2011(81)90026-4
   Saxena RK, 2003, J MICROBIOL METH, V52, P1, DOI 10.1016/S0167-7012(02)00161-6
   Sharma R, 2001, BIOTECHNOL ADV, V19, P627, DOI 10.1016/S0734-9750(01)00086-6
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Silva WOB, 2005, PROCESS BIOCHEM, V40, P321, DOI [10.1016/j.procbio.2003.11.053, 10.1016/j.procbio.2004.01.005]
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Smoot DT, 1997, GASTROENTEROLOGY, V113, pS31, DOI 10.1016/S0016-5085(97)80008-X
   Stehr F, 2004, FEMS YEAST RES, V4, P401, DOI 10.1016/S1567-1356(03)00205-8
   Stehr F, 2003, J MOL CATAL B-ENZYM, V22, P347, DOI 10.1016/S1381-1177(03)00049-3
   TAHOUN MK, 1986, ENZYME MICROB TECH, V8, P429, DOI 10.1016/0141-0229(86)90152-3
   Yu MR, 2007, PROCESS BIOCHEM, V42, P384, DOI 10.1016/j.procbio.2006.09.019
NR 31
TC 27
Z9 30
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD AUG
PY 2009
VL 44
IS 8
BP 829
EP 834
DI 10.1016/j.procbio.2009.03.019
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA 465WJ
UT WOS:000267619700006
DA 2020-11-24
ER

PT J
AU Reck, J
   Berger, M
   Terra, RMS
   Marks, FS
   Vaz, ID
   Guimaraes, JA
   Termignoni, C
AF Reck, J. JrY
   Berger, M.
   Terra, R. M. S.
   Marks, F. S.
   Vaz, I. da Silva, Jr.
   Guimaraes, J. A.
   Termignoni, C.
TI Systemic alterations of bovine hemostasis due to Rhipicephalus
   (Boophilus) microplus infestation
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Rhipicephalus (Boophilus) microplus; Cattle tick; Hemostasis; Platelet;
   Coagulation; Hemostatic disorders
ID CELL-BASED MODEL; CATTLE TICK; SALIVARY-GLANDS; HEREFORD CATTLE;
   IXODES-DAMMINI; FACTOR VIIA; COAGULATION; DISORDERS; CONTAINS;
   PURIFICATION
AB The tick Rhipicephalus (Boophilus) microplus is a hematophagous ectoparasite that causes considerable economic losses to cattle breeding. Although R. microplus saliva contains several molecules that interfere with the blood coagulation process, so far the systemic alterations in the host hemostatic system have not been described. This study aims to determine if R. microplus infestation induces any disturbance to the host's hemostatic system. To address these questions, six calves were experimentally infested with 20,000 R. microplus larvae and their blood was collected before and 7, 14 and 21 days post-infestation. Collagen and ADP-induced platelet aggregation as well as coagulation (activated partial thromboplastin time and prothrombin time) decreased in infested bovines. Platelet blood count and fibrinogen increased during the course of infestation, probably as a compensatory response. These alterations may play a role in host health status, and show that the host cannot fully counteract the tick anti-hemostatic mechanisms. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Reck, J. JrY; Berger, M.; Terra, R. M. S.; Vaz, I. da Silva, Jr.; Guimaraes, J. A.; Termignoni, C.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   [Reck, J. JrY; Marks, F. S.; Vaz, I. da Silva, Jr.] Univ Fed Rio Grande do Sul, Fac Vet, BR-91501970 Porto Alegre, RS, Brazil.
   [Termignoni, C.] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas Saude, BR-91501970 Porto Alegre, RS, Brazil.
RP Termignoni, C (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,PO 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM ctermignoni@cbiot.ufrgs.br
RI Reck, Jose/M-4805-2013; Reck, Jose/AAH-3373-2020; Silva Vaz,
   I/A-5943-2009; Berger, Markus/U-7682-2019; vaz, itabajara/F-5244-2014;
   Termignoni, Carlos/AAB-8943-2020; Guimaraes, Jorge Almeida/V-2196-2019
OI Reck, Jose/0000-0002-0969-792X; Silva Vaz, I/0000-0003-0309-9328;
   Berger, Markus/0000-0001-7670-2584; vaz, itabajara/0000-0003-0309-9328;
   Termignoni, Carlos/0000-0002-2789-2518; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU Conselho Nacional de Pesquisa (CNPq)National Council for Scientific and
   Technological Development (CNPq); Fundacao de Amparo a Pesquisa do
   Estado do Rio Grande do Sul (FAPERGS)Foundation for Research Support of
   the State of Rio Grande do Sul (FAPERGS); Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES)CAPES; Programa Nacional de
   Excelencia (PRONEX)
FX We are indebted to Conselho Nacional de Pesquisa (CNPq), Fundacao de
   Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Programa
   Nacional de Excelencia (PRONEX) for financial support. Special thanks to
   Prof. Brasilio Ricardo Cirillo da Silva for help in statistical analysis
   (Departamento de Estatistica - Pontificia Universidade Catolica do Rio
   Grande do Sul, PUCRS) and to Prof. Alexandre Jose Macedo (Centro de
   Biotecnologia - Universidade Federal do Rio Grande do Sul, UFRGS) for
   critical review of this manuscript.
CR ALLEN JR, 1977, CAN J COMP MED, V41, P26
   Alvinerie M, 1999, RES VET SCI, V67, P229, DOI 10.1053/rvsc.1999.0312
   Andreotti R, 2007, EXP PARASITOL, V116, P66, DOI 10.1016/j.exppara.2006.11.009
   BARBUI T, 1998, THROMBOSIS HEMORRHAG, P665
   Bastiani M, 2002, INSECT BIOCHEM MOLEC, V32, P1439, DOI 10.1016/S0965-1748(02)00064-4
   Berger M, 2008, TOXICON, V51, P488, DOI [10.1016/j.toxicon.2007-09.005, 10.1016/j.toxicon.2007.09.005]
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   Bowman AS, 2004, PARASITOLOGY, V129, pS67, DOI 10.1017/S0031182004006468
   CAFRUNE MM, 1995, RES VET SCI, V58, P284, DOI 10.1016/0034-5288(95)90119-1
   Ciprandi Alessandra, 2003, Rev. Bras. Hematol. Hemoter., V25, P250, DOI 10.1590/S1516-84842003000400012
   Ciprandi A, 2006, EXP PARASITOL, V114, P40, DOI 10.1016/j.exppara.2006.02.010
   CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
   CORRIER DE, 1979, TROP ANIM HEALTH PRO, V11, P215, DOI 10.1007/BF02237806
   Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005
   Cury MC, 2002, VET PARASITOL, V104, P139, DOI 10.1016/S0304-4017(01)00616-1
   Daugschies A, 1998, INT J PARASITOL, V28, P1187, DOI 10.1016/S0020-7519(98)00103-9
   FASS, 1999, GUID CAR US AGR AN A
   Frazzon APG, 2000, VET PARASITOL, V94, P117, DOI 10.1016/S0304-4017(00)00368-X
   George JE, 2004, PARASITOLOGY, V129, pS353, DOI 10.1017/S0031182003004682
   Gibbons GH, 1998, THROMBOSIS HEMORRHAG, P307
   GORDON JR, 1991, J PARASITOL, V77, P167, DOI 10.2307/3282577
   Guimaraes J.H., 2001, ECTOPARASITOS IMPORT
   HART SW, 1994, J VET INTERN MED, V8, P355, DOI 10.1111/j.1939-1676.1994.tb03250.x
   HELLMANN K, 1967, THROMB DIATH HAEMOST, V18, P617, DOI 10.1055/s-0038-1655071
   Hoffman M, 2003, BLOOD REV, V17, pS1, DOI 10.1016/S0268-960X(03)90000-2
   Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958
   Horn F, 2000, ARCH BIOCHEM BIOPHYS, V384, P68, DOI 10.1006/abbi.2000.2076
   HUNTER DT, 1967, J CLIN PATHOL, V20, P244, DOI 10.1136/jcp.20.3.244
   Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967
   Jongejan F, 1998, PARASITOL TODAY, V14, P173, DOI 10.1016/S0169-4758(98)01235-6
   Jonsson NN, 2006, VET PARASITOL, V137, P1, DOI 10.1016/j.vetpar.2006.01.010
   KROLL MH, 1998, THROMBOSIS HEMORRHAG, P261
   Labruna M. B., 2001, Arquivos do Instituto Biologico (Sao Paulo), V68, P115
   Leal AT, 2006, VET IMMUNOL IMMUNOP, V114, P341, DOI 10.1016/j.vetimm.2006.08.011
   LEITE R. C., 1995, REV BRASILEIRA PARAS, V4, P283
   LERNER RG, 1973, MED CLIN N AM, V57, P1609, DOI 10.1016/S0025-7125(16)32215-5
   Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P573, DOI 10.1016/j.ibmb.2004.03.005
   Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002
   Maritz-Olivier C, 2007, TRENDS PARASITOL, V23, P397, DOI 10.1016/j.pt.2007.07.005
   Murrell A, 2003, SYST PARASITOL, V56, P169, DOI 10.1023/B:SYPA.0000003802.36517.a0
   OPDEBEECK JP, 1989, IMMUNOLOGY, V67, P388
   PARRY BW, 1989, VET CLIN N AM-SMALL, V19, P729, DOI 10.1016/S0195-5616(89)50081-0
   RECK J, 2005, REV PATOLOGIA TROPIC, V34, P22
   RIBEIRO JMC, 1986, EXP PARASITOL, V62, P292, DOI 10.1016/0014-4894(86)90034-2
   RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   RIBEIRO JMC, 1991, COMP BIOCHEM PHYS A, V100, P109, DOI 10.1016/0300-9629(91)90190-N
   RIDING GA, 1994, J IMMUNOL, V153, P5158
   RIEK R. F., 1957, AUSTRALIAN JOUR AGRIC RES, V8, P209, DOI 10.1071/AR9570209
   Roberts B, 2006, ELECTRON BUS, V32, P38
   Samish M, 2000, ANN NY ACAD SCI, V916, P172, DOI 10.1111/j.1749-6632.2000.tb05287.x
   Simmonds RE, 1998, THROMBOSIS HEMORRHAG, P45
   Sonenshine DE, 2006, TRENDS PARASITOL, V22, P550, DOI 10.1016/j.pt.2006.09.003
   SPILLERT CR, 1993, J NATL MED ASSOC, V85, P611
   STONE BF, 1963, NATURE, V200, P1233, DOI 10.1038/2001233a0
   TATCHELL RJ, 1969, EXP PARASITOL, V26, P369, DOI 10.1016/0014-4894(69)90130-1
   Turni C, 2002, PARASITE IMMUNOL, V24, P355, DOI 10.1046/j.1365-3024.2002.00471.x
   Valladares JE, 1998, RES VET SCI, V64, P195, DOI 10.1016/S0034-5288(98)90124-2
   Vaz ID, 1998, VET IMMUNOL IMMUNOP, V66, P331
   VAZ ID, 1994, VET PARASITOL, V52, P71
   Veldman A, 2003, CURR MED CHEM, V10, P797, DOI 10.2174/0929867033457728
   WIKEL SK, 1994, INT J PARASITOL, V24, P59, DOI 10.1016/0020-7519(94)90059-0
   Wikel Stephen K., 1996, P107
   Yarovaya GA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P13, DOI 10.1023/A:1013991828598
NR 65
TC 32
Z9 32
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD FEB
PY 2009
VL 86
IS 1
BP 56
EP 62
DI 10.1016/j.rvsc.2008.05.007
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA 398DY
UT WOS:000262714000009
PM 18571684
DA 2020-11-24
ER

PT J
AU Bugalho, P
   Vale, J
   Silveira, I
   Sequeiras, J
   Guimaraes, J
   Coutinho, P
AF Bugalho, P.
   Vale, J.
   Silveira, I.
   Sequeiras, J.
   Guimaraes, J.
   Coutinho, P.
TI Autossomal dominant cerebellar ataxia- frequency analysis and clinical
   characterization of 45 families from Portugal
SO MOVEMENT DISORDERS
LA English
DT Meeting Abstract
CT 13th International Congress of Parkinsons Disease and Movement Disorders
CY JUN 07-11, 2009
CL Paris, FRANCE
RI Silveira, Isabel/D-6881-2012; Bugalho, Paulo/H-7317-2019; Coutinho,
   Paula/K-6053-2013
OI Silveira, Isabel/0000-0002-2610-5260; Bugalho,
   Paulo/0000-0003-2186-9541; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0885-3185
J9 MOVEMENT DISORD
JI Mov. Disord.
PY 2009
VL 24
BP S8
EP S8
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 453NS
UT WOS:000266618100005
DA 2020-11-24
ER

PT J
AU Giesel, GM
   Lima, LMTR
   Faber-Barata, J
   Guimaraes, JA
   Verli, H
AF Giesel, Guilherme Menegon
   Lima, Luis Mauricio T. R.
   Faber-Barata, Joana
   Guimaraes, Jorge Almeida
   Verli, Hugo
TI Characterization of the papillomavirus alpha(1)E2 peptide unfolded to
   folded transition upon DNA binding
SO FEBS LETTERS
LA English
DT Article
DE Molecular dynamics; Papillomavirus; E2 protein; DNA structure; Induced
   fit
ID MOLECULAR-DYNAMICS SIMULATIONS; E2 TRANSACTIVATION DOMAIN; PARTICLE-MESH
   EWALD; BOVINE PAPILLOMAVIRUS; CRYSTAL-STRUCTURE; FUNCTIONAL INTERACTION;
   STRUCTURAL BASIS; NUCLEIC-ACIDS; PROTEIN; MECHANISM
AB Transcriptional regulation depends on sequence-specific binding of regulatory proteins to their responsive elements in viral DNA. The papillomavirus E2 protein binds to DNA through the consensus sequence ACCG-NNNN-CGGT, activating or inhibiting viral replication. Through molecular dynamics simulations we were able to characterize the role of the DNA molecule on E2 binding region ( named alpha(1)E2) conformation, acquiring structural insights for previous works suggesting an unfolded to folded transition upon alpha(1)E2 complexation to DNA. Moreover, the results indicate sites to guide the design of alpha(1)E2 synthetic derivatives to inhibit the HPV infection. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
C1 [Giesel, Guilherme Menegon; Guimaraes, Jorge Almeida; Verli, Hugo] Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91500970 Porto Alegre, RS, Brazil.
   [Verli, Hugo] Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   [Lima, Luis Mauricio T. R.; Faber-Barata, Joana] Univ Fed Rio Grande do Sul, Fac Farm, Ilha Fundao, BR-21941590 Rio De Janeiro, Brazil.
   [Guimaraes, Jorge Almeida] Univ Fed Rio Grande do Sul, Inst Bioquim Med, Ilha Fundao, BR-21941590 Rio De Janeiro, Brazil.
RP Verli, H (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Av Bento Gonclaves 9500,CP 15005, BR-91500970 Porto Alegre, RS, Brazil.
EM hverli@cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012; Menegon Giesel, Guilherme/C-5361-2013
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [420015/05-1, 472174/2007-0]; MCT; Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES), MEC, Brasilia, DF, BrazilCAPES
FX The authors would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq # 420015/05-1 and 472174/2007-0), MCT,
   and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES), MEC, Brasilia, DF, Brazil, for their financial support.
CR [Anonymous], 1989, EMBO J, V8, P1
   Antson AA, 2000, NATURE, V403, P805
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208
   Bussiere DE, 1998, ACTA CRYSTALLOGR D, V54, P1367, DOI 10.1107/S0907444998005587
   Cicero DO, 2006, BIOCHEMISTRY-US, V45, P6551, DOI 10.1021/bi060123h
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Souza ON, 1999, J BIOMOL STRUCT DYN, V16, P1205, DOI 10.1080/07391102.1999.10508328
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Dell C, 2001, CELL MOL LIFE SCI, V58, P1923, DOI 10.1007/PL00000827
   Dell G, 2003, J MOL BIOL, V334, P979, DOI 10.1016/j.jmb.2003.10.009
   DEWITTE RS, 1994, PROTEIN SCI, V3, P1570, DOI 10.1002/pro.5560030922
   Djuranovic D, 2005, BIOPHYS J, V89, P2542, DOI 10.1529/biophysj.104.057109
   Faber-Barata J, 2006, FEBS LETT, V580, P1919, DOI 10.1016/j.febslet.2006.02.047
   Falconi M, 2008, BIOPHYS J, V95, P1108, DOI 10.1529/biophysj.108.130849
   Falconi M, 2007, FEBS J, V274, P2385, DOI 10.1111/j.1742-4658.2007.05773.x
   Giudice E, 2002, ACCOUNTS CHEM RES, V35, P350, DOI 10.1021/ar010023y
   GRYK MR, 1995, J MOL BIOL, V246, P618, DOI 10.1016/S0022-2836(05)80111-1
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Harris SF, 1999, SCIENCE, V284, P1673, DOI 10.1126/science.284.5420.1673
   HEDGE RS, 1998, J MOL BIOL, V276, P797
   HEDGE RS, 2002, ANNU REV BIOPH BIOM, V31, P343
   HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0
   Hegde RS, 1998, J MOL BIOL, V284, P1479, DOI 10.1006/jmbi.1998.2260
   Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644
   Hooley E, 2006, NUCLEIC ACIDS RES, V34, P3897, DOI 10.1093/nar/gkl466
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kim SS, 2000, J BIOL CHEM, V275, P31245, DOI 10.1074/jbc.M004541200
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483
   LAVERY R, 1994, BIOPHYS CHEM, V50, P33, DOI 10.1016/0301-4622(94)85018-6
   Liang H, 1996, BIOCHEMISTRY-US, V35, P2095, DOI 10.1021/bi951932w
   LIANG H, 1994, P NATL ACAD SCI USA, V91, P11655, DOI 10.1073/pnas.91.24.11655
   Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407
   Nadra AD, 2004, J BIOMOL NMR, V30, P211, DOI 10.1023/B:JNMR.0000048942.96866.76
   Rollins GC, 2008, BIOPHYS J, V94, pL38, DOI 10.1529/biophysj.107.126698
   Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938
   Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390
   *UB IUPAC I, 1970, J MOL BIOL, V52, P1
   van der Spoel D., 2005, GROMACS USER MANUAL
   Veeraraghavan S, 1999, BIOCHEMISTRY-US, V38, P16115, DOI 10.1021/bi991633x
   Verli H, 2005, J MOL GRAPH MODEL, V24, P203, DOI 10.1016/j.jmgm.2005.07.002
   WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0
   Yao JM, 1998, J VIROL, V72, P1013, DOI 10.1128/JVI.72.2.1013-1019.1998
NR 49
TC 4
Z9 4
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD OCT 29
PY 2008
VL 582
IS 25-26
BP 3619
EP 3624
DI 10.1016/j.febslet.2008.09.041
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 371BT
UT WOS:000260807500009
PM 18834883
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Dragulev, B
   Guimaraes, JA
   Fox, JW
AF Pinto, Antonio F. M.
   Dragulev, Bojan
   Guimaraes, Jorge A.
   Fox, Jay W.
TI Novel perspectives on the pathogenesis of Lonomia obliqua caterpillar
   envenomation based on assessment of host response by gene expression
   analysis
SO TOXICON
LA English
DT Article
DE Lonomia; coagulopathy; gene chips; gene expression profiling; hemostasis
ID BRISTLE EXTRACT; HEMORRHAGIC SYNDROME; BLOOD-COAGULATION;
   ENDOTHELIAL-CELLS; TISSUE FACTOR; IN-VITRO; FACTOR-X; VENOM;
   PROCOAGULANT; PROTHROMBIN
AB Animal venomous secretions have been explored as source of active substances affecting mammal hemostasis. These active principles impinge on key elements of almost all physiologic pathways and have an enormous potential in the development of new therapeutic drugs. The envenomation caused by the caterpillar Lonomia obliqua (lonomism) is characterized by a hemorrhagic clinical profile. Investigations of caterpillar venom have, in general, involved the isolation and biochemical characterization of active principles related to the pathophysiology of envenomation. In the last few years, these studies focused on the caterpillar's secretions pro-coagulant, fibrin(ogen)olytic, hemolytic, edematogenic and nociceptive activities. Recently, a significant advance was achieved as a result of a transcriptome study, which generated a catalog of putative toxic proteins in the caterpillar venom, giving rise to hypotheses on the molecular basis of pathogenesis which could be experimentally explored. In this investigation, using a microarray methodology, we analyzed the effects of the caterpillar venom on the gene expression profile of cultured human fibroblasts with the aim of gaining insight into genes possibly associated with the clinical manifestations of lonomism. Our hypothesis was that both the direct action L. obliqua venomous proteins on the host as well as an indirect effect caused by alteration in the gene expression pattern in host tissues could function in concert and perhaps synergistically to give rise to the profound symptoms observed during lonomism. Interesting changes in the expression pattern of some genes, such as IL-8, prostaglandin-endoperoxide synthase 2, urokinase-type plasminogen activator receptor and tissue factor, were observed in treated fibroblasts, which could contribute to some of the observed pathological sequela in lonomism. Thus, lonomism appears to be a result of both the previously described direct effects of the venom as well as indirect effects caused by changes in host gene expression profiles. These studies have enhanced our understanding of lonomism and may contribute to insights into more effective treatments. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Pinto, Antonio F. M.; Dragulev, Bojan; Fox, Jay W.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.
   [Pinto, Antonio F. M.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-43431 Porto Alegre, RS, Brazil.
RP Fox, JW (corresponding author), Univ Virginia, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.
EM jwf8x@virginia.edu
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Pinto,
   Antonio/0000-0002-1573-8011
CR Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   AROCHAPINANGO CL, 1969, LANCET, V1, P810
   AROCHAPINANGO CL, 1981, THROMB HAEMOSTASIS, V46, P710
   Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841
   Bohrer CB, 2007, TOXICON, V49, P663, DOI 10.1016/j.toxicon.2006.11.005
   Coll-Sangrona E, 1998, BRAZ J MED BIOL RES, V31, P779, DOI 10.1590/S0100-879X1998000600009
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   Duarte AC, 1996, LANCET, V348, P1033, DOI 10.1016/S0140-6736(05)64961-6
   Fritzen M, 2005, BIOCHEM BIOPH RES CO, V333, P517, DOI 10.1016/j.bbrc.2005.05.140
   Fritzen M, 2003, THROMB RES, V112, P105, DOI 10.1016/j.thromres.2003.11.005
   Gallagher P, 2005, ARCH BIOCHEM BIOPHYS, V441, P1, DOI 10.1016/j.abb.2005.06.007
   Gallagher PG, 2003, TOXICON, V41, P429, DOI 10.1016/S0041-0101(02)00359-8
   Gouveia AID, 2005, TOXICON, V45, P403, DOI 10.1016/j.toxicon.2004.11.008
   Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098
   Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121
   Miller SB, 2006, SEMIN ARTHRITIS RHEU, V36, P37, DOI 10.1016/j.semarthrit.2006.03.005
   Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004
   Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Reis CV, 2001, THROMB RES, V102, P437, DOI 10.1016/S0049-3848(01)00268-7
   Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073
   Scoble M.J., 1992, LEPIDOPTERA FORM FUN
   Seibert CS, 2006, BIOCHEM BIOPH RES CO, V342, P1027, DOI 10.1016/j.bbrc.2006.02.071
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   Seibert CS, 2003, TOXICON, V41, P831, DOI 10.1016/S0041-0101(03)00040-0
   Szotowski B, 2005, CIRC RES, V96, P1233, DOI 10.1161/01.RES.0000171805.24799.fa
   VANDAMME J, 1988, J EXP MED, V167, P1364, DOI 10.1084/jem.167.4.1364
   VAUGHAN DE, 1998, THROMBOSIS HEMORRHAG, P155
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 34
TC 15
Z9 16
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAY
PY 2008
VL 51
IS 6
BP 1119
EP 1128
DI 10.1016/j.toxicon.2008.01.010
PG 10
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 310AC
UT WOS:000256500300017
PM 18367225
DA 2020-11-24
ER

PT J
AU Berger, M
   Pinto, AFM
   Guimaraes, JA
AF Berger, Markus
   Pinto, Antonio F. M.
   Guimaraes, Jorge A.
TI Purification and functional characterization of bothrojaractivase, a
   prothrombin-activating metalloproteinase isolated from Bothrops jararaca
   snake venom
SO TOXICON
LA English
DT Article
DE Bothrops jararaca; snake venom; prothrombin activator;
   metalloproteinase; bleeding disorders; hemostasis
ID ECHIS-CARINATUS VENOM; COAGULATION-FACTOR-XA; AMINO-ACID-SEQUENCE;
   BLOOD-COAGULATION; PLATELET-AGGREGATION; PATIENTS BITTEN; THROMBIN;
   MECHANISM; HEMOSTASIS; HEMORRHAGE
AB Bleeding at the site of bite and/or systemic hemorrhage are symptoms frequently observed in envenomation by Bothrops jararaca snakes. In this study, we purified and characterized a prothrombin activator from B. jararaca that is probably involved in these clinical manifestations. The enzyme was isolated by a combination of gel filtration and ion exchange chromatographies and named bothrojaractivase. It has a single polypeptide chain with a molecular weight of 22,829 Da as measured by mass spectroscopy. Bothrojaractivase generates active thrombin from prothrombin, independently of cofactors. SDS-PAGE analysis of the prothrombin activation products shows that bothrojaractivase converts prothrombin into meizothrombin producing similar fragments to those generated by group A prothrombin's activators. In addition, bothrojaractivase degraded fibrinogen and fibrin. Chelating agents completely inhibited the enzymatic activity, whereas inhibitors of serine and cysteine proteinases had no effect. Amino acid sequence of four peptides demonstrated high similarity of bothrojaractivase with P-I class of snake venom metalloproteinases. Thus, our results indicate that bothrojaractivase is a new metalloproteinase that acts on different protein factors of the clotting cascade especially displaying a key and most relevant functional action in the generation of thrombin through prothrombin activation in a similar mode of action as that of group A activators. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Berger, Markus; Pinto, Antonio F. M.; Guimaraes, Jorge A.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Bioquim Farmacol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Berger, Markus/U-7682-2019
OI Berger, Markus/0000-0001-7670-2584; Guimaraes, Jorge
   A./0000-0001-6354-6789; Pinto, Antonio/0000-0002-1573-8011
CR Bello CA, 2006, BIOCHIMIE, V88, P189, DOI 10.1016/j.biochi.2005.07.008
   BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0
   Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515
   Cidade DAP, 2006, TOXICON, V48, P437, DOI 10.1016/j.toxicon.2006.07.008
   GOVERSRIEMSLAG JWP, 1987, BIOCHIM BIOPHYS ACTA, V916, P388, DOI 10.1016/0167-4838(87)90185-3
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   Gutierrez JM, 2000, BIOCHIMIE, V82, P841, DOI 10.1016/S0300-9084(00)01163-9
   Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150
   HOFMANN H, 1987, BIOCHEMISTRY-US, V26, P772, DOI 10.1021/bi00377a018
   Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631
   Joseph JS, 2001, HAEMOSTASIS, V31, P234
   KAMIGUTI AS, 1991, TOXICON, V29, P1097, DOI 10.1016/0041-0101(91)90207-8
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   Kini RM, 2005, TOXICON, V45, P1133, DOI 10.1016/j.toxicon.2005.02.019
   Kini RM, 2001, THROMB HAEMOSTASIS, V86, P710
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Loria GD, 2003, ARCH BIOCHEM BIOPHYS, V418, P13, DOI 10.1016/S0003-9861(03)00385-0
   MARUYAMA M, 1990, THROMB HAEMOSTASIS, V63, P449
   *MIN SAUD, 1998, MAN DIAGN TRAT AC AN
   Modesto JCD, 2005, BIOL CHEM, V386, P589, DOI 10.1515/BC.2005.069
   NAHAS L, 1979, THROMB HAEMOSTASIS, V41, P314
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   NISHIDA S, 1995, BIOCHEMISTRY-US, V34, P1771, DOI 10.1021/bi00005a034
   NISHIDA S, 1994, BIOCHEMISTRY-US, V33, P1843, DOI 10.1021/bi00173a030
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Rao VS, 2002, THROMB HAEMOSTASIS, V88, P611
   RHEE MJ, 1982, BIOCHEMISTRY-US, V21, P3437, DOI 10.1021/bi00257a029
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   Ribeiro L A, 1997, Rev Soc Bras Med Trop, V30, P475, DOI 10.1590/S0037-86821997000600006
   Rodrigues VM, 2000, ARCH BIOCHEM BIOPHYS, V381, P213, DOI 10.1006/abbi.2000.1958
   ROSING J, 1992, TOXICON, V30, P1515, DOI 10.1016/0041-0101(92)90023-X
   SanoMartins IS, 1997, THROMB RES, V87, P183, DOI 10.1016/S0049-3848(97)00118-7
   Santoro ML, 2004, THROMB HAEMOSTASIS, V92, P369, DOI 10.1160/TH04-02-0120
   Senis YA, 2006, BBA-PROTEINS PROTEOM, V1764, P863, DOI 10.1016/j.bbapap.2006.03.004
   Silva MB, 2003, BIOCHEM J, V369, P129, DOI 10.1042/BJ20020449
   STENFLO J, 1976, J BIOL CHEM, V251, P355
   WALKER FJ, 1980, BIOCHEMISTRY-US, V19, P1020, DOI 10.1021/bi00546a029
   Watanabe L, 2003, PROTEIN SCI, V12, P2273, DOI 10.1110/ps.03102403
   White J, 2005, TOXICON, V45, P951, DOI 10.1016/j.toxicon.2005.02.030
   Wu JR, 2002, BIOCHEMISTRY-US, V41, P935, DOI 10.1021/bi0116893
   Yamada D, 1996, J BIOL CHEM, V271, P5200, DOI 10.1074/jbc.271.9.5200
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 43
TC 47
Z9 51
U1 1
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR 15
PY 2008
VL 51
IS 4
BP 488
EP 501
DI 10.1016/j.toxicon.2007-09.005
PG 14
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 294AU
UT WOS:000255377300002
PM 18262582
DA 2020-11-24
ER

PT J
AU de Oliveira, TC
   de Amorim, HLN
   Guimaraes, JA
AF de Oliveira, Tiago Charao
   Neubauer de Amorim, Hermes Luis
   Guimaraes, Jorge Almeida
TI Interfacial activation of snake venom phospholipases A(2) (svPLA(2))
   probed by molecular dynamics simulations
SO JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM
LA English
DT Article
DE molecular dynamics; molecular modeling; structural bioinformatics;
   svPLA(2)
ID CRYSTAL-STRUCTURE; MECHANISM; SPECIFICITY; PROTEINS; INSIGHT; COMPLEX;
   CA2+
AB Asp49 plays a key role coordinating calcium in the catalytic site of phospholipases A(2) (PLA(2)'S), thus assisting the stabilization of the ES intermediary transition state, which induces the enzyme activation. In this work, molecular dynamics simulations of an acidic PLA(2) from the venom of Agkistrodon halys pallas were performed in water, methanol and octanol. Because of the low affinity of svPLA(2)'s for calcium ion in aqueous systems, different positional restraint forces were applied and the coordinates describing svPLA(2)-Ca2+ ligand properties were simulated and evaluated. The results of the simulations were used to propose an interfacial activation model for svPLA(2)'s. In this model, events related with enzyme activation involve: (a) the reorganization of calcium binding loop at membrane proximity followed by the Ca2+ uptake; (b) side chain reorientation of Trp31, which defines a new specificity pocket for the phospholipid chain; (c) reduction of the distance between His48 and Asp49, increasing the nucleophilicity of N epsilon-His48; (d) side chain reorientation of Lys69 concomitant with projection of the 69-loop to solvent. In addition to existing biochemical and crystallographic data, our results allow us to describe a more detailed model for the interfacial activation of phospholipases A(2). (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Luterana Brasil, Lab Bioinformat Estrutural, BR-92450 Canoas, RS, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, Lab Bioquim Farmacol, Lab 202, BR-15005 Porto Alegre, RS, Brazil.
RP de Oliveira, TC (corresponding author), Univ Luterana Brasil, Lab Bioinformat Estrutural, Av Farroupilha 1001,Predio 01,Sala 122, BR-92450 Canoas, RS, Brazil.
EM tcharao@yahoo.com; hamorim@cbiot.ufrgs.br; guimar@cbiot.ufrgs.br
RI Amorim, Hermes/E-4072-2013; Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; de Amorim,
   Hermes/0000-0001-8362-078X
CR Bahnson BJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P96, DOI 10.1016/j.abb.2004.08.013
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w
   Chandra V, 2002, J MOL BIOL, V320, P215, DOI 10.1016/S0022-2836(02)00473-4
   Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126
   De Mori GMS, 2005, MINI-REV MED CHEM, V5, P353, DOI 10.2174/1389557053544038
   DEMARET JP, 1990, PROTEIN ENG, V4, P163, DOI 10.1093/protein/4.2.163
   DEMARET JP, 1992, J MOL GRAPHICS, V10, P257, DOI 10.1016/0263-7855(92)80079-S
   Diraviyam K, 2006, BIOCHEMISTRY-US, V45, P2584, DOI 10.1021/bi051901t
   Fully AL, 2002, BIOCHEM PHARMACOL, V63, P1589, DOI 10.1016/S0006-2952(02)00873-0
   Fuly AL, 2004, BIOCHIMIE, V86, P731, DOI 10.1016/j.biochi.2004.07.001
   Fuly AL, 2003, INT J BIOCHEM CELL B, V35, P1470, DOI 10.1016/S1357-2725(03)00129-8
   Glattli A, 2006, EUR BIOPHYS J BIOPHY, V35, P255, DOI 10.1007/s00249-005-0033-7
   GOODFELLOW JW, 1990, MOL DYNAMICS OVERVIE
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   JONES ST, 1993, BIOCHIM BIOPHYS ACTA, V1162, P135, DOI 10.1016/0167-4838(93)90139-I
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Kini RM, 1997, VENON PHOSPHOLIPASE
   KUIPERS OP, 1991, BIOCHEMISTRY-US, V30, P8771, DOI 10.1021/bi00100a008
   Lathrop B, 2001, BIOCHEMISTRY-US, V40, P3264, DOI 10.1021/bi001901n
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   MEBS D, 1983, TOXINS TOOLS NEUROCH, P337
   Nagano N, 2005, J PHARMACOL SCI, V97, P355, DOI 10.1254/jphs.FMJ04007X6
   RAMIREZ F, 1991, PROTEINS, V9, P229, DOI 10.1002/prot.340090402
   Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   SCOTT DL, 1990, SCIENCE, V250, P1541, DOI 10.1126/science.2274785
   Sekar K, 1997, BIOCHEMISTRY-US, V36, P14186, DOI 10.1021/bi971370b
   SESSIONS RB, 1989, J MOL BIOL, V210, P617, DOI 10.1016/0022-2836(89)90136-8
   Singh G, 2001, J MOL BIOL, V307, P1049, DOI 10.1006/jmbi.2001.4550
   Snitko Y, 1997, BIOCHEM J, V321, P737, DOI 10.1042/bj3210737
   Tsai YC, 2006, BBA-BIOMEMBRANES, V1758, P653, DOI 10.1016/j.bbamem.2006.04.003
   Valentin E, 2000, BIOCHIMIE, V82, P815, DOI 10.1016/S0300-9084(00)01168-8
   van der Spoel D, 1998, J CHEM PHYS, V108, P10220, DOI 10.1063/1.476482
   van Gunsteren W.F., 1996, BIOMOLECULAR SIMULAT
   VERGER R, 1973, J BIOL CHEM, V248, P4023
   VERHEIJ HM, 1981, REV PHYSIOL BIOCH P, V91, P91
   VISHWANATH BS, 1987, TOXICON, V25, P501
   Wang XQ, 1996, J MOL BIOL, V255, P669, DOI 10.1006/jmbi.1996.0054
   Yu BZ, 1998, BIOCHEMISTRY-US, V37, P12576, DOI 10.1021/bi9728607
   YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024
   Zhou F, 1996, PROTEINS, V25, P12, DOI 10.1002/(SICI)1097-0134(199605)25:1<12::AID-PROT2>3.0.CO;2-M
   2006, GROMACS WORLDS FASTE
NR 44
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-1280
J9 J MOL STRUC-THEOCHEM
JI Theochem-J. Mol. Struct.
PD SEP 30
PY 2007
VL 818
IS 1-3
BP 31
EP 41
DI 10.1016/j.theochem.2007.05.006
PG 11
WC Chemistry, Physical
SC Chemistry
GA 213ZV
UT WOS:000249706700004
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Ma, L
   Dragulev, B
   Guimaraes, JA
   Fox, JW
AF Pinto, A. F. M.
   Ma, L.
   Dragulev, B.
   Guimaraes, J. A.
   Fox, J. W.
TI Use of SILAC for exploring sheddase and matrix degradation of
   fibroblasts in culture by the PIIISUMP atrolysin A: Identification of
   two novel substrates with functional relevance
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE snake venom metalloproteinases; SILAC; sheddase; annexin V; collagen VI;
   extracellular matrix
ID SNAKE-VENOM METALLOPROTEINASES; CYSTEINE-RICH DOMAIN;
   VON-WILLEBRAND-FACTOR; CROTALUS-ATROX VENOM; PLATELET-AGGREGATION;
   HEMORRHAGIC METALLOPROTEINASES; COLLAGEN; INHIBITION; PROTEINS;
   FIBRONECTIN
AB Snake venom metalloproteinases (SVMPs) in Viperid venoms primarily function to give rise to local and systemic hemorrhage following snake envenomation. Years of research on these toxins, both in vitro and in vivo, indicate that they function by disrupting capillary basement membranes, stromal matrix and cell-cell and cell-matrix contacts to allow escape of capillary contents under pressure. However, most of these studies used either defined substrates in vitro or were limited by relevant antibodies for detection of sites of action in vivo. In this investigation we use stable isotope-labeled amino acids in culture (SILAC) to determine novel proteolytic activities for exogenously added atrolysin A, a hemorrhagic PIII SVMP isolated from Crotalus atrox venom. When comparing the solubilized products of SILAC-labeled cultured human fibroblasts treated with atrolysin A to that of untreated fibroblasts using LC/MS/MS, several proteins were identified as being released into the culture media specifically due to atrolysin A proteolytic activity. These included collagen VI, fibronectin, fibulin 2 and annexin V. Of particular interest was the observation of collagen VI and annexin V in that the release of these substrates could play a role in altering hemostasis and promote hemorrhage caused by the more typical actions of atrolysin A. In summary, this study demonstrates the utility of SILAC for exploring sheddase activity with cells in culture and suggests the presence of two novel substrates for SVMPs that may play a pathological role in altering host hemostasis during envenomation. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil.
RP Fox, JW (corresponding author), Univ Virginia, Dept Microbiol, PO Box 800734, Charlottesville, VA 22908 USA.
EM jwf8x@virginia.edu
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Pinto, Antonio/0000-0002-1573-8011; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANDREE HAM, 1992, J BIOL CHEM, V267, P17907
   BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0
   BJARNASON JB, 1988, BIOL CHEM H-S, V369, P121
   BJARNASON JB, 1978, BIOCHEMISTRY-US, V17, P3395, DOI 10.1021/bi00609a033
   Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4
   de Moraes CK, 2006, TOXICON, V48, P641, DOI 10.1016/j.toxicon.2006.07.028
   Escalante T, 2006, ARCH BIOCHEM BIOPHYS, V455, P144, DOI 10.1016/j.abb.2006.09.018
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   Gallagher P, 2005, ARCH BIOCHEM BIOPHYS, V441, P1, DOI 10.1016/j.abb.2005.06.007
   Gallagher PG, 2003, TOXICON, V41, P429, DOI 10.1016/S0041-0101(02)00359-8
   Gutierrez JM, 2005, TOXICON, V45, P997, DOI 10.1016/j.toxicon.2005.02.029
   Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006
   Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517
   Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094
   Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635
   Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3
   Keene DR, 1998, J HISTOCHEM CYTOCHEM, V46, P215, DOI 10.1177/002215549804600210
   Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008
   Mazzucato M, 1999, J BIOL CHEM, V274, P3033, DOI 10.1074/jbc.274.5.3033
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   OWNBY CL, 1974, AM J PATHOL, V76, P401
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   Reviakine I, 1998, J STRUCT BIOL, V121, P356, DOI 10.1006/jsbi.1998.4003
   Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483
   Serrano SMT, 2006, J BIOL CHEM, V281, P39746, DOI 10.1074/jbc.M604855200
   Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Zigrino P, 2002, J BIOL CHEM, V277, P40528, DOI 10.1074/jbc.M202049200
NR 30
TC 16
Z9 17
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD SEP 1
PY 2007
VL 465
IS 1
BP 11
EP 15
DI 10.1016/j.abb.2007.04.037
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 206IF
UT WOS:000249176400002
PM 17543881
DA 2020-11-24
ER

PT J
AU Fuly, AL
   Machado, AL
   Castro, P
   Abrahao, A
   Redner, P
   Lopes, UG
   Guimaraes, JA
   Koatz, VLG
AF Fuly, Andre L.
   Machado, Alexandre L.
   Castro, Paulo
   Abrahao, Agessandro
   Redner, Paulo
   Lopes, Ulisses G.
   Guimaraes, Jorge A.
   Koatz, Vera Lucia G.
TI Lysophosphatidylcholine produced by the phospholipase A(2) isolated from
   Lachesis muta snake venom modulates natural killer activity as a protein
   kinase C effector
SO TOXICON
LA English
DT Article
DE lysophosphatidylcholine; phospholipase A(2); Lachesis muta; snake venom;
   lymphocytes; protein kinase C
ID RETRACTED ARTICLE. SEE; ARACHIDONIC-ACID; KAPPA-B; A(2); ACTIVATION;
   CYTOTOXICITY; SPHINGOSYLPHOSPHORYLCHOLINE; PHOSPHORYLATION; INVOLVEMENT;
   METABOLISM
AB We have showed that a phospholipase A(2) isolated from Lachesis muta snake venom, denoted LM-PLA(2)-I, had some biological effects. Here, we examined its effects on lymphocytes. Pre-incubation of human peripheral blood lymphocytes with LM-PLA(2)-I plus phosphatidylcholine (PC) stimulated the natural killer (NK) activity. This was accompanied by DNA binding of nuclear transcription factor kappa B and the increase in PKC activity with translocation of the enzyme from the cytoplasma into the plasma membrane. These effects were reproduced when lymphocytes were pre-incubated with commercial lysophosphatidyleholine (LPC) and abolished by stausrosporin or p-bromophenacyl bromide. Evaluation of phosphorylated PKC isoforms showed that pre-incubation with LPC activated the autophosphorylation of the PKC isoform. Taken together, these results confirm that the enzymatic activity of the phospholipase A2 present in L. muta venom is for the biological activity of the snake venom, and strongly suggest that the LPC produced may be acting as a modulator of PKC isoforms. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, BR-24210150 Niteroi, RJ, Brazil.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP Fuly, AL (corresponding author), Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, Campus Valonguinho S-N, BR-24210150 Niteroi, RJ, Brazil.
EM andfuly@vm.uff.br
RI Redner, Paulo/A-1870-2013; Guimaraes, Jorge Almeida/V-2196-2019;
   Abrahao, Agessandro/E-6437-2012; Lopes, Ulisses Gazos/T-6634-2019;
   Lopes, Ulisses/N-4416-2013; Fuly, Andre/U-1538-2019
OI Redner, Paulo/0000-0003-2844-9769; Abrahao,
   Agessandro/0000-0003-1142-2842; Guimaraes, Jorge A./0000-0001-6354-6789
CR Balsinde J, 2002, FEBS LETT, V531, P2, DOI 10.1016/S0014-5793(02)03413-0
   Caccin P, 2006, FEBS LETT, V580, P6317, DOI 10.1016/j.febslet.2006.10.039
   Castro P, 2004, EUR J PHARMACOL, V498, P279, DOI 10.1016/j.ejphar.2004.07.047
   CHOW SC, 1988, CELL IMMUNOL, V114, P96, DOI 10.1016/0008-8749(88)90257-2
   CIFONE MG, 1993, CELL IMMUNOL, V148, P247, DOI 10.1006/cimm.1993.1109
   COMPTON MM, 1990, POULTRY SCI, V69, P1292, DOI 10.3382/ps.0691292
   Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061
   DEEM RL, 1987, CELL IMMUNOL, V110, P253, DOI 10.1016/0008-8749(87)90121-3
   DEMORAES VLG, 1989, FASEB J, V3, P2425
   DENNIS EA, 1991, FASEB J, V5, P2068
   Diaz C, 2001, ARCH BIOCHEM BIOPHYS, V391, P56, DOI 10.1006/abbi.2001.2386
   Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.E05-11-1001
   Fabbri M, 2003, INT J BIOCHEM CELL B, V35, P1004, DOI 10.1016/S1357-2725(03)00037-2
   Fuly AL, 2003, INT J BIOCHEM CELL B, V35, P1470, DOI 10.1016/S1357-2725(03)00129-8
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   Fuly AL, 2000, TOXICON, V38, P961, DOI 10.1016/S0041-0101(99)00208-1
   GLASER KB, 1993, TRENDS PHARMACOL SCI, V14, P92, DOI 10.1016/0165-6147(93)90071-Q
   GRAVES SS, 1986, J IMMUNOL, V137, P1977
   HOFFMAN T, 1981, P NATL ACAD SCI-BIOL, V78, P3839, DOI 10.1073/pnas.78.6.3839
   Kabarowski JHS, 2002, BIOCHEM PHARMACOL, V64, P161, DOI 10.1016/S0006-2952(02)01179-6
   Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781
   KAZUHIKO O, 1998, J BIOL CHEM, V263, P6865
   Keenan C, 1997, INT IMMUNOL, V9, P1431, DOI 10.1093/intimm/9.10.1431
   Keenan C, 1998, CELL SIGNAL, V10, P225, DOI 10.1016/S0898-6568(97)00121-6
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Kini RM, 1997, VENOM PHOSPHOLIPASE, P1
   Littler DR, 2006, BIOCHEM BIOPH RES CO, V349, P1182, DOI 10.1016/j.bbrc.2006.08.160
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Masamune A, 2001, DIGEST DIS SCI, V46, P1871, DOI 10.1023/A:1010622828502
   Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103
   Nishizuka Y, 2003, J BIOCHEM, V133, P155, DOI 10.1093/jb/mvg035
   PESTRONK A, 1982, MUSCLE NERVE, V5, P209, DOI 10.1002/mus.880050306
   Prokazova NV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P31
   Rigoni M, 2005, SCIENCE, V310, P1678, DOI 10.1126/science.1120640
   Schilling T, 2004, J PHYSIOL-LONDON, V557, P105, DOI 10.1113/jphysiol.2004.060632
   Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0
   STEELE TA, 1988, CELL IMMUNOL, V112, P402, DOI 10.1016/0008-8749(88)90309-7
   Sugiyama S, 1998, ARTERIOSCL THROM VAS, V18, P568, DOI 10.1161/01.ATV.18.4.568
   Whalen MM, 1999, CELL PHYSIOL BIOCHEM, V9, P297, DOI 10.1159/000016324
   Xu Y, 2002, BBA-MOL CELL BIOL L, V1582, P81, DOI 10.1016/S1388-1981(02)00140-3
   YASUDA I, 1990, BIOCHEM BIOPH RES CO, V166, P1220, DOI 10.1016/0006-291X(90)90996-Z
   Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200
NR 42
TC 17
Z9 17
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD SEP 1
PY 2007
VL 50
IS 3
BP 400
EP 410
DI 10.1016/j.toxicon.2007.04.008
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 206GR
UT WOS:000249172400011
PM 17537472
DA 2020-11-24
ER

PT J
AU Verli, H
   Calazans, A
   Brindeiro, R
   Tanuri, A
   Guimaraes, JA
AF Verli, Hugo
   Calazans, Alexandre
   Brindeiro, Rodrigo
   Tanuri, Amilcar
   Guimaraes, Jorge A.
TI Molecular dynamics analysis of HIV-1 matrix protein: Clarifying
   differences between crystallographic and solution structures
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE molecular dynamics; HIV-1 matrix protein; crystallographic contacts;
   p17; p24
ID VIRUS-LIKE PARTICLES; GAG-PROTEIN; SECONDARY STRUCTURE; SIMULATIONS;
   ORGANIZATION; ASSEMBLIES; MECHANISM; SHELL
AB One of the main structural features of the mature HIV-1 virion is the matrix protein (p17). This partially globular protein presents four helixes centrally organized and a fifth one, H5, projecting away from the packed bundle of helixes. Comparison between solution and crystallographic data of p17 indicates a 6 angstrom displacement of a short 3(10) helix and a partial unfolding of H5 in solution related to crystal. While the behavior of the 3 10 helix has been previously addressed to virion assembly, the relevance and origin of H5 partial unfolding is possibly related to the contacts between p17 and other viral elements, such as p24. In this context, we present a 40 ns conformational sampling of monomeric p17 using molecular dynamics simulations. The performed simulations presented a progressive conversion of the p17 crystallographic structure to the NMR conformation, suggesting that the biological form of this protein may have its C-terminal portion partially unfolded. (C) 2006 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21944970 Rio De Janeiro, Brazil.
RP Verli, H (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga,2752, BR-90610000 Porto Alegre, RS, Brazil.
EM hverli@cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
CR Baumketner A, 2005, J PHYS CHEM B, V109, P21322, DOI 10.1021/jp051325a
   Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI DOI 10.1007/978-94-015-7658-1_21
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bouamr F, 2003, BIOCHEMISTRY-US, V42, P6408, DOI 10.1021/bi020692z
   BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   DeLano WL, 2002, PYMOL MOL GRAPHYCS S
   Eaton WA, 1998, ACCOUNTS CHEM RES, V31, P745, DOI 10.1021/ar9700825
   EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303
   Forster MJ, 2000, J MOL BIOL, V298, P841, DOI 10.1006/jmbi.2000.3715
   Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099
   HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644
   Huseby D, 2005, J BIOL CHEM, V280, P17664, DOI 10.1074/jbc.M412325200
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Massiah MA, 1996, PROTEIN SCI, V5, P2391, DOI 10.1002/pro.5560051202
   MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719
   Matthews S, 1995, BIOCHEM SOC T, V23, P725, DOI 10.1042/bst0230725
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763
   Nermut MV, 1998, J STRUCT BIOL, V123, P143, DOI 10.1006/jsbi.1998.4024
   NERMUT MV, 1994, VIROLOGY, V198, P288, DOI 10.1006/viro.1994.1032
   Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160
   SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994
   Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2
   Turner BG, 1999, J MOL BIOL, V285, P1, DOI 10.1006/jmbi.1998.2354
   VANDERSPOEL D, 2004, GROMACS USER MANUAL
   Verli H, 2005, J MOL GRAPH MODEL, V24, P203, DOI 10.1016/j.jmgm.2005.07.002
NR 35
TC 25
Z9 25
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1093-3263
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD JUL
PY 2007
VL 26
IS 1
BP 62
EP 68
DI 10.1016/j.jmgm.2006.09.009
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA 198RZ
UT WOS:000248646500006
PM 17067836
DA 2020-11-24
ER

PT J
AU Becker, CF
   Guimaraes, JA
   Mourao, PAS
   Verli, H
AF Becker, Camila F.
   Guimaraes, Jorge A.
   Mourao, Paulo A. S.
   Verli, Hugo
TI Conformation of sulfated galactan and sulfated fucan in aqueous
   solutions: Implications to their anticoagulant activities
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE carbohydrate modeling; molecular dynamics; anticoagulant activity;
   antithrombin; selective desulfation
ID MOLECULAR-DYNAMICS; HEPARIN; POLYSACCHARIDES; MECHANISM
AB The discovery of sulfated galactans and sulfated fucans in marine invertebrates with simple and ordered structures opened new perspectives to investigate the biological activity of these molecules and to determine whether different structures confer high affinity for a particular protein. We undertook a conformational analysis of a 2-sulfated, 3-linked U-L-galactan and of a alpha-L-fucan with similar structure. Through comparison between theoretical and NMR derived coupling constants, we observed that the pyranose rings are predominantly in the C-1(4) conformation in these polysaccharides. Additionally, the geometry of the glycosidic linkages was determined based on force field calculations, indicating that the two polysaccharides have similar conformations in solution. Since the sulfated beta-L-galactan, but not the alpha-L-fucan potentiates antithrombin (AT) inhibition of thrombin, the solution conformations of the compounds were docked into AT and the complexes obtained were refined through molecular dynamics calculations. The obtained results indicates extremely different orientations for the two poly saccharides, which well correlates and explain their distinct anticoagulant activities. Finally, the molecular mechanism of a selective 2-desulfation reaction, observed among sulfated fucans, was explained as a consequence of an intramolecular hydrogen bond capable of assisting in the removal of the charged group. (C) 2007 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, Lab Tecido Conjuntivo, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
RP Verli, H (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Apiranga 2752, BR-90610000 Porto Alegre, RS, Brazil.
EM hverli@cbiot.ufrgs.br
RI Mourao, Paulo/AAA-5386-2020
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965
   Alves AP, 1998, GLYCOBIOLOGY, V8, P939, DOI 10.1093/glycob/8.9.939
   Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Caffarena ER, 2005, J MOL STRUC-THEOCHEM, V714, P189, DOI 10.1016/j.theochem.2004.11.009
   CASU B, 1975, CARBOHYD RES, V39, P168, DOI 10.1016/S0008-6215(00)82654-3
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810
   GATTI G, 1979, MACROMOLECULES, V12, P1001, DOI 10.1021/ma60071a044
   HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4
   Hirohashi N, 2002, BIOCHEM BIOPH RES CO, V298, P403, DOI 10.1016/S0006-291X(02)02441-5
   Horita DA, 1997, GLYCOCONJUGATE J, V14, P691, DOI 10.1023/A:1018561215401
   Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265
   Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j
   *IUPAC IUB JOINT C, 1983, EUR J BIOCHEM, V131, P5, DOI DOI 10.1111/J.1432-1033.1983.TB07224.X
   KARPLUS M, 1963, J AM CHEM SOC, V85, P2870, DOI 10.1021/ja00901a059
   Melo FR, 2004, J BIOL CHEM, V279, P20824, DOI 10.1074/jbc.M308688200
   Mikhailov D, 1997, BIOCHEM J, V328, P51, DOI 10.1042/bj3280051
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Mulloy B, 2005, AN ACAD BRAS CIENC, V77, P651, DOI 10.1590/S0001-37652005000400007
   Pereira MS, 1999, J BIOL CHEM, V274, P7656, DOI 10.1074/jbc.274.12.7656
   Pereira MS, 2002, GLYCOBIOLOGY, V12, P573, DOI 10.1093/glycob/cwf077
   Pereira MS, 2002, CARBOHYD RES, V337, P2231, DOI 10.1016/S0008-6215(02)00215-X
   Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030
   SCHAFTENAAR G, 1997, MOLDEN CAOS CAMM CTR
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047
   VANBOECKEL CAA, 1993, ANGEW CHEM INT EDIT, V32, P1671, DOI 10.1002/anie.199316713
   VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423
   VANDERSPOEL D, 2004, GROMACS USER MANUAL
   Verli H, 2005, J MOL GRAPH MODEL, V24, P203, DOI 10.1016/j.jmgm.2005.07.002
   Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026
   Vilela-Silva ACES, 2002, J BIOL CHEM, V277, P379, DOI 10.1074/jbc.M108496200
   Vilela-Silva ACES, 1999, GLYCOBIOLOGY, V9, P927, DOI 10.1093/glycob/9.9.927
NR 34
TC 42
Z9 45
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1093-3263
EI 1873-4243
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD JUL
PY 2007
VL 26
IS 1
BP 391
EP 399
DI 10.1016/j.jmgm.2007.01.008
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA 198RZ
UT WOS:000248646500037
PM 17307002
DA 2020-11-24
ER

PT J
AU de Oliveira, SK
   Hoffmeister, M
   Gambaryan, S
   Muller-Esterl, W
   Guimaraes, JA
   Smolenski, AP
AF de Oliveira, Simone Kobe
   Hoffmeister, Meike
   Gambaryan, Stepan
   Mueller-Esterl, Werner
   Guimaraes, Jorge A.
   Smolenski, Albert P.
TI Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and
   regulates nuclear translocation of the aryl hydrocarbon receptor
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID AH RECEPTOR; PROTEIN; CAMP; CGMP; BINDING; TRANSACTIVATION; ACTIVATION;
   DETERMINANTS; LOCALIZATION; MECHANISMS
AB Phosphodiesterase type 2A (PDE2A) hydrolyzes cyclic nucleotides cAMP and cGMP, thus efficiently controlling cAMP-dependent signaling pathways. PDE2A is composed of an amino-terminal region, two regulatory GAF domains, and a catalytic domain. Cyclic nucleotide hydrolysis is known to be activated by cGMP binding to GAF-B; however, other mechanisms may operate to fine-tune local cyclic nucleotide levels. In a yeast two-hybrid screening we identified XAP2, a crucial component of the aryl hydrocarbon receptor (AhR) complex, as a major PDE2A-interacting protein. We mapped the XAP2 binding site to the GAF-B domain of PDE2A. PDE assays with purified proteins showed that XAP2 binding does not change the enzymatic activity of PDE2A. To analyze whether PDE2A could affect the function of XAP2, we studied nuclear translocation of AhR, i.e. the master transcription factor controlling the expression of multiple detoxification genes. Notably, regulation of AhR target gene expression is initiated by tetrachlorodibenzodioxin (TCDD) binding to AhR and by a poorly understood cAMP-dependent pathway followed by the translocation of AhR from the cytosol into the nucleus. Binding of PDE2A to XAP2 inhibited TCDD- and cAMP-induced nuclear translocation of AhR in Hepa1c1c7 hepatocytes. Furthermore, PDE2A attenuated TCDD- induced transcription in reporter gene assays. We conclude that XAP2 targets PDE2A to the AhR complex, thereby restricting AhR mobility, possibly by a local reduction of cAMP levels. Our results provide first insights into the elusive cAMP-dependent regulation of AhR.
C1 Univ Frankfurt Klinikum, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Wurzburg, Ins Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany.
   Russian Acad Sci, Sechenov Inst Evolut Physiol & Biochem, St Petersburg 194223, Russia.
RP Smolenski, AP (corresponding author), Univ Frankfurt Klinikum, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM smolenski@biochem2.de
RI Gambaryan, Stepan/I-3940-2016
OI Gambaryan, Stepan/0000-0002-1470-0791; Smolenski,
   Albert/0000-0001-9210-9406; Guimaraes, Jorge A./0000-0001-6354-6789
CR Bell DR, 2000, J BIOL CHEM, V275, P36407, DOI 10.1074/jbc.M004236200
   Bentley JK, 2001, J NEUROCHEM, V76, P1252, DOI 10.1046/j.1471-4159.2001.00133.x
   Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017
   Bolger GB, 2003, J BIOL CHEM, V278, P33351, DOI 10.1074/jbc.M303269200
   Carlson DB, 2002, J BIOCHEM MOL TOXIC, V16, P317, DOI 10.1002/jbt.10051
   Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580
   D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007
   Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828
   Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778
   Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162
   Gross-Langenhoff M, 2006, J BIOL CHEM, V281, P2841, DOI 10.1074/jbc.M511468200
   Harper PA, 2006, BIOCHEM PHARMACOL, V72, P267, DOI 10.1016/j.bcp.2006.01.007
   Iffland A, 2005, BIOCHEMISTRY-US, V44, P8312, DOI 10.1021/bi047313h
   Kashuba EV, 2006, J BIOL CHEM, V281, P1215, DOI 10.1074/jbc.M509036200
   Kuzhandaivelu N, 1996, NUCLEIC ACIDS RES, V24, P4741, DOI 10.1093/nar/24.23.4741
   LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4
   Ma Q, 1997, J BIOL CHEM, V272, P8878
   MACFARLAND RT, 1991, J BIOL CHEM, V266, P136
   Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656
   Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899
   Meurer S, 2005, J BIOL CHEM, V280, P33149, DOI 10.1074/jbc.M507565200
   Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978
   Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93
   Oesch-Bartlomowicz B, 2005, P NATL ACAD SCI USA, V102, P9218, DOI 10.1073/pnas.0503488102
   Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200
   Ramadoss P, 2005, BIOCHEMISTRY-US, V44, P11148, DOI 10.1021/bi050948b
   Ramadoss Preeti, 2005, Expert Opin Drug Metab Toxicol, V1, P9, DOI 10.1517/17425255.1.1.9
   Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2
   Schultess J, 2005, BLOOD, V105, P3185, DOI 10.1182/blood-2004-09-3605
   Seybold J, 2005, BLOOD, V105, P3569, DOI 10.1182/blood-2004-07-2729
   Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3
   Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100
   Wu AY, 2004, J BIOL CHEM, V279, P37928, DOI 10.1074/jbc.M404287200
   Zaccolo M, 2006, BIOCHEM SOC T, V34, P495, DOI 10.1042/BST0340495
NR 34
TC 83
Z9 85
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 4
PY 2007
VL 282
IS 18
BP 13656
EP 13663
DI 10.1074/jbc.M610942200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 162BC
UT WOS:000246060300055
PM 17329248
OA Bronze
DA 2020-11-24
ER

PT J
AU Bohrer, CB
   Reck, J
   Fernandes, D
   Sordi, R
   Guimaraes, JA
   Assreuy, J
   Termignoni, C
AF Bohrer, C. B.
   Reck Junior, J.
   Fernandes, D.
   Sordi, R.
   Guimaraes, J. A.
   Assreuy, J.
   Termignoni, C.
TI Kallikrein-kinin system activation by Lonomia obliqua caterpillar
   bristles: Involvement in edema and hypotension responses to envenomation
SO TOXICON
LA English
DT Article
DE Lonomia obliqua; venom; kallikrein; bradykinin; edema; hypotension
ID BLOOD-COAGULATION; BRADYKININ; PROCOAGULANT; EXTRACT; VENOM; SKIN
AB Lonomia obliqua envenomation induces an intense burning sensation at the site of contact and severe hemorrhage followed by edema and hypotension, and after few days death can occur usually due to acute renal failure. In order to understand more about the envenomation syndrome, the present study investigates the role played by kallikrein-kinin system (KKS) in edematogenic and hypotensive responses to the envenomation by L. obliqua. The incubation of L. obliqua caterpillar bristles extract (LOCBE) with plasma results in kallikrein activation, measured by cromogenic assay using the kallikrein synthetic substrate S-2302 (H-D-Pro-Phe-Arg-pNA). It was also showed that LOCBE was able to release kinins from low-molecular weight kininogen (LMWK). Moreover, it was demonstrated that previous administration of a kallikrein inhibitor (aprotinin) or bradykinin B2 receptor antagonist (HOE-140) significantly reduces the edema and hypotension in response to LOCBE, using mouse paw edema bioassay and mean arterial blood pressure analysis, respectively. The results demonstrate a direct involvement of the KKS in the edema formation and in the fall of arterial pressure that occur in the L. obliqua envenomation syndrome. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Fac Vet, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Santa Catarina, Ctr Ciencias Biol, Dept Farmacol, Florianopolis, SC, Brazil.
   Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, BR-91501970 Porto Alegre, RS, Brazil.
RP Termignoni, C (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM ctermignoni@cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Sordi, Regina/O-3377-2014;
   Termignoni, Carlos/AAB-8943-2020; Reck, Jose/M-4805-2013; Reck,
   Jose/AAH-3373-2020; Fernandes, Daniel/B-7147-2012; Assreuy,
   Jamil/A-4205-2013
OI Sordi, Regina/0000-0003-0264-7062; Termignoni,
   Carlos/0000-0002-2789-2518; Reck, Jose/0000-0002-0969-792X; Fernandes,
   Daniel/0000-0002-8935-4176; Guimaraes, Jorge A./0000-0001-6354-6789
CR ANTUNES E, 1993, TOXICON, V31, P1385, DOI 10.1016/0041-0101(93)90204-V
   Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   Arocha-Pinango CL, 2001, HAEMOSTASIS, V31, P288
   BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2
   Corrêa Maria Sueli, 2004, Rev. Soc. Bras. Med. Trop., V37, P418, DOI 10.1590/S0037-86822004000500011
   de Castro Bastos L, 2004, TOXICON, V43, P273, DOI 10.1016/j.toxicon.2003.12.003
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   DRAY A, 1997, KININ SYSTEM, P157
   FARIA L, 2001, TOXICON, V39, P825, DOI DOI 10.1016/S0041-0101(00)00213-0
   FERREIRA S H, 1979, Journal of Pharmacy and Pharmacology, V31, P648
   Griesbacher T, 1998, EUR J PHARMACOL, V351, P95, DOI 10.1016/S0014-2999(98)00276-3
   Herwald H, 2003, SCAND J INFECT DIS, V35, P604, DOI 10.1080/00365540310016268
   KAPLAN AP, 1987, BLOOD, V70, P1
   MULLERESTERL W, 1986, TRENDS BIOCHEM SCI, V11, P336, DOI 10.1016/0968-0004(86)90293-8
   Pan ZK, 1996, J CLIN INVEST, V98, P2042, DOI 10.1172/JCI119009
   PIERCE JV, 1974, CHEM BIOL KALLIKREIN, P121
   Pinto AFM, 2006, TOXICON, V47, P113, DOI 10.1016/j.toxicon.2005.10.004
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Prezoto BC, 2002, BRAZ J MED BIOL RES, V35, P703, DOI 10.1590/S0100-879X2002000600011
   REGOLI D, 1993, CAN J PHYSIOL PHARM, V71, P556, DOI 10.1139/y93-079
   Seibert CS, 2003, TOXICON, V41, P831, DOI 10.1016/S0041-0101(03)00040-0
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Wang HB, 2006, BIOL CHEM, V387, P11, DOI 10.1515/BC.2006.003
   WANG JP, 1988, EUR J PHARMACOL, V157, P61, DOI 10.1016/0014-2999(88)90471-2
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 27
TC 20
Z9 21
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD APR
PY 2007
VL 49
IS 5
BP 663
EP 669
DI 10.1016/j.toxicon.2006.11.005
PG 7
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 159LB
UT WOS:000245866100008
PM 17188732
DA 2020-11-24
ER

PT J
AU Terra, RMS
   Guimaraes, JA
   Verli, H
AF Terra, Renata M. S.
   Guimaraes, Jorge A.
   Verli, Hugo
TI Structural and functional behavior of biologically active monomeric
   melittin
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE melittin; molecular dynamics; bee venom; Apis mellifera; peptide
   folding; melittin biological unit
ID MOLECULAR-DYNAMICS SIMULATIONS; CIRCULAR-DICHROISM; BEE VENOM;
   CONFORMATION; TETRAMER; AGGREGATION; REFINEMENT; BILAYERS; METHANOL;
   MODEL
AB Melittin is a well-known water-soluble toxic peptide present in bee venom of Apis mellifera, capable of interacting with and disrupting cell membranes thus producing many effects on living cells. Additionally, melittin induces activation of phospholipases and calmodulin upon interaction with cellular membranes. The conformation and aggregation state adopted by melittin in solution depends on several factors including the peptide concentration, ionic strength, pH and the nature of the ions in the aqueous medium. Such conformational dependence on the peptide environment gives new insights over the currently available 3D structures of melittin and, ultimately, over its biologically functional unit. Based on crystallographic data, the melittin tetramer has been proposed as its bioactive form. Contrarily to such data, we show in this work the results obtained from molecular dynamics simulations, which clearly indicate that the tetrameric organization of melittin is not stable under biological conditions dissociating after 2.5 ns through a 10 ns trajectory. We found that the terrameric form of melittin is stable only in conditions of high pH and high peptide concentration in the molecular dynamics simulations. Moreover, when in plasma melittin appears to be a random coil monomer, folding only upon interaction with biological membranes. In summary, these findings elucidate several properties of melittin structure and dynamics, projecting significant implications in the study of its biological function. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Fac Farm, BR-90610000 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,CP 15005, BR-91500970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
CR BAZZO R, 1988, EUR J BIOCHEM, V173, P139, DOI 10.1111/j.1432-1033.1988.tb13977.x
   Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201
   BELLO J, 1982, BIOCHEMISTRY-US, V21, P461, DOI 10.1021/bi00532a007
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Constantinescu I, 2004, BBA-BIOMEMBRANES, V1667, P26, DOI 10.1016/j.bbamem.2004.08.012
   DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X
   GAULDIE J, 1976, EUR J BIOCHEM, V61, P369, DOI 10.1111/j.1432-1033.1976.tb10030.x
   Glattli A, 2006, EUR BIOPHYS J BIOPHY, V35, P255, DOI 10.1007/s00249-005-0033-7
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644
   Iwadate M, 1998, EUR J BIOCHEM, V257, P479, DOI 10.1046/j.1432-1327.1998.2570479.x
   KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lin JH, 2000, BIOPHYS J, V78, P1714, DOI 10.1016/S0006-3495(00)76723-3
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Liu HL, 2003, CHEM PHYS LETT, V375, P119, DOI 10.1016/S0009-2614(03)00846-7
   Liu P, 2005, NATURE, V437, P159, DOI 10.1038/nature03926
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Naito A, 2000, BIOPHYS J, V78, P2405, DOI 10.1016/S0006-3495(00)76784-1
   OKADA A, 1994, BIOCHEMISTRY-US, V33, P9438, DOI 10.1021/bi00198a009
   Qiu WH, 2005, J PHYS CHEM B, V109, P16901, DOI 10.1021/jp0511754
   Saini SS, 1997, BIOCHEM BIOPH RES CO, V238, P436, DOI 10.1006/bbrc.1997.7295
   Scaloni A, 1998, J MOL BIOL, V277, P945, DOI 10.1006/jmbi.1998.1629
   SHIER WT, 1979, P NATL ACAD SCI USA, V76, P195, DOI 10.1073/pnas.76.1.195
   TALBOT JC, 1979, FEBS LETT, V102, P191, DOI 10.1016/0014-5793(79)80957-6
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   van Gunsteren W.F., 1996, BIOMOLECULAR SIMULAT
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   Wang F, 2003, BIOPOLYMERS, V70, P614, DOI 10.1002/bip.10504
   Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X
NR 34
TC 35
Z9 43
U1 1
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1093-3263
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD MAR
PY 2007
VL 25
IS 6
BP 767
EP 772
DI 10.1016/j.jmgm.2006.06.006
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA 158PG
UT WOS:000245802900002
PM 16905347
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Terra, RMS
   Guimaraes, JA
   Fox, JW
AF Pinto, Antonio F. M.
   Terra, Renata M. S.
   Guimaraes, Jorge A.
   Fox, Jay W.
TI Mapping von Willebrand factor A domain binding sites on a snake venom
   metalloproteinase cysteine-rich domain
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE snake venom metalloproteinases; von Willebrand factor; cysteine-rich
   domain; SVMP; vWF A domains
ID INDUCED PLATELET-AGGREGATION; FACTOR-CLEAVING PROTEASE; HEMORRHAGIC
   METALLOPROTEINASES; CRYSTAL-STRUCTURE; GLYCOPROTEIN IB; COLLAGEN;
   INHIBITION; JARARHAGIN; ATROLYSIN; PROTEINS
AB The Pill class of the snake venom metalloproteinases (SVMPS) are acknowledged to be one of the major hemorrhage producing toxins in crotalid venoms. This class of SVMPS are structurally distinguished by the presence of disintegrin-like and cysteine-rich domains carboxy to the metalloproteinase domain and thus share structural homology with many of the ADAMs proteins. It has been suggested that the presence of the carboxy domain are the key structural determinants for potent hemorrhagic activity in that they may serve to target the proteinases to specific key extracellular matrix and cell surface substrates for proteolysis leading to hemorrhage production at the capillaries. Following from previous studies in our laboratory in this investigation we scanned the cysteine-rich domain of the Pill hemorrhagic SVMP jararhagin using synthetic peptides in an attempt to identify regions which could bind to von Willebrand factor (vWF), a known binding partner for jararhagin. From these studies we identified two such peptide, Jar6 and Jar? that could support binding to vWF as well as block the recombinant cysteine-rich domain of jararhagin binding to vWF. Using the coordinates for the recently solved crystal structure of the PIII SVMP VAP1, we modeled the structure of jararhagin and attempted to dock the modeled cysteine-rich structure of that protein to the Al domain of vWF. These studies indicated that effective protein-protein interaction between the two ligands was possible and supported the data indicating that the Jar6 peptide was involved, whereas the Jar? peptide was observed to be sterically blocked from interaction. In summary, our studies have identified a region on the cysteine-rich domain of a Pill SVMP that interacts with vWF and based on molecular modeling could be involving in the interaction of the cysteine-rich domain of the SVMP with the Al domain of vWF thus serving to target the toxin to the protein for subsequent proteolytic degradation. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.
   Univ Fed Rio Grande Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP Fox, JW (corresponding author), Univ Virginia, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.
EM jwf8x@virginia.edu
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Pinto,
   Antonio/0000-0002-1573-8011
CR BARAMOVA EN, 1989, ARCH BIOCHEM BIOPHYS, V275, P63, DOI 10.1016/0003-9861(89)90350-0
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   BJARNASON JB, 1998, HDB PROTEOLYTIC ENZY, P1246
   Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662
   Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hamako J, 1998, THROMB HAEMOSTASIS, V80, P499
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Jia LG, 2000, ARCH BIOCHEM BIOPHYS, V373, P281, DOI 10.1006/abbi.1999.1517
   Jia LG, 1997, J BIOL CHEM, V272, P13094, DOI 10.1074/jbc.272.20.13094
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   Kamiguti AS, 1996, BIOCHEM J, V320, P635, DOI 10.1042/bj3200635
   KAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7
   Kamiguti AS, 2003, FEBS LETT, V549, P129, DOI 10.1016/S0014-5793(03)00799-3
   Kokame K, 2002, P NATL ACAD SCI USA, V99, P11902, DOI 10.1073/pnas.172277399
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200
   Matsui T, 2005, TOXICON, V45, P1075, DOI 10.1016/j.toxicon.2005.02.023
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424
   Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y
   Serrano SMT, 2005, BIOCHEM J, V391, P69, DOI 10.1042/BJ20050483
   Soejima K, 2001, J BIOCHEM-TOKYO, V130, P475, DOI 10.1093/oxfordjournals.jbchem.a003009
   Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131
   USAMI Y, 1994, BIOCHEM BIOPH RES CO, V201, P331, DOI 10.1006/bbrc.1994.1706
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Zheng XL, 2003, J BIOL CHEM, V278, P30136, DOI 10.1074/jbc.M305331200
   ZHOU Q, 1995, BIOCHEM J, V307, P411, DOI 10.1042/bj3070411
   Zigrino P, 2002, J BIOL CHEM, V277, P40528, DOI 10.1074/jbc.M202049200
NR 37
TC 23
Z9 23
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 1
PY 2007
VL 457
IS 1
BP 41
EP 46
DI 10.1016/j.abb.2006.10.010
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 123QX
UT WOS:000243311600006
PM 17118332
DA 2020-11-24
ER

PT J
AU de Meis, L
   Arruda, AP
   Guimaraes, J
AF de Meis, Leopoldo
   Arruda, Ana Paula
   Guimaraes, Jorge
TI The impact of science in Brazil
SO IUBMB LIFE
LA English
DT Editorial Material
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP de Meis, L (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM demeis@bioqmed.ufrj.br
OI Arruda, Ana Paula/0000-0001-6179-2687; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR de Meis L, 2003, BRAZ J MED BIOL RES, V36, P1135, DOI 10.1590/S0100-879X2003000900001
   DEMEIS L, 2002, CIENCIA ED CONFLITO, P1
   *FAPESP, 2004, IND CIENC TECN IN 20
   *FAPESP, 2002, IND CIENC TECN IN 20
   Kiger Joseph C., 1993, INT ENCY LEARNED SOC
   Narin F, 1997, RES POLICY, V26, P317, DOI 10.1016/S0048-7333(97)00013-9
   SCHWARTZMAN S, 1979, FORMACAO COMUNIDADE
NR 7
TC 22
Z9 25
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1521-6543
J9 IUBMB LIFE
JI IUBMB Life
PY 2007
VL 59
IS 4-5
BP 227
EP 234
DI 10.1080/15216540701258140
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 171SX
UT WOS:000246756800012
PM 17505957
OA Bronze
DA 2020-11-24
ER

PT J
AU Zorzetto, R
   Razzouk, D
   Dubugras, MTB
   Gerolin, J
   Schor, N
   Guimaraes, JA
   Mari, JJ
AF Zorzetto, R.
   Razzouk, D.
   Dubugras, M. T. B.
   Gerolin, J.
   Schor, N.
   Guimaraes, J. A.
   Mari, J. J.
TI The scientific production in health and biological sciences of the top
   20 Brazilian universities
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE health sciences; scientific publications; information science;
   scientometrics; bibliometric analysis
ID IMPACT
AB Brazilian scientific output exhibited a 4-fold increase in the last two decades because of the stability of the investment in research and development activities and of changes in the policies of the main funding agencies. Most of this production is concentrated in public universities and research institutes located in the richest part of the country. Among all areas of knowledge, the most productive are Health and Biological Sciences. During the 1998-2002 period these areas presented heterogeneous growth ranging from 4.5% (Pharmacology) to 191% (Psychiatry), with a median growth rate of 47.2%. In order to identify and rank the 20 most prolific institutions in these areas, searches were made in three databases (DataCAPES, ISI and MEDLINE) which permitted the identification of 109,507 original articles produced by the 592 Graduate Programs in Health and Biological Sciences offered by 118 public universities and research institutes. The 20 most productive centers, ranked according to the total number of ISI-indexed articles published during the 1998-2003 period, produced 78.7% of the papers in these areas and are strongly concentrated in the Southern part of the country, mainly in Sao Paulo State.
C1 Univ Fed Sao Paulo, Dept Psiquiat, BR-04026001 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Ctr Avaliacao & Integracao Dados Institucionais, BR-04026001 Sao Paulo, Brazil.
   Univ Fed Sao Paulo, Proreitoria Posgrad & Pesquisa, BR-04026001 Sao Paulo, Brazil.
   Coordenacao Aperfeicoamento Pessoal Nivel Super, Brasilia, DF, Brazil.
RP Mari, JJ (corresponding author), Univ Fed Sao Paulo, Dept Psiquiat, Rua Dr Bacelar 334, BR-04026001 Sao Paulo, Brazil.
EM jamari@attglobal.net
RI Gerolin, Jeronimo/C-6041-2012; de Jesus Mari, Jair/A-7309-2008; Gerolin,
   Jeronimo/AAX-6822-2020; Batista, Marcelo/K-4305-2013; Guimaraes, Jorge
   Almeida/V-2196-2019; Schor, Nestor/K-4364-2013; Razzouk,
   Denise/A-2336-2011
OI de Jesus Mari, Jair/0000-0002-5403-0112; Razzouk,
   Denise/0000-0003-4228-8949; Gerolin, Jeronimo/0000-0002-9610-5792;
   Guimaraes, Jorge A./0000-0001-6354-6789
CR ANSELMO FP, 2002, INDICADORES NACL CIE
   Bressan RA, 2005, BRAZ J MED BIOL RES, V38, P649, DOI 10.1590/S0100-879X2005000500001
   CAMEIRO S, 2003, INDICADORES CIENCIA, P173
   *CAPES, BANC DAD COORD AP PE
   *CAPES, COORD PERF HIGH ED P
   CASTRO MHG, 2005, INDICADORES CIENCIA
   *CNPQ, NAT COUNC SCI TECHN
   de Meis L, 2003, BRAZ J MED BIOL RES, V36, P1135, DOI 10.1590/S0100-879X2003000900001
   GREGOLIN JAR, 2005, INDICADORES CIENCIA
   GUIMARAES J, 2004, CIENC SAUDE COLETIVA, V9, P307
   GUIMARAES JA, 1995, SCIENTOMETRICS, V34, P101, DOI 10.1007/BF02019176
   HOLLANDA S, 2003, INDICADORES CIENCIA, P93
   HOLLANDA S, 2005, INDICADORES CIENCIA
   King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a
   Leta J, 1996, SCIENTOMETRICS, V35, P33, DOI 10.1007/BF02018231
   LETA J, 2003, INDICADORES CIENCIA, P121
   Liu NC, 2005, HIGHER ED EUROPE, V30, P127, DOI DOI 10.1080/03797720500260116
   Marchelli PS, 2005, RBPG, V2, P7
   Mari JD, 2006, REV SAUDE PUBL, V40, P161, DOI 10.1590/S0034-89102006000100024
   Paraje G, 2005, SCIENCE, V308, P959, DOI 10.1126/science.1108705
   SCHWARTZMAN S, 1991, 16 INT C LAT AM STUD
   *SHANG JIAO TONG U, AC RANK WORLD U AC R
   *THOMS CORP, SCI CIT IND EXP SCIE
   Velloso A, 2004, SCIENTOMETRICS, V61, P207, DOI 10.1023/B:SCIE.0000041649.24713.ca
NR 24
TC 41
Z9 53
U1 0
U2 21
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD DEC
PY 2006
VL 39
IS 12
BP 1513
EP 1520
DI 10.1590/S0100-879X2006005000040
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 120RJ
UT WOS:000243103300001
PM 17160259
OA DOAJ Gold, Green Published
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Terra, RMS
   Guimaraes, JA
   Kashiwagi, M
   Nagase, H
   Serrano, SMT
   Fox, JW
AF Pinto, Antonio F. M.
   Terra, Renata M. S.
   Guimaraes, Jorge a
   Kashiwagi, Masahide
   Nagase, Hideaki
   Serrano, Solange M. T.
   Fox, Jay W.
TI Structural features of the reprolysin atrolysin C and tissue inhibitors
   of metalloproteinases (TIMPs) interaction
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE TIMP; atrolysin C; SVMP; molecular docking; molecular dynamics
   simulation; binding affinity
ID MATRIX-METALLOPROTEINASES; SHAPE COMPLEMENTARITY; EXPRESSION
AB Atrolysin C is a P-I snake venom metalloproteinase (SVMP) from Crotalus atrox venom, which efficiently degrades capillary basement membranes, extracellular matrix, and cell surface proteins to produce hemorrhage. The tissue inhibitors of metalloproteinases (TIMPs) are effective inhibitors of matrix metalloproteinases which share some structural similarity with the SVMPs. In this work, we evaluated the inhibitory profile of TIMP-1, TIMP-2, and the N-terminal domain of TIMP-3 (N-TIMP-3) on the proteolytic activity of atrolysin C and analyzed the structural requirements and molecular basis of inhibitor-enzyme interaction using molecular modeling. While TIMP-1 and TIMP-2 had no inhibitory activity upon atrolysin C, the N-terminal domain of TIMP-3 (N-TIMP-3) was a potent inhibitor with a K-i value of approximately 150 nM. The predicted docking structures of atrolysin C and TIMPs were submitted to molecular dynamics simulations and the complex atrolysin C/N-TIMP-3 was the only one that maintained the inhibitory conformation. This study is the first to shed light on the structural determinants required for the interaction between a SVMP and a TIMP, and suggests a structural basis for TIMP-3 inhibitory action and related proteins such as the ADAMs. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA.
   Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
   Imperial Coll, Dept Matrix Biol, Kennedy Inst, Div Rheumatol, London W6 8LH, England.
   Inst Butantan, Lab Especial Toxinol Aplicada, CAT, CEPID, BR-05503900 Sao Paulo, Brazil.
RP Fox, JW (corresponding author), Univ Virginia, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.
EM jwf8x@virginia.edu
RI Serrano, Solange M. T./A-7132-2008
OI Serrano, Solange M. T./0000-0001-8994-1904; Guimaraes, Jorge
   A./0000-0001-6354-6789; Pinto, Antonio/0000-0002-1573-8011
FU NIAMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Arthritis &
   Musculoskeletal & Skin Diseases (NIAMS) [AR40994] Funding Source:
   Medline; Wellcome TrustWellcome Trust Funding Source: Medline; NATIONAL
   INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal
   & Skin Diseases (NIAMS) [R01AR040994, R01AR040994, R01AR040994,
   R01AR040994, R01AR040994, R01AR040994, R01AR040994, R01AR040994,
   R01AR040994, R01AR040994, R01AR040994, R01AR040994, R01AR040994,
   R01AR040994, R01AR040994, R01AR040994, R01AR040994, R01AR040994,
   R01AR040994] Funding Source: NIH RePORTER
CR Arumugam S, 2003, BIOCHEMISTRY-US, V42, P7950, DOI 10.1021/bi034545s
   Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548
   Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4
   Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334
   Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238
   Fox JW, 2005, TOXICON, V45, P969, DOI 10.1016/j.toxicon.2005.02.012
   Gallagher P, 2005, ARCH BIOCHEM BIOPHYS, V441, P1, DOI 10.1016/j.abb.2005.06.007
   Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157
   GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3
   Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200
   Lee MH, 2004, J BIOL CHEM, V279, P45121, DOI 10.1074/jbc.M406611200
   Lee MH, 2002, PROTEIN SCI, V11, P2493, DOI 10.1110/ps.0216202
   Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Maskos K, 2005, BIOCHIMIE, V87, P249, DOI 10.1016/j.biochi.2004.11.019
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   Troeberg L, 2002, BIOCHEMISTRY-US, V41, P15025, DOI 10.1021/bi026454l
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200
   ZHANG DC, 1994, P NATL ACAD SCI USA, V91, P8447, DOI 10.1073/pnas.91.18.8447
NR 32
TC 2
Z9 2
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 1
PY 2006
VL 347
IS 3
BP 641
EP 648
DI 10.1016/j.bbrc.2006.06.143
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 071GN
UT WOS:000239587200014
PM 16842758
DA 2020-11-24
ER

PT J
AU Assafim, M
   Ferreira, MS
   Frattani, FS
   Guimaraes, JA
   Monteiro, RQ
   Zingali, RB
AF Assafim, Mariane
   Ferreira, Marcos S.
   Frattani, Flavia S.
   Guimaraes, Jorge A.
   Monteiro, Robson Q.
   Zingali, Russolina B.
TI Counteracting effect of glycyrrhizin on the hemostatic abnormalities
   induced by Bothrops jararaca snake venom
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE glycyrrhizin; B. jararaca venom; venous thrombosis; antibothropic serum
ID THROMBIN INHIBITOR; BLOOD-COAGULATION; MECHANISM; PLANTS; ANTIVENOM;
   EXTRACTS; FAILURE; HEPARIN; SYSTEM
AB 1 Envenomation by the snake Bothrops jararaca is typically associated with hemostatic abnormalities including pro- and anticoagulant disturbances. Glycyrrhizin (GL) is a plant-derived thrombin inhibitor that also exhibits in vivo antithrombotic properties. Here, we evaluated the ability of GL to counteract the hemostatic abnormalities promoted by B. jararaca venom.
   2 GL inhibited the human fibrinogen clotting (IC50 = similar to 1.0 mg ml(-1); 1.2 mM), H-D-phenylalanyl-L-pipecolyl-L-arginine-p-nitroanilide dihydrochloride hydrolysis (IC50 = similar to 0.4 mg ml(-1); 0.47 mM) and platelet aggregation (IC50 = similar to 0.28 mg ml(-1); 0.33 mM) induced by B. jararaca venom, in vitro.
   3 The in vivo effect of GL was tested in rats using a model of venous thrombosis in which intravenous (i.v.) administration of B. jararaca venom (100 mu g kg(-1)) produced in all animals a thrombus with a mean weight of 10.6 +/- 1.7 mg.
   4 Prior administration of GL (180 mg kg(-1)) or antibothropic serum (27 mu l kg(-1)) inhibited thrombus formation by 86 and 67%, respectively. Remarkably, co-administration of ineffective doses of GL and antibothropic serum markedly decreased thrombus weight, suggesting a synergistic effect.
   5 Co-administration of GL with antibothropic serum abolished venom-induced bleeding. Ex vivo clotting times showed that rat plasma was non-clotting after i.v. administration of B. jararaca venom. Treatment with GL, antibothropic serum or both before venom administration efficiently prevented this abnormality.
   6 Altogether, we demonstrate here that GL prevents both in vitro and in vivo venom-induced changes in hemostasis, suggesting a potential antiophidic activity.
C1 Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrut, Ctr Ciencias Saude, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio Grande Sul, Ctr Biotecnol, BR-90000 Porto Alegre, RS, Brazil.
RP Zingali, RB (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrut, Ctr Ciencias Saude, Av Trompovski S-No,CCS Bloco H2sala 04,Cidade Uni, BR-21941590 Rio De Janeiro, Brazil.
EM lzingali@bioqmed.ufrj.br
RI Guimaraes, Jorge Almeida/V-2196-2019; de Queiroz Monteiro,
   Robson/M-7097-2019; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Zingali,
   Russolina/G-4862-2012
OI de Queiroz Monteiro, Robson/0000-0002-5260-2332; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR AHUJA ML, 1946, NATURE, V158, P878, DOI 10.1038/158878a0
   BURDMANN EA, 1993, AM J TROP MED HYG, V48, P82, DOI 10.4269/ajtmh.1993.48.82
   Cardoso JLC, 1990, MEM I BUTANTAN, V52, P43
   Castro HC, 2004, CELL MOL LIFE SCI, V61, P843, DOI 10.1007/s00018-003-3325-z
   Castro KNC, 2003, TOXICON, V41, P929, DOI 10.1016/S0041-0101(03)00087-4
   Fogden E, 2003, LIVER INT, V23, P213, DOI 10.1034/j.1600-0676.2003.00843.x
   Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p
   Heard K, 1999, DRUGS, V58, P5, DOI 10.2165/00003495-199958010-00002
   Herbert JM, 1996, CIRC RES, V79, P590, DOI 10.1161/01.RES.79.3.590
   HOUGHTON PJ, 1994, J ETHNOPHARMACOL, V44, P99, DOI 10.1016/0378-8741(94)90075-2
   HOUGHTON PJ, 1993, J ETHNOPHARMACOL, V39, P1, DOI 10.1016/0378-8741(93)90047-9
   KAMIGUTI AS, 1986, BRAZ J MED BIOL RES, V19, P199
   KAMIGUTI AS, 1991, TOXICON, V29, P961, DOI 10.1016/0041-0101(91)90079-7
   KRSTENANSKY JL, 1987, FEBS LETT, V211, P10, DOI 10.1016/0014-5793(87)81264-4
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   MARSH NA, 1994, BLOOD COAGUL FIBRIN, V5, P399
   MARTZ W, 1992, TOXICON, V30, P1131, DOI 10.1016/0041-0101(92)90429-9
   MARUYAMA M, 1990, THROMB HAEMOSTASIS, V63, P449
   Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735
   Mendes-Silva W, 2003, THROMB RES, V112, P93, DOI 10.1016/j.thromres.2003.10.014
   MORS WB, 1989, TOXICON, V27, P1003, DOI 10.1016/0041-0101(89)90151-7
   Mors WB, 2000, PHYTOCHEMISTRY, V55, P627, DOI 10.1016/S0031-9422(00)00229-6
   Mors WB, 1991, EC MED PLANT RES, V5, P353
   NAHAS L, 1975, TOXICON, V13, P457, DOI 10.1016/0041-0101(75)90175-0
   NAHAS L, 1979, THROMB HAEMOSTASIS, V41, P314
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   ONUAGULUCHI G, 1989, PHYTOTHER RES, V3, P11, DOI 10.1002/ptr.2650030104
   SANOMARTINS IS, 1995, BRAZ J MED BIOL RES, V28, P303
   STUBBS MT, 1995, TRENDS BIOCHEM SCI, V20, P23, DOI 10.1016/S0968-0004(00)88945-8
   THOMAS L, 1995, AM J TROP MED HYG, V52, P419, DOI 10.4269/ajtmh.1995.52.419
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 31
TC 11
Z9 12
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0007-1188
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PD JUL
PY 2006
VL 148
IS 6
BP 807
EP 813
DI 10.1038/sj.bjp.0706786
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 068PC
UT WOS:000239385900008
PM 16751793
OA Green Published
DA 2020-11-24
ER

PT J
AU da Costa, BEP
   Scocco, C
   de Figueiredo, CEP
   Guimaraes, JA
AF da Costa, BEP
   Scocco, C
   de Figueiredo, CEP
   Guimaraes, JA
TI Increased serum phosphodiesterase activity in women with pre-eclampsia
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
DE nitric oxide; phosphodiesterase; pre-eclampsia; pregnancy
ID L-ARGININE INFUSION; NITRIC-OXIDE; BLOOD-PRESSURE; PREGNANCY
AB Objective To measure the activity of serum phosphodiesterase (PDE) in pre-eclampsia.
   Design Case-control study.
   Setting Nephrology Laboratory and Obstetrics Unit at Sao Lucas Hospital from Pontificia Universidade Catolica do Rio Grande do Sul, Porto Alegre, Brazil.
   Sample Twenty-nine normal and 28 pregnant women with pre-eclampsia.
   Methods Serum was collected from women with pre-eclampsia, at the time of diagnosis, and from gestation-matched controls. Circulating PDE activity was assessed by measuring consumption of the substrate thymidine 5'-monophosphate p-nitrophenyl ester and expressed as PDE units/l.
   Main outcome measures Serum PDE Activity.
   Results Mean substrate consumption was higher in pre-eclamptic condition (V-max= 15.8 +/- 1.4 versus 12.7 +/- 0.9 U/L, P= 3.7 x 10(-14)).
   Conclusion These data suggest that altered PDE activity may play a role in pre-eclampsia endothelial dysfunction.
C1 Pontificia Univ Catolica Rio Grande do Sul, IPB, Lab Nefrol,Programa Posgrad Med & Ciencias Saude, HSL,Fac Med, BR-90610000 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Programa Posgrad Biol Celular & Mol, Ctr Biotecnol Rio Grande Sul, Porto Alegre, RS, Brazil.
RP da Costa, BEP (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, IPB, Lab Nefrol,Programa Posgrad Med & Ciencias Saude, HSL,Fac Med, Av Ipiranga,6690, BR-90610000 Porto Alegre, RS, Brazil.
EM bart@pucrs.br
RI de Figueiredo, Carlos E Poli/A-2027-2013; da Costa, Bartira E
   Pinheiro/E-4183-2013
OI de Figueiredo, Carlos E Poli/0000-0002-7333-8884; da Costa, Bartira E
   Pinheiro/0000-0001-8015-3952; Guimaraes, Jorge A./0000-0001-6354-6789
CR Alexander BT, 2004, HYPERTENSION, V43, P832, DOI 10.1161/01.HYP.0000119192.32360.a9
   Conrad KP, 1999, AM J PHYSIOL-RENAL, V277, pF48
   Downing JW, 2004, MED HYPOTHESES, V63, P1057, DOI 10.1016/j.mehy.2004.03.042
   Facchinetti F, 1999, J SOC GYNECOL INVEST, V6, P202, DOI 10.1016/S1071-5576(99)00017-9
   Germain AM, 2004, HYPERTENSION, V44, pE1, DOI 10.1161/01.HYP.0000129825.52269.9e
   Grunewald C, 1998, GYNECOL OBSTET INVES, V46, P232, DOI 10.1159/000010040
   ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O
   Schneider F, 1996, ACTA OBSTET GYN SCAN, V75, P40, DOI 10.3109/00016349609033281
   Teran E, 2004, HYPERTENS PREGNANCY, V23, P303, DOI 10.1081/PRG-200030860
   Wareing M, 2005, J CLIN ENDOCR METAB, V90, P2550, DOI 10.1210/jc.2004-1831
   Wareing M, 2004, AM J OBSTET GYNECOL, V190, P1283, DOI 10.1016/j.ajog.2003.12.024
   Yamamoto T, 2005, AM J OBSTET GYNECOL, V192, P558, DOI 10.1016/j.ajog.2004.08.031
NR 12
TC 16
Z9 16
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD MAY
PY 2006
VL 113
IS 5
BP 577
EP 579
DI 10.1111/j.1471-0528.2006.00916.x
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 035OV
UT WOS:000237012100012
PM 16637900
OA Bronze
DA 2020-11-24
ER

PT J
AU Bugalho, P
   Guimaraes, J
AF Bugalho, P.
   Guimaraes, J.
TI Gait disturbance in normal pressure hydrocephalus: A clinical study
SO MOVEMENT DISORDERS
LA English
DT Meeting Abstract
CT 10th International Congress of Parkinson's Disease and Movement
   Disorders
CY OCT 30-NOV 02, 2006
CL Kyoto, JAPAN
RI Bugalho, Paulo/H-7317-2019
OI Bugalho, Paulo/0000-0003-2186-9541
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0885-3185
J9 MOVEMENT DISORD
JI Mov. Disord.
PY 2006
VL 21
SU 15
MA P410
BP S440
EP S440
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 091WC
UT WOS:000241058000409
DA 2020-11-24
ER

PT J
AU Bugalho, P
   Correa, B
   Guimaraes, J
   Xavier, M
AF Bugalho, P.
   Correa, B.
   Guimaraes, J.
   Xavier, M.
TI Obsessive compulsive symptoms and executive dysfunction in primary
   dystonia
SO MOVEMENT DISORDERS
LA English
DT Meeting Abstract
CT 10th International Congress of Parkinson's Disease and Movement
   Disorders
CY OCT 30-NOV 02, 2006
CL Kyoto, JAPAN
RI Bugalho, Paulo/H-7317-2019
OI Bugalho, Paulo/0000-0003-2186-9541
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0885-3185
J9 MOVEMENT DISORD
JI Mov. Disord.
PY 2006
VL 21
SU 15
MA P221
BP S390
EP S390
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 091WC
UT WOS:000241058000220
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Silva, KRLM
   Guimaraes, JA
AF Pinto, AFM
   Silva, KRLM
   Guimaraes, JA
TI Proteases from Lonomia obliqua venomous secretions: Comparison of
   procoagulant, fibrin(ogen)olytic and amidolytic activities
SO TOXICON
LA English
DT Article
DE Lonomia obliqua; coagulation; fibrinolysis; hemostasis; bleeding
   disorder
ID ACHELOUS CATERPILLAR VENOM; HEMORRHAGIC SYNDROME;
   BIOCHEMICAL-CHARACTERIZATION; BLOOD-COAGULATION; SERINE-PROTEASE;
   FACTOR-XIII; PROTHROMBIN; PURIFICATION; ACTIVATION; PROTEINS
AB The hemorrhagic syndrome caused by Lonomia obliqua caterpillars is an increasing problem in Southern Brazil. The clinical profile is characterized by both hemorrhagic and pro-coagulant symptoms, constituting a paradoxical action of the venom. The effects upon blood coagulation and fibrin(ogen)olysis have been shown to result from the combined action of several active principles found mostly in the bristle extract. The present study reports quali-quantitative differences among L. obliqua secretions: Cryosecretion, hemolymph, bristle extract and tegument extract. Cryosecretion and hemolymph displayed strong amidolytic activity upon several substrates, presented moderated procoagulant activity and high fibrinogen degrading ability. Bristle and tegument extracts presented low amidolytic activity, but bristle extract showed the most potent procoagulant activity and both extracts presented low fibrinogen degrading ability. The differential involvement of these secretions during the accidents with L. obliqua can elucidate the different symptoms presented after envenomation. (C) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande Sul, Ctr Biotecnol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Pinto,
   Antonio/0000-0002-1573-8011
CR ABELLA HB, 1998, MANUAL DIAGNOSTICO T
   AROCHAPINANGO CL, 1969, LANCET, V1, P810
   AROCHAPINANGO CL, 1992, THROMB HAEMOSTASIS, V67, P402
   Couppie P, 1998, ANN DERMATOL VENER, V125, P489
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   DATTA G, 1995, ARCH BIOCHEM BIOPHYS, V317, P365, DOI 10.1006/abbi.1995.1176
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Fritzen M, 2003, THROMB RES, V112, P105, DOI 10.1016/j.thromres.2003.11.005
   Guerrero B, 1999, THROMB RES, V93, P243, DOI 10.1016/S0049-3848(98)00169-8
   Guerrero BAG, 1997, THROMB RES, V87, P83, DOI 10.1016/S0049-3848(97)00107-2
   Guerrero BAG, 1997, THROMB RES, V87, P171, DOI 10.1016/S0049-3848(97)00117-5
   Hougie C, 1963, FUNDAMENTALS BLOOD C, P25
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   NETO HF, 1985, 20 C SOC BRAS MED TR, P24
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   PINTO AFM, 2000, TOXINS ANIMALSS PLAN, P178
   Reis CV, 2001, THROMB RES, V102, P427, DOI 10.1016/S0049-3848(01)00265-1
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   Seibert CS, 2003, TOXICON, V41, P831, DOI 10.1016/S0041-0101(03)00040-0
   Veiga ABG, 2005, GENE, V355, P11, DOI 10.1016/j.gene.2005.05.002
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   VONIHERING R, 1914, ANN PAULISTAS MED CI, V3, P129
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 27
TC 21
Z9 23
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JAN
PY 2006
VL 47
IS 1
BP 113
EP 121
DI 10.1016/j.toxicon.2005.10.004
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 013AE
UT WOS:000235381200013
PM 16360724
DA 2020-11-24
ER

PT J
AU Verli, H
   Guimaraes, JA
AF Verli, H
   Guimaraes, JA
TI Insights into the induced fit mechanism in antithrombin-heparin
   interaction using molecular dynamics simulations
SO JOURNAL OF MOLECULAR GRAPHICS & MODELLING
LA English
DT Article
DE carbohydrate; molecular dynamics; serpin; antithrombin; synthetic
   pentasaccharide; heparin; induced fit
ID CRYSTAL-STRUCTURE; REACTIVE CENTER; CONFORMATIONAL-CHANGE; ANGSTROM
   RESOLUTION; AQUEOUS-SOLUTION; BINDING; PENTASACCHARIDE; ACTIVATION;
   PROGRAM; ALPHA(1)-ANTITRYPSIN
AB Heparin was isolated in the beginning of the 20th century and until today remains as one of the most important drugs able to interfere with the haemostatic process. Due to the side effects produced by heparin therapy, new promising drugs have been developed, as the synthetic pentasaccharide (synthetically derived from the sequence GlcN-GlcA-GlcN-IdoA-GlcN). The anticoagulant activity of this compound is based on potentiation of antithrombin (AT) inhibitory activity upon serine protemases of clotting cascade, a mechanism based on the conformational modification of AT. In this context, we present here a molecular dynamics (MD) study of the interaction between the synthetic pentasaccharide and AT. The obtained data correctly predicted an induced fit mechanism in AT-pentasaccharide interaction, showing a solvent-exposed P1 residue instead of a hided conformation. Also, the specific contribution of important amino acid residues to the overall process was also characterized, both in S-2(0) and C-1(4) conformations of IdoA residue, suggesting that there is no conformational requirement to the interaction of this residue with AT. Altogether, the results show that MD simulations could be used to characterize and quantify the interaction of synthetic compounds with AT, predicting its specific capacity to induce conformational changes in AT structure. Thus, MD simulations of heparin (and heparin-derived)-AT interactions are proposed here as a powerful tool to assist and support drug design of new antithrombotic agents. (C) 2005 Elsevier Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91500970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,CP 15005, BR-91500970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
CR Arocas V, 1999, BIOCHEMISTRY-US, V38, P10196, DOI 10.1021/bi990686b
   Arocas V, 2001, J BIOL CHEM, V276, P43809, DOI 10.1074/jbc.M105294200
   Becker CF, 2005, CARBOHYD RES, V340, P1499, DOI 10.1016/j.carres.2005.03.018
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   Desai U, 2000, J BIOL CHEM, V275, P18976, DOI 10.1074/jbc.M001340200
   DEWITTE RS, 1994, PROTEIN SCI, V3, P1570, DOI 10.1002/pro.5560030922
   Elliott PR, 1996, NAT STRUCT BIOL, V3, P676, DOI 10.1038/nsb0896-676
   Futamura A, 2001, BIOCHEMISTRY-US, V40, P6680, DOI 10.1021/bi0029346
   Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Harrop SJ, 1999, STRUCTURE, V7, P43, DOI 10.1016/S0969-2126(99)80008-2
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   Hirsh J, 2003, THROMB RES, V109, pS1, DOI 10.1016/S0049-3848(03)00250-0
   HIRST JD, 1994, J MOL BIOL, V243, P173, DOI 10.1006/jmbi.1994.1644
   Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j
   *IUPAC IUB COMM BI, 1970, J MOL BIOL, V52, P1
   Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0
   Kim SJ, 2001, J MOL BIOL, V306, P109, DOI 10.1006/jmbi.2000.4357
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kridel SJ, 1997, J BIOL CHEM, V272, P7656, DOI 10.1074/jbc.272.12.7656
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811
   LIN PH, 2001, BIOCHIM BIOPHYS ACTA, V1562, P105
   Melo FR, 2004, J BIOL CHEM, V279, P20824, DOI 10.1074/jbc.M308688200
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   Nader HB, 2001, BRAZ J MED BIOL RES, V34, P699, DOI 10.1590/S0100-879X2001000600002
   OLSON ST, 1992, J BIOL CHEM, V267, P12528
   SCHAFTENAAR G, 1997, MOLDEN
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Schedin-Weiss S, 2002, BIOCHEMISTRY-US, V41, P4779, DOI 10.1021/bi012163l
   SILVA ME, 1975, J BIOL CHEM, V250, P6841
   Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598
   Skinner R, 1997, J MOL BIOL, V266, P601, DOI 10.1006/jmbi.1996.0798
   STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0
   vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047
   VANBOECKEL CAA, 1994, NAT STRUCT BIOL, V1, P423, DOI 10.1038/nsb0794-423
   VANDERSPOEL D, 2004, GROMACS USER MANUAL
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
NR 49
TC 38
Z9 38
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1093-3263
EI 1873-4243
J9 J MOL GRAPH MODEL
JI J. Mol. Graph.
PD DEC
PY 2005
VL 24
IS 3
BP 203
EP 212
DI 10.1016/j.jmgm.2005.07.002
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Crystallography; Mathematical &
   Computational Biology
SC Biochemistry & Molecular Biology; Computer Science; Crystallography;
   Mathematical & Computational Biology
GA 985TZ
UT WOS:000233402900005
PM 16146701
DA 2020-11-24
ER

PT J
AU Faco, PE
   Bezerra, GP
   Barbosa, PSF
   Martins, AMC
   Guimaraes, JA
   Ferreira, ML
   Monteiro, HSA
AF Faco, PE
   Bezerra, GP
   Barbosa, PSF
   Martins, AMC
   Guimaraes, JA
   Ferreira, ML
   Monteiro, HSA
TI Epidemiology of the injuries caused by Thalassophryne nattereri (niquim)
   in Ceara State (1992-2002)
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA Portuguese
DT Article
DE Thalassophryne nattereri; epidemiology; niquim; accident.
ID FISH VENOM; NEUTRALIZATION
AB In Ceara State (1992 to 2002) 16 cases of envenomation by Thalassophyne nattered occurred in the seaside of Ceara, 87.5% of cases in the region of Fortaleza and 12.5% in the interior of Ceara State. Ninety four percent were men and 6% women. Age range: 75% between 21 and 40 years and 19% between 41 and 60 years old. The time between medical assistance and the accident varied from 1 to 5 hours (4 cases), 6 to 12 hours (3 cases), over 12 hours in 4 cases and 5 patients did not know Clinical manifestations observed were pain, local edema, transitory ischemia, paresthesia, ecchymosis and burned skin sensation. Anti inflammatory and analgesic drugs were used. In some cases, anesthetic, hot water, surgical peeling and anti-histaminic drugs were used. In 75% of cases cure was confirmed and in 12% cure was not confirmed. The number of accidents is probably higher than was found due to subnotification.
C1 UFC, FM, Dept Fisiol & Farmacol, BR-60430270 Fortaleza, Ceara, Brazil.
   Univ Fed Ceara, Dept Anal Clin & Toxicol, Fortaleza, Ceara, Brazil.
   Inst Butantan, Lab Imunopatol, Sao Paulo, Brazil.
   Ctr Assistencia Toxicol Ceara, Fortaleza, Ceara, Brazil.
RP Monteiro, HSA (corresponding author), UFC, FM, Dept Fisiol & Farmacol, Rua Cel Nunes Melo 1127, BR-60430270 Fortaleza, Ceara, Brazil.
EM martinsalice@gmail.com; serrazul@baydenet.com.br
RI Martins, Alice Maria Costa/AAX-3093-2020
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR AUTO HF, 1992, REV ESC CIENCIAS MED, V5, P35
   COLLETTE BB, 1966, COPEIA, P846
   Faco PEG, 2003, TOXICON, V42, P509, DOI 10.1016/S0041-0101(03)00229-0
   FACO PEG, 2003, THESIS U FEDERAL CEA
   FROES HP, 1933, BAHIA MED, V4, P225
   Froes HP, 1932, REV SUD AM MED CHIR, V3, P871
   Haddad Junior Vidal, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P221, DOI 10.1590/S0036-46652003000400009
   Lima C, 2003, TOXICON, V42, P499, DOI 10.1016/S0041-0101(03)00228-9
   Lopes-Ferreira M, 2004, BIOCHEM PHARMACOL, V68, P2151, DOI 10.1016/j.bcp.2004.07.037
   Lopes-Ferreira M, 1998, TOXICON, V36, P405, DOI 10.1016/S0041-0101(97)00115-3
   Lopes-Ferreira M, 2000, TOXICON, V38, P1149, DOI 10.1016/S0041-0101(99)00211-1
   LOPESFERREIRA M, 2000, THESIS U SAO PAULO S
   Maretic Z., 1988, P445
   WALLACE LB, 1893, J MORPHOL, V8, P563
NR 14
TC 9
Z9 10
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2005
VL 38
IS 6
BP 479
EP 482
DI 10.1590/S0037-86822005000600006
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA 000KU
UT WOS:000234461500006
PM 16410922
OA DOAJ Gold
DA 2020-11-24
ER

PT J
AU Veiga, ABG
   Ribeiro, JMC
   Guimaraes, JA
   Francischetti, IMB
AF Veiga, ABG
   Ribeiro, JMC
   Guimaraes, JA
   Francischetti, IMB
TI A catalog for the transcripts from the venomous structures of the
   caterpillar Lonomia obliqua: Identification of the proteins potentially
   involved in the coagulation disorder and hemorrhagic syndrome
SO GENE
LA English
DT Article
DE caterpillar venom; coagulation; fibrinolysis; hemorrhage; toxins
ID BLOOD-COAGULATION; FIBRIN FORMATION; SIALOME; ENVENOMATION; PROTEOLYSIS;
   CONTACT; INSECT; GLAND; CDNA
AB Accidents with the caterpillar Lonomia obliqua are often associated with a coagulation disorder and hemorrhagic syndrome in humans. In the present study, we have constructed cDNA libraries from two venomous structures of the caterpillar, namely the tegument and the bristle. High-throughput sequencing and bioinformatics analyses were performed in parallel. Over one thousand cDNAs were obtained and clustered to produce a database of 538 contigs and singletons (clusters) for the tegument library and 368 for the bristle library. We have thus identified dozens of full-length cDNAs coding for proteins with sequence homology to snake venom prothrombin activator, trypsin-like enzymes, blood coagulation factors and prophenoloxidase cascade activators. We also report cDNA coding for cysteine proteases, Group III phospholipase A2, C-type lectins, lipocalins, in addition to protease inhibitors including serpins, Kazal-type inhibitors, cystatins and trypsin inhibitor-like molecules. Antibacterial proteins and housekeeping genes are also described. A significant number of sequences were devoid of database matches, suggesting that their biologic function remains to be defined. We also report the N-terminus of the most abundant proteins present in the bristle, tegument, hemolymph, and "cryosecretion". Thus, we have created a catalog that contains the predicted molecular weight, isoetectric point, accession number, and putative function for each selected molecule from the venomous structures of L. obliqua. The role of these molecules in the coagulation disorder and hemorrhagic syndrome caused by envenomation with this caterpillar is discussed. All sequence information and the Supplemental Data, including figures and tables with hyperlinks to FASTA-formatted files for each contig and the best match to the databases, are available at http://www.ncbi.nih.gov/projects/omes. (c) 2005 Elsevier B.V. All rights reserved.
C1 NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-43421 Porto Alegre, RS, Brazil.
RP Francischetti, IMB (corresponding author), NIAID, Vector Biol Sect, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkway,Twinbrook 3,Room 2E-28, Bethesda, MD 20892 USA.
EM ifrancischetti@niaid.nih.gov
RI Veiga, Ana B. G./N-8581-2013; Guimaraes, Jorge Almeida/V-2196-2019
OI Veiga, Ana B. G./0000-0003-1462-5506; Guimaraes, Jorge
   A./0000-0001-6354-6789; Ribeiro, Jose/0000-0002-9107-0818
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [Z99 AI999999, Z01
   AI000810-11] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND
   INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [Z01AI000810, Z01AI000810,
   Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810,
   Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810, Z01AI000810] Funding
   Source: NIH RePORTER
CR Aird SD, 2002, TOXICON, V40, P335, DOI 10.1016/S0041-0101(01)00232-X
   Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0
   AMARANT T, 1991, BIOCHIM BIOPHYS ACTA, V1079, P214, DOI 10.1016/0167-4838(91)90128-M
   Arocha-Pinango CL, 2001, HAEMOSTASIS, V31, P288
   Bell WR, 1997, DRUGS, V54, P18, DOI 10.2165/00003495-199700543-00005
   Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0
   Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052
   Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63
   Dempfle CE, 2000, BLOOD, V96, P2793
   Dempfle CE, 2001, ANN NY ACAD SCI, V936, P210
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   Fox JW, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P97
   Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024
   Francischetti IMB, 2002, J EXP BIOL, V205, P2429
   FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216
   Harrison RA, 2003, GENE, V315, P95, DOI 10.1016/S0378-1119(03)00716-9
   Harrison RA, 2003, TOXICON, V41, P441, DOI 10.1016/S0041-0101(02)00360-4
   Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631
   Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x
   Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, P283, DOI 10.3109/15569549509019465
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0
   LARSON PJ, 1998, THROMBOSIS HEMORRHAG, P29
   Lopes-Ferreira M, 1998, TOXICON, V36, P405, DOI 10.1016/S0041-0101(97)00115-3
   Lopez-Ordonez T, 2001, INSECT MOL BIOL, V10, P505, DOI 10.1046/j.0962-1075.2001.00290.x
   Markland FS, 1997, DRUGS, V54, P1, DOI 10.2165/00003495-199700543-00003
   MARKLAND FS, 1982, P NATL ACAD SCI-BIOL, V79, P1688, DOI 10.1073/pnas.79.6.1688
   Murakami M, 2003, J BIOL CHEM, V278, P10657, DOI 10.1074/jbc.M211325200
   Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1
   Pinto AFM, 2004, THROMB RES, V113, P147, DOI 10.1016/j.thromres.2004.01.012
   Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P61, DOI 10.1016/j.ibmb.2003.09.004
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0
   Seibert CS, 2004, TOXICON, V44, P793, DOI 10.1016/j.toxicon.2004.08.019
   Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   WILLIAMS E, 1998, THROMBOSIS HEMORRHAG, P963
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
NR 41
TC 66
Z9 80
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD AUG 1
PY 2005
VL 355
BP 11
EP 27
DI 10.1016/j.gene.2005.05.002
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA 960WU
UT WOS:000231624700002
PM 16023793
OA Green Accepted
DA 2020-11-24
ER

PT J
AU Becker, CF
   Guimaraes, JA
   Verli, H
AF Becker, CF
   Guimaraes, JA
   Verli, H
TI Molecular dynamics and atomic charge calculations in the study of
   heparin conformation in aqueous solution
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE heparin; molecular dynamics; polysaccharide structure; GROMACS; Lowdin
   charges; NMR refinement
ID NMR SOLUTION CONFORMATION; COUPLING-CONSTANTS; OLIGOSACCHARIDES;
   SIMULATION
AB HF/6-31G** and molecular dynamics (MD) simulations were used to evaluate the performance of different atomic charge basis sets (i.e., Mulliken, Lowdin, and Electrostatic Potential Derived Charges - ESP) in heparin simulations. HF/3-21G calculations were also used to study the NMR conformation of the IdoA residue. The results thus obtained indicated that ESP and Lowdin charges gave the better results in heparin simulations, followed by Mulliken charges, and that the minimum-energy conformation of IdoA can be different from that observed by NMR spectroscopy by less than 1 angstrom. However, it was found that this small conformational modification is capable of inducing a change of almost 200 kJ/mol in the interactions of heparin with the surrounding environment, which is a meaningful amount of energy in the context of ligand-receptor interactions. This information can be potentially of great relevance in the design of heparin-derived antithrombotic compounds. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91500970 Porto Alegre, RS, Brazil.
RP Verli, H (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Av Bento Goncalves 9500,CP 15005, BR-91500970 Porto Alegre, RS, Brazil.
EM hverli@cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
CR BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   BRUYN A, 1991, J CARBOHYD CHEM, V10, P159
   Clare BW, 1998, THEOCHEM-J MOL STRUC, V428, P109, DOI 10.1016/S0166-1280(97)00265-0
   CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011
   CREMER D, 1995, CONFORMATIONAL BEHAV, P71
   CUMMING DA, 1987, BIOCHEMISTRY-US, V26, P6664, DOI 10.1021/bi00395a016
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116
   FERRO DR, 1986, J AM CHEM SOC, V108, P6773, DOI 10.1021/ja00281a052
   Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+
   HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4
   Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j
   *IUPAC IUB COMM BI, 1970, J MOL BIOL, V52, P1
   KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0
   LEACH AR, 2001, MOL MODELING PRINCIP, P79
   LINKER A, 1984, CARBOHYD RES, V127, P75, DOI 10.1016/0008-6215(84)85107-1
   Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0
   Markley John L, 2003, Methods Biochem Anal, V44, P89
   Mikhailov D, 1996, BIOCHEM J, V318, P93, DOI 10.1042/bj3180093
   Mikhailov D, 1997, BIOCHEM J, V328, P51, DOI 10.1042/bj3280051
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   Nader HB, 2001, BRAZ J MED BIOL RES, V34, P699, DOI 10.1590/S0100-879X2001000600002
   Nieduszynski I. A., 1977, ACS SYM SER, V48, P73
   Perez S, 1998, CARBOHYD RES, V314, P141, DOI 10.1016/S0008-6215(98)00305-X
   Peters T, 1996, CURR OPIN STRUC BIOL, V6, P710, DOI 10.1016/S0959-440X(96)80039-X
   RAGAZZI M, 1990, CARBOHYD RES, V195, P169, DOI 10.1016/0008-6215(90)84165-Q
   RAGAZZI M, 1986, J COMPUT CHEM, V7, P105, DOI 10.1002/jcc.540070203
   SCHAFTENAAR G, 1997, MOLDEN
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   SILVA ME, 1975, J BIOL CHEM, V250, P6841
   TVAROSKA I, 1989, CARBOHYD RES, V189, P359, DOI 10.1016/0008-6215(89)84112-6
   VANDERSPOEL D, 2001, GROMACS USER MANUAL
   VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921
   Verli H, 2004, CARBOHYD RES, V339, P281, DOI 10.1016/j.carres.2003.09.026
   Woods RJ, 1998, EUR J BIOCHEM, V258, P372, DOI 10.1046/j.1432-1327.1998.2580372.x
NR 38
TC 39
Z9 39
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
EI 1873-426X
J9 CARBOHYD RES
JI Carbohydr. Res.
PD JUN 13
PY 2005
VL 340
IS 8
BP 1499
EP 1507
DI 10.1016/j.carres.2005.03.018
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 934CM
UT WOS:000229684500007
PM 15882850
DA 2020-11-24
ER

PT J
AU Calazans, A
   Brindeiro, R
   Brindeiro, P
   Verli, H
   Arruda, MB
   Gonzalez, LMF
   Guimaraes, JA
   Diaz, RS
   Antunes, OAC
   Tanuri, A
AF Calazans, A
   Brindeiro, R
   Brindeiro, P
   Verli, H
   Arruda, MB
   Gonzalez, LMF
   Guimaraes, JA
   Diaz, RS
   Antunes, OAC
   Tanuri, A
TI Low accumulation of L90M in protease from subtype FHIV-1 with resistance
   to protease inhibitors is caused by the L89M polymorphism
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID DRUG-RESISTANCE; HIV-1 PROTEASE; REVERSE-TRANSCRIPTASE; PHENOTYPIC
   RESISTANCE; NUCLEOSIDE ANALOGS; MUTATION PATTERNS; IN-VIVO;
   ANTIRETROVIRAL THERAPY; RELATIVE FITNESS; TYPE-1 SUBTYPES
AB Background. This work evaluates the role of subtype F human immunodeficiency virus type 1 (HIV-1) protease ( PR) substitutions L89M and L90M in viral replication and resistance to PR inhibitors (PIs).
   Methods. Subtype B and F PR genes were subjected to site-directed mutagenesis, to create and reverse the methionine at positions 89 and 90. Viruses were re-created in cell culture, and their replicative capacity was assessed by fitness assay. Generated viruses were also phenotyped for PI resistance.
   Results. The subtype F clone (89M90L) showed a replicative capacity comparable to that of the PI-susceptible subtype B clone (89L90L) and was more fit than the L89M mutated subtype B clone ( 89M90L). Both 89M90M subtype B and F clones presented the lowest fitness s values. The L89M mutation impacted phenotypic resistance to all PIs in half of the subtype F isolates but not in the subtype B isolates. Subtype F isolates presented a phenotypic profile similar to that of subtype B isolates when the M89L mutation was introduced.
   Conclusion. The L89M mutation in subtype F viruses is a high genetic barrier to the accumulation of the L90M resistance mutation and can function as a resistance mutation, depending on the presence of other polymorphisms in the subtype F PR backbone.
C1 Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Inst Biol, BR-21944970 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Chem, Dept Inorgan Chem, BR-21944970 Rio De Janeiro, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil.
   Univ Fed Sao Paulo, Retrovirol Lab, Sao Paulo, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Mol Virol Lab, Inst Biol, CCS Bloco A,Cidade Univ, BR-21944970 Rio De Janeiro, Brazil.
EM atanuri@biologia.ufrj.br
RI Verli, Hugo/G-8703-2012; Diaz, Ricardo/K-3978-2012
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
CR Abecasis A, 2003, ANTIVIR THER, V8, pU121
   ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986
   Boden D, 1998, ANTIMICROB AGENTS CH, V42, P2775, DOI 10.1128/AAC.42.11.2775
   Brindeiro PA, 2002, J CLIN MICROBIOL, V40, P4512, DOI 10.1128/JCM.40.12.4512-4519.2002
   Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016
   Caride E, 2001, VIRUS GENES, V23, P193, DOI 10.1023/A:1011812810397
   Caride E, 2002, J CLIN VIROL, V23, P179, DOI 10.1016/S1386-6532(01)00218-9
   Carpenter CCJ, 1996, JAMA-J AM MED ASSOC, V276, P146, DOI 10.1001/jama.276.2.146
   Condra JH, 1996, J VIROL, V70, P8270, DOI 10.1128/JVI.70.12.8270-8276.1996
   CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0
   Fleury H, 2003, AIDS RES HUM RETROV, V19, P41, DOI 10.1089/08892220360473952
   Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35
   Haas DW, 2003, AIDS, V17, P1339, DOI 10.1097/00002030-200306130-00008
   Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101
   Harrigan PR, 2001, AIDS, V15, P1671, DOI 10.1097/00002030-200109070-00010
   Hertogs K, 1998, ANTIMICROB AGENTS CH, V42, P269, DOI 10.1093/jac/42.2.269
   Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417
   HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255
   HOLLAND JJ, 1991, J VIROL, V65, P2960, DOI 10.1128/JVI.65.6.2960-2967.1991
   Iversen AKN, 1996, J VIROL, V70, P1086, DOI 10.1128/JVI.70.2.1086-1090.1996
   Ives KJ, 1997, J ANTIMICROB CHEMOTH, V39, P771, DOI 10.1093/jac/39.6.771
   Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098
   Kantor R, 2002, ANTIMICROB AGENTS CH, V46, P1086, DOI 10.1128/AAC.46.4.1086-1092.2002
   Kantor R, 2001, NUCLEIC ACIDS RES, V29, P296, DOI 10.1093/nar/29.1.296
   Kantor Rami, 2003, AIDS Reviews, V5, P25
   Kijak G H, 2003, HIV Med, V4, P72, DOI 10.1046/j.1468-1293.2003.00131.x
   Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709
   Maree AFM, 2000, J VIROL, V74, P11067, DOI 10.1128/JVI.74.23.11067-11072.2000
   Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999
   MASCHERA B, 1995, J VIROL, V69, P5431, DOI 10.1128/JVI.69.9.5431-5436.1995
   Molla A, 1996, NAT MED, V2, P760, DOI 10.1038/nm0796-760
   MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569
   Muzammil S, 2003, BIOCHEMISTRY-US, V42, P631, DOI 10.1021/bi027019u
   Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006
   Patick AK, 1998, ANTIMICROB AGENTS CH, V42, P2637, DOI 10.1128/AAC.42.10.2637
   Pieniazek D, 2000, AIDS, V14, P1489, DOI 10.1097/00002030-200007280-00004
   Piliero PJ, 2002, EXPERT OPIN INV DRUG, V11, P1295, DOI 10.1517/13543784.11.9.1295
   Pillay D, 2002, J INFECT DIS, V186, P617, DOI 10.1086/342680
   Rose RB, 1998, BIOCHEMISTRY-US, V37, P2607, DOI 10.1021/bi9716074
   Ruiz L, 1998, J ACQ IMMUN DEF SYND, V19, P19, DOI 10.1097/00042560-199809010-00003
   Sanne I, 2003, JAIDS-J ACQ IMM DEF, V32, P18, DOI 10.1097/00126334-200301010-00004
   Schmidt B, 2000, AIDS, V14, P1731, DOI 10.1097/00002030-200008180-00007
   Schmidt Barbara, 2002, AIDS Reviews, V4, P148
   Schmit JC, 1996, J INFECT DIS, V174, P962, DOI 10.1093/infdis/174.5.962
   Scott WRP, 2000, STRUCTURE, V8, P1259, DOI 10.1016/S0969-2126(00)00537-2
   Shafer RW, 1999, J VIROL, V73, P6197, DOI 10.1128/JVI.73.7.6197-6202.1999
   Tanuri A, 1999, ANTIMICROB AGENTS CH, V43, P253, DOI 10.1093/jac/43.2.253
   Van Laethem K, 2002, ANTIVIR THER, V7, P123
   Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003
   Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707
   Zhang YM, 1997, J VIROL, V71, P6662, DOI 10.1128/JVI.71.9.6662-6670.1997
NR 51
TC 45
Z9 48
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2005
VL 191
IS 11
BP 1961
EP 1970
DI 10.1086/430002
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 923AN
UT WOS:000228881100024
PM 15871131
OA Bronze, Green Published
DA 2020-11-24
ER

PT S
AU Pazzini, F
   Oliveira, F
   Guimaraes, JA
   de Amorim, HLN
AF Pazzini, F
   Oliveira, F
   Guimaraes, JA
   de Amorim, HLN
BE Setubal, JC
   VerjovskiAlmeida, S
TI Prediction of myotoxic and neurotoxic activities in Phospholipases A2
   from primary sequence analysis
SO ADVANCES IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, PROCEEDINGS
SE Lecture Notes in Computer Science
LA English
DT Article; Proceedings Paper
CT Brazilian Symposium on Bioinformatics (BSB 2005)
CY JUL 27-29, 2005
CL Univ Vale do Rio dos Sinos, Sao Leopoldo, BRAZIL
HO Univ Vale do Rio dos Sinos
ID HIDDEN MARKOV-MODELS; PROTEIN FAMILIES
AB We developed a methodology to predict myotoxicity and neurotoxicity of proteins of the family of Phospholipases A2 (PLA2) from sequence data. Combining two bioinformatics tools, MEME and HMMER, it was possible to detect conserved motifs and represent them as Hidden Markov Models (HMMs). In ten-fold cross validation testing we have determined the efficacy of each motif on prediction of PLA2 function. We selected motifs whose efficacy in predict function were above 60% at the Minimum Error Point (MEP), the score in which there are fewest both false positives and false negatives. Combining HMMs of the best motifs for each function, we have achieved a mean efficacy of 98 +/- 4% on prediction of myotoxic function and 77.4 +/- 4.8% on prediction of neurotoxicity. We have used the results of this work to build a web tool (available at www.cbiot.ufrgs.br/bioinfo/phospholipase) to classify PLA2s of unknown function regarding myotoxic or neurotoxic activity.
C1 Univ Fed Rio Grande Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
   Lutheran Univ Brazil, Dept Chem, BR-92420280 Porto Alegre, RS, Brazil.
RP Pazzini, F (corresponding author), Univ Fed Rio Grande Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
EM fabianopasin@cbiot.ufrgs.br
RI Amorim, Hermes/E-4072-2013
OI de Amorim, Hermes/0000-0001-8362-078X; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR BAILEY TL, 1994, P 2 INT C INT SYST M, P28
   Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Grundy WN, 1997, COMPUT APPL BIOSCI, V13, P397
   HAUSSLER D, 1996, CABIOS, V12, P327
   Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002
   McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435
   Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265
NR 8
TC 1
Z9 1
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
EI 1611-3349
BN 3-540-28008-1
J9 LECT NOTES COMPUT SC
PY 2005
VL 3594
BP 194
EP 197
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology; Computer
   Science, Interdisciplinary Applications; Computer Science, Theory &
   Methods
SC Biochemistry & Molecular Biology; Computer Science
GA BCT87
UT WOS:000231193100021
DA 2020-11-24
ER

PT J
AU Russo, C
   de Amorim, HLN
   Guimaraes, JA
AF Russo, C
   de Amorim, HLN
   Guimaraes, JA
TI Modeling and docking of factor IXa and an anticoagulant peptide
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 49th Annual Meeting of the Biopysical-Society
CY FEB 12-16, 2005
CL Long Beach, CA
SP Biopys Soc
C1 Florida State Univ, Tallahassee, FL 32306 USA.
   Univ Fed Rio Grande Sul, Porto Alegre, RS, Brazil.
   ULBRA, Canoas, Brazil.
RI Guimaraes, Jorge Almeida/V-2196-2019; Amorim, Hermes/E-4072-2013
CR RUSSO C, 2002, SBBQ PROGRAMME ABSTR, P170
   RUSSO C, 2004, WISICT, P249
NR 2
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2005
VL 88
IS 1
SU S
BP 217A
EP 218A
PN 2
PG 2
WC Biophysics
SC Biophysics
GA 888MM
UT WOS:000226378501055
DA 2020-11-24
ER

PT J
AU Guimaraes, JA
   Carlini, CR
AF Guimaraes, JA
   Carlini, CR
TI Most cited papers in Toxicon
SO TOXICON
LA English
DT Review
DE impact factor; citation; snakes; cyanobacteria; plant toxins
ID BLUE-GREEN-ALGAE; BOTHROPS-ASPER VENOM; CYANOBACTERIUM
   MICROCYSTIS-AERUGINOSA; ECLIPTA-PROSTRATA ASTERACEAE; PARALYTIC
   SHELLFISH TOXINS; LINKED-IMMUNOSORBENT-ASSAY; ENGADDENSIS BURROWING ASP;
   BUTHUS-MARTENSI KARSCH; PLANT LANTANA-CAMARA; ANABAENA-FLOS-AQUAE
AB Citation of a published work is one of the parameters considered in the analysis of relevance and importance of scientific contributions. In 2002. for the first time the Impact Factor of Toxicon has risen above 2.0, placing it at the 17th position among 76 journals in the 'toxicology' field. The aim of this article was to identify the most cited articles in Toxicon, that have contributed to the steady increase of its Impact Factor. The number of citations, complete reference and type of all documents appearing in Toxicon in the period 1963-2003 were retrieved from the ISI Web-of-Science homepage. The documents retrieved were sorted by the number of citations received. A 'citation index', defined as the number of citations divided by the number of years since publication, was calculated for each document. It was clearly seen that reviews in Toxicon received 4.4-fold more citations than articles. Unexpectedly, it was found that recent papers were proportionally more cited than old ones. A decrease in the proportion of papers dealing on 'snake*' through out the period and the broadened range of subjects of the most cited papers recently published in Toxicon reflects an increased 'visibility' in other fields of toxinology. Research on plant toxins gained its own space in Toxicon with newer publications showing high citation indexes. It can be postulated that these facts helped to increase Toxicon's Impact Factor from 1.248 in 1999 to 2.003 in 2002. With the increased number of issues in Toxicon as well as publications of subject-dedicated volumes containing mostly reviews, the Impact Factor of Toxicon is expected to keep rising in the near future. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biophys, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Carlini, CR (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biophys, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM ccarlini@ufrgs.br
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ABBAS HK, 1993, TOXICON, V31, P345, DOI 10.1016/0041-0101(93)90152-9
   AIRD SD, 1985, TOXICON, V23, P361, DOI 10.1016/0041-0101(85)90020-0
   AN JS, 1994, TOXICON, V32, P1495, DOI 10.1016/0041-0101(94)90308-5
   Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X
   ANDERSEN RJ, 1993, TOXICON, V31, P1315, DOI 10.1016/0041-0101(93)90404-7
   Arni RK, 1996, TOXICON, V34, P827, DOI 10.1016/0041-0101(96)00036-0
   BADEN DG, 1982, TOXICON, V20, P457, DOI 10.1016/0041-0101(82)90009-5
   BADEN DG, 1981, TOXICON, V19, P455, DOI 10.1016/0041-0101(81)90003-9
   BAGNIS R, 1980, TOXICON, V18, P199, DOI 10.1016/0041-0101(80)90074-4
   BALODA SB, 1983, TOXICON, V21, P785, DOI 10.1016/0041-0101(83)90067-3
   Becerril B, 1997, TOXICON, V35, P821, DOI 10.1016/S0041-0101(96)00198-5
   BEISEL WR, 1972, TOXICON, V10, P433, DOI 10.1016/0041-0101(72)90167-5
   BENOIT E, 1986, TOXICON, V24, P357, DOI 10.1016/0041-0101(86)90195-9
   BERESS L, 1975, TOXICON, V13, P359, DOI 10.1016/0041-0101(75)90196-8
   BERMUDEZ MV, 1986, TOXICON, V24, P1091, DOI 10.1016/0041-0101(86)90135-2
   BIYITI L, 1990, TOXICON, V28, P275, DOI 10.1016/0041-0101(90)90063-D
   Bodenhorn H, 2003, J ECON EDUC, V34, P341, DOI 10.1080/00220480309595228
   BOTES DP, 1982, TOXICON, V20, P945, DOI 10.1016/0041-0101(82)90097-6
   BOTES DP, 1982, TOXICON, V20, P1037, DOI 10.1016/0041-0101(82)90105-2
   BRAND JM, 1972, TOXICON, V10, P259, DOI 10.1016/0041-0101(72)90011-6
   BROAD AJ, 1979, TOXICON, V17, P661, DOI 10.1016/0041-0101(79)90245-9
   Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1
   BURNETT JW, 1977, TOXICON, V15, P177, DOI 10.1016/0041-0101(77)90044-7
   Camey KU, 2002, TOXICON, V40, P501, DOI 10.1016/S0041-0101(01)00245-8
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARMICHAEL WW, 1979, TOXICON, V17, P229, DOI 10.1016/0041-0101(79)90212-5
   CARMICHAEL WW, 1988, TOXICON, V26, P971, DOI 10.1016/0041-0101(88)90195-X
   CESSI C, 1969, TOXICON, V6, P309, DOI 10.1016/0041-0101(69)90104-4
   CHANG CC, 1977, TOXICON, V15, P571, DOI 10.1016/0041-0101(77)90108-8
   CHEN YC, 1987, TOXICON, V25, P401, DOI 10.1016/0041-0101(87)90073-0
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   CONDREA E, 1981, TOXICON, V19, P61, DOI 10.1016/0041-0101(81)90118-5
   CONDREA E, 1981, TOXICON, V19, P705, DOI 10.1016/0041-0101(81)90108-2
   COURAUD F, 1982, TOXICON, V20, P9, DOI 10.1016/0041-0101(82)90138-6
   Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5
   Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4
   DALY JW, 1978, TOXICON, V16, P163, DOI 10.1016/0041-0101(78)90036-3
   DALY JW, 1987, TOXICON, V25, P1023, DOI 10.1016/0041-0101(87)90265-0
   DASGUPTA BR, 1984, TOXICON, V22, P415, DOI 10.1016/0041-0101(84)90085-0
   Dawson RM, 1998, TOXICON, V36, P953, DOI 10.1016/S0041-0101(97)00102-5
   DELORI P, 1981, TOXICON, V19, P393, DOI 10.1016/0041-0101(81)90044-1
   DENSON KWE, 1972, TOXICON, V10, P557, DOI 10.1016/0041-0101(72)90116-X
   DENSON KWE, 1969, TOXICON, V7, P5, DOI 10.1016/0041-0101(69)90154-8
   DICKEY RW, 1990, TOXICON, V28, P371, DOI 10.1016/0041-0101(90)90074-H
   DUFOURCQ J, 1982, TOXICON, V20, P165, DOI 10.1016/0041-0101(82)90187-8
   EDERY H, 1972, TOXICON, V10, P13, DOI 10.1016/0041-0101(72)90085-2
   ENDEAN R, 1969, TOXICON, V6, P179, DOI 10.1016/0041-0101(69)90118-4
   FERLAN I, 1974, TOXICON, V12, P57, DOI 10.1016/0041-0101(74)90099-3
   FERREIRA LAF, 1992, TOXICON, V30, P1211, DOI 10.1016/0041-0101(92)90437-A
   FIORENTINI C, 1988, TOXICON, V26, P1047, DOI 10.1016/0041-0101(88)90203-6
   FLETCHER JE, 1993, TOXICON, V31, P669, DOI 10.1016/0041-0101(93)90375-S
   FOHLMAN J, 1977, TOXICON, V15, P385, DOI 10.1016/0041-0101(77)90116-7
   FONTECILLACAMPS JC, 1982, TOXICON, V20, P1, DOI 10.1016/0041-0101(82)90137-4
   Garcia ML, 2001, TOXICON, V39, P739, DOI 10.1016/S0041-0101(00)00214-2
   GELDERBLOM WCA, 1983, TOXICON, V21, P467, DOI 10.1016/0041-0101(83)90124-1
   GLENN JL, 1983, TOXICON, V21, P119, DOI 10.1016/0041-0101(83)90055-7
   GOPALAKRISHNAKONE P, 1984, TOXICON, V22, P85, DOI 10.1016/0041-0101(84)90141-7
   Gordon D, 2003, TOXICON, V41, P125, DOI 10.1016/S0041-0101(02)00294-5
   Goudet C, 2002, TOXICON, V40, P1239, DOI 10.1016/S0041-0101(02)00142-3
   Graudins A, 2002, TOXICON, V40, P767, DOI 10.1016/S0041-0101(01)00280-X
   Graudins A, 2002, TOXICON, V40, P259, DOI 10.1016/S0041-0101(01)00210-0
   Guimaraes JA, 2000, INTERCIENCIA, V25, P182
   GUTIERREZ JM, 1989, TOXICON, V27, P735, DOI 10.1016/0041-0101(89)90040-8
   GUTIERREZ JM, 1988, TOXICON, V26, P411, DOI 10.1016/0041-0101(88)90010-4
   GUTIERREZ JM, 1980, TOXICON, V18, P603, DOI 10.1016/0041-0101(80)90087-2
   GUTIERREZ JM, 1985, TOXICON, V23, P887, DOI 10.1016/0041-0101(85)90380-0
   GUTIERREZ JM, 1981, TOXICON, V19, P493, DOI 10.1016/0041-0101(81)90007-6
   GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z
   GUTIERREZ JM, 1984, TOXICON, V22, P115, DOI 10.1016/0041-0101(84)90144-2
   HABERMANN E, 1975, TOXICON, V13, P465, DOI 10.1016/0041-0101(75)90176-2
   HABERMANN E, 1989, TOXICON, V27, P1171, DOI 10.1016/0041-0101(89)90026-3
   HABERMEHL GG, 1985, TOXICON, V23, P731, DOI 10.1016/0041-0101(85)90003-0
   HARADA K, 1991, TOXICON, V29, P479, DOI 10.1016/0041-0101(91)90022-J
   HARADA K, 1990, TOXICON, V28, P55, DOI 10.1016/0041-0101(90)90006-S
   HARADA K, 1994, TOXICON, V32, P73, DOI 10.1016/0041-0101(94)90023-X
   HARADA KI, 1988, TOXICON, V26, P433, DOI 10.1016/0041-0101(88)90182-1
   HARRIS JB, 1981, TOXICON, V19, P419, DOI 10.1016/0041-0101(81)90046-5
   HARVEY AL, 1982, TOXICON, V20, P379, DOI 10.1016/0041-0101(82)90001-0
   Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8
   Hawkins PR, 1997, TOXICON, V35, P341, DOI 10.1016/S0041-0101(96)00185-7
   HO M, 1986, TOXICON, V24, P211, DOI 10.1016/0041-0101(86)90147-9
   HOKAMA Y, 1977, TOXICON, V15, P317, DOI 10.1016/0041-0101(77)90014-9
   HOLMES CFB, 1991, TOXICON, V29, P469, DOI 10.1016/0041-0101(91)90021-I
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HONKANAN RE, 1994, TOXICON, V32, P339, DOI 10.1016/0041-0101(94)90086-8
   Inoue M, 2003, TOXICON, V41, P469, DOI 10.1016/S0041-0101(02)00369-0
   ISHIKAWA Y, 1977, TOXICON, V15, P477, DOI 10.1016/0041-0101(77)90098-8
   ISMAIL M, 1995, TOXICON, V33, P825, DOI 10.1016/0041-0101(95)00005-7
   ISMAIL M, 1992, TOXICON, V30, P1257, DOI 10.1016/0041-0101(92)90442-8
   James KJ, 2003, TOXICON, V41, P145, DOI 10.1016/S0041-0101(02)00244-1
   James KJ, 2002, TOXICON, V40, P909, DOI 10.1016/S0041-0101(02)00082-X
   James KJ, 2003, TOXICON, V41, P277, DOI 10.1016/S0041-0101(02)00288-X
   JELLETT JF, 1992, TOXICON, V30, P1143, DOI 10.1016/0041-0101(92)90430-D
   Ji YH, 1996, TOXICON, V34, P987, DOI 10.1016/0041-0101(96)00065-7
   Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7
   KAO CY, 1967, TOXICON, V5, P25, DOI 10.1016/0041-0101(67)90114-6
   KARLSSON E, 1972, TOXICON, V10, P405, DOI 10.1016/0041-0101(72)90066-9
   Kim HJ, 2001, ARCH PHARM RES, V24, P527, DOI 10.1007/BF02975159
   KIMURA LH, 1982, TOXICON, V20, P907, DOI 10.1016/0041-0101(82)90078-2
   KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z
   KINI RM, 1992, TOXICON, V30, P265, DOI 10.1016/0041-0101(92)90869-7
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   KINI RM, 1986, TOXICON, V24, P895
   KOCHOLATY WF, 1971, TOXICON, V9, P131, DOI 10.1016/0041-0101(71)90006-7
   KOCHVA E, 1982, TOXICON, V20, P581, DOI 10.1016/0041-0101(82)90052-6
   KOCHVA E, 1987, TOXICON, V25, P65, DOI 10.1016/0041-0101(87)90150-4
   KOGURE K, 1988, TOXICON, V26, P191, DOI 10.1016/0041-0101(88)90171-7
   KRISHNAMURTHY T, 1986, TOXICON, V24, P865, DOI 10.1016/0041-0101(86)90087-5
   Lagos N, 1999, TOXICON, V37, P1359, DOI 10.1016/S0041-0101(99)00080-X
   LEWIS RJ, 1991, TOXICON, V29, P1115, DOI 10.1016/0041-0101(91)90209-A
   LOMONTE B, 1989, TOXICON, V27, P725, DOI 10.1016/0041-0101(89)90039-1
   LUTZ F, 1979, TOXICON, V17, P467, DOI 10.1016/0041-0101(79)90280-0
   MACEK P, 1988, TOXICON, V26, P441, DOI 10.1016/0041-0101(88)90183-3
   MAEDA N, 1978, TOXICON, V16, P431, DOI 10.1016/0041-0101(78)90140-X
   MAHMOOD NA, 1986, TOXICON, V24, P175, DOI 10.1016/0041-0101(86)90120-0
   MANDELBAUM FR, 1982, TOXICON, V20, P955, DOI 10.1016/0041-0101(82)90098-8
   MARETIC Z, 1983, TOXICON, V21, P457, DOI 10.1016/0041-0101(83)90123-X
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   MARTZ W, 1992, TOXICON, V30, P1131, DOI 10.1016/0041-0101(92)90429-9
   MATTOCKS AR, 1989, TOXICON, V27, P561, DOI 10.1016/0041-0101(89)90117-7
   MCKINSTRY DM, 1978, TOXICON, V16, P523, DOI 10.1016/0041-0101(78)90179-4
   MEIER J, 1986, TOXICON, V24, P395, DOI 10.1016/0041-0101(86)90199-6
   MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0
   Menez A, 1998, TOXICON, V36, P1557, DOI 10.1016/S0041-0101(98)00148-2
   MERILUOTO JAO, 1989, TOXICON, V27, P1021, DOI 10.1016/0041-0101(89)90153-0
   MORS WB, 1989, TOXICON, V27, P1003, DOI 10.1016/0041-0101(89)90151-7
   NAKAMURA M, 1985, TOXICON, V23, P271, DOI 10.1016/0041-0101(85)90149-7
   NAKANISHI K, 1985, TOXICON, V23, P473, DOI 10.1016/0041-0101(85)90031-5
   Nirthanan S, 2003, TOXICON, V41, P397, DOI 10.1016/S0041-0101(02)00388-4
   NOGUCHI T, 1969, TOXICON, V7, P325, DOI 10.1016/0041-0101(69)90033-6
   NOGUCHI T, 1973, TOXICON, V11, P305, DOI 10.1016/0041-0101(73)90060-3
   Norton RS, 1998, TOXICON, V36, P1573, DOI 10.1016/S0041-0101(98)00149-4
   NORTON RS, 1991, TOXICON, V29, P1051, DOI 10.1016/0041-0101(91)90205-6
   NUKINA M, 1984, TOXICON, V22, P169, DOI 10.1016/0041-0101(84)90017-5
   Olsnes S, 2001, TOXICON, V39, P1723, DOI 10.1016/S0041-0101(01)00158-1
   OSHIMA Y, 1987, TOXICON, V25, P1105, DOI 10.1016/0041-0101(87)90267-4
   OUYANG C, 1992, TOXICON, V30, P945, DOI 10.1016/0041-0101(92)90040-C
   OVADIA M, 1977, TOXICON, V15, P541, DOI 10.1016/0041-0101(77)90105-2
   OWNBY CL, 1984, TOXICON, V22, P227, DOI 10.1016/0041-0101(84)90023-0
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   OWNBY CL, 1983, TOXICON, V21, P35, DOI 10.1016/0041-0101(83)90047-8
   Papini E, 2001, TOXICON, V39, P1757, DOI 10.1016/S0041-0101(01)00162-3
   PETERSON JW, 1983, TOXICON, V21, P761, DOI 10.1016/0041-0101(83)90065-X
   Plakas SM, 2002, TOXICON, V40, P721, DOI 10.1016/S0041-0101(01)00267-7
   PROCTOR NH, 1975, TOXICON, V13, P1, DOI 10.1016/0041-0101(75)90152-X
   Rash LD, 2002, TOXICON, V40, P225, DOI 10.1016/S0041-0101(01)00199-4
   Rates SMK, 2001, TOXICON, V39, P603, DOI 10.1016/S0041-0101(00)00154-9
   REZENDE L, 1991, TOXICON, V29, P1225, DOI 10.1016/0041-0101(91)90195-W
   ROSENBERG P, 1989, TOXICON, V27, P137, DOI 10.1016/0041-0101(89)90128-1
   ROTHSCHILD M, 1970, TOXICON, V8, P293, DOI 10.1016/0041-0101(70)90006-1
   RUNNEGAR MTC, 1986, TOXICON, V24, P109, DOI 10.1016/0041-0101(86)90112-1
   RUNNEGAR MTC, 1987, TOXICON, V25, P1235, DOI 10.1016/0041-0101(87)90142-5
   RUNNEGAR MTC, 1991, TOXICON, V29, P43, DOI 10.1016/0041-0101(91)90038-S
   RUSSELL FE, 1973, TOXICON, V11, P461, DOI 10.1016/0041-0101(73)90003-2
   SAMPAIO SV, 1983, TOXICON, V21, P265, DOI 10.1016/0041-0101(83)90011-9
   SEYBERTH HW, 1972, TOXICON, V10, P491, DOI 10.1016/0041-0101(72)90175-4
   SHARMA OP, 1988, TOXICON, V26, P975, DOI 10.1016/0041-0101(88)90196-1
   SHARMA OP, 1980, TOXICON, V18, P485, DOI 10.1016/0041-0101(80)90058-6
   SUGANUMA M, 1992, TOXICON, V30, P873, DOI 10.1016/0041-0101(92)90385-I
   TAKASAKI C, 1988, TOXICON, V26, P543, DOI 10.1016/0041-0101(88)90234-6
   TERAO K, 1986, TOXICON, V24, P1141, DOI 10.1016/0041-0101(86)90140-6
   TERAO K, 1994, TOXICON, V32, P833, DOI 10.1016/0041-0101(94)90008-6
   THEAKSTON RDG, 1991, TOXICON, V29, P1419, DOI 10.1016/0041-0101(91)90002-9
   THEAKSTON RDG, 1983, TOXICON, V21, P341, DOI 10.1016/0041-0101(83)90090-9
   THELESTAM M, 1988, TOXICON, V26, P51, DOI 10.1016/0041-0101(88)90137-7
   THOMPSON WL, 1986, TOXICON, V24, P985, DOI 10.1016/0041-0101(86)90004-8
   TSAO SW, 1986, TOXICON, V24, P831, DOI 10.1016/0041-0101(86)90108-X
   TSAO SW, 1990, TOXICON, V28, P1183, DOI 10.1016/0041-0101(90)90118-Q
   TSETLIN VI, 1982, TOXICON, V20, P83, DOI 10.1016/0041-0101(82)90171-4
   Vetter J, 2000, TOXICON, V38, P11, DOI 10.1016/S0041-0101(99)00128-2
   VISHWANATH BS, 1987, TOXICON, V25, P501
   WATANABE MF, 1988, TOXICON, V26, P1017, DOI 10.1016/0041-0101(88)90200-0
   WOLLBERG Z, 1988, TOXICON, V26, P525, DOI 10.1016/0041-0101(88)90232-2
   YANG CC, 1981, TOXICON, V19, P645, DOI 10.1016/0041-0101(81)90102-1
   YANG CC, 1974, TOXICON, V12, P1, DOI 10.1016/0041-0101(74)90096-8
   YOSHIZUMI K, 1990, TOXICON, V28, P43, DOI 10.1016/0041-0101(90)90005-R
   YOTSU M, 1987, TOXICON, V25, P225, DOI 10.1016/0041-0101(87)90245-5
   ZLOTKIN E, 1971, TOXICON, V9, P1, DOI 10.1016/0041-0101(71)90037-7
   ZLOTKIN E, 1969, TOXICON, V7, P217, DOI 10.1016/0041-0101(69)90008-7
   ZLOTKIN E, 1972, TOXICON, V10, P211, DOI 10.1016/0041-0101(72)90005-0
   ZLOTKIN E, 1972, TOXICON, V10, P207, DOI 10.1016/0041-0101(72)90004-9
NR 181
TC 28
Z9 28
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD SEP 15
PY 2004
VL 44
IS 4
BP 345
EP 359
DI 10.1016/j.toxicon.2004.05.002
PG 15
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 851AB
UT WOS:000223654600002
PM 15302519
DA 2020-11-24
ER

PT J
AU Fuly, AL
   Soares, AM
   Marcussi, S
   Giglio, JR
   Guimaraes, JA
AF Fuly, AL
   Soares, AM
   Marcussi, S
   Giglio, JR
   Guimaraes, JA
TI Signal transduction pathways involved in the platelet aggregation
   induced by a D-49 phospholipase A(2) isolated from Bothrops jararacussu
   snake venom
SO BIOCHIMIE
LA English
DT Article
DE platelets; signal transduction; phospholipase A(2); snake venom;
   Bothrops
ID GLYCOPROTEIN-VI; INTEGRIN ALPHA(2)BETA(1); TYROSYL-PHOSPHORYLATION;
   PISCIVORUS-PISCIVORUS; COLLAGEN RECEPTOR; ACTIVATION; PROTEIN;
   CONVULXIN; MECHANISM; PEPTIDE
AB Bothropstoxin-II (Bthtx-II), an Asp-49 phospholipase A(2) (D-PLA(2)) isolated from Bothrops jararacussu snake venom is able to induce platelet aggregation in a concentration-dependent manner. This effect was not due to the release of ADP from platelets since the aggregation was not suppressed by ADP scavenger systems. PMSF and PPACK were unable to inhibit Bthtx-II-induced platelet aggregation. Thus, a thrombin-like proaggregating activity of Bthtx-II can be excluded as its mechanism of action. On the other hand, indomethacin at low concentrations inhibited more markedly the ATP-release reaction than the aggregation induced by Bthtx-II, indicating that generation of cyclooxigenase products is not the most important event for the platelet aggregation reaction. It was also found that staurosporine and genistein suppressed both platelet aggregation and ATP-release reactions, but not the platelet shape-change induced by Bthtx-II. Substances that either directly activates adenylyl cyclase enzyme (forskolin and PGE(1)) or cell-permeant increasing agents (dibutyril-cAMP) inhibited in a concentration-dependent fashion, the platelet aggregation effects induced by the protein. It is concluded that Bthtx-II induces platelet aggregation and secretion through multiple signal transduction pathways. (C) 2004 Elsevier SAS. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB, CCS, BR-21941590 Rio De Janeiro, Brazil.
   Univ Ribeirao Preto, UNAERP, Dept Biotecnol, Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049900 Sao Paulo, SP, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@cbiot.ufrgs.br
RI Soares, Andreimar M/K-5556-2014; Guimaraes, Jorge Almeida/V-2196-2019;
   Fuly, Andre/U-1538-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Soares,
   Andreimar/0000-0003-1032-2188
CR Andriao-Escarso SH, 2000, BIOCHIMIE, V82, P755, DOI 10.1016/S0300-9084(00)01150-0
   Asazuma N, 2001, BLOOD, V97, P3989, DOI 10.1182/blood.V97.12.3989
   Brass LF, 1999, J CLIN INVEST, V104, P1663, DOI 10.1172/JCI8944
   Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CHANNON JY, 1990, J BIOL CHEM, V265, P5409
   Chaves F, 1998, TOXICON, V36, P1861, DOI 10.1016/S0041-0101(98)00107-X
   COLMAN RW, 1987, HEMOSTASIS THROMBOSI, P3
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DHILLON DS, 1987, BIOCHEM PHARMACOL, V36, P1723, DOI 10.1016/0006-2952(87)90059-1
   Dormann D, 2001, BLOOD, V97, P929, DOI 10.1182/blood.V97.4.929
   EMMS H, 1986, BRIT J PHARMACOL, V87, P109, DOI 10.1111/j.1476-5381.1986.tb10162.x
   Evans J, 1999, TOXICON, V37, P633, DOI 10.1016/S0041-0101(98)00202-5
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V354, P255, DOI 10.1006/abbi.1998.0637
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Francischetti IMB, 1998, PLATELETS, V9, P185, DOI 10.1080/09537109876663
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   GARTNER TK, 1980, BIOCHEM BIOPH RES CO, V96, P1747, DOI 10.1016/0006-291X(80)91376-5
   Ghazaleh FA, 1997, ARCH BIOCHEM BIOPHYS, V339, P362, DOI 10.1006/abbi.1997.9898
   HAWIGER J, 1994, HEMOSTASIS THROMBOSI, P603
   HOMSIBRANDEBURGO MI, 1988, TOXICON, V26, P615, DOI 10.1016/0041-0101(88)90244-9
   HUANG TF, 1995, BIOCHEM J, V309, P1021, DOI 10.1042/bj3091021
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   Kamiguti AS, 2000, ARCH BIOCHEM BIOPHYS, V374, P356, DOI 10.1006/abbi.1999.1627
   KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z
   Kini RM, 1995, TOXICON, V33, P1585, DOI 10.1016/0041-0101(95)00103-4
   Kowalska MA, 1998, THROMB HAEMOSTASIS, V79, P609
   LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E
   Liu CZ, 1997, ARCH BIOCHEM BIOPHYS, V337, P291, DOI 10.1006/abbi.1996.9787
   Liu W, 1998, ACTA PHARMACOL SIN, V19, P540
   MAJERUS PW, 1985, TRENDS BIOCHEM SCI, V10, P168, DOI 10.1016/0968-0004(85)90160-4
   Mangin P, 2003, FEBS LETT, V542, P53, DOI 10.1016/S0014-5793(03)00337-5
   MARKUS B, 1999, BLOOD, V94, P1665
   Navdaev A, 2001, J BIOL CHEM, V276, P20882, DOI 10.1074/jbc.M101585200
   OGILVIE ML, 1986, J BIOCHEM-TOKYO, V100, P1428
   OUYANG C, 1984, TOXICON, V22, P705, DOI 10.1016/0041-0101(84)90154-5
   Park HS, 1999, BRIT J PHARMACOL, V127, P1359, DOI 10.1038/sj.bjp.0702690
   Pereira MF, 1998, J PROTEIN CHEM, V17, P381, DOI 10.1023/A:1022563401413
   Pirkle H, 1998, THROMB HAEMOSTASIS, V79, P675
   Quinton TM, 2002, BLOOD, V99, P3228, DOI 10.1182/blood.V99.9.3228
   Rosado JA, 2001, J BIOL CHEM, V276, P15666, DOI 10.1074/jbc.M009217200
   ROSING J, 1992, TOXICON, V30, P1515, DOI 10.1016/0041-0101(92)90023-X
   SANTORO SA, 1991, CELL REGUL, V2, P905
   SANTORO SA, 1989, J CELL BIOL, V108, P917
   SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   Sheu JR, 1995, EUR J PHARMACOL, V294, P231, DOI 10.1016/0014-2999(95)00530-7
   Sim KL, 1998, BBA-GEN SUBJECTS, V1379, P198, DOI 10.1016/S0304-4165(97)00097-4
   Smirnova IV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P710
   Sugidachi A, 2001, BRIT J PHARMACOL, V132, P47, DOI 10.1038/sj.bjp.0703761
   TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2
   TANG WJ, 1992, CELL, V70, P869, DOI 10.1016/0092-8674(92)90236-6
   TANG WJ, 1995, SCIENCE, V268, P1769, DOI 10.1126/science.7792604
   Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5
   Yamamoto S, 2002, BIOCHEM PHARMACOL, V64, P375, DOI 10.1016/S0006-2952(02)01053-5
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
   Zhao KH, 1998, ACTA CRYSTALLOGR D, V54, P510, DOI 10.1107/S0907444997013644
NR 57
TC 27
Z9 27
U1 2
U2 7
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0300-9084
EI 1638-6183
J9 BIOCHIMIE
JI Biochimie
PD SEP-OCT
PY 2004
VL 86
IS 9-10
BP 731
EP 739
DI 10.1016/j.biochi.2004.07.001
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 878BN
UT WOS:000225621600017
PM 15556284
DA 2020-11-24
ER

PT J
AU Russo, CC
   de Amorim, HN
   Guimaraes, JA
AF Russo, CC
   de Amorim, HN
   Guimaraes, JA
TI Molecular modeling studies of complete factor IXa and a nitrophorin-2
   anticoagulant peptide
SO PROTEIN SCIENCE
LA English
DT Meeting Abstract
CT 18th Symposium of the Protein-Society
CY AUG 14-18, 2004
CL San Diego, CA
SP Protein Soc, Abbott Lab Fund, Amer Peptide Soc, Amgen, Biogen Idec, DARPA, Eli Lilly & Co, Eli Lilly Res Labs, Biotechnol Discovery Res, Genencor Int, Genentech Inc, Merck Res Labs, Natl Sci Fdn, NIH, New England BioLabs, Novartis Inst Biomed Res, Pfizer Inc, Protein Soc Educ Comm, Protein Soc Young Protein Sci Comm, Roche Pharmaceut, Sunesis Pharmaceut Inc
C1 UFRGS, Ctr Biotechnol, Porto Alegre, RS, Brazil.
RI Guimaraes, Jorge Almeida/V-2196-2019; Amorim, Hermes/E-4072-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD AUG
PY 2004
VL 13
SU 1
MA 153
BP 100
EP 101
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 866TL
UT WOS:000224796100154
DA 2020-11-24
ER

PT J
AU Verli, H
   Guimaraes, JA
AF Verli, H
   Guimaraes, JA
TI Molecular dynamics investigation of the synthetic pentasaccharide
   recognition by antithrombin
SO PROTEIN SCIENCE
LA English
DT Meeting Abstract
CT 18th Symposium of the Protein-Society
CY AUG 14-18, 2004
CL San Diego, CA
SP Protein Soc, Abbott Lab Fund, Amer Peptide Soc, Amgen, Biogen Idec, DARPA, Eli Lilly & Co, Eli Lilly Res Labs, Biotechnol Discovery Res, Genencor Int, Genentech Inc, Merck Res Labs, Natl Sci Fdn, NIH, New England BioLabs, Novartis Inst Biomed Res, Pfizer Inc, Protein Soc Educ Comm, Protein Soc Young Protein Sci Comm, Roche Pharmaceut, Sunesis Pharmaceut Inc
C1 Univ Fed Rio Grande Sul, Ctr Biotechnol, Porto Alegre, RS, Brazil.
RI Verli, Hugo/G-8703-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Verli, Hugo/0000-0002-4796-8620; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI WOODBURY
PA 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2924 USA
SN 0961-8368
J9 PROTEIN SCI
JI Protein Sci.
PD AUG
PY 2004
VL 13
SU 1
MA 154
BP 101
EP 101
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 866TL
UT WOS:000224796100155
DA 2020-11-24
ER

PT J
AU de Castro Bastos, L
   Veiga, ABG
   Guimaraes, JA
   Tonussi, CR
AF de Castro Bastos, L
   Veiga, ABG
   Guimaraes, JA
   Tonussi, CR
TI Nociceptive and edematogenic responses elicited by a crude bristle
   extract of Lonomia obliqua caterpillars
SO TOXICON
LA English
DT Article
DE aftersensation; allodynia; inflammation; pain; hematuria
ID SYMPATHETIC COMPONENT; HYPERALGESIA; HUMANS; TOXINS; PAIN
AB Lyophilized Lonomia obliqua crude bristle extract (LOCBE) diluted in physiological saline (15, 35 and 50 mug of protein/paw) was injected in the plantar surface of the hind paw of the rat, causing a nociceptive response which lasted from 30 to a maximum of 50 min, peaking in the first 5 min. The animals also presented hematuria and nasal bleeding. Nociception was inhibited by indomethacin pretreatment (2.5 mg/kg, i.p., 60 min before), but not by guanethidine (30 mg/kg/day, s.c., for 3 days) or loratadine (5 mg/kg, p.o., 60 min before). LOCBE injection also produced paw edema peaking I h after injection and lasting for 6 h. Loratadine pretreatment, but neither guanethidine nor indomethacin, reduced edema. After the period of overt nociception, a nociceptive aftersensation response could be evoked up to 6 h after by immersing the paw into cold water (15 degreesC for 10 s. Capsaicin (1.6 mug), formalin (0.5%) or prostaglandin E, (500 ng) did not produce the same aftersensation phenomenon. These results suggest that LOCBE-induced nociception is largely facilitated by prostaglandin production, and edematogenic response seems to be facilitated by prostanoids and histamine. Finally, LOCBE induced a state of sensitization to cold, which seemed to be specific as it was not caused by other noxious chemicals. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Fed Santa Catarina, Dept Pharmacol, BR-88040900 Florianopolis, SC, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Tonussi, CR (corresponding author), Univ Fed Santa Catarina, Dept Pharmacol, POB 476, BR-88040900 Florianopolis, SC, Brazil.
EM tonussi@farmaco.ufsc.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Veiga, Ana B. G./N-8581-2013;
   Tonussi, Carlos/E-6985-2013
OI Veiga, Ana B. G./0000-0003-1462-5506; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019
   Kinnman E, 1997, PAIN, V69, P79, DOI 10.1016/S0304-3959(96)03257-5
   Liu MW, 1996, J NEUROSCI, V16, P7331
   Lorenzetti BB, 2002, EUR CYTOKINE NETW, V13, P456
   NAKAMURA M, 1987, EUR J PHARMACOL, V135, P145, DOI 10.1016/0014-2999(87)90606-6
   RAJA SN, 1999, TXB PAIN, P11
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   Seibert CS, 2003, TOXICON, V41, P831, DOI 10.1016/S0041-0101(03)00040-0
   TONUSSI CR, 1992, PAIN, V48, P421, DOI 10.1016/0304-3959(92)90095-S
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   WOOLF CJ, 1992, SYMP PAIN R, P221
   ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4
NR 16
TC 20
Z9 22
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAR 1
PY 2004
VL 43
IS 3
BP 273
EP 278
DI 10.1016/j.toxicon.2003.12.003
PG 6
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 815DB
UT WOS:000221021900006
PM 15033325
DA 2020-11-24
ER

PT J
AU da Costa, BP
   Steibel, JP
   Antonello, IC
   Guimaraes, JA
   de Figueiredo, CEP
AF da Costa, BP
   Steibel, JP
   Antonello, IC
   Guimaraes, JA
   de Figueiredo, CEP
TI L-arginine erythrocyte transport in normal pregnant and preeclamptic
   women
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE hypertension; pregnancy; nitric oxide; membrane transporters
ID NITRIC-OXIDE SYNTHASE; HUMAN UMBILICAL VESSELS; INHIBITOR; CELLS
AB Objective: Uptake Of L-arginine by the cell via amino acid transporter systems is the first step for nitric oxide (NO) production. The current study aimed to assess the total L-arginine uptake in erythrocytes of normal pregnant and preeclamptic women.
   Study design: Twenty-one normal pregnant and 21 preeclamptic women were studied. To measure total L-arginine uptake in erythrocytes, carbon 14 was used as a. marker and Michaelis-Menten kinetic parameters (V-max and K-m) were evaluated.
   Results: In preeclamptic women, there was a significant increase (P < .004) in the mean maximal capacity of transport in erythrocytes (V-max = 982.69 mumol/L cells/h +/- 433.51) in comparison with normal pregnant women (V-max = 584.73 mumol/L cells/h +/- 422.33). No significant difference was detected in the half-saturation constant (P = 0.978).
   Conclusion: The transport kinetics of the NO precursor, L-arginine, is altered in erythrocytes of preeclamptic women. It is possible that abnormal L-arginine uptake may contribute to the pathophysiologic mechanisms of preeclampsia syndrome. (C) 2004 Elsevier Inc. All rights reserved.
C1 Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Fac Med,Inst Pesquisas Biomed, Programa Posgrad Clin Med & Ciencias Saude Nefrol, Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotecnol Rio Grande Sul, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil.
RP da Costa, BP (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Fac Med,Inst Pesquisas Biomed, Programa Posgrad Clin Med & Ciencias Saude Nefrol, Porto Alegre, RS, Brazil.
RI da Costa, Bartira E Pinheiro/E-4183-2013; de Figueiredo, Carlos E
   Poli/A-2027-2013
OI da Costa, Bartira E Pinheiro/0000-0001-8015-3952; de Figueiredo, Carlos
   E Poli/0000-0002-7333-8884; Guimaraes, Jorge A./0000-0001-6354-6789
CR AKAR F, 1994, J HYPERTENS, V12, P1235
   [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1689
   Baylis C, 1998, SEMIN NEPHROL, V18, P208
   Boccardo P, 1996, BRIT J OBSTET GYNAEC, V103, P879, DOI 10.1111/j.1471-0528.1996.tb09906.x
   Brennecke SP, 1997, CLIN SCI, V93, P51, DOI 10.1042/cs0930051
   Conrad KP, 1995, PLACENTA, V16, P691, DOI 10.1016/0143-4004(95)90013-6
   DAVIDGE ST, 1995, AM J PHYSIOL-HEART C, V269, pH1106
   Deves R, 1998, PHYSIOL REV, V78, P487
   ELLORY JC, 1977, MEMBRANE TRANSPORT R
   Facchinetti F, 1999, J SOC GYNECOL INVEST, V6, P202, DOI 10.1016/S1071-5576(99)00017-9
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Haller H, 1998, LANCET, V351, P945
   Holden DP, 1998, AM J OBSTET GYNECOL, V178, P551, DOI 10.1016/S0002-9378(98)70437-5
   Kaye DM, 2000, CIRCULATION, V102, P2707, DOI 10.1161/01.CIR.102.22.2707
   King RG, 1995, REPROD FERT DEVELOP, V7, P1407, DOI 10.1071/RD9951407
   MACALLISTER RJ, 1994, BRIT J PHARMACOL, V112, P43, DOI 10.1111/j.1476-5381.1994.tb13026.x
   MCCARTHY AL, 1993, AM J OBSTET GYNECOL, V168, P1323, DOI 10.1016/0002-9378(93)90389-Z
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   Myatt L, 1997, HUM REPROD, V12, P167, DOI 10.1093/humrep/12.1.167
   PAN M, 1995, ANN SURG, V221, P590, DOI 10.1097/00000658-199505000-00017
   Pettersson A, 1998, ACTA OBSTET GYN SCAN, V77, P808, DOI 10.1034/j.1600-0412.1998.770805.x
   PINTO A, 1991, AM J OBSTET GYNECOL, V164, P507, DOI 10.1016/S0002-9378(11)80010-4
   Ribeiro ACM, 1997, CLIN SCI, V93, P57, DOI 10.1042/cs0930057
   Rutherford RAD, 1995, BRIT J PHARMACOL, V116, P3099, DOI 10.1111/j.1476-5381.1995.tb15111.x
NR 24
TC 13
Z9 13
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD FEB
PY 2004
VL 190
IS 2
BP 468
EP 471
DI 10.1016/j.ajog.2003.08.042
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 778PT
UT WOS:000189250500028
PM 14981391
DA 2020-11-24
ER

PT J
AU Verli, H
   Guimaraes, JA
AF Verli, H
   Guimaraes, JA
TI Molecular dynamics simulation of a decasaccharide fragment of heparin in
   aqueous solution
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE heparin; molecular dynamics; polysaccharide; structure; GROMACS
ID NMR SOLUTION CONFORMATION; FORCE-FIELD; WATER; OLIGOSACCHARIDES;
   ANTITHROMBIN; DESCRIPTORS
AB Molecular dynamics (MD) simulations on heparin-water-sodium systems were carried out in order to establish a simulation protocol able to represent heparin solution conformation under physiological conditions. Atomic charges suitable for heparin oligosaccharides were obtained from ab initio quantum-mechanical computations, at the 6-31G** level. The GROMACS forcefield, the SPC, and SPC/E water models were employed. Also heparin was simulated with IdoA residues in C-1(4) or S-2(0) conformational states. The results of the performed MD simulations are in agreement with the available experimental data, suggesting that this approach can be applied for the study of heparin interactions with its target proteins and thus play a role in the development of new antithrombotic agents. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande Sul, Ctr Biotechnol, BR-91500970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande Sul, Ctr Biotechnol, Caixa Postal 15051,Av Bento Goncalves, BR-91500970 Porto Alegre, RS, Brazil.
EM guimar@dna.cbiot.ufrgs.br
RI Verli, Hugo/G-8703-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Verli, Hugo/0000-0002-4796-8620; Guimaraes, Jorge A./0000-0001-6354-6789
CR ANGULO J, 2003, CHEM COMMUN, V13, P1512
   Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI DOI 10.1007/978-94-015-7658-1_21
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Clare BW, 1998, THEOCHEM-J MOL STRUC, V428, P109, DOI 10.1016/S0166-1280(97)00265-0
   COMPSTON DAS, 1995, ACTA NEUROL SCAND, V91, P43, DOI 10.1111/j.1600-0404.1995.tb05855.x
   Cros S, 1997, BIOORGAN MED CHEM, V5, P1301, DOI 10.1016/S0968-0896(97)00087-4
   DANIELSSON A, 1986, J BIOL CHEM, V261, P5467
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   Engelsen SB, 2001, BIOPHYS CHEM, V93, P103, DOI 10.1016/S0301-4622(01)00215-0
   FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P
   Ferro DR, 1997, J COMPUT CHEM, V18, P351, DOI 10.1002/(SICI)1096-987X(199702)18:3<351::AID-JCC6>3.0.CO;2-T
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
   HOMANS SW, 1990, BIOCHEMISTRY-US, V29, P9110, DOI 10.1021/bi00491a003
   Imberty A, 2000, CHEM REV, V100, P4567, DOI 10.1021/cr990343j
   *IUPAC IUB COMM BI, 1970, J MOL BIOL, V52, P1
   Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683
   Kirschner KN, 2001, P NATL ACAD SCI USA, V98, P10541, DOI 10.1073/pnas.191362798
   LEACH AR, 1996, MOL MODELING PRINCIP, P115
   Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0
   Mikhailov D, 1996, BIOCHEM J, V318, P93, DOI 10.1042/bj3180093
   Mikhailov D, 1997, BIOCHEM J, V328, P51, DOI 10.1042/bj3280051
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849
   Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147
   Nader HB, 2001, BRAZ J MED BIOL RES, V34, P699, DOI 10.1590/S0100-879X2001000600002
   Perez S, 1998, CARBOHYD RES, V314, P141, DOI 10.1016/S0008-6215(98)00305-X
   RAHEM S, 1996, SCIENCE, V276, P1116
   SCHAFTENAAR G, 1997, MOLTEN
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   SILVA ME, 1975, J BIOL CHEM, V250, P6841
   Uedaira H, 2001, B CHEM SOC JPN, V74, P1857, DOI 10.1246/bcsj.74.1857
   vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047
   VANDERSPOEL D, 2001, GROMACS USERS MANUAL
NR 36
TC 58
Z9 59
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
EI 1873-426X
J9 CARBOHYD RES
JI Carbohydr. Res.
PD JAN 22
PY 2004
VL 339
IS 2
BP 281
EP 290
DI 10.1016/j.carres.2003.09.026
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 763UF
UT WOS:000188118300012
PM 14698886
DA 2020-11-24
ER

PT J
AU Pinto, AFM
   Dobrovolski, R
   Veiga, ABG
   Guimaraes, JA
AF Pinto, AFM
   Dobrovolski, R
   Veiga, ABG
   Guimaraes, JA
TI Lonofibrase, a novel alpha-fibrinogenase from Lonomia obliqua
   caterpillars
SO THROMBOSIS RESEARCH
LA English
DT Article
DE lonomia obliqua; fibrinogenase; lonofibrase; hemostasis; hemorrhage;
   bleeding disorder
ID MARINE GREEN-ALGA; FIBRINOLYTIC ENZYME; SERINE-PROTEASE;
   BIOCHEMICAL-CHARACTERIZATION; PROTHROMBIN ACTIVATOR; BETA-FIBRINOGENASE;
   PURIFICATION; VENOM; CONTACT
AB Envenomation caused by Lonomia obliqua caterpillars is an increasing problem in Southern Brazil. The clinical profile is characterized by a profound hemorrhagic disorder. In the present study, we describe the characterization of a fibrin(ogen)olytic factor (lonofibrase) isolated from a venomous secretion of the caterpillars. The crude extract showed a dose-dependent inhibitory effect in the rate of thrombin-induced fibrinogen clotting and produced fragmentation of fibrinogen. Isolation of the fibrin(ogen)olytic enzyme was achieved by combining ion exchange chromatography followed by get filtration in a fast protein liquid chromatography (FPLC) system. A single 35-kDa band was identified and the isolated enzyme named lonofibrase. Lonofibrase rapidly degrades Aalpha and Bbeta chains of fibrinogen, also being able to cleave fibrin in a distinct way from that observed with plasmin. The presence of lonofibrase with both fibrinogenolytic and fibrinolytic activities in L. obliqua secretion is coherent with the severe hemorrhagic clinical profile resulting from envenomation caused by these insects. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@dna.cbiot.ufrgs.br
RI Dobrovolski, Ricardo/B-2580-2013; Guimaraes, Jorge Almeida/V-2196-2019;
   Veiga, Ana B. G./N-8581-2013
OI Dobrovolski, Ricardo/0000-0002-8775-5486; Veiga, Ana B.
   G./0000-0003-1462-5506; Guimaraes, Jorge A./0000-0001-6354-6789; Pinto,
   Antonio/0000-0002-1573-8011
CR ABELLA HB, 1998, MANUAL DIAGOSTICO TR
   Arocha-Pinango CL, 2000, BIOCHIMIE, V82, P937, DOI 10.1016/S0300-9084(00)01164-0
   Arocha-Pinango CL, 2001, HAEMOSTASIS, V31, P288
   AROCHAPINANGO CL, 1969, LANCET, V1, P810
   AROCHAPINANGO CL, 1992, THROMB HAEMOSTASIS, V67, P402
   AROCHAPINANGO CL, 1981, THROMB HAEMOSTASIS, V46, P710
   Cho SY, 1999, J BIOCHEM MOL BIOL, V32, P579
   Coll-Sangrona E, 1998, BRAZ J MED BIOL RES, V31, P779, DOI 10.1590/S0100-879X1998000600009
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   DATTA G, 1995, ARCH BIOCHEM BIOPHYS, V317, P365, DOI 10.1006/abbi.1995.1176
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   Duarte AC, 1996, LANCET, V348, P1033, DOI 10.1016/S0140-6736(05)64961-6
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Gao R, 2002, ARCH BIOCHEM BIOPHYS, V408, P87, DOI 10.1016/S0003-9861(02)00447-2
   Guo YW, 2001, PROTEIN EXPRES PURIF, V23, P483, DOI 10.1006/prep.2001.1531
   Hahn BS, 1999, BBA-PROTEIN STRUCT M, V1430, P376, DOI 10.1016/S0167-4838(99)00024-2
   Hahn BS, 2001, INSECT BIOCHEM MOLEC, V31, P573, DOI 10.1016/S0965-1748(00)00162-4
   Hrzenjak T, 1998, COMP BIOCHEM PHYS B, V119, P825, DOI 10.1016/S0305-0491(98)00060-1
   Jin Y, 2001, TOXICON, V39, P1203, DOI 10.1016/S0041-0101(00)00261-0
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, P283, DOI 10.3109/15569549509019465
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leonardi A, 2002, TOXICON, V40, P55, DOI 10.1016/S0041-0101(01)00188-X
   MARSH NA, 1994, BLOOD COAGUL FIBRIN, V5, P399
   Maruyama M, 2002, TOXICON, V40, P1223, DOI 10.1016/S0041-0101(02)00116-2
   Matsubara K, 2000, COMP BIOCHEM PHYS B, V125, P137, DOI 10.1016/S0305-0491(99)00161-3
   Matsubara K, 1998, COMP BIOCHEM PHYS B, V119, P177, DOI 10.1016/S0305-0491(97)00303-9
   Matsubara K, 1999, PHYTOCHEMISTRY, V52, P993, DOI 10.1016/S0031-9422(99)00356-8
   *MIN SAUD, 1998, MAN DIAGN TRAT AC AM
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   OUYANG C, 1983, TOXICON, V21, P25, DOI 10.1016/0041-0101(83)90046-6
   PINTO AFM, 2000, 6 S SOC BRAS TOX SAO, P140
   Reis CV, 2001, THROMB RES, V102, P427, DOI 10.1016/S0049-3848(01)00265-1
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   Rocha-Campos ACM, 2001, AM J TROP MED HYG, V64, P283, DOI 10.4269/ajtmh.2001.64.283
   ROCHACAMPOS ACM, 1997, 12 WORLD C INT SOC T
   Samel M, 2002, TOXICON, V40, P51, DOI 10.1016/S0041-0101(01)00187-8
   SCOBLE MJ, 1992, LEPIDOPTERA FORM FUN, P117
   SIIGUR E, 1991, TOXICON, V29, P107, DOI 10.1016/0041-0101(91)90043-Q
   Swenson S, 2000, ARCH BIOCHEM BIOPHYS, V384, P227, DOI 10.1006/abbi.2000.2129
   TENG CM, 1985, TOXICON, V23, P777
   Veiga ABG, 2003, THROMB RES, V111, P95, DOI 10.1016/j.thromres.2003.08.020
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
NR 43
TC 44
Z9 49
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PY 2004
VL 113
IS 2
BP 147
EP 154
DI 10.1016/j.thromres.2004.01.012
PG 8
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 819FZ
UT WOS:000221301500007
PM 15115670
DA 2020-11-24
ER

PT J
AU Fuly, AL
   Calil-Elias, S
   Martinez, AMB
   Melo, PA
   Guimaraes, JA
AF Fuly, AL
   Calil-Elias, S
   Martinez, AMB
   Melo, PA
   Guimaraes, JA
TI Myotoxicity induced by an acidic Asp-49 phospholipase A(2) isolated from
   Lachesis muta snake venom Comparison with lysophosphatidylcholine
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Lachesis muta venom; phospholipase A(2); Asp-49 PLA(2); myotoxicity;
   lysophosphatidylcholine
ID AGKISTRODON-PISCIVORUS-PISCIVORUS; BOTHROPS-ASPER TERCIOPELO;
   P-BROMOPHENACYL BROMIDE; LYSINE-49 PHOSPHOLIPASE-A2; PIRATOXIN-I;
   PHOSPHATIDYLCHOLINE BREAKDOWN; PHARMACOLOGICAL PROPERTIES;
   BIOLOGICAL-ACTIVITIES; SARCOPLASMIC ENZYMES; SIGNAL-TRANSDUCTION
AB In a previous report we showed that Lachesis muta crude venom displays potent indirect hemolytic activity and myotoxicity when injected into mice. Then, a phospholipase A(2) (PLA(2)) (LM-PLA(2)-I) responsible for these activities was isolated. More recently, a catalytically active isoenzyme (LM-PLA(2)-II) with molecular mass of 18 kDa and isoeletric point at pH 5.4 was isolated from the same snake venom. LM-PLA(2)-II inhibited ADP- and collagen-induced platelet aggregation as well as induced a potent paw edema reaction in rats. Here we show that LM-PLA(2)-II induced myotoxic effects both in vitro characterized by an increase on the rate of creatine kinase (CK) release from isolated mice extensor digitorum longus (EDL) muscles and in vivo by increasing plasma CK activity of injected mice. Histological analysis showed an intense damage in muscle cells injected with LM-PLA(2)-II. It was also shown that exogenous lysophosphatidylcholine (lyso-pe) behaved as a typical myotoxin damaging muscle cells, producing myonecrosis characterized by local infiltration of inflammatory cells similarly to that observed for LM-PLA(2)-II. Hemorrhage and lethal effects were not observed neither with LM-PLA(2)-II nor lyso-pc. As previously observed for other biological activities, pretreatment of LM-PLA(2)-II with p-bromophenacyl bromide (p-BPB) or acetic anhydride abolished all the enzyme's actions. The data confirms that biological activities displayed by LM-PLA(2)-II, including the myotoxic effects reported here, are all dependent on its enzymatic activity where the product formed (lyso-pc) may play an important function on such myotoxicity. (C) 2003 Elsevier Science Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Dept Farmacol Basica & Clin, Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Histol & Embriol, Rio De Janeiro, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Av Bento Goncalves 9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@dna.cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Martinez, Ana/C-6318-2014; Fuly,
   Andre/U-1538-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR Calderon L, 1999, TOXICON, V37, P683, DOI 10.1016/S0041-0101(98)00211-6
   Chaves F, 1998, TOXICON, V36, P1861, DOI 10.1016/S0041-0101(98)00107-X
   Chioato L, 2002, BIOCHEM J, V366, P971, DOI 10.1042/BJ20020092
   Chun J, 1999, CRIT REV NEUROBIOL, V13, P151, DOI 10.1615/CritRevNeurobiol.v13.i2.20
   De Azevedo WF, 1998, TOXICON, V36, P1395, DOI 10.1016/S0041-0101(98)00017-8
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DIAZ C, 1993, TOXICON, V31, P1202, DOI 10.1016/0041-0101(93)90136-7
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   Evans J, 1999, TOXICON, V37, P633, DOI 10.1016/S0041-0101(98)00202-5
   EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4
   EXTON JH, 1990, J BIOL CHEM, V265, P1
   Fletcher JE, 1998, TOXICON, V36, P1549, DOI 10.1016/S0041-0101(98)00147-0
   FRANCIS B, 1991, ARCH BIOCHEM BIOPHYS, V284, P352, DOI 10.1016/0003-9861(91)90307-5
   Fully AL, 2002, BIOCHEM PHARMACOL, V63, P1589, DOI 10.1016/S0006-2952(02)00873-0
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   Fuly AL, 2000, TOXICON, V38, P961, DOI 10.1016/S0041-0101(99)00208-1
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071
   HOLLAND DR, 1990, J BIOL CHEM, V265, P17649
   KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   Kini RM, 1997, VENOM PHOSPHOLIPASE, P1
   Kondo H., 1960, Japanese Journal of Medical Science and Biology, V18, P43
   Landucci ECT, 1998, EUR J PHARMACOL, V343, P257, DOI 10.1016/S0014-2999(97)01546-X
   Landucci ECT, 2000, BIOCHEM PHARMACOL, V59, P1289, DOI 10.1016/S0006-2952(00)00248-3
   MARAGANORE JM, 1986, J BIOL CHEM, V261, P4797
   Masamune A, 2001, DIGEST DIS SCI, V46, P1871, DOI 10.1023/A:1010622828502
   Masamune A, 2001, PANCREAS, V22, P75, DOI 10.1097/00006676-200101000-00014
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   MELO PA, 1988, TOXICON, V26, P87, DOI 10.1016/0041-0101(88)90140-7
   MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545
   Melo PA, 1999, TOXICON, V37, P199, DOI 10.1016/S0041-0101(98)00183-4
   MOURADASILVA AM, 1991, TOXICON, V29, P713, DOI 10.1016/0041-0101(91)90063-W
   Nunez CE, 2001, TOXICON, V39, P1587, DOI 10.1016/S0041-0101(01)00141-6
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Prokazova NV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P31
   SCOTT DL, 1992, J BIOL CHEM, V267, P22645
   Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5
   Soares AM, 2001, ARCH BIOCHEM BIOPHYS, V387, P188, DOI 10.1006/abbi.2000.2244
   SUAREZKURTZ G, 1981, AM J PHYSIOL, V241, pC98
   Sugiyama S, 1998, ARTERIOSCL THROM VAS, V18, P568, DOI 10.1161/01.ATV.18.4.568
   Ward RJ, 2002, BIOCHEM J, V362, P89, DOI 10.1042/0264-6021:3620089
   Weiner JA, 1998, J COMP NEUROL, V398, P587
   Yuan YP, 1996, J BIOL CHEM, V271, P27090, DOI 10.1074/jbc.271.43.27090
   Zhao HY, 1998, TOXICON, V36, P875, DOI 10.1016/S0041-0101(97)00169-4
   Zhao KH, 1998, ACTA CRYSTALLOGR D, V54, P510, DOI 10.1107/S0907444997013644
NR 46
TC 35
Z9 35
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD OCT
PY 2003
VL 35
IS 10
BP 1470
EP 1481
DI 10.1016/S1357-2725(03)00129-8
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 706VG
UT WOS:000184475300007
PM 12818242
DA 2020-11-24
ER

PT J
AU Mendes-Silva, W
   Assafim, M
   Ruta, B
   Monteiro, RQ
   Guimaraes, JA
   Zingali, RB
AF Mendes-Silva, W
   Assafim, M
   Ruta, B
   Monteiro, RQ
   Guimaraes, JA
   Zingali, RB
TI Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin
   inhibitor
SO THROMBOSIS RESEARCH
LA English
DT Article
DE Glycyrrhizin; thrombin; venous thrombosis; arteriovenous shunt; rats
ID ANION-BINDING EXOSITE; HUMAN ALPHA-THROMBIN; VENOUS THROMBOSIS;
   IN-VITRO; HEPARIN; MODELS; RATS; ARTERIAL; HIRUDIN; PHARMACOKINETICS
AB Glycyrrhizin (GL), an anti-inflammatory compound isolated from licorice (Glycyrrhiza glabra), has been previously identified as a thrombin inhibitor (Francischetti et al., Biochem Biophys Res Commun 1997;235:259-63). Here we report the in vivo effects of GL upon two experimental models of induced thrombosis in rats. Intravenous administration of GL caused a dose-dependent reduction in thrombus size on a venous thrombosis model that combines stasis and hypercoagulability. It was observed that GL doses of 180 mg/kg body weight produced 93% decrease on thrombus weight. This effect showed a time-dependent pattern being significantly reduced when the thrombogenic stimulus was applied 60 min after drug administration. GL was also able to prevent thrombosis using an arteriovenous shunt model. GL doses of 180 and 360 mg/kg decreased the thrombus weight by 35 and 90%, respectively. Accordingly, the APTT ex vivo was enhanced by 1.5- and 4.3-fold at GL doses of 180 and 360 mg/kg, respectively. In addition, GL doses above 90 mg/kg caused significant hemorrhagic effect. In contrast with heparin, GL did not potentiate the inhibitory activity of antithrombin III or heparin cofactor 11 towards thrombin. Altogether, data indicate that GL is an effective thrombin inhibitor in vivo, which may account for its other known pharmacological properties. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio Grande Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP Zingali, RB (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
EM lzingali@bioqmed.ufrj.br
RI DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; de Queiroz Monteiro,
   Robson/M-7097-2019; Zingali, Russolina/G-4862-2012; Guimaraes, Jorge
   Almeida/V-2196-2019
OI de Queiroz Monteiro, Robson/0000-0002-5260-2332; Mendes da Silva,
   Wallace/0000-0002-5195-4061; Guimaraes, Jorge A./0000-0001-6354-6789
CR AKAMATSU H, 1991, PLANTA MED, V57, P119, DOI 10.1055/s-2006-960045
   Akao T, 1998, BIOL PHARM BULL, V21, P1036
   AKAO T, 1991, BIOCHEM PHARMACOL, V41, P1025
   BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310
   Cho J, 2000, THROMB RES, V100, P97, DOI 10.1016/S0049-3848(00)00298-X
   Cho JH, 2001, THROMB HAEMOSTASIS, V86, P1512
   Farias WRL, 2001, THROMB HAEMOSTASIS, V86, P1540
   FENTON JW, 1988, BIOCHEMISTRY-US, V27, P7106, DOI 10.1021/bi00418a066
   Finkle CD, 1998, THROMB HAEMOSTASIS, V79, P431
   Gillis S, 1997, SEMIN HEMATOL, V34, P336
   GUILLIN MC, 1995, THROMB HAEMOSTASIS, V74, P129
   Herbert JM, 1996, CIRC RES, V79, P590, DOI 10.1161/01.RES.79.3.590
   ISHIDA S, 1992, CHEM PHARM BULL, V40, P1917
   KRSTENANSKY JL, 1987, FEBS LETT, V211, P10, DOI 10.1016/0014-5793(87)81264-4
   LIU LW, 1991, J BIOL CHEM, V266, P16977
   LONGSTAFF C, 1992, THROMB HAEMOSTASIS, V67, P533
   Maragoudakis ME, 2000, MATRIX BIOL, V19, P345, DOI 10.1016/S0945-053X(00)00079-2
   Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735
   MONDER C, 1989, ENDOCRINOLOGY, V125, P1046, DOI 10.1210/endo-125-2-1046
   Muramatsu R, 1997, THROMB RES, V86, P453, DOI 10.1016/S0049-3848(97)00094-7
   NGAI PK, 1991, BIOCHEM J, V280, P805, DOI 10.1042/bj2800805
   NIERODZIK ML, 1995, THROMB HAEMOSTASIS, V74, P282
   NISHINO H, 1984, CARCINOGENESIS, V5, P1529, DOI 10.1093/carcin/5.11.1529
   Pineo G F, 1999, Curr Opin Hematol, V6, P298, DOI 10.1097/00062752-199909000-00005
   POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0
   RAO BNN, 1994, J BIOL CHEM, V269, P19663
   SCHUMACHER WA, 1993, J PHARMACOL EXP THER, V267, P1237
   SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518
   STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6
   TAKEDA H, 1991, Tokai Journal of Experimental and Clinical Medicine, V16, P183
   TOLLEFSEN DM, 1995, THROMB HAEMOSTASIS, V74, P1209
   TSAI TH, 1992, J PHARM SCI-US, V81, P961, DOI 10.1002/jps.2600810925
   UMETSU T, 1978, THROMB HAEMOSTASIS, V39, P74
   Verstraete M, 1997, THROMB HAEMOSTASIS, V78, P357
   VOGEL GMT, 1989, THROMB RES, V54, P399, DOI 10.1016/0049-3848(89)90210-7
   Weitz JI, 2001, CHEST, V119, p95S, DOI 10.1378/chest.119.1_suppl.95S
NR 36
TC 52
Z9 56
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PY 2003
VL 112
IS 1-2
BP 93
EP 98
DI 10.1016/j.thromres.2003.10.014
PG 6
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 775KP
UT WOS:000189039700015
PM 15013279
DA 2020-11-24
ER

PT J
AU Veiga, ABG
   Pinto, AFM
   Guimaraes, JA
AF Veiga, ABG
   Pinto, AFM
   Guimaraes, JA
TI Fibrinogenolytic and procoagulant activities in the hemorrhagic syndrome
   caused by Lonomia obliqua caterpillars
SO THROMBOSIS RESEARCH
LA English
DT Article
DE fibrinogenolytic activity; hemorrhagic syndrome; Lonomia obliqua;
   procoagulant activity; venoms
ID BLOOD-COAGULATION; SERINE-PROTEASE; VENOM; PROTHROMBIN; ACTIVATION;
   BOTHROJARACIN; PURIFICATION; PROTEINS; CONTACT
AB The hemorrhagic syndrome caused by accidents with caterpillars of the genus Lonomia has been the focus of several clinical and biochemical studies, since its venom is composed of many active principles that interfere with the hemostatic system. Whereas a fibrinolytic agent has been characterized in the venom of Lonomia achelous, in Lonomia obliqua, only a prothrombin activator activity has been reported so far, even though both species cause similar bleeding disorders, characterized by hemorrhage, disseminated intravascular coagulation (DIC), and acute renal failure. Considering the possibility that the hemorrhagic syndrome resulting from envenoming by L. obliqua may be due to fibrinolytic and procoagulant activities acting together, we decided to investigate the effects of bristle extract (BE) of this species upon blood coagulation and fibrin(ogen)olysis. This study shows that besides a procoagulant activity related to the activation of prothrombin, the venom contains at least one fibrin(ogen)olytic activity as shown by fibrinolysis in a fibrin (F) plate assay, by interference in thrombin-catalyzed fibrinocoagulation, and by polyacrylamide gel electrophoresis profile of fibrin and fibrinogen (Fg) degradation. Considering that a recombinant prothrombin activator from L. obliqua has been suggested in other studies to be used as an anti-thrombotic agent, it is important in the first place to better characterize the different active principles of this venom. (C) 2003 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, Av Bento Goncalves,9500,POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@dna.cbiot.ufrgs.br
RI Veiga, Ana B. G./N-8581-2013; Guimaraes, Jorge Almeida/V-2196-2019
OI Veiga, Ana B. G./0000-0003-1462-5506; Pinto,
   Antonio/0000-0002-1573-8011; Guimaraes, Jorge A./0000-0001-6354-6789
CR Arocha-Pinango C.L., 1988, Hematology (New York), V7, P223
   Arocha-Pinango CL, 1999, LANCET, V354, P1304, DOI 10.1016/S0140-6736(05)76080-3
   Arocha-Pinango CL, 2001, HAEMOSTASIS, V31, P288
   AROCHAPINANGO CL, 1981, THROMB HAEMOSTASIS, V45, P233
   AROCHAPINANGO CL, 1967, ACTA CIENT VENEZ, V18, P136
   Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0
   Couppie P, 1998, ANN DERMATOL VENER, V125, P489
   daSilva WD, 1996, TOXICON, V34, P1045, DOI 10.1016/0041-0101(96)00052-9
   DING ZK, 1995, PREP BIOCHEM, V25, P21, DOI 10.1080/10826069508010105
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   Duarte AC, 1996, LANCET, V348, P1033, DOI 10.1016/S0140-6736(05)64961-6
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Fan Hui Wen, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P119
   GUERRERO B, 1992, THROMB RES, V66, P169, DOI 10.1016/0049-3848(92)90187-F
   Guerrero B, 2001, BLOOD COAGUL FIBRIN, V12, P521, DOI 10.1097/00001721-200110000-00003
   Guerrero BAG, 1997, THROMB RES, V87, P83, DOI 10.1016/S0049-3848(97)00107-2
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lopez M, 2000, THROMB RES, V98, P103, DOI 10.1016/S0049-3848(99)00209-1
   Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3
   Markwardt F, 1970, METHOD ENZYMOL, V19, P924, DOI [10.1016/0076-6879(70)19082-3, DOI 10.1016/0076-6879(70)19082-3]
   Marval E, 1999, TOXICON, V37, P1491, DOI 10.1016/S0041-0101(99)00085-9
   Matsui T, 2000, BBA-PROTEIN STRUCT M, V1477, P146, DOI 10.1016/S0167-4838(99)00268-X
   Monteiro RQ, 1999, BIOCHEM BIOPH RES CO, V262, P819, DOI 10.1006/bbrc.1999.1297
   NICOLELLA, 2003, RELATORIO ATENDIMENT, P16
   Parkin JD, 2002, PATHOLOGY, V34, P162, DOI 10.1080/003130201201118098
   PINTO AFM, 2000, TOXINS ANIMALSS PLAN, P178
   PIRKLW H, 1988, HEMATOLOGY, V7
   Prezoto BC, 2002, BRAZ J MED BIOL RES, V35, P703, DOI 10.1590/S0100-879X2002000600011
   Reis CV, 2001, THROMB RES, V102, P427, DOI 10.1016/S0049-3848(01)00265-1
   Reis CV, 1999, LANCET, V353, P1942, DOI 10.1016/S0140-6736(99)01777-8
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   SHACTER E, 1995, FREE RADICAL BIO MED, V18, P815, DOI 10.1016/0891-5849(95)93872-4
   Veiga ABG, 2001, TOXICON, V39, P1343, DOI 10.1016/S0041-0101(01)00086-1
   Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
   2001, PESQUISA FAPESP, V67, P42
NR 36
TC 31
Z9 35
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PY 2003
VL 111
IS 1-2
BP 95
EP 101
DI 10.1016/j.thromres.2003.08.020
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 758CT
UT WOS:000187615500016
PM 14644086
DA 2020-11-24
ER

PT J
AU Bastiani, M
   Hillebrand, S
   Horn, F
   Kist, TBL
   Guimaraes, JA
   Termignoni, C
AF Bastiani, M
   Hillebrand, S
   Horn, F
   Kist, TBL
   Guimaraes, JA
   Termignoni, C
TI Cattle tick Boophilus microplus salivary gland contains a
   thiol-activated metalloendopeptidase displaying kininase activity
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE kininase; Boophilus; tick salivary glands; thimet oligoendopeptidase
ID ANGIOTENSIN-CONVERTING ENZYME; THIMET OLIGOPEPTIDASE; CONCEALED ANTIGEN;
   ENDOPEPTIDASE; PURIFICATION; DEGRADATION; INHIBITORS; HYDROLYSIS
AB This work reports on the characterization of a metalloendopeptidase kininase present in Boophilus microplus salivary glands. Using the guinea pig ileum assay, salivary gland whole extracts (SGE). were found to have a potent kininase activity. Ion-exchange chromatography separated two kininase activities from SGE. The major enzymatic component, eluted at lower ionic strength, was named BooKase (Boophilus Kininase). Analysis of the hydrolysis products by capillary electrophoresis identified Phe(5)-Ser(6) as the only hydrolyzable peptide bond in bradykinin after BooKase treatment. This is the same specificity as the mammalian thimet oligoendopeptidase (EC 3.4.24.15). Like this enzyme, BooKase is also a metallo-peptidase (requires Mn2+) and is activated by SH protecting reagents. In addition, BooKase was partially inhibited by cFP-AAF-pAB, a specific inhibitor of thimet oligopeptidase. Contrary to other kininases, BooKase had no actitivy upon angiontensin I. Our results show that BooKase behaves as a typical peptidase with kinase activity. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Dept Biofis, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Dept Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio Grande do Sul, Dept Bioquim, BR-91501970 Porto Alegre, RS, Brazil.
RP Termignoni, C (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Caixa Postal 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM trmgn@dna.cbiot.ufrgs.br
RI Bastiani, Michele/J-1823-2014; Guimaraes, Jorge Almeida/V-2196-2019;
   Termignoni, Carlos/AAB-8943-2020; Horn, Fabiana/K-9637-2013; Kist,
   Tarso/Q-2414-2016
OI Bastiani, Michele/0000-0001-6752-4157; Termignoni,
   Carlos/0000-0002-2789-2518; Kist, Tarso/0000-0002-4739-8066; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR BARRETT AJ, 1990, BIOCHEM J, V271, P701, DOI 10.1042/bj2710701
   BHOOLA KD, 1992, PHARMACOL REV, V44, P1
   BORGES DR, 1979, N-S ARCH PHARMACOL, V309, P197, DOI 10.1007/BF00501229
   Calixto JB, 2000, PAIN, V87, P1, DOI 10.1016/S0304-3959(00)00335-3
   Camargo A C, 1983, Adv Exp Med Biol, V156 (Pt B), P855
   CAMARGO ACM, 1983, BIOCHEM BIOPH RES CO, V116, P1151, DOI 10.1016/S0006-291X(83)80263-0
   DANDO PM, 1993, BIOCHEM J, V294, P451, DOI 10.1042/bj2940451
   ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363
   FERREIRA SH, 1985, DRUGS, V30, P1, DOI 10.2165/00003495-198500301-00002
   Horn F, 2000, ARCH BIOCHEM BIOPHYS, V384, P68, DOI 10.1006/abbi.2000.2076
   HRYCYNA CA, 1993, BIOCHEMISTRY-US, V32, P11293, DOI 10.1021/bi00093a005
   JARMEY JM, 1995, INSECT BIOCHEM MOLEC, V25, P969, DOI 10.1016/0965-1748(95)00038-W
   KIST TBL, 1994, BRAZ J MED BIOL RES, V27, P11
   Lamango NS, 1997, PEPTIDES, V18, P47, DOI 10.1016/S0196-9781(96)00232-X
   Lesser M, 1996, PEPTIDES, V17, P13, DOI 10.1016/0196-9781(95)02061-6
   Molina HM, 2000, LIFE SCI, V67, P509, DOI 10.1016/S0024-3205(00)00650-0
   OLIVEIRA MCF, 1992, ANAL BIOCHEM, V203, P39, DOI 10.1016/0003-2697(92)90040-E
   ORLOWSKI M, 1988, BIOCHEMISTRY-US, V27, P597, DOI 10.1021/bi00402a015
   Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251
   Quinto BMR, 2000, INT J BIOCHEM CELL B, V32, P1161, DOI 10.1016/S1357-2725(00)00060-1
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   Ribeiro JMC, 1998, EXP PARASITOL, V89, P213, DOI 10.1006/expr.1998.4296
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   RIDING GA, 1994, J IMMUNOL, V153, P5158
   Sauer JR, 2000, J INSECT PHYSIOL, V46, P1069, DOI 10.1016/S0022-1910(99)00210-3
   SILVA MRE, 1949, AM J PHYSIOL, V156, P261, DOI 10.1152/ajplegacy.1949.156.2.261
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777
NR 28
TC 17
Z9 17
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD NOV
PY 2002
VL 32
IS 11
BP 1439
EP 1446
AR PII S0965-1748(02)00064-4
DI 10.1016/S0965-1748(02)00064-4
PG 8
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA 608MH
UT WOS:000178849800010
PM 12530211
DA 2020-11-24
ER

PT J
AU Fully, AL
   de Miranda, ALP
   Zingali, RB
   Guimaraes, JA
AF Fully, AL
   de Miranda, ALP
   Zingali, RB
   Guimaraes, JA
TI Purification and characterization of a phospholipase A(2) isoenzyme
   isolated from Lachesis muta snake venom
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE Lachesis muta venom; purification of phospholipase A(2); platelet
   aggregation; edema; myotoxicity; lysophosphatidylcholine
ID PLATELET-AGGREGATION; PAW EDEMA; A(2); LYSOPHOSPHATIDYLCHOLINE;
   ACTIVATION; PROTEINS; TRIMERESURUS; RELEASE; ENZYMES; ACID
AB A new phospholipase A(2) (PLA(2)) isoenzyme was isolated from Lachesis muta crude venom, and was named LM-PLA(2)-II. This enzyme was purified by gel filtration on a Sephacryl S-200 HR column followed by reverse-phase chromatography on a C-2/C-18 column. LM-PLA(2)-II consists of a single polypeptide chain with an apparent molecular mass of 18 kDa and an isoelectric point at pH 5.4. The amino terminal sequence of the enzyme revealed a high degree of homology with other PLA(2)s from several sources. LM-PLA(2)-II has a high indirect hemolytic activity and a potent inhibitory effect on platelet aggregation induced by ADP and collagen. It also produces a significant paw edema reaction in rats. The edematous response in rats was abolished by pretreatment with either indomethacin or dexamethasone, suggesting the involvement of cyclo-oxygenase. Pretreatment of LM-PLA(2)-II with p-bromophenacyl bromide abolished all of these actions, clearly indicating that the biological activities, including the edematogenic effect, are dependent entirely on its enzymatic activity. (C) 2002 Elsevier Science Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21945 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio de Janeiro, Fac Farm, BR-21945 Rio De Janeiro, RJ, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, POB 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@dna.cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019; Zingali, Russolina/G-4862-2012
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR ARDLIE NG, 1970, BRIT J HAEMATOL, V19, P7, DOI 10.1111/j.1365-2141.1970.tb01596.x
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CHEN YC, 1987, TOXICON, V25, P401, DOI 10.1016/0041-0101(87)90073-0
   de Moura RS, 1998, TOXICON, V36, P771, DOI 10.1016/S0041-0101(97)00113-X
   DHILLON DS, 1987, BIOCHEM PHARMACOL, V36, P1723, DOI 10.1016/0006-2952(87)90059-1
   EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4
   FERREIRA S H, 1979, Journal of Pharmacy and Pharmacology, V31, P648
   FLEER EAM, 1978, EUR J BIOCHEM, V82, P261, DOI 10.1111/j.1432-1033.1978.tb12019.x
   Fortes-Dias CL, 1999, TOXICON, V37, P1747, DOI 10.1016/S0041-0101(99)00116-6
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V353, P239, DOI 10.1006/abbi.1998.0598
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   FULY AL, 1993, BRAZ J MED BIOL RES, V26, P459
   Fuly AL, 2000, TOXICON, V38, P961, DOI 10.1016/S0041-0101(99)00208-1
   Geoghegan P, 1999, TOXICON, V37, P1735, DOI 10.1016/S0041-0101(99)00115-4
   Huang MZ, 1997, ARCH BIOCHEM BIOPHYS, V338, P150, DOI 10.1006/abbi.1996.9814
   KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Landucci ECT, 1998, EUR J PHARMACOL, V343, P257, DOI 10.1016/S0014-2999(97)01546-X
   MEBS D, 1983, TOXINS TOOLS NEUROCH, P337
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Prokazova NV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P31
   Rosenberg P., 1986, NATURAL TOXINS ANIMA, P129
   Serrano SMT, 1999, ARCH BIOCHEM BIOPHYS, V367, P26, DOI 10.1006/abbi.1999.1230
   TETSUTARO S, 1991, P NATL ACAD SCI USA, V88, P5149
   TOMOO K, 1992, BIOCHEM BIOPH RES CO, V184, P137, DOI 10.1016/0006-291X(92)91169-Q
   VALIENTE C, 1992, TOXICON, V30, P815, DOI 10.1016/0041-0101(92)90379-J
   VISHWANATH BS, 1987, TOXICON, V25, P501
   WANG JP, 1990, EUR J PHARMACOL, V190, P347, DOI 10.1016/0014-2999(90)94199-8
   WANG JP, 1990, J PHARM PHARMACOL, V42, P846, DOI 10.1111/j.2042-7158.1990.tb07038.x
   Wong JT, 1998, J BIOL CHEM, V273, P6830, DOI 10.1074/jbc.273.12.6830
   Yuan YP, 1996, J BIOL CHEM, V271, P27090, DOI 10.1074/jbc.271.43.27090
NR 31
TC 58
Z9 63
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD MAY 1
PY 2002
VL 63
IS 9
BP 1589
EP 1597
AR PII S0006-2952(02)00873-0
DI 10.1016/S0006-2952(02)00873-0
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 565JA
UT WOS:000176365100003
PM 12007562
DA 2020-11-24
ER

PT J
AU Follmer, C
   Barcellos, GBS
   Zingali, RB
   Machado, OLT
   Alves, EW
   Barja-Fidalgo, C
   Guimaraes, JA
   Carlini, CR
AF Follmer, C
   Barcellos, GBS
   Zingali, RB
   Machado, OLT
   Alves, EW
   Barja-Fidalgo, C
   Guimaraes, JA
   Carlini, CR
TI Canatoxin, a toxic protein from jack beans (Canavalia ensiformis), is a
   variant form of urease (EC 3.5.1.5): biological effects of urease
   independent of its ureolytic activity
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE isoenzyme; multidomain; nickel; metalloprotein; zinc
ID AMINO-ACID SEQUENCE; AFFINITY-CHROMATOGRAPHY; PROTEOLYTIC ACTIVATION;
   CIRCULATING LEVELS; CONCANAVALIN-A; SEEDS; PLANT; ENZYME; RAT;
   INHIBITION
AB Canatoxin is a toxic protein from Canavalia ensiformis seeds, lethal to mice (LD50 = 2 mg/kg) and insects. Further characterization of canatoxin showed that its main native form (184 kDa) is a non-covalently linked dimer of a 95 kDa polypeptide containing zinc and nickel. Partial sequencing of internal peptides indicated homology with urease (EC 3.5.1.5) from the same seed. Canatoxin has approx. 30% of urease's activity for urea, and K-m of 2-7 mM. The proteins differ in their affinities for metal ions and were separated by affinity chromatography on a Zn2+ matrix. Similar to canatoxin, urease activates blood platelets and interacts with glycoconjugates. In contrast with canatoxin, no lethality was seen in mice injected with urease (10 mg/kg). Pretreatment with p-hydroxymercuribenzoate irreversibly abolished the ureolytic activity of both proteins. On the other hand, p-hydroxymercuribenzoate-treated canatoxin was still lethal to mice, and both treated proteins were fully active in promoting platelet aggregation and binding to glycoconjugates. Taken together, our data indicate that canatoxin is a variant form of urease. Moreover, we show for the first time that these proteins display several biological effects that are unrelated to their enzymic activity for urea.
C1 Univ Fed Rio Grande do Sul, Dept Biophys, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, ICB, Dept Biochem, BR-21941590 Rio De Janeiro, Brazil.
   Univ Esadual Rio De Janeiro, Dept Pharmacol, BR-20551030 Rio De Janeiro, RJ, Brazil.
   Univ Fed Rio Grande do Sul, Ctr Biotechnol, Dept Mol Biol & Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
RP Carlini, CR (corresponding author), Univ Fed Rio Grande do Sul, Dept Biophys, 1B,Av Bento Goncalves N 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM ccarlini@vortex.ufrgs.br
RI Machado, Olga/P-1944-2019; Machado, Olga/G-7461-2012; Follmer,
   Cristian/O-6134-2016; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011; Guimaraes, Jorge Almeida/V-2196-2019; Zingali,
   Russolina/G-4862-2012
OI Follmer, Cristian/0000-0001-6178-0432; da Silva Carlini, Celia Regina
   Ribeiro/0000-0002-7027-2445; Guimaraes, Jorge A./0000-0001-6354-6789
CR ALVES EW, 1992, TOXICON, V30, P1411, DOI 10.1016/0041-0101(92)90516-8
   ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BARCELLOS GBS, 1993, PLANTA, V189, P397, DOI 10.1007/BF00194437
   BARJAFIDALGO C, 1991, TOXICON, V29, P453, DOI 10.1016/0041-0101(91)90019-N
   BARJAFIDALGO C, 1991, ENDOCRINOLOGY, V128, P675, DOI 10.1210/endo-128-2-675
   BENJAMIN CF, 1992, TOXICON, V30, P879, DOI 10.1016/0041-0101(92)90386-J
   Campbell JL, 2000, NUCL INSTRUM METH B, V170, P193, DOI 10.1016/S0168-583X(00)00156-7
   Carlini CR, 1997, J ECON ENTOMOL, V90, P340, DOI 10.1093/jee/90.2.340
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1991, TOXICON, V29, P791, DOI 10.1016/0041-0101(91)90216-E
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   Cleland W W, 1979, Methods Enzymol, V63, P103
   COLLARES CB, 1988, BRAZ J MED BIOL RES, V21, P107
   DELLAMORAORTIZ GM, 1986, ARCH BIOCHEM BIOPHYS, V251, P205, DOI 10.1016/0003-9861(86)90067-6
   DIXON NE, 1980, CAN J BIOCHEM CELL B, V58, P1323, DOI 10.1139/o80-180
   DIXON NE, 1975, J AM CHEM SOC, V97, P4130, DOI 10.1021/ja00847a044
   DIXON NE, 1975, J AM CHEM SOC, V97, P4131, DOI 10.1021/ja00847a045
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Ferreira-DaSilva CT, 2000, ARCH INSECT BIOCHEM, V44, P162, DOI 10.1002/1520-6327(200008)44:4&lt;162::AID-ARCH3&gt;3.0.CO;2-#
   FISHBEIN WN, 1976, ARCH BIOCHEM BIOPHYS, V172, P726, DOI 10.1016/0003-9861(76)90130-2
   FISHBEIN WN, 1969, NATURE, V223, P191, DOI 10.1038/223191a0
   Ghazaleh FA, 1997, ARCH BIOCHEM BIOPHYS, V339, P362, DOI 10.1006/abbi.1997.9898
   GRASSIKASSISSE DM, 1992, AGENTS ACTIONS, V37, P204, DOI 10.1007/BF02028110
   JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395
   JONES BD, 1989, J BACTERIOL, V171, P6414, DOI 10.1128/jb.171.12.6414-6422.1989
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   LYNN KR, 1971, ENZYMOLOGIA, V41, P329
   LYNN KR, 1970, CAN J BIOCHEM CELL B, V48, P631, DOI 10.1139/o70-101
   MALMQVIST KG, 1990, NUCL INSTRUM METH B, V49, P183, DOI 10.1016/0168-583X(90)90239-Q
   MAMIYA G, 1985, P JPN ACAD B-PHYS, V61, P395, DOI 10.2183/pjab.61.395
   MANGELSON NF, 1977, NUCL INSTRUM METHODS, V142, P133, DOI 10.1016/0029-554X(77)90821-7
   MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995
   MOBLEY HLT, 1991, SCAND J GASTROENTERO, V26, P39, DOI 10.3109/00365529109098223
   NISHINO N, 1979, BIOCHEMISTRY-US, V18, P4340, DOI 10.1021/bi00587a012
   OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347
   PEC EA, 1992, J PHARM SCI-US, V81, P626, DOI 10.1002/jps.2600810707
   POLACCO JC, 1979, J BIOL CHEM, V254, P1707
   POLACCO JC, 1984, PLANT PHYSIOL, V74, P800, DOI 10.1104/pp.74.4.800
   POLACCO JC, 1985, PLANT PHYSIOL, V79, P794, DOI 10.1104/pp.79.3.794
   POLACCO JC, 1993, INT REV CYTOL, V145, P65, DOI 10.1016/S0074-7696(08)60425-8
   PORATH J, 1992, PROTEIN EXPRES PURIF, V3, P263, DOI 10.1016/1046-5928(92)90001-D
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P387
   RIBEIRODASILVA G, 1993, TOXICON, V31, P1131, DOI 10.1016/0041-0101(93)90128-6
   RIDDLES PW, 1991, GENE, V108, P265, DOI 10.1016/0378-1119(91)90443-F
   RIDDLES PW, 1983, BIOCHIM BIOPHYS ACTA, V743, P115, DOI 10.1016/0167-4838(83)90424-7
   SAMMOUR RH, 1984, PLANTA, V161, P61, DOI 10.1007/BF00951461
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   Sumner JB, 1926, J BIOL CHEM, V69, P435
   Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936
   TAKISHIMA K, 1988, EUR J BIOCHEM, V175, P151, DOI 10.1111/j.1432-1033.1988.tb14177.x
   Tauber H, 1931, J BIOL CHEM, V92, P177
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   ZERNER B, 1991, BIOORG CHEM, V19, P116, DOI 10.1016/0045-2068(91)90048-T
NR 56
TC 66
Z9 67
U1 0
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD NOV 15
PY 2001
VL 360
BP 217
EP 224
DI 10.1042/0264-6021:3600217
PN 1
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 497QL
UT WOS:000172466900025
PM 11696010
OA Green Published
DA 2020-11-24
ER

PT J
AU Veiga, ABG
   Blochtein, B
   Guimaraes, JA
AF Veiga, ABG
   Blochtein, B
   Guimaraes, JA
TI Structures involved in production, secretion and injection of the venom
   produced by the caterpillar Lonomia obliqua (Lepidoptera, Saturniidae)
SO TOXICON
LA English
DT Article
DE Lonomia obliqua; caterpillar; urticating spines; venoms; morphology
AB The number of accidents caused by injection of the venom of Lonomia obliqua caterpillars in Southern Brazil has increased in the last years. Even though this kind of envenomation has an important social and medical impact, nothing is known about the cellular structures responsible for the production and secretion of this venom. Here we identify and analyse morphological structures possibly responsible for the production and secretion of the active principles of the venom, as well as the histological relationship of these structures with the urticating spines of L. obliqua. Detailed microscopic observations showed that: (a) L. obliqua has a complex tegument, with several cuticular specializations, (b) there are no pores along the tegument neither in the spines and (c) the spines bear a hollow canal-where the venom is deposited-and an area that can be easily broken when touched, releasing the venom. Histological and histochemical techniques revealed that: (a) there is no single gland cell that produces the venom, (b) a secretory epithelium, composed of cells containing Vesicles that increase in size and number as they reach the apical region, underlies the tegument and the spines and is responsible for secretion of the venomous substances and (c) the venom is deposited in the subcuticular space and at the tips of the spines. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1 Univ Fed Rio Grande Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Pontificia Univ Catolica Rio Grand Sul, Histol Lab, Fac Biociencias, BR-90619900 Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande Sul, Ctr Biotecnol, Av Bento Goncalves,CP 15005, BR-91501970 Porto Alegre, RS, Brazil.
RI Guimaraes, Jorge Almeida/V-2196-2019; Veiga, Ana B. G./N-8581-2013;
   /B-9412-2014
OI Veiga, Ana B. G./0000-0003-1462-5506; /0000-0001-8452-1716; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ABELLA HB, 1998, MANUAL DIAGNOSTICO T, P19
   [Anonymous], 1998, MAN DIAGN TRAT AC AN, P75
   AROCHAPINANGO CL, 1969, LANCET, V1, P810
   AROCHAPINANGO CL, 1967, ACTA CIENT VENEZ, V18, P136
   AROCHAPINANGO CL, 1981, THROMB HAEMOSTASIS, V46, P710
   BARTH R., 1957, AN ACAD BRASIL CIENC, V29, P465
   BOCK P, 1984, SEMIDUNNSCHNITT, P57
   BUCHERL W, 1971, VENOMOUS ANIMALS VEN, V3, P1
   Coll-Sangrona E, 1998, BRAZ J MED BIOL RES, V31, P779, DOI 10.1590/S0100-879X1998000600009
   Donato JL, 1998, THROMB HAEMOSTASIS, V79, P539
   DUARTE AC, 1990, J BRAS NEFROL, V12, P184
   Eaton J. L, 1988, LEPIDOPTERAN ANATOMY, P211
   Gilmer P. M., 1925, Annals of the Entomological Society of America, V18, P203, DOI 10.1093/aesa/18.2.203
   KELEN EMA, 1995, J TOXICOL-TOXIN REV, V14, P283, DOI 10.3109/15569549509019465
   Lorini L. M, 1999, TATURANA ASPECTOS BI, P67
   MASCHWITZ UWJ, 1971, VENOMOUS ANIMALS THE, V3, P1
   Matos E., 1991, Revista Brasileira de Biologia, V51, P341
   PESCE H, 1971, VENOMOUS ANIMALS THE, V3, P120
   Picarelli Z., 1971, VENOMOUS ANIMALS THE, V3, P103
   REIS CV, 1999, LANCET, P353
   Rotberg A, 1971, VENOMOUS ANIMALS THE, V1, P157, DOI 10.1016/B978-0-12-138903-1.50013-2
   SCOBLE MJ, 1992, LEPIDOPTERA FORM FUN, P105
   Silva Wilmar Dias Da, 1996, Toxicon, V34, P1045
   Stehr F.W., 1987, P288
   VONIHERING R, 1914, ANN PAULISTAS MED CI, V3, P129
   Vulinec K., 1990, P251
   Whitman D.W., 1990, P289
NR 27
TC 46
Z9 48
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD SEP
PY 2001
VL 39
IS 9
BP 1343
EP 1351
DI 10.1016/S0041-0101(01)00086-1
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 446ND
UT WOS:000169518600010
PM 11384722
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Gombarovits, MEC
   Valenzuela, JG
   Carlini, CR
   Guimaraes, JA
AF Francischetti, IMB
   Gombarovits, MEC
   Valenzuela, JG
   Carlini, CR
   Guimaraes, JA
TI Intraspecific variation in the venoms of the South American rattlesnake
   (Crotalus durissus terrificus)
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
LA English
DT Article
DE Crotalus durissus terrificus; South American rattlesnake; intraspecific
   variation; Minas Gerais State; crotoxin; convulxin; crotamine; isoforms
ID THROMBIN-LIKE ENZYME; NOTECHIS-ATER-NIGER; SNAKE-VENOMS;
   SCUTULATUS-SCUTULATUS; BIOLOGICAL-ACTIVITIES; BOTHROPS; POPULATIONS;
   PROTEINS; A(2); CHROMATOGRAPHY
AB The venom of eight individual Crotalus durissus terrificus snakes from the State of Minas Gerais, Brazil, in addition to pooled venom from Butantan Institute, were compared. Snakes were captured in distinct locations, some of them 600 km apart: Conselheiro Lafaiete, Entre Rios de Minas, Itauna, Itapecerica, Lavras, Patos de Minas, Paracatu, and Santo Antonio do Amparo. The crude venoms were tested for proteolytic, phospholipase A2, platelet aggregating, and hemagglutinating activities. The venoms were also analyzed by polyacrylamide gel electrophoresis (PAGE) and isoelectric focusing (IEF). Chromatographic patterns of venom proteins on both gel-filtration and anion-exchange chromatographies were also performed. All venoms presented high phospholipase A2 and platelet-aggregating activities, but only minimal hemagglutinating or proteolytic activities were found. Gel-filtration chromatography showed a characteristic profile for most venoms where four main peaks were separated, including the typical ones where convulxin and crotoxin were identified; however, peaks with high amounts of lower molecular weight proteins were found in the venoms from the Santo Antonio do Amparo location and Butantan Institute, characterizing these venoms as crotamine positive. Anion-exchange chromatographies presented a similar protein distribution pattern, although the number of peaks (up to ten) distinguished some Venom samples. Consistent with these results, polyacrylamide gels that were silver stained after venom separation by PAGE or IEF presented a similar qualitative band distribution, although a quantitative heterogeneity was detected among venoms. Our results suggest that the variability found in venom components of C. d. terrificus venoms captured in Minas Gerais State may be genetically inherited and/or environmentally induced. (C) 2000 Elsevier Science Inc. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, CCS, ICB, Dept Biochem Med, BR-21941590 Rio De Janeiro, Brazil.
   NIAID, Parasit Dis Lab, Med Entomol Sect, NIH, Bethesda, MD 20892 USA.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Av Bento Goncalves 9500,CP 15005, BR-91501970 Porto Alegre, RS, Brazil.
EM guimar@dna.cbiot.ufrgs.br
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR AIRD SD, 1985, TOXICON, V23, P361, DOI 10.1016/0041-0101(85)90020-0
   AIRD SD, 1985, TOXICON, V23, P1000, DOI 10.1016/0041-0101(85)90394-0
   ALEXANDER G, 1988, TOXICON, V26, P953, DOI 10.1016/0041-0101(88)90260-7
   AMARAL CFS, 1988, REV INST MED TROP SP, V30, P288, DOI 10.1590/S0036-46651988000400007
   ANDERSON SG, 1993, TOXICON, V31, P1051, DOI 10.1016/0041-0101(93)90263-I
   ARAUJO A L D, 1987, Toxicon, V25, P1181
   AZEVEDOMARQUES MM, 1985, TOXICON, V23, P631, DOI 10.1016/0041-0101(85)90367-8
   BRAZIL OV, 1971, J PHYSIOL-LONDON, V212, pP34
   CARLINI CR, 1988, PHYTOCHEMISTRY, V27, P25, DOI 10.1016/0031-9422(88)80587-9
   Chaves F, 1998, TOXICON, V36, P1861, DOI 10.1016/S0041-0101(98)00107-X
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   CUPO P, 1990, T ROY SOC TROP MED H, V84, P447, DOI 10.1016/0035-9203(90)90358-L
   Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0
   Daltry JC, 1996, TOXICON, V34, P67, DOI 10.1016/0041-0101(95)00122-0
   DASILVA NJ, 1991, COMP BIOCHEM PHYS B, V100, P117, DOI 10.1016/0305-0491(91)90093-S
   FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x
   FAURE G, 1991, BIOCHEMISTRY-US, V30, P8074, DOI 10.1021/bi00246a028
   FERREIRA ML, 1992, TOXICON, V30, P1603, DOI 10.1016/0041-0101(92)90032-Z
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Francischetti IMB, 1998, COMP BIOCHEM PHYS C, V119, P21, DOI 10.1016/S0742-8413(97)00163-1
   FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GENE JA, 1989, TOXICON, V27, P841, DOI 10.1016/0041-0101(89)90096-2
   Gibbs HL, 1997, MOL ECOL, V6, P1123, DOI 10.1046/j.1365-294X.1997.00284.x
   GIORGI R, 1993, TOXICON, V31, P1257, DOI 10.1016/0041-0101(93)90399-4
   GLENN JL, 1985, TOXICON, V23, P769, DOI 10.1016/0041-0101(85)90007-8
   GLENN JL, 1983, TOXICON, V21, P119, DOI 10.1016/0041-0101(83)90055-7
   GLENN JL, 1989, TOXICON, V27, P411, DOI 10.1016/0041-0101(89)90203-1
   GREGORYDWYER VM, 1986, TOXICON, V24, P995, DOI 10.1016/0041-0101(86)90005-X
   JAYANTHI GP, 1988, TOXICON, V26, P257, DOI 10.1016/0041-0101(88)90216-4
   KORNALIK F, 1988, HEMOSTASIS ANIMAL VE, P503
   LEITE LCC, 1992, COMP BIOCHEM PHYS B, V102, P515, DOI 10.1016/0305-0491(92)90042-P
   LI QZ, 1993, TOXICON, V31, P1197, DOI 10.1016/0041-0101(93)90135-6
   Mancin AC, 1997, BIOCHEM MOL BIOL INT, V42, P1171
   Ownby CL, 1999, TOXICON, V37, P411, DOI 10.1016/S0041-0101(98)00188-3
   Ownby CL, 1997, TOXICON, V35, P111, DOI 10.1016/S0041-0101(96)00054-2
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   RAW I, 1986, BRAZ J MED BIOL RES, V19, P333
   ROSENBERG P, 1979, HDB EXPT PHARM, V52, P404
   ROSENFELD G, 1976, DOENCAS INFECCIOSAS, P970
   SANCHEZ EF, 1992, TOXICON, V30, P95, DOI 10.1016/0041-0101(92)90505-Y
   SCHENBERG S, 1959, SCIENCE, V129, P1361, DOI 10.1126/science.129.3359.1361
   SERRANO SMT, 1995, BIOCHEMISTRY-US, V34, P7186, DOI 10.1021/bi00021a033
   SOTO JG, 1989, COMP BIOCHEM PHYS B, V93, P847, DOI 10.1016/0305-0491(89)90056-4
   SOTO JG, 1988, TOXICON, V26, P875, DOI 10.1016/0041-0101(88)90328-5
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   WILLIAMS V, 1988, TOXICON, V26, P1067, DOI 10.1016/0041-0101(88)90205-X
   WILLIAMS V, 1987, TOXICON, V25, P1240, DOI 10.1016/0041-0101(87)90143-7
NR 48
TC 36
Z9 39
U1 0
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1532-0456
EI 1878-1659
J9 COMP BIOCHEM PHYS C
JI Comp. Biochem. Physiol. C-Toxicol. Pharmacol.
PD AUG
PY 2000
VL 127
IS 1
BP 23
EP 36
DI 10.1016/S0742-8413(00)00129-8
PG 14
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
GA 398TT
UT WOS:000166773100003
PM 11081410
DA 2020-11-24
ER

PT J
AU Guimaraes, JA
AF Guimaraes, JA
TI The world of citations. A challenge for Latin American science
SO INTERCIENCIA
LA English
DT Editorial Material
C1 UFRGS, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RP Guimaraes, JA (corresponding author), UFRGS, Ctr Biotecnol, Porto Alegre, RS, Brazil.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 2
Z9 2
U1 0
U2 0
PU INTERCIENCIA
PI CARACAS
PA APARTADO 51842, CARACAS 1050A, VENEZUELA
SN 0378-1844
J9 INTERCIENCIA
JI Interciencia
PD JUL
PY 2000
VL 25
IS 4
BP 182
EP 183
PG 2
WC Ecology
SC Environmental Sciences & Ecology
GA 332QC
UT WOS:000088084100001
DA 2020-11-24
ER

PT J
AU Fuly, AL
   Calil-Elias, S
   Zingali, RB
   Guimaraes, JA
   Melo, PA
AF Fuly, AL
   Calil-Elias, S
   Zingali, RB
   Guimaraes, JA
   Melo, PA
TI Myotoxic activity of an acidic phospholipase A(2) isolated from Lachesis
   muta (Bushmaster) snake venom
SO TOXICON
LA English
DT Article
ID BOTHROPS-ASPER; PURIFICATION; MUSCLE
AB An acidic phospholipase A(2) isolated from Lachesis muta snake venom denoted LM-PLA(2), showed neither toxic nor anticoagulant activities in contrast to a potent inhibitory effect of collagen-induced platelet aggregation [Fuly, A.L., Machado, O.L.T., Alves, E.W. and Carlini, C.R., 1997, Thromb. Haemost 78, 1372-1380.]. Now, the myotoxicity induced by LM-PLA2 was investigated by using both in vivo and in vitro experiments. LM-PLA(2) induced in vitro a dose- and time-dependent release of creatine-kinase (CK) from mouse Extensor Digitorium Longus (EDL) muscles and also increased the plasma CK activity in treated animals. Histopathological studies confirm myonecrosis of mouse skeletal muscles as a major effect. Edema could also be seen in muscle tissue. The amino-terminal sequence of LM-PLA(2) (previously reported) indicates an aspartic acid residue located at position 49, together with other conserved amino acids present in the Asp-49 phospholipases, such as Tyr-28, Gly-30, Gly-32, His-48. Chemical modification of the protein moiety was also performed. Histidine alkylation with p-bromophenacyl bromide and lysine acetylation with acetic anhydride, abolished both indirect hemolytic and myotoxic activities of LM-PLA(2). On the other hand. contrarily to what has been observed with several basic myotoxic phospholipases, the myotoxic effect induced by LM-PLA(2) was not abolished by heparin. (C) 2000 Elsevier Science. Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Farmacol Basica & Clin, BR-21941590 Rio De Janeiro, Brazil.
   Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotechnol, BR-91501970 Porto Alegre, RS, Brazil.
RI Zingali, Russolina/G-4862-2012; Guimaraes, Jorge Almeida/V-2196-2019;
   Fuly, Andre/U-1538-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR DASILVA NJ, 1989, TOXICON, V27, P763, DOI 10.1016/0041-0101(89)90043-3
   deAraujo HSS, 1996, ARCH BIOCHEM BIOPHYS, V326, P21, DOI 10.1006/abbi.1996.0042
   DENNIS EA, 1994, J BIOL CHEM, V269, P13057
   DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6
   Fuly AL, 1997, THROMB HAEMOSTASIS, V78, P1372
   FULY AL, 1993, BRAZ J MED BIOL RES, V26, P459
   GOMORI G, 1950, AM J CLIN PATHOL, V20, P661
   Gutierrez J.M., 1997, VENOM PHOSPHOLIPASE, P321
   GUTIERREZ JM, 1987, TOXICON, V25, P713, DOI 10.1016/0041-0101(87)90121-8
   Kondo H., 1960, Japanese Journal of Medical Science and Biology, V18, P43
   Kuch U, 1996, TOXICON, V34, P714, DOI 10.1016/0041-0101(96)00016-5
   LOMONTE B, 1994, J BIOL CHEM, V269, P29867
   Lomonte B, 1999, TOXICON, V37, P145, DOI 10.1016/S0041-0101(98)00171-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAGALHAES A, 1981, TOXICON, V19, P279, DOI 10.1016/0041-0101(81)90032-5
   MEBS D, 1983, TOXICON, V21, P393, DOI 10.1016/0041-0101(83)90096-X
   MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C
   MELO PA, 1988, TOXICON, V26, P87, DOI 10.1016/0041-0101(88)90140-7
   MELO PA, 1988, BRAZ J MED BIOL RES, V21, P545
   Melo PA, 1999, TOXICON, V37, P199, DOI 10.1016/S0041-0101(98)00183-4
   MELO PA, 1994, TOXICON, V32, P595, DOI 10.1016/0041-0101(94)90207-0
   MELO PA, 1993, TOXICON, V31, P285, DOI 10.1016/0041-0101(93)90146-A
   NEWMAN WP, 1955, BIOCHEM Z, V327, P170
   OWNBY CL, 1976, AM J PATHOL, V85, P149
   OWNBY CL, 1990, HDB TOXINOLOGY, P601
   SANCHEZ EF, 1987, TOXICON, V25, P611, DOI 10.1016/0041-0101(87)90107-3
   Sanchez EF, 1995, TOXICON, V33, P1653, DOI 10.1016/0041-0101(95)00097-6
   SILVA LM, 1995, TOXICON, V28, P707
   SUAREZKURTZ G, 1981, AM J PHYSIOL, V240, pC98
   TORRES JR, 1995, LANCET, V346, P449, DOI 10.1016/S0140-6736(95)92825-1
NR 30
TC 41
Z9 43
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JUL
PY 2000
VL 38
IS 7
BP 961
EP 972
DI 10.1016/S0041-0101(99)00208-1
PG 12
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 287UJ
UT WOS:000085524600006
PM 10728833
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Chiang, TM
   Guimaraes, JA
   Bon, C
AF Francischetti, IMB
   Chiang, TM
   Guimaraes, JA
   Bon, C
TI Role of the recombinant non-integrin platelet collagen receptor P65 on
   platelet activation induced by convulxin
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID CROTALUS-DURISSUS-TERRIFICUS; GLYCOPROTEIN-VI; MOLECULAR-BASIS; VENOM;
   AGGREGATION; ADHESION; PROTEIN
AB Convulxin (Cvx) isolated from Crotalus durissus terrificus venom selectively binds with a high affinity to platelets and induces platelet aggregation by a mechanism that resembles that induced by collagen. Taking advantage that P65 has been recently cloned and expressed as a recombinant soluble protein (rec-P65), we examined the role of this non-integrin collagen receptor in platelet activation induced by Cvx. Rec-P65 blocked platelet adhesion to collagen-coated surfaces and inhibited platelet aggregation and ATP secretion induced by type I collagen. On the other hand, rec-P65 did not inhibit platelet aggregation and ATP secretion induced by Cvx, and it did not affect platelet adhesion to Cvx. In addition, ligand-blotting indicated that the Cvx binding to the collagen receptor GPVI was preserved in the presence of rec-P65. These observations indicate that P65 does not play a significant role in platelet activation by Cvx; in contrast, platelet response to collagen involves multiple receptors, (C) 2000 Academic Press.
C1 Inst Pasteur, Unite Venins, F-75724 Paris, France.
   Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB, CCS, BR-21941590 Rio De Janeiro, Brazil.
   Univ Tennessee, Ctr Hlth Sci, Dept Med, Memphis, TN 38163 USA.
   Univ Tennessee, Ctr Hlth Sci, Dept Biochem, Memphis, TN 38163 USA.
   Univ Tennessee, Ctr Hlth Sci, Memphis VA Med Ctr, Memphis, TN 38163 USA.
   Univ Fed Rio Grande Sul, Ctr Biotecnol, BR-91509900 Porto Alegre, RS, Brazil.
RP Francischetti, IMB (corresponding author), NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR Chiang TM, 1997, J CLIN INVEST, V100, P514, DOI 10.1172/JCI119560
   Clemetson JM, 1999, J BIOL CHEM, V274, P29019, DOI 10.1074/jbc.274.41.29019
   Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023
   Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V354, P255, DOI 10.1006/abbi.1998.0637
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V353, P239, DOI 10.1006/abbi.1998.0598
   Geiger J, 1999, ARTERIOSCL THROM VAS, V19, P2007, DOI 10.1161/01.ATV.19.8.2007
   Hechler B, 1998, BLOOD, V92, P152, DOI 10.1182/blood.V92.1.152.413k27_152_159
   Jandrot-Perrus M, 1999, BLOOD, V94, p371A
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070
   Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030
   Kamiguti AS, 2000, ARCH BIOCHEM BIOPHYS, V374, P356, DOI 10.1006/abbi.1999.1627
   Lagrue AH, 1999, FEBS LETT, V448, P95, DOI 10.1016/S0014-5793(99)00340-3
   Leduc M, 1998, BIOCHEM J, V333, P389, DOI 10.1042/bj3330389
   Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108
   Peerschke EIB, 1998, IMMUNOBIOLOGY, V199, P239, DOI 10.1016/S0171-2985(98)80030-2
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   TAKAHARA K, 1990, J BIOL CHEM, V265, P6836
   TANDON NN, 1989, J BIOL CHEM, V264, P7576
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1983, EUR J PHARMACOL, V92, P57, DOI 10.1016/0014-2999(83)90108-5
   Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5
NR 24
TC 4
Z9 6
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD APR 21
PY 2000
VL 270
IS 3
BP 932
EP 935
DI 10.1006/bbrc.2000.2529
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 309WX
UT WOS:000086793200046
PM 10772928
DA 2020-11-24
ER

PT J
AU Monteiro, RQ
   Raposo, JG
   Wisner, A
   Guimaraes, JA
   Bon, C
   Zingali, RB
AF Monteiro, RQ
   Raposo, JG
   Wisner, A
   Guimaraes, JA
   Bon, C
   Zingali, RB
TI Allosteric changes of thrombin catalytic site induced by interaction of
   bothrojaracin with anion-binding exosites I and II
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID SPECIFICITY; THROMBOMODULIN; ANTICOAGULANT; INHIBITION; ACTIVATION;
   HEPARIN; HIRUDIN; ALTERS
AB Bothrojaracin, a 27-kDa C-type lectin from Bothrops jararaca venom, is a selective and potent thrombin inhibitor (K-d = 0.6 nM) which interacts with the two thrombin anion-binding exosites (I and II) but not with its catalytic site. In the present study, we analyzed the allosteric effects produced in the catalytic site by bothrojaracin binding to thrombin exosites. Opposite effects were observed with cu-thrombin, which possesses both exosites I and II, and with gamma-thrombin, which lacks exosite I. On the one hand, bothrojaracin altered both kinetic parameters K-m and k(cat) of alpha-thrombin for small synthetic substrates, resulting in an increased efficiency of alpha-thrombin catalytic activity, This effect was similar to that produced by hirugen, a peptide based on the C-terminal hirudin sequence (residues 54-65) which interacts exclusively with exosite I. On the other hand, bothrojaracin decreased the amidolytic activity of gamma-thrombin toward chromogenic substrates, although this effect was observed with higher concentrations of bothrojaracin than those used with alpha-thrombin. In agreement with these observations, bothrojaracin produced opposite effects on the fluorescence intensity of alpha- and gamma-thrombin derivatives labeled at the active site with fluorescein-Phe-Pro-Arg-chloromethylketone. These observations support the conclusion that bothrojaracin binding to thrombin produces two different structural changes in its active site, depending on whether it interacts exclusively with exosite II, as seen with gamma-thrombin, or with exosite I (or both I and II) as observed with alpha-thrombin. The ability of bothrojaracin to evoke distinct modifications in the thrombin catalytic site environment when interacting with exosites I and II make this molecule an interesting tool for the study of allosteric changes in the thrombin molecule. (C) 1999 Academic Press.
C1 Univ Fed Rio de Janeiro, CCS, ICB, Dept Bioquim Med, Rio De Janeiro, Brazil.
   Inst Pasteur, Unite Venins, Paris, France.
RP Zingali, RB (corresponding author), Univ Fed Rio de Janeiro, CCS, ICB, Dept Bioquim Med, Rio De Janeiro, Brazil.
RI de Queiroz Monteiro, Robson/M-7097-2019; Guimaraes, Jorge
   Almeida/V-2196-2019; DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; Zingali,
   Russolina/G-4862-2012
OI de Queiroz Monteiro, Robson/0000-0002-5260-2332; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ARNI RK, 1993, BIOCHEMISTRY-US, V32, P4727, DOI 10.1021/bi00069a006
   Arocas V, 1998, THROMB HAEMOSTASIS, V79, P1157
   Arocas V, 1996, BIOCHEMISTRY-US, V35, P9083, DOI 10.1021/bi960043l
   BOUTON MC, 1993, EUR J BIOCHEM, V215, P143, DOI 10.1111/j.1432-1033.1993.tb18016.x
   DITTMAN WA, 1990, BLOOD, V75, P329
   Fredenburgh JC, 1997, J BIOL CHEM, V272, P25493, DOI 10.1074/jbc.272.41.25493
   GUILLIN MC, 1995, THROMB HAEMOSTASIS, V74, P129
   Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088
   HORTIN GL, 1991, J BIOL CHEM, V266, P6866
   LIU LW, 1991, J BIOL CHEM, V266, P16977
   LIU LW, 1994, J BIOL CHEM, V269, P11807
   Mauricio I, 1997, BIOCHEM BIOPH RES CO, V235, P259, DOI 10.1006/bbrc.1997.6735
   MUSCI G, 1988, BIOCHEMISTRY-US, V27, P769, DOI 10.1021/bi00402a042
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   RYDEL TJ, 1994, J BIOL CHEM, V269, P22000
   SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518
   YE J, 1991, J BIOL CHEM, V266, P23016
   YE J, 1992, J BIOL CHEM, V267, P11023
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 19
TC 22
Z9 22
U1 0
U2 0
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD SEP 7
PY 1999
VL 262
IS 3
BP 819
EP 822
DI 10.1006/bbrc.1999.1297
PG 4
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 235AH
UT WOS:000082516200045
PM 10471408
DA 2020-11-24
ER

PT J
AU Lagrue, AH
   Francischetti, IMB
   Guimaraes, J
   Jandrot-Perrus, M
AF Lagrue, AH
   Francischetti, IMB
   Guimaraes, J
   Jandrot-Perrus, M
TI Platelet activation by convulxin: Phospholipase C gamma-2 activation is
   under the control of phosphatidyl-inositol-3-kinase and of phosphatases.
   Comparison to PLC-gamma 2 activation by collagen
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 Fac Xavier Bichat, Lab Rech Thrombose & Hemostase, Paris, France.
   Univ Fed Rio de Janeiro, Dept Med Biochem, ICB, CCS, BR-21941 Rio De Janeiro, Brazil.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 43, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD AUG
PY 1999
SU S
MA 55
BP 19
EP 19
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 290FP
UT WOS:000085665900056
DA 2020-11-24
ER

PT J
AU Monteiro, RQ
   Raposo, JG
   Wisner, A
   Guimaraes, JA
   Bon, C
   Zingali, RB
AF Monteiro, RQ
   Raposo, JG
   Wisner, A
   Guimaraes, JA
   Bon, C
   Zingali, RB
TI Allosteric changes on thrombin catalytic site induced by interaction of
   bothrojaracin with anion-binding exosites I and II
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 Univ Fed Rio de Janeiro, Dept Bioquim Med, ICB, CCS, BR-21941 Rio De Janeiro, Brazil.
   Inst Pasteur, Unite des Venins, Paris, France.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 43, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD AUG
PY 1999
SU S
MA 2222
BP 703
EP 704
PG 2
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 290FP
UT WOS:000085665902231
DA 2020-11-24
ER

PT J
AU Lagrue, AH
   Francischetti, IMB
   Guimaraes, JA
   Jandrot-Perrus, M
AF Lagrue, AH
   Francischetti, IMB
   Guimaraes, JA
   Jandrot-Perrus, M
TI Phosphatidylinositol 3 '-kinase and tyrosine-phosphatase activation
   positively modulate Convulxin-induced platelet activation. Comparison
   with collagen
SO FEBS LETTERS
LA English
DT Article
DE Convulxin; phospholipase C gamma; protein tyrosine phosphorylation;
   phenylarsine oxide; phosphatidylinositol 3-kinase; tyrosine phosphatase;
   Wortmannin; Crotalus durissus terrificus
ID CROTALUS-DURISSUS-TERRIFICUS; RECEPTOR-GAMMA-CHAIN; PHOSPHOLIPASE
   C-GAMMA; SRC FAMILY KINASES; GLYCOPROTEIN-VI; INCLUDING PLC-GAMMA-2;
   AGGREGATING PROTEIN; MEDIATED ACTIVATION; PHENYLARSINE OXIDE;
   PHOSPHORYLATION
AB In this report we have studied the role of phosphatidylinositol 3'-kinase (PI3-K) and tyrosine phosphatase activation on platelet activation by Convulxin (Cvx), Wortmannin, a specific PI3-K inhibitor, and phenylarsine oxide (PAO), a sulfhydryl reagent that inhibits tyrosine phosphatase (PTPase), block Cvx-induced platelet aggregation, granule secretion, inositol phosphate production, and increase in [Ca2+](i). However, PAO does not inhibit Cvx-induced tyrosine phosphorylation of platelet proteins, including Syk and PLC gamma 2, but blocked collagen-induced platelet aggregation as well as tyrosine phosphorylation of PLC gamma 2. In contrast, Cvx-induced PLC gamma 2 tyrosyl phosphorylation was partially inhibited by wortmannin, We conclude that (i) although Cvx and collagen activate platelets by a similar mechanism, different regulatory processes are specific to each agonist; (ii) mechanisms other than tyrosine phosphorylation regulate PLC gamma 2, activity; and (iii) besides protein tyrosine kinases, PI3-K land PTPase) positively modulate platelet activation by both Cvx and collagen, and this enzyme is required for effective transmission of GPVI-Fc receptor gamma chain signal to result in full activation and tyrosine phosphorylation of PLC gamma 2 in Cvx-stimulated platelets. (C) 1999 Federation of European Biochemical Societies.
C1 Fac Xavier Bichat, Lab Rech Hemostase & Thrombose, F-75870 Paris 18, France.
   Univ Fed Rio de Janeiro, CCS, ICB, Dept Med Biochem,Ilha Fundao, BR-21941590 Rio De Janeiro, Brazil.
RP Francischetti, IMB (corresponding author), NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike,Bldg 4,Room 126, Bethesda, MD 20892 USA.
EM ifrancischetti@atlas.niaid.nih.gov
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; JANDROT-PERRUS,
   Martine/0000-0002-8450-9247
CR Bae YS, 1998, J BIOL CHEM, V273, P4465, DOI 10.1074/jbc.273.8.4465
   BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4
   Chiang TM, 1997, J CLIN INVEST, V100, P514, DOI 10.1172/JCI119560
   Corey SJ, 1999, BLOOD, V93, P1, DOI 10.1182/blood.V93.1.1
   DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617
   Erdreich-Epstein A, 1997, EXP CELL RES, V237, P288, DOI 10.1006/excr.1997.3795
   EZUMI Y, 1995, J BIOL CHEM, V270, P11927, DOI 10.1074/jbc.270.20.11927
   Ezumi Y, 1998, J EXP MED, V188, P267, DOI 10.1084/jem.188.2.267
   FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087
   Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V354, P255, DOI 10.1006/abbi.1998.0637
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V353, P239, DOI 10.1006/abbi.1998.0598
   FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x
   Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437
   Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5
   Giuriato S, 1997, J BIOL CHEM, V272, P26857, DOI 10.1074/jbc.272.43.26857
   Gratacap MP, 1998, J BIOL CHEM, V273, P24314, DOI 10.1074/jbc.273.38.24314
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Guilherme A, 1996, J BIOL CHEM, V271, P29533, DOI 10.1074/jbc.271.47.29533
   ICHINOHE T, 1995, J BIOL CHEM, V270, P28029
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927
   Leduc M, 1998, BIOCHEM J, V333, P389, DOI 10.1042/bj3330389
   LevyToledano S, 1997, THROMB HAEMOSTASIS, V78, P226
   Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820
   Lu PJ, 1998, BIOCHEMISTRY-US, V37, P9776, DOI 10.1021/bi980163o
   MARLAS G, 1985, BIOCHIMIE, V67, P1231, DOI 10.1016/S0300-9084(85)80132-2
   Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X
   Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576
   Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   Quek LS, 1998, CURR BIOL, V8, P1137, DOI 10.1016/S0960-9822(98)70471-3
   Rameh LE, 1998, J BIOL CHEM, V273, P23750, DOI 10.1074/jbc.273.37.23750
   Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045
   Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401
   SANTORO SA, 1995, THROMB HAEMOSTASIS, V74, P813
   Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31
   TANDON NN, 1989, J BIOL CHEM, V264, P7576
   Tsuji M, 1997, J BIOL CHEM, V272, P23528, DOI 10.1074/jbc.272.38.23528
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5
   YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471
   YANAGA F, 1995, FEBS LETT, V368, P377, DOI 10.1016/0014-5793(95)00670-5
NR 44
TC 26
Z9 28
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD APR 1
PY 1999
VL 448
IS 1
BP 95
EP 100
DI 10.1016/S0014-5793(99)00340-3
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 186VD
UT WOS:000079750100021
PM 10217417
OA Bronze
DA 2020-11-24
ER

PT J
AU Monteiro, RQ
   Dutra, DLS
   Machado, OLT
   Carlini, CR
   Guimaraes, JA
   Bon, C
   Zingali, RB
AF Monteiro, RQ
   Dutra, DLS
   Machado, OLT
   Carlini, CR
   Guimaraes, JA
   Bon, C
   Zingali, RB
TI Bothrops jararaca snakes produce several bothrojaracin isoforms
   following an individual pattern
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE snake; venom; Bothrops jararaca; bothrojaracin; thrombin; isoforms;
   individual variation; N-terminal sequence; IEF pattern
ID CROTALUS-DURISSUS-TERRIFICUS; RATTLESNAKE VENOM PROTEINS; THROMBIN
   INHIBITOR; PHOSPHOLIPASE-A2 NEUROTOXIN; ACCELERATED EVOLUTION;
   BIOLOGICAL PROPERTIES; SEASONAL-VARIATION; EXPRESSION; CROTOXIN;
   PRECURSOR
AB More than one isoform of bothrojaracin (BJC), a potent and specific thrombin inhibitor isolated from Bothrops jararaca venom, has been found in individual venoms collected from adult snakes. Variations in snake venom composition have previously been associated with factors such as age, sex, geographic origin, season of the year and diet. In order to obtain further information concerning individual patterns of expression of BJC isoforms, we have analyzed five individual Bothrops jararaca snake venoms collected at the same time from adult female snakes from the same geographic region. As expected, crude venoms showed a similar migration pattern on SDS-PAGE. BJC was purified using a procedure which includes an affinity chromatography step (PPACK-thrombin Sepharose). A slight variation in the amount of BJC obtained from individual venom samples was noticed. Inhibition of thrombin-induced platelet aggregation as well as migration pattern on SDS-PAGE (under reducing and non-reducing conditions) and isoelectric focusing varied considerably among BJC samples from the five snakes. The amino-terminal sequences (residues 1-34) of individual BJC samples were compared with the sequence deduced from isolated cDNAs encoding alpha and beta chains of BJC. A high degree of homology was detected, although some residues differed from one sample to other. Altogether, data confirmed the heterogeneity found for BJC purified from individual snakes. Thus, the results indicate that: (1) individual specimens of Bothrops jararaca have different patterns of BJC isoform expression; and (2) it seems that genetic factors, at least in part, determine the variability found in BJC production. (C) 1998 Elsevier Science Inc. All rights reserved.
C1 UFRJ, CCS, ICB, Dept Bioquim Med, BR-21941590 Rio De Janeiro, Brazil.
   Inst Pasteur, Unite Venins, Paris, France.
RP Zingali, RB (corresponding author), UFRJ, CCS, ICB, Dept Bioquim Med, Cidade Univ, BR-21941590 Rio De Janeiro, Brazil.
EM lzingali@server.bioqmed.ufrj.br
RI Machado, Olga/P-1944-2019; Zingali, Russolina/G-4862-2012; da Silva
   Carlini, Celia Regina Ribeiro/H-4017-2011; de Queiroz Monteiro,
   Robson/M-7097-2019; Machado, Olga/G-7461-2012; DE QUEIROZ MONTEIRO,
   ROBSON/B-8007-2014; Guimaraes, Jorge Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; de Queiroz
   Monteiro, Robson/0000-0002-5260-2332; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR Arocas V, 1996, BIOCHEMISTRY-US, V35, P9083, DOI 10.1021/bi960043l
   Arocas V, 1997, EUR J BIOCHEM, V248, P550, DOI 10.1111/j.1432-1033.1997.00550.x
   BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y
   BIEBER AL, 1979, SNAKE VENOMS, P295
   BOUCHIER C, 1991, BIOCHIM BIOPHYS ACTA, V1088, P401, DOI 10.1016/0167-4781(91)90132-6
   BRUNE DC, 1992, ANAL BIOCHEM, V207, P285, DOI 10.1016/0003-2697(92)90013-W
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   Cousin X, 1996, J BIOL CHEM, V271, P15099, DOI 10.1074/jbc.271.25.15099
   Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0
   Deshimaru M, 1996, FEBS LETT, V397, P83, DOI 10.1016/S0014-5793(96)01144-1
   DETRAIT J, 1966, ANN I PASTEUR PARIS, V111, P93
   FAURE G, 1991, BIOCHEMISTRY-US, V30, P8074, DOI 10.1021/bi00246a028
   FAURE G, 1987, TOXICON, V25, P229, DOI 10.1016/0041-0101(87)90246-7
   FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2
   GLENN JL, 1983, TOXICON, V21, P119, DOI 10.1016/0041-0101(83)90055-7
   GREGORY VM, 1984, P W PHARMACOL SOC, V27, P233
   GREGORYDWYER VM, 1986, TOXICON, V24, P995, DOI 10.1016/0041-0101(86)90005-X
   GUBENSEK F, 1974, TOXICON, V12, P167, DOI 10.1016/0041-0101(74)90241-4
   Hider R.C., 1991, P1
   Kini RM, 1996, TOXICON, V34, P1287, DOI 10.1016/S0041-0101(96)00107-9
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOMONTE B, 1992, COMP BIOCHEM PHYS B, V102, P325, DOI 10.1016/0305-0491(92)90129-F
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARSH N, 1974, TOXICON, V12, P621, DOI 10.1016/0041-0101(74)90196-2
   MEBS D, 1984, TOXICON, V22, P831, DOI 10.1016/0041-0101(84)90170-3
   MEIER J, 1986, TOXICON, V24, P41, DOI 10.1016/0041-0101(86)90164-9
   MINTON SA, 1986, TOXICON, V24, P71, DOI 10.1016/0041-0101(86)90167-4
   Monteiro RQ, 1997, TOXICON, V35, P649, DOI 10.1016/S0041-0101(96)00176-6
   Monteiro RQ, 1998, TOXICON, V36, P153, DOI 10.1016/S0041-0101(97)00061-5
   MORENO E, 1988, TOXICON, V26, P363, DOI 10.1016/0041-0101(88)90004-9
   Ogawa T, 1996, TOXICON, V34, P1229, DOI 10.1016/S0041-0101(96)00112-2
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   TAN NH, 1993, COMP BIOCHEM PHYS B, V106, P651, DOI 10.1016/0305-0491(93)90144-T
   TAN NH, 1992, COMP BIOCHEM PHYS B, V103, P585, DOI 10.1016/0305-0491(92)90375-2
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 35
TC 15
Z9 15
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0305-0491
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD AUG
PY 1998
VL 120
IS 4
BP 791
EP 798
PG 8
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA 134WU
UT WOS:000076767400021
PM 9854824
DA 2020-11-24
ER

PT J
AU Zhang, Y
   Ribeiro, JMC
   Guimaraes, JA
   Walsh, PN
AF Zhang, Y
   Ribeiro, JMC
   Guimaraes, JA
   Walsh, PN
TI Nitrophorin-2: A novel mixed-type reversible specific inhibitor of the
   intrinsic factor-X activating complex
SO BIOCHEMISTRY
LA English
DT Article
ID RAPID EXTRUSION PROCEDURE; COAGULATION FACTOR-X; FACTOR-IXA;
   HUMAN-PLATELETS; FACTOR-VIII; BLOOD-COAGULATION; RHODNIUS-PROLIXUS;
   STUART FACTOR; TISSUE FACTOR; BINDING-SITE
AB Nitrophorin-2 (NP-2), isolated from salivary glands of the blood-sucking insect Rhodnius prolixus, has been shown to be a specific inhibitor of the intrinsic factor X-(FX)-activating complex. The inhibitory effect of NP-2 is most potent in the presence of both FVIIIa and phospholipids (artificial phospholipid vesicles or activated human platelets). Detailed kinetic analyses of the inhibitory mechanism of NP-2 demonstrated a decrease in both V-max and K-m of activated FIX-(FIXa)-catalyzed FX activation in the presence of FVIIIa and phospholipid vesicles, characteristic of a hyperbolic mixed-type reversible inhibitor. NP-2 exhibits a higher binding affinity for the enzyme-substrate complex, i.e., FIXa/FVIIIa/Ca2+/phospholipids/FX complex (K-i' = 6.2 nM) than for the enzyme complex, i.e., FIXa/FVIIIa/Ca2+/phospholipids (K-i = 16.5 nM). The same inhibitory kinetic mechanism is valid in platelet-mediated FIXa-catalyzed FX activation (K-i' = 5.9 nM and K-i = 12.6 nM, respectively). The fact that NP-2 increases the concentrations (EC50) of FIXa, FVIIIa, and phospholipid vesicles required for half-maximal rates of FX activation suggests that NP-2 interferes with the functioning of all three major components of the intrinsic FX-activating complex. NP-2 was found to inhibit FX activation when either phospholipids or FVIIIa are present, but not in the absence of both factors. Taken together, we conclude that NP-2 is a unique, potent, and highly specific inhibitor of the intrinsic FX-activating complex that inhibits FIXa bound either to the phospholipid or activated platelet surface or to the cofactor FVIIIa by interfering with the assembly of FX-activating complex on these surfaces.
C1 Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Dept Biochem, Philadelphia, PA 19140 USA.
   Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA.
   NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.
   Fed Univ Rio De Janeiro, Dept Biochem Med, ICB, Rio De Janeiro, Brazil.
RP Walsh, PN (corresponding author), Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Ribeiro, Jose/0000-0002-9107-0818; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL55407, HL56914, HL46213] Funding Source: Medline;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [P01HL056914, R01HL046213,
   P01HL056914, P01HL056914, P01HL056914, P01HL056914, P01HL056914,
   R01HL046213, P01HL056914, P01HL056914, R01HL046213, P01HL056914,
   P01HL056914, R01HL046213, R01HL046213, P01HL056914, P01HL056914,
   R01HL046213, P01HL056914, R01HL046213, R01HL055407, R01HL046213,
   P01HL056914, P01HL056914, P01HL056914, P01HL056914, R01HL046213,
   R01HL046213, P01HL056914, P01HL056914, P01HL056914, P01HL056914,
   P01HL056914, P01HL056914, P01HL056914, R01HL046213, P01HL056914,
   P01HL056914, P01HL056914, P01HL056914, P01HL056914, R01HL055407,
   R01HL046213, R01HL046213, R01HL046213, P01HL056914, P01HL056914,
   R01HL046213, P01HL056914, R01HL046213, P01HL056914, P01HL056914,
   P01HL056914, R01HL046213, P01HL056914, P01HL056914, R01HL046213,
   P01HL056914, P01HL056914, R01HL046213, P01HL056914, R01HL046213,
   R01HL046213, P01HL056914] Funding Source: NIH RePORTER
CR AHMAD SS, 1989, J BIOL CHEM, V264, P20012
   AHMAD SS, 1989, J BIOL CHEM, V264, P3244
   AMADOR E, 1972, CLIN CHEM, V18, P601
   BAICI A, 1981, EUR J BIOCHEM, V119, P9, DOI 10.1111/j.1432-1033.1981.tb05570.x
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015
   DUFFY EJ, 1992, J BIOL CHEM, V267, P17006
   Freedman SJ, 1996, J BIOL CHEM, V271, P16227, DOI 10.1074/jbc.271.27.16227
   FUJIKAWA K, 1974, BIOCHEMISTRY-US, V13, P5290, DOI 10.1021/bi00723a006
   GILBERT GE, 1992, J BIOL CHEM, V267, P15861
   GRIFFITH MJ, 1985, J CLIN INVEST, V75, P4, DOI 10.1172/JCI111694
   HELLMANN K, 1965, NATURE, V207, P265, DOI 10.1038/207265a0
   HEMKER HC, 1967, NATURE, V215, P1201, DOI 10.1038/2151201a0
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   JESTY J, 1974, J BIOL CHEM, V249, P5614
   KRISHNASWAMY S, 1992, J BIOL CHEM, V267, P26110
   MANN KG, 1990, BLOOD, V76, P1
   MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0
   MERTENS K, 1990, THROMB HAEMOSTASIS, V64, P138
   NEMERSON Y, 1992, SEMIN HEMATOL, V29, P170
   NESHEIM ME, 1988, J BIOL CHEM, V263, P16467
   NESHEIM ME, 1979, J BIOL CHEM, V254, P952
   OBRIEN LM, 1995, J BIOL CHEM, V270, P27087, DOI 10.1074/jbc.270.45.27087
   RAWALASHEIKH R, 1990, BIOCHEMISTRY-US, V29, P2606, DOI 10.1021/bi00462a025
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   ROSING J, 1985, BLOOD, V65, P319
   ROSING J, 1980, J BIOL CHEM, V255, P274
   Scandura JM, 1996, BIOCHEMISTRY-US, V35, P8903, DOI 10.1021/bi9525031
   Scandura JM, 1996, BIOCHEMISTRY-US, V35, P8890, DOI 10.1021/bi9525029
   Scandura Joseph M., 1992, Circulation, V86, pI464
   Scandura Joseph M., 1995, Blood, V86, p887A
   Sun JX, 1996, THROMB HAEMOSTASIS, V75, P573
   VANDIEIJEN G, 1985, THROMB HAEMOSTASIS, V53, P396
   VANRIJN J, 1983, EUR J BIOCHEM, V133, P1
   WALSH PN, 1977, BRIT J HAEMATOL, V36, P281, DOI 10.1111/j.1365-2141.1977.tb00649.x
   ZUR M, 1980, J BIOL CHEM, V255, P5703
NR 36
TC 42
Z9 42
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 28
PY 1998
VL 37
IS 30
BP 10681
EP 10690
DI 10.1021/bi973050y
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 108RZ
UT WOS:000075280400016
PM 9692958
DA 2020-11-24
ER

PT J
AU Ribeiro, JMC
   Schneider, M
   Isaias, T
   Jurberg, J
   Galvao, C
   Guimaraes, JA
AF Ribeiro, JMC
   Schneider, M
   Isaias, T
   Jurberg, J
   Galvao, C
   Guimaraes, JA
TI Role of salivary antihemostatic components in blood feeding by
   triatomine bugs (Heteroptera)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE triatomine bugs; saliva; feeding; hematophagy; hemostasis platelets
ID MOSQUITO AEDES-AEGYPTI; RHODNIUS-PROLIXUS; NITRIC-OXIDE; BLOODSUCKING
   INSECT; CONTRACTING FACTORS; HEME PROTEIN; ANTICOAGULANT; ENDOTHELIUM;
   GLANDS; PURIFICATION
AB Salivary gland homogenates from 4 genera of triatomine bugs were assayed for anticlotting, apyrase, and vasodilatory activities, and these activities were correlated with the efficiency of each bug species to initiate a blood meal. Antihemostatic activities spanned a large range of values. Apyrase activity in members of the genus Rhodnius was markedly different from that in other genera with respect to their sensitivity to divalent cation activators. Apyrase and vasodilatory activities, but not anticlotting activity, correlated with feeding efficiency of bugs taking a blood meal on a rat. Results are discussed within the context of the evolution of blood-feeding by insects.
C1 Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.
RP Ribeiro, JMC (corresponding author), NIH, Parasit Dis Lab, Bldg 4,Room 126,9000 Rockville Pike, Bethesda, MD 20892 USA.
RI Galvao, Cleber/F-7088-2011; Guimaraes, Jorge Almeida/V-2196-2019;
   Jurberg, Jose/C-3103-2013
OI Galvao, Cleber/0000-0003-4027-9205; Guimaraes, Jorge
   A./0000-0001-6354-6789; Ribeiro, Jose/0000-0002-9107-0818
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI018694, R01AI018694, R01AI018694, R01AI018694, R01AI018694,
   R01AI018694, R01AI018694, R37AI018694, R01AI018694, R01AI018694,
   R01AI018694, R01AI018694] Funding Source: NIH RePORTER; NIAID NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-18694] Funding Source: Medline
CR CAMP RDR, 1982, CLIN EXP DERMATOL, V7, P435, DOI 10.1111/j.1365-2230.1982.tb02453.x
   CHAMPAGNE DE, 1995, J BIOL CHEM, V270, P8691, DOI 10.1074/jbc.270.15.8691
   CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138
   CUPP EW, 1994, AM J TROP MED HYG, V50, P235, DOI 10.4269/ajtmh.1994.50.235
   DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537
   FURCHGOTT RF, 1989, FASEB J, V3, P2007
   HASEGAWA K, 1993, AM J PHYSIOL, V264, pR903
   HAWKINS RI, 1966, BRIT J HAEMATOL, V12, P86, DOI 10.1111/j.1365-2141.1966.tb00130.x
   HELLMANN K, 1965, NATURE, V207, P265, DOI 10.1038/207265a0
   HELLMANN K, 1964, NATURE, V201, P1008, DOI 10.1038/2011008a0
   JANDEL, 1995, SIGMA STAT WINDOWS 9
   Jurberg J, 1997, MEM I OSWALDO CRUZ, V92, P181, DOI 10.1590/S0074-02761997000200009
   LAW JH, 1992, ANNU REV BIOCHEM, V61, P87, DOI 10.1146/annurev.bi.61.070192.000511
   LENT H, 1995, MEM I OSWALDO CRUZ, V90, P33, DOI 10.1590/S0074-02761995000100008
   LENT H, 1994, MEM I OSWALDO CRUZ, V89, P353, DOI 10.1590/S0074-02761994000300009
   Lent H, 1979, B AM MUS NAT HIST, V163, P127
   Lewis J. H., 1996, COMP HEMOSTASIS VERT
   LIARD JF, 1986, J CARDIOVASC PHARM, V8, pS61, DOI 10.1097/00005344-198600087-00012
   MARINOTTI O, 1990, J INSECT PHYSIOL, V36, P545, DOI 10.1016/0022-1910(90)90021-7
   Martenson R., 1987, INT MARKET REV, V4, P7
   MONCADA S, 1978, BRIT MED BULL, V34, P129, DOI 10.1093/oxfordjournals.bmb.a071482
   MONCADA S, 1991, PHARMACOL REV, V43, P109
   NOESKEJUNGBLUT C, 1995, J BIOL CHEM, V270, P28629, DOI 10.1074/jbc.270.48.28629
   Pereira MH, 1996, ACTA TROP, V61, P255, DOI 10.1016/0001-706X(96)00007-1
   REGOLI D, 1974, PHARMACOL REV, V26, P69
   RIBEIRO JMC, 1982, J INSECT PHYSIOL, V28, P69, DOI 10.1016/0022-1910(82)90024-5
   RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393
   RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251
   RIBEIRO JMC, 1994, J MED ENTOMOL, V31, P747, DOI 10.1093/jmedent/31.5.747
   RIBEIRO JMC, 1993, J EXP BIOL, V179, P273
   RIBEIRO JMC, 1981, J EXP BIOL, V94, P219
   RIBEIRO JMC, 1980, J INSECT PHYSIOL, V26, P303, DOI 10.1016/0022-1910(80)90138-9
   RIBEIRO JMC, 1984, J EXP BIOL, V108, P1
   RIBEIRO JMC, 1992, J EXP BIOL, V165, P61
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   RIBEIRO JMC, 1985, J INSECT PHYSL, V9, P551
   RUBANYI GM, 1991, J CELL BIOCHEM, V46, P27, DOI 10.1002/jcb.240460106
   SCHRIER RW, 1985, VASOPRESSIN
   Stark KR, 1996, J MED ENTOMOL, V33, P645, DOI 10.1093/jmedent/33.4.645
   Stark KR, 1995, EXP PARASITOL, V81, P321, DOI 10.1006/expr.1995.1123
   Sun JX, 1996, THROMB HAEMOSTASIS, V75, P573
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   WILSON KM, 1985, PEPTIDES, V6, P695, DOI 10.1016/0196-9781(85)90174-3
   Wu KK, 1996, ANNU REV MED, V47, P315
NR 45
TC 54
Z9 56
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 1998
VL 35
IS 4
BP 599
EP 610
DI 10.1093/jmedent/35.4.599
PG 12
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA 108PE
UT WOS:000075274000042
PM 9701952
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Carlini, CR
   Guimaraes, JA
AF Francischetti, IMB
   Carlini, CR
   Guimaraes, JA
TI CAMP does not inhibit convulxin-induced tyrosyl-phosphorylation of human
   platelet proteins, including PLC gamma 2, but completely blocks the
   integrin alpha(IIb)beta(3)-dependent dephosphorylation step: Comparisons
   with RGDS peptide, cytochalasin D, and phenylarsine oxide
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE GPVI; convulxin; cAMP; collagen; tyrosine-phosphatases;
   tyrosine-kinases; PLC gamma 2; snake venoms
ID CROTALUS-DURISSUS-CASCAVELLA; GLYCOPROTEIN-IIB-IIIA; PHOSPHOLIPASE
   C-GAMMA-2; CYCLIC-AMP; CALCIUM MOBILIZATION; ACTIN POLYMERIZATION;
   ACTIVATION; COLLAGEN; RECEPTOR; MEMBRANE
AB Convulxin (Cvx) isolated from Crotalus durissus terrificus venom, induces platelet aggregation, phospholipase C (PLC) activation, and tyrosyl-phosphorylation (PTP) of multiple proteins, including PLC gamma 2 by a mechanism independent of integrin alpha(IIb)beta(3). However, PTP induced by Cvx is followed by a dephosphorylation step in a platelet aggregation-dependent manner. Here we show that increasing intraplatelet content of cAMP with forskolin is associated with the inhibition of Cvx-induced platelet aggregation, ATP secretion, and inositol-phosphates production. However, the early onset of Cvx-induced PTP is not sensitive to cAMP (including PLC gamma 2), and it also occurs in the presence of integrin alpha(IIb)beta(3)-antagonist (RGDS peptide, RGDS) or inhibitors of actin polymerization (cytochalasin D, CD) and tyrosine-phosphatases (phenylarsine oxide, PAO). However, forskolin, RGDS, and CD prevented the dephosphorylation step together with inhibition of platelet aggregation, whereas in the presence of phenylarsine oxide (PAO) the dephosphorylation step was replaced by an increase in the number and intensity of tyrosyl-phosphorylated proteins. Our data provide evidence to conclude that (i) cAMP inhibits platelet aggregation at a downstream site to PLC gamma 2 tyrosyl-phosphorylation; (ii) Cvx-induced PTP is independent on integrin alpha(IIb)beta(3) engagement, actin polymerization, and tyrosine-phosphatases activation; (iii) integrin alpha(IIb)beta(3) mediates the dephosphorylation step in a platelet aggregation-dependent manner; and (iv) Cvx and collagen stimulate platelets by a similar signal transduction pathway. (C) 1998 Academic Press.
C1 Univ Fed Rio de Janeiro, CCS, ICB, Dept Biochem Med, BR-21941590 Rio De Janeiro, Brazil.
RP Carlini, CR (corresponding author), Univ Fed Rio Grande Sul, Ctr Biotecnol, Av Bento Goncalves 9500,Predio 43421,Campus Vale, BR-91501970 Porto Alegre, RS, Brazil.
EM Guimar@Dna.cbiot.ufrgs.br
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR Asazuma N, 1996, THROMB HAEMOSTASIS, V75, P648
   Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235
   BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4
   DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617
   EZUMI Y, 1995, J BIOL CHEM, V270, P11927, DOI 10.1074/jbc.270.20.11927
   FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087
   FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   Francischetti IMB, 1998, ARCH BIOCHEM BIOPHYS, V353, P239, DOI 10.1006/abbi.1998.0598
   FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x
   Gibbins JM, 1997, FEBS LETT, V413, P255, DOI 10.1016/S0014-5793(97)00926-5
   GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117
   HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868
   HORSTRUP K, 1994, EUR J BIOCHEM, V225, P21, DOI 10.1111/j.1432-1033.1994.00021.x
   ICHINOHE T, 1995, J BIOL CHEM, V270, P28029
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   LAPETINA EG, 1986, FEBS LETT, V195, P111, DOI 10.1016/0014-5793(86)80141-7
   LEFEBVRE P, 1993, EUR J CELL BIOL, V62, P194
   MARLAS G, 1985, BIOCHIMIE, V67, P1231, DOI 10.1016/S0300-9084(85)80132-2
   NAKANO T, 1989, J BIOL CHEM, V264, P5400
   PEERSCHKE EIB, 1985, AM J PHYSIOL, V248, pC466
   Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576
   RADVANYIHOFMANN H, 1992, NOUV REV FR HEMATOL, V34, P133
   RANDON J, 1981, NATURE, V293, P660, DOI 10.1038/293660a0
   SANOMARTINS IS, 1992, TOXICON, V30, P141, DOI 10.1016/0041-0101(92)90467-J
   SMITH JB, 1993, BIOCHEM BIOPH RES CO, V191, P695, DOI 10.1006/bbrc.1993.1273
   TAKAYAMA H, 1993, BIOCHEM BIOPH RES CO, V194, P472, DOI 10.1006/bbrc.1993.1843
   Torti M, 1996, THROMB HAEMOSTASIS, V76, P444
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1983, EUR J PHARMACOL, V92, P57, DOI 10.1016/0014-2999(83)90108-5
   VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V
   WAL F, 1985, THROMB HAEMOSTASIS, V54, P99
   YANAGA F, 1995, FEBS LETT, V368, P377, DOI 10.1016/0014-5793(95)00670-5
   YATOMI Y, 1993, BIOCHEM BIOPH RES CO, V191, P453, DOI 10.1006/bbrc.1993.1239
NR 34
TC 10
Z9 11
U1 0
U2 2
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JUN 15
PY 1998
VL 354
IS 2
BP 255
EP 262
DI 10.1006/abbi.1998.0637
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ZW771
UT WOS:000074446700008
PM 9637734
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Ghazaleh, FA
   Reis, RAM
   Carlini, CR
   Guimaraes, JA
AF Francischetti, IMB
   Ghazaleh, FA
   Reis, RAM
   Carlini, CR
   Guimaraes, JA
TI Convulxin induces platelet activation by a tyrosine-kinase-dependent
   pathway and stimulates tyrosine phosphorylation of platelet proteins,
   including PLC gamma 2, independently of integrin alpha(IIb)beta(3)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE convulxin; tyrosyl phosphorylation; platelet activation; collagen; snake
   venom; C-d-terrificus; GPV1
ID CROTALUS-DURISSUS-CASCAVELLA; GLYCOPROTEIN-IIB-IIIA; PHOSPHOLIPASE
   C-GAMMA-2; SIGNAL-TRANSDUCTION; RABBIT PLATELETS; BLOOD-PLATELETS;
   SNAKE-VENOM; COLLAGEN; THROMBIN; GENISTEIN
AB (1)Convulxin (Cvx) is a well characterized platelet aggregating glycoprotein isolated from Crotalus durissus terrificus and C. d cascavella venoms. In the present report we show that Cvx induces tyrosine phosphorylation of human platelet proteins, including phospholipase C-gamma 2 (PLC gamma 2), and also stimulates [H-3]arachidonic acid ([H-3]AA) mobilization, pleckstrin phosphorylation, and an increase in the cytosolic Ca2+ concentration ([Ca2+](in)) due to both Ca2+ entry and internal Ca2+ mobilization. Staurosporine, a potent protein kinase inhibitor, and genistein, a specific inhibitor of protein tyrosine kinases (PTK), were used to evaluate the role of protein tyrosine phosphorylation (PTP) in the signal transduction evoked by Cvx. Staurosporine and genistein inhibited in a dose-dependent manner platelet aggregation induced by Cvx. Both inhibitors significantly blocked to near basal levels breakdown of phosphatidylinositol 4,5-bisphosphate from [myo-2-H-3]inositol-labeled platelets and the production of [H-3]AA metabolites from [H-3]AA-labeled platelets after challenge with Cvx. Cvx provokes an increase in [Ca2+](in), in Fura-loaded platelets that was abolished by concentrations of staurosporine which also inhibited Cvx-induced platelet aggregation. In addition, Cvx stimulates a rapid increase in tyrosine phosphorylation of human platelets proteins with molecular masses Of 40, 72/74, 78/80, 105, 120, and 145 kDa, followed by dephosphorylation. Furthermore, Cvx stimulates a rapid tyrosyl phosphorylation of a 145-kDa molecular mass protein that was identified as PLC gamma 2. PTP induced by Cvx was not inhibited when platelets were stimulated in the presence of indomethacin, apyrase, EDTA, or RODS peptide. These results indicate that PTP is chronologically proximal to Cvx binding to platelets, and is independent of aggregation or fibrinogen binding to the integrin alpha(IIb)beta(3). On the other hand, the dephosphorylation step is inhibited by RGDS peptide or EDTA, suggesting that integrin alpha(IIb)beta(3) is envolved in this step. The profile obtained with Cvx resembles that obtained in platelets adherent to an immobilized ligand, such as immobilized collagen, in which PTP is independent on integrin alpha(IIb)beta(3). Thus, we suggest that Cvx is an example of a protein with adhesion molecule-like properties; i.e., it is an adhesin. In conclusion, our results show that Cvx induces multiple signaling pathways in platelets via a PTK-dependent pathway involving PLC gamma 2 tyrosyl phosphorylation, with the subsequent platelet responses. Cvx is unique among platelet soluble agonists because under test tube stirring conditions it induces a PTP profile independently of integrin alpha(IIb)beta(3). (C) 1998 Academic Press.
C1 Fed Univ Rio De Janeiro, Dept Med Biochem, BR-21941590 Rio De Janeiro, Brazil.
   Fed Univ Rio De Janeiro, Inst Biophys, ICB, CCS, BR-21941590 Rio De Janeiro, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio Grande Sul, Ctr Biotecnol, Caixa Postal 15005, BR-91509900 Porto Alegre, RS, Brazil.
RI Reis, Ricardo/E-9962-2011; Guimaraes, Jorge Almeida/V-2196-2019; da
   Silva Carlini, Celia Regina Ribeiro/H-4017-2011
OI Reis, Ricardo/0000-0001-9689-4085; da Silva Carlini, Celia Regina
   Ribeiro/0000-0002-7027-2445; Guimaraes, Jorge A./0000-0001-6354-6789
CR AKIYAMA T, 1987, J BIOL CHEM, V262, P5592
   Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235
   BACHELOT C, 1992, BIOCHEM J, V284, P923, DOI 10.1042/bj2840923
   BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4
   BOLEN JB, 1992, FASEB J, V6, P3403
   CLARK EA, 1994, J BIOL CHEM, V269, P21940
   CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7
   CLARK EA, 1994, J BIOL CHEM, V269, P28859
   DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617
   FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087
   FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234
   FOX JEB, 1993, THROMB HAEMOSTASIS, V70, P884
   FOX JEB, 1993, J BIOL CHEM, V268, P25973
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x
   FURMAN MI, 1994, CIRC RES, V75, P172, DOI 10.1161/01.RES.75.1.172
   GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117
   GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852
   GUINEBAULT C, 1993, BIOCHEM J, V292, P851, DOI 10.1042/bj2920851
   HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868
   HARGREAVES PG, 1994, THROMB HAEMOSTASIS, V72, P634
   HAWIGER J, 1994, HEMOSTASIS THROMBOSI, P603
   HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844
   HUANG TF, 1995, BIOCHEM J, V309, P1021, DOI 10.1042/bj3091021
   ICHINOHE T, 1995, J BIOL CHEM, V270, P28029
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   KAJIYAMA Y, 1989, ARCH BIOCHEM BIOPHYS, V274, P200, DOI 10.1016/0003-9861(89)90431-1
   KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z
   LIPFERT L, 1992, J CELL BIOL, V119, P905, DOI 10.1083/jcb.119.4.905
   MARLAS G, 1985, BIOCHIMIE, V67, P1231, DOI 10.1016/S0300-9084(85)80132-2
   NAKASHIMA S, 1991, MOL PHARMACOL, V39, P475
   NIEWIAROWSKI S, 1977, THROMB RES, V10, P863, DOI 10.1016/0049-3848(77)90144-X
   NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866
   OHTA S, 1992, BIOCHEM BIOPH RES CO, V185, P1128, DOI 10.1016/0006-291X(92)91743-A
   POLANOWSKAGRABOWSKA R, 1993, BIOCHEM J, V296, P543, DOI 10.1042/bj2960543
   Polgar J, 1997, J BIOL CHEM, V272, P13576, DOI 10.1074/jbc.272.21.13576
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C
   RODRIGUEZLINARES B, 1994, FEBS LETT, V352, P335, DOI 10.1016/0014-5793(94)00983-X
   SARGEANT P, 1993, J BIOL CHEM, V268, P18151
   SHATTIL SJ, 1994, CURR OPIN CELL BIOL, V6, P695, DOI 10.1016/0955-0674(94)90096-5
   TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2
   TENG CM, 1993, THROMB HAEMOSTASIS, V69, P286
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1983, EUR J PHARMACOL, V92, P57, DOI 10.1016/0014-2999(83)90108-5
   VASSBOTN FS, 1994, J BIOL CHEM, V269, P13874
   VOSTAL JG, 1991, J BIOL CHEM, V266, P1691
   YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471
NR 48
TC 23
Z9 23
U1 2
U2 5
PU ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD MAY 15
PY 1998
VL 353
IS 2
BP 239
EP 250
DI 10.1006/abbi.1998.0598
PG 12
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA ZQ203
UT WOS:000073833100007
PM 9606958
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Castro, HC
   Zingali, RB
   Carlini, CR
   Guimaraes, JA
AF Francischetti, IMB
   Castro, HC
   Zingali, RB
   Carlini, CR
   Guimaraes, JA
TI Bothrops sp. snake venoms: Comparison of some biochemical and
   physicochemical properties and interference in platelet functions
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
LA English
DT Article
DE snake venom; crotalinae; Bothrops; platelet aggregation; platelet
   inhibition; coagulation hemostase; proteases; phospholipase A(2)
ID CROTALUS-DURISSUS-TERRIFICUS; BOTHROPS-MOOJENI-(CAISSACA) VENOM;
   REGIONAL VARIATION; BASIC PROTEINASES; AGGREGATION; JARARACA;
   PURIFICATION; METALLOPROTEINASES; ACTIVATION; MECHANISMS
AB Procoagulant, proteolytic, phospholipase and platelet pro-aggregating and inhibiting activities were screened for pooled venoms of seven Bothrops species as well as Crotalus durissus terrificus and Lachesis muta snakes typical of the Brazilian territory. As reported by other authors, we also found that examination of the electrophoretic and gel filtration patterns of Bothrops snakes venoms could not be used for identification of the species of a given venom because of the lack of marked interspecific differences within the same genus. Our data indicated that B. cotiara, B. alternatus and B. atrox possess no platelet pro-aggregating activity, low inhibitory effect on platelet aggregation and very low or intermediate levels for the other activities. B. moojeni, B. neuwiedi and B. jararacussu whose venoms possess high procoagulant, platelet pro-aggregating and phospholipase activities are low in both proteolytic and platelet inhibitory activities. B, jararaca venom showed the highest inhibitory effect on platelet aggregation and very low platelet pro-aggregating activity. Compared with the Bothrops venoms studied, L. muta venom showed that highest proteolytic activity while C. d. terrificus venom presented remarkable high platelet pro-aggregating and phospholipase activities. In all venoms, proteolytic activity could be completely inhibited by EDTA (2 mM) alone. In contrast, the presence of phenylmethylsulfonyl fluoride (5 mM) inhibited partially the caseinolytic activity of all venoms, except that L. muta venom, which was almost completely blocked by this reagent. Altogether, these data confirm the presence of high levels of metalloproteinases in the venoms of Crotalinae snakes. Most of these enzymes are dependent of the availability of Ca2+, being much less the same concerning the presence of serine residues in their active sites. The data indicated that the presence and levels of procoagulant, azocaseinolytic and phospholipase A(2) activities alone could not differentiated the species of the Bothrops venoms studied, particularly in the cases of B. jararaca, B. moojeni and B. atrox. However, the platelet inhibiting property of low doses of B, jararaca venom can be useful to differentiate it from B. moojeni venom. In the same way, the platelet pro-aggregating activity of high doses of B. jararaca venom may be used to distinguish it from B. atl ox crude venom, otherwise very similar but incapable to activate platelets. In conclusion, our comparative screening of biological properties has indicated that platelet studies may serve as a tool to distinguish among venoms that otherwise behave biochemically in a very similar way. Although promising, the general applicability of platelet activation studies by snake venoms for classification or taxanomical purposes has yet to be extended to other family of snakes to be proven useful. (C) 1998 Elsevier Science Inc.
C1 Univ Fed Rio de Janeiro, ICB, Dept Bioquim Med, BR-21910590 Rio De Janeiro, Brazil.
RP Guimaraes, JA (corresponding author), Univ Fed Rio de Janeiro, ICB, Dept Bioquim Med, Ilha Fundao CP 68041, BR-21910590 Rio De Janeiro, Brazil.
EM GUIMAR@DNA.CBIOT.UFRGS.BR
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011; Zingali, Russolina/G-4862-2012; Castro,
   Helena/V-2137-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789; Castro, Helena Carla/0000-0001-5283-1541
CR ADAME BL, 1990, COMP BIOCHEM PHYS B, V97, P95, DOI 10.1016/0305-0491(90)90184-U
   AIRD SD, 1985, TOXICON, V23, P361, DOI 10.1016/0041-0101(85)90020-0
   AIRD SD, 1985, TOXICON, V23, P100
   AMARAL CFS, 1988, REV INST MED TROP SP, V30, P288, DOI 10.1590/S0036-46651988000400007
   ARAUJO A L D, 1987, Toxicon, V25, P1181
   BERNADSKY G, 1986, TOXICON, V24, P721, DOI 10.1016/0041-0101(86)90035-8
   BJARNASON JB, 1994, PHARMACOL THERAPEUT, V62, P325, DOI 10.1016/0163-7258(94)90049-3
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087
   FERREIRA ML, 1992, TOXICON, V30, P1603, DOI 10.1016/0041-0101(92)90032-Z
   FULY AL, 1993, BRAZ J MED BIOL RES, V26, P459
   FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GENE JA, 1989, TOXICON, V27, P841, DOI 10.1016/0041-0101(89)90096-2
   GLENN JL, 1994, COMP BIOCHEM PHYS C, V107, P337, DOI 10.1016/1367-8280(94)90059-0
   KINI RM, 1990, TOXICON, V28, P1387, DOI 10.1016/0041-0101(90)90155-Z
   KINI RM, 1992, TOXICON, V30, P265, DOI 10.1016/0041-0101(92)90869-7
   KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5
   KORNALIK F, 1988, HEMOSTASIS ANIMAL VE, P503
   KROLL MH, 1989, BLOOD, V74, P1181
   MARKWARD.F, 1966, N-S ARCH PHARMAKOL, V252, P297, DOI 10.1007/BF00246745
   MARSH NA, 1994, BLOOD COAGUL FIBRIN, V5, P399
   NIEWIAROWSKI S, 1979, BIOCHEMISTRY-US, V18, P3570, DOI 10.1021/bi00583a021
   OWNBY CL, 1990, TOXICON, V28, P189, DOI 10.1016/0041-0101(90)90413-2
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   READ MS, 1978, P NATL ACAD SCI USA, V75, P4514, DOI 10.1073/pnas.75.9.4514
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335
   ROSENBERG P, 1979, HDB EXPT PHARM, V52, P404
   ROSENFELD G, 1976, DOENCAS INFECCIOSAS, P970
   SERRANO SMT, 1993, TOXICON, V31, P483, DOI 10.1016/0041-0101(93)90183-J
   SERRANO SMT, 1993, TOXICON, V31, P471, DOI 10.1016/0041-0101(93)90182-I
   SERRANO SMT, 1995, BIOCHEMISTRY-US, V34, P7186, DOI 10.1021/bi00021a033
   SOTO JG, 1988, TOXICON, V26, P875, DOI 10.1016/0041-0101(88)90328-5
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   TAN NH, 1992, COMP BIOCHEM PHYS B, V102, P103, DOI 10.1016/0305-0491(92)90280-5
   TAN NH, 1991, COMP BIOCHEM PHYS B, V100, P361, DOI 10.1016/0305-0491(91)90387-S
   TANIZAKI MM, 1989, TOXICON, V27, P747, DOI 10.1016/0041-0101(89)90041-X
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
   ZINGALI RB, 1988, BRAZ J MED BIOL RES, V21, P763
   ZINGALI RB, 1990, THROMB RES, V58, P303, DOI 10.1016/0049-3848(90)90100-Q
NR 40
TC 21
Z9 22
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1532-0456
EI 1878-1659
J9 COMP BIOCHEM PHYS C
JI Comp. Biochem. Physiol. C-Toxicol. Pharmacol.
PD JAN
PY 1998
VL 119
IS 1
BP 21
EP 29
DI 10.1016/S0742-8413(97)00163-1
PG 9
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism;
   Toxicology; Zoology
GA ZB249
UT WOS:000072452100004
PM 9580495
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Carlini, CR
   Guimaraes, JA
AF Francischetti, IMB
   Carlini, CR
   Guimaraes, JA
TI Human platelets activation by convulxin is accompanied by
   tyrosyl-phosphorylation of PLC gamma 2 and occurs independently of
   integrin alpha(IIb)beta(3)
SO PLATELETS
LA English
DT Article; Proceedings Paper
CT Workshop on Platelet Activation, at the 31st Annual Meeting of the
   European-Society-for-Clinical-Investigation
CY MAR, 1997
CL KIEL, GERMANY
SP European Soc Clin Investigat
ID CROTALUS-DURISSUS-CASCAVELLA; PHOSPHOLIPASE C-GAMMA-1; RABBIT PLATELETS;
   COLLAGEN; KINASES; VENOM; GLYCOPROTEIN; MECHANISMS; RECEPTOR
AB In the present report we show that convulxin (Cvx), a C-type lectin from Crotalus durissus terrificus venom, induces platelet agregation and phospholipase C (PLC) activation by a protein tyrosine kinase (PTK)-dependent pathway. In addition, Cvx stimulates a rapid increase in tyrosine phosphorylation of human platelet proteins with molecular masses of 40, 72/74, 78/80 and 120kDa, followed by dephosphorylation of some proteins. However, platelet aggregation was accompanied by the phosphorylation of a 105-kDa molecular mass protein. Furthermore, Cvx stimulates a rapid-tyrosyl phosphorylation of a 145-kDa protein that was identified as PLC gamma 2. Protein tyrose phosphatase (PTP) induced by Cvx was not blocked when platelets were stimulated in the presence of indomethacin, apyrase, EDTA or PODS peptide, but inhibited by staurosporine and genistein. These results indicate that PTP is chronologically proximal to Cvx binding to platelets, and it is independent of platelet aggregation or fibrinogen binding to integrin alpha(IIb)beta(3). On the other hand, the dephosphorylation step, and the phosphorylation of the 105-kDa protein, were both inhibited by PODS and EDTA, which suggests that the integrin alpha(IIb)beta(3) is involved in these steps. Our results, taken together, show that Cvx induces platelet aggregation in a similar manner as collagen and collagen-related peptides that also trigger platelet aggregation by a PTK-dependent pathway, and stimulate tyrosyl-phosphorylation of PLC gamma 2. However, Cvx is unique among platelet receptor agonists, because under test-tube stirring conditions it induces a PTP profile independently of integrin alpha(IIb)beta(3).
C1 Univ Fed Rio de Janeiro, Dept Med Biochem, BR-21941590 Rio De Janeiro, Brazil.
RP Guimaraes, JA (corresponding author), UFRGS, Ctr Biotecnol, Av Bento Goncalves 9500, BR-91501970 Porto Alegre, RS, Brazil.
EM Guimar@dna.cbiot.vfrgs.br
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR Asselin J, 1997, BLOOD, V89, P1235, DOI 10.1182/blood.V89.4.1235
   BACHELOT C, 1992, BIOCHEM J, V284, P923, DOI 10.1042/bj2840923
   BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4
   CLARK EA, 1994, TRENDS BIOCHEM SCI, V19, P464, DOI 10.1016/0968-0004(94)90131-7
   DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617
   FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087
   Francischetti IMB, 1997, TOXICON, V35, P1217, DOI 10.1016/S0041-0101(97)00021-4
   FURMAN MI, 1994, CIRC RES, V75, P172, DOI 10.1161/01.RES.75.1.172
   HAIMOVICH B, 1993, J BIOL CHEM, V268, P15868
   Holmsen H, 1996, PLATELETS, V7, P336
   Ichinohe T, 1997, J BIOL CHEM, V272, P63
   ICHINOHE T, 1995, J BIOL CHEM, V270, P28029
   Jamieson GA, 1997, THROMB HAEMOSTASIS, V78, P242
   JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035
   KROLL MH, 1989, BLOOD, V74, P1181
   MARLAS G, 1985, BIOCHIMIE, V67, P1231, DOI 10.1016/S0300-9084(85)80132-2
   MURPHY CT, 1993, EUR J BIOCHEM, V216, P639, DOI 10.1111/j.1432-1033.1993.tb18184.x
   NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C
   SHATTIL SJ, 1994, CURR OPIN CELL BIOL, V6, P695, DOI 10.1016/0955-0674(94)90096-5
   SIESS W, 1989, PHYSIOL REV, V69, P58
   TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1983, EUR J PHARMACOL, V92, P57, DOI 10.1016/0014-2999(83)90108-5
   YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471
NR 26
TC 3
Z9 3
U1 0
U2 3
PU CARFAX PUBL CO
PI ABINGDON
PA PO BOX 25, ABINGDON, OXFORDSHIRE, ENGLAND OX14 3UE
SN 0953-7104
J9 PLATELETS
JI Platelets
PY 1998
VL 9
IS 3-4
BP 185
EP 189
DI 10.1080/09537109876663
PG 5
WC Cell Biology; Hematology
SC Cell Biology; Hematology
GA ZY415
UT WOS:000074619000007
PM 16793699
DA 2020-11-24
ER

PT J
AU Monteiro, RQ
   Yamanouye, N
   Carlini, CR
   Guimaraes, JA
   Bon, C
   Zingali, RB
AF Monteiro, RQ
   Yamanouye, N
   Carlini, CR
   Guimaraes, JA
   Bon, C
   Zingali, RB
TI Variability of bothrojaracin isoforms and other venom principles in
   individual jararaca (Bothrops jararaca) snakes maintained under
   seasonally invariant conditions
SO TOXICON
LA English
DT Article
ID BIOLOGICAL PROPERTIES; THROMBIN INHIBITOR; RHODNIUS-PROLIXUS;
   PURIFICATION; PROTEINS; ATROX; PHOSPHOLIPASE-A2; JUVENILE; LECTIN; ASSAY
AB Bothrojaracin (BJC) is a potent thrombin inhibitor isolated from the venom of Bothrops jararaca. Venoms from individual snakes have been shown to vary in BJC content, and more than one molecular variant (isoform) has been identified in the same venom. In order to determine whether the production of this protein and its isoforms varies under seasonally invariant conditions, an analysis was made of BJC isolated from venoms collected individually once a month for 10 months from two female B. jararaca snakes kept under conditions of constant temperature and photoperiod. The crude venom from each individual snake exhibited a characteristic pattern of protein bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), with no noticeable variation throughout the collecting period. BJC from individual venoms was purified by gel filtration on Sephacryl S-200 followed by an affinity column (PPACK-thrombin Sepharose). BJC content and other activities such as phospholipase A(2), azocaseinolytic activity and inhibition of thrombin-induced platelet aggregation varied considerably among the samples. Purified BJC from both snakes inhibited fibrin coagulation and migrated as a single band of 27,000 mol. wt on SDS-PAGE. However, the BJC pattern on non-denaturing PAGE differed between the two snakes, with four to six bands per sample each month, which were all recognized by polyclonal anti-BJC antibodies. The isoelectric focusing pattern of BJC was also characteristic for each snake, with only minor differences throughout the collecting period. These results indicate that under seasonally invariant conditions: (1) there was a considerable variation over the 10-month period in the production of BJC and other important venom activities such as phospholipase A(2) and proteinases; (2) individual B. jararaca snakes produced a distinctive array of BJC isoforms; and (3) despite quantitative differences, there were essentially no qualitative differences in the production of BJC isoforms by individual snakes during the 10-month period. (C) 1998 Elsevier Science Ltd. All rights reserved.
C1 Cidade Univ, UFRJ, CCS,ICB, Dept Bioquim Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
   Inst Pasteur, Unite Venins, Paris, France.
   Inst Butantan, Serv Farmacol, Sao Paulo, Brazil.
RP Zingali, RB (corresponding author), Cidade Univ, UFRJ, CCS,ICB, Dept Bioquim Med, BR-21941590 Rio De Janeiro, RJ, Brazil.
RI de Queiroz Monteiro, Robson/M-7097-2019; Yamanouye, Norma/I-3348-2013;
   da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; DE QUEIROZ MONTEIRO,
   ROBSON/B-8007-2014; Zingali, Russolina/G-4862-2012; Guimaraes, Jorge
   Almeida/V-2196-2019
OI de Queiroz Monteiro, Robson/0000-0002-5260-2332; Yamanouye,
   Norma/0000-0001-6007-0199; da Silva Carlini, Celia Regina
   Ribeiro/0000-0002-7027-2445; Guimaraes, Jorge A./0000-0001-6354-6789
CR Arocas V, 1996, BIOCHEMISTRY-US, V35, P9083, DOI 10.1021/bi960043l
   BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0
   DEARAUJO AL, 1987, TOXICON, V25, P1181, DOI 10.1016/0041-0101(87)90136-X
   DETRAIT J, 1966, ANN I PASTEUR PARIS, V111, P93
   FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GARTNER TK, 1980, FEBS LETT, V117, P13, DOI 10.1016/0014-5793(80)80902-1
   GLENN JL, 1983, TOXICON, V21, P119, DOI 10.1016/0041-0101(83)90055-7
   GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B
   GREGORY VM, 1984, P W PHARMACOL SOC, V27, P233
   GREGORYDWYER VM, 1986, TOXICON, V24, P995, DOI 10.1016/0041-0101(86)90005-X
   GUBENSEK F, 1974, TOXICON, V12, P167, DOI 10.1016/0041-0101(74)90241-4
   ISHII A, 1970, JPN J EXP MED, V40, P141
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MACHADO OLT, 1993, BRAZ J MED BIOL RES, V26, P163
   MANDELBAUM FR, 1982, TOXICON, V20, P955, DOI 10.1016/0041-0101(82)90098-8
   MARSH N, 1974, TOXICON, V12, P621, DOI 10.1016/0041-0101(74)90196-2
   MEBS D, 1984, TOXICON, V22, P831, DOI 10.1016/0041-0101(84)90170-3
   MEIER J, 1986, TOXICON, V24, P41, DOI 10.1016/0041-0101(86)90164-9
   MINTON SA, 1986, TOXICON, V24, P71, DOI 10.1016/0041-0101(86)90167-4
   Monteiro RQ, 1997, TOXICON, V35, P649, DOI 10.1016/S0041-0101(96)00176-6
   OZEKI Y, 1994, ARCH BIOCHEM BIOPHYS, V308, P306, DOI 10.1006/abbi.1994.1043
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   SEEGERS WH, 1979, SNAKE VENOMS HDB EXP, V52, P684
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   TAN NH, 1993, COMP BIOCHEM PHYS B, V106, P651, DOI 10.1016/0305-0491(93)90144-T
   TAN NH, 1992, COMP BIOCHEM PHYS B, V103, P585, DOI 10.1016/0305-0491(92)90375-2
   TANIZAKI MM, 1989, TOXICON, V27, P747, DOI 10.1016/0041-0101(89)90041-X
   WILLEMSE GT, 1979, TOXICON, V17, P37, DOI 10.1016/0041-0101(79)90253-8
   WILLIAMS V, 1992, TOXICON, V30, P202, DOI 10.1016/0041-0101(92)90473-I
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 33
TC 12
Z9 12
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD JAN
PY 1998
VL 36
IS 1
BP 153
EP 163
DI 10.1016/S0041-0101(97)00061-5
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA ZK968
UT WOS:000073385700013
PM 9604289
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Monteiro, RQ
   Guimaraes, JA
AF Francischetti, IMB
   Monteiro, RQ
   Guimaraes, JA
TI Identification of glycyrrhizin as a thrombin inhibitor (vol 235, pg 259,
   1997)
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Correction, Addition
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Monteiro, Robson/0000-0002-5260-2332
CR FRANCISCHETTI IMB, 1997, BIOCHEM BIOPH RES CO, V235, P259
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 8
PY 1997
VL 237
IS 1
BP 203
EP 203
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA XR065
UT WOS:A1997XR06500042
DA 2020-11-24
ER

PT J
AU Mauricio, I
   Francischetti, B
   Monteiro, RQ
   Guimaraes, JA
AF Mauricio, I
   Francischetti, B
   Monteiro, RQ
   Guimaraes, JA
TI Identification of glycyrrhizin as a thrombin inhibitor
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
ID SIALYL-LEWIS-X; E-SELECTIN; HUMAN THROMBOMODULIN; BINDING; LIGAND;
   SPECIFICITY; RECEPTOR; OLIGOSACCHARIDE; MECHANISM; EXOSITE
AB Glycyrrhizin (GL), an anti-inflammatory compound isolated from Glcyrrhiza glabra, was identified as a new thrombin inhibitor: (a) It prolonged plasma recalcification and thrombin and fibrinogen clotting times, and (b) it inhibited thrombin-induced, but not collagen-, PAF- or convulxin-induced platelet aggregation. On the other hand, GL did not block thrombin's amidolytic activity upon S-2238. Furthermore, the fluorescence emission intensity of dansyl-thronnbin was increased upon GL binding. Moreover, GL displaced hirudin as an inhibitor of thrombin-catalyzed hydrolysis of S-2238. Our data provide evidence that GL is a selective inhibitor of thrombin (the first one isolated from plants) that is able to exert its anti-thrombin action by interacting with the enzyme's anion binding exosite 1. A pharmacophoric search identified GL as a sialyl Lewis X (SLe(X)) mimetic compound able to inhibit selectin binding to SLe(X). However, SLe(X) did not affect thrombin clotting activities, which indicates a lack of its interaction with thrombin and distinguishes both molecules. It is suggested that the anti-inflammatory effect of GL may be due to its effective anti-thrombin action. (C) 1997 Academic Press.
C1 FED UNIV RIO DE JANEIRO,DEPT BIOCHEM MED,ICB CCB,BR-21941590 RIO JANEIRO,BRAZIL.
RI de Queiroz Monteiro, Robson/M-7097-2019; DE QUEIROZ MONTEIRO,
   ROBSON/B-8007-2014; Guimaraes, Jorge Almeida/V-2196-2019
OI de Queiroz Monteiro, Robson/0000-0002-5260-2332; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR BERLINER LJ, 1977, THROMB RES, V12, P15
   BERTOZZI CR, 1995, BIOCHEMISTRY-US, V34, P14271, DOI 10.1021/bi00044a001
   BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.immunol.11.1.767
   BOUTON MC, 1995, BIOCHEM J, V305, P635, DOI 10.1042/bj3050635
   CLEMETSON KJ, 1995, THROMB HAEMOSTASIS, V74, P111
   COOLING LLW, 1995, GLYCOBIOLOGY, V5, P571, DOI 10.1093/glycob/5.6.571
   DEMARCO L, 1994, J BIOL CHEM, V269, P678
   FAILI A, 1994, BIOCHEM J, V298, P87, DOI 10.1042/bj2980087
   FINNEY RSH, 1958, J PHARM PHARMACOL, V10, P613, DOI 10.1111/j.2042-7158.1958.tb10349.x
   FOXALL C, 1992, J CELL BIOL, V117, P895, DOI 10.1083/jcb.117.4.895
   GUILLIN MC, 1995, THROMB HAEMOSTASIS, V74, P129
   ITO M, 1988, ANTIVIR RES, V10, P289, DOI 10.1016/0166-3542(88)90047-2
   JACOB GS, 1995, BIOCHEMISTRY-US, V34, P1210, DOI 10.1021/bi00004a014
   JANDROTPERRUS M, 1992, BLOOD, V80, P2781
   LEE RT, 1991, J BIOL CHEM, V266, P4810
   LEWIS SD, 1976, ARCH BIOCHEM BIOPHYS, V172, P689, DOI 10.1016/0003-9861(76)90125-9
   LIU LW, 1991, J BIOL CHEM, V266, P16977
   MAFFRAND JP, 1992, NOUV REV FR HEMATOL, V34, P405
   MARAGANORE JM, 1993, THROMB HAEMOSTASIS, V70, P208
   MARCUS AJ, 1993, FASEB J, V7, P516
   MCEVER RP, 1991, THROMB HAEMOSTASIS, V66, P80
   NAKAMURA T, 1991, LIPIDS, V26, P1297, DOI 10.1007/BF02536552
   NASKI MC, 1990, J BIOL CHEM, V265, P13484
   NELSON RM, 1993, J CLIN INVEST, V91, P1157, DOI 10.1172/JCI116275
   NISHINO H, 1984, CARCINOGENESIS, V5, P1529, DOI 10.1093/carcin/5.11.1529
   NOESKEJUNGBLUT C, 1995, J BIOL CHEM, V270, P28629, DOI 10.1074/jbc.270.48.28629
   NUMAZAKI K, 1994, J LEUKOCYTE BIOL, V55, P24
   POMPEI R, 1979, NATURE, V281, P689, DOI 10.1038/281689a0
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P875, DOI 10.1016/0041-0101(81)90085-4
   RAO BNN, 1994, J BIOL CHEM, V269, P19663
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   SAUTER NK, 1989, BIOCHEMISTRY-US, V28, P8388, DOI 10.1021/bi00447a018
   SHEEHAN JP, 1994, P NATL ACAD SCI USA, V91, P5518, DOI 10.1073/pnas.91.12.5518
   TAKEDA H, 1991, TOKAI J EXP CLIN MED, V16, P3
   TOLLEFSEN DM, 1995, THROMB HAEMOSTASIS, V74, P1209
   TONG PY, 1989, J BIOL CHEM, V264, P7962
   TSIANG M, 1992, J BIOL CHEM, V267, P6164
   WU QY, 1992, J BIOL CHEM, V267, P7083
   YUEN CT, 1994, J BIOL CHEM, V269, P1595
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
NR 40
TC 65
Z9 67
U1 0
U2 5
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUN 9
PY 1997
VL 235
IS 1
BP 259
EP 263
DI 10.1006/bbrc.1997.6735
PG 5
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA XE346
UT WOS:A1997XE34600050
PM 9196073
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Carlini, CR
   Guimaraes, JA
AF Francischetti, IMB
   Carlini, CR
   Guimaraes, JA
TI Convulxin induces tyrosine phosphorylation of platelet proteins,
   including PLC gamma 2, by a cAMP and integrin alpha IIb/beta 3
   independent mechanism
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 UFRJ,DEPT BIOQUIM MED,ICB,CCS,BR-21941590 RIO JANEIRO,RJ,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUN
PY 1997
SU S
BP P1078
EP P1078
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA XE898
UT WOS:A1997XE89801076
DA 2020-11-24
ER

PT J
AU Francischetti, IMB
   Monteiro, RQ
   Guimaraes, JA
AF Francischetti, IMB
   Monteiro, RQ
   Guimaraes, JA
TI Identification of glycyrrhizin as a thrombin inhibitor
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO, DEPT BIOQUIM MED, ICB, CCS, RIO DE JANEIRO, BRAZIL.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUN
PY 1997
SU S
BP PS380
EP PS380
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA XE898
UT WOS:A1997XE89800379
DA 2020-11-24
ER

PT J
AU Guimaraes, JA
   Schneider, M
   Ribeiro, JMC
AF Guimaraes, JA
   Schneider, M
   Ribeiro, JMC
TI Disruption of Xase complex by nitrophorin 2, the salivary anticoagulant
   of the blood-sucking bug R-prolixus
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO, DEPT BIOCHEM MED, RIO DE JANEIRO, BRAZIL.
   NIAID, PARASIT DIS LAB, BETHESDA, MD 20892 USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUN
PY 1997
SU S
BP P2813
EP P2813
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA XE898
UT WOS:A1997XE89802812
DA 2020-11-24
ER

PT J
AU Zhang, Y
   Ribeiro, JMC
   Guimaraes, JA
   Walsh, PN
AF Zhang, Y
   Ribeiro, JMC
   Guimaraes, JA
   Walsh, PN
TI Nitrophorin-2: A novel mixed-type reversible specific inhibitor of
   surface-dependent factor IXa-catalyzed factor-X activation
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 TEMPLE UNIV, SCH MED, SOL SHERRY THROMBOSIS RES CTR, PHILADELPHIA, PA 19122 USA.
   NIAID, MED ENTOMOL SECT, NIH, BETHESDA, MD 20892 USA.
   FED UNIV RIO DE JANEIRO, ICB, DEPT BIOCHEM MED, RIO DE JANEIRO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD JUN
PY 1997
SU S
BP P1780
EP P1780
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA XE898
UT WOS:A1997XE89801779
DA 2020-11-24
ER

PT J
AU Monteiro, RQ
   Carlini, CR
   Guimaraes, JA
   Bon, C
   Zingali, RB
AF Monteiro, RQ
   Carlini, CR
   Guimaraes, JA
   Bon, C
   Zingali, RB
TI Distinct bothrojaracin isoforms produced by individual jararaca
   (Bothrops jararaca) snakes
SO TOXICON
LA English
DT Article
ID CROTALUS-DURISSUS-TERRIFICUS; AMINO-ACID-SEQUENCE; VENOM; PURIFICATION;
   PHOSPHOLIPASE-A2; CROTOXIN; AGGREGATION; BOTROCETIN; LECTIN; ATROX
AB Bothrojaracin (apparent mel. wt 27,000) is a potent inhibitor of thrombin previously isolated from the venom of Bothrops jararaca. Several molecular variants (isoforms) have been identified in a pool of venom collected from a large number of animals. In order to determine whether an individual snake produces a single type of bothrojaracin or multiple isoforms, we analyzed the bothrojaracin content of venoms collected individually from six adult B. jararaca snakes. Bothrojaracin was found in all venoms, but its activity was especially high in three of them. After purification on an alpha-thrombin affinity column, followed by gel filtration on Superose 12 HR, proteins from these three venoms migrated on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as single bands of 27,000 and their amino-terminal sequences (residues 1-28) revealed extensive homology with bothrojaracin. In contrast, the material purified from the three venoms with low bothrojaracin activity consisted of bothrojaracin together with inactive proteins. Differences in the sequences obtained for bothrojaracin isolated from individual venoms indicated the existence of more than one isoform in the venom of an individual snake. (C) 1997 Elsevier Science Ltd.
C1 UNIV FED RIO DE JANEIRO, CCS, ICB, DEPT BIOQUIM MED, BR-21941590 RIO DE JANEIRO, BRAZIL.
   INST PASTEUR, UNITE VENINS, PARIS, FRANCE.
RI de Queiroz Monteiro, Robson/M-7097-2019; Zingali, Russolina/G-4862-2012;
   DE QUEIROZ MONTEIRO, ROBSON/B-8007-2014; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011; Guimaraes, Jorge Almeida/V-2196-2019
OI de Queiroz Monteiro, Robson/0000-0002-5260-2332; da Silva Carlini, Celia
   Regina Ribeiro/0000-0002-7027-2445; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANDREWS RK, 1989, BIOCHEMISTRY-US, V28, P8317, DOI 10.1021/bi00447a009
   BRINKHOUS KM, 1989, METHOD ENZYMOL, V169, P149
   CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9
   DEARAUJO AL, 1987, TOXICON, V25, P1181, DOI 10.1016/0041-0101(87)90136-X
   FAURE G, 1994, EUR J BIOCHEM, V223, P161, DOI 10.1111/j.1432-1033.1994.tb18978.x
   FAURE G, 1991, BIOCHEMISTRY-US, V30, P8074, DOI 10.1021/bi00246a028
   FAURE G, 1987, TOXICON, V25, P229, DOI 10.1016/0041-0101(87)90246-7
   FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GARTNER TK, 1980, FEBS LETT, V117, P13, DOI 10.1016/0014-5793(80)80902-1
   GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEITE LCC, 1992, COMP BIOCHEM PHYS B, V102, P515, DOI 10.1016/0305-0491(92)90042-P
   LOMONTE B, 1992, COMP BIOCHEM PHYS B, V102, P325, DOI 10.1016/0305-0491(92)90129-F
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MACHADO OLT, 1993, BRAZ J MED BIOL RES, V26, P163
   MANDELBAUM FR, 1982, TOXICON, V20, P955, DOI 10.1016/0041-0101(82)90098-8
   MEIER J, 1986, TOXICON, V24, P41, DOI 10.1016/0041-0101(86)90164-9
   OZEKI Y, 1994, ARCH BIOCHEM BIOPHYS, V308, P306, DOI 10.1006/abbi.1994.1043
   SEEGERS WH, 1979, SNAKE VENOMS HDB EXP, V52, P684
   SERRANO SMT, 1995, BIOCHEMISTRY-US, V34, P7186, DOI 10.1021/bi00021a033
   TRIKHA M, 1994, TOXICON, V32, P1521, DOI 10.1016/0041-0101(94)90310-7
   WILLIAMS V, 1992, TOXICON, V30, P202, DOI 10.1016/0041-0101(92)90473-I
   ZINGALI RB, 1993, BIOCHEMISTRY-US, V32, P10794, DOI 10.1021/bi00091a034
   ZINGALI RB, 1990, THROMB RES, V58, P303, DOI 10.1016/0049-3848(90)90100-Q
   ZINGALI RB, 1991, ANN I PASTEUR, V4, P267
NR 26
TC 19
Z9 22
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PD MAY
PY 1997
VL 35
IS 5
BP 649
EP 657
DI 10.1016/S0041-0101(96)00176-6
PG 9
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA XE623
UT WOS:A1997XE62300003
PM 9203289
DA 2020-11-24
ER

PT J
AU Valenzuela, JG
   Guimaraes, JA
   Ribeiro, JMC
AF Valenzuela, JG
   Guimaraes, JA
   Ribeiro, JMC
TI A novel inhibitor of factor X activation from the salivary glands of the
   bed bug Cimex lectularius
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
ID COAGULATION FACTOR-XA; BLOOD-COAGULATION; RHODNIUS-PROLIXUS;
   ANTICOAGULANT; COMPLEX
AB Cimex lectularius salivary gland homogenate delayed the recalcification time of human citrated plasma. Separation of the salivary gland homogenate by molecular sieving HPLC chromatography resulted in a single major peak of anticlotting activity with an apparent molecular mass of 17,000. The anticoagulant principle inhibited the activation of factor X to factor Xa in the tenase complex (FVIII, FIXa, FX, phospholipids, and calcium). However, it did nor directly inhibit already activated factor Xa, suggesting that the anticlotting activity is not an anti-factor Xa. Additionally, this salivary gland anticoagulant further retarded the recalcification time of factor VIII- and factor IX-deficient plasmas, suggesting that the anticlotting principle is nor directly inhibiting either the coagulation factor VIII or factor IXa. Altogether these data suggest that the anticlotting activity is an inhibitor of the activation of factor X to factor Xa in rile tenase complex. (C) 1996 Academic Press, Inc.
C1 UNIV FED RIO DE JANEIRO,DEPT MED BIOCHEM ICB,BR-21941590 RIO JANEIRO,BRAZIL.
RP Valenzuela, JG (corresponding author), UNIV ARIZONA,DEPT ENTOMOL,ROOM 410,FORBES BLDG,TUCSON,AZ 85721, USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Ribeiro,
   Jose/0000-0002-9107-0818
CR AHMAD SS, 1992, SEMIN THROMB HEMOST, V18, P311, DOI 10.1055/s-2007-1002570
   AHMAD SS, 1994, TRENDS CARDIOVAS MED, V4, P271, DOI 10.1016/1050-1738(94)90031-0
   CHAMPAGNE DE, 1996, IMMUNOLOGY HOST ECTO
   DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310
   FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216
   FURIE B, 1992, NEW ENGL J MED, V326, P800
   FURIE B, 1982, J BIOL CHEM, V257, P3875
   GORDON JR, 1991, J PARASITOL, V77, P167, DOI 10.2307/3282577
   HELLMANN K, 1966, BRIT J HAEMATOL, V12, P376, DOI 10.1111/j.1365-2141.1966.tb05647.x
   HELLMANN K, 1965, NATURE, V207, P265, DOI 10.1038/207265a0
   JACOBS JW, 1990, THROMB HAEMOSTASIS, V64, P235
   Lehane M, 1991, BIOL BLOOD SUCKING I
   MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0
   MARCUS AJ, 1993, FASEB J, V7, P516
   PARKER KR, 1979, THROMB HAEMOSTASIS, V42, P743
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335
   RIBEIRO JMC, 1995, BIOCHEM J, V308, P243, DOI 10.1042/bj3080243
   SPICER EK, 1987, P NATL ACAD SCI USA, V84, P5148, DOI 10.1073/pnas.84.15.5148
   VALENZUELA JG, 1996, IN PRESS INSECT BIOC
   WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510
NR 20
TC 23
Z9 25
U1 0
U2 2
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0014-4894
J9 EXP PARASITOL
JI Exp. Parasitol.
PD JUL
PY 1996
VL 83
IS 2
BP 184
EP 190
DI 10.1006/expr.1996.0065
PG 7
WC Parasitology
SC Parasitology
GA UZ397
UT WOS:A1996UZ39700003
PM 8682187
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   HUMANN, MC
AF GUIMARAES, JA
   HUMANN, MC
TI TRAINING OF HUMAN-RESOURCES IN SCIENCE AND TECHNOLOGY IN BRAZIL - THE
   IMPORTANCE OF A VIGOROUS POSTGRADUATE PROGRAM AND ITS IMPACT ON THE
   DEVELOPMENT OF THE COUNTRY
SO SCIENTOMETRICS
LA English
DT Article
AB A national plan, designed to establish and support training and development of human resources for strengthening science and technology activities in Brazil was initiated almost three decades ago. This plan, named PNPG, can be viewed today as a successful program in terms of the quality of its general output. During this period research activity has been institutionalized and a few thousand active groups in several universities and research centers have been consolidated. Numerous technological advances in many areas have been achieved and continue throughout the country. A most impressive result of this effort was the acceleration and improvement of a more productive and internationally competitive agriculture, metallurgical engineering including metal-mechanic industry and paper-cellulose complex exploitation. These results also stimulated better performance of related areas such as agribusiness. The existence of an effective system based on a group of multi-funding agencies was an essential additional factor.
C1 CNPQ,CONSELHO NACL DESENVOLVIMENTO CIENTIF & TECNOL,BR-70740 BRASILIA,DF,BRAZIL.
RP GUIMARAES, JA (corresponding author), UNIV FED RIO DE JANEIRO,ILHA FUNDAO,CP 68041,BR-21910590 RIO JANEIRO,BRAZIL.
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR BRENNAN MB, 1994, CHEM ENG NEWS, V72, P34, DOI 10.1021/cen-v072n034.p034
   *CNPQ, 1994, SER HIST BOLS PAIS E, P120
   *CNPQ, 1994, REL GEST 1993 1994
   *CNPQ MCT, 1994, DIR GRUP PESQ BRAS, V1
   Durham Eunice Ribeiro, 1993, REV BRASILEIRA CIENC, V8, P5
   *EST INT AT CNPQ, 1994, REL GER, P34
   GARFIELD E, 1984, CURR CONTENTS, V19, P5
   GUIMARAES JA, 1993, 1ST M BRAZ POST GRAD, P6
   GUIMARAES JA, 1993, REV BRAS CIENC SOCIA, V23, P42
   GUIMARAES JA, 1993, SCI TECHNOLOGY AM PE, P65
   *I SCI INF, 1993, CIT IND
   KRAUSKOPF M, 1986, SCIENTOMETRICS, V10, P199, DOI 10.1007/BF02026041
   *MCT CNPQ IBICT, 1994, REL EST 1993, P105
   *MCT CNPQ IBICT, 1993, DESP REAL UN CIENC T
   *NAT SCI F, 1989, SCI TECHN DAT BOOK, P51
   ORREGO C, 1989, EXCELLENCE ADVERSITY
   *PNUD UNESCO, 1993, HUM DEV IND, P135
   *REL MEC CAPES DAS, 1994, CONC BOLS PAIS
   SANTANA A, 1994, INFOCAPES, V2, P7
   SCHWARTZMAN S, 1992, INTERCIENCIA, V17, P24
   SOBERON G, 1993, SCI TECHNOLOGY AM PE, P33
   1993, J CIENCIA HOJE, V269, P2
   1992, CHRON HIGHER EDUC, V39, P15
   1994, RELATORIO FAPESP 199
   1993, INFOCAPES, V1, P10
   1995, SCIENCE, V267, P807
NR 26
TC 19
Z9 20
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0138-9130
J9 SCIENTOMETRICS
JI Scientometrics
PD SEP
PY 1995
VL 34
IS 1
BP 101
EP 119
DI 10.1007/BF02019176
PG 19
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA TC012
UT WOS:A1995TC01200008
DA 2020-11-24
ER

PT J
AU RIBEIRO, JMC
   SCHNEIDER, M
   GUIMARAES, JA
AF RIBEIRO, JMC
   SCHNEIDER, M
   GUIMARAES, JA
TI PURIFICATION AND CHARACTERIZATION OF PROLIXIN-S (NITROPHORIN-2), THE
   SALIVARY ANTICOAGULANT OF THE BLOODSUCKING BUG RHODNIUS-PROLIXUS
SO BIOCHEMICAL JOURNAL
LA English
DT Article
ID COAGULATION FACTOR-XA; INHIBITOR; HOOKWORM; INVITRO; HIRUDIN; PEPTIDE;
   INSECT
AB The salivary anticoagulant of the blood-sucking bug Rhodnius prolixus was purified to homogeneity using a protocol consisting of weak cation-exchange, DEAE, hydrophobic-interaction and octadecyl reverse-phase chromatography, yielding a protein with the same N-terminal sequence as nitrophorin 2, one of the four NO haem protein carriers present in the salivary glands of Rhodnius with a molecular mass of 19689 Da [D. Champagne, R.H. Nussenzveig and J.M.C. Ribeiro, (1995) J. Biol. Chem. 270, in the press]. To exclude the possibility of the nitrophorin being a contaminant, another chromatographic protocol was performed, consisting of chromatofocusing followed by strong-cation-exchange chromatography. Again the anticoagulant was eluted with nitrophorin 2. Nitrophorin 2 inhibits coagulation Factor VIII-mediated activation of Factor X and accounts for all the anti-clotting activity observed in Rhodnius salivary glands.
C1 UNIV ARIZONA,CTR INSECT SCI,TUCSON,AZ 85721.
   UNIV FED RIO DE JANEIRO,DEPT MED BIOCHEM ICB,BR-21945 RIO JANEIRO,BRAZIL.
RP RIBEIRO, JMC (corresponding author), UNIV ARIZONA,DEPT ENTOMOL,FORBES BLDG,ROOM 410,TUCSON,AZ 85721, USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Ribeiro,
   Jose/0000-0002-9107-0818
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-18696] Funding Source: Medline
CR CAPPELLO M, 1993, J INFECT DIS, V167, P1474, DOI 10.1093/infdis/167.6.1474
   CARROLL SM, 1984, THROMB HAEMOSTASIS, V51, P222
   CHAMPAGNE D, 1995, IN PRESS J BIOL CHEM, V270
   CORNWALL J. W., 1914, Indian Journal of Medical Research, V2, P569
   EIFF JA, 1966, J PARASITOL, V52, P833, DOI 10.2307/3276520
   FAREED J, 1991, BLOOD COAGUL FIBRIN, V2, P135, DOI 10.1097/00001721-199102000-00021
   FAY PJ, 1993, THROMB HAEMOSTASIS, V70, P63
   FRIEDRICH T, 1993, J BIOL CHEM, V268, P16216
   HAWKEY C, 1967, BRIT J HAEMATOL, V13, P1014, DOI 10.1111/j.1365-2141.1967.tb08870.x
   HELLMANN K, 1965, NATURE, V207, P265, DOI 10.1038/207265a0
   JACOBS JW, 1990, THROMB HAEMOSTASIS, V64, P235
   JORDAN SP, 1990, BIOCHEMISTRY-US, V29, P11095, DOI 10.1021/bi00502a012
   LAW JH, 1992, ANNU REV BIOCHEM, V61, P87, DOI 10.1146/annurev.bi.61.070192.000511
   MARKWARDT F, 1991, THROMB HAEMOSTASIS, V66, P141
   PROCTOR RR, 1961, AM J CLIN PATHOL, V3, P212
   RIBEIRO JMC, 1993, SCIENCE, V260, P539, DOI 10.1126/science.8386393
   RIBEIRO JMC, 1994, J EXP MED, V180, P2251, DOI 10.1084/jem.180.6.2251
   RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P63
   WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510
NR 19
TC 121
Z9 123
U1 0
U2 5
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD MAY 15
PY 1995
VL 308
BP 243
EP 249
DI 10.1042/bj3080243
PN 1
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA QZ913
UT WOS:A1995QZ91300035
PM 7755571
OA Green Published
DA 2020-11-24
ER

PT J
AU FRANCISCHETTI, IMB
   GHAZALEH, FA
   REIS, RM
   CARLINI, CR
   GUIMARAES, JA
AF FRANCISCHETTI, IMB
   GHAZALEH, FA
   REIS, RM
   CARLINI, CR
   GUIMARAES, JA
TI THE ROLE OF PROTEIN-TYROSINE KINASE ACTIVATION ON THE MECHANISM OF
   PHOSPHOLIPASE-C AND PLATELET ACTIVATION BY CONVULXIN, A GLYCOPROTEIN
   FROM THE VENOM OF THE RATTLESNAKE CROTALUS-DURISSUS-TERRIFICUS
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO, CCS, ICB, DEPT BIOCHEM, BR-21945 RIO DE JANEIRO, BRAZIL.
   UNIV FED RIO DE JANEIRO, CCS, ICB, INST BIOPHYS, BR-21945 RIO DE JANEIRO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445
NR 0
TC 0
Z9 0
U1 0
U2 1
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR 24
PY 1995
VL 9
IS 6
BP A1408
EP A1408
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA QV274
UT WOS:A1995QV27400972
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
AF GUIMARAES, JA
TI RESEARCH IN LATIN-AMERICA
SO SCIENCE
LA English
DT Letter
RP GUIMARAES, JA (corresponding author), UNIV ARIZONA,COLL AGR,DEPT ENTOMOL,TUCSON,AZ 85721, USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR AYALA FJ, 1995, SCIENCE, V267, P826, DOI 10.1126/science.267.5199.826
   1995, SCIENCE, V267, P807
NR 2
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC ADVAN SCIENCE
PI WASHINGTON
PA 1333 H ST NW, WASHINGTON, DC 20005
SN 0036-8075
J9 SCIENCE
JI Science
PD APR 7
PY 1995
VL 268
IS 5207
BP 14
EP 14
DI 10.1126/science.268.5207.14
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA QR454
UT WOS:A1995QR45400003
PM 17755216
DA 2020-11-24
ER

PT J
AU VASCONCELOS, IM
   TRENTIM, A
   GUIMARAES, JA
   CARLINI, CR
AF VASCONCELOS, IM
   TRENTIM, A
   GUIMARAES, JA
   CARLINI, CR
TI PURIFICATION AND PHYSICOCHEMICAL CHARACTERIZATION OF SOYATOXIN, A NOVEL
   TOXIC PROTEIN ISOLATED FROM SOYBEANS (GLYCINE-MAX)
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
ID TRYPSIN-INHIBITORS; SEED PROTEIN; AFFINITY-CHROMATOGRAPHY;
   POLYACRYLAMIDE GELS; CONCANAVALIN-A; TETANUS TOXIN; CANATOXIN; ACID;
   TRANSPORT; FAMILY
AB Physicochemical characterization and biological properties of a new toxic protein isolated from soybeans (Glycine max) is reported. The purification procedure consisted basically of ammonium sulfate fractionation, ion exchange, and affinity chromatographies, the latter being used for the removal of the seed's lectin and of its trypsin inhibitor. The highly purified protein, designated soyatoxin, is a single chain acidic protein (pI 4.4-4.6) of 21 kDa, dependent on reduced thiol groups to maintain its solubility and biological activities. The toxin is a metalloprotein containing iron, calcium, zinc, and magnesium. Soyatoxin is highly toxic to mice (LD(50) 7-8 mg/kg mouse body wt upon intraperitoneal injection). It produces dyspnoea, tonic-clonic convulsions, and flaccid paralysis prior to death of intraperitoneally injected mice. Furthermore, soyatoxin is immunologically related to another toxic protein (canatoxin), isolated from Canavalia ensiformis seeds, which is distinct from soyatoxin in containing 18 X 10 kDa noncovalently bound subunits. Some biological properties including acute intraperitoneal toxicity, canatoxin-like immunoreactivity, hemagglutination, trypsin inhibitory activity, induction of platelet release reaction, and aggregation displayed by soyatoxin mere studied and used to differentiate soyatoxin from soybean lectin and trypsin inhibitors. (C) 1994 Academic Press, Inc.
C1 UNIV FED CEARA, DEPT BIOCHEM & MOLEC BIOL, FORTALEZA, CEARA, BRAZIL.
   UNIV FED RIO DE JANEIRO, ICB CCS, DEPT BIOCHEM, BR-21910510 RIO DE JANEIRO, BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR APPUKUTTAN PS, 1977, INDIAN J BIOCHEM BIO, V14, P382
   BARCELLOS GBS, 1993, PLANTA, V189, P397, DOI 10.1007/BF00194437
   BARCELLOS GBS, 1992, THESIS U FEDERAL DO
   BARJAFIDALGO C, 1991, TOXICON, V29, P453, DOI 10.1016/0041-0101(91)90019-N
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1988, PHYTOCHEMISTRY, V27, P25, DOI 10.1016/0031-9422(88)80587-9
   CARLINI CR, 1991, TOXICON, V29, P791, DOI 10.1016/0041-0101(91)90216-E
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CARLINI CR, 1990, TOXICON, V28, pA604
   DEKLEVA ML, 1989, ARCH BIOCHEM BIOPHYS, V274, P235, DOI 10.1016/0003-9861(89)90435-9
   DORNBOS DL, 1992, J AM OIL CHEM SOC, V69, P228, DOI 10.1007/BF02635891
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   FAHRNEY DE, 1963, J AM CHEM SOC, V85, P997, DOI 10.1021/ja00890a037
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GRANT G, 1989, RECENT ADVANCES OF RESEARCH IN ANTINUTRITIONAL FACTORS IN LEGUME SEEDS, P34
   GRANT G, 1989, PROG FOOD NUTR SCI, V13, P317
   HERGET T, 1990, MOL GEN GENET, V224, P469, DOI 10.1007/BF00262442
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liener I. E., 1980, Toxic constituents of plant foodstuffs., P7
   LIENER IE, 1958, J BIOL CHEM, V233, P401
   LIENER IE, 1952, J BIOL CHEM, V197, P29
   LIENER IE, 1953, J NUTR, V49, P527
   LIENER IE, 1986, LECTINS PROPERTIES F, P527
   LOTAN R, 1975, FEBS LETT, V57, P100, DOI 10.1016/0014-5793(75)80161-X
   MADAR Z, 1979, COMP BIOCHEM PHYS A, V62, P1057, DOI 10.1016/0300-9629(79)90049-5
   MONTECUCCO C, 1993, TRENDS BIOCHEM SCI, V18, P324, DOI 10.1016/0968-0004(93)90065-U
   OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0
   OSBORN TC, 1988, PLANT PHYSIOL, V86, P399, DOI 10.1104/pp.86.2.399
   OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347
   PRICE DL, 1975, SCIENCE, V188, P945, DOI 10.1126/science.49080
   PUSZTAI A, 1988, ANAL BIOCHEM, V172, P108, DOI 10.1016/0003-2697(88)90418-6
   Richardson M., 1991, METHODS PLANT BIOCH, V5, P259
   RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233
   SAMBETH W, 1967, J NUTR, V92, P479
   SCHINGOETHE DJ, 1970, J NUTR, V100, P739
   SCHWAB ME, 1979, J CELL BIOL, V82, P798, DOI 10.1083/jcb.82.3.798
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   SRINIVAS H, 1992, J AGR FOOD CHEM, V40, P276, DOI 10.1021/jf00014a022
   STEAD RH, 1966, ARCH BIOCHEM BIOPHYS, V113, P703, DOI 10.1016/0003-9861(66)90251-7
   STIRPE F, 1986, FEBS LETT, V195, P1, DOI 10.1016/0014-5793(86)80118-1
   TAI HY, 1991, PLANT MOL BIOL, V16, P913, DOI 10.1007/BF00015084
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   VASCONCELOS IM, 1991, J FOOD BIOCHEM, V15, P137, DOI 10.1111/j.1745-4514.1991.tb00150.x
   VASCONCELOS IM, 1992, ANN ACAD BRAS CIENC, V64, P415
   WADA S, 1958, J BIOL CHEM, V233, P395
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2
   XAVIER J, 1983, BRAZ J MED BIOL RES, V16, P11
   Xavier-Filho J., 1992, Revista Brasileira de Fisiologia Vegetal, V4, P1
NR 49
TC 36
Z9 37
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD AUG 1
PY 1994
VL 312
IS 2
BP 357
EP 366
DI 10.1006/abbi.1994.1320
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA NX805
UT WOS:A1994NX80500006
PM 8037448
DA 2020-11-24
ER

PT J
AU VIEIRA, MAR
   MOREIRA, MF
   MAACK, T
   GUIMARAES, JA
AF VIEIRA, MAR
   MOREIRA, MF
   MAACK, T
   GUIMARAES, JA
TI CONVERSION OF T-KININ TO BRADYKININ BY THE RAT-KIDNEY
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
DE T-KININ; BRADYKININ; KININ CONVERSION; PERFUSED RAT KIDNEY; RENAL
   AMINOPEPTIDASE
ID CONVERTING AMINOPEPTIDASE; CHLORIDE SECRETION; HUMAN-URINE; KALLIKREIN;
   METABOLISM; PLASMA; CARBOXYPEPTIDASE; PEPTIDES; SYSTEM
AB Isolated rat kidneys were perfused with T-kinin (TK, Ile-Ser-BK) and bradykinin (BK). HPLC analysis of perfusate samples taken at 2-10 min during the TK perfusion (0.5 nmol/mL initial concentration) showed two peptide peaks, the first one eluting at 14.42 min, the same retention time for standard BK, and the second at 16.20 min, corresponding to that of TK. When BK (0.5 nmol/mL) was perfused, only its corresponding peak was obtained although total BK recovery was reduced quickly, as expected. Using both HPLC analysis and a kinin bioassay on the isolated guinea pig ileum, it was found that 12% of the added TK was converted to BK during the first perfusion cycle (2 min). While the BK recovered (12-14% from the initial TK concentration) was maintained at a similar proportion between the 2nd and the 10th min of perfusion, the rate of TK disappearance, as well as its full recovery from the perfusate, indicated further fragmentation of peptides during kinin perfusion. In the presence of 5 mu M DL-mercaptomethyl-3-guanidino-ethylthiopropane acid (Mergetpa), an inhibitor of plasma carboxypeptidase N (EC 3.4.17.3), the rate of conversion of TK to BK was not affected. On the other hand, the kininase II inhibitor bradykinin potentiating peptide 9a (BPP9a) increased both the proportion of TK converted to BK and the disappearance rate of TK from the perfusate. In the presence of BPP9a, the rate of BK production increased from 1.5 +/- 0.2 to 7.6 +/- 0.9 nmol/min. Furthermore, the recovery of BK was reduced during the first 2 min of perfusion to 7.6% and the conversion rate to 0.9 nmol/min when TK was perfused into the kidney in the presence of 10 mu M bestatin, a known inhibitor of aminopeptidases. These data indicate that in the kidney TK is converted to BK, probably by aminopeptidase M, thus suggesting that BK is, in fact, an additional and functional kinin, inducing physiological and/or pathophysiological effects in the rat kidney in which TK is the main kinin released.
C1 FED UNIV RIO DE JANEIRO,INST CIENCIAS BIOL,DEPT BIOCHEM,BR-21945 RIO JANEIRO,BRAZIL.
   CORNELL UNIV,COLL MED,DEPT PHYSIOL,NEW YORK,NY.
RP VIEIRA, MAR (corresponding author), UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT PHYSIOL & BIOPHYS,AVE ANTONIO CARLOS 6627,BR-31270 BELO HORIZONT,MG,BRAZIL.
RI Moreira, Monica F./J-4507-2016; Guimaraes, Jorge Almeida/V-2196-2019
OI Moreira, Monica F./0000-0002-3720-415X; Guimaraes, Jorge
   A./0000-0001-6354-6789
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK 14241] Funding Source: Medline;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R01DK014241, R01DK014241, R01DK014241,
   R01DK014241, R01DK014241, R01DK014241, R01DK014241, R01DK014241,
   R01DK014241, R01DK014241] Funding Source: NIH RePORTER
CR ADETUYIBI A, 1972, LANCET, V2, P203
   ALVES KB, 1984, INT J BIOCHEM, V16, P1295, DOI 10.1016/0020-711X(84)90231-3
   BARLAS A, 1985, BIOCHEM BIOPH RES CO, V129, P280, DOI 10.1016/0006-291X(85)91434-2
   BARLAS A, 1985, FEBS LETT, V190, P268, DOI 10.1016/0014-5793(85)81297-7
   CHAILLET P, 1983, EUR J PHARMACOL, V86, P329, DOI 10.1016/0014-2999(83)90181-4
   CUTHBERT AW, 1982, BRIT J PHARMACOL, V75, P587, DOI 10.1111/j.1476-5381.1982.tb09178.x
   DEMELLO G, 1976, AM J PHYSIOL, V231, P1699
   DRAPEAU G, 1991, PEPTIDES, V12, P631, DOI 10.1016/0196-9781(91)90112-3
   FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005
   GILL JOHN R., 1965, AMER J PHYSIOL, V209, P844
   Greenbaum L M, 1986, Adv Exp Med Biol, V198 Pt A, P55
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   GUIMARAES JA, 1986, EUR J PHARMACOL, V130, P177, DOI 10.1016/0014-2999(86)90266-9
   HIAL V, 1976, BIOCHEM PHARMACOL, V25, P2499, DOI 10.1016/0006-2952(76)90456-1
   LEWIS GP, 1979, HDB EXP PHARM, V25, P516
   MANNING DC, 1982, NATURE, V299, P256, DOI 10.1038/299256a0
   MARGOLIUS HS, 1984, ANNU REV PHYSIOL, V46, P309
   MARINKOVIC DV, 1983, P SOC EXP BIOL MED, V165, P6
   MCGIFF JC, 1975, CLIN SCI MOL MED, V49, P125, DOI 10.1042/cs0490125
   MILLS IH, 1979, NEPHRON, V23, P61, DOI 10.1159/000181611
   MIWA I, 1969, P SOC EXP BIOL MED, V131, P768
   ODYA CE, 1979, HDB EXP PHARMACOL  S, V25, P287
   Okamoto H, 1986, Adv Exp Med Biol, V198 Pt A, P69
   OKAMOTO H, 1983, BIOCHEM PHARMACOL, V32, P2637, DOI 10.1016/0006-2952(83)90039-4
   OKAMOTO H, 1983, BIOCHEM BIOPH RES CO, V112, P701, DOI 10.1016/0006-291X(83)91519-X
   PALMIERI FE, 1986, BIOCHEM PHARMACOL, V35, P2749, DOI 10.1016/0006-2952(86)90185-1
   PALMIERI FE, 1989, BIOCHEM PHARMACOL, V38, P173, DOI 10.1016/0006-2952(89)90165-2
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   ROBIERO J, 1973, RES COMMUN CHEM PATH, V6, P207
   SCICLI AG, 1986, KIDNEY INT, V29, P120, DOI 10.1038/ki.1986.14
   SUGIO K, 1988, INFLAMMATION, V12, P407, DOI 10.1007/BF00919434
   WARD PE, 1991, BIOCHEM PHARMACOL, V42, P721, DOI 10.1016/0006-2952(91)90028-4
   WEBSTER ME, 1964, AM J PHYSIOL, V206, P714
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   WRIGHT JW, 1991, BRAIN RES BULL, V27, P545, DOI 10.1016/0361-9230(91)90027-H
NR 35
TC 17
Z9 17
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PD APR 29
PY 1994
VL 47
IS 9
BP 1693
EP 1699
DI 10.1016/0006-2952(94)90549-5
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA NK696
UT WOS:A1994NK69600030
PM 8185685
DA 2020-11-24
ER

PT J
AU ANDRADE, SP
   FEITOSA, MH
   GUIMARAES, JA
   ROGANA, E
   OLIVEIRA, GMR
   FERREIRA, MAD
   BERALDO, WT
AF ANDRADE, SP
   FEITOSA, MH
   GUIMARAES, JA
   ROGANA, E
   OLIVEIRA, GMR
   FERREIRA, MAD
   BERALDO, WT
TI PHARMACOLOGICAL DEMONSTRATION OF A BARRIER FOR PROTEASE, PEPTIDES AND
   ACETYLCHOLINE IN THE ENDOMETRIUM OF THE RAT
SO ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE
LA English
DT Article
ID CHLORIDE SECRETION; KININS; COLON
AB Contractions of the rat uterus in response to trypsin, kallikrein, bradykinin, angiotensin II, oxytocin and acetylcholine, were abolished when an inside-out preparation was used. Sensitivity to Ba++, however, was preserved. In preparations in which the endometrium was mechanically removed, all above cited agonists elicited contractions. By treating the uterus with both collagenase and hyaluronidase, acetylcholine was able to induce a contraction when applied to the endometrium side of the uterus. The results show that a barrier for protease, peptides and acetylcholine is present in the mucosa of the rat uterus.
C1 UNIV FED MINAS GERAIS,INST BIOL SCI,DEPT PHYSIOL & BIOPHYS,BELO HORIZONT,MG,BRAZIL.
   UNIV FED MINAS GERAIS,INST BIOL SCI,DEPT BIOCHEM & IMMUNOL,BELO HORIZONT,MG,BRAZIL.
   FED UNIV RIO DE JANEIRO,HLTH SCI CTR,DEPT BIOCHEM,RIO JANEIRO,BRAZIL.
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR ASCARRUNZ ME, 1982, ARQULV BIOL TECNOL, V25, pP1
   CUTHBERT AW, 1984, BRIT J PHARMACOL, V82, P597, DOI 10.1111/j.1476-5381.1984.tb10798.x
   CUTHBERT AW, 1982, BRIT J PHARMACOL, V75, P587, DOI 10.1111/j.1476-5381.1982.tb09178.x
   HOULT JRS, 1986, BRIT J PHARMACOL, V88, P3, DOI 10.1111/j.1476-5381.1986.tb09463.x
   MANNING DC, 1982, NATURE, V299, P256, DOI 10.1038/299256a0
   MEYER K, 1952, ADV ENZYMOL REL S BI, V13, P199
   SCHOEDER DD, 1968, J BIOL CHEM, V243, P2943
NR 7
TC 1
Z9 1
U1 0
U2 0
PU ARCH INT PHARMACODYNAMIE
PI GHENT
PA DE PINTELAAN 185, B-9000 GHENT, BELGIUM
SN 0003-9780
J9 ARCH INT PHARMACOD T
JI Arch. Int. Pharmacodyn. Ther.
PD NOV-DEC
PY 1993
VL 326
BP 95
EP 100
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA MY111
UT WOS:A1993MY11100009
PM 8185417
DA 2020-11-24
ER

PT J
AU BARJAFIDALGO, C
   CARLINI, CR
   GUIMARAES, JA
   FLORES, CA
   CUNHA, FQ
   FERREIRA, SH
AF BARJAFIDALGO, C
   CARLINI, CR
   GUIMARAES, JA
   FLORES, CA
   CUNHA, FQ
   FERREIRA, SH
TI ROLE OF RESIDENT MACROPHAGES IN CANATOXIN-INDUCED INVIVO NEUTROPHIL
   MIGRATION
SO INFLAMMATION
LA English
DT Article
AB Canatoxin (Cntx), a toxic protein purified from Canavalia ensiformis seeds, was shown to have lipoxygenase-mediated effects either in vivo or in vitro. Data here show that Cntx induced a dose-dependent migration of neutrophils and mononuclear cells when injected into rat peritoneal cavities. Furthermore, Cntx was able to induce neutrophil migration into pleural cavities and into air pouches. These effects were inhibited by dexamethasone but not by inhibitors of arachidonic acid metabolism (indomethacin, NDGA, and BW-755c) or by a PAF antagonist (BN 52021). In the peritoneal cavity Cntx caused an increase in vascular permeability inhibited by dexamethasone and BW-755c. Neutrophil migration induced by this toxin was dependent on the number of resident macrophages, since the migratory effect was enhanced by increasing the peritoneal macrophage population with thioglycollate pretreatment and was diminished when this population was reduced by peritoneal wash. It was also observed that Cntx induced release of a chemotactic factor from macrophage monolayers in vitro. Dexamethasone blocked this release but did not affect in vivo neutrophil recruitment induced by that factor. These data suggest that Cntx-induced neutrophil migration may be mediated by the same macrophage-derived neutrophil chemotactic factor released by other stimuli such as LPS, IL-1, and INF-gamma.
C1 UNIV FED RIO DE JANEIRO, INST BIOL SCI, DEPT BIOCHEM, BR-21910 RIO DE JANEIRO, BRAZIL.
   UNIV SAO PAULO, FAC MED RIBEIRAO PRETO, DEPT PHARMACOL, BR-14049 RIBEIRAO PRETO, SP, BRAZIL.
RP BARJAFIDALGO, C (corresponding author), UNIV ESTADO RIO DE JANEIRO, INST BIOL, DEPT PHARMACOL, BR-20551 RIO DE JANEIRO, RJ, BRAZIL.
RI Cunha, Fernando Q/M-3090-2014; Guimaraes, Jorge Almeida/V-2196-2019; da
   Silva Carlini, Celia Regina Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Cunha,
   Fernando Queiroz/0000-0003-4755-1670; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ABRAMSON SB, 1990, INFLAMMATION, V14, P11, DOI 10.1007/BF00914026
   ADAMSON IYR, 1982, AM J PATHOL, V109, P71
   BARJAFIDALGO C, 1988, BRAZ J MED BIOL RES, V21, P549
   BARJAFIDALGO C, 1990, 3 P PAN S PLANT AN M, P38
   BECK G, 1986, J IMMUNOL, V136, P3025
   BEDNAR M, 1985, CIRC RES, V57, P131, DOI 10.1161/01.RES.57.1.131
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CARLOS TM, 1990, IMMUNOL REV, V114, P5, DOI 10.1111/j.1600-065X.1990.tb00559.x
   CODILTZ IG, 1984, J IMMUNOL, V133, P2163
   COLDITZ I, 1989, AM J PATHOL, V134, P755
   CUNHA FQ, 1990, EUR J PHARMACOL, V183, P2245, DOI 10.1016/0014-2999(90)93783-M
   CUNHA FQ, 1986, EUR J PHARMACOL, V129, P65, DOI 10.1016/0014-2999(86)90337-7
   CYBULSKY MI, 1988, LAB INVEST, V58, P365
   DASILVA GR, 1989, TOXICON, V27, P73
   DASILVA GR, 1989, BRAZ J MED BIOL RES, V22, P387
   DESOUZA GEP, 1985, AGENTS ACTIONS, V17, P97
   EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205
   FACCIOLI LH, 1990, AGENTS ACTIONS, V30, P344, DOI 10.1007/BF01966298
   FORDHUTCHINSON AW, 1984, PROSTAGLANDINS, V28, P13, DOI 10.1016/0090-6980(84)90110-2
   GRASSI D, 1989, 4 P ANN M BRAZ FED E, P214
   HENDERSON B, 1988, BIOCHEM PHARMACOL, V37, P4171, DOI 10.1016/0006-2952(88)90112-8
   ISSEKUTZ AC, 1987, LAB INVEST, V56, P49
   LINDLEY I, 1988, P NATL ACAD SCI USA, V85, P9199, DOI 10.1073/pnas.85.23.9199
   MERRILL W, 1978, CLIN RES, V26, pA635
   MULLANE KM, 1988, ANN NY ACAD SCI, V524, P103
   RIBEIRO RA, 1990, INT J EXP PATHOL, V71, P717
   Snyderman R., 1988, INFLAMMATION BASIC P, P309
   SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296
   SPECTOR AA, 1988, PROG LIPID RES, V27, P271, DOI 10.1016/0163-7827(88)90009-4
   WEISS SJ, 1989, NEW ENGL J MED, V320, P365
   WEISS SJ, 1986, ACTA PHYSIOL SCAND, V126, P9
   WERNS SW, 1990, TRENDS PHARMACOL SCI, V11, P161, DOI 10.1016/0165-6147(90)90068-J
NR 34
TC 21
Z9 21
U1 0
U2 2
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0360-3997
EI 1573-2576
J9 INFLAMMATION
JI Inflammation
PD FEB
PY 1992
VL 16
IS 1
BP 1
EP 12
DI 10.1007/BF00917510
PG 12
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA GY325
UT WOS:A1992GY32500001
PM 1544678
DA 2020-11-24
ER

PT J
AU CAMPOS, MM
   CARLINI, CR
   GUIMARAES, JA
   MARQUESSILVA, VM
   RUMJANEK, VM
AF CAMPOS, MM
   CARLINI, CR
   GUIMARAES, JA
   MARQUESSILVA, VM
   RUMJANEK, VM
TI EFFECT OF CANATOXIN ON CELL-CULTURES
SO CELL BIOLOGY INTERNATIONAL REPORTS
LA English
DT Article
ID CONVULSANT PROTEIN; PSEUDOMONAS TOXIN; CONCANAVALIN-A; SEEDS; ABRIN;
   RICIN; INHIBITORS; PATHWAY; ENTRY; RATS
C1 INST NACL CANC,BASIC RES CTR,RIO DE JANEIRO,BRAZIL.
   UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOCHEM,RIO DE JANEIRO,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019; Rumjanek, Vivian Mary/V-8741-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ALI ATMM, 1982, AGENTS ACTIONS, V12, P645
   BARJAFIDALGO C, 1988, BRAZ J MED BIOL RES, V21, P549
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1988, PHYTOCHEMISTRY, V27, P25, DOI 10.1016/0031-9422(88)80587-9
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   GUIMARAES JA, 1985, AN ACAD BRAS CIENC, V57, P387
   LIN JY, 1970, NATURE, V227, P292, DOI 10.1038/227292a0
   OLSNES S, 1989, IMMUNOL TODAY, V10, P291
   PARRY RM, 1965, P SOC EXP BIOL MED, V119, P384
   RIBEIRODASILVA G, 1986, TOXICON, V24, P775, DOI 10.1016/0041-0101(86)90102-9
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P387
   SANDVIG K, 1982, J BIOL CHEM, V257, P7504
   SANDVIG K, 1986, CANCER RES, V46, P6418
   SUNDAN A, 1984, CANCER RES, V44, P4919
NR 15
TC 5
Z9 5
U1 0
U2 3
PU ACADEMIC PRESS LTD
PI LONDON
PA 24-28 OVAL RD, LONDON, ENGLAND NW1 7DX
SN 0309-1651
J9 CELL BIOL INT REP
PD JUL
PY 1991
VL 15
IS 7
BP 581
EP 594
DI 10.1016/0309-1651(91)90005-4
PG 14
WC Cell Biology
SC Cell Biology
GA GB467
UT WOS:A1991GB46700005
PM 1934082
DA 2020-11-24
ER

PT J
AU TERMIGNONI, C
   FREITAS, JO
   GUIMARAES, JA
AF TERMIGNONI, C
   FREITAS, JO
   GUIMARAES, JA
TI METHIONYL AMINOPEPTIDASE FROM RAT-LIVER - DISTRIBUTION OF THE
   MEMBRANE-BOUND SUBCELLULAR ENZYME
SO MOLECULAR AND CELLULAR BIOCHEMISTRY
LA English
DT Article
DE METHIONYL AMINOPEPTIDASE; N-TERMINAL METHIONINE; AMINOPEPTIDASE;
   ARYLAMIDASE; RAT LIVER
AB The selective distribution of methionyl aminopeptidase (MAP) among rat liver mitochondria (heavy and light) and microsomes is reported. Several properties of MAP from the three subcellular fractions showed that the enzyme is a typical aminopeptidase able to remove N-terminal methionine from oligopeptides and methionyl-2-naphthylamide but not from Met-Ala-Ser. MAP is a membrane-bound enzyme sensitive to SH-group oxidants and inhibitable by L-methionine but not by usual arylaminopeptidase inhibitors. It is suggested that, MAP may play an important role during protein synthesis in rat liver.
C1 UNIV FED RIO DE JANEIRO, ICB, DEPT BIOCHEM, CP 68041, BR-21910 RIO DE JANEIRO, BRAZIL.
   UNIV FED RIO GRANDE SUL, DEPT BIOCHEM, BR-91501 PORTO ALEGRE, RS, BRAZIL.
   UNIV FED RIO GRANDE SUL, CTR BIOTECHNOL, BR-91501 PORTO ALEGRE, RS, BRAZIL.
   ESCOLA PAULISTA MED SCH, DEPT BIOCHEM, BR-01000 SAO PAULO, BRAZIL.
RI Termignoni, Carlos/AAB-8943-2020; Guimaraes, Jorge Almeida/V-2196-2019
OI Termignoni, Carlos/0000-0002-2789-2518; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ALONZO N, 1968, ANAL BIOCHEM, V23, P272, DOI 10.1016/0003-2697(68)90359-X
   ALVES KB, 1984, INT J BIOCHEM, V16, P1295, DOI 10.1016/0020-711X(84)90231-3
   ANTONOV VK, 1984, FEBS LETT, V171, P227, DOI 10.1016/0014-5793(84)80493-7
   ARAUJO PS, 1976, BIOCHIM BIOPHYS ACTA, V452, P121
   ARFIN SM, 1988, BIOCHEMISTRY-US, V27, P7979, DOI 10.1021/bi00421a001
   BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930
   BARRETT AJ, 1972, ANAL BIOCHEM, V47, P280, DOI 10.1016/0003-2697(72)90302-8
   BENBASSAT A, 1987, J BACTERIOL, V169, P751, DOI 10.1128/jb.169.2.751-757.1987
   BERG MJ, 1984, J NEUROSCI RES, V11, P313, DOI 10.1002/jnr.490110311
   BERGMEYER HU, 1975, Z KLIN CHEM KLIN BIO, V13, P507
   BOISSEL JP, 1988, J BIOL CHEM, V263, P8443
   BORGES DR, 1974, N-S ARCH PHARMACOL, V281, P403, DOI 10.1007/BF00499435
   BURBACH JPH, 1980, NATURE, V283, P96, DOI 10.1038/283096a0
   CHAMBERS JA, 1979, CENTRIFUGATION PRACT, P33
   CHANEY AL, 1962, CLIN CHEM, V8, P130
   CHURCHILL L, 1987, BIOCHIM BIOPHYS ACTA, V923, P35, DOI 10.1016/0304-4165(87)90122-X
   DESNUELLE P, 1979, EUR J BIOCHEM, V101, P1, DOI 10.1111/j.1432-1033.1979.tb04209.x
   DONLON J, 1973, BIOCHIM BIOPHYS ACTA, V327, P425, DOI 10.1016/0005-2744(73)90426-9
   DUVE CD, 1955, BIOCHEM J, V60, P604
   ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X
   FREITAS JO, 1979, INT J BIOCHEM, V10, P81, DOI 10.1016/0020-711X(79)90143-5
   FREITAS JO, 1981, INT J BIOCHEM, V13, P991, DOI 10.1016/0020-711X(81)90004-5
   FREITAS JO, 1985, INT J BIOCHEM, V17, P1285, DOI 10.1016/0020-711X(85)90049-7
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   GUIMARAES JA, 1986, EUR J PHARMACOL, V130, P177, DOI 10.1016/0014-2999(86)90266-9
   HAMBROOK JM, 1976, NATURE, V262, P782, DOI 10.1038/262782a0
   HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247
   HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033
   JACKSON R, 1970, NATURE, V227, P672, DOI 10.1038/227672a0
   KENNY AJ, 1977, PROTEINASES MAMMALIA, P393
   KERWAR SS, 1971, ARCH BIOCHEM BIOPHYS, V143, P336, DOI 10.1016/0003-9861(71)90215-3
   MAKINEN PL, 1970, ACTA CHEM SCAND, V24, P1101, DOI 10.3891/acta.chem.scand.24-1101
   MAROUX S, 1973, BIOCHIM BIOPHYS ACTA, V321, P282, DOI 10.1016/0005-2744(73)90083-1
   McDonald I., 1977, PROTEINASES MAMMALIA, P311
   MCDONALD JK, 1986, MAMMALIAN PROTEASES, V2, P99
   MILLER CG, 1987, P NATL ACAD SCI USA, V84, P2718, DOI 10.1073/pnas.84.9.2718
   ORAWSKI AT, 1987, MOL CELL BIOCHEM, V75, P123
   PALMIERI FE, 1985, BIOCHEM PHARMACOL, V34, P2309, DOI 10.1016/0006-2952(85)90787-7
   RADHAKRISHNA G, 1986, J BIOL CHEM, V261, P9572
   SHERMAN F, 1985, BIOESSAYS, V3, P27, DOI 10.1002/bies.950030108
   SHIMAMURA M, 1988, BRAIN RES, V445, P350, DOI 10.1016/0006-8993(88)91197-3
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   SUDA H, 1980, BIOCHIM BIOPHYS ACTA, V616, P60, DOI 10.1016/0005-2744(80)90263-6
   SWANSON MA, 1955, METHOD ENZYMOL, V2, P541, DOI 10.1016/S0076-6879(55)02247-7
   TERMIGNONI C, 1986, BIOCHEM J, V234, P469, DOI 10.1042/bj2340469
   TERMINGNONI C, 1979, AN ACAD BRAS CIENC, V51, P770
   TSUNASAWA S, 1985, J BIOL CHEM, V260, P5382
   Tuppy H, 1957, MONATSH CHEM, V88, P977
   WIGLE DT, 1970, NATURE, V227, P676, DOI 10.1038/227676a0
   YOSHIDA A, 1972, J BIOL CHEM, V247, P952
   YOSHIDA A, 1970, P NATL ACAD SCI USA, V67, P1600, DOI 10.1073/pnas.67.3.1600
NR 51
TC 5
Z9 5
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0300-8177
EI 1573-4919
J9 MOL CELL BIOCHEM
JI Mol. Cell. Biochem.
PD APR 10
PY 1991
VL 102
IS 2
BP 101
EP 113
PG 13
WC Cell Biology
SC Cell Biology
GA FG129
UT WOS:A1991FG12900002
PM 1881386
DA 2020-11-24
ER

PT J
AU FERNANDES, PD
   GUIMARAES, JA
   ASSREUY, J
AF FERNANDES, PD
   GUIMARAES, JA
   ASSREUY, J
TI COMPARATIVE EFFECTS OF 2 POTENTIATING PEPTIDES (KPP AND BPP9A) ON
   KININ-INDUCED RAT PAW EDEMA
SO AGENTS AND ACTIONS
LA English
DT Article
ID BRADYKININ; PHARMACOLOGY
AB We have previously shown that KPP, a kinin potentiating peptide generated by tryptic digestion of human plasma proteins potentiated kinin effects on isolated smooth muscle preparations like guinea-pig ileum with high potency and specificity.  We also obtained evidence suggesting that, unlike other potentiating peptides, KPP exerts its effect by a mechanism different from the inhibition of kinin metabolism by angiotensin converting enzyme, neutral endopeptidase and kininase I.  Here we show the potentiating effect of KPP and of BPP9a, a potentiator derived from snake venom, towards the rat paw edema induced by bradykinin (BK).  Our results show that:  a) KPP is 25-fold more active than BPP9a in potentiating rat paw edema elicited by BK; b) like BPP9a, KPP is specific in potentiating kinin-induced edema, being ineffective in potentiating edema induced by histamine or serotonin; and c) DesArg9-BK (DABK) elicits a small edematogenic response which can be potentiated by both KPP and BPP9a.
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,CTR CIENCIAS SAUDE,DEPT BIOQUIM,BR-21944 RIO DE JANEIRO,BRAZIL.
   UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,CTR CIENCIAS SAUDE,DEPT FARMACOL BASICA & CLIN,BR-21944 RIO DE JANEIRO,BRAZIL.
RI Assreuy, Jamil/A-4205-2013; Fernandes, Patricia Dias/C-4489-2013;
   Fernandes, Patricia/W-1565-2019; Fernandes, Patricia/B-4117-2010;
   Guimaraes, Jorge Almeida/V-2196-2019
OI Fernandes, Patricia Dias/0000-0001-6870-6745; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANTONACCIO MJ, 1981, FED PROC, V40, P2275
   ASSREUY J, 1989, EUR J PHARMACOL, V168, P231, DOI 10.1016/0014-2999(89)90569-4
   ASSREUYFILHO J, 1988, BRAZ J MED BIOL RES, V21, P453
   BAGGIOLINI M, 1985, HDB INFLAMMATION, V5, P117
   BLOMBACK B, 1966, BIOCHIM BIOPHYS ACTA, V115, P371, DOI 10.1016/0304-4165(66)90437-5
   ERDOS EG, 1979, HDB EXPT PHARMACOLOG, V25, P428
   FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005
   FERREIRA SH, 1979, J PHARM, V31
   GUIMARAES JA, 1982, AGENTS ACTIONS, V9, P295
   LEME JG, 1978, HDB EXP PHARMACOL, V50, P464
   MARCEAU F, 1983, GEN PHARMACOL, V14, P209, DOI 10.1016/0306-3623(83)90001-0
   MARUYAMA S, 1985, AGR BIOL CHEM TOKYO, V49, P1405, DOI 10.1080/00021369.1985.10866901
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   STEWART JM, 1979, HDB EXP PHARMACOL  S, V25, P227
   UFKES JGR, 1977, EUR J PHARMACOL, V44, P89, DOI 10.1016/0014-2999(77)90094-2
NR 15
TC 1
Z9 1
U1 0
U2 2
PU BIRKHAUSER VERLAG AG
PI BASEL
PA PO BOX 133 KLOSTERBERG 23, CH-4010 BASEL, SWITZERLAND
SN 0065-4299
J9 AGENTS ACTIONS
JI Agents Actions
PD MAR
PY 1991
VL 32
IS 3-4
BP 182
EP 187
DI 10.1007/BF01980871
PG 6
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA FG662
UT WOS:A1991FG66200006
PM 1862741
DA 2020-11-24
ER

PT J
AU VIEIRA, MAR
   MAACK, T
   GUIMARAES, JA
AF VIEIRA, MAR
   MAACK, T
   GUIMARAES, JA
TI T-KININ IS CONVERTED TO BRADYKININ BY ENZYMES FROM THE RAT RENAL
   VASCULAR BED
SO HYPERTENSION
LA English
DT Meeting Abstract
C1 FED UNIV MINAS GERAIS,DEPT PHYSIOL & BIOPHYS,BR-30000 BELO HORIZONTE,MG,BRAZIL.
   CORNELL UNIV,MED CTR,COLL MED,DEPT PHYSIOL,NEW YORK,NY 10021.
   UNIV FED RIO DE JANEIRO,DEPT BIOCHEM,RIO DE JANEIRO,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Maack, Thomas/AAN-7878-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER HEART ASSOC
PI DALLAS
PA 7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596
SN 0194-911X
J9 HYPERTENSION
JI Hypertension
PD MAR
PY 1991
VL 17
IS 3
BP 421
EP 421
PG 1
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA FA882
UT WOS:A1991FA88200079
DA 2020-11-24
ER

PT J
AU BARJAFIDALGO, C
   GUIMARAES, JA
   CARLINI, CR
AF BARJAFIDALGO, C
   GUIMARAES, JA
   CARLINI, CR
TI CANATOXIN, A PLANT PROTEIN, INDUCES INSULIN RELEASE FROM ISOLATED
   PANCREATIC-ISLETS
SO ENDOCRINOLOGY
LA English
DT Article
ID ARACHIDONIC-ACID METABOLISM; LIPOXYGENASE INHIBITORS; CONVULSANT
   PROTEIN; RAT ISLETS; SECRETION; INVOLVEMENT; DISTINCT; HYPOXIA; PATHWAY
AB Canatoxin (CNTX), the toxic protein purified from Canavalia ensiformis, has been shown to induce secretion from different cellular systems through a mechanism involving a lipoxygenase-mediated pathway.  Here it is shown that CNTX causes insulin release from isolated rat pancreatic islets.  This effect is time and dose dependent, occurs in the absence as well in the presence of glucose, and is markedly reduced at lower temperatures (15 C).  At 1-2-mu-M, the insulinotropic effect of CNTX is equivalent to that of 20 mM glucose, and the two responses are not additive.  The stimulatory effect of CNTX is not caused by a toxic or lytic effect of the toxin on the islets, since islets once exposed to CNTX are able to respond a new insulinotropic stimulus.  The phospholipase inhibitor mepacrine impairs insulin release induced by either CNTX or glucose.  Indomethacin, an inhibitor of the cyclooxygenation of arachidonic acid, fails to affect insulin release, but two lipoxygenase inhibitors block it, and epinephrine reduces it.  These data suggest that CNTX may act on islets through the same pathway as that used by glucose, with both effects being mediated by lipoxygenases.
C1 UNIV ESTADO RIO DE JANEIRO,IB,DEPT PHARMACOL,RIO DE JANEIRO,BRAZIL.
RP BARJAFIDALGO, C (corresponding author), UNIV FED RIO DE JANEIRO,ICB,CCS,DEPT BIOCHEM,ILHA FUNDAO,CIDADE UNIV,BR-21910 RIO DE JANEIRO,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR BARCELLOS GBS, 1990, 6TH P PAABS C, P141
   BARJAFIDALGO C, 1988, BRAZ J MED BIOL RES, V21, P549
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CHANG J, 1984, INFLAMMATION, V8, P143, DOI 10.1007/BF00916090
   COLLARES CB, 1988, BRAZ J MED BIOL RES, V21, P107
   GRASSI DM, 1988, 4TH P ANN M BRAZ FED, P214
   GUIMARAES JA, 1985, AN ACAD BRAS CIENC, V57, P387
   MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182
   METZ SA, 1989, BIOCHEM PHARMACOL, V38, P1849, DOI 10.1016/0006-2952(89)90421-8
   METZ SA, 1986, DIABETES, V35, P808, DOI 10.2337/diabetes.35.7.808
   METZ SA, 1988, DIABETES, V37, P65, DOI 10.2337/diabetes.37.1.65
   METZ SA, 1985, P NATL ACAD SCI USA, V82, P198, DOI 10.1073/pnas.82.1.198
   MORAN M, 1988, PROSTAG LEUKOTR ESS, V32, P95, DOI 10.1016/0952-3278(88)90102-0
   RIBEIRO-DASILVA G, 1989, Toxicon, V27, P73
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P877
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P387
   TURK J, 1987, PROG LIPID RES, V26, P125, DOI 10.1016/0163-7827(87)90010-5
   TURK J, 1988, DIABETES, V37, P992, DOI 10.2337/diabetes.37.7.992
   TURK J, 1984, BIOCHIM BIOPHYS ACTA, V774, P110
NR 21
TC 25
Z9 25
U1 0
U2 4
PU ENDOCRINE SOC
PI BETHESDA
PA 4350 EAST WEST HIGHWAY SUITE 500, BETHESDA, MD 20814-4110
SN 0013-7227
J9 ENDOCRINOLOGY
JI Endocrinology
PD FEB
PY 1991
VL 128
IS 2
BP 675
EP 679
DI 10.1210/endo-128-2-675
PG 5
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA EV503
UT WOS:A1991EV50300006
PM 1899218
DA 2020-11-24
ER

PT J
AU BARJAFIDALGO, C
   GUIMARAES, JA
   CARLINI, CR
AF BARJAFIDALGO, C
   GUIMARAES, JA
   CARLINI, CR
TI LIPOXYGENASE-MEDIATED SECRETORY EFFECT OF CANATOXIN, THE TOXIC PROTEIN
   FROM CANAVALIA-ENSIFORMIS SEEDS
SO TOXICON
LA English
DT Article
ID ARACHIDONIC-ACID; INSULIN-SECRETION; CONVULSANT PROTEIN;
   HORMONE-RELEASE; PATHWAY; RATS; INVOLVEMENT; METABOLITES; ISLETS; CELLS
AB Canatoxin was shown to induce serotonin release from rabbit platelets and rat brain synaptosomes, as well as to release insulin from isolated pancreatic islets.  All these effects were dose-dependent and were inhibited by lipoxygenase inhibitors, such as nordihydroguaiaretic acid and esculetin, but not by indomethacin, a cyclo-oxygenase inhibitor.  The data suggest that canatoxin-induced secretory effect results from the activation of the lipoxygenase pathway which would elicit exocytosis.  Thus, canatoxin might be a useful tool for the study of biological events that involve lipoxygenase mediation.
C1 UNIV ESTADO RIO DE JANEIRO,INST BIOL,DEPT PHARMACOL,RIO DE JANEIRO,BRAZIL.
RP BARJAFIDALGO, C (corresponding author), UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST BIOMED SCI,DEPT BIOCHEM,CIDADE UNIV,PO 68041,BR-21910 RIO DE JANEIRO,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR BARJAFIDALGO C, 1988, BRAZ J MED BIOL RES, V21, P549
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   COLLARES CB, 1988, BRAZ J MED BIOL RES, V21, P107
   DAPRADA M, 1988, EXPERIENTIA, V44, P115
   JONES DB, 1987, J ENDOCRINOL, V112, P253, DOI 10.1677/joe.0.1120253
   MCDANIEL ML, 1983, METHOD ENZYMOL, V98, P182
   METZ S, 1983, J CLIN INVEST, V71, P1191, DOI 10.1172/JCI110868
   METZ SA, 1986, DIABETES, V35, P808, DOI 10.2337/diabetes.35.7.808
   METZ SA, 1985, P NATL ACAD SCI USA, V82, P198, DOI 10.1073/pnas.82.1.198
   NADLER JL, 1987, J CLIN INVEST, V80, P1763, DOI 10.1172/JCI113269
   NAOR Z, 1985, J STEROID BIOCHEM, V23, P711, DOI 10.1016/S0022-4731(85)80006-6
   PETERS SP, 1981, NATURE, V292, P455, DOI 10.1038/292455a0
   PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0
   PLETSCHER A, 1988, EXPERIENTIA, V44, P152, DOI 10.1007/BF01952200
   RIBEIRO-DASILVA G, 1989, Toxicon, V27, P73
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P877
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P387
   SEKYIA K, 1982, BIOCHIM BIOPHYS ACTA, V613, P68
   SNIDER RM, 1984, P NATL ACAD SCI-BIOL, V81, P3905, DOI 10.1073/pnas.81.12.3905
   SPECTOR AA, 1988, PROG LIPID RES, V27, P271, DOI 10.1016/0163-7827(88)90009-4
   TURK J, 1987, PROG LIPID RES, V26, P125, DOI 10.1016/0163-7827(87)90010-5
   YAMAMOTO S, 1985, J PHARMACOL EXP THER, V233, P176
NR 24
TC 38
Z9 38
U1 0
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PY 1991
VL 29
IS 4-5
BP 453
EP 459
DI 10.1016/0041-0101(91)90019-N
PG 7
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA FG047
UT WOS:A1991FG04700007
PM 1907411
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   GUIMARAES, JA
AF CARLINI, CR
   GUIMARAES, JA
TI PLANT AND MICROBIAL TOXIC PROTEINS AS HEMILECTINS - EMPHASIS ON
   CANATOXIN
SO TOXICON
LA English
DT Review
ID N-GLYCOSIDASE ACTIVITY; RICIN A-CHAIN; RIBOSOME-INACTIVATING PROTEINS;
   ARACHIDONIC-ACID METABOLISM; BITTER PEAR MELON; GROWTH FACTOR-II;
   EUKARYOTIC RIBOSOMES; CONCANAVALIN-A; DIPHTHERIA-TOXIN; BINDING-PROTEIN
AB Ribosome-inactivating plant toxic proteins and ADP-ribosylating microbial toxins share a common structural organization. These proteins present domains displaying different biological properties: a target cell membrane-binding component (B-subunit or haptomer) and an enzymatically active component (A-subunit or effectomer). Interactions of these toxins with the target cells are mediated by the hemilectin-like haptomer, which recognizes and specifically binds to a given glycoderivative present at the cell surface. After binding the holoprotein is internalized via endocytosis. Inside the endocytic compartment the toxin is processed to release its effectomer moiety which catalytically modifies a cytoplasmic component, and this step accounts for its toxic effect. The structural relationships between toxic hemilectins and plant lectins are discussed, with emphasis on the example of canatoxin and concanavalin A, both present in the seeds of the jack bean Canavalia ensiformis. Contrary to other plant toxic proteins, which inhibit protein synthesis, canatoxin-induced toxicity includes central nervous system-mediated effects. In vivo as well as in vitro canatoxin acts as lipoxygenase-mediated secretagogue in several types of cells: blood platelets, mast cells, pancreatic islets and synaptosomes. Elucidation of structure vs biological activity relationships of canatoxin and other toxic proteins may provide data for their utilization as pharmacological tools and as therapeutic agents.
RP CARLINI, CR (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOCHEM, CP 68041, BR-21910 RIO DE JANEIRO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0
   BARBIERI L, 1982, BIOCHEM J, V203, P55, DOI 10.1042/bj2030055
   BARBIERI L, 1980, BIOCHEM J, V185, P203, DOI 10.1042/bj1850203
   BARBIERI L, 1980, BIOCHEM J, V186, P443, DOI 10.1042/bj1860443
   BARBIERI L, 1984, FEBS LETT, V171, P277, DOI 10.1016/0014-5793(84)80503-7
   BARJAFIDALGO C, 1988, BRAZ J MED BIOL RES, V21, P549
   BARJAFIDALGO TC, 1991, IN PRESS ENDOCRINOLO
   BARONDES SH, 1988, TRENDS BIOCHEM SCI, V13, P480, DOI 10.1016/0968-0004(88)90235-6
   BISCHOFF J, 1987, J BIOL CHEM, V262, P11825
   BLAKEY DC, 1988, PROG ALLERGY, V45, P50
   BOKOCH GM, 1988, J BIOL CHEM, V263, P16744
   Brown J C, 1978, Int Rev Cytol, V52, P277, DOI 10.1016/S0074-7696(08)60758-5
   BUSHUEVA TL, 1988, FEBS LETT, V229, P119, DOI 10.1016/0014-5793(88)80809-3
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1988, PHYTOCHEMISTRY, V27, P25, DOI 10.1016/0031-9422(88)80587-9
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CARLINI CR, 1980, CIENCIA CULTURA S, V32, P86
   CARLINI CR, 1989, TOXICON, V28, pA604
   CARLINI CR, 1989, TOXICON, V27, pA35
   CARRINGTON DM, 1985, NATURE, V313, P64, DOI 10.1038/313064a0
   CASSEL D, 1978, P NATL ACAD SCI USA, V75, P2669, DOI 10.1073/pnas.75.6.2669
   COLLARES CB, 1988, BRAZ J MED BIOL RES, V21, P107
   CRITCHLEY DR, 1986, J NEUROCHEM, V47, P213
   CUNNINGHAM BA, 1975, PURE APPL CHEM, V41, P31, DOI 10.1351/pac197541010031
   DEURS BV, 1987, EXP CELL RES, V171, P137
   DIXON HBF, 1981, NATURE, V292, P192, DOI 10.1038/292192e0
   DUFAU ML, 1973, J BIOL CHEM, V248, P6973
   DURRANT LG, 1989, CLIN EXP IMMUNOL, V75, P258
   EDELMAN GM, 1972, P NATL ACAD SCI USA, V69, P2580, DOI 10.1073/pnas.69.9.2580
   EIDELS L, 1983, MICROBIOL REV, V47, P596, DOI 10.1128/MMBR.47.4.596-620.1983
   ENDO Y, 1988, BIOCHEM BIOPH RES CO, V150, P1032, DOI 10.1016/0006-291X(88)90733-4
   ENDO Y, 1988, J BIOL CHEM, V263, P8735
   ENDO Y, 1987, J BIOL CHEM, V262, P8128
   ENDO Y, 1989, FEBS LETT, V248, P115, DOI 10.1016/0014-5793(89)80443-0
   ENDO Y, 1987, J BIOL CHEM, V262, P5908
   ENDO Y, 1988, BIOCHIM BIOPHYS ACTA, V954, P224, DOI 10.1016/0167-4838(88)90075-1
   ETZLER ME, 1985, ANNU REV PLANT PHYS, V36, P209, DOI 10.1146/annurev.pp.36.060185.001233
   FALASCA A, 1982, BIOCHEM J, V207, P505, DOI 10.1042/bj2070505
   FORIERS A, 1977, BIOCHEM BIOPH RES CO, V75, P980, DOI 10.1016/0006-291X(77)91478-4
   FOSTER JW, 1985, CRC CR REV MICROBIOL, V11, P273
   FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481
   GASPERICAMPANI A, 1979, EXPERIENTIA, V35, P1086, DOI 10.1007/BF01949957
   GILL DM, 1978, BACTERIAL TOXINS CEL, P291
   Goldstein I.J., 1986, LECTINS PROPERTIES F, P35
   GOLDSTEIN IJ, 1980, NATURE, V285, P66, DOI 10.1038/285066b0
   GUIMARAES JA, 1985, AN ACAD BRAS CIENC, V57, P387
   GURTLER LG, 1973, BIOCHIM BIOPHYS ACTA, V295, P582, DOI 10.1016/0005-2795(73)90056-1
   Hellin H., 1891, THESIS U DORPAT DORP
   HEMPERLY JJ, 1983, TRENDS BIOCHEM SCI, V8, P100, DOI 10.1016/0968-0004(83)90260-8
   HINEK A, 1988, SCIENCE, V239, P1539, DOI 10.1126/science.2832941
   HOCK RA, 1979, NATURE, V277, P403, DOI 10.1038/277403a0
   HONJO T, 1969, J BIOL CHEM, V262, P12298
   HOUSTON LL, 1982, J BIOL CHEM, V257, P4147
   IGLEWSKI BH, 1977, INFECT IMMUN, V15, P138, DOI 10.1128/IAI.15.1.138-144.1977
   IRVIN JD, 1980, ARCH BIOCHEM BIOPHYS, V200, P418, DOI 10.1016/0003-9861(80)90372-0
   ISHIGURO M, 1964, J BIOCHEM, V55, P587
   JIMENEZ A, 1985, ANNU REV MICROBIOL, V39, P649, DOI 10.1146/annurev.mi.39.100185.003245
   JUDD AM, 1988, NEUROENDOCRINOLOGY, V48, P407, DOI 10.1159/000125042
   KATADA T, 1982, J BIOL CHEM, V257, P3739
   KERNAN NA, 1988, JAMA-J AM MED ASSOC, V259, P3154, DOI 10.1001/jama.259.21.3154
   KIKUCHI A, 1988, J BIOL CHEM, V263, P16303
   KILLEN JA, 1984, J IMMUNOL, V133, P2549
   KISHIDA K, 1983, FEBS LETT, V153, P209, DOI 10.1016/0014-5793(83)80149-5
   LIENER IE, 1986, LECTINS PROPERTIES F, P527
   Liener IE, 1986, LECTINS PROPERTIES F, P1
   LIN JY, 1978, TOXICON, V16, P653, DOI 10.1016/0041-0101(78)90193-9
   LIN JY, 1971, TOXICON, V9, P97, DOI 10.1016/0041-0101(71)90001-8
   LIS H, 1986, ANNU REV BIOCHEM, V55, P35, DOI 10.1146/annurev.bi.55.070186.000343
   LIS H, 1986, LECTINS PROPERTIES F, P266
   MACDONALD RG, 1988, SCIENCE, V239, P1134, DOI 10.1126/science.2964083
   MARAGANORE JM, 1987, J BIOL CHEM, V262, P11628
   MARXEN P, 1989, TOXICON, V27, P849, DOI 10.1016/0041-0101(89)90097-4
   MATTER K, 1989, J NEUROCHEM, V52, P370, DOI 10.1111/j.1471-4159.1989.tb09131.x
   MCKENZIE IFC, 1989, TRANSPLANT P, V21, P823
   METZ SA, 1985, P NATL ACAD SCI USA, V82, P198, DOI 10.1073/pnas.82.1.198
   MIDDLEBROOK JL, 1981, RECEPTOR MEDIATED BI, P1
   MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677
   MONTECUCCO C, 1986, TRENDS BIOCHEM SCI, V11, P314, DOI 10.1016/0968-0004(86)90282-3
   MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0
   MOSKAUG JO, 1987, J BIOL CHEM, V262, P10339
   MOYA M, 1985, J CELL BIOL, V101, P548, DOI 10.1083/jcb.101.2.548
   NADLER JL, 1987, J CLIN INVEST, V80, P1763, DOI 10.1172/JCI113269
   NAOR Z, 1985, J STEROID BIOCHEM, V23, P711, DOI 10.1016/S0022-4731(85)80006-6
   NEUFELD EF, 1980, BIOCH GLYCOPROTEINS, P241
   OBRIG TG, 1973, ARCH BIOCHEM BIOPHYS, V155, P278, DOI 10.1016/0003-9861(73)90116-1
   OFLAHERTY JT, 1985, PROSTA LEUKOTR MED, V17, P199, DOI 10.1016/0262-1746(85)90107-6
   OLSNES S, 1982, J BIOL CHEM, V257, P13263
   OLSNES S, 1974, J BIOL CHEM, V249, P803
   OLSNES S, 1973, BIOCHEMISTRY-US, V12, P3121, DOI 10.1021/bi00740a028
   OLSNES S, 1973, MOL BIOL REP, V1, P15, DOI 10.1007/BF00357400
   OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0
   OLSNES S, 1989, IMMUNOL TODAY, V10, P291
   PANKEWYCZ O, 1989, TRANSPLANTATION, V47, P318, DOI 10.1097/00007890-198902000-00026
   PAPPENHEIMER AM, 1977, ANNU REV BIOCHEM, V46, P69, DOI 10.1146/annurev.bi.46.070177.000441
   PETERS SP, 1981, NATURE, V292, P455, DOI 10.1038/292455a0
   PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0
   PREIJERS FWMB, 1989, BLOOD, V74, P1152
   READY M, 1984, J BIOL CHEM, V259, P5252
   READY MP, 1984, BIOCHIM BIOPHYS ACTA, V791, P314, DOI 10.1016/0167-4838(84)90342-X
   RIBEIRODASILVA G, 1986, TOXICON, V24, P775, DOI 10.1016/0041-0101(86)90102-9
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P877
   RIBEIRODASILVA G, 1989, BRAZ J MED BIOL RES, V22, P387
   RIBEIRODASILVA G, 1989, TOXICON, V27, pA73
   ROBERTS LM, 1985, J BIOL CHEM, V260, P5682
   ROBERTS WK, 1979, BIOCHEMISTRY-US, V18, P2615, DOI 10.1021/bi00579a028
   ROUGE P, 1987, BIOCHEM SYST ECOL, V15, P341, DOI 10.1016/0305-1978(87)90009-3
   RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0
   SAHAGIAN GG, 1981, P NATL ACAD SCI-BIOL, V78, P4289, DOI 10.1073/pnas.78.7.4289
   SALTVEDT E, 1976, BIOCHIM BIOPHYS ACTA, V451, P536, DOI 10.1016/0304-4165(76)90149-5
   SANTANA JM, 1989, AM J TROP MED HYG, V41, P177, DOI 10.4269/ajtmh.1989.41.177
   SASAKAWA N, 1984, BIOCHEM PHARMACOL, V33, P2733, DOI 10.1016/0006-2952(84)90689-0
   SCHNEIDER WJ, 1982, J BIOL CHEM, V257, P2664
   SHARON N, 1987, TRENDS BIOCHEM SCI, V12, P488, DOI 10.1016/0968-0004(87)90235-0
   SHARON N, 1989, SCIENCE, V246, P227, DOI 10.1126/science.2552581
   SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949
   SIMPSON LL, 1983, J PHARMACOL EXP THER, V225, P546
   SNIDER RM, 1984, P NATL ACAD SCI-BIOL, V81, P3905, DOI 10.1073/pnas.81.12.3905
   STILLMARK H, 1888, ARB PHARMAKOL I DORP, V3, P59
   STIRPE F, 1980, J BIOL CHEM, V255, P6947
   STIRPE F, 1986, FEBS LETT, V195, P1, DOI 10.1016/0014-5793(86)80118-1
   STROSBERG D, 1986, LECTINS, P251
   Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936
   TURK J, 1989, BIOCHIM BIOPHYS ACTA, V1001, P16, DOI 10.1016/0005-2760(89)90301-9
   UTSUMI T, 1984, BIOCHIM BIOPHYS ACTA, V772, P202, DOI 10.1016/0005-2736(84)90045-2
   VITETTA ES, 1985, ANNU REV IMMUNOL, V3, P197
   VLASKOVSKA M, 1984, NEUROENDOCRINOLOGY, V39, P334, DOI 10.1159/000124001
   WADA HG, 1979, J BIOL CHEM, V254, P2629
   WALLER GR, 1966, P SOC EXP BIOL MED, V121, P685
   WEI CH, 1974, J BIOL CHEM, V249, P3061
   ZAMBONI M, 1989, BIOCHEM J, V259, P639, DOI 10.1042/bj2590639
   ZHAO JM, 1986, P NATL ACAD SCI USA, V83, P2002, DOI 10.1073/pnas.83.7.2002
   ZISKA P, 1981, EXPERIENTIA, V37, P219, DOI 10.1007/BF01991618
NR 133
TC 31
Z9 32
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PY 1991
VL 29
IS 7
BP 791
EP 806
DI 10.1016/0041-0101(91)90216-E
PG 16
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA FW548
UT WOS:A1991FW54800001
PM 1926181
DA 2020-11-24
ER

PT J
AU MURTA, ACM
   PERSECHINI, PM
   PADRON, TD
   DESOUZA, W
   GUIMARAES, JA
   SCHARFSTEIN, J
AF MURTA, ACM
   PERSECHINI, PM
   PADRON, TD
   DESOUZA, W
   GUIMARAES, JA
   SCHARFSTEIN, J
TI STRUCTURAL AND FUNCTIONAL IDENTIFICATION OF GP57/51 ANTIGEN OF
   TRYPANOSOMA-CRUZI AS A CYSTEINE PROTEINASE
SO MOLECULAR AND BIOCHEMICAL PARASITOLOGY
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO, INST BIOFIS CARLOS CHAGAS FILHO, MOLEC IMMUNOL LAB, BR-21941 RIO DE JANEIRO, BRAZIL.
   UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM, RIO DE JANEIRO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Persechini, Pedro/A-9477-2009
OI Persechini, Pedro/0000-0002-3278-1951; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ABUIN G, 1989, MOL BIOCHEM PARASIT, V35, P229, DOI 10.1016/0166-6851(89)90209-0
   AMORIM DS, 1979, TRYPANOSOMA CRUZI DO, P265
   Andrade ZA, 1979, TRYPANOSOMA CRUZI DO, P199
   ANDREWS NW, 1989, MOL BIOCHEM PARASIT, V33, P249, DOI 10.1016/0166-6851(89)90086-8
   BARRETT AJ, 1982, BIOCHEM J, V201, P189, DOI 10.1042/bj2010189
   BARRETT AJ, 1987, TRENDS BIOCHEM SCI, V12, P193, DOI 10.1016/0968-0004(87)90092-2
   BARRETT AJ, 1980, BIOCHEM J, V187, P909, DOI 10.1042/bj1870909
   BENDAYAN M, 1987, J HISTOCHEM CYTOCHEM, V35, P983, DOI 10.1177/35.9.3302022
   BONTEMPI E, 1989, MOL BIOCHEM PARASIT, V33, P43, DOI 10.1016/0166-6851(89)90040-6
   BONTEMPI E, 1984, COMP BIOCHEM PHYS B, V77, P599, DOI 10.1016/0305-0491(84)90282-7
   BRENER Z, 1973, ANNU REV MICROBIOL, V27, P347, DOI 10.1146/annurev.mi.27.100173.002023
   CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93
   Carvalho T.M.U., 1983, Z PARASITENKD, V69, P571
   CAZZULO JJ, 1990, MOL BIOCHEM PARASIT, V38, P41, DOI 10.1016/0166-6851(90)90203-X
   CAZZULO JJ, 1989, MOL BIOCHEM PARASIT, V33, P33, DOI 10.1016/0166-6851(89)90039-X
   CICARELLI RMB, 1989, J IMMUNOL, V142, P1685
   Drenth J, 1971, Adv Protein Chem, V25, P79, DOI 10.1016/S0065-3233(08)60279-X
   EAKIN AE, 1990, MOL BIOCHEM PARASIT, V39, P1, DOI 10.1016/0166-6851(90)90002-4
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   GAZZINELLI RT, IN PRESS INFECT IMMU
   KEENE WE, 1986, J EXP MED, V163, P536, DOI 10.1084/jem.163.3.536
   KESSLER SW, 1975, J IMMUNOL, V115, P1617
   LACKS SA, 1980, J BIOL CHEM, V255, P7467
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LONDSDALLEECCLE.JD, 1986, EUR J BIOCHEM, V155, P469
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASON RW, 1986, BIOCHEM J, V240, P373, DOI 10.1042/bj2400373
   MASON RW, 1986, BIOMED BIOCHIM ACTA, V45, P1433
   MASON RW, 1987, BIOCHEM J, V248, P449, DOI 10.1042/bj2480449
   MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035
   MENDONCAPREVIATO L, 1983, BIOCHEMISTRY-US, V22, P4980, DOI 10.1021/bi00290a016
   MOTTRAM JC, 1989, FEBS LETT, V258, P211, DOI 10.1016/0014-5793(89)81655-2
   NOGUEIRA N, 1978, J EXP MED, V148, P288, DOI 10.1084/jem.148.1.288
   OUAISSI MA, 1986, MOL BIOCHEM PARASIT, V19, P201, DOI 10.1016/0166-6851(86)90002-2
   PIRAS MM, 1985, MOL BIOCHEM PARASIT, V14, P151, DOI 10.1016/0166-6851(85)90034-9
   RANGEL HA, 1981, TROPENMED PARASITOL, V32, P87
   REED SL, IN PRESS J CLIN MICR
   SCHAFSTEIN J, 1983, J IMMUNOL, V131, P942
   SCHARFSTEIN J, 1986, J IMMUNOL, V137, P1336
   SCHARFSTEIN J, 1985, AM J TROP MED HYG, V34, P1153, DOI 10.4269/ajtmh.1985.34.1153
   SCHARFSTEIN J, 1984, PONTIFICIAE SCI SCRI, V51, P149
   SINGH H, 1978, J BIOL CHEM, V253, P4319
   TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X
   WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324
   ZINGALES B, 1985, CURR TOP MICROBIOL, V117, P129
   ZINGALES B, 1982, MOL BIOCHEM PARASIT, V6, P111, DOI 10.1016/0166-6851(82)90069-X
NR 46
TC 157
Z9 159
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-6851
EI 1872-9428
J9 MOL BIOCHEM PARASIT
JI Mol. Biochem. Parasitol.
PD NOV
PY 1990
VL 43
IS 1
BP 27
EP 38
DI 10.1016/0166-6851(90)90127-8
PG 12
WC Biochemistry & Molecular Biology; Parasitology
SC Biochemistry & Molecular Biology; Parasitology
GA ED881
UT WOS:A1990ED88100003
PM 1705310
DA 2020-11-24
ER

PT J
AU ZINGALI, RB
   CARLINI, CR
   FRANCISCHETTI, IM
   GUIMARAES, JA
AF ZINGALI, RB
   CARLINI, CR
   FRANCISCHETTI, IM
   GUIMARAES, JA
TI BOTHROPS-JARARACA SNAKE-VENOM - EFFECTS ON PLATELET-AGGREGATION
SO THROMBOSIS RESEARCH
LA English
DT Article
RP ZINGALI, RB (corresponding author), UNIV FED RIO DE JANEIRO, ICB, DEPT BIOCHEM, IIHA FUNDAO, CP68041, RIO DE JANEIRO, RJ, BRAZIL.
RI Zingali, Russolina/G-4862-2012; Guimaraes, Jorge Almeida/V-2196-2019; da
   Silva Carlini, Celia Regina Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ARDLIE NG, 1970, BRIT J HAEMATOL, V19, P7, DOI 10.1111/j.1365-2141.1970.tb01596.x
   BAJWA SS, 1981, TOXICON, V19, P53, DOI 10.1016/0041-0101(81)90117-3
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   BRINKHOUS KM, 1988, HEMOSTASIS ANIMAL VE, P377
   BRINKHOUS KM, 1988, HEMOSTASIS ANIMAL VE, P364
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CHEN RH, 1989, TOXICON, V27, P675, DOI 10.1016/0041-0101(89)90018-4
   CLAESON G, 1977, NEW METHODS ANAL COA, P37
   DENSON KWE, 1972, TOXICON, V10, P557, DOI 10.1016/0041-0101(72)90116-X
   DENSON KWE, 1970, TOXICON, V8, P15, DOI 10.1016/0041-0101(70)90167-4
   DHAR A, 1988, BRIT J HAEMATOL, V70, P71, DOI 10.1111/j.1365-2141.1988.tb02436.x
   FURUKAWA Y, 1977, TOXICON, V15, P107, DOI 10.1016/0041-0101(77)90029-0
   GARTNER TK, 1980, FEBS LETT, V117, P13, DOI 10.1016/0014-5793(80)80902-1
   GUTIERREZ JM, 1986, COMP BIOCHEM PHYS C, V84, P159, DOI 10.1016/0742-8413(86)90183-0
   HOFMANN H, 1987, BIOCHEMISTRY-US, V26, P772, DOI 10.1021/bi00377a018
   HOFMANN H, 1987, BIOCHEMISTRY-US, V26, P780, DOI 10.1021/bi00377a019
   HOLLEMAN WH, 1976, J BIOL CHEM, V251, P1663
   HUANG TF, 1984, TOXICON, V22, P243, DOI 10.1016/0041-0101(84)90025-4
   KOERNER TAW, 1986, TRANSFUSION, V26, P77, DOI 10.1046/j.1537-2995.1986.26186124038.x
   LONGENECKER GL, 1984, J TOXICOL-TOXIN REV, V3, P223, DOI 10.3109/15569548409097926
   MAGALHAES A, 1981, TOXICON, V19, P279, DOI 10.1016/0041-0101(81)90032-5
   MANDELBAUM FR, 1984, TOXICON, V22, P193, DOI 10.1016/0041-0101(84)90020-5
   NEUMANN WP, 1955, BIOCHEM Z, V327, P170
   NIEWIAROWSKI S, 1977, THROMB RES, V10, P863, DOI 10.1016/0049-3848(77)90144-X
   NIEWIAROWSKI S, 1979, BIOCHEMISTRY-US, V18, P3570, DOI 10.1021/bi00583a021
   Ouyang C., 1982, Journal of the Formosan Medical Association, V81, P781
   OUYANG C, 1983, TOXICON, V21, P797, DOI 10.1016/0041-0101(83)90068-5
   OUYANG C, 1984, TOXICON, V22, P705, DOI 10.1016/0041-0101(84)90154-5
   OUYANG C, 1987, ASIA PAC J PHARMACOL, V2, P169
   PANDYA BV, 1984, BIOCHEMISTRY-US, V23, P460, DOI 10.1021/bi00298a010
   PIRKLE H, 1988, HEMOSTASIS ANIMAL VE, P525
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P661, DOI 10.1016/0041-0101(81)90103-3
   QUICK AJ, 1951, PHYSL HEMOSTASIS, P108
   RAW I, 1986, BRAZ J MED BIOL RES, V19, P333
   READ MS, 1978, P NATL ACAD SCI USA, V75, P4514, DOI 10.1073/pnas.75.9.4514
   READ MS, 1989, BLOOD, V74, P1031
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   Stocker K., 1976, Methods Enzymol, V45, P214
   TENG CM, 1985, SEMIN THROMB HEMOST, V11, P367, DOI 10.1055/s-2007-1004396
   TENG CM, 1986, THROMB RES, V44, P875, DOI 10.1016/0049-3848(86)90033-2
   TENG CM, 1984, BIOCHIM BIOPHYS ACTA, V772, P393, DOI 10.1016/0005-2736(84)90156-1
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1982, TOXICON, V20, P279, DOI 10.1016/0041-0101(82)90227-6
   VIDAL JC, 1971, ARCH BIOCHEM BIOPHYS, V145, P543, DOI 10.1016/S0003-9861(71)80014-0
NR 44
TC 23
Z9 24
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0049-3848
J9 THROMB RES
JI Thromb. Res.
PD MAY 1
PY 1990
VL 58
IS 3
BP 303
EP 316
DI 10.1016/0049-3848(90)90100-Q
PG 14
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA DC495
UT WOS:A1990DC49500011
PM 2353342
DA 2020-11-24
ER

PT J
AU ASSREUY, J
   ALMEIDA, AA
   GUIMARAES, JA
AF ASSREUY, J
   ALMEIDA, AA
   GUIMARAES, JA
TI PHARMACOLOGICAL PROPERTIES OF A NEW KININ-POTENTIATING PEPTIDE GENERATED
   FROM HUMAN-SERUM PROTEINS
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO, CTR CIENCIAS SAUDE,INST BIOMED SCI,DEPT BIOCHEM, POB 68041, BR-21910 RIO DE JANEIRO, RJ, BRAZIL.
RI Almeida-junior, Armando AA/K-9770-2015; Assreuy, Jamil/A-4205-2013;
   Guimaraes, Jorge Almeida/V-2196-2019
OI Almeida-junior, Armando AA/0000-0003-0096-5016; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR AARSEN PN, 1968, BRIT J PHARMACOL, V32, P453, DOI 10.1111/j.1476-5381.1968.tb00446.x
   ASSREUYFILHO J, 1988, BRAZ J MED BIOL RES, V21, P453
   BLOMBACK B, 1966, BIOCHIM BIOPHYS ACTA, V115, P371, DOI 10.1016/0304-4165(66)90437-5
   CHI CW, 1985, PEPTIDES, V6, P339
   CUSHMAN DW, 1971, BIOCHIM BIOPHYS ACTA, V250, P261, DOI 10.1016/0005-2744(71)90142-2
   ERDOS EG, 1989, FASEB J, V3, P145
   ERDOS EG, 1979, HDB EXPT PHARMACOLOG, V25, P428
   FABER DB, 1973, ARCH INT PHARMACOD T, V205, P226
   FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005
   FERREIRA SH, 1965, BRIT J PHARM CHEMOTH, V24, P163, DOI 10.1111/j.1476-5381.1965.tb02091.x
   GLADNER JA, 1966, HYPOTENSIVE PEPTIDES, P344
   GUIMARAES JA, 1982, AGENTS ACTIONS, V9, P295
   GUIMARAES JA, 1980, CLIN RES, V28, pA331
   HAMBERG U, 1969, SCAND J CLIN LAB INV, VS 24, P21
   HENRIQUES OB, 1987, BIOCHEM PHARMACOL, V36, P182, DOI 10.1016/0006-2952(87)90398-4
   KATO H, 1971, BIOCHEMISTRY-US, V10, P972, DOI 10.1021/bi00782a007
   LEME JG, 1978, HDB EXP PHARMACOL, V50, P464
   MARUYAMA S, 1985, AGR BIOL CHEM TOKYO, V49, P1405, DOI 10.1080/00021369.1985.10866901
   ONDETTI MA, 1982, ANNU REV BIOCHEM, V51, P283, DOI 10.1146/annurev.bi.51.070182.001435
   ROBLERO J, 1973, RES COMMUN CHEM PATH, V6, P207
   SALGADO MCO, 1982, HYPERTENSION, V4, P77
   STEWART JM, 1979, HDB EXP PHARMACOL  S, V25, P227
   UFKES JGR, 1977, EUR J PHARMACOL, V44, P89, DOI 10.1016/0014-2999(77)90094-2
   UFKES JGR, 1978, EUR J PHARMACOL, V50, P119, DOI 10.1016/0014-2999(78)90006-7
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   WEYERS R, 1972, BIOCHIM BIOPHYS ACTA, V279, P331, DOI 10.1016/0304-4165(72)90151-1
NR 26
TC 4
Z9 4
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD SEP 13
PY 1989
VL 168
IS 2
BP 231
EP 237
DI 10.1016/0014-2999(89)90569-4
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AT146
UT WOS:A1989AT14600012
PM 2606151
DA 2020-11-24
ER

PT J
AU ATALLAH, AN
   GUIMARAES, JAG
   GEBARA, M
   SUSTOVICH, DR
   MARTINEZ, TR
   CAMANO, L
AF ATALLAH, AN
   GUIMARAES, JAG
   GEBARA, M
   SUSTOVICH, DR
   MARTINEZ, TR
   CAMANO, L
TI PROGESTERONE INCREASES GLOMERULAR-FILTRATION RATE, URINARY KALLIKREIN
   EXCRETION AND URIC-ACID CLEARANCE IN NORMAL WOMEN
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Letter
C1 ESCOLA PAULISTA MED,DEPT MED,PESQUISA HIPERTENSAO ARTERIAL GESTACAO LAB,BR-04023 SAO PAULO,SP,BRAZIL.
RP ATALLAH, AN (corresponding author), ESCOLA PAULISTA MED,DEPT MED,DISCIPLINA OBSTET,RUA BOTUCATU 720,BR-04023 SAO PAULO,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Atallah, Alvaro N/K-7182-2013
OI Leme da Rocha Martinez, Tania/0000-0002-1027-6954; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ADETUYIBI A, 1972, LANCET, V2, P203
   ATALLAH AN, 1979, THESIS ESCOLA PAULIS
   EVERETT RB, 1978, AM J OBSTET GYNECOL, V131, P352, DOI 10.1016/0002-9378(78)90407-6
   KAGEIAMA N, 1976, CLIN CHIMICA ACTA, V31, P421
   KEISER HR, 1976, FED PROC, V35, P199
   OPARIL S, 1975, CLIN SCI MOL MED, V49, P139, DOI 10.1042/cs0490139
   REDMAN CWG, 1976, LANCET, V2, P753
NR 7
TC 16
Z9 17
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1988
VL 21
IS 1
BP 71
EP 74
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA M3161
UT WOS:A1988M316100012
PM 3179582
DA 2020-11-24
ER

PT J
AU ASSREUYFILHO, J
   ALMEIDA, AA
   GUIMARAES, JA
AF ASSREUYFILHO, J
   ALMEIDA, AA
   GUIMARAES, JA
TI CHARACTERIZATION OF A NEW KININ POTENTIATING PEPTIDE OBTAINED FROM
   HUMAN-PLASMA PROTEINS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Letter
C1 UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT BIOQUIM,CAIXA POSTAL 68041,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Almeida-junior, Armando
   AA/K-9770-2015
OI Almeida-junior, Armando AA/0000-0003-0096-5016; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR AARSEN PN, 1968, BRIT J PHARMACOL, V32, P453, DOI 10.1111/j.1476-5381.1968.tb00446.x
   ANTONACCIO MJ, 1981, FED PROC, V40, P2275
   CUSHMAN DW, 1971, BIOCHIM BIOPHYS ACTA, V250, P261, DOI 10.1016/0005-2744(71)90142-2
   FABER DB, 1973, ARCH INT PHARMACOD T, V205, P226
   FERREIRA SH, 1965, EXPERIENTIA, V21, P347, DOI 10.1007/BF02144709
   FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005
   GLADNER JA, 1966, HYPOTENSIVE PEPTIDES, P344
   GUIMARAES JA, 1982, AGENTS ACTIONS, V9, P295
   HAMBERG U, 1969, SCAND J CLIN LAB INV, VS 24, P21
   HENRIQUES OB, 1987, BIOCHEM PHARMACOL, V36, P182, DOI 10.1016/0006-2952(87)90398-4
   HOLMQUIST B, 1979, ANAL BIOCHEM, V95, P540, DOI 10.1016/0003-2697(79)90769-3
   KATO H, 1971, BIOCHEMISTRY-US, V10, P972, DOI 10.1021/bi00782a007
   LEME JG, 1978, HDB EXP PHARMACOL, V50, P464
   MARUYAMA S, 1982, AGR BIOL CHEM TOKYO, V46, P1393, DOI 10.1080/00021369.1982.10865255
   OSBAHR AJ, 1964, BIOCHIM BIOPHYS ACTA, V86, P535, DOI 10.1016/0304-4165(64)90093-5
   ROBLERO J, 1973, RES COMMUN CHEM PATH, V6, P207
   SILVA MR, 1960, ARCH INT PHARMACOD T, V128, P355
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   WEYERS P, 1972, BIOCH BIOPHYSICA ACT, V279, P331
NR 19
TC 4
Z9 4
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1988
VL 21
IS 3
BP 453
EP 455
PG 3
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA N9180
UT WOS:A1988N918000007
PM 3228625
DA 2020-11-24
ER

PT J
AU BARJAFIDALGO, C
   GUIMARAES, JA
   CARLINI, CR
AF BARJAFIDALGO, C
   GUIMARAES, JA
   CARLINI, CR
TI THE SECRETORY EFFECT OF CANATOXIN ON RAT-BRAIN SYNAPTOSOMES INVOLVES A
   LIPOXYGENASE-MEDIATED PATHWAY
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Letter
C1 UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT BIOQUIM,CAIXA POSTAL 68041,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
   UNIV ESTADO RIO DE JANEIRO,INST BIOL,DEPT CIENCIAS FISIOL,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR BRADFORD HF, 1970, BRAIN RES, V19, P239, DOI 10.1016/0006-8993(70)90437-3
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   DASILVA GR, 1988, IN PRESS TOXICON
   DASILVA GR, 1988, IN PRESS BRAZILIAN J, V21
   PLETSCHER A, 1980, PLATELETS CELLULAR R, P267
   ROBINSON PJ, 1983, J NEUROCHEM, V41, P909, DOI 10.1111/j.1471-4159.1983.tb09034.x
   SUN AY, 1974, J NEUROCHEM, V22, P551, DOI 10.1111/j.1471-4159.1974.tb06893.x
NR 9
TC 11
Z9 11
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1988
VL 21
IS 3
BP 549
EP 552
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA N9180
UT WOS:A1988N918000027
PM 3147798
DA 2020-11-24
ER

PT J
AU ZINGALI, RB
   FRANCISCHETTI, IM
   CARLINI, CR
   GUIMARAES, JA
AF ZINGALI, RB
   FRANCISCHETTI, IM
   CARLINI, CR
   GUIMARAES, JA
TI BIOCHEMICAL AND PHARMACOLOGICAL SCREENING OF SNAKE (BOTHROPS) VENOMS -
   CHARACTERIZATION OF COMPONENTS ACTING ON BLOOD-COAGULATION AND
   PLATELET-AGGREGATION
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Letter
RP ZINGALI, RB (corresponding author), UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOL,DEPT BIOQUIM,ILHA FUNDAO,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RI Zingali, Russolina/G-4862-2012; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011; Guimaraes, Jorge Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ARDLIE NG, 1970, BRIT J HAEMATOL, V19, P7, DOI 10.1111/j.1365-2141.1970.tb01596.x
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   GARTNER TK, 1980, FEBS LETT, V117, P13, DOI 10.1016/0014-5793(80)80902-1
   HOFMANN H, 1983, BIOCHIMIE, V65, P201, DOI 10.1016/S0300-9084(83)80085-6
   HOFMANN H, 1987, BIOCHEMISTRY-US, V26, P772, DOI 10.1021/bi00377a018
   LABIB RS, 1981, TOXICON, V19, P85, DOI 10.1016/0041-0101(81)90120-3
   MAGALHAES A, 1981, TOXICON, V19, P279, DOI 10.1016/0041-0101(81)90032-5
   MANDELBAUM FR, 1984, TOXICON, V22, P193, DOI 10.1016/0041-0101(84)90020-5
   NEWMAN WP, 1955, BIOCHEM Z, V327, P170
   NIEWIAROWSKI S, 1977, THROMB RES, V10, P863, DOI 10.1016/0049-3848(77)90144-X
   OUYANG C, 1983, TOXICON, V21, P797, DOI 10.1016/0041-0101(83)90068-5
   PANDYA BV, 1984, BIOCHEMISTRY-US, V23, P460, DOI 10.1021/bi00298a010
   RAW I, 1986, BRAZ J MED BIOL RES, V19, P333
   Stocker K., 1976, Methods Enzymol, V45, P214
   TENG CM, 1985, SEMIN THROMB HEMOST, V11, P367, DOI 10.1055/s-2007-1004396
   TENG CM, 1984, BIOCHIM BIOPHYS ACTA, V772, P393, DOI 10.1016/0005-2736(84)90156-1
   ZINGALI RB, 1987, 2 REUN AN FED SOC BI, P410
NR 17
TC 9
Z9 11
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1988
VL 21
IS 4
BP 763
EP 765
PG 3
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA P7507
UT WOS:A1988P750700005
PM 3240377
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   BARCELLOS, GBS
   BAETANEVES, ADV
   GUIMARAES, JA
AF CARLINI, CR
   BARCELLOS, GBS
   BAETANEVES, ADV
   GUIMARAES, JA
TI IMMUNOREACTIVITY FOR CANATOXIN AND CONCANAVALIN-A AMONG PROTEINS OF
   LEGUMINOUS SEEDS
SO PHYTOCHEMISTRY
LA English
DT Article
RP CARLINI, CR (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOCHEM, CP 68041, BR-21910 RIO DE JANEIRO, RJ, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ALLEN NK, 1969, J IMMUNOL, V102, P1295
   BARCELLOS GBS, 1986, ANQ BIOL TECNOL, V29, P215
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   FORIERS A, 1977, BIOCHEM BIOPH RES CO, V75, P980, DOI 10.1016/0006-291X(77)91478-4
   FORIERS A, 1978, P NATL ACAD SCI USA, V75, P1136, DOI 10.1073/pnas.75.3.1136
   GALBRAIT.W, 1972, BIOCHEMISTRY-US, V11, P3976, DOI 10.1021/bi00771a022
   GUIMARAES JA, 1985, AN ACAD BRAS CIENC, V57, P387
   HAMAGUCHI Y, 1977, J NUTR SCI VITAMINOL, V23, P525, DOI 10.3177/jnsv.23.525
   LIENER IE, 1952, J BIOL CHEM, V197, P29
   LIN JY, 1978, TOXICON, V16, P653, DOI 10.1016/0041-0101(78)90193-9
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   NEVES ADV, 1981, CIENCIA CULTURA S, V33, P721
   NICOLSON GL, 1974, BIOCHEMISTRY-US, V13, P196, DOI 10.1021/bi00698a029
   OLSNES S, 1973, EUR J BIOCHEM, V35, P179, DOI 10.1111/j.1432-1033.1973.tb02823.x
   OLSNES S, 1978, J BIOL CHEM, V253, P5069
   OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347
   PEREIRA M E A, 1979, Critical Reviews in Immunology, V1, P33
   ROBERTS LM, 1985, J BIOL CHEM, V260, P5682
   SCHNEBLI HP, 1972, EUR J IMMUNOL, V2, P607, DOI 10.1002/eji.1830020626
   SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949
   SIMPSON LL, 1986, ANNU REV PHARMACOL, V26, P427, DOI 10.1146/annurev.pa.26.040186.002235
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   STEAD RH, 1966, ARCH BIOCHEM BIOPHYS, V113, P703, DOI 10.1016/0003-9861(66)90251-7
   STILLMARK K, 1889, ARB PHARMAKOL I DORP, V3, P59
   Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936
   TAKAHASHI T, 1962, J BIOCHEM-TOKYO, V52, P50, DOI 10.1093/oxfordjournals.jbchem.a127572
NR 26
TC 20
Z9 20
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0031-9422
J9 PHYTOCHEMISTRY
JI Phytochemistry
PY 1988
VL 27
IS 1
BP 25
EP 30
DI 10.1016/0031-9422(88)80587-9
PG 6
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA L4907
UT WOS:A1988L490700006
DA 2020-11-24
ER

PT J
AU KOUYOUMDJIAN, M
   BORGES, DR
   MICHELACCI, YM
   GUIMARAES, JA
   SAMPAIO, CAM
   PRADO, JL
AF KOUYOUMDJIAN, M
   BORGES, DR
   MICHELACCI, YM
   GUIMARAES, JA
   SAMPAIO, CAM
   PRADO, JL
TI PURIFICATION AND CHARACTERIZATION OF THE ALPHA-FORM OF RAT PLASMA
   KALLIKREIN
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Letter
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,CAIXA POSTAL 20239,BR-04023 SAO PAULO,SP,BRAZIL.
   ESCOLA PAULISTA MED,DEPT MED,BR-04023 SAO PAULO,SP,BRAZIL.
   UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOL,DEPT BIOQUIM,BR-21941 RIO DE JANEIRO,RJ,BRAZIL.
RI Michelacci, Yara/C-4049-2013; Borges, Durval/E-1200-2012; Kouyoumdjian,
   Maria/E-1718-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Michelacci, Yara/0000-0001-8721-0251; Borges,
   Durval/0000-0001-6055-5110; Kouyoumdjian, Maria/0000-0001-7177-0035;
   Guimaraes, Jorge A./0000-0001-6354-6789
CR ASCARRUNZ ME, 1982, ARQ BIOL TECHNOL, V25, P71
   BEDI GS, 1984, PREP BIOCHEM, V14, P257, DOI 10.1080/10826068408070634
   BORGES DR, 1981, BIOCHEM PHARMACOL, V30, P1065, DOI 10.1016/0006-2952(81)90443-3
   BORGES DR, 1985, BRAZ J MED BIOL RES, V18, P187
   COLMAN RW, 1985, BLOOD, V65, P311
   HEIMARK RL, 1981, METHOD ENZYMOL, V80, P157
   HEIMARK RL, 1980, NATURE, V286, P456, DOI 10.1038/286456a0
   HOJIMA Y, 1985, J BIOL CHEM, V260, P400
   KOUYOUMDJIAN M, 1987, THESIS ESCOLA PAULIS, P65
   MOVAT HZ, 1979, HDB EXPT PHARMACOLOG, V25, P1
   NAGASE H, 1981, BIOCHEM J, V193, P187, DOI 10.1042/bj1930187
   PISANO JJ, 1975, PROTEASES BIOL CONTR, P199
   SAMPAIO C, 1974, ARCH BIOCHEM BIOPHYS, V165, P133, DOI 10.1016/0003-9861(74)90150-7
   SCHWICK HG, 1977, GLYCOCONJUGATES, V1, P262
   TREVELYAN WE, 1950, NATURE, V166, P444, DOI 10.1038/166444b0
   VANDERGRAAF F, 1982, J BIOL CHEM, V257, P4300
   WEBSTER ME, 1970, METHODS ENZYMOLOGY, V19, P41
NR 17
TC 18
Z9 18
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1987
VL 20
IS 5
BP 549
EP 552
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA L2142
UT WOS:A1987L214200009
PM 3452443
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   VIEIRA, MAR
   CAMARGO, MJF
   MAACK, T
AF GUIMARAES, JA
   VIEIRA, MAR
   CAMARGO, MJF
   MAACK, T
TI RENAL VASOCONSTRICTIVE EFFECT OF KININS MEDIATED BY B1-KININ RECEPTORS
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
C1 CORNELL UNIV, MED CTR, COLL MED, DEPT PHYSIOL, 1300 YORK AVE, NEW YORK, NY 10021 USA.
   UNIV FED RIO DE JANEIRO, DEPT BIOCHEM, RIO DE JANEIRO, RJ, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
FU NIADDK NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [AM-14241] Funding
   Source: Medline
CR ALVES KB, 1984, INT J BIOCHEM, V16, P1295, DOI 10.1016/0020-711X(84)90231-3
   BLASINGHAM MC, 1979, AM J PHYSIOL, V237, pF182
   CAMARGO MJF, 1984, AM J PHYSIOL, V246, pF447
   CARONE FA, 1976, AM J PHYSIOL, V230, P1420
   CARRETERO DA, 1980, AM J PHYSIOL, V238, pF247
   CHAPNICK BM, 1977, CIRC RES, V40, P348, DOI 10.1161/01.RES.40.4.348
   CURTIN JP, 1984, 9TH P INT C NEPHR LO, pA447
   DEMELLO G, 1976, AM J PHYSIOL, V231, P1699
   ERDOS EG, 1970, HDB EXPERIMENTAL PHA, V25, P289
   FLAMENBAUM W, 1979, AM J PHYSIOL, V237, pF433
   GILL JOHN R., 1965, AMER J PHYSIOL, V209, P844
   GOLDBERG LI, 1965, J CLIN INVEST, V44, P1052
   GUIMARAES JA, 1984, 9 P INT C NEPHR, pA452
   INOKUCHI K, 1984, AM J PHYSIOL, V246, pF387
   KLOTMAN PE, 1985, KIDNEY INT, V28, P118, DOI 10.1038/ki.1985.130
   LEVINSKY NG, 1979, CIRC RES, V44, P441, DOI 10.1161/01.RES.44.4.441
   LONIGRO AJ, 1978, CIRC RES, V43, P447, DOI 10.1161/01.RES.43.3.447
   MALIK KU, 1979, BRIT J PHARMACOL, V67, P269, DOI 10.1111/j.1476-5381.1979.tb08676.x
   MARGOLIUS HS, 1984, ANNU REV PHYSIOL, V46, P309
   MCGIFF JC, 1972, CIRC RES, V31, P36, DOI 10.1161/01.RES.31.1.36
   MCGIFF JC, 1975, CLIN SCI MOL MED, V49, P125, DOI 10.1042/cs0490125
   MORRISON AR, 1981, KIDNEY INT, V19, P786, DOI 10.1038/ki.1981.81
   MULLANE KM, 1980, EUR J PHARMACOL, V66, P355, DOI 10.1016/0014-2999(80)90468-9
   NASJLETTI A, 1975, CIRC RES, V37, P59, DOI 10.1161/01.RES.37.1.59
   NISHIKAWA K, 1977, J CLIN INVEST, V59, P1143, DOI 10.1172/JCI108738
   OLSEN UB, 1979, EUR J PHARMACOL, V54, P229, DOI 10.1016/0014-2999(79)90081-5
   Regoli D, 1983, Adv Exp Med Biol, V156, P569
   REGOLI D, 1978, CAN J PHYSIOL PHARM, V56, P674, DOI 10.1139/y78-109
   REGOLI D, 1977, CAN J PHYSIOL PHARM, V55, P855, DOI 10.1139/y77-115
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   STEIN JH, 1971, J CLIN INVEST, V50, P1429, DOI 10.1172/JCI106626
   STRAND JC, 1982, RENAL PHYSIOL BIOCH, V5, P286
   SUSIC H, 1980, CLIN SCI, V59, pS145, DOI 10.1042/cs059145s
   TERRAGNO NA, 1972, EXPERIENTIA, V28, P437, DOI 10.1007/BF02008327
   THOMAS M, 1980, AM J PHYSIOL, V238, pF71, DOI 10.1152/ajprenal.1980.238.2.F71
   WEBSTER ME, 1964, AM J PHYSIOL, V206, P714
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
NR 37
TC 42
Z9 42
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD NOV 4
PY 1986
VL 130
IS 3
BP 177
EP 185
DI 10.1016/0014-2999(86)90266-9
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA F0158
UT WOS:A1986F015800003
PM 2878818
DA 2020-11-24
ER

PT J
AU TERMIGNONI, C
   FREITAS, JO
   GUIMARAES, JA
AF TERMIGNONI, C
   FREITAS, JO
   GUIMARAES, JA
TI REMOVAL OF N-TERMINAL METHIONINE FROM HEMOGLOBIN NASCENT PEPTIDES BY A
   MEMBRANE-BOUND RAT-LIVER METHIONINE AMINOPEPTIDASE
SO BIOCHEMICAL JOURNAL
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,CP 68041,BR-21910 RIO DE JANEIRO,BRAZIL.
   ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-01000 SAO PAULO,BRAZIL.
RI Termignoni, Carlos/AAB-8943-2020; Guimaraes, Jorge Almeida/V-2196-2019
OI Termignoni, Carlos/0000-0002-2789-2518; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR BARRETT AJ, 1972, ANAL BIOCHEM, V47, P280, DOI 10.1016/0003-2697(72)90302-8
   BARRETT AJ, 1977, PROTEINASES MAMMALIA, P1
   BERG MJ, 1984, J NEUROSCI RES, V11, P313, DOI 10.1002/jnr.490110311
   BURCH JPH, 1980, NATURE LONDON, V283, P96
   CHAMBERS JAA, 1978, CENTRIFUGATION PRACT, P33
   Delange R. J., 1971, ENZYMES, VIII, P81
   FREITAS JO, 1979, INT J BIOCHEM, V10, P81, DOI 10.1016/0020-711X(79)90143-5
   FREITAS JO, 1981, INT J BIOCHEM, V13, P991, DOI 10.1016/0020-711X(81)90004-5
   FREITAS JO, 1985, INT J BIOCH, V17
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   HAMBROOK JM, 1976, NATURE, V262, P782, DOI 10.1038/262782a0
   HERSH LB, 1980, NATURE, V286, P160, DOI 10.1038/286160a0
   HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P567, DOI 10.1016/0003-9861(66)90381-X
   MAKINEN PL, 1968, ACTA CHEM SCAND, V22, P3111, DOI 10.3891/acta.chem.scand.22-3111
   McDonald I., 1977, PROTEINASES MAMMALIA, P311
   OLSON KC, 1981, NATURE, V293, P408, DOI 10.1038/293408a0
   SIDOROWICZ W, 1981, CLIN CHIM ACTA, V111, P69, DOI 10.1016/0009-8981(81)90423-X
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   SUDA H, 1980, BIOCHIM BIOPHYS ACTA, V616, P60, DOI 10.1016/0005-2744(80)90263-6
   Tuppy H, 1957, MONATSH CHEM, V88, P977
   YOSHIDA A, 1972, J BIOL CHEM, V247, P952
   YOSHIDA A, 1970, P NATL ACAD SCI USA, V67, P1600, DOI 10.1073/pnas.67.3.1600
NR 22
TC 13
Z9 13
U1 0
U2 1
PU PORTLAND PRESS
PI LONDON
PA 59 PORTLAND PLACE, LONDON, ENGLAND W1N 3AJ
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD MAR 1
PY 1986
VL 234
IS 2
BP 469
EP 473
DI 10.1042/bj2340469
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA A3521
UT WOS:A1986A352100030
PM 3087345
OA Green Published
DA 2020-11-24
ER

PT J
AU SARKIS, JJF
   GUIMARAES, JA
   RIBEIRO, JMC
AF SARKIS, JJF
   GUIMARAES, JA
   RIBEIRO, JMC
TI SALIVARY APYRASE OF RHODNIUS-PROLIXUS - KINETICS AND PURIFICATION
SO BIOCHEMICAL JOURNAL
LA English
DT Article
C1 FED UNIV RIO DE JANEIRO, CTR CIENCIAS SAUDE, DEPT BIOCHEM, BR-21910 RIO DE JANEIRO, RJ, BRAZIL.
   HARVARD UNIV, SCH PUBL HLTH, DEPT TROP PUBL MED, BOSTON, MA 02115 USA.
RP SARKIS, JJF (corresponding author), FED UNIV RIO GRANDE DO SUL, INST BIOSCI, DEPT BIOCHEM, BR-90000 PORTO ALEGRE, RS, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789; Ribeiro,
   Jose/0000-0002-9107-0818
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 18694] Funding Source: Medline; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI018694, R01AI018694, R01AI018694, R01AI018694, R01AI018694,
   R01AI018694, R01AI018694, R01AI018694, R01AI018694, R01AI018694,
   R37AI018694, R01AI018694] Funding Source: NIH RePORTER
CR BOCK RM, 1956, ARCH BIOCHEM BIOPHYS, V62, P253, DOI 10.1016/0003-9861(56)90123-0
   BURNSTOCK G, 1972, PHARMACOL REV, V24, P509
   COHN WE, 1957, METHOD ENZYMOL, V3, P724, DOI 10.1016/S0076-6879(57)03450-3
   DEMEIS L, 1972, BIOCHEMISTRY-US, V11, P2460, DOI 10.1021/bi00763a012
   Dixon M., 1979, ENZYMES, P72
   EGGLESTON LV, 1952, BIOCHEM J, V52, P156, DOI 10.1042/bj0520156
   ERNSTER L, 1962, J CELL BIOL, V15, P563, DOI 10.1083/jcb.15.3.563
   Fiske CH, 1925, J BIOL CHEM, V66, P375
   GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147
   HAMLYN JM, 1983, BIOCHEM J, V214, P59, DOI 10.1042/bj2140059
   KALCKAR HM, 1945, J BIOL CHEM, V158, P313
   KANAZAWA T, 1973, J BIOL CHEM, V248, P3163
   KNOWLES AF, 1983, BIOCHIM BIOPHYS ACTA, V731, P88, DOI 10.1016/0005-2736(83)90401-7
   LALIBERTE JF, 1983, BIOCHIM BIOPHYS ACTA, V257, P3869
   LEBEL D, 1980, J BIOL CHEM, V255, P1227
   LEHNINGER AL, 1975, BIOCHEMISTRY-US, P410
   LIENHARD GE, 1973, J BIOL CHEM, V248, P1121
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MANT MJ, 1981, BRIT J HAEMATOL, V48, P601, DOI 10.1111/j.1365-2141.1981.00601.x
   MEYERHOF O, 1945, J BIOL CHEM, V157, P105
   PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910
   PREISS J, 1982, ANNU REV PLANT PHYS, V33, P431, DOI 10.1146/annurev.pp.33.060182.002243
   RIBEIRO JMC, 1981, EXPERIENTIA, V37, P384, DOI 10.1007/BF01959876
   RIBEIRO JMC, 1981, J EXP BIOL, V94, P219
   RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6
   RIBEIRO JMC, 1980, J INSECT PHYSIOL, V26, P303, DOI 10.1016/0022-1910(80)90138-9
   RIBEIRO JMC, 1984, J EXP BIOL, V108, P1
   RIBEIRO JMC, 1985, J EXP MED, V161, P332, DOI 10.1084/jem.161.2.332
   RIBEIRO JMC, 1985, J INSECT PHYSIOL, V31, P689, DOI 10.1016/0022-1910(85)90048-4
   ROSSIGNOL PA, 1984, AM J TROP MED HYG, V33, P17, DOI 10.4269/ajtmh.1984.33.17
   SADLER JE, 1982, METHOD ENZYMOL, V83, P458
   SMITH JJB, 1980, EXPERIENTIA, V36, P898, DOI 10.1007/BF01953780
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   TOGNOLI L, 1981, BIOCHIM BIOPHYS ACTA, V642, P1, DOI 10.1016/0005-2736(81)90132-2
   TRAVERSO.A, 1965, ARCH BIOCHEM BIOPHYS, V109, P173, DOI 10.1016/0003-9861(65)90303-6
   TRAVERSOCORI A, 1965, ARCH BIOCHEM BIOPHYS, V137, P133
   VARGAFTIG BB, 1981, BIOCHEM PHARMACOL, V30, P263, DOI 10.1016/0006-2952(81)90052-6
NR 37
TC 87
Z9 87
U1 0
U2 0
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD FEB 1
PY 1986
VL 233
IS 3
BP 885
EP 891
DI 10.1042/bj2330885
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AZJ45
UT WOS:A1986AZJ4500036
PM 3010945
OA Green Published
DA 2020-11-24
ER

PT J
AU ASSREUYFILHO, J
   GUIMARAES, JA
AF ASSREUYFILHO, J
   GUIMARAES, JA
TI PARTIAL PURIFICATON AND SPECIFICITY OF ACTION OF A KININ-POTENTIATING
   PEPTIDE GENERATED FROM HUMAN-PLASMA PROTEINS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV ESTADO RIO DE JANEIRO,FAC CIENCIAS MED,RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR GUIMARAES, 1981, AGENTS ACTIONS, V9, P295
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1986
VL 19
IS 4-5
BP A582
EP A582
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA H2829
UT WOS:A1986H282900211
DA 2020-11-24
ER

PT J
AU VIEIRA, MAR
   GUIMARAES, JA
AF VIEIRA, MAR
   GUIMARAES, JA
TI KININASES AND A KININ-CONVERTING AMINOPEPTIDASE IN ISOLATED PERFUSED
   RAT-KIDNEY
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR ALVES, 1984, INT J BIOCH, V12, P1295
NR 1
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1986
VL 19
IS 4-5
BP A538
EP A538
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA H2829
UT WOS:A1986H282900137
DA 2020-11-24
ER

PT J
AU RIBEIRODASILVA, G
   CARLINI, CR
   PIRESBARBOSA, R
   GUIMARAES, JA
AF RIBEIRODASILVA, G
   CARLINI, CR
   PIRESBARBOSA, R
   GUIMARAES, JA
TI BLOOD-GLUCOSE ALTERATIONS INDUCED IN RATS BY CANATOXIN, A PROTEIN
   ISOLATED FROM JACK BEAN (CANAVALIA-ENSIFORMIS) SEEDS
SO TOXICON
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOCHEM,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RP RIBEIRODASILVA, G (corresponding author), UNIV ESTADUAL CAMPINAS,FAC CIENCIAS MED,DEPT INNERE,CP 6109,BR-13100 CAMPINAS,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR BELLVILLE JS, 1979, J PHYSL, V297, P289
   BILSKI A, 1980, BRIT J PHARMACOL, V69, P292
   BLACKARD W, 1980, P SOC EXP BIOL MED, V153, P213
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1985, BRIT J PHARMACOL, V84, P551, DOI 10.1111/j.1476-5381.1985.tb12940.x
   CUATRECASAS P, 1973, J BIOL CHEM, V248, P3528
   CUATRECASAS P, 1973, P NATL ACAD SCI USA, V70, P485, DOI 10.1073/pnas.70.2.485
   FELIG P, 1975, NEW ENGL J MED, V293, P1078
   FURMAN BC, 1973, BRIT J PHARMACOL, V49, P145
   GUIMARAES JA, 1985, ANAIS ACAD BRAS CIEN, V57, P388
   HARVEY CS, 1980, PHARMACOL BASIS THER, P339
   HELTING TB, 1977, J BIOL CHEM, V252, P187
   LEBLANC H, 1977, J CLIN ENDOCR METAB, V44, P196, DOI 10.1210/jcem-44-1-196
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   MAIER V, 1975, H-S Z PHYSIOL CHEM, V356, P887, DOI 10.1515/bchm2.1975.356.s1.887
   Nelson N, 1944, J BIOL CHEM, V153, P375
   NIRMUL G, 1976, MT SINAI J MED, V43, P238
   NOPANITAYA W, 1976, P SOC EXP BIOL MED, V153, P213
   OLSNES S, 1974, J BIOL CHEM, V249, P803
   PORETZ RD, 1968, IMMUNOLOGY, V14, P165
   SMITH PH, 1979, 1ST P INT S END PANC, P64
   SOUZA MLO, 1982, PHARMACOL BIOCHEM BE, V16, P903, DOI 10.1016/0091-3057(82)90042-9
   SOUZA MLO, 1981, PHARM BIOCH BEHAV, V15, P551
   UNGER RH, 1971, NEW ENGL J MED, V285, P443
   VIRJI MA, 1984, DIABETES, V33, P164, DOI 10.2337/diabetes.33.2.164
   WOODS SC, 1974, PHYSIOL REV, V54, P596
NR 27
TC 16
Z9 16
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PY 1986
VL 24
IS 8
BP 775
EP 782
DI 10.1016/0041-0101(86)90102-9
PG 8
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA E3575
UT WOS:A1986E357500005
PM 3775792
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   UBATUBA, S
   CARLINI, CRS
AF GUIMARAES, JA
   UBATUBA, S
   CARLINI, CRS
TI PHYSICOCHEMICAL PROPERTIES OF CANATOXIN, A HEMILECTIN DISPLAYING
   CONVULSANT ACTIVITY
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT BIOQUIM,BR-21910 RIO DE JANEIRO,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; 
CR CARLINI, 1984, ACTA PHARM TOX, V54, P161
   CARLINI, 1985, BR J PHARM, V84, P551
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   OLSNES S, 1981, NATURE, V290, P84, DOI 10.1038/290084a0
   OLSNES S, 1974, J BIOL CHEM, V249, P803
   OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0
NR 6
TC 9
Z9 9
U1 0
U2 2
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1985
VL 57
IS 3
BP 387
EP 388
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AWA43
UT WOS:A1985AWA4300041
DA 2020-11-24
ER

PT J
AU CARLINI, CRS
   GUIMARAES, JA
AF CARLINI, CRS
   GUIMARAES, JA
TI CANATOXIN INDUCES CELLULAR SECRETION - THROUGH ACTIVATION OF
   LIPOXYGENASE PATHWAY
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT BIOQUIM,BR-21910 RIO DE JANEIRO,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR CARLINI, 1984, ACTA PHARM TOX, V54, P161
   CARLINI, 1985, BR J PHARM, V84, P551
   PAGLIUSI, 1983, NAUNYNSCHMIEDEBERGS, V322, P210
   SASAKAWA N, 1984, BIOCHEM PHARMACOL, V33, P2733, DOI 10.1016/0006-2952(84)90689-0
   SNIDER, 1984, P NATL ACAD SCI US, V81, P3905
   SUN AY, 1974, J NEUROCHEM, V22, P551, DOI 10.1111/j.1471-4159.1974.tb06893.x
   VLASKOVSKA M, 1984, NEUROENDOCRINOLOGY, V39, P334, DOI 10.1159/000124001
NR 7
TC 2
Z9 2
U1 0
U2 1
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1985
VL 57
IS 3
BP 388
EP 389
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AWA43
UT WOS:A1985AWA4300042
DA 2020-11-24
ER

PT J
AU BORGES, DR
   GORDON, AH
   GUIMARAES, JA
   PRADO, JL
AF BORGES, DR
   GORDON, AH
   GUIMARAES, JA
   PRADO, JL
TI RAT PLASMA KALLIKREIN CLEARANCE BY PERFUSED RAT-LIVER
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
RP BORGES, DR (corresponding author), ESCOLA PAULISTA MED,INST FARMACOL,DEPT BIOQUIM,CAIXA POSTALE 20239,BR-01000 SAO PAULO,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR AMMUNDSEN E, 1977, NEW METHODS ANAL COA, P211
   ANDERSCH MA, 1947, AM J CLIN PATHOL, V17, P571
   ASCARRUNZ ME, 1982, ARQ BIOL TECHNOL, V25, P71
   ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531
   BLOMHOFF R, 1982, J BIOL CHEM, V257, P7456
   BORGES DR, 1981, BIOCHEM PHARMACOL, V30, P1065, DOI 10.1016/0006-2952(81)90443-3
   BORGES DR, 1976, N-S ARCH PHARMACOL, V295, P33, DOI 10.1007/BF00509769
   BORGES DR, 1982, AGENTS ACTIONS S, V9, P46
   BORGES DR, 1981, ANAIS ACADEMIA BRASI, V53, P846
   BORGES DR, 1984, ARQUIVOS BIOL TECNOL, V27, P249
   FREEMAN T, 1958, BRIT J EXP PATHOL, V39, P459
   HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2
   IKEKITA M, 1981, CHEM PHARM BULL, V29, P545
   JEEJEEBHOY KN, 1975, BIOCHEM J, V146, P141, DOI 10.1042/bj1460141
   Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
   OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327
   ROSS BD, 1972, PERFUSION TECHNIQUES, P176
   SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x
   TUPPY H, 1972, BBA LIBR           A, V5, P403
   WARREN L, 1959, J BIOL CHEM, V234, P1971
NR 20
TC 19
Z9 19
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1985
VL 18
IS 2
BP 187
EP 194
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA ALF77
UT WOS:A1985ALF7700008
PM 3006849
DA 2020-11-24
ER

PT J
AU ANDRADE, SP
   FEITOSA, MH
   GUIMARAES, JA
   ROGANA, E
   BERALDO, WT
AF ANDRADE, SP
   FEITOSA, MH
   GUIMARAES, JA
   ROGANA, E
   BERALDO, WT
TI A BARRIER FOR PROTEASE AND PEPTIDE IN THE MUCOSA OF THE RAT UTERUS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,RIO DE JANEIRO,RJ,BRAZIL.
   UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT FISIOL & BIOFIS,BR-30000 BELO HORIZONTE,MG,BRAZIL.
   UNIV FED MINAS GERAIS,INST CIENCIAS BIOL,DEPT BIOQUIM & IMMUNOL,BR-30000 BELO HORIZONTE,MG,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1985
VL 18
IS 5-6
BP A754
EP A754
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA A8926
UT WOS:A1985A892600335
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   GUIMARAES, JA
   RIBEIRO, JMC
AF CARLINI, CR
   GUIMARAES, JA
   RIBEIRO, JMC
TI PLATELET-RELEASE REACTION AND AGGREGATION INDUCED BY CANATOXIN, A
   CONVULSANT PROTEIN - EVIDENCE FOR THE INVOLVEMENT OF THE PLATELET
   LIPOXYGENASE PATHWAY
SO BRITISH JOURNAL OF PHARMACOLOGY
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,ICB,DEPT BIOCHEM,CP 68041,BR-21910 RIO DE JANEIRO,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789; Ribeiro, Jose/0000-0002-9107-0818
CR AHARONY D, 1982, BIOCHIM BIOPHYS ACTA, V718, P193, DOI 10.1016/0304-4165(82)90219-7
   ARDLIE NG, 1970, BRIT J HAEMATOL, V19, P7, DOI 10.1111/j.1365-2141.1970.tb01596.x
   BILLS TK, 1976, BIOCHIM BIOPHYS ACTA, V424, P303, DOI 10.1016/0005-2760(76)90198-3
   BLACKWELL GJ, 1978, BRIT J PHARMACOL, V62, P79, DOI 10.1111/j.1476-5381.1978.tb07009.x
   BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185
   BOULLIN DJ, 1978, BRIT J PHARMACOL, V62, P537, DOI 10.1111/j.1476-5381.1978.tb07758.x
   BRODDE OE, 1983, ARCH INT PHARMACOD T, V266, P208
   CARLINI CR, 1984, ACTA PHARMACOL TOX, V54, P161
   CARLINI CR, 1982, AN ACAD BRAS CIENC, V54, P762
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CAZENAVE JP, 1979, LAB INVEST, V41, P275
   CERLETTI C, 1983, BIOCHIM BIOPHYS ACTA, V759, P125, DOI 10.1016/0304-4165(83)90197-6
   COSTA JL, 1975, NATURE, V255, P407, DOI 10.1038/255407a0
   CROSET M, 1983, BIOCHEM BIOPH RES CO, V112, P878, DOI 10.1016/0006-291X(83)91699-6
   Dutilh C E, 1980, Adv Prostaglandin Thromboxane Res, V6, P101
   DUTILH CE, 1981, PROSTAG LEUKOTR ESS, V6, P111, DOI 10.1016/0161-4630(81)90081-1
   GORMAN RR, 1977, PROSTAGLANDINS, V13, P377, DOI 10.1016/0090-6980(77)90018-1
   GRAF M, 1979, BRIT J PHARMACOL, V65, P601, DOI 10.1111/j.1476-5381.1979.tb07870.x
   HABERMANN E, 1978, HDB CLIN NEUROLOGY, V33, P491
   HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P3400, DOI 10.1073/pnas.71.9.3400
   HAMBERG M, 1976, BIOCHIM BIOPHYS ACTA, V431, P651, DOI 10.1016/0005-2760(76)90232-0
   HIGGS GA, 1983, BRIT MED BULL, V39, P265, DOI 10.1093/oxfordjournals.bmb.a071831
   HIGGS GA, 1979, BIOCHEM PHARMACOL, V28, P1959, DOI 10.1016/0006-2952(79)90651-8
   JENKINS CSP, 1971, BLOOD-J HEMATOL, V37, P395, DOI 10.1182/blood.V37.4.395.395
   KATTLOVE HE, 1975, BLOOD, V45, P91
   KINLOUGHRATHBONE RL, 1983, THROMB HAEMOSTASIS, V49, P162
   KINLOUGHRATHBONE RL, 1975, THROMB RES, V7, P435, DOI 10.1016/0049-3848(75)90038-9
   KIRBY EP, 1975, J CLIN INVEST, V56, P491, DOI 10.1172/JCI108116
   LAPETINA EG, 1978, P NATL ACAD SCI USA, V75, P818, DOI 10.1073/pnas.75.2.818
   MUSTARD JF, 1970, PHARMACOL REV, V22, P97
   MUSTARD JF, 1978, BLOOD, V52, P435
   NADER HB, 1981, GLYCOCONJUGATES, P339
   NISHIZAWA EE, 1983, THROMB RES, V30, P289, DOI 10.1016/0049-3848(83)90082-8
   NUGTEREN DH, 1982, METHODS ENZYMOLOGY, V86, P550
   PLETSCHER A, 1980, PLATELETS CELLULAR R, P267
   PRADOFRANCESCHI J, 1981, TOXICON, V19, P661, DOI 10.1016/0041-0101(81)90103-3
   Sneddon J M, 1973, Prog Neurobiol, V1, P151, DOI 10.1016/0301-0082(73)90019-1
   STORMORKEN H, 1969, SCANDINAVIAN J HAE S, V9, P3
   TAYLOR GW, 1983, BRIT MED BULL, V39, P219, DOI 10.1093/oxfordjournals.bmb.a071822
   Vargaftig B B, 1980, Acta Med Scand Suppl, V642, P23
   VARGAFTIG BB, 1980, EUR J PHARMACOL, V68, P451, DOI 10.1016/0014-2999(80)90420-3
   VARGAFTIG BB, 1981, BIOCHEM PHARMACOL, V30, P263, DOI 10.1016/0006-2952(81)90052-6
   VARGAFTIG BB, 1983, EUR J PHARMACOL, V92, P57, DOI 10.1016/0014-2999(83)90108-5
   VARGAFTIG BB, 1972, J PHARM PHARMACOL, V24, P159, DOI 10.1111/j.2042-7158.1972.tb08953.x
   VARGAFTIG BB, 1973, NATURE-NEW BIOL, V244, P144
   WATANABE T, 1982, J BIOL CHEM, V257, P4847
NR 46
TC 58
Z9 58
U1 0
U2 3
PU STOCKTON PRESS
PI BASINGSTOKE
PA HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS
SN 0007-1188
J9 BRIT J PHARMACOL
JI Br. J. Pharmacol.
PY 1985
VL 84
IS 2
BP 551
EP 560
DI 10.1111/j.1476-5381.1985.tb12940.x
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ABP82
UT WOS:A1985ABP8200029
PM 3919794
OA Green Published
DA 2020-11-24
ER

PT J
AU FREITAS, JO
   TERMIGNONI, C
   GUIMARAES, JA
AF FREITAS, JO
   TERMIGNONI, C
   GUIMARAES, JA
TI MICROSOMAL METHIONINE AMINOPEPTIDASE - PROPERTIES OF THE
   DETERGENT-SOLUBILIZED ENZYME
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO, ICB, DEPT BIOCHEM, BR-21910 RIO DE JANEIRO, RJ, BRAZIL.
RP FREITAS, JO (corresponding author), ESCOLA PAULISTA MED, DEPT BIOCHEM, BR-04023 SAO PAULO, SP, BRAZIL.
RI Termignoni, Carlos/AAB-8943-2020; Guimaraes, Jorge Almeida/V-2196-2019
OI Termignoni, Carlos/0000-0002-2789-2518; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR BARRETT AJ, 1972, ANAL BIOCHEM, V47, P280, DOI 10.1016/0003-2697(72)90302-8
   BARRETT AJ, 1977, PROTEINASES MAMMALIA, P1
   BEHAL FJ, 1969, BIOCHIM BIOPHYS ACTA, V178, P118, DOI 10.1016/0005-2744(69)90138-7
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   DONLON J, 1973, BIOCHIM BIOPHYS ACTA, V327, P425, DOI 10.1016/0005-2744(73)90426-9
   FREITAS JO, 1981, INT J BIOCHEM, V13, P991, DOI 10.1016/0020-711X(81)90004-5
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P403
   JACKSON R, 1970, NATURE, V227, P672, DOI 10.1038/227672a0
   KERWAR SS, 1971, ARCH BIOCHEM BIOPHYS, V143, P336, DOI 10.1016/0003-9861(71)90215-3
   LEHKY P, 1973, BIOCHIM BIOPHYS ACTA, V321, P274, DOI 10.1016/0005-2744(73)90082-X
   LEHNINGER AL, 1982, PRINCIPLES BIOCH, P689
   McDonald I., 1977, PROTEINASES MAMMALIA, P311
   ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   SMITH EE, 1965, J BIOL CHEM, V240, P1718
   SMITH EL, 1955, J BIOL CHEM, V212, P271
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   SUDA H, 1980, BIOCHIM BIOPHYS ACTA, V616, P60, DOI 10.1016/0005-2744(80)90263-6
   UMEZAWA H, 1976, J ANTIBIOT, V29, P97, DOI 10.7164/antibiotics.29.97
   WACHSMUTH ED, 1966, BIOCHEMISTRY-US, V5, P169, DOI 10.1021/bi00865a022
   WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324
   WILSON DB, 1970, P NATL ACAD SCI USA, V66, P1282, DOI 10.1073/pnas.66.4.1282
   YOSHIDA A, 1972, J BIOL CHEM, V247, P952
NR 23
TC 13
Z9 13
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-711X
J9 INT J BIOCHEM
JI Int. J. Biochem.
PY 1985
VL 17
IS 12
BP 1285
EP 1291
DI 10.1016/0020-711X(85)90049-7
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AXJ27
UT WOS:A1985AXJ2700001
PM 3937747
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   RIBEIRO, JMC
   GUIMARAES, JA
AF CARLINI, CR
   RIBEIRO, JMC
   GUIMARAES, JA
TI CANATOXIN, THE NEUROTOXIC PROTEIN FROM CANAVALIA-ENSIFORMIS SEEDS,
   INDUCES PLATELET-RELEASE REACTION AND AGGREGATION
SO TOXICON
LA English
DT Meeting Abstract
C1 UNIV FED RIO JANEIRO,DEPT BIOCHEM,BR-21910 RIO DE JANEIRO,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445
CR CARLINI, 1984, ACTA PHARM TOX
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   GRAF M, 1979, BRIT J PHARMACOL, V65, P601, DOI 10.1111/j.1476-5381.1979.tb07870.x
   STORMORKEN H, 1969, SCANDINAVIAN J HAE S, V9, P3
NR 4
TC 1
Z9 1
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0041-0101
J9 TOXICON
JI Toxicon
PY 1985
VL 23
IS 1
BP 25
EP 25
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA AEU17
UT WOS:A1985AEU1700014
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   GOMES, C
   GUIMARAES, JA
   MARKUS, RP
   SATO, H
   TROLIN, G
AF CARLINI, CR
   GOMES, C
   GUIMARAES, JA
   MARKUS, RP
   SATO, H
   TROLIN, G
TI CENTRAL NERVOUS EFFECTS OF THE CONVULSANT PROTEIN CANATOXIN
SO ACTA PHARMACOLOGICA ET TOXICOLOGICA
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT PHARMACOL,BR-01000 SAO PAULO,BRAZIL.
RP CARLINI, CR (corresponding author), UNIV FED RIO DE JANEIRO,DEPT BIOCHEM,IC8,RIO DE JANEIRO,RJ,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ANTONACCIO MJ, 1977, EUR J PHARMACOL, V46, P283, DOI 10.1016/0014-2999(77)90345-4
   Assman F., 1911, ARCH GES PHYSL, V137, P489
   ATACK C, 1978, ACTA PHARMACOL TOX, V42, P35
   ATACK C, 1977, ACTA PHYSL SCAND S, V451
   Brown J C, 1978, Int Rev Cytol, V52, P277, DOI 10.1016/S0074-7696(08)60758-5
   BYCK R, 1975, PHARMACOL BASIS, P152
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   CARLINI CR, 1980, CIENCIA CULTURA S, V32, P86
   CARMONA E, 1980, ACTA PHARMACOL TOX, V46, P235
   CONDREA E, 1967, BIOCHIM BIOPHYS ACTA, V135, P669, DOI 10.1016/0005-2736(67)90097-1
   CURTIS DR, 1973, BRAIN RES, V51, P358, DOI 10.1016/0006-8993(73)90389-2
   FEDINEC AA, 1971, J NEUROCHEM, V18, P2229, DOI 10.1111/j.1471-4159.1971.tb05081.x
   FRANZ DN, 1975, PHARMACOL BASIS THER, P359
   FUXE K, 1972, J PHARM PHARMACOL, V24, P702, DOI 10.1111/j.2042-7158.1972.tb09093.x
   HELTING TB, 1977, J BIOL CHEM, V252, P187
   JENG TW, 1978, P NATL ACAD SCI USA, V75, P600, DOI 10.1073/pnas.75.2.600
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   NEWMAN WP, 1955, BIOCHEM Z, V327, P170
   OLSON MOJ, 1967, BIOCHEMISTRY-US, V6, P105, DOI 10.1021/bi00853a018
   PERSSON B, 1980, ACTA PHARMACOL TOX, V47, P135
   PRICE DL, 1975, SCIENCE, V188, P945, DOI 10.1126/science.49080
   Reid J L, 1975, Adv Neurol, V9, P73
   SATO H, 1980, 8 P C LAT AM FARM
   SCHNEBLI HP, 1972, EUR J IMMUNOL, V2, P606
   SCHWAB ME, 1979, J CELL BIOL, V82, P798, DOI 10.1083/jcb.82.3.798
   SEEMAN P, 1972, PHARMACOL REV, V24, P583
   SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949
   SOFOLA OA, 1976, J PHARMACOL EXP THER, V196, P29
   Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936
   TROLIN G, 1975, ACTA PHYSL SCAND S, V403
NR 30
TC 31
Z9 31
U1 0
U2 2
PU MUNKSGAARD INT PUBL LTD
PI COPENHAGEN
PA 35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK
SN 0001-6683
J9 ACTA PHARMACOL TOX
PY 1984
VL 54
IS 3
BP 161
EP 166
PG 6
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA SK663
UT WOS:A1984SK66300001
PM 6144234
DA 2020-11-24
ER

PT J
AU ALVES, KB
   BRANDI, CMW
   SOUZAPINTO, JC
   GUIMARAES, JA
AF ALVES, KB
   BRANDI, CMW
   SOUZAPINTO, JC
   GUIMARAES, JA
TI PURIFICATION AND PROPERTIES OF HUMAN URINARY AMINOPEPTIDASE
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,BR-04023 SAO PAULO,SP,BRAZIL.
   UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOL,RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR BRANDI, 1976, INT J BIOCH, V7, P335
NR 1
TC 0
Z9 0
U1 0
U2 2
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1984
VL 56
IS 1
BP 106
EP 106
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA SR915
UT WOS:A1984SR91500019
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   UBATUBA, S
   GUIMARAES, JA
AF CARLINI, CR
   UBATUBA, S
   GUIMARAES, JA
TI AGGREGATION AND SEROTONINE-C-14 RELEASE REACTION OF RABBIT PLATELETS
   INDUCED BY THE CONVULSANT PROTEIN CANATOXIN
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOL,DEPT BIOCHEM,RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445
CR CARLINI, 1982, AN ACAD BRASIL CIENC, V54, P762
   CARLINI, 1983, UNPUB
   CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   GRAF M, 1979, BRIT J PHARMACOL, V65, P601, DOI 10.1111/j.1476-5381.1979.tb07870.x
   STORMORKEN H, 1969, SCANDINAVIAN J HAE S, V9, P3
NR 5
TC 0
Z9 0
U1 0
U2 1
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1984
VL 56
IS 1
BP 107
EP 107
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA SR915
UT WOS:A1984SR91500021
DA 2020-11-24
ER

PT J
AU VIEIRA, MAR
   GUIMARAES, JA
AF VIEIRA, MAR
   GUIMARAES, JA
TI INCREASED RENAL RESISTANCE INDUCED BY KPP, A KININ POTENTIATING PEPTIDE
   DERIVED FROM HUMAN-PLASMA PROTEINS
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOQUIM,RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR GUIMARAES, 1982, AGENTS ACTIONS S, V9, P295
   MAACK, 1980, AM J PHYSL, V238, pF71
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1984
VL 17
IS 5-6
BP 394
EP 394
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA AGA05
UT WOS:A1984AGA0500058
DA 2020-11-24
ER

PT J
AU ATALLAH, AN
   MARTINEZ, TLR
   PINTO, LESA
   NICOLAU, LMPG
   GUIMARAES, J
   AURIEMO, CRC
   SUSTOVICH, DR
AF ATALLAH, AN
   MARTINEZ, TLR
   PINTO, LESA
   NICOLAU, LMPG
   GUIMARAES, J
   AURIEMO, CRC
   SUSTOVICH, DR
TI URINARY AMINOPEPTIDASE ACTIVITIES IN NORMAL PREGNANT AND NORMAL AND
   HYPERTENSIVE PREGNANT-WOMEN
SO CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED,DEPT MED,BR-04023 SAO PAULO,SP,BRAZIL.
RI Atallah, Alvaro N/K-7182-2013; Martinez, Tania L R/L-4271-2018;
   Guimaraes, Jorge Almeida/V-2196-2019; da Rocha Martinez, Tania
   Leme/M-6547-2019
OI da Rocha Martinez, Tania Leme/0000-0002-1027-6954
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0730-0085
J9 CLIN EXP HYPERTENS B
PY 1984
VL 3
IS 2-3
BP 463
EP 463
PG 1
WC Cardiac & Cardiovascular Systems; Physiology
SC Cardiovascular System & Cardiology; Physiology
GA TZ288
UT WOS:A1984TZ28800278
DA 2020-11-24
ER

PT J
AU ALVES, KB
   BRANDI, CMW
   SOUZAPINTO, JC
   GUIMARAES, JA
AF ALVES, KB
   BRANDI, CMW
   SOUZAPINTO, JC
   GUIMARAES, JA
TI KININ-CONVERTING AMINOPEPTIDASE FROM HUMAN-URINE - FURTHER PURIFICATION
   AND CHARACTERIZATION THROUGH KINETIC AND INHIBITORY STUDIES
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 UNIV FED RIO DE JANEIRO,DEPT BIOCHEM,BR-21910 RIO DE JANEIRO,RJ,BRAZIL.
RP ALVES, KB (corresponding author), ESCOLA PAULISTA MED,DEPT BIOCHEM,CP 20372,BR-01000 SAO PAULO,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR BEHAL FJ, 1966, ARCH BIOCHEM BIOPHYS, V115, P545, DOI 10.1016/0003-9861(66)90074-9
   BORGES DR, 1974, N-S ARCH PHARMACOL, V281, P403, DOI 10.1007/BF00499435
   BRANDI CMW, 1976, INT J BIOCHEM, V7, P335, DOI 10.1016/0020-711X(76)90096-3
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3
   Fields R, 1972, Methods Enzymol, V25, P464, DOI 10.1016/S0076-6879(72)25042-X
   FREITAS JO, 1979, INT J BIOCHEM, V10, P81, DOI 10.1016/0020-711X(79)90143-5
   Guimaraes J A, 1976, Adv Exp Med Biol, V70, P265
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P403
   HIAL V, 1976, BIOCHEM PHARMACOL, V25, P2499, DOI 10.1016/0006-2952(76)90456-1
   HIWADA K, 1980, EUR J BIOCHEM, V104, P155, DOI 10.1111/j.1432-1033.1980.tb04411.x
   HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P557, DOI 10.1016/0003-9861(66)90380-8
   LEDEME N, 1981, BIOCHIM BIOPHYS ACTA, V660, P262, DOI 10.1016/0005-2744(81)90169-8
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARGOLIUS HS, 1976, FED PROC, V35, P203
   MARKS N, 1968, J BIOL CHEM, V243, P2882
   McDonald I., 1977, PROTEINASES MAMMALIA, P311
   MCGRIFF JC, 1972, CIRC RES, V31, P36
   NIINOBE M, 1979, CANCER RES, V39, P4212
   PATTERSON EK, 1963, J BIOL CHEM, V238, P3611
   PETERS T, 1973, J BIOL CHEM, V248, P2447
   PIERCE JV, 1961, BIOCHEM BIOPH RES CO, V5, P353, DOI 10.1016/0006-291X(61)90039-0
   REGOLI D, 1980, PHARMACOL REV, V32, P1
   SIDOROWICZ W, 1981, CLIN CHIM ACTA, V111, P69, DOI 10.1016/0009-8981(81)90423-X
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   STARNES WL, 1982, EUR J BIOCHEM, V124, P363
   TUPPY HANS, 1962, ZEIT PHYSIOL CHEM, V329, P278
   UMEZAWA H, 1976, J ANTIBIOT, V29, P97, DOI 10.7164/antibiotics.29.97
   WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324
NR 29
TC 9
Z9 9
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0020-711X
J9 INT J BIOCHEM
JI Int. J. Biochem.
PY 1984
VL 16
IS 12
BP 1295
EP 1300
DI 10.1016/0020-711X(84)90231-3
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AEW69
UT WOS:A1984AEW6900017
PM 6530015
DA 2020-11-24
ER

PT J
AU BARRIOS, M
   GUIMARAES, J
   ARAUJO, L
   FICCHINO, M
   PAULISTA, P
   JATENE, A
   SOUSA, I
AF BARRIOS, M
   GUIMARAES, J
   ARAUJO, L
   FICCHINO, M
   PAULISTA, P
   JATENE, A
   SOUSA, I
TI SIMULTANEOUS SURGICAL-TREATMENT OF LESIONS OF THE AORTIC-VALVE AND
   CORONARY CIRCULATION
SO REVISTA MEDICA DE CHILE
LA Spanish
DT Meeting Abstract
C1 INST DANTE PAZZANESE CARDIOL,SAO PAULO,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC MEDICA SANTIAGO
PI SANTIAGO 9
PA BERNARDA MORIN 488 PROVIDENCIA, CASILLA 168 CORREO 55, SANTIAGO 9, CHILE
SN 0034-9887
J9 REV MED CHILE
JI Rev. Medica Chile
PY 1984
VL 112
IS 3
BP 9
EP 9
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA SM232
UT WOS:A1984SM23200039
DA 2020-11-24
ER

PT J
AU DEAZAMBUJA, P
   GUIMARAES, JA
   GARCIA, ES
AF DEAZAMBUJA, P
   GUIMARAES, JA
   GARCIA, ES
TI HEMOLYTIC FACTOR FROM THE CROP OF RHODNIUS-PROLIXUS - EVIDENCE AND
   PARTIAL CHARACTERIZATION
SO JOURNAL OF INSECT PHYSIOLOGY
LA English
DT Article
C1 FDN OSWALDO CRUZ, DEPT ENTOMOL, BR-20000 RIO DE JANEIRO, BRAZIL.
   UNIV FED RIO DE JANEIRO, CTR CIENCIAS SAUDE, DEPT BIOCHEM, RIO DE JANEIRO, RJ, BRAZIL.
RP DEAZAMBUJA, P (corresponding author), FDN OSWALDO CRUZ, DEPT BIOCHEM & MOLEC BIOL, AVE BRASIAL 4365, CX POSSTAL 926, BR-20000 RIO DE JANEIRO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR AZAMBUJA PD, 1982, ANAIS ACAD BRAS CIEN, V54, P762
   BERNHEIMER AW, 1980, TOXICON, V18, P271, DOI 10.1016/0041-0101(80)90005-7
   DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537
   GARCIA ES, 1981, J MED ENTOMOL, V18, P441, DOI 10.1093/jmedent/18.5.441
   GEERING K, 1975, Acta Tropica, V32, P145
   GOODING RH, 1977, CAN J ZOOL, V55, P1899, DOI 10.1139/z77-243
   HABERMANN E, 1967, H-S Z PHYSIOL CHEM, V348, P37, DOI 10.1515/bchm2.1967.348.1.37
   SCHMIDT JO, 1978, TOXICON, V16, P645, DOI 10.1016/0041-0101(78)90192-7
   SCHMIDT JO, 1982, ANNU REV ENTOMOL, V27, P339, DOI 10.1146/annurev.en.27.010182.002011
   SPATES GE, 1982, INSECT BIOCHEM, V12, P707, DOI 10.1016/0020-1790(82)90060-9
   SPATES GE, 1980, COMP BIOCHEM PHYS B, V67, P121, DOI 10.1016/0305-0491(80)90279-5
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   Vankampen E, 1961, CLIN CHIM ACTA, V6, P538, DOI 10.1016/0009-8981(61)90145-0
NR 13
TC 40
Z9 40
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-1910
EI 1879-1611
J9 J INSECT PHYSIOL
JI J. Insect Physiol.
PY 1983
VL 29
IS 11
BP 833
EP 837
DI 10.1016/0022-1910(83)90149-X
PG 5
WC Entomology; Physiology; Zoology
SC Entomology; Physiology; Zoology
GA RR891
UT WOS:A1983RR89100004
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   RIBEIRO, JMC
   GUIMARAES, JA
AF CARLINI, CR
   RIBEIRO, JMC
   GUIMARAES, JA
TI STRUCTURE-ACTIVITY-RELATIONSHIPS OF CANATOXIN EFFECTS ON
   PLATELET-AGGREGATION
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,INST CIENCIAS BIOMED,DEPT BIOCHEM,RIO DE JANEIRO,RJ,BRAZIL.
RP CARLINI, CR (corresponding author), UNIV FED FLUMINENSE,DEPT PHYSIOL,BR-24000 NITEROI,RJ,BRAZIL.
RI da Silva Carlini, Celia Regina Ribeiro/H-4017-2011; Guimaraes, Jorge
   Almeida/V-2196-2019
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; 
CR CARLINI CR, 1981, TOXICON, V19, P667, DOI 10.1016/0041-0101(81)90104-5
   GRAY, 1979, BR J PHARM, V65, P601
   STORMORKEN H, 1969, SCANDINAVIAN J HAE S, V9, P3
NR 3
TC 1
Z9 1
U1 0
U2 1
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1982
VL 54
IS 4
BP 762
EP 763
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA QB738
UT WOS:A1982QB73800047
DA 2020-11-24
ER

PT J
AU DEAZAMBUJA, P
   GUIMARAES, JA
   GARCIA, ES
AF DEAZAMBUJA, P
   GUIMARAES, JA
   GARCIA, ES
TI HEMOLYTIC FACTOR FROM RHODNIUS-PROLIXUD CROP
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
C1 UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,FDN OSWALDO CRUZ,DEPT MOLEC BIOL,RIO DE JANEIRO,RJ,BRAZIL.
   UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT BIOCHEM,RIO DE JANEIRO,RJ,BRAZIL.
RP DEAZAMBUJA, P (corresponding author), UNIV FED RIO DE JANEIRO,CTR CIENCIAS SAUDE,INST CIENCIAS BIOMED,DEPT ENTOMOL,RIO DE JANEIRO,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR GEERING, 1975, ACTA TROP, V32, P145
   GOODING R H, 1972, Quaestiones Entomologicae, V8, P5
   GOODING RH, 1977, CAN J ZOOL, V55, P1899, DOI 10.1139/z77-243
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1982
VL 54
IS 4
BP 762
EP 762
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA QB738
UT WOS:A1982QB73800046
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   RIBEIRO, JMC
   GUIMARAES, JA
AF CARLINI, CR
   RIBEIRO, JMC
   GUIMARAES, JA
TI INHIBITION OF PLATELET-AGGREGATION BY CANATOXIN
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Meeting Abstract
C1 UNIV FED FLUMINENSE,DEPT FISIOL,BR-24000 NITEROI,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445
CR CARLINI, 1982, TOXICON
   CARLINI, 1979, TOXICON, V19, P667
NR 2
TC 0
Z9 0
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 1982
VL 15
IS 4-5
BP 330
EP 330
PG 1
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA PW022
UT WOS:A1982PW02200086
DA 2020-11-24
ER

PT J
AU ATALLAH, AN
   DELASCIO, D
   RAMOS, OL
   GUIMARAES, JA
   PESTANA, JOA
   SUSTOVICH, DR
AF ATALLAH, AN
   DELASCIO, D
   RAMOS, OL
   GUIMARAES, JA
   PESTANA, JOA
   SUSTOVICH, DR
TI RENAL KALLIKREIN AND SODIUM-EXCRETION IN NORMAL AND PRE-ECLAMPTIC
   PREGNANCIES
SO CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED,DEPT INTERNAL MED,BR-04023 SAO PAULO,SP,BRAZIL.
   ESCOLA PAULISTA MED,DEPT OBSTET,BR-04023 SAO PAULO,SP,BRAZIL.
   ESCOLA PAULISTA MED,DEPT BIOCHEM,BR-04023 SAO PAULO,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Atallah, Alvaro N/K-7182-2013
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MARCEL DEKKER INC
PI NEW YORK
PA 270 MADISON AVE, NEW YORK, NY 10016
SN 0730-0085
J9 CLIN EXP HYPERTENS B
PY 1982
VL 1
IS 2-3
BP 321
EP 321
PG 1
WC Cardiac & Cardiovascular Systems; Physiology
SC Cardiovascular System & Cardiology; Physiology
GA PK717
UT WOS:A1982PK71700116
DA 2020-11-24
ER

PT J
AU BORGES, DR
   WEBSTER, ME
   GUIMARAES, JA
   PRADO, JL
AF BORGES, DR
   WEBSTER, ME
   GUIMARAES, JA
   PRADO, JL
TI SYNTHESIS OF PREKALLIKREIN AND METABOLISM OF PLASMA KALLIKREIN BY
   PERFUSED-RAT-LIVER
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT BIOCHEM,SAO PAULO 04023,SP,BRAZIL.
   ESCOLA PAULISTA MED,DEPT MED,SAO PAULO 04023,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR AMMUNDSEN E, 1977, NEW METHODS ANAL COA, P210
   BORGES DR, 1976, J PHARM PHARMACOL, V28, P44, DOI 10.1111/j.2042-7158.1976.tb04021.x
   BORGES DR, 1976, N-S ARCH PHARMACOL, V295, P33, DOI 10.1007/BF00509769
   CLAESON G, 1977, NEW METHODS ANAL COA, P37
   COLMAN RW, 1977, THROMB HAEMOSTASIS, V38, P751, DOI 10.1055/s-0038-1651896
   DERKX FHM, 1979, J CLIN ENDOCR METAB, V49, P765, DOI 10.1210/jcem-49-5-765
   DEYKIN D, 1968, AM J PHYSIOL, V214, P414
   HIGHSMITH RF, 1973, AM J PHYSIOL, V225, P1032
   HOFFENBERG R, 1971, BIOCHEM J, V122, P129, DOI 10.1042/bj1220129
   IMANARI T, 1977, FOGARTY INT P, V27, P205
   Inagami T, 1979, Adv Exp Med Biol, V120B, P415
   KAPLAN A P, 1976, Seminars in Thrombosis and Hemostasis, V3, P1
   Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
   MANDLE R, 1977, J BIOL CHEM, V252, P6097
   MANDLE RJ, 1976, P NATN ACAD SCI US, V73, P4119
   MOVAT HZ, 1979, HDB EXPT PHARMACOLOG, V25, P1
   NUSTAD K, 1974, BIOCHEMISTRY-US, V13, P2312, DOI 10.1021/bi00708a012
   PIERCE JV, 1977, FOGARTY INT CTR P, V27, P121
   SAMPAIO C, 1974, ARCH BIOCHEM BIOPHYS, V165, P133, DOI 10.1016/0003-9861(74)90150-7
   SEALEY JE, 1979, P NATL ACAD SCI USA, V76, P5914, DOI 10.1073/pnas.76.11.5914
   WEBSTER ME, 1979, BIOCHEM PHARMACOL, V28, P2717, DOI 10.1016/0006-2952(79)90553-7
NR 21
TC 28
Z9 28
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0006-2952
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PY 1981
VL 30
IS 10
BP 1065
EP 1069
DI 10.1016/0006-2952(81)90443-3
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA LR494
UT WOS:A1981LR49400008
PM 6455122
DA 2020-11-24
ER

PT J
AU FREITAS, JO
   TERMIGNONI, C
   BORGES, DR
   SAMPAIO, CAM
   PRADO, JL
   GUIMARAES, JA
AF FREITAS, JO
   TERMIGNONI, C
   BORGES, DR
   SAMPAIO, CAM
   PRADO, JL
   GUIMARAES, JA
TI METHIONINE AMINOPEPTIDASE ASSOCIATED WITH LIVER-MITOCHONDRIA AND
   MICROSOMES
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT MED,SAO PAULO 04023,SP,BRAZIL.
   UNIV FED FLUMINENSE,DEPT PHYSIOL,NITEROI 24000,RJ,BRAZIL.
RP FREITAS, JO (corresponding author), ESCOLA PAULISTA MED,DEPT BIOCHEM,SAO PAULO 04023,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Termignoni, Carlos/AAB-8943-2020;
   Borges, Durval/E-1200-2012
OI Termignoni, Carlos/0000-0002-2789-2518; Borges,
   Durval/0000-0001-6055-5110; Guimaraes, Jorge A./0000-0001-6354-6789
CR ALONZO N, 1968, ANAL BIOCHEM, V23, P272, DOI 10.1016/0003-2697(68)90359-X
   ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BARRETT AJ, 1972, ANAL BIOCHEM, V47, P280, DOI 10.1016/0003-2697(72)90302-8
   BEHAL FJ, 1969, BIOCHIM BIOPHYS ACTA, V178, P118, DOI 10.1016/0005-2744(69)90138-7
   BORGES DR, 1976, N-S ARCH PHARMACOL, V295, P33, DOI 10.1007/BF00509769
   BORGES DR, 1974, N-S ARCH PHARMACOL, V281, P403, DOI 10.1007/BF00499435
   BRANDI CMW, 1976, INT J BIOCHEM, V7, P335, DOI 10.1016/0020-711X(76)90096-3
   CAMARGO ACM, 1972, J NEUROCHEM, V19, P37, DOI 10.1111/j.1471-4159.1972.tb01251.x
   FREITAS JO, 1979, INT J BIOCHEM, V10, P81, DOI 10.1016/0020-711X(79)90143-5
   GORDON AH, 1969, ELECTROPHORESIS PROT
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P567, DOI 10.1016/0003-9861(66)90381-X
   HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P557, DOI 10.1016/0003-9861(66)90380-8
   HOPSUHAV.VK, 1966, NATURE, V212, P1271, DOI 10.1038/2121271a0
   KAZUYUKI K, 1980, CHEM PHARM B TOKYO, V28, P42
   KERWAR SS, 1971, ARCH BIOCHEM BIOPHYS, V143, P336, DOI 10.1016/0003-9861(71)90215-3
   Little G H, 1976, Methods Enzymol, V45, P495
   MAHLER HR, 1966, BIOLOGICAL CHEMISTRY, P393
   PRADO JL, 1975, N-S ARCH PHARMACOL, V290, P191, DOI 10.1007/BF00510550
   SCHRODER E, 1970, HDB EXPTL PHARMAKOLO, V25, P324
   SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P144
   SUDA H, 1980, BIOCHIM BIOPHYS ACTA, V616, P60, DOI 10.1016/0005-2744(80)90263-6
   TERMIGNONI C, 1979, AN ACAD CIENC BRASIL, V51, P4
   TERMIGNONI C, 1980, THESIS ESCOLA PAULIS
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
   WEIGL DR, 1972, CIEN CULT S PAULO  S, V24, P212
   YOSHIDA A, 1972, J BIOL CHEM, V247, P952
NR 28
TC 13
Z9 13
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0020-711X
J9 INT J BIOCHEM
JI Int. J. Biochem.
PY 1981
VL 13
IS 9
BP 991
EP 997
DI 10.1016/0020-711X(81)90004-5
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA MJ953
UT WOS:A1981MJ95300004
PM 6795069
DA 2020-11-24
ER

PT J
AU NADER, HB
   TAKAHASHI, HK
   GUIMARAES, JA
   DIETRICH, CP
   BIANCHINI, P
   OZIMA, B
AF NADER, HB
   TAKAHASHI, HK
   GUIMARAES, JA
   DIETRICH, CP
   BIANCHINI, P
   OZIMA, B
TI HETEROGENEITY OF HEPARIN - CHARACTERIZATION OF 100 COMPONENTS WITH
   DIFFERENT ANTICOAGULANT ACTIVITIES BY A COMBINATION OF ELECTROPHORETIC
   AND AFFINITY-CHROMATOGRAPHY METHODS
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
C1 OPOCRIN RES LABS,MODENA,ITALY.
RP NADER, HB (corresponding author), ESCOLA PAULISTA MED,DEPT BIOQUIM,B-01000 SAO PAULO,SP,BRAZIL.
RI Takahashi, Helio/J-1725-2012; Guimaraes, Jorge Almeida/V-2196-2019;
   Nader, Helena B/D-9253-2012
OI NADER, HELENA/0000-0002-7569-2166; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR CASSARO CMF, 1977, J BIOL CHEM, V252, P2254
   Cautrecases P., 1971, METHOD ENZYMOL, V22, P345
   DIETRICH CP, 1974, BIOCHIM BIOPHYS ACTA, V343, P34, DOI 10.1016/0304-4165(74)90237-2
   DIETRICH CP, 1976, ANAL BIOCHEM, V70, P645, DOI 10.1016/0003-2697(76)90496-6
   DIETRICH CP, 1975, AN ACAD BRAS CIENC, V47, P301
   HILBORN JC, 1971, ANAL BIOCH, V31, P88
   HOOK M, 1976, FEBS LETT, V66, P90, DOI 10.1016/0014-5793(76)80592-3
   KUIZENGA MH, 1941, J BIOL CHEM, V148, P641
   LAM LH, 1976, BIOCHEM BIOPH RES CO, V69, P570, DOI 10.1016/0006-291X(76)90558-1
   LAURENT TC, 1978, BIOCHEM J, V175, P691, DOI 10.1042/bj1750691
   LINDAHL U, 1979, P NATL ACAD SCI USA, V76, P3198, DOI 10.1073/pnas.76.7.3198
   MCDUFFIE NM, 1975, BIOPOLYMERS, V14, P1473, DOI 10.1002/bip.1975.360140713
   MILLERANDERSSON M, 1974, THROMB RES, V5, P439, DOI 10.1016/0049-3848(74)90001-2
   NADER HB, 1974, BIOCHEM BIOPH RES CO, V57, P488, DOI 10.1016/0006-291X(74)90958-9
   PIEPKORN MW, 1978, BIOCHEM BIOPH RES CO, V85, P851, DOI 10.1016/0006-291X(78)91240-8
   ROSENBERG RD, 1978, P NATL ACAD SCI USA, V75, P3065, DOI 10.1073/pnas.75.7.3065
   SCOTT JE, 1955, BIOCHIM BIOPHYS ACTA, V18, P428, DOI 10.1016/0006-3002(55)90108-6
NR 17
TC 45
Z9 45
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PY 1981
VL 3
IS 6
BP 356
EP 360
DI 10.1016/0141-8130(81)90089-1
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA MT021
UT WOS:A1981MT02100002
DA 2020-11-24
ER

PT J
AU GARCIA, ES
   GARCIA, MLM
   GUIMARAES, JA
AF GARCIA, ES
   GARCIA, MLM
   GUIMARAES, JA
TI PEPSTATIN INHIBITION OF MOLTING AND OVIPOSITION IN RHODNIUS-PROLIXUS
   (HEMIPTERA, REDUVIIDAE)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
RP GARCIA, ES (corresponding author), UNIV FED FLUMINENSE, DEPT PHYSL, BR-24000 NITEROI, RJ, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR AOYAGI T, 1971, J ANTIBIOT, V24, P687, DOI 10.7164/antibiotics.24.687
   BARRETT AJ, 1972, BIOCHEM J, V127, P439, DOI 10.1042/bj1270439
   CHARNEY J, 1947, J BIOL CHEM, V171, P501
   DEAN RT, 1975, NATURE, V257, P414, DOI 10.1038/257414a0
   DESOUZAGARCIA E, 1975, AN ACAD BRAS CIENC, V47, P537
   FRIEND WG, 1965, CAN J ZOOLOG, V43, P891, DOI 10.1139/z65-092
   GARCIA EDS, 1977, J INSECT PHYSIOL, V23, P247, DOI 10.1016/0022-1910(77)90038-5
   GARCIA EDS, 1973, REV BRAS BIOL, V33, P315
   GARCIA ES, 1979, EXPERIENTIA, V35, P305, DOI 10.1007/BF01964315
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GARCIA ES, 1975, AN ACAD BRAS CIENC, V47, P580
   GARCIA MLM, 1979, J INSECT PHYSIOL, V25, P695, DOI 10.1016/0022-1910(79)90121-5
   OKASHA AYK, 1968, J EXP BIOL, V48, P475
   PERSAUD CE, 1971, J INSECT PHYSIOL, V17, P1429, DOI 10.1016/0022-1910(71)90152-1
   STEEL CGH, 1975, NATURE, V253, P267, DOI 10.1038/253267a0
   STEEL CGH, 1971, GEN COMP ENDOCR, V17, P125, DOI 10.1016/0016-6480(71)90160-2
   UBATUBA FB, 1969, AN ACAD BRAS CIENC, V41, P650
   VANDERKLOOT WG, 1961, AM ZOOL, V1, P3
   WIGGLESWORTH V. B., 1964, ADVANCES INSECT PHYSIOL, V2, P247, DOI 10.1016/S0065-2806(08)60076-4
   Wigglesworth V.B., 1972, PRINCIPLES INSECT PH
   WIGGLESWORTH VB, 1952, J EXP BIOL, V29, P561
   WIGGLESWORTH VB, 1963, J INSECT PHYSIOL, V9, P105, DOI 10.1016/0022-1910(63)90087-8
   Wigglesworth VB, 1936, Q J MICROSC SCI, V79, P91
   Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191
NR 24
TC 6
Z9 6
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PY 1981
VL 18
IS 5
BP 441
EP 445
DI 10.1093/jmedent/18.5.441
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA MK570
UT WOS:A1981MK57000017
DA 2020-11-24
ER

PT J
AU CARLINI, CR
   GUIMARAES, JA
AF CARLINI, CR
   GUIMARAES, JA
TI ISOLATION AND CHARACTERIZATION OF A TOXIC PROTEIN FROM
   CANAVALIA-ENSIFORMIS (JACK BEAN) SEEDS, DISTINCT FROM CONCANAVALIN-A
SO TOXICON
LA English
DT Article
C1 UNIV FED FLUMINENSE, DEPT PHYSIOL, BR-24210 NITEROI, RJ, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; da Silva Carlini, Celia Regina
   Ribeiro/H-4017-2011
OI da Silva Carlini, Celia Regina Ribeiro/0000-0002-7027-2445; Guimaraes,
   Jorge A./0000-0001-6354-6789
CR ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   Assman F., 1911, ARCH GES PHYSL, V137, P489
   Brown J C, 1978, Int Rev Cytol, V52, P277, DOI 10.1016/S0074-7696(08)60758-5
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   HAMAGUCHI Y, 1977, J NUTR SCI VITAMINOL, V23, P525, DOI 10.3177/jnsv.23.525
   JAFFE WG, 1960, ARZNEIMITTEL-FORSCH, V10, P1012
   LIENER IE, 1952, J BIOL CHEM, V197, P29
   LIN JY, 1978, TOXICON, V16, P653, DOI 10.1016/0041-0101(78)90193-9
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   OLSNES S, 1974, NATURE, V249, P627, DOI 10.1038/249627a0
   OLSNES S, 1973, EUR J BIOCHEM, V35, P179, DOI 10.1111/j.1432-1033.1973.tb02823.x
   OLSON MOJ, 1967, BIOCHEMISTRY-US, V6, P105, DOI 10.1021/bi00853a018
   PORETZ RD, 1968, IMMUNOLOGY, V14, P165
   PRICE DL, 1975, SCIENCE, V188, P945, DOI 10.1126/science.49080
   ROOS O, 1980, ARZNEIMITTEL-FORSCH, V30-1, P759
   SAMBETH W, 1967, J NUTR, V92, P479
   SCHWAB ME, 1979, J CELL BIOL, V82, P798, DOI 10.1083/jcb.82.3.798
   SHARON N, 1972, SCIENCE, V177, P949, DOI 10.1126/science.177.4053.949
   SPECTOR T, 1978, ANAL BIOCHEM, V86, P142, DOI 10.1016/0003-2697(78)90327-5
   STEAD RH, 1966, ARCH BIOCHEM BIOPHYS, V113, P703, DOI 10.1016/0003-9861(66)90251-7
   Sumner JB, 1936, J BACTERIOL, V32, P227, DOI 10.1128/JB.32.2.227-237.1936
   TAKAHASHI T, 1962, J BIOCHEM-TOKYO, V52, P50, DOI 10.1093/oxfordjournals.jbchem.a127572
   WALLER GR, 1966, P SOC EXP BIOL MED, V121, P685
NR 23
TC 93
Z9 93
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0041-0101
J9 TOXICON
JI Toxicon
PY 1981
VL 19
IS 5
BP 667
EP +
DI 10.1016/0041-0101(81)90104-5
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA MN678
UT WOS:A1981MN67800007
PM 7302956
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   VOOS, A
   ALMEIDA, FA
   AJZEN, H
   RIBEIRO, AB
AF GUIMARAES, JA
   VOOS, A
   ALMEIDA, FA
   AJZEN, H
   RIBEIRO, AB
TI EFFECT OF CONVERTING ENZYME-INHIBITION (CEI) UPON THE PRECURSORS OF THE
   KALLIKREIN-KININ SYSTEM (KKS)
SO CLINICAL RESEARCH
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED, SAO PAULO 04023, SP, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PY 1980
VL 28
IS 2
BP A331
EP A331
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA JN160
UT WOS:A1980JN16001077
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   VOOS, A
   FILHO, GA
   RAMOS, OL
   RIBEIRO, AB
AF GUIMARAES, JA
   VOOS, A
   FILHO, GA
   RAMOS, OL
   RIBEIRO, AB
TI CHARACTERIZATION OF A BRADYKININ POTENTIATING PEPTIDE GENERATED IN
   PLASMA OF PATIENTS WITH ESSENTIAL-HYPERTENSION
SO CLINICAL RESEARCH
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED, SAO PAULO 04023, SP, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0009-9279
J9 CLIN RES
JI Clin. Res.
PY 1980
VL 28
IS 2
BP A331
EP A331
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA JN160
UT WOS:A1980JN16001076
DA 2020-11-24
ER

PT J
AU TERMINGNONI, C
   FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
AF TERMINGNONI, C
   FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
TI METHIONYL-AMINOPEPTIDASE FROM RAT-LIVER
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
RP TERMINGNONI, C (corresponding author), ESCOLA PAULISTA MED,DEPT BIOCHEM,SAO PAULO 04023,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110
CR FREITAS, 1979, INT J BIOCH, V10, P81
   PRADO JL, 1975, N-S ARCH PHARMACOL, V290, P191, DOI 10.1007/BF00510550
NR 2
TC 1
Z9 1
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1979
VL 51
IS 4
BP 770
EP 770
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JD827
UT WOS:A1979JD82700033
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   CARLINI, CR
   NETO, RM
AF GUIMARAES, JA
   CARLINI, CR
   NETO, RM
TI ROLE OF NEGATIVELY CHARGED DEXTRAN SULFATE POLYMERS IN BLOOD-COAGULATION
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
RP GUIMARAES, JA (corresponding author), ESCOLA PAULISTA MED,DEPT BIOQUIM,SAO PAULO 04023,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR COCHRANE CG, 1973, J EXP MED, V138, P1564, DOI 10.1084/jem.138.6.1564
   GUIMARAES, 1977, AN ACAD BRASIL CIENC, V49, P484
   MORRISON DC, 1974, J EXP MED, V140, P797, DOI 10.1084/jem.140.3.797
   RATNOFF OD, 1964, J LAB CLIN MED, V63, P359
NR 4
TC 0
Z9 0
U1 0
U2 1
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1979
VL 51
IS 4
BP 771
EP 772
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA JD827
UT WOS:A1979JD82700036
DA 2020-11-24
ER

PT J
AU ALVES, KB
   BRANDI, CMW
   GUIMARAES, JA
AF ALVES, KB
   BRANDI, CMW
   GUIMARAES, JA
TI KINETIC STUDIES WITH HUMAN URINARY AMINOPEPTIDASE
SO ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES
LA Spanish
DT Meeting Abstract
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,SAO PAULO 04023,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC BIOL CHILE
PI SANTIAGO
PA CASILLA 14164 CORREO, SANTIAGO 9, CHILE
SN 0004-0533
J9 ARCH BIOL MED EXP
PY 1979
VL 12
IS 2
BP 259
EP 259
PG 1
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA HR917
UT WOS:A1979HR91700027
DA 2020-11-24
ER

PT J
AU BORGES, DR
   WEBSTER, ME
   GUIMARAES, JA
   PRADO, JL
AF BORGES, DR
   WEBSTER, ME
   GUIMARAES, JA
   PRADO, JL
TI SYNTHESIS AND METABOLISM OF PLASMA KALLIKREIN BY PERFUSED RAT-LIVER
SO ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED,DEPT BIOQUIM,SAO PAULO 04023,SP,BRAZIL.
RI Borges, Durval/E-1200-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Borges, Durval/0000-0001-6055-5110; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC BIOL CHILE
PI SANTIAGO
PA CASILLA 14164 CORREO, SANTIAGO 9, CHILE
SN 0004-0533
J9 ARCH BIOL MED EXP
PY 1979
VL 12
IS 2
BP 261
EP 261
PG 1
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA HR917
UT WOS:A1979HR91700035
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   CARLINICELIA, R
AF GUIMARAES, JA
   CARLINICELIA, R
TI INHIBITION OF THROMBIN BY DEXTRAN SULFATE
SO ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES
LA English
DT Meeting Abstract
C1 ESCOLA PAULISTA MED,DEPT BIOCHEM,SAO PAULO 04023,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC BIOL CHILE
PI SANTIAGO
PA CASILLA 14164 CORREO, SANTIAGO 9, CHILE
SN 0004-0533
J9 ARCH BIOL MED EXP
PY 1979
VL 12
IS 2
BP 271
EP 271
PG 1
WC Biology; Medicine, General & Internal; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; General & Internal Medicine;
   Research & Experimental Medicine
GA HR917
UT WOS:A1979HR91700074
DA 2020-11-24
ER

PT J
AU GARCIA, ES
   GUIMARAES, JA
AF GARCIA, ES
   GUIMARAES, JA
TI PROTEOLYTIC-ENZYMES IN THE RHODNIUS-PROLIXUS MIDGUT
SO EXPERIENTIA
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT BIOCHEM & PHARMACOL,SAO PAULO 01000,SP,BRAZIL.
RP GARCIA, ES (corresponding author), UNIV FED FLUMINENSE,DEPT PHYSIOL,NITEROI,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR FOLK JE, 1960, J BIOL CHEM, V235, P2272
   FOLK JE, 1963, J BIOL CHEM, V238, P2884
   GARCIA EDS, 1977, J INSECT PHYSIOL, V23, P247, DOI 10.1016/0022-1910(77)90038-5
   GARCIA EDS, 1973, REV BRAS BIOL, V33, P315
   GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0
   GARCIA ES, 1977, 6TH M BRAZ BIOCH SOC
   GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8
   KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291
   MATHESON AT, 1964, CAN J BIOCHEM PHYS, V42, P95, DOI 10.1139/o64-010
   PERSAUD CE, 1977, J INSECT PHYSL, V17, P1429
   Wigglesworth V.B., 1972, PRINCIPLES INSECT PH
NR 11
TC 13
Z9 13
U1 0
U2 0
PU BIRKHAUSER VERLAG AG
PI BASEL
PA PO BOX 133 KLOSTERBERG 23, CH-4010 BASEL, SWITZERLAND
SN 0014-4754
J9 EXPERIENTIA
JI Experientia
PY 1979
VL 35
IS 3
BP 305
EP 306
DI 10.1007/BF01964315
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GN540
UT WOS:A1979GN54000012
PM 376330
DA 2020-11-24
ER

PT J
AU FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
AF FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
TI 2 ARYLAMIDASES FROM HUMAN LIVER AND THEIR KININ-CONVERTING ACTIVITY
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY
LA English
DT Article
RP FREITAS, JO (corresponding author), ESCOLA PAULISTA MED,DEPT BIOCHEM & PHARMACOL,SAO PAULO 01000,SP,BRAZIL.
RI Borges, Durval/E-1200-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BARTON CJ, 1948, ANAL CHEM, V20, P1068, DOI 10.1021/ac60023a024
   BEHAL FJ, 1969, BIOCHIM BIOPHYS ACTA, V178, P118, DOI 10.1016/0005-2744(69)90138-7
   BORGES DR, 1974, N-S ARCH PHARMACOL, V281, P403, DOI 10.1007/BF00499435
   BRANDI CMW, 1976, INT J BIOCHEM, V7, P335, DOI 10.1016/0020-711X(76)90096-3
   GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   Little G H, 1976, Methods Enzymol, V45, P495
   LITTLE GH, 1971, BIOCHIM BIOPHYS ACTA, V243, P312, DOI 10.1016/0005-2795(71)90088-2
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAHLER HR, 1966, BIOLOGICAL CHEMISTRY, P393
   MATHESON AT, 1964, CAN J BIOCHEM PHYS, V42, P95, DOI 10.1139/o64-010
   PETERS T, 1973, J BIOL CHEM, V248, P2447
   SMITH EE, 1965, J BIOL CHEM, V240, P1718
   STARNES WL, 1974, BIOCHEMISTRY, V13, P3222
   WEIGL DR, 1972, CIEN CULT S PAULO  S, V24, P212
NR 16
TC 15
Z9 15
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0020-711X
J9 INT J BIOCHEM
JI Int. J. Biochem.
PY 1979
VL 10
IS 1
BP 81
EP 89
DI 10.1016/0020-711X(79)90143-5
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GG790
UT WOS:A1979GG79000013
PM 421959
DA 2020-11-24
ER

PT J
AU SCICLI, AG
   WALDMANN, R
   GUIMARAES, JA
   SCICLI, G
   CARRETERO, OA
   KATO, H
   HAN, YN
   IWANAGA, S
AF SCICLI, AG
   WALDMANN, R
   GUIMARAES, JA
   SCICLI, G
   CARRETERO, OA
   KATO, H
   HAN, YN
   IWANAGA, S
TI RELATIONSHIP BETWEEN STRUCTURE AND CORRECTING ACTIVITY OF BOVINE HIGH
   MOLECULAR-WEIGHT KININOGEN UPON THE CLOTTING TIME OF FITZGERALD-TRAIT
   PLASMA
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
C1 INST PROT RES,OSAKA,JAPAN.
RP SCICLI, AG (corresponding author), HENRY FORD HOSP,DEPT MED,DETROIT,MI 48202, USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR CARRETERO OA, 1976, BIOCHEM PHARMACOL, V25, P2265, DOI 10.1016/0006-2952(76)90008-3
   COCHRANE CG, 1973, J EXP MED, V138, P1564, DOI 10.1084/jem.138.6.1564
   COCHRANE CG, 1972, INFLAMMATION MECHANI, P119
   COLMAN RW, 1975, J CLIN INVEST, V56, P1650, DOI 10.1172/JCI108247
   FASCIOLO JC, 1962, ACTA PHYSIOL LAT AM, V12, P360
   GUIMARAES JA, 1978, ADV EXPT MEDICINE BI
   HABAL FM, 1974, CHEM BIOL KALLIKREIN, V27, P129
   HAN YN, 1975, J BIOCHEM-TOKYO, V77, P55
   HAN YN, 1975, FEBS LETT, V57, P254, DOI 10.1016/0014-5793(75)80311-5
   HAN YN, 1976, J BIOCHEM, V79, P1201, DOI 10.1093/oxfordjournals.jbchem.a131175
   HAN YN, 1978, J BIOCHEM, V83, P223, DOI 10.1093/oxfordjournals.jbchem.a131895
   HATHAWAY WE, 1965, BLOOD-J HEMATOL, V26, P521, DOI 10.1182/blood.V26.5.521.521
   KATO H, 1976, J BIOCHEM, V80, P1299, DOI 10.1093/oxfordjournals.jbchem.a131402
   KOMIYA M, 1974, J BIOCHEM-TOKYO, V76, P833
   MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179
   MATHESON RT, 1976, J CLIN INVEST, V58, P1395, DOI 10.1172/JCI108595
   NAGASAWA S, 1974, CHEM BIOL KALLIKREIN, V27, P139
   REVAK SD, 1974, J CLIN INVEST, V54, P619, DOI 10.1172/JCI107799
   SAITO H, 1977, J CLIN INVEST, V60, P584, DOI 10.1172/JCI108810
   SAITO H, 1976, BLOOD, V48, P941
   SAITO H, 1975, J CLIN INVEST, V55, P1082, DOI 10.1172/JCI108009
   SCHIFFMAN S, 1977, BLOOD, V49, P935
   SCHIFFMAN S, 1974, BRIT J HAEMATOL, V27, P101, DOI 10.1111/j.1365-2141.1974.tb06778.x
   THOMPSON RE, 1977, J CLIN INVEST, V60, P1376, DOI 10.1172/JCI108898
   THOMPSON RE, 1978, J EXP MED, V147, P488, DOI 10.1084/jem.147.2.488
   WALDMANN R, 1976, THROMB RES, V8, P785, DOI 10.1016/0049-3848(76)90007-4
   WALDMANN R, 1974, BLOOD, V44, P134
   WEBSTER ME, 1976, KININS PHARMACODYNAM, P285
   WEISS AS, 1974, J CLIN INVEST, V53, P622, DOI 10.1172/JCI107597
   WIGGINS RC, 1977, P NATL ACAD SCI USA, V74, P4636, DOI 10.1073/pnas.74.10.4636
   WUEPPER KD, 1975, J CLIN INVEST, V56, P1663, DOI 10.1172/JCI108248
   WUEPPER KD, 1975, FED PROC, V34, P859
   WUEPPER KD, 1972, INFLAMMATION MECHANI, P93
NR 33
TC 18
Z9 18
U1 0
U2 0
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021
SN 0022-1007
J9 J EXP MED
JI J. Exp. Med.
PY 1979
VL 149
IS 4
BP 847
EP 855
DI 10.1084/jem.149.4.847
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GQ809
UT WOS:A1979GQ80900006
PM 429963
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU BORGES, DR
   GUIMARAES, JA
   LIMAOS, EA
   PRADO, JL
   CAMARGO, ACM
AF BORGES, DR
   GUIMARAES, JA
   LIMAOS, EA
   PRADO, JL
   CAMARGO, ACM
TI BRADYKININ INACTIVATION BY PERFUSED RAT-LIVER - ROLE OF A THIOL
   ACTIVATED ENDOPEPTIDASE
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED,DEPT BIOCHEM & PHARMACOL,SAO PAULO 01000,SP,BRAZIL.
   UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,DEPT PHARMACOL,RIBEIRAO PRETO,SP,BRAZIL.
   UNIV SAO PAULO,FAC MED RIBEIRAO PRETO,PROT CHEM LAB,RIBEIRAO PRETO,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANDERSCH MA, 1947, AM J CLIN PATHOL, V17, P571
   BAKHLE YS, 1974, HDB EXPTL PHARMACOLO, V37, P41
   BORGES DR, 1976, N-S ARCH PHARMACOL, V295, P33, DOI 10.1007/BF00509769
   CAMARGO ACM, 1973, BIOCHEMISTRY-US, V12, P1838, DOI 10.1021/bi00733a028
   CARLINI EA, 1958, B SOC CHIM BIOL, V40, P1825
   CICILINI MA, 1977, BIOCHEM J, V163, P433, DOI 10.1042/bj1630433
   CUSHMAN DW, 1971, BIOCHIM BIOPHYS ACTA, V250, P261, DOI 10.1016/0005-2744(71)90142-2
   FRIMMER M, 1967, N-S ARCH PHARMAKOL, V258, P197, DOI 10.1007/BF00535792
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   HANKS GE, 1960, J LAB CLIN MED, V56, P486
   OLIVEIRA EB, 1976, BIOCHEMISTRY-US, V15, P1967, DOI 10.1021/bi00654a026
   WROBLEWSKI F, 1955, P SOC EXP BIOL MED, V90, P210
NR 12
TC 8
Z9 8
U1 0
U2 0
PU SPRINGER VERLAG
PI NEW YORK
PA 175 FIFTH AVE, NEW YORK, NY 10010
SN 0028-1298
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PY 1979
VL 309
IS 2
BP 197
EP 201
DI 10.1007/BF00501229
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA HV349
UT WOS:A1979HV34900015
PM 522905
DA 2020-11-24
ER

PT J
AU FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
AF FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
TI CHARACTERIZATION OF 2 AMINOPEPTIDASES FROM HUMAN LIVER
SO AGENTS AND ACTIONS
LA English
DT Note
RP FREITAS, JO (corresponding author), ESCOLA PAULISTA MED,DEPT BIOCHEM & PHARMACOL,SAO PAULO,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIRKHAUSER VERLAG AG
PI BASEL
PA PO BOX 133 KLOSTERBERG 23, CH-4010 BASEL, SWITZERLAND
SN 0065-4299
J9 AGENTS ACTIONS
JI Agents Actions
PY 1978
VL 8
IS 1-2
BP 164
EP 164
DI 10.1007/BF01972434
PG 1
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA EM649
UT WOS:A1978EM64900039
PM 636949
DA 2020-11-24
ER

PT J
AU FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
AF FREITAS, JO
   GUIMARAES, JA
   BORGES, DR
   PRADO, JL
TI FURTHER CHARACTERIZATION OF 2 ARYLAMINOPEPTIDASES FROM HUMAN LIVER
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
RP FREITAS, JO (corresponding author), ESCOLA PAULISTA MED,DEPT BIOCHEM & PHARMACOL,SAO PAULO,SP,BRAZIL.
RI Borges, Durval/E-1200-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR 1976, AN ACAD BRASIL CIENC, V48, P602
   1975, NAUNYNSCHMIEDEBERGS, V290, P191
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1978
VL 50
IS 1
BP 115
EP 116
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY599
UT WOS:A1978FY59900021
PM 666122
DA 2020-11-24
ER

PT J
AU GARCIA, ES
   GARCIA, MLM
   GUIMARAES, JA
AF GARCIA, ES
   GARCIA, MLM
   GUIMARAES, JA
TI PROTEIN DIGESTION AND MOLTING IN RHODNIUS-PROLIXUS
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
RP GARCIA, ES (corresponding author), UNIV FED FLUMINENSE,DEPT PHYSIOL,NITEROI,RJ,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR GARCIA, 1973, REV BRAS BIOL, V33, P315
   GARCIA EDS, 1977, J INSECT PHYSIOL, V23, P247, DOI 10.1016/0022-1910(77)90038-5
   PERSAUD CE, 1971, J INSECT PHYSIOL, V17, P1429, DOI 10.1016/0022-1910(71)90152-1
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO DE JANEIRO
PA CAIXA POSTAL 229 OU 1587 CEP 2000, RIO DE JANEIRO, BRAZIL
SN 0001-3765
J9 AN ACAD BRAS CIENC
PY 1978
VL 50
IS 4
BP 597
EP 597
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH716
UT WOS:A1978GH71600021
DA 2020-11-24
ER

PT J
AU GARCIA, ES
   GUIMARAES, JA
   PRADO, JL
AF GARCIA, ES
   GUIMARAES, JA
   PRADO, JL
TI PURIFICATION AND CHARACTERIZATION OF A SULFHYDRYL-DEPENDENT PROTEASE
   FROM RHODNIUS-PROLIXUS-MIDGUT
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
C1 ESCOLA PAULISTO MED,DEPT BIOCHEM & PHARMACOL,CAIXA POSTAL 20372,SAO PAULO 01000,SP,BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BUXTON P. A., 1930, TRANS ENT SOC LONDON, V78, P227
   CHARNEY J, 1947, J BIOL CHEM, V171, P501
   DAVEY KG, 1965, J EXP BIOL, V42, P373
   ELLIOTT SD, 1970, METHOD ENZYMOL, V19, P252
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   FISK FRANK W., 1950, ANN ENT SOC AMERICA, V43, P555
   GARCIA E S, 1976, Anais da Academia Brasileira de Ciencias, V48, P601
   GARCIA EDS, 1977, J INSECT PHYSIOL, V23, P247, DOI 10.1016/0022-1910(77)90038-5
   GARCIA EDS, 1973, REV BRAS BIOL, V33, P315
   GARCIA ES, 1975, AN ACAD BRAS CIENC, V47, P580
   GARCIA ES, 1975, ANN ACAD BRASIL CIEN, V47, P537
   GARCIA ES, 1977, M BRAZILIAN BIOCH SO, P63
   GILMAN A, 1946, AM J PHYSIOL, V147, P115
   GOODING RH, 1966, COMP BIOCHEM PHYSIOL, V17, P115, DOI 10.1016/0010-406X(66)90013-2
   GOODING RH, 1969, P ENTOMOL SOC ONT, V100, P139
   HUMMEL BCW, 1959, CAN J BIOCHEM PHYS, V37, P1393, DOI 10.1139/o59-157
   JANATOVA J, 1968, J BIOL CHEM, V243, P3612
   KUNIMOTO S, 1972, J ANTIBIOT, V25, P251, DOI 10.7164/antibiotics.25.251
   KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   OKASHA AYK, 1968, J EXP BIOL, V48, P475
   PERSAUD CE, 1971, J INSECT PHYSIOL, V17, P1429, DOI 10.1016/0022-1910(71)90152-1
   SHAMBAUGH GEORGE F., 1954, OHIO JOUR SCI, V54, P151
   SLYTERMAN LA, 1970, BIOCH BIOPHYS ACTA, V200, P593
   VENTURA MM, 1966, AN ACAD BRAS CIENC, V38, P553
   Walsh KA, 1970, METHOD ENZYMOL, V19, P31, DOI DOI 10.1016/0076-6879(70)19005-7
   Wigglesworth V. B., 1972, PRINCIPLES INSECT PH, P700
   WILKINSON G, 1961, BIOCHEM J, V80, P324, DOI 10.1042/bj0800324
   YANG YJ, 1971, J INSECT PHYSIOL, V17, P117, DOI 10.1016/0022-1910(71)90048-5
NR 30
TC 79
Z9 79
U1 0
U2 8
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0003-9861
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PY 1978
VL 188
IS 2
BP 315
EP 322
DI 10.1016/S0003-9861(78)80015-0
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA FD596
UT WOS:A1978FD59600011
PM 28087
DA 2020-11-24
ER

PT J
AU SCICLI, AG
   WALDMANN, R
   SCICLI, G
   GUIMARAES, J
   CARRETERO, OA
AF SCICLI, AG
   WALDMANN, R
   SCICLI, G
   GUIMARAES, J
   CARRETERO, OA
TI EFFECTS OF VARIOUS PLASMA PROTEASES ON FITZGERALD FACTOR
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 HENRY FORD HOSP,DETROIT,MI 48202.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 1
Z9 1
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0014-9446
J9 FED PROC
PY 1978
VL 37
IS 3
BP 327
EP 327
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA ES454
UT WOS:A1978ES45400616
DA 2020-11-24
ER

PT J
AU WALDMANN, R
   SCICLI, AG
   SCICLI, GM
   GUIMARAES, JA
   CARRETERO, OA
   KATO, H
   HAN, YN
   IWANAGA, S
AF WALDMANN, R
   SCICLI, AG
   SCICLI, GM
   GUIMARAES, JA
   CARRETERO, OA
   KATO, H
   HAN, YN
   IWANAGA, S
TI SIGNIFICANT ROLE OF FRAGMENT 1-2 PLUS LIGHT CHAIN OF BOVINE HIGH
   MOLECULAR-WEIGHT KININOGEN IN CONTACT MEDIATED COAGULATION
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Meeting Abstract
C1 HENRY FORD HOSP,DETROIT,MI 48202.
   OSAKA UNIV,INST PROT RES,OSAKA,JAPAN.
RI Guimaraes, Jorge Almeida/V-2196-2019
NR 0
TC 9
Z9 9
U1 0
U2 0
PU F K SCHATTAUER VERLAG GMBH
PI STUTTGART
PA P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PY 1977
VL 38
IS 1
BP 14
EP 14
PG 1
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA DY456
UT WOS:A1977DY45600030
DA 2020-11-24
ER

PT J
AU COLMAN, RW
   BAGDASARIAN, A
   TALAMO, RC
   SCOTT, CF
   SEAVEY, M
   GUIMARAES, JA
   PIERCE, JV
   KAPLAN, AP
AF COLMAN, RW
   BAGDASARIAN, A
   TALAMO, RC
   SCOTT, CF
   SEAVEY, M
   GUIMARAES, JA
   PIERCE, JV
   KAPLAN, AP
TI WILLIAMS TRAIT - HUMAN KININOGEN DEFICIENCY WITH DIMINISHED LEVELS OF
   PLASMINOGEN PROACTIVATOR AND PREKALLIKREIN ASSOCIATED WITH ABNORMALITIES
   OF HAGEMAN FACTOR-DEPENDENT PATHWAYS
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
C1 UNIV PENN, DEPT MED, HEMATOL ONCOL SECT, COAGULATION UNIT, PHILADELPHIA, PA 19104 USA.
   JOHNS HOPKINS HOSP, DEPT PEDIAT, BALTIMORE, MD 21205 USA.
   NHLI, HYPOTENSION ENDOCRINE BRANCH, SECT PHYSIOL CHEM, BETHESDA, MD 21205 USA.
   NIAID, LAB CLIN INVEST, ALLERGIC DIS SECT, BETHESDA, MD 20014 USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
OI Guimaraes, Jorge A./0000-0001-6354-6789
CR ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832
   AXEN R, 1967, NATURE, V214, P1302, DOI 10.1038/2141302a0
   BACHMANN F, 1958, THROMB DIATH HAEMOST, V2, P24
   BAGDASARIAN A, 1973, J BIOL CHEM, V248, P3456
   BAGDASARIAN A, 1974, J CLIN INVEST, V54, P1444, DOI 10.1172/JCI107892
   BAGDASARIAN A, 1973, J BIOL CHEM, V248, P7742
   BELL WN, 1955, BRIT MED J, V1, P330, DOI 10.1136/bmj.1.4909.330
   CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
   COCHRANE CG, 1973, J EXP MED, V138, P1564, DOI 10.1084/jem.138.6.1564
   COLMAN RW, 1969, J CLIN INVEST, V48, P11, DOI 10.1172/JCI105959
   COLMAN RW, 1969, ANN INTERN MED, V71, P763, DOI 10.7326/0003-4819-71-4-763
   COLMAN RW, 1975, FED PROC, V34, P859
   DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095
   DONALDSON VH, 1975, 5TH C INT SOC THROMB
   GARVEY MB, 1972, J CLIN PATHOL, V25, P680, DOI 10.1136/jcp.25.8.680
   GIGLI I, 1970, J IMMUNOL, V104, P574
   GUIMARAES JA, 1974, FED PROC, V33, P641
   HABAL FM, 1974, BIOCHEM PHARMACOL, V23, P2291, DOI 10.1016/0006-2952(74)90558-9
   IATRIDIS SG, 1962, J CLIN INVEST, V41, P1277, DOI 10.1172/JCI104590
   IVERSEN T, 1956, BRIT J HAEMATOL, V2, P265, DOI 10.1111/j.1365-2141.1956.tb06698.x
   JACOBSEN S, 1967, BRIT J PHARM CHEMOTH, V29, P25, DOI 10.1111/j.1476-5381.1967.tb01935.x
   JOHNSTON AR, 1974, J IMMUNOL, V113, P103
   KAPLAN AP, 1972, J EXP MED, V136, P1378, DOI 10.1084/jem.136.6.1378
   KAPLAN AP, 1971, J EXP MED, V133, P696, DOI 10.1084/jem.133.4.696
   KAPLAN AP, 1970, J IMMUNOL, V105, P802
   KAPLAN AP, 1975, CLIN RES, V23, pA403
   KAPLAN AP, 1971, BIOCHEMISTRY ACUTE A, P279
   LEWIS ML, 1953, P SOC EXP BIOL MED, V84, P640
   Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
   MARGOLIS J, 1958, J PHYSIOL-LONDON, V144, P1
   NIEWIAROWSKI S, 1959, THROMB DIATH HAEMOST, V3, P593
   OUCHTERLONY O, 1953, ACTA PATHOL MIC SC, V32, P231
   OWREN PA, 1951, SCAND J CLIN LAB INV, V3, P201, DOI 10.3109/00365515109060600
   PECHET L, 1964, BLOOD COAGULATION HE, P213
   PIERCE JV, 1968, FED PROC, V27, P52
   PIERCE JV, 1966, HYPOTENSIVE PEPTIDES, V1, P130
   PIERCE JV, 1975, 27 FOG INT CTR P
   PROCTOR RR, 1961, AM J CLIN PATHOL, V36, P212
   RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109
   RATNOFF OD, 1961, J CLIN INVEST, V40, P803, DOI 10.1172/JCI104314
   ROSENTHAL RL, 1953, P SOC EXP BIOL MED, V82, P171
   SAITO H, 1975, J CLIN INVEST, V55, P1082, DOI 10.1172/JCI108009
   SCHREIBER AD, 1973, J CLIN INVEST, V52, P1394, DOI 10.1172/JCI107312
   SIEGELMAN AM, 1962, ARCH BIOCHEM BIOPHYS, V97, P159, DOI 10.1016/0003-9861(62)90058-9
   SPRAGG J, 1971, J IMMUNOL, V107, P1512
   TALAMO RC, 1969, J LAB CLIN MED, V74, P816
   WEBER K, 1969, J BIOL CHEM, V244, P4406
   WEISS AS, 1974, J CLIN INVEST, V53, P622, DOI 10.1172/JCI107597
   WUEPPER KD, 1973, J EXP MED, V138, P1345, DOI 10.1084/jem.138.6.1345
   WUEPPER KD, 1975, FED PROC, V34, P859
   WUEPPER KD, 1972, INFLAMMATION MECHANI, P93
   ZIEGLER JB, 1975, J CLIN INVEST, V55, P668, DOI 10.1172/JCI107975
NR 52
TC 330
Z9 330
U1 1
U2 2
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PY 1975
VL 56
IS 6
BP 1650
EP 1662
DI 10.1172/JCI108247
PG 13
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AY260
UT WOS:A1975AY26000033
PM 1202089
OA Green Published, Bronze
DA 2020-11-24
ER

PT J
AU PIERCE, JV
   GUIMARAES, JA
AF PIERCE, JV
   GUIMARAES, JA
TI FURTHER CHARACTERIZATION OF HIGHLY PURIFIED HUMAN PLASMA KININOGEN
SO LIFE SCIENCES
LA English
DT Meeting Abstract
C1 NHLI,HYPERTENSION ENDOCRINE BRANCH,SECT PHYSIOL CHEM,BETHESDA,MD.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR GUIMARAES JA, 1974, FED P, V33
NR 1
TC 4
Z9 4
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB
SN 0024-3205
J9 LIFE SCI
JI Life Sci.
PY 1975
VL 16
IS 5
BP 790
EP 791
DI 10.1016/0024-3205(75)90371-9
PG 2
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA V8416
UT WOS:A1975V841600028
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   LU, RC
   WEBSTER, ME
   PIERCE, JV
AF GUIMARAES, JA
   LU, RC
   WEBSTER, ME
   PIERCE, JV
TI MULTIPLE FORMS OF HUMAN PLASMA KININOGEN
SO FEDERATION PROCEEDINGS
LA English
DT Meeting Abstract
C1 NHLI, BETHESDA, MD 20014 USA.
RI Guimaraes, Jorge Almeida/V-2196-2019
CR PIERCE JV, 1968, FED PROC, V27, P52
NR 1
TC 10
Z9 10
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0014-9446
J9 FED PROC
PY 1974
VL 33
IS 3
BP 641
EP 641
PG 1
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA YY902
UT WOS:A1974YY90200136
DA 2020-11-24
ER

PT J
AU BORGES, DR
   PRADO, JL
   GUIMARAES, JA
AF BORGES, DR
   PRADO, JL
   GUIMARAES, JA
TI CHARACTERIZATION OF A KININ-CONVERTING ARYLAMINOPEPTIDASE FROM HUMAN
   LIVER
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED, DEPT MED, SAO PAULO, BRAZIL.
   ESCOLA PAULISTA MED, DEPT BIOCHEM & PHARMACOL, RUA BOTUCATU 862, CAIXAPOSTAL 20372, 01000 SAO PAULO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR AMUNDSEN E, 1965, J PHYSIOL-LONDON, V179, P479, DOI 10.1113/jphysiol.1965.sp007674
   ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BEHAL FJ, 1966, ARCH BIOCHEM BIOPHYS, V115, P545, DOI 10.1016/0003-9861(66)90074-9
   BORGES DR, 1973, CIENC CULTURA S S159, V25
   CAMARGO ACM, 1972, J NEUROCHEM, V19, P37, DOI 10.1111/j.1471-4159.1972.tb01251.x
   DIETRICH CP, 1973, ANAL BIOCHEM, V51, P345, DOI 10.1016/0003-2697(73)90487-9
   GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8
   GUIMARAES JA, 1973, BIOCHEM PHARMACOL, V22, P3157, DOI 10.1016/0006-2952(73)90090-7
   GUIMARAES JA, 1972, THESIS ESCOLA PAULIS
   HOPSUHAV.VK, 1966, NATURE, V212, P1271, DOI 10.1038/2121271a0
   JAQUES LB, 1968, CAN J PHYSIOL PHARM, V46, P351, DOI 10.1139/y68-055
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MARKS N, 1968, J BIOL CHEM, V243, P2882
   MATHESON AT, 1964, CAN J BIOCHEM PHYS, V42, P95, DOI 10.1139/o64-010
   PRADO ES, 1971, BIOCHEM PHARMACOL, V20, P2009, DOI 10.1016/0006-2952(71)90400-X
   SMITH EE, 1965, J BIOL CHEM, V240, P1718
   SMITH EE, 1963, NATURE, V197, P800, DOI 10.1038/197800a0
   SMITH EL, 1960, ENZYMES, V4
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
NR 19
TC 13
Z9 13
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
EI 1432-1912
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PY 1974
VL 281
IS 4
BP 403
EP 414
DI 10.1007/BF00499435
PG 12
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA S2424
UT WOS:A1974S242400007
PM 4275260
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   BORGES, DR
   PRADO, ES
   PRADO, JL
AF GUIMARAES, JA
   BORGES, DR
   PRADO, ES
   PRADO, JL
TI KININ-CONVERTING ENZYME FROM HUMAN-SERUM
SO ACTA PHYSIOLOGICA LATINOAMERICANA
LA English
DT Article
C1 ESCOLA PAULISTA MED, DEPT BIOCHEM & PHARMACOL, CAIXA POSTAL 20372, 04023 SAO PAULO, BRAZIL.
RI Borges, Durval/E-1200-2012; Guimaraes, Jorge Almeida/V-2196-2019
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BORGES DR, 1973, CIENC CULT S PAULO S, V25, P159
   DIETRICH CP, 1973, ANAL BIOCHEM, V51, P345, DOI 10.1016/0003-2697(73)90487-9
   ERDOS EG, 1963, ANN NY ACAD SCI, V104, P222, DOI 10.1111/j.1749-6632.1963.tb17666.x
   GOLDBARG JA, 1958, CANCER, V11, P283, DOI 10.1002/1097-0142(195803/04)11:2<283::AID-CNCR2820110209>3.0.CO;2-8
   JAQUES LB, 1968, CAN J PHYSIOL PHARM, V46, P351, DOI 10.1139/y68-055
   PRADO ES, 1971, BIOCHEM PHARMACOL, V20, P2009, DOI 10.1016/0006-2952(71)90400-X
   WEBSTER ME, 1963, ANN NY ACAD SCI, V104, P91, DOI 10.1111/j.1749-6632.1963.tb17655.x
NR 8
TC 0
Z9 0
U1 0
U2 0
PU ASSN LATINOAMER CIENC FISIOL
PI BUENOS AIRES
PA SERRANO 665, 1414 BUENOS AIRES, ARGENTINA
SN 0001-6764
J9 ACTA PHYSIOL LAT AM
PY 1973
VL 23
IS 6
BP 564
EP 565
PG 2
WC Physiology
SC Physiology
GA T7003
UT WOS:A1973T700300054
PM 4795038
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   BORGES, DR
   PRADO, ES
   PRADO, JL
AF GUIMARAES, JA
   BORGES, DR
   PRADO, ES
   PRADO, JL
TI KININ-CONVERTING AMINOPEPTIDASE FROM HUMAN-SERUM
SO BIOCHEMICAL PHARMACOLOGY
LA English
DT Article
C1 ESCOLA PAULISTA MED, DEPT BIOCHEM & PHARMACOL, SAO PAULO, BRAZIL.
   UNIV FED RURAL, DEPT CIENCI FISIOL, RIO DE JANEIRO, BRAZIL.
RI Guimaraes, Jorge Almeida/V-2196-2019; Borges, Durval/E-1200-2012
OI Borges, Durval/0000-0001-6055-5110; Guimaraes, Jorge
   A./0000-0001-6354-6789
CR ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222
   BABEL I, 1968, BIOCHEM PHARMACOL, V17, P2232, DOI 10.1016/0006-2952(68)90200-1
   BERRENS L, 1968, CLIN CHIM ACTA, V20, P170, DOI 10.1016/0009-8981(68)90402-6
   BRECHER AS, 1969, BIOCHEM J, V112, P335, DOI 10.1042/bj1120335
   CAMARGO ACM, 1972, J NEUROCHEM, V19, P37, DOI 10.1111/j.1471-4159.1972.tb01251.x
   DIETRICH CP, 1973, ANAL BIOCHEM, V51, P345, DOI 10.1016/0003-2697(73)90487-9
   DIETRICH CP, 1970, CAN J BIOCHEM CELL B, V48, P725, DOI 10.1139/o70-114
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   ERDOS EG, 1963, ANN NY ACAD SCI, V104, P222, DOI 10.1111/j.1749-6632.1963.tb17666.x
   ERDOS EG, 1970, HDB EXPTL PHARMACOLO, V25
   FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005
   GOLDBARG JA, 1958, CANCER, V11, P28
   GORDON AH, 1969, ELECTROPHORESIS PROT
   GREENBAU.LM, 1965, BIOCHEM PHARMACOL, V14, P411, DOI 10.1016/0006-2952(65)90214-5
   GUIMARAES JA, 1971, AN ACAD BRAS CIENC, V43, P834
   GUIMARAES JA, 1972, CIENC CULT S PAULO, V24, P99
   HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P567, DOI 10.1016/0003-9861(66)90381-X
   HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P557, DOI 10.1016/0003-9861(66)90380-8
   HOPSUHAV.VK, 1966, NATURE, V212, P1271, DOI 10.1038/2121271a0
   JAQUES LB, 1968, CAN J PHYSIOL PHARM, V46, P351, DOI 10.1139/y68-055
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MAKINEN KK, 1967, ARCH BIOCHEM BIOPHYS, V118, P257, DOI 10.1016/0003-9861(67)90306-2
   MARKS N, 1968, J BIOL CHEM, V243, P2882
   MATHESON AT, 1964, CAN J BIOCHEM PHYS, V42, P95, DOI 10.1139/o64-010
   MCDONALD JK, 1964, BIOCHEM BIOPH RES CO, V16, P135, DOI 10.1016/0006-291X(64)90350-X
   ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004
   PAIVA ACM, 1960, BIOCHEM PHARMACOL, V5, P187, DOI 10.1016/0006-2952(60)90062-9
   PICARELLI ZP, 1954, CIRC RES, V2, P354, DOI 10.1161/01.RES.2.4.354
   PRADO ELINE S., 1967, P141
   PRADO ES, 1971, BIOCHEM PHARMACOL, V20, P2009, DOI 10.1016/0006-2952(71)90400-X
   SCHRODER E, 1970, HDB EXPTL PHARMACOLO, V25
   SEILER N, 1964, EXPERIENTIA, V20, P559, DOI 10.1007/BF02150289
   SMITH EE, 1965, J BIOL CHEM, V240, P1718
   SUSKIW JB, 1970, BIOCHEMISTRY NY, V9, P4008
   WEBSTER ME, 1963, ANN NY ACAD SCI, V104, P91, DOI 10.1111/j.1749-6632.1963.tb17655.x
   WEBSTER ME, 1970, METHOD ENZYMOL, V19, P681
NR 36
TC 50
Z9 50
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0006-2952
EI 1873-2968
J9 BIOCHEM PHARMACOL
JI Biochem. Pharmacol.
PY 1973
VL 22
IS 24
BP 3157
EP 3172
DI 10.1016/0006-2952(73)90090-7
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA R3099
UT WOS:A1973R309900002
PM 4358723
DA 2020-11-24
ER

PT J
AU GUIMARAES, JA
   PRADO, ES
   PRADO, JL
AF GUIMARAES, JA
   PRADO, ES
   PRADO, JL
TI PLASMA AMINOPEPTIDASE CAPABLE OF CONVERTING KALLIDIN (LYSYLBRADYKININ)
   TO BRADYKININ AND PLASMA L-LYSYL-(BETA)-NAPHTHYLAMIDASE
SO ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
LA English
DT Meeting Abstract
RI Guimaraes, Jorge Almeida/V-2196-2019
CR HOPSU VK, 1966, ARCH BIOCHEM BIOPHYS, V114, P557, DOI 10.1016/0003-9861(66)90380-8
NR 1
TC 1
Z9 1
U1 0
U2 0
PU ACAD BRASILEIRA DE CIENCIAS
PI RIO JANEIRO
PA RUA ANFILOFIO DE CARVALHO, 29, 3 ANDAR, 20030-060 RIO JANEIRO, BRAZIL
SN 0001-3765
EI 1678-2690
J9 AN ACAD BRAS CIENC
JI An. Acad. Bras. Cienc.
PY 1971
VL 43
IS 3-4
BP 834
EP +
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA N4593
UT WOS:A1971N459300048
DA 2020-11-24
ER

EF